DrugID|Name|Code
92038|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
92035|DIAGNOSTIC AGENTS|T
92034|ANTIPSYCHOTICS|N5A
92034|NOOTROPICS|N6D
92030|CARDIOVASCULAR SYSTEM|C
92027|ANTIVIRALS FOR SYSTEMIC USE|J5
92010|ANTIHYPERTENSIVES|C2
92010|CALCIUM ANTAGONISTS|C8
92010|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
92008|NOOTROPICS|N6D
92008|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
92007|NOOTROPICS|N6D
92007|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
91984|BPH (benign prostatic hypertrophy) products |G4C
91983|SYSTEMIC ANTIBACTERIALS|J1
91983|CEPHALOSPORINS|J1D
91982|BPH (benign prostatic hypertrophy) products |G4C
91979|ANALGESICS|N2
91978|ANTIHYPERTENSIVES|C2
91961|WOUND HEALING AGENTS|D3
91960|ALKYLATING AGENTS|L1A
91959|ANTHELMINTICS, EXCLUDING SCHISTOSOMICIDES|P1B
91950|BPH (benign prostatic hypertrophy) products |G4C
91946|IMMUNOSTIMULATING AGENTS|L3
91944|RADIODIAGNOSTIC AGENTS|T1G
91937|SYSTEMIC ANTIBACTERIALS|J1
91935|ANAESTHETICS, LOCAL|N1B
91935|ANTI-EPILEPTICS|N3
91934|SYSTEMIC ANTIBACTERIALS|J1
91934|MACROLIDES AND SIMILAR TYPES|J1F
91932|ANTIVIRALS FOR SYSTEMIC USE|J5
91928|NOOTROPICS|N6D
91924|CARDIOVASCULAR SYSTEM|C
91918|DERMATOLOGICALS|D
91916|SYSTEMIC ANTIBACTERIALS|J1
91915|SYSTEMIC ANTIBACTERIALS|J1
91915|ANTIVIRALS FOR SYSTEMIC USE|J5
91914|SYSTEMIC ANTIBACTERIALS|J1
91912|ANALGESICS|N2
91904|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
91901|ANALGESICS|N2
91900|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
91896|Factor VIII|B2D1
91877|TRANQUILLISERS|N5C
91869|SYSTEMIC ANTIBACTERIALS|J1
91869|ANTIVIRALS FOR SYSTEMIC USE|J5
91868|ANTIPSYCHOTICS|N5A
91868|NOOTROPICS|N6D
91866|CALCIUM ANTAGONISTS|C8
91865|Statins (HMG-CoA reductase inhibitors)|C10A1
91864|IMMUNOSTIMULATING AGENTS|L3
91863|PARASITOLOGY|P
91862|PARASITOLOGY|P
91861|SYSTEMIC ANTIBACTERIALS|J1
91860|OPHTHALMOLOGICALS|S1
91859|ANALGESICS|N2
91857|ANALGESICS|N2
91854|ANALGESICS|N2
91853|OPHTHALMOLOGICALS|S1
91852|ANTI-EPILEPTICS|N3A
91849|OPHTHALMOLOGICALS|S1
91848|OPHTHALMOLOGICALS|S1
91845|SYSTEMIC ANTIBACTERIALS|J1
91841|OPHTHALMOLOGICALS|S1
91839|OPHTHALMOLOGICALS|S1
91839|Ocular antineovascularisation products|S1P
91837|ANTI-EPILEPTICS|N3A
91836|ANTI-EPILEPTICS|N3A
91824|ANTI-MALARIALS|P1D
91823|ANTI-MALARIALS|P1D
91821|RADIODIAGNOSTIC AGENTS|T1G
91795|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
91794|ANTIVIRALS FOR SYSTEMIC USE|J5
91794|ANTITUSSIVES|R5D
91793|ANTIVIRALS FOR SYSTEMIC USE|J5
91793|ANTITUSSIVES|R5D
91792|ANTIVIRALS FOR SYSTEMIC USE|J5
91792|ANTITUSSIVES|R5D
91790|ANTIVIRALS FOR SYSTEMIC USE|J5
91790|ANTITUSSIVES|R5D
91788|Factor VIII|B2D1
91785|ANTIVIRALS FOR SYSTEMIC USE|J5
91785|INTERFERONS|L3B
91783|ANTIVIRALS FOR SYSTEMIC USE|J5
91783|ANTITUSSIVES|R5D
91781|PARASITOLOGY|P
91776|PARASITOLOGY|P
91755|SYSTEMIC ANTIBACTERIALS|J1
91754|ANTIVIRALS FOR SYSTEMIC USE|J5
91753|CENTRAL NERVOUS SYSTEM|N
91746|Antigrowth hormones|H1C2
91745|RESPIRATORY SYSTEM|R
91744|SYSTEMIC ANTIBACTERIALS|J1
91744|CEPHALOSPORINS|J1D
91743|MUSCULO-SKELETAL SYSTEM|M
91739|RADIODIAGNOSTIC AGENTS|T1G
91734|RADIODIAGNOSTIC AGENTS|T1G
91732|ANALGESICS|N2
91732|ANTI-MIGRAINE PREPARATIONS|N2C
91732|ANTI-EPILEPTICS|N3A
91731|CENTRAL NERVOUS SYSTEM|N
91723|SYSTEMIC ANTIBACTERIALS|J1
91722|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
91722|DRUGS USED IN DIABETES|A10
91721|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
91721|DRUGS USED IN DIABETES|A10
91721|GLUCAGON|H4B
91714|CARDIOVASCULAR SYSTEM|C
91714|Statins (HMG-CoA reductase inhibitors)|C10A1
91713|ANTIVIRALS FOR SYSTEMIC USE|J5
91712|DRUGS USED IN DIABETES|A10
91712|DPP-IV inhibitor antidiabetics|A10B6
91711|ANTIVIRALS FOR SYSTEMIC USE|J5
91711|ANTITUSSIVES|R5D
91710|ANTIVIRALS FOR SYSTEMIC USE|J5
91703|DRUGS USED IN DIABETES|A10
91699|ANALGESICS|N2
91697|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
91697|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
91696|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
91690|SYSTEMIC ANTIHISTAMINES|R6
91688|ANALGESICS|N2
91687|ANTI-ARRHYTHMICS|C1B
91683|ANALGESICS|N2
91682|ANTIVIRALS FOR SYSTEMIC USE|J5
91681|DRUGS USED IN DIABETES|A10
91678|CENTRAL NERVOUS SYSTEM|N
91676|Factors II, VII, IX and X|B2D2
91675|Factor VIII|B2D1
91674|RADIODIAGNOSTIC AGENTS|T1G
91673|ANTIPSYCHOTICS|N5A
91671|RADIODIAGNOSTIC AGENTS|T1G
91670|Biguanide antidiabetics|A10B2
91670|DPP-IV inhibitor antidiabetics|A10B6
91669|VACCINES|J7
91666|RADIODIAGNOSTIC AGENTS|T1G
91661|RADIODIAGNOSTIC AGENTS|T1G
91660|SYSTEMIC ANTIBACTERIALS|J1
91660|CEPHALOSPORINS|J1D
91659|NOOTROPICS|N6D
91658|ANTIHYPERTENSIVES|C2
91658|RESPIRATORY SYSTEM|R
91657|ANTIHYPERTENSIVES|C2
91650|OPHTHALMOLOGICALS|S1
91649|IMMUNOSUPPRESSIVE AGENTS|L4
91645|ANTIHYPERTENSIVES|C2
91640|ANTI-EPILEPTICS|N3A
91633|DRUGS USED IN DIABETES|A10
91632|DRUGS USED IN DIABETES|A10
91630|CARDIOVASCULAR SYSTEM|C
91623|ANTIVIRALS FOR SYSTEMIC USE|J5
91621|ANTIHYPERTENSIVES|C2
91614|Systemic dermatological antifungals|D1A2
91614|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
91613|ANTI-GOUT PREPARATIONS|M4
91612|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
91611|DRUGS USED IN DIABETES|A10
91609|DRUGS USED IN DIABETES|A10
91606|B2-STIMULANTS|R3A
91604|DRUGS USED IN DIABETES|A10
91601|ALKYLATING AGENTS|L1A
91600|PLATELET AGGREGATION INHIBITORS|B1C
91600|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
91598|IMMUNOSUPPRESSIVE AGENTS|L4
91596|ANTIPSYCHOTICS|N5A
91595|ANTIPSYCHOTICS|N5A
91592|IMMUNOSUPPRESSIVE AGENTS|L4
91588|ANALGESICS|N2
91587|SYSTEMIC ANTIBACTERIALS|J1
91586|Non-nucleoside reverse transcriptase inhibitors|J5C3
91585|ANTIVIRALS FOR SYSTEMIC USE|J5
91578|ANTI-EPILEPTICS|N3
91578|TRANQUILLISERS|N5C
91577|NOOTROPICS|N6D
91576|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
91576|Statins (HMG-CoA reductase inhibitors)|C10A1
91573|DRUGS USED IN DIABETES|A10
91571|ANALGESICS|N2
91567|DRUGS USED IN DIABETES|A10
91563|ANTIVIRALS FOR SYSTEMIC USE|J5
91562|ANTIVIRALS FOR SYSTEMIC USE|J5
91561|ANTIVIRALS FOR SYSTEMIC USE|J5
91558|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
91552|CENTRAL NERVOUS SYSTEM|N
91551|CENTRAL NERVOUS SYSTEM|N
91549|TRANQUILLISERS|N5C
91548|IMMUNOSUPPRESSIVE AGENTS|L4
91547|CARDIOVASCULAR SYSTEM|C
91545|PLATELET AGGREGATION INHIBITORS|B1C
91541|IMMUNOSTIMULATING AGENTS|L3
91540|IMMUNOSTIMULATING AGENTS|L3
91539|SYSTEMIC ANTIBACTERIALS|J1
91538|SYSTEMIC ANTIBACTERIALS|J1
91537|PARASITOLOGY|P
91533|SYSTEMIC ANTIBACTERIALS|J1
91528|ANTIVIRALS FOR SYSTEMIC USE|J5
91527|ANTIVIRALS FOR SYSTEMIC USE|J5
91526|PLATELET AGGREGATION INHIBITORS|B1C
91526|ANTIHYPERTENSIVES|C2
91525|SYSTEMIC ANTIBACTERIALS|J1
91514|HYPNOTICS/SEDATIVES|N5B
91512|RADIODIAGNOSTIC AGENTS|T1G
91511|WOUND HEALING AGENTS|D3
91497|ANTIPSYCHOTICS|N5A
91496|CARDIOVASCULAR SYSTEM|C
91496|ANTIHYPERTENSIVES|C2
91496|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
91493|NOOTROPICS|N6D
91492|NOOTROPICS|N6D
91490|Coxibs|M1A3
91490|OPHTHALMOLOGICALS|S1
91488|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
91488|OPHTHALMOLOGICALS|S1
91486|ANALGESICS|N2
91485|IMMUNOSUPPRESSIVE AGENTS|L4
91484|IMMUNOSUPPRESSIVE AGENTS|L4
91483|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
91477|ANAESTHETICS|N1
91470|Ocular antineovascularisation products|S1P
91469|ANTIVIRALS FOR SYSTEMIC USE|J5
91464|ALKYLATING AGENTS|L1A
91462|ALKYLATING AGENTS|L1A
91461|SYSTEMIC ANTIBACTERIALS|J1
91461|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
91461|ANALGESICS|N2
91460|HUMAN INSULINS AND ANALOGUES|A10C
91460|Human insulins and analogues, intermediate-acting|A10C2
91459|DIRECT THROMBIN INHIBITORS|B1E
91458|ANTI-GOUT PREPARATIONS|M4
91455|IMMUNOSUPPRESSIVE AGENTS|L4
91450|SYSTEMIC ANTIBACTERIALS|J1
91449|SYSTEMIC ANTIBACTERIALS|J1
91446|ANALGESICS|N2
91442|IMMUNOSTIMULATING AGENTS|L3
91441|ANTI-EPILEPTICS|N3
91441|ANTIPSYCHOTICS|N5A
91437|ANTIHYPERTENSIVES|C2
91436|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
91435|ANTIHYPERTENSIVES|C2
91432|ANTIHYPERTENSIVES|C2
91427|CARDIOVASCULAR SYSTEM|C
91426|CARDIOVASCULAR SYSTEM|C
91425|CARDIOVASCULAR SYSTEM|C
91424|OPHTHALMOLOGICALS|S1
91423|OPHTHALMOLOGICALS|S1
91421|SYSTEMIC ANTIBACTERIALS|J1
91420|OPHTHALMOLOGICALS|S1
91415|SYSTEMIC ANTIBACTERIALS|J1
91407|ANTIVIRALS FOR SYSTEMIC USE|J5
91402|IMMUNOSUPPRESSIVE AGENTS|L4
91401|DRUGS USED IN DIABETES|A10
91396|ANTIVIRALS FOR SYSTEMIC USE|J5
91396|ANTITUSSIVES|R5D
91394|ANTIVIRALS FOR SYSTEMIC USE|J5
91392|ALKYLATING AGENTS|L1A
91390|ANTIVIRALS FOR SYSTEMIC USE|J5
91390|ANTITUSSIVES|R5D
91388|CEPHALOSPORINS|J1D
91387|ANTIVIRALS FOR SYSTEMIC USE|J5
91379|ANALGESICS|N2
91378|ANALGESICS|N2
91364|WOUND HEALING AGENTS|D3
91363|WOUND HEALING AGENTS|D3
91361|RADIODIAGNOSTIC AGENTS|T1G
91359|ANTIVIRALS FOR SYSTEMIC USE|J5
91349|ANTIVIRALS FOR SYSTEMIC USE|J5
91348|ANALGESICS|N2
91342|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
91341|OPHTHALMOLOGICALS|S1
91339|ANTIPSYCHOTICS|N5A
91336|Topical dermatological antifungals|D1A1
91336|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
91333|ANTIPSYCHOTICS|N5A
91331|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
91330|ANTIHYPERTENSIVES|C2
91330|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
91330|Statins (HMG-CoA reductase inhibitors)|C10A1
91316|ANTIVIRALS FOR SYSTEMIC USE|J5
91315|SYSTEMIC ANTIBACTERIALS|J1
91313|SYSTEMIC ANTIBACTERIALS|J1
91311|ANALGESICS|N2
91307|DRUGS USED IN DIABETES|A10
91302|ANTI-EPILEPTICS|N3A
91297|SYSTEMIC ANTIBACTERIALS|J1
91296|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
91294|ANALGESICS|N2
91293|CARDIOVASCULAR SYSTEM|C
91286|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
91285|PARASITOLOGY|P
91285|ANTI-MALARIALS|P1D
91284|PARASITOLOGY|P
91283|ANTIVIRALS FOR SYSTEMIC USE|J5
91282|SYSTEMIC ANTIBACTERIALS|J1
91281|ANTIVIRALS FOR SYSTEMIC USE|J5
91276|DRUGS USED IN DIABETES|A10
91276|HUMAN INSULINS AND ANALOGUES|A10C
91276|Human insulins and analogues, intermediate-acting|A10C2
91275|ANTIVIRALS FOR SYSTEMIC USE|J5
91274|ANTIVIRALS FOR SYSTEMIC USE|J5
91273|ANTIHYPERTENSIVES|C2
91261|WOUND HEALING AGENTS|D3
91258|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
91255|ANAESTHETICS, LOCAL|N1B
91255|ANALGESICS|N2
91250|DRUGS USED IN DIABETES|A10
91250|HUMAN INSULINS AND ANALOGUES|A10C
91250|Human insulins and analogues, intermediate-acting|A10C2
91248|OPHTHALMOLOGICALS|S1
91234|IMMUNOSTIMULATING AGENTS|L3
91233|ANTIVIRALS FOR SYSTEMIC USE|J5
91229|NOOTROPICS|N6D
91223|SYSTEMIC ANTIBACTERIALS|J1
91222|SYSTEMIC ANTIBACTERIALS|J1
91219|IMMUNOSTIMULATING AGENTS|L3
91218|SYSTEMIC ANTIBACTERIALS|J1
91218|IMMUNOSTIMULATING AGENTS|L3
91214|ANTIPSYCHOTICS|N5A
91212|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
91212|DRUGS USED IN DIABETES|A10
91211|ANTIHYPERTENSIVES|C2
91210|TRANQUILLISERS|N5C
91210|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
91197|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
91197|ANTIVIRALS FOR SYSTEMIC USE|J5
91197|Non-nucleoside reverse transcriptase inhibitors|J5C3
91196|ANTIVIRALS FOR SYSTEMIC USE|J5
91192|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
91188|ANTIVIRALS FOR SYSTEMIC USE|J5
91187|ANTIVIRALS FOR SYSTEMIC USE|J5
91175|Factor VIII|B2D1
91173|ANALGESICS|N2
91172|Ocular antineovascularisation products|S1P
91171|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
91170|ANTIVIRALS FOR SYSTEMIC USE|J5
91169|ANTIVIRALS FOR SYSTEMIC USE|J5
91168|ANTIVIRALS FOR SYSTEMIC USE|J5
91167|ALKYLATING AGENTS|L1A
91166|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
91166|SSRI antidepressants|N6A4
91165|ANTIVIRALS FOR SYSTEMIC USE|J5
91164|ANTIVIRALS FOR SYSTEMIC USE|J5
91163|SYSTEMIC ANTIBACTERIALS|J1
91162|ANTIVIRALS FOR SYSTEMIC USE|J5
91160|MUSCULO-SKELETAL SYSTEM|M
91155|Factor VIII|B2D1
91154|ANTIVIRALS FOR SYSTEMIC USE|J5
91153|NOOTROPICS|N6D
91150|PLATELET AGGREGATION INHIBITORS|B1C
91142|SYSTEMIC ANTIBACTERIALS|J1
91141|CARDIOVASCULAR SYSTEM|C
91139|WOUND HEALING AGENTS|D3
91136|ANTIVIRALS FOR SYSTEMIC USE|J5
91135|NOOTROPICS|N6D
91129|ANTIVIRALS FOR SYSTEMIC USE|J5
91128|ANTIVIRALS FOR SYSTEMIC USE|J5
91127|ANTIVIRALS FOR SYSTEMIC USE|J5
91125|ANTIVIRALS FOR SYSTEMIC USE|J5
91124|ANALGESICS|N2
91122|DRUGS USED IN DIABETES|A10
91121|ANTIVIRALS FOR SYSTEMIC USE|J5
91119|OPHTHALMOLOGICALS|S1
91118|Coxibs|M1A3
91118|ANTI-GOUT PREPARATIONS|M4
91118|ANALGESICS|N2
91117|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
91116|IMMUNOSTIMULATING AGENTS|L3
91114|ANTIVIRALS FOR SYSTEMIC USE|J5
91111|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
91105|ANTI-GOUT PREPARATIONS|M4
91101|ANTIVIRALS FOR SYSTEMIC USE|J5
91099|ANTIHYPERTENSIVES|C2
91099|DIURETICS|C3
91099|CALCIUM ANTAGONISTS|C8
91097|DPP-IV inhibitor antidiabetics|A10B6
91097|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
91097|Statins (HMG-CoA reductase inhibitors)|C10A1
91092|DRUGS USED IN DIABETES|A10
91092|HUMAN INSULINS AND ANALOGUES|A10C
91092|Human insulins and analogues, intermediate-acting|A10C2
91072|CARDIOVASCULAR SYSTEM|C
91070|ANTIVIRALS FOR SYSTEMIC USE|J5
91069|ANTIVIRALS FOR SYSTEMIC USE|J5
91062|Inhibitors of the Kallikrein-kinin-system|B2C2
91062|OPHTHALMOLOGICALS|S1
91057|SYSTEMIC ANTIBACTERIALS|J1
91054|ANTIVIRALS FOR SYSTEMIC USE|J5
91044|ANTI-EPILEPTICS|N3A
91037|OPHTHALMOLOGICALS|S1
91036|SYSTEMIC ANTIBACTERIALS|J1
91035|SYSTEMIC ANTIBACTERIALS|J1
91034|SYSTEMIC ANTIBACTERIALS|J1
91033|SYSTEMIC ANTIBACTERIALS|J1
91032|ANTIVIRALS FOR SYSTEMIC USE|J5
91030|ANTIVIRALS FOR SYSTEMIC USE|J5
91027|RESPIRATORY SYSTEM|R
91024|ANALGESICS|N2
91023|NOOTROPICS|N6D
91017|ANTIPSYCHOTICS|N5A
91016|ANTIPSYCHOTICS|N5A
90998|VACCINES|J7
90997|ANTIVIRALS FOR SYSTEMIC USE|J5
90992|NOOTROPICS|N6D
90991|TRANQUILLISERS|N5C
90991|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
90990|ANTIVIRALS FOR SYSTEMIC USE|J5
90986|DERMATOLOGICALS|D
90981|DERMATOLOGICALS|D
90978|DERMATOLOGICALS|D
90977|DERMATOLOGICALS|D
90974|ANTIVIRALS FOR SYSTEMIC USE|J5
90972|DIRECT THROMBIN INHIBITORS|B1E
90970|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
90969|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
90967|DIAGNOSTIC AGENTS|T
90955|ANTIHYPERTENSIVES|C2
90955|ANALGESICS|N2
90952|SYSTEMIC ANTIBACTERIALS|J1
90947|SYSTEMIC ANTIBACTERIALS|J1
90944|SYSTEMIC ANTIBACTERIALS|J1
90941|Factor VIII|B2D1
90933|ANTIVIRALS FOR SYSTEMIC USE|J5
90917|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
90916|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
90915|RESPIRATORY SYSTEM|R
90914|CARDIOVASCULAR SYSTEM|C
90911|ANALGESICS|N2
90910|ANTIULCERANTS|A2B
90908|RESPIRATORY SYSTEM|R
90905|Ocular antineovascularisation products|S1P
90902|OPHTHALMOLOGICALS|S1
90897|SYSTEMIC ANTIBACTERIALS|J1
90895|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
90888|DERMATOLOGICALS|D
90868|ANTI-EPILEPTICS|N3
90866|ANALGESICS|N2
90864|ANTIVIRALS FOR SYSTEMIC USE|J5
90861|AMINOGLYCOSIDES|J1K
90856|IMMUNOSUPPRESSIVE AGENTS|L4
90852|ANTIVIRALS FOR SYSTEMIC USE|J5
90848|ANTI-EPILEPTICS|N3A
90847|ALKYLATING AGENTS|L1A
90846|SYSTEMIC ANTIBACTERIALS|J1
90842|ANTIPSYCHOTICS|N5A
90842|TRANQUILLISERS|N5C
90842|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
90841|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
90830|ANALGESICS|N2
90827|ANTIVIRALS FOR SYSTEMIC USE|J5
90826|ANTIPSYCHOTICS|N5A
90825|ANTIPSYCHOTICS|N5A
90820|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90820|DRUGS USED IN DIABETES|A10
90815|ANTIVIRALS FOR SYSTEMIC USE|J5
90797|ANTIVIRALS FOR SYSTEMIC USE|J5
90789|SYSTEMIC ANTIBACTERIALS|J1
90787|ANAESTHETICS|N1
90787|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
90784|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90784|DRUGS USED IN DIABETES|A10
90766|ANTIHYPERTENSIVES|C2
90765|ANTIVIRALS FOR SYSTEMIC USE|J5
90761|ANTIVIRALS FOR SYSTEMIC USE|J5
90760|DRUGS USED IN DIABETES|A10
90758|DRUGS USED IN DIABETES|A10
90757|DRUGS USED IN DIABETES|A10
90750|SYSTEMIC ANTIBACTERIALS|J1
90742|CARDIOVASCULAR SYSTEM|C
90741|CARDIOVASCULAR SYSTEM|C
90740|ANTIVIRALS FOR SYSTEMIC USE|J5
90739|ANTIVIRALS FOR SYSTEMIC USE|J5
90738|ANTIVIRALS FOR SYSTEMIC USE|J5
90732|DRUGS USED IN DIABETES|A10
90732|HUMAN INSULINS AND ANALOGUES|A10C
90732|Human insulins and analogues, intermediate-acting|A10C2
90731|CARDIOVASCULAR SYSTEM|C
90728|DRUGS USED IN DIABETES|A10
90728|HUMAN INSULINS AND ANALOGUES|A10C
90728|Human insulins and analogues, intermediate-acting|A10C2
90725|Ocular antineovascularisation products|S1P
90722|CARDIOVASCULAR SYSTEM|C
90718|CENTRAL NERVOUS SYSTEM|N
90715|ANAESTHETICS|N1
90715|TRANQUILLISERS|N5C
90714|ANTI-EPILEPTICS|N3A
90711|ANTIVIRALS FOR SYSTEMIC USE|J5
90710|RADIODIAGNOSTIC AGENTS|T1G
90707|ANTI-MALARIALS|P1D
90706|ANTIPSYCHOTICS|N5A
90704|ANALGESICS|N2
90703|ANALGESICS|N2
90702|ANALGESICS|N2
90700|ANALGESICS|N2
90696|ANALGESICS|N2
90692|CARDIOVASCULAR SYSTEM|C
90690|IMMUNOSUPPRESSIVE AGENTS|L4
90688|SYSTEMIC ANTIBACTERIALS|J1
90687|SYSTEMIC ANTIBACTERIALS|J1
90686|NOOTROPICS|N6D
90680|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
90676|ANTI-MIGRAINE PREPARATIONS|N2C
90663|PARASITOLOGY|P
90663|ANTI-MALARIALS|P1D
90662|PARASITOLOGY|P
90660|ANALGESICS|N2
90659|ANTI-EPILEPTICS|N3A
90652|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90651|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90650|SYSTEMIC ANTIBACTERIALS|J1
90648|PARASITOLOGY|P
90643|ANTIVIRALS FOR SYSTEMIC USE|J5
90621|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
90621|PARASITOLOGY|P
90620|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
90620|PARASITOLOGY|P
90588|SYSTEMIC ANTIBACTERIALS|J1
90576|DRUGS USED IN DIABETES|A10
90562|ANTIVIRALS FOR SYSTEMIC USE|J5
90562|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
90560|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90559|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
90558|OPHTHALMOLOGICALS|S1
90557|OPHTHALMOLOGICALS|S1
90557|Ocular antineovascularisation products|S1P
90554|OPHTHALMOLOGICALS|S1
90551|ANALGESICS|N2
90549|ANTI-EPILEPTICS|N3
90545|PARASITOLOGY|P
90543|ALKYLATING AGENTS|L1A
90542|OPHTHALMOLOGICALS|S1
90540|ANTIPSYCHOTICS|N5A
90539|ANTIPSYCHOTICS|N5A
90533|Coxibs|M1A3
90533|ANALGESICS|N2
90532|Coxibs|M1A3
90532|ANALGESICS|N2
90531|ANTIEMETICS AND ANTINAUSEANTS|A4
90525|ANTIHYPERTENSIVES|C2
90525|Erectile dysfunction products|G4B3
90524|ANALGESICS|N2
90519|OPHTHALMOLOGICALS|S1
90517|ANTIVIRALS FOR SYSTEMIC USE|J5
90515|ANTIMETABOLITES|L1B
90514|DIRECT THROMBIN INHIBITORS|B1E
90510|ANTIEMETICS AND ANTINAUSEANTS|A4
90503|ANTIVIRALS FOR SYSTEMIC USE|J5
90502|Factor VIII|B2D1
90486|ANTIVIRALS FOR SYSTEMIC USE|J5
90484|ALKYLATING AGENTS|L1A
90473|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90471|ANTIVIRALS FOR SYSTEMIC USE|J5
90470|ANTIVIRALS FOR SYSTEMIC USE|J5
90464|SYSTEMIC ANTIBACTERIALS|J1
90459|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
90458|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
90457|IMMUNOSUPPRESSIVE AGENTS|L4
90456|IMMUNOSUPPRESSIVE AGENTS|L4
90455|ANAESTHETICS, LOCAL|N1B
90455|ANALGESICS|N2
90434|DRUGS USED IN DIABETES|A10
90434|ANALGESICS|N2
90432|SYSTEMIC ANTIBACTERIALS|J1
90428|Coxibs|M1A3
90428|ANALGESICS|N2
90426|ANTIVIRALS FOR SYSTEMIC USE|J5
90423|ANTIVIRALS FOR SYSTEMIC USE|J5
90422|ANTIVIRALS FOR SYSTEMIC USE|J5
90421|ANTI-EPILEPTICS|N3A
90419|ANTIMETABOLITES|L1B
90418|CENTRAL NERVOUS SYSTEM|N
90417|PARASITOLOGY|P
90416|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
90416|SSRI antidepressants|N6A4
90415|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
90406|IMMUNOSUPPRESSIVE AGENTS|L4
90404|ANTIVIRALS FOR SYSTEMIC USE|J5
90403|ANTI-ACNE PREPARATIONS|D10
90403|ORAL ANTI-ACNE PREPARATIONS|D10B
90396|IMMUNOSTIMULATING AGENTS|L3
90394|SYSTEMIC ANTIBACTERIALS|J1
90393|ANALGESICS|N2
90392|ANTI-EPILEPTICS|N3A
90392|NOOTROPICS|N6D
90391|ANTI-EPILEPTICS|N3A
90391|NOOTROPICS|N6D
90390|VACCINES|J7
90389|SYSTEMIC ANTIBACTERIALS|J1
90386|ANTIVIRALS FOR SYSTEMIC USE|J5
90385|ANTIPSYCHOTICS|N5A
90383|ANTIPSYCHOTICS|N5A
90381|SYSTEMIC ANTIBACTERIALS|J1
90380|ANTIVIRALS FOR SYSTEMIC USE|J5
90379|ANTIVIRALS FOR SYSTEMIC USE|J5
90378|ANTIVIRALS FOR SYSTEMIC USE|J5
90377|ANAESTHETICS|N1
90376|ANAESTHETICS|N1
90375|ANAESTHETICS|N1
90374|DRUGS USED IN DIABETES|A10
90373|ANALGESICS|N2
90372|DRUGS USED IN DIABETES|A10
90370|Topical dermatological antifungals|D1A1
90370|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
90361|ANTIPSYCHOTICS|N5A
90357|ANDROGENS, EXCLUDING G3E, G3F|G3B
90354|WOUND HEALING AGENTS|D3
90350|ANTIVIRALS FOR SYSTEMIC USE|J5
90349|Interferons, beta|L3B2
90348|DRUGS USED IN DIABETES|A10
90347|PARASITOLOGY|P
90347|ANTI-MALARIALS|P1D
90346|ANTIVIRALS FOR SYSTEMIC USE|J5
90345|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90343|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90342|ANTIPSYCHOTICS|N5A
90341|TRANQUILLISERS|N5C
90336|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
90328|SYSTEMIC ANTIBACTERIALS|J1
90327|ANTI-EPILEPTICS|N3A
90320|WOUND HEALING AGENTS|D3
90318|ANDROGENS, EXCLUDING G3E, G3F|G3B
90309|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90307|PLATELET AGGREGATION INHIBITORS|B1C
90305|VACCINES|J7
90304|VACCINES|J7
90303|ANALGESICS|N2
90301|ANTIVIRALS FOR SYSTEMIC USE|J5
90300|ANTIVIRALS FOR SYSTEMIC USE|J5
90297|ANTIHYPERTENSIVES|C2
90297|Statins (HMG-CoA reductase inhibitors)|C10A1
90296|PARASITOLOGY|P
90295|Ocular antineovascularisation products|S1P
90294|ANALGESICS|N2
90293|ANTIVIRALS FOR SYSTEMIC USE|J5
90292|ANTIVIRALS FOR SYSTEMIC USE|J5
90291|MUSCLE RELAXANTS|M3
90291|RESPIRATORY SYSTEM|R
90290|SYSTEMIC ANTIBACTERIALS|J1
90288|SYSTEMIC ANTIBACTERIALS|J1
90285|CENTRAL NERVOUS SYSTEM|N
90285|NOOTROPICS|N6D
90284|WOUND HEALING AGENTS|D3
90283|PARASITOLOGY|P
90283|ANTI-MALARIALS|P1D
90280|DRUGS USED IN DIABETES|A10
90277|PLATELET AGGREGATION INHIBITORS|B1C
90277|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
90273|ANTIVIRALS FOR SYSTEMIC USE|J5
90272|HYALURONIDASE|B6B
90272|IMMUNOSTIMULATING AGENTS|L3
90271|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
90271|Protease inhibitors|J5C2
90268|CARDIOVASCULAR SYSTEM|C
90267|CARDIOVASCULAR SYSTEM|C
90265|CARDIOVASCULAR SYSTEM|C
90262|ANTIVIRALS FOR SYSTEMIC USE|J5
90261|OPHTHALMOLOGICALS|S1
90257|OPHTHALMOLOGICALS|S1
90234|ANTIVIRALS FOR SYSTEMIC USE|J5
90234|Non-nucleoside reverse transcriptase inhibitors|J5C3
90232|ANALGESICS|N2
90232|OPHTHALMOLOGICALS|S1
90227|Erectile dysfunction products|G4B3
90222|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
90212|OPHTHALMOLOGICALS|S1
90209|SYSTEMIC ANTIBACTERIALS|J1
90207|ANTIEMETICS AND ANTINAUSEANTS|A4
90205|ANALGESICS|N2
90198|SYSTEMIC ANTIBACTERIALS|J1
90184|CARDIOVASCULAR SYSTEM|C
90178|ANTIHYPERTENSIVES|C2
90175|ANTIVIRALS FOR SYSTEMIC USE|J5
90173|MUSCULO-SKELETAL SYSTEM|M
90173|Coxibs|M1A3
90173|ANALGESICS|N2
90167|ANALGESICS|N2
90167|ANTI-MIGRAINE PREPARATIONS|N2C
90165|ANTIVIRALS FOR SYSTEMIC USE|J5
90164|ANALGESICS|N2
90161|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
90160|DRUGS USED IN DIABETES|A10
90155|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90155|DRUGS USED IN DIABETES|A10
90153|ANTI-GOUT PREPARATIONS|M4
90147|SYSTEMIC ANTIBACTERIALS|J1
90146|Factor VIII|B2D1
90141|Ocular antineovascularisation products|S1P
90139|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
90139|DRUGS USED IN DIABETES|A10
90131|RESPIRATORY SYSTEM|R
90122|SYSTEMIC ANTIBACTERIALS|J1
90120|DIRECT THROMBIN INHIBITORS|B1E
90118|NOOTROPICS|N6D
90117|CALCIUM ANTAGONISTS|C8
90117|LABOUR INHIBITORS|G2E
90115|DIAGNOSTIC AGENTS|T
90115|MRI AGENTS|T1E
90114|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
90111|OPHTHALMOLOGICALS|S1
90102|SYSTEMIC ANTIBACTERIALS|J1
90101|DRUGS USED IN DIABETES|A10
90097|ANTIEMETICS AND ANTINAUSEANTS|A4
90096|ANALGESICS|N2
90095|PLATELET AGGREGATION INHIBITORS|B1C
90095|CARDIOVASCULAR SYSTEM|C
90084|ANTIEMETICS AND ANTINAUSEANTS|A4
90083|ANTIEMETICS AND ANTINAUSEANTS|A4
90082|ANALGESICS|N2
90071|SYSTEMIC ANTIBACTERIALS|J1
90069|SYSTEMIC ANTIBACTERIALS|J1
90068|ANTIVIRALS FOR SYSTEMIC USE|J5
90065|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
90060|ANTI-EPILEPTICS|N3A
90059|OPHTHALMOLOGICALS|S1
90052|ANTI-ARRHYTHMICS|C1B
90051|RADIODIAGNOSTIC AGENTS|T1G
90044|ANTI-ARRHYTHMICS|C1B
90044|BETA-BLOCKING AGENTS|C7
90041|HUMAN INSULINS AND ANALOGUES|A10C
90041|Human insulins and analogues, intermediate-acting|A10C2
90038|SYSTEMIC ANTIBACTERIALS|J1
90036|DRUGS USED IN DIABETES|A10
90036|CARDIOVASCULAR SYSTEM|C
90035|MACROLIDES AND SIMILAR TYPES|J1F
90031|ANTIVIRALS FOR SYSTEMIC USE|J5
90029|DPP-IV inhibitor antidiabetics|A10B6
90019|ANTIVIRALS FOR SYSTEMIC USE|J5
90015|ANALGESICS|N2
90014|ANTIMETABOLITES|L1B
90006|PARASITOLOGY|P
90006|ANTI-MALARIALS|P1D
90003|SYSTEMIC ANTIBACTERIALS|J1
90002|SYSTEMIC ANTIBACTERIALS|J1
90001|TRANQUILLISERS|N5C
89997|ANALGESICS|N2
89996|ANALGESICS|N2
89994|ANALGESICS|N2
89989|HYPNOTICS/SEDATIVES|N5B
89983|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
89983|SSRI antidepressants|N6A4
89976|PARASITOLOGY|P
89974|ANAESTHETICS, LOCAL|N1B
89974|ANALGESICS|N2
89973|RESPIRATORY SYSTEM|R
89972|ANTIVIRALS FOR SYSTEMIC USE|J5
89971|ANTIVIRALS FOR SYSTEMIC USE|J5
89970|SYSTEMIC ANTIBACTERIALS|J1
89966|SYSTEMIC ANTIBACTERIALS|J1
89963|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89961|DRUGS USED IN DIABETES|A10
89957|SYSTEMIC ANTIBACTERIALS|J1
89937|CARDIOVASCULAR SYSTEM|C
89932|SYSTEMIC ANTIBACTERIALS|J1
89931|HYPNOTICS/SEDATIVES|N5B
89925|ANALGESICS|N2
89923|ANALGESICS|N2
89920|PLATELET AGGREGATION INHIBITORS|B1C
89914|SYSTEMIC ANTIBACTERIALS|J1
89910|ANTIVIRALS FOR SYSTEMIC USE|J5
89908|ANTIVIRALS FOR SYSTEMIC USE|J5
89906|SYSTEMIC ANTIBACTERIALS|J1
89906|AMINOGLYCOSIDES|J1K
89905|ANTIHYPERTENSIVES|C2
89905|ACE INHIBITORS, PLAIN|C9A
89903|ANAESTHETICS, LOCAL|N1B
89903|ANALGESICS|N2
89901|B2-STIMULANTS|R3A
89898|CARDIOVASCULAR SYSTEM|C
89894|WOUND HEALING AGENTS|D3
89894|AMINOGLYCOSIDES|J1K
89893|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89891|ANTI-MALARIALS|P1D
89890|SYSTEMIC ANTIBACTERIALS|J1
89888|ANALGESICS|N2
89877|WOUND HEALING AGENTS|D3
89876|ANTIVIRALS FOR SYSTEMIC USE|J5
89875|ANTIVIRALS FOR SYSTEMIC USE|J5
89863|CARDIAC THERAPY|C1
89858|SYSTEMIC ANTIBACTERIALS|J1
89857|SYSTEMIC ANTIBACTERIALS|J1
89855|ANTIVIRALS FOR SYSTEMIC USE|J5
89854|ANALGESICS|N2
89835|MUSCULO-SKELETAL SYSTEM|M
89833|MUSCULO-SKELETAL SYSTEM|M
89831|RESPIRATORY SYSTEM|R
89828|IMMUNOSTIMULATING AGENTS|L3
89827|SYSTEMIC ANTIBACTERIALS|J1
89826|CENTRAL NERVOUS SYSTEM|N
89826|SSRI antidepressants|N6A4
89826|SRNI antidepressants|N6A5
89824|SYSTEMIC ANTIBACTERIALS|J1
89822|WOUND HEALING AGENTS|D3
89816|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89812|ANAESTHETICS|N1
89811|MACROLIDES AND SIMILAR TYPES|J1F
89810|SYSTEMIC ANTIBACTERIALS|J1
89809|ANTIVIRALS FOR SYSTEMIC USE|J5
89808|ANTIVIRALS FOR SYSTEMIC USE|J5
89798|ANTIVIRALS FOR SYSTEMIC USE|J5
89785|SYSTEMIC ANTIBACTERIALS|J1
89785|ANTIVIRALS FOR SYSTEMIC USE|J5
89784|SYSTEMIC ANTIBACTERIALS|J1
89784|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
89783|ANTIVIRALS FOR SYSTEMIC USE|J5
89780|NOOTROPICS|N6D
89777|ANTIVIRALS FOR SYSTEMIC USE|J5
89774|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
89773|DRUGS USED IN DIABETES|A10
89771|NOOTROPICS|N6D
89767|WOUND HEALING AGENTS|D3
89762|ANTIVIRALS FOR SYSTEMIC USE|J5
89762|IMMUNOSTIMULATING AGENTS|L3
89759|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89756|PARASITOLOGY|P
89755|PARASITOLOGY|P
89753|SYSTEMIC ANTIBACTERIALS|J1
89752|CARDIOVASCULAR SYSTEM|C
89750|ANTIVIRALS FOR SYSTEMIC USE|J5
89748|ANALGESICS|N2
89747|OPHTHALMOLOGICALS|S1
89745|OPHTHALMOLOGICALS|S1
89742|RESPIRATORY SYSTEM|R
89741|GASTROPROKINETICS|A3F
89737|Coxibs|M1A3
89737|ANALGESICS|N2
89736|Coxibs|M1A3
89736|ANALGESICS|N2
89720|ANAESTHETICS, LOCAL|N1B
89717|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
89713|ANALGESICS|N2
89709|IMMUNOSTIMULATING AGENTS|L3
89708|PARASITOLOGY|P
89707|ANTIVIRALS FOR SYSTEMIC USE|J5
89702|RESPIRATORY SYSTEM|R
89697|PARASITOLOGY|P
89688|ANALGESICS|N2
89687|ANALGESICS|N2
89685|SYSTEMIC ANTIBACTERIALS|J1
89680|ANTIVIRALS FOR SYSTEMIC USE|J5
89677|SYSTEMIC ANTIBACTERIALS|J1
89677|CEPHALOSPORINS|J1D
89676|ANTI-EPILEPTICS|N3
89676|NOOTROPICS|N6D
89676|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
89672|PLATELET AGGREGATION INHIBITORS|B1C
89670|OPHTHALMOLOGICALS|S1
89669|FIBRINOLYTICS|B1D
89664|MUSCULO-SKELETAL SYSTEM|M
89663|ANTIVIRALS FOR SYSTEMIC USE|J5
89662|ANTIVIRALS FOR SYSTEMIC USE|J5
89662|Non-nucleoside reverse transcriptase inhibitors|J5C3
89640|ANTIVIRALS FOR SYSTEMIC USE|J5
89632|ANALGESICS|N2
89630|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
89627|ANTIVIRALS FOR SYSTEMIC USE|J5
89623|DIAGNOSTIC AGENTS|T
89622|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
89621|CARDIOVASCULAR SYSTEM|C
89618|RADIODIAGNOSTIC AGENTS|T1G
89616|OPHTHALMOLOGICALS|S1
89613|ANTIVIRALS FOR SYSTEMIC USE|J5
89611|RADIODIAGNOSTIC AGENTS|T1G
89609|ANTI-EPILEPTICS|N3A
89607|RESPIRATORY SYSTEM|R
89605|ANTIVIRALS FOR SYSTEMIC USE|J5
89603|SYSTEMIC ANTIBACTERIALS|J1
89601|NOOTROPICS|N6D
89600|ANTIPSYCHOTICS|N5A
89597|ANTIVIRALS FOR SYSTEMIC USE|J5
89595|SYSTEMIC ANTIBACTERIALS|J1
89593|Erectile dysfunction products|G4B3
89592|Erectile dysfunction products|G4B3
89591|ANTIPSYCHOTICS|N5A
89590|ANTIVIRALS FOR SYSTEMIC USE|J5
89587|SYSTEMIC ANTIBACTERIALS|J1
89587|IMMUNOSTIMULATING AGENTS|L3
89577|ANTI-GOUT PREPARATIONS|M4
89576|ANTI-GOUT PREPARATIONS|M4
89575|ANTI-GOUT PREPARATIONS|M4
89573|DRUGS USED IN DIABETES|A10
89573|HUMAN INSULINS AND ANALOGUES|A10C
89573|Human insulins and analogues, intermediate-acting|A10C2
89570|CENTRAL NERVOUS SYSTEM|N
89568|ANALGESICS|N2
89567|SYSTEMIC ANTIBACTERIALS|J1
89558|SYSTEMIC ANTIBACTERIALS|J1
89552|SYSTEMIC ANTIBACTERIALS|J1
89551|ANTITUSSIVES|R5D
89550|ANALGESICS|N2
89545|ANTI-ACNE PREPARATIONS|D10
89542|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
89537|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
89534|DIRECT THROMBIN INHIBITORS|B1E
89531|ANALGESICS|N2
89529|RADIODIAGNOSTIC AGENTS|T1G
89523|ANTIVIRALS FOR SYSTEMIC USE|J5
89517|ANALGESICS|N2
89514|ANTIVIRALS FOR SYSTEMIC USE|J5
89506|Ocular antineovascularisation products|S1P
89503|ANTIHYPERTENSIVES|C2
89500|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
89489|ANTIVIRALS FOR SYSTEMIC USE|J5
89488|ANAESTHETICS, LOCAL|N1B
89485|WOUND HEALING AGENTS|D3
89482|ANTI-EPILEPTICS|N3
89461|CENTRAL NERVOUS SYSTEM|N
89460|SYSTEMIC ANTIBACTERIALS|J1
89449|DRUGS USED IN DIABETES|A10
89449|HUMAN INSULINS AND ANALOGUES|A10C
89449|Human insulins and analogues, intermediate-acting|A10C2
89447|ANTI-EPILEPTICS|N3A
89445|DRUGS USED IN DIABETES|A10
89441|FIBRINOLYTICS|B1D
89438|SYSTEMIC ANTIBACTERIALS|J1
89422|ANTIVIRALS FOR SYSTEMIC USE|J5
89406|CENTRAL NERVOUS SYSTEM|N
89404|ANTIVIRALS FOR SYSTEMIC USE|J5
89403|DIRECT THROMBIN INHIBITORS|B1E
89394|IMMUNOSUPPRESSIVE AGENTS|L4
89390|RESPIRATORY SYSTEM|R
89387|SYSTEMIC ANTIBACTERIALS|J1
89383|PARASITOLOGY|P
89382|PARASITOLOGY|P
89381|PARASITOLOGY|P
89380|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89379|DRUGS USED IN DIABETES|A10
89372|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
89372|SSRI antidepressants|N6A4
89372|SRNI antidepressants|N6A5
89371|PARASITOLOGY|P
89371|ANTI-MALARIALS|P1D
89370|ANTI-EPILEPTICS|N3
89368|SYSTEMIC ANTIBACTERIALS|J1
89366|SYSTEMIC ANTIBACTERIALS|J1
89366|ANTIVIRALS FOR SYSTEMIC USE|J5
89365|SYSTEMIC ANTIBACTERIALS|J1
89361|ANALGESICS|N2
89355|Ocular antineovascularisation products|S1P
89354|Ocular antineovascularisation products|S1P
89351|CARDIOVASCULAR SYSTEM|C
89349|ANTI-EPILEPTICS|N3A
89348|OPHTHALMOLOGICALS|S1
89342|SYSTEMIC ANTIBACTERIALS|J1
89340|SYSTEMIC ANTIBACTERIALS|J1
89339|IMMUNOSUPPRESSIVE AGENTS|L4
89335|ANTIHYPERTENSIVES|C2
89335|BETA-BLOCKING AGENTS|C7
89335|OPHTHALMOLOGICALS|S1
89335|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
89333|BETA-BLOCKING AGENTS|C7
89333|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
89332|NOOTROPICS|N6D
89332|DIAGNOSTIC AGENTS|T
89330|ANTIVIRALS FOR SYSTEMIC USE|J5
89327|MUSCULO-SKELETAL SYSTEM|M
89325|RESPIRATORY SYSTEM|R
89322|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89322|ANTIPSYCHOTICS|N5A
89321|ANTI-EPILEPTICS|N3
89295|ANTIHYPERTENSIVES|C2
89295|OPHTHALMOLOGICALS|S1
89295|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
89284|ANALGESICS|N2
89284|ANTI-EPILEPTICS|N3
89283|PROLACTIN INHIBITORS|G2D
89277|IMMUNOSTIMULATING AGENTS|L3
89274|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
89266|SYSTEMIC ANTIBACTERIALS|J1
89266|AMINOGLYCOSIDES|J1K
89265|ANTIVIRALS FOR SYSTEMIC USE|J5
89256|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
89235|ACTH|H1A
89235|ANTI-EPILEPTICS|N3
89234|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
89229|FIBRINOLYTICS|B1D
89219|OPHTHALMOLOGICALS|S1
89210|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
89208|PARASITOLOGY|P
89202|DRUGS USED IN DIABETES|A10
89201|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89201|DRUGS USED IN DIABETES|A10
89199|Interferons, alpha|L3B1
89193|Erectile dysfunction products|G4B3
89193|ANALGESICS|N2
89193|SSRI antidepressants|N6A4
89185|ANTIHYPERTENSIVES|C2
89185|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
89184|ANTIHYPERTENSIVES|C2
89180|RADIODIAGNOSTIC AGENTS|T1G
89177|ANTIVIRALS FOR SYSTEMIC USE|J5
89164|ANTIVIRALS FOR SYSTEMIC USE|J5
89154|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
89153|ANALGESICS|N2
89152|PLATELET AGGREGATION INHIBITORS|B1C
89149|RADIODIAGNOSTIC AGENTS|T1G
89143|IMMUNOSTIMULATING AGENTS|L3
89141|SYSTEMIC ANTIBACTERIALS|J1
89125|ANTIHYPERTENSIVES|C2
89123|ANTIVIRALS FOR SYSTEMIC USE|J5
89109|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89108|OPHTHALMOLOGICALS|S1
89106|ANTIVIRALS FOR SYSTEMIC USE|J5
89104|SYSTEMIC ANTIBACTERIALS|J1
89102|CARDIOVASCULAR SYSTEM|C
89097|ANTIEMETICS AND ANTINAUSEANTS|A4
89096|ANALGESICS|N2
89094|RESPIRATORY SYSTEM|R
89084|IMMUNOSUPPRESSIVE AGENTS|L4
89082|Ocular antineovascularisation products|S1P
89072|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
89072|DRUGS USED IN DIABETES|A10
89069|SYSTEMIC ANTIBACTERIALS|J1
89060|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
89058|ANTIVIRALS FOR SYSTEMIC USE|J5
89041|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
89037|ANALGESICS|N2
89036|ANTIHYPERTENSIVES|C2
89036|DIURETICS|C3
89036|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
89035|ANALGESICS|N2
89035|TRANQUILLISERS|N5C
89030|ANTI-EPILEPTICS|N3A
89030|NOOTROPICS|N6D
89029|ANTIVIRALS FOR SYSTEMIC USE|J5
89023|ANTIMETABOLITES|L1B
89022|ANTIMETABOLITES|L1B
89021|ANTIMETABOLITES|L1B
89020|ANTIMETABOLITES|L1B
89019|ANTIMETABOLITES|L1B
89018|ANTIMETABOLITES|L1B
89017|ANTIMETABOLITES|L1B
89015|ANTIMETABOLITES|L1B
89014|Statins (HMG-CoA reductase inhibitors)|C10A1
89012|ANTIMETABOLITES|L1B
89011|ANTI-EPILEPTICS|N3A
89010|ANTIMETABOLITES|L1B
89005|DPP-IV inhibitor antidiabetics|A10B6
89003|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
89000|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
89000|ANALGESICS|N2
88999|RADIODIAGNOSTIC AGENTS|T1G
88997|NOOTROPICS|N6D
88984|ANTIVIRALS FOR SYSTEMIC USE|J5
88983|DRUGS USED IN DIABETES|A10
88983|DPP-IV inhibitor antidiabetics|A10B6
88974|Factor VIII|B2D1
88972|ANTI-EPILEPTICS|N3A
88964|ANTIVIRALS FOR SYSTEMIC USE|J5
88963|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88963|DRUGS USED IN DIABETES|A10
88961|ANTIVIRALS FOR SYSTEMIC USE|J5
88957|SYSTEMIC ANTIBACTERIALS|J1
88957|ANTIVIRALS FOR SYSTEMIC USE|J5
88953|PARASITOLOGY|P
88953|ANTI-MALARIALS|P1D
88952|SYSTEMIC ANTIBACTERIALS|J1
88948|WOUND HEALING AGENTS|D3
88946|OPHTHALMOLOGICALS|S1
88945|SYSTEMIC ANTIBACTERIALS|J1
88941|DIURETICS|C3
88934|RADIODIAGNOSTIC AGENTS|T1G
88933|DRUGS USED IN DIABETES|A10
88931|ANTIHYPERTENSIVES|C2
88928|PARASITOLOGY|P
88922|RESPIRATORY SYSTEM|R
88920|ANTIHYPERTENSIVES|C2
88915|SYSTEMIC ANTIBACTERIALS|J1
88910|ANALGESICS|N2
88909|CARDIOVASCULAR SYSTEM|C
88904|DRUGS USED IN DIABETES|A10
88900|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
88899|ANALGESICS|N2
88898|ANTIPSYCHOTICS|N5A
88896|SYSTEMIC ANTIBACTERIALS|J1
88895|SYSTEMIC ANTIBACTERIALS|J1
88886|ANTIVIRALS FOR SYSTEMIC USE|J5
88881|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
88881|ANALGESICS|N2
88880|ANTI-EPILEPTICS|N3
88879|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
88877|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
88875|ANALGESICS|N2
88870|IMMUNOSUPPRESSIVE AGENTS|L4
88867|ANTIVIRALS FOR SYSTEMIC USE|J5
88865|ANTIVIRALS FOR SYSTEMIC USE|J5
88853|SYSTEMIC ANTIBACTERIALS|J1
88849|DRUGS USED IN DIABETES|A10
88849|HUMAN INSULINS AND ANALOGUES|A10C
88849|Human insulins and analogues, intermediate-acting|A10C2
88848|SYSTEMIC ANTIBACTERIALS|J1
88838|CENTRAL NERVOUS SYSTEM|N
88837|ANALGESICS|N2
88831|ANTIVIRALS FOR SYSTEMIC USE|J5
88825|ANDROGENS, EXCLUDING G3E, G3F|G3B
88822|CENTRAL NERVOUS SYSTEM|N
88821|ANALGESICS|N2
88817|ANALGESICS|N2
88812|ANALGESICS|N2
88810|ANTI-EPILEPTICS|N3
88809|IMMUNOSTIMULATING AGENTS|L3
88805|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
88805|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
88801|ANTIVIRALS FOR SYSTEMIC USE|J5
88795|DRUGS USED IN DIABETES|A10
88794|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
88791|ANALGESICS|N2
88789|SRNI antidepressants|N6A5
88786|ANTIVIRALS FOR SYSTEMIC USE|J5
88784|ANTIVIRALS FOR SYSTEMIC USE|J5
88781|CENTRAL NERVOUS SYSTEM|N
88778|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
88775|PARASITOLOGY|P
88772|WOUND HEALING AGENTS|D3
88769|ANALGESICS|N2
88768|IMMUNOSUPPRESSIVE AGENTS|L4
88766|SYSTEMIC ANTIBACTERIALS|J1
88765|IMMUNOSUPPRESSIVE AGENTS|L4
88759|HYALURONIDASE|B6B
88744|ANTIPSYCHOTICS|N5A
88735|IMMUNOSUPPRESSIVE AGENTS|L4
88733|ANALGESICS|N2
88732|SYSTEMIC ANTIBACTERIALS|J1
88729|ANTIVIRALS FOR SYSTEMIC USE|J5
88728|ANTIVIRALS FOR SYSTEMIC USE|J5
88726|ANTIVIRALS FOR SYSTEMIC USE|J5
88724|IMMUNOSUPPRESSIVE AGENTS|L4
88722|OPHTHALMOLOGICALS|S1
88721|CENTRAL NERVOUS SYSTEM|N
88720|CENTRAL NERVOUS SYSTEM|N
88719|CENTRAL NERVOUS SYSTEM|N
88717|IMMUNOSUPPRESSIVE AGENTS|L4
88715|ANTIVIRALS FOR SYSTEMIC USE|J5
88715|IMMUNOSTIMULATING AGENTS|L3
88705|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88704|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
88702|IMMUNOSTIMULATING AGENTS|L3
88699|IMMUNOSTIMULATING AGENTS|L3
88698|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
88696|CARDIOVASCULAR SYSTEM|C
88690|CENTRAL NERVOUS SYSTEM|N
88687|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
88685|CENTRAL NERVOUS SYSTEM|N
88685|NOOTROPICS|N6D
88677|ANTIVIRALS FOR SYSTEMIC USE|J5
88676|SYSTEMIC ANTIBACTERIALS|J1
88676|ANTIVIRALS FOR SYSTEMIC USE|J5
88676|IMMUNOSTIMULATING AGENTS|L3
88672|PLATELET AGGREGATION INHIBITORS|B1C
88670|ANTIPSYCHOTICS|N5A
88669|IMMUNOSUPPRESSIVE AGENTS|L4
88667|IMMUNOSUPPRESSIVE AGENTS|L4
88666|ANALGESICS|N2
88665|ANTI-EPILEPTICS|N3A
88663|ANTI-EPILEPTICS|N3
88663|NOOTROPICS|N6D
88662|TRANQUILLISERS|N5C
88660|NOOTROPICS|N6D
88659|Non-nucleoside reverse transcriptase inhibitors|J5C3
88654|RADIODIAGNOSTIC AGENTS|T1G
88649|CARDIOVASCULAR SYSTEM|C
88649|CENTRAL NERVOUS SYSTEM|N
88645|ANTIVIRALS FOR SYSTEMIC USE|J5
88641|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
88640|ANTIVIRALS FOR SYSTEMIC USE|J5
88639|ANTIVIRALS FOR SYSTEMIC USE|J5
88634|OPHTHALMOLOGICALS|S1
88634|Ocular antineovascularisation products|S1P
88620|IMMUNOSUPPRESSIVE AGENTS|L4
88619|ANTIVIRALS FOR SYSTEMIC USE|J5
88608|SYSTEMIC ANTIBACTERIALS|J1
88607|NOOTROPICS|N6D
88604|NOOTROPICS|N6D
88601|ANTI-EPILEPTICS|N3
88601|TRANQUILLISERS|N5C
88595|FIBRINOLYTICS|B1D
88591|NOOTROPICS|N6D
88587|NOOTROPICS|N6D
88580|CENTRAL NERVOUS SYSTEM|N
88578|ANALGESICS|N2
88570|ANTIVIRALS FOR SYSTEMIC USE|J5
88567|RESPIRATORY SYSTEM|R
88553|OPHTHALMOLOGICALS|S1
88550|ANTIVIRALS FOR SYSTEMIC USE|J5
88548|OPHTHALMOLOGICALS|S1
88547|OPHTHALMOLOGICALS|S1
88540|OPHTHALMOLOGICALS|S1
88539|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
88528|ANTI-EPILEPTICS|N3A
88527|ANTI-EPILEPTICS|N3A
88525|NOOTROPICS|N6D
88523|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88523|DRUGS USED IN DIABETES|A10
88523|MUSCULO-SKELETAL SYSTEM|M
88522|ANTI-EPILEPTICS|N3
88521|ANTI-EPILEPTICS|N3A
88520|NOOTROPICS|N6D
88516|IMMUNOSUPPRESSIVE AGENTS|L4
88515|PARASITOLOGY|P
88512|ANTI-EPILEPTICS|N3
88507|SYSTEMIC ANTIBACTERIALS|J1
88505|SYSTEMIC ANTIBACTERIALS|J1
88503|ANTIVIRALS FOR SYSTEMIC USE|J5
88501|ANTI-EPILEPTICS|N3
88499|ANTIVIRALS FOR SYSTEMIC USE|J5
88498|ANTIVIRALS FOR SYSTEMIC USE|J5
88494|ANTIVIRALS FOR SYSTEMIC USE|J5
88491|ANALGESICS|N2
88490|ANALGESICS|N2
88487|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88487|DRUGS USED IN DIABETES|A10
88485|ANAESTHETICS, LOCAL|N1B
88485|OPHTHALMOLOGICALS|S1
88482|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88482|DRUGS USED IN DIABETES|A10
88474|RADIODIAGNOSTIC AGENTS|T1G
88473|ANTI-EPILEPTICS|N3A
88472|RADIODIAGNOSTIC AGENTS|T1G
88461|ANALGESICS|N2
88459|OPHTHALMOLOGICALS|S1
88458|ANTI-EPILEPTICS|N3A
88456|SYSTEMIC ANTIBACTERIALS|J1
88452|RESPIRATORY SYSTEM|R
88451|RESPIRATORY SYSTEM|R
88450|ANTI-EPILEPTICS|N3
88449|ANTIPSYCHOTICS|N5A
88448|ANTIPSYCHOTICS|N5A
88443|OPHTHALMOLOGICALS|S1
88441|ANALGESICS|N2
88439|ANTI-EPILEPTICS|N3
88437|ANTIPSYCHOTICS|N5A
88435|ANTIHYPERTENSIVES|C2
88430|CARDIOVASCULAR SYSTEM|C
88426|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
88424|ANTIVIRALS FOR SYSTEMIC USE|J5
88421|ANAESTHETICS, GENERAL|N1A
88421|HYPNOTICS/SEDATIVES|N5B
88416|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88404|DRUGS USED IN DIABETES|A10
88403|ANTIVIRALS FOR SYSTEMIC USE|J5
88402|ANTIVIRALS FOR SYSTEMIC USE|J5
88401|ANTIVIRALS FOR SYSTEMIC USE|J5
88396|ANTIFIBRINOLYTICS|B2A
88393|SYSTEMIC ANTIBACTERIALS|J1
88391|SYSTEMIC ANTIBACTERIALS|J1
88387|SYSTEMIC ANTIBACTERIALS|J1
88384|SYSTEMIC ANTIBACTERIALS|J1
88373|ANTI-EPILEPTICS|N3
88371|SYSTEMIC ANTIBACTERIALS|J1
88371|ANTIVIRALS FOR SYSTEMIC USE|J5
88370|SYSTEMIC ANTIBACTERIALS|J1
88369|SYSTEMIC ANTIBACTERIALS|J1
88364|ANTIVIRALS FOR SYSTEMIC USE|J5
88358|SYSTEMIC ANTIBACTERIALS|J1
88352|SYSTEMIC ANTIBACTERIALS|J1
88351|ANTIVIRALS FOR SYSTEMIC USE|J5
88350|ANTIVIRALS FOR SYSTEMIC USE|J5
88344|ANALGESICS|N2
88343|SYSTEMIC ANTIBACTERIALS|J1
88339|ANALGESICS|N2
88336|ANTIVIRALS FOR SYSTEMIC USE|J5
88329|ANTIFIBRINOLYTICS|B2A
88328|ANTIVIRALS FOR SYSTEMIC USE|J5
88327|ANTIPSYCHOTICS|N5A
88326|ANTI-EPILEPTICS|N3A
88326|ANTIPSYCHOTICS|N5A
88326|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
88322|ANTIVIRALS FOR SYSTEMIC USE|J5
88320|ANALGESICS|N2
88318|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88318|DERMATOLOGICALS|D
88318|ANALGESICS|N2
88316|ANTIHYPERTENSIVES|C2
88314|OPHTHALMOLOGICALS|S1
88312|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
88311|ANTIVIRALS FOR SYSTEMIC USE|J5
88309|ANTIVIRALS FOR SYSTEMIC USE|J5
88305|DIURETICS|C3
88299|ALKYLATING AGENTS|L1A
88298|CARDIAC THERAPY|C1
88294|SYSTEMIC ANTIBACTERIALS|J1
88292|ANTIHYPERTENSIVES|C2
88285|SYSTEMIC ANTIBACTERIALS|J1
88281|CALCIUM ANTAGONISTS|C8
88277|ANTIMETABOLITES|L1B
88276|IMMUNOSUPPRESSIVE AGENTS|L4
88271|ALKYLATING AGENTS|L1A
88270|SYSTEMIC ANTIBACTERIALS|J1
88270|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
88269|ALKYLATING AGENTS|L1A
88265|ANALGESICS|N2
88261|ANALGESICS|N2
88260|ANTIVIRALS FOR SYSTEMIC USE|J5
88258|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
88257|ANTIVIRALS FOR SYSTEMIC USE|J5
88255|IMMUNOSTIMULATING AGENTS|L3
88245|FIBRINOLYTICS|B1D
88243|PARASITOLOGY|P
88242|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
88241|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
88240|ANTIVIRALS FOR SYSTEMIC USE|J5
88234|ANTIPSYCHOTICS|N5A
88229|WOUND HEALING AGENTS|D3
88225|OPHTHALMOLOGICALS|S1
88222|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88220|PLATELET AGGREGATION INHIBITORS|B1C
88217|ANTIVIRALS FOR SYSTEMIC USE|J5
88217|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
88214|SYSTEMIC ANTIBACTERIALS|J1
88210|CARDIOVASCULAR SYSTEM|C
88209|DERMATOLOGICALS|D
88208|ANTIVIRALS FOR SYSTEMIC USE|J5
88205|CEPHALOSPORINS|J1D
88199|CEPHALOSPORINS|J1D
88193|CEPHALOSPORINS|J1D
88192|SYSTEMIC ANTIBACTERIALS|J1
88192|CEPHALOSPORINS|J1D
88191|ANTIVIRALS FOR SYSTEMIC USE|J5
88179|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88179|ANTIPSYCHOTICS|N5A
88179|NOOTROPICS|N6D
88178|ANTIVIRALS FOR SYSTEMIC USE|J5
88169|ANTI-EPILEPTICS|N3
88160|SYSTEMIC ANTIBACTERIALS|J1
88158|ANTIVIRALS FOR SYSTEMIC USE|J5
88153|ANTIVIRALS FOR SYSTEMIC USE|J5
88152|ANTIVIRALS FOR SYSTEMIC USE|J5
88151|IMMUNOSUPPRESSIVE AGENTS|L4
88149|SYSTEMIC ANTIBACTERIALS|J1
88145|ANTI-EPILEPTICS|N3A
88142|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
88142|DRUGS USED IN DIABETES|A10
88142|CARDIOVASCULAR SYSTEM|C
88135|NOOTROPICS|N6D
88135|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
88134|ANTIHYPERTENSIVES|C2
88134|CALCIUM ANTAGONISTS|C8
88133|ANTIHYPERTENSIVES|C2
88133|CALCIUM ANTAGONISTS|C8
88132|ANTIHYPERTENSIVES|C2
88132|CALCIUM ANTAGONISTS|C8
88132|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
88132|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
88132|Statins (HMG-CoA reductase inhibitors)|C10A1
88130|PARASITOLOGY|P
88130|ANTI-MALARIALS|P1D
88126|ANTIVIRALS FOR SYSTEMIC USE|J5
88121|WOUND HEALING AGENTS|D3
88120|ANALGESICS|N2
88118|ANALGESICS|N2
88114|NOOTROPICS|N6D
88111|NOOTROPICS|N6D
88111|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
88110|NOOTROPICS|N6D
88110|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
88105|Factor VIII|B2D1
88101|ANALGESICS|N2
88098|NOOTROPICS|N6D
88097|NOOTROPICS|N6D
88096|BPH (benign prostatic hypertrophy) products |G4C
88091|ANTIFIBRINOLYTICS|B2A
88080|DPP-IV inhibitor antidiabetics|A10B6
88070|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
88063|ANTIHYPERTENSIVES|C2
88063|ACE INHIBITORS, PLAIN|C9A
88063|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
88063|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
88063|Statins (HMG-CoA reductase inhibitors)|C10A1
88062|DPP-IV inhibitor antidiabetics|A10B6
88060|PARASITOLOGY|P
88051|SYSTEMIC ANTIBACTERIALS|J1
88044|OPHTHALMOLOGICALS|S1
88037|RESPIRATORY SYSTEM|R
88012|ANTIVIRALS FOR SYSTEMIC USE|J5
88008|DRUGS USED IN DIABETES|A10
88008|DPP-IV inhibitor antidiabetics|A10B6
88007|SYSTEMIC ANTIBACTERIALS|J1
88005|SYSTEMIC ANTIBACTERIALS|J1
88000|SYSTEMIC ANTIBACTERIALS|J1
87989|ANALGESICS|N2
87988|ANALGESICS|N2
87986|ANTIHYPERTENSIVES|C2
87981|ANTIVIRALS FOR SYSTEMIC USE|J5
87979|OPHTHALMOLOGICALS|S1
87975|ANALGESICS|N2
87969|IMMUNOSTIMULATING AGENTS|L3
87968|IMMUNOSTIMULATING AGENTS|L3
87966|IMMUNOSTIMULATING AGENTS|L3
87965|IMMUNOSTIMULATING AGENTS|L3
87964|ANTIPSYCHOTICS|N5A
87963|IMMUNOSTIMULATING AGENTS|L3
87955|ANTIHYPERTENSIVES|C2
87955|CALCIUM ANTAGONISTS|C8
87955|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
87955|Statins (HMG-CoA reductase inhibitors)|C10A1
87951|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
87949|WOUND HEALING AGENTS|D3
87933|OPHTHALMOLOGICALS|S1
87930|ANALGESICS|N2
87930|ANTI-MIGRAINE PREPARATIONS|N2C
87928|OPHTHALMOLOGICALS|S1
87926|ANTIVIRALS FOR SYSTEMIC USE|J5
87917|ANTIVIRALS FOR SYSTEMIC USE|J5
87915|ANTIVIRALS FOR SYSTEMIC USE|J5
87914|SYSTEMIC ANTIBACTERIALS|J1
87914|CEPHALOSPORINS|J1D
87913|ANTIVIRALS FOR SYSTEMIC USE|J5
87911|ANTIVIRALS FOR SYSTEMIC USE|J5
87910|ANTI-MALARIALS|P1D
87906|ANTIVIRALS FOR SYSTEMIC USE|J5
87904|ANTIVIRALS FOR SYSTEMIC USE|J5
87899|ANTI-EPILEPTICS|N3A
87896|ANTIHYPERTENSIVES|C2
87896|BETA-BLOCKING AGENTS|C7
87894|ANTIVIRALS FOR SYSTEMIC USE|J5
87890|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
87888|SYSTEMIC ANTIBACTERIALS|J1
87877|ANTIVIRALS FOR SYSTEMIC USE|J5
87868|HUMAN INSULINS AND ANALOGUES|A10C
87868|Human insulins and analogues, intermediate-acting|A10C2
87867|HUMAN INSULINS AND ANALOGUES|A10C
87867|Human insulins and analogues, intermediate-acting|A10C2
87866|NOOTROPICS|N6D
87862|TRANQUILLISERS|N5C
87859|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
87847|ANTI-EPILEPTICS|N3A
87847|RADIODIAGNOSTIC AGENTS|T1G
87845|ANTI-EPILEPTICS|N3A
87844|CARDIOVASCULAR SYSTEM|C
87843|MRI AGENTS|T1E
87843|RADIODIAGNOSTIC AGENTS|T1G
87842|MRI AGENTS|T1E
87842|RADIODIAGNOSTIC AGENTS|T1G
87841|ANTIVIRALS FOR SYSTEMIC USE|J5
87841|Non-nucleoside reverse transcriptase inhibitors|J5C3
87836|DRUGS USED IN DIABETES|A10
87831|ANTIHYPERTENSIVES|C2
87829|ANTIHYPERTENSIVES|C2
87827|CARDIOVASCULAR SYSTEM|C
87825|ANTI-EPILEPTICS|N3A
87815|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
87811|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
87810|ANAESTHETICS, LOCAL|N1B
87805|Ocular antineovascularisation products|S1P
87797|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
87789|ANTI-ACNE PREPARATIONS|D10
87777|ANTIEMETICS AND ANTINAUSEANTS|A4
87774|RADIODIAGNOSTIC AGENTS|T1G
87772|SYSTEMIC ANTIBACTERIALS|J1
87765|ANALGESICS|N2
87764|ANTIVIRALS FOR SYSTEMIC USE|J5
87763|SYSTEMIC ANTIBACTERIALS|J1
87758|RADIODIAGNOSTIC AGENTS|T1G
87753|ANALGESICS|N2
87747|ANTIVIRALS FOR SYSTEMIC USE|J5
87743|ALKYLATING AGENTS|L1A
87742|ANTIPSYCHOTICS|N5A
87737|RADIODIAGNOSTIC AGENTS|T1G
87734|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
87733|NOOTROPICS|N6D
87729|DRUGS USED IN DIABETES|A10
87728|IMMUNOSUPPRESSIVE AGENTS|L4
87728|OPHTHALMOLOGICAL ANTI-INFECTIVES|S1A
87725|ANTIVIRALS FOR SYSTEMIC USE|J5
87724|SYSTEMIC ANTIBACTERIALS|J1
87716|SYSTEMIC ANTIBACTERIALS|J1
87715|ANTIVIRALS FOR SYSTEMIC USE|J5
87714|ANALGESICS|N2
87714|ANTI-MIGRAINE PREPARATIONS|N2C
87712|SYSTEMIC ANTIBACTERIALS|J1
87707|ANTIVIRALS FOR SYSTEMIC USE|J5
87697|SYSTEMIC ANTIBACTERIALS|J1
87693|SYSTEMIC ANTIBACTERIALS|J1
87692|RESPIRATORY SYSTEM|R
87669|ANALGESICS|N2
87661|ANTIVIRALS FOR SYSTEMIC USE|J5
87652|SYSTEMIC ANTIBACTERIALS|J1
87651|ANTIMETABOLITES|L1B
87650|CENTRAL NERVOUS SYSTEM|N
87650|NOOTROPICS|N6D
87649|OPHTHALMOLOGICALS|S1
87639|ANTIHYPERTENSIVES|C2
87639|DERMATOLOGICALS|D
87636|RESPIRATORY SYSTEM|R
87634|CARDIOVASCULAR SYSTEM|C
87625|DERMATOLOGICALS|D
87622|ANTIVIRALS FOR SYSTEMIC USE|J5
87621|ANTIVIRALS FOR SYSTEMIC USE|J5
87620|ANTIVIRALS FOR SYSTEMIC USE|J5
87617|ANALGESICS|N2
87616|CARDIOVASCULAR SYSTEM|C
87612|IMMUNOSUPPRESSIVE AGENTS|L4
87610|ANTACIDS, ANTIFLATULENTS, CARMINATIVES|A2A
87610|ANALGESICS|N2
87604|SYSTEMIC ANTIBACTERIALS|J1
87601|CARDIOVASCULAR SYSTEM|C
87600|SYSTEMIC ANTIBACTERIALS|J1
87596|RESPIRATORY SYSTEM|R
87588|ANALGESICS|N2
87586|DERMATOLOGICALS|D
87585|ANTIVIRALS FOR SYSTEMIC USE|J5
87584|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
87581|ANALGESICS|N2
87579|ANALGESICS|N2
87576|ANALGESICS|N2
87575|ANTIVIRALS FOR SYSTEMIC USE|J5
87572|ANTIVIRALS FOR SYSTEMIC USE|J5
87571|PLATELET AGGREGATION INHIBITORS|B1C
87571|CARDIOVASCULAR SYSTEM|C
87565|SYSTEMIC ANTIBACTERIALS|J1
87558|ANTI-EPILEPTICS|N3A
87554|Coxibs|M1A3
87554|ANALGESICS|N2
87551|ANTIVIRALS FOR SYSTEMIC USE|J5
87550|SYSTEMIC ANTIBACTERIALS|J1
87549|ANTIVIRALS FOR SYSTEMIC USE|J5
87548|ANTIVIRALS FOR SYSTEMIC USE|J5
87547|MACROLIDES AND SIMILAR TYPES|J1F
87543|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
87540|ANTIVIRALS FOR SYSTEMIC USE|J5
87540|IMMUNOSTIMULATING AGENTS|L3
87538|RESPIRATORY SYSTEM|R
87537|DERMATOLOGICALS|D
87537|ANTI-ACNE PREPARATIONS|D10
87536|SYSTEMIC ANTIBACTERIALS|J1
87534|ANTIHYPERTENSIVES|C2
87533|ANALGESICS|N2
87532|AMINOGLYCOSIDES|J1K
87530|SYSTEMIC ANTIBACTERIALS|J1
87529|SYSTEMIC ANTIBACTERIALS|J1
87526|SYSTEMIC ANTIBACTERIALS|J1
87523|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
87522|SYSTEMIC ANTIBACTERIALS|J1
87520|B2-STIMULANTS|R3A
87515|PLATELET AGGREGATION INHIBITORS|B1C
87515|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
87514|SYSTEMIC ANTIBACTERIALS|J1
87514|Carbapenems|J1P2
87513|ANTIVIRALS FOR SYSTEMIC USE|J5
87505|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
87504|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
87495|SYSTEMIC ANTIBACTERIALS|J1
87474|ANALGESICS|N2
87474|ANTI-MIGRAINE PREPARATIONS|N2C
87473|ANALGESICS|N2
87473|ANTI-MIGRAINE PREPARATIONS|N2C
87467|ANALGESICS|N2
87450|CARDIOVASCULAR SYSTEM|C
87450|MRI AGENTS|T1E
87449|ANDROGENS, EXCLUDING G3E, G3F|G3B
87443|PLATELET AGGREGATION INHIBITORS|B1C
87443|BETA-BLOCKING AGENTS|C7
87443|ACE INHIBITORS, PLAIN|C9A
87443|Statins (HMG-CoA reductase inhibitors)|C10A1
87442|ANTIPSYCHOTICS|N5A
87441|SYSTEMIC ANTIBACTERIALS|J1
87441|CEPHALOSPORINS|J1D
87440|SYSTEMIC ANTIBACTERIALS|J1
87439|ANTI-EPILEPTICS|N3A
87437|ALKYLATING AGENTS|L1A
87436|ANTI-EPILEPTICS|N3A
87435|WOUND HEALING AGENTS|D3
87428|ANTIPSYCHOTICS|N5A
87414|ANTIHYPERTENSIVES|C2
87414|CALCIUM ANTAGONISTS|C8
87414|Statins (HMG-CoA reductase inhibitors)|C10A1
87405|CENTRAL NERVOUS SYSTEM|N
87403|OPHTHALMOLOGICALS|S1
87402|ANALGESICS|N2
87401|SYSTEMIC ANTIBACTERIALS|J1
87399|ANTI-EPILEPTICS|N3
87399|NOOTROPICS|N6D
87394|ANTI-MIGRAINE PREPARATIONS|N2C
87391|WOUND HEALING AGENTS|D3
87390|GASTROPROKINETICS|A3F
87390|RESPIRATORY SYSTEM|R
87389|ANTIHYPERTENSIVES|C2
87385|CENTRAL NERVOUS SYSTEM|N
87370|ANTIHYPERTENSIVES|C2
87370|ACE INHIBITORS, PLAIN|C9A
87362|Coxibs|M1A3
87362|ANALGESICS|N2
87360|SYSTEMIC ANTIBACTERIALS|J1
87358|ANTI-ARRHYTHMICS|C1B
87356|SYSTEMIC ANTIBACTERIALS|J1
87356|ANTIPROTOZOALS AND ANTHELMINTICS|P1
87353|ANTIVIRALS FOR SYSTEMIC USE|J5
87346|ANTIEMETICS AND ANTINAUSEANTS|A4
87346|SYSTEMIC ANTIBACTERIALS|J1
87344|ANTIEMETICS AND ANTINAUSEANTS|A4
87344|SYSTEMIC ANTIBACTERIALS|J1
87343|ANTIVIRALS FOR SYSTEMIC USE|J5
87340|ANALGESICS|N2
87338|IMMUNOSTIMULATING AGENTS|L3
87335|ANTIHYPERTENSIVES|C2
87334|ANTIEMETICS AND ANTINAUSEANTS|A4
87333|SYSTEMIC ANTIBACTERIALS|J1
87332|SYSTEMIC ANTIBACTERIALS|J1
87330|RESPIRATORY SYSTEM|R
87327|Coxibs|M1A3
87327|ANALGESICS|N2
87323|ANTI-ACNE PREPARATIONS|D10
87318|ANDROGENS, EXCLUDING G3E, G3F|G3B
87314|SYSTEMIC ANTIBACTERIALS|J1
87313|ALKYLATING AGENTS|L1A
87300|ANTIMETABOLITES|L1B
87297|ANTI-EPILEPTICS|N3
87289|ANTI-EPILEPTICS|N3
87281|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
87281|Statins (HMG-CoA reductase inhibitors)|C10A1
87278|ANTIVIRALS FOR SYSTEMIC USE|J5
87277|ANTIVIRALS FOR SYSTEMIC USE|J5
87270|ANALGESICS|N2
87269|ANALGESICS|N2
87269|ANTI-MIGRAINE PREPARATIONS|N2C
87261|Factor VIII|B2D1
87257|ANALGESICS|N2
87252|ANTI-GOUT PREPARATIONS|M4
87251|ANTI-GOUT PREPARATIONS|M4
87249|ANTIVIRALS FOR SYSTEMIC USE|J5
87247|ANTIVIRALS FOR SYSTEMIC USE|J5
87243|ANALGESICS|N2
87241|ANTIPROTOZOALS AND ANTHELMINTICS|P1
87240|ANALGESICS|N2
87236|ANTI-EPILEPTICS|N3A
87222|SYSTEMIC ANTIBACTERIALS|J1
87221|SYSTEMIC ANTIBACTERIALS|J1
87219|SYSTEMIC ANTIBACTERIALS|J1
87216|BPH (benign prostatic hypertrophy) products |G4C
87214|ANDROGENS, EXCLUDING G3E, G3F|G3B
87211|PLATELET AGGREGATION INHIBITORS|B1C
87208|ANTIVIRALS FOR SYSTEMIC USE|J5
87207|ANALGESICS|N2
87199|CENTRAL NERVOUS SYSTEM|N
87192|RESPIRATORY SYSTEM|R
87185|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
87182|DIAGNOSTIC AGENTS|T
87179|WOUND HEALING AGENTS|D3
87174|DERMATOLOGICALS|D
87173|OPHTHALMOLOGICAL ANTI-INFLAMMATORY/ANTI-INFECTIVE COMBINATIONS|S1C
87172|CENTRAL NERVOUS SYSTEM|N
87169|ANALGESICS|N2
87162|SYSTEMIC ANTIBACTERIALS|J1
87159|ANALGESICS|N2
87155|ANALGESICS|N2
87154|ANALGESICS|N2
87153|ANTIVIRALS FOR SYSTEMIC USE|J5
87144|Statins (HMG-CoA reductase inhibitors)|C10A1
87143|IMMUNOSUPPRESSIVE AGENTS|L4
87141|IMMUNOSUPPRESSIVE AGENTS|L4
87139|ANAESTHETICS, LOCAL|N1B
87138|ANTIHYPERTENSIVES|C2
87134|DIAGNOSTIC AGENTS|T
87132|SYSTEMIC ANTIBACTERIALS|J1
87130|ANTIVIRALS FOR SYSTEMIC USE|J5
87130|Protease inhibitors|J5C2
87120|AMINOGLYCOSIDES|J1K
87109|ANTIVIRALS FOR SYSTEMIC USE|J5
87107|ANALGESICS|N2
87106|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
87105|ANTIHYPERTENSIVES|C2
87105|ACE INHIBITORS, PLAIN|C9A
87104|ANTI-EPILEPTICS|N3
87099|ANTIVIRALS FOR SYSTEMIC USE|J5
87093|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
87093|RESPIRATORY SYSTEM|R
87091|ANTIPSYCHOTICS|N5A
87091|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
87090|DRUGS USED IN DIABETES|A10
87090|HUMAN INSULINS AND ANALOGUES|A10C
87090|Human insulins and analogues, intermediate-acting|A10C2
87089|GROWTH HORMONES|H4C
87081|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
87078|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
87075|CARDIOVASCULAR SYSTEM|C
87067|OPHTHALMOLOGICALS|S1
87064|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
87064|DRUGS USED IN DIABETES|A10
87064|ANTIHYPERTENSIVES|C2
87057|ANTIVIRALS FOR SYSTEMIC USE|J5
87056|DIRECT THROMBIN INHIBITORS|B1E
87055|IMMUNOSUPPRESSIVE AGENTS|L4
87054|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
87047|ANTIVIRALS FOR SYSTEMIC USE|J5
87045|ANTI-EPILEPTICS|N3
87043|ANALGESICS|N2
87037|ANALGESICS|N2
87034|SYSTEMIC ANTIBACTERIALS|J1
87034|CEPHALOSPORINS|J1D
87032|ANTIVIRALS FOR SYSTEMIC USE|J5
87029|SYSTEMIC ANTIBACTERIALS|J1
87028|SYSTEMIC ANTIBACTERIALS|J1
87027|SYSTEMIC ANTIBACTERIALS|J1
87026|ANTI-EPILEPTICS|N3
87025|ANTIVIRALS FOR SYSTEMIC USE|J5
87011|ANTIVIRALS FOR SYSTEMIC USE|J5
87009|PLATELET AGGREGATION INHIBITORS|B1C
86964|PARASITOLOGY|P
86961|SYSTEMIC ANTIBACTERIALS|J1
86959|CARDIOVASCULAR SYSTEM|C
86958|WOUND HEALING AGENTS|D3
86948|OPHTHALMOLOGICALS|S1
86947|ANDROGENS, EXCLUDING G3E, G3F|G3B
86946|ANTIVIRALS FOR SYSTEMIC USE|J5
86945|ANTIVIRALS FOR SYSTEMIC USE|J5
86944|SYSTEMIC ANTIBACTERIALS|J1
86943|SYSTEMIC ANTIBACTERIALS|J1
86942|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86942|DRUGS USED IN DIABETES|A10
86941|ANTI-EPILEPTICS|N3A
86941|NOOTROPICS|N6D
86940|TRANQUILLISERS|N5C
86931|IMMUNOSUPPRESSIVE AGENTS|L4
86928|IMMUNOSTIMULATING AGENTS|L3
86927|IMMUNOSUPPRESSIVE AGENTS|L4
86926|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
86924|SYSTEMIC ANTIBACTERIALS|J1
86923|SYSTEMIC ANTIBACTERIALS|J1
86921|IMMUNOSTIMULATING AGENTS|L3
86920|SYSTEMIC ANTIBACTERIALS|J1
86915|B2-STIMULANTS|R3A
86911|ANTIVIRALS FOR SYSTEMIC USE|J5
86910|DRUGS USED IN DIABETES|A10
86910|Alpha-glucosidase inhibitor antidiabetics|A10B5
86908|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
86907|ANTIVIRALS FOR SYSTEMIC USE|J5
86905|DRUGS USED IN DIABETES|A10
86903|ANTIVIRALS FOR SYSTEMIC USE|J5
86902|ANTIVIRALS FOR SYSTEMIC USE|J5
86901|ANTIVIRALS FOR SYSTEMIC USE|J5
86898|IMMUNOSTIMULATING AGENTS|L3
86893|ANALGESICS|N2
86891|Statins (HMG-CoA reductase inhibitors)|C10A1
86888|CARDIOVASCULAR SYSTEM|C
86887|ANTIVIRALS FOR SYSTEMIC USE|J5
86886|ANTIVIRALS FOR SYSTEMIC USE|J5
86880|ANTI-MALARIALS|P1D
86875|ANALGESICS|N2
86872|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
86866|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
86865|ANALGESICS|N2
86862|ANTI-EPILEPTICS|N3
86858|ANALGESICS|N2
86855|RESPIRATORY SYSTEM|R
86854|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86854|GLUCAGON|H4B
86853|SYSTEMIC ANTIBACTERIALS|J1
86845|ANTIVIRALS FOR SYSTEMIC USE|J5
86842|BPH (benign prostatic hypertrophy) products |G4C
86840|ANTIHYPERTENSIVES|C2
86840|CALCIUM ANTAGONISTS|C8
86838|SYSTEMIC ANTIBACTERIALS|J1
86830|WOUND HEALING AGENTS|D3
86829|WOUND HEALING AGENTS|D3
86826|ANTIVIRALS FOR SYSTEMIC USE|J5
86825|ANTIULCERANTS|A2B
86823|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86821|IMMUNOSUPPRESSIVE AGENTS|L4
86820|ANTIVIRALS FOR SYSTEMIC USE|J5
86818|IMMUNOSUPPRESSIVE AGENTS|L4
86816|ANTIHYPERTENSIVES|C2
86816|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
86815|DIURETICS|C3
86814|OPHTHALMOLOGICALS|S1
86806|ANTIHYPERTENSIVES|C2
86805|DRUGS USED IN DIABETES|A10
86805|ANTIHYPERTENSIVES|C2
86804|DRUGS USED IN DIABETES|A10
86798|SYSTEMIC ANTIBACTERIALS|J1
86798|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
86797|RESPIRATORY SYSTEM|R
86796|DRUGS USED IN DIABETES|A10
86794|ANALGESICS|N2
86785|SYSTEMIC ANTIBACTERIALS|J1
86780|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86780|DRUGS USED IN DIABETES|A10
86779|RESPIRATORY SYSTEM|R
86778|DRUGS USED IN DIABETES|A10
86777|ANTIVIRALS FOR SYSTEMIC USE|J5
86764|ANTIVIRALS FOR SYSTEMIC USE|J5
86763|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
86763|Statins (HMG-CoA reductase inhibitors)|C10A1
86762|ANTIVIRALS FOR SYSTEMIC USE|J5
86757|ANTIHYPERTENSIVES|C2
86755|SYSTEMIC ANTIBACTERIALS|J1
86749|ANTIVIRALS FOR SYSTEMIC USE|J5
86746|FIBRINOLYTICS|B1D
86745|ANTIVIRALS FOR SYSTEMIC USE|J5
86744|ANTIHYPERTENSIVES|C2
86743|ANTIVIRALS FOR SYSTEMIC USE|J5
86742|ANTI-EPILEPTICS|N3
86741|BPH (benign prostatic hypertrophy) products |G4C
86739|ANTIHYPERTENSIVES|C2
86737|ANTIHYPERTENSIVES|C2
86737|BPH (benign prostatic hypertrophy) products |G4C
86735|ANTIHYPERTENSIVES|C2
86732|SYSTEMIC ANTIBACTERIALS|J1
86731|ANALGESICS|N2
86730|ANTIHYPERTENSIVES|C2
86725|IMMUNOSTIMULATING AGENTS|L3
86715|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86712|PARASITOLOGY|P
86712|ANTIPROTOZOALS AND ANTHELMINTICS|P1
86705|ANTIHYPERTENSIVES|C2
86702|ANTIVIRALS FOR SYSTEMIC USE|J5
86702|Interferons, alpha|L3B1
86700|PARASITOLOGY|P
86699|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
86695|DRUGS USED IN DIABETES|A10
86692|ANTIVIRALS FOR SYSTEMIC USE|J5
86688|IMMUNOSTIMULATING AGENTS|L3
86682|PARASITOLOGY|P
86678|ANALGESICS|N2
86677|DRUGS USED IN DIABETES|A10
86676|ANTIVIRALS FOR SYSTEMIC USE|J5
86674|ANTIVIRALS FOR SYSTEMIC USE|J5
86672|SYSTEMIC ANTIBACTERIALS|J1
86670|ANTIHYPERTENSIVES|C2
86670|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
86670|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
86670|Statins (HMG-CoA reductase inhibitors)|C10A1
86669|IMMUNOSUPPRESSIVE AGENTS|L4
86668|ANTIVIRALS FOR SYSTEMIC USE|J5
86667|ANTIVIRALS FOR SYSTEMIC USE|J5
86664|ANTIVIRALS FOR SYSTEMIC USE|J5
86661|ANTIVIRALS FOR SYSTEMIC USE|J5
86660|ANTIVIRALS FOR SYSTEMIC USE|J5
86659|SYSTEMIC ANTIBACTERIALS|J1
86658|SYSTEMIC ANTIBACTERIALS|J1
86657|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
86656|PARASITOLOGY|P
86655|PARASITOLOGY|P
86654|ANTIVIRALS FOR SYSTEMIC USE|J5
86653|ANTIVIRALS FOR SYSTEMIC USE|J5
86652|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
86651|ANTIHYPERTENSIVES|C2
86650|TOPICAL ANTI-ACNE PREPARATIONS|D10A
86648|ANTIHYPERTENSIVES|C2
86643|ANTIVIRALS FOR SYSTEMIC USE|J5
86643|IMMUNOSTIMULATING AGENTS|L3
86642|ANTIVIRALS FOR SYSTEMIC USE|J5
86642|IMMUNOSTIMULATING AGENTS|L3
86639|SYSTEMIC ANTIBACTERIALS|J1
86635|ANTIHYPERTENSIVES|C2
86635|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
86631|ANTI-EPILEPTICS|N3
86630|SYSTEMIC ANTIBACTERIALS|J1
86629|TRANQUILLISERS|N5C
86624|GASTROPROKINETICS|A3F
86622|Colony-stimulating factors|L3A1
86621|DPP-IV inhibitor antidiabetics|A10B6
86614|ANTIHYPERTENSIVES|C2
86614|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
86612|NOOTROPICS|N6D
86610|ANTIVIRALS FOR SYSTEMIC USE|J5
86608|ANALGESICS|N2
86607|CARDIOVASCULAR SYSTEM|C
86603|ANTIVIRALS FOR SYSTEMIC USE|J5
86602|OPHTHALMOLOGICALS|S1
86598|SYSTEMIC ANTIBACTERIALS|J1
86598|AMINOGLYCOSIDES|J1K
86592|ANTI-ARRHYTHMICS|C1B
86590|ANTIHYPERTENSIVES|C2
86590|OPHTHALMOLOGICALS|S1
86589|ANTIVIRALS FOR SYSTEMIC USE|J5
86588|ANTIVIRALS FOR SYSTEMIC USE|J5
86587|SYSTEMIC ANTIBACTERIALS|J1
86585|ANTIVIRALS FOR SYSTEMIC USE|J5
86582|ANTIVIRALS FOR SYSTEMIC USE|J5
86580|ANTIVIRALS FOR SYSTEMIC USE|J5
86579|ANTI-EPILEPTICS|N3A
86574|NOOTROPICS|N6D
86573|PARASITOLOGY|P
86572|TRANQUILLISERS|N5C
86568|WOUND HEALING AGENTS|D3
86564|IMMUNOSTIMULATING AGENTS|L3
86563|ANTIVIRALS FOR SYSTEMIC USE|J5
86562|RESPIRATORY SYSTEM|R
86556|ANALGESICS|N2
86554|ANALGESICS|N2
86551|OPHTHALMOLOGICALS|S1
86547|ANTIFIBRINOLYTICS|B2A
86547|WOUND HEALING AGENTS|D3
86546|IMMUNOSTIMULATING AGENTS|L3
86544|ANTIVIRALS FOR SYSTEMIC USE|J5
86544|IMMUNOSTIMULATING AGENTS|L3
86542|Interferons, gamma|L3B3
86541|ANTIVIRALS FOR SYSTEMIC USE|J5
86540|Interferons, beta|L3B2
86538|ANTIVIRALS FOR SYSTEMIC USE|J5
86533|WOUND HEALING AGENTS|D3
86533|GROWTH HORMONES|H4C
86531|ANTIVIRALS FOR SYSTEMIC USE|J5
86528|SYSTEMIC ANTIBACTERIALS|J1
86527|Interferons, alpha|L3B1
86523|CARDIOVASCULAR SYSTEM|C
86523|ANTIPSYCHOTICS|N5A
86521|ANTIVIRALS FOR SYSTEMIC USE|J5
86519|ANTIHYPERTENSIVES|C2
86518|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
86517|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
86516|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
86514|GLUCAGON|H4B
86512|DRUGS USED IN DIABETES|A10
86512|HUMAN INSULINS AND ANALOGUES|A10C
86512|Human insulins and analogues, intermediate-acting|A10C2
86511|FIBRINOLYTICS|B1D
86510|SYSTEMIC ANTIBACTERIALS|J1
86508|Factors II, VII, IX and X|B2D2
86507|Factor VIII|B2D1
86506|ANTIVIRALS FOR SYSTEMIC USE|J5
86505|SYSTEMIC ANTIBACTERIALS|J1
86503|SYSTEMIC ANTIBACTERIALS|J1
86501|SYSTEMIC ANTIBACTERIALS|J1
86500|SYSTEMIC ANTIBACTERIALS|J1
86499|CARDIOVASCULAR SYSTEM|C
86499|CENTRAL NERVOUS SYSTEM|N
86497|ANTIVIRALS FOR SYSTEMIC USE|J5
86493|SYSTEMIC ANTIBACTERIALS|J1
86493|ANTIVIRALS FOR SYSTEMIC USE|J5
86490|SYSTEMIC ANTIBACTERIALS|J1
86487|ANALGESICS|N2
86486|ANALGESICS|N2
86485|ANALGESICS|N2
86482|ANTI-EPILEPTICS|N3A
86481|ANTI-EPILEPTICS|N3A
86480|ANTI-EPILEPTICS|N3
86479|CENTRAL NERVOUS SYSTEM|N
86477|ANTIVIRALS FOR SYSTEMIC USE|J5
86473|ANTIPSYCHOTICS|N5A
86473|NOOTROPICS|N6D
86471|CARDIOVASCULAR SYSTEM|C
86469|DRUGS USED IN DIABETES|A10
86468|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
86468|SSRI antidepressants|N6A4
86468|SRNI antidepressants|N6A5
86461|SYSTEMIC ANTIBACTERIALS|J1
86458|Protease inhibitors|J5C2
86457|ANALGESICS|N2
86450|MUSCULO-SKELETAL SYSTEM|M
86446|ANALGESICS|N2
86445|IMMUNOSTIMULATING AGENTS|L3
86443|ANTIVIRALS FOR SYSTEMIC USE|J5
86442|ANTIVIRALS FOR SYSTEMIC USE|J5
86440|ANALGESICS|N2
86433|DRUGS USED IN DIABETES|A10
86433|HUMAN INSULINS AND ANALOGUES|A10C
86433|Human insulins and analogues, intermediate-acting|A10C2
86431|SYSTEMIC ANTIBACTERIALS|J1
86430|ANTI-EPILEPTICS|N3A
86430|NOOTROPICS|N6D
86429|ANTIVIRALS FOR SYSTEMIC USE|J5
86426|SYSTEMIC ANTIBACTERIALS|J1
86424|SYSTEMIC ANTIBACTERIALS|J1
86423|ANTIHYPERTENSIVES|C2
86416|ANTIVIRALS FOR SYSTEMIC USE|J5
86414|CARDIOVASCULAR SYSTEM|C
86405|ANALGESICS|N2
86405|ANTI-EPILEPTICS|N3
86401|ANALGESICS|N2
86401|ANTI-EPILEPTICS|N3
86401|TRANQUILLISERS|N5C
86397|SYSTEMIC ANTIBACTERIALS|J1
86395|ANALGESICS|N2
86394|ANTIVIRALS FOR SYSTEMIC USE|J5
86393|ANTIVIRALS FOR SYSTEMIC USE|J5
86391|IMMUNOSTIMULATING AGENTS|L3
86386|NOOTROPICS|N6D
86385|NOOTROPICS|N6D
86374|CARDIOVASCULAR SYSTEM|C
86369|AMINOGLYCOSIDES|J1K
86368|CARDIOVASCULAR SYSTEM|C
86367|ANTI-EPILEPTICS|N3
86363|CARDIOVASCULAR SYSTEM|C
86360|Ocular antineovascularisation products|S1P
86359|OPHTHALMOLOGICALS|S1
86358|SYSTEMIC ANTIBACTERIALS|J1
86355|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86352|ANTIVIRALS FOR SYSTEMIC USE|J5
86351|ANTIVIRALS FOR SYSTEMIC USE|J5
86351|Coxibs|M1A3
86350|ANTIHYPERTENSIVES|C2
86349|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
86349|SSRI antidepressants|N6A4
86349|SRNI antidepressants|N6A5
86344|OPHTHALMOLOGICALS|S1
86337|SYSTEMIC ANTIBACTERIALS|J1
86331|SYSTEMIC ANTIBACTERIALS|J1
86330|DRUGS USED IN DIABETES|A10
86328|ANTIVIRALS FOR SYSTEMIC USE|J5
86324|SYSTEMIC ANTIBACTERIALS|J1
86323|ANTI-EPILEPTICS|N3
86320|ANTIPROTOZOALS AND ANTHELMINTICS|P1
86317|SYSTEMIC ANTIBACTERIALS|J1
86314|IMMUNOSUPPRESSIVE AGENTS|L4
86312|ANTIPROTOZOALS AND ANTHELMINTICS|P1
86307|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
86307|SSRI antidepressants|N6A4
86307|SRNI antidepressants|N6A5
86305|DIAGNOSTIC AGENTS|T
86303|WOUND HEALING AGENTS|D3
86302|ANTITUSSIVES|R5D
86296|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86296|DRUGS USED IN DIABETES|A10
86296|CARDIOVASCULAR SYSTEM|C
86292|SYSTEMIC ANTIBACTERIALS|J1
86287|ANTIVIRALS FOR SYSTEMIC USE|J5
86283|CARDIAC THERAPY|C1
86283|WOUND HEALING AGENTS|D3
86274|CENTRAL NERVOUS SYSTEM|N
86272|ANTIVIRALS FOR SYSTEMIC USE|J5
86272|NOOTROPICS|N6D
86270|IMMUNOSTIMULATING AGENTS|L3
86268|CENTRAL NERVOUS SYSTEM|N
86266|ANTIPSYCHOTICS|N5A
86264|ANTIHYPERTENSIVES|C2
86254|WOUND HEALING AGENTS|D3
86250|ANTIVIRALS FOR SYSTEMIC USE|J5
86250|INTERFERONS|L3B
86249|SYSTEMIC ANTIBACTERIALS|J1
86248|ANTIVIRALS FOR SYSTEMIC USE|J5
86248|INTERFERONS|L3B
86247|ANTIVIRALS FOR SYSTEMIC USE|J5
86247|INTERFERONS|L3B
86244|ANTIVIRALS FOR SYSTEMIC USE|J5
86239|Statins (HMG-CoA reductase inhibitors)|C10A1
86238|NOOTROPICS|N6D
86238|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
86237|CARDIOVASCULAR SYSTEM|C
86237|WOUND HEALING AGENTS|D3
86230|CARDIOVASCULAR SYSTEM|C
86228|NOOTROPICS|N6D
86214|PARASITOLOGY|P
86212|PARASITOLOGY|P
86209|IMMUNOSTIMULATING AGENTS|L3
86207|FIBRINOLYTICS|B1D
86206|WOUND HEALING AGENTS|D3
86205|SYSTEMIC ANTIBACTERIALS|J1
86202|ANTIVIRALS FOR SYSTEMIC USE|J5
86200|ANTIPROTOZOALS AND ANTHELMINTICS|P1
86193|RESPIRATORY SYSTEM|R
86192|ANTIHYPERTENSIVES|C2
86188|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
86183|ANTIMETABOLITES|L1B
86182|ANTIVIRALS FOR SYSTEMIC USE|J5
86179|IMMUNOSUPPRESSIVE AGENTS|L4
86175|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86175|DRUGS USED IN DIABETES|A10
86173|SYSTEMIC ANTIBACTERIALS|J1
86173|ANTIPROTOZOALS AND ANTHELMINTICS|P1
86172|ANTIVIRALS FOR SYSTEMIC USE|J5
86166|WOUND HEALING AGENTS|D3
86162|SYSTEMIC ANTIBACTERIALS|J1
86156|CARDIAC THERAPY|C1
86154|ANTIVIRALS FOR SYSTEMIC USE|J5
86154|Interferons, alpha|L3B1
86153|ANTIHYPERTENSIVES|C2
86151|ANTIVIRALS FOR SYSTEMIC USE|J5
86148|ANTIVIRALS FOR SYSTEMIC USE|J5
86146|SYSTEMIC ANTIBACTERIALS|J1
86133|ANTIVIRALS FOR SYSTEMIC USE|J5
86127|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86127|WOUND HEALING AGENTS|D3
86124|ANTIULCERANTS|A2B
86123|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
86123|Statins (HMG-CoA reductase inhibitors)|C10A1
86122|ANTIVIRALS FOR SYSTEMIC USE|J5
86120|NOOTROPICS|N6D
86119|SYSTEMIC ANTIBACTERIALS|J1
86114|ANALGESICS|N2
86110|ANTIVIRALS FOR SYSTEMIC USE|J5
86109|ANTIVIRALS FOR SYSTEMIC USE|J5
86108|SYSTEMIC ANTIBACTERIALS|J1
86100|RESPIRATORY SYSTEM|R
86089|ANTIVIRALS FOR SYSTEMIC USE|J5
86084|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
86083|IMMUNOSUPPRESSIVE AGENTS|L4
86077|ANALGESICS|N2
86076|SYSTEMIC ANTIBACTERIALS|J1
86074|ANTIVIRALS FOR SYSTEMIC USE|J5
86073|ANALGESICS|N2
86071|WOUND HEALING AGENTS|D3
86068|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86066|ANTIVIRALS FOR SYSTEMIC USE|J5
86066|IMMUNOSTIMULATING AGENTS|L3
86062|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86061|ANTIVIRALS FOR SYSTEMIC USE|J5
86057|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
86057|DRUGS USED IN DIABETES|A10
86057|GLUCAGON|H4B
86055|SYSTEMIC ANTIBACTERIALS|J1
86054|OPHTHALMOLOGICALS|S1
86053|OPHTHALMOLOGICALS|S1
86052|CARDIOVASCULAR SYSTEM|C
86052|CALCIUM ANTAGONISTS|C8
86050|Coxibs|M1A3
86050|ANALGESICS|N2
86048|IMMUNOSTIMULATING AGENTS|L3
86046|IMMUNOSUPPRESSIVE AGENTS|L4
86043|ANTIVIRALS FOR SYSTEMIC USE|J5
86041|Interferons, beta|L3B2
86038|Topical dermatological antifungals|D1A1
86038|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
86034|ANTIVIRALS FOR SYSTEMIC USE|J5
86032|ANTIVIRALS FOR SYSTEMIC USE|J5
86031|ANTIVIRALS FOR SYSTEMIC USE|J5
86029|SYSTEMIC ANTIBACTERIALS|J1
86027|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
86027|SSRI antidepressants|N6A4
86026|ANTIVIRALS FOR SYSTEMIC USE|J5
86025|SYSTEMIC ANTIBACTERIALS|J1
86023|OPHTHALMOLOGICALS|S1
86021|SYSTEMIC ANTIBACTERIALS|J1
86020|SSRI antidepressants|N6A4
86020|SRNI antidepressants|N6A5
86018|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
86016|ANTIVIRALS FOR SYSTEMIC USE|J5
86013|CALCIUM ANTAGONISTS|C8
86012|DIURETICS|C3
86010|SYSTEMIC ANTIBACTERIALS|J1
86006|WOUND HEALING AGENTS|D3
86003|NOOTROPICS|N6D
86000|OPHTHALMOLOGICALS|S1
85999|LUNG SURFACTANTS|R7C
85996|ANTIVIRALS FOR SYSTEMIC USE|J5
85996|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
85996|Protease inhibitors|J5C2
85994|ANTIVIRALS FOR SYSTEMIC USE|J5
85994|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
85994|Protease inhibitors|J5C2
85991|ANTIVIRALS FOR SYSTEMIC USE|J5
85991|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
85991|Non-nucleoside reverse transcriptase inhibitors|J5C3
85988|IMMUNOSTIMULATING AGENTS|L3
85984|ANALGESICS|N2
85981|IMMUNOSUPPRESSIVE AGENTS|L4
85978|RADIODIAGNOSTIC AGENTS|T1G
85976|B2-STIMULANTS|R3A
85972|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
85966|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
85966|SSRI antidepressants|N6A4
85966|SRNI antidepressants|N6A5
85964|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
85962|ANTIVIRALS FOR SYSTEMIC USE|J5
85961|SYSTEMIC ANTIBACTERIALS|J1
85960|SYSTEMIC ANTIBACTERIALS|J1
85954|ANALGESICS|N2
85950|IMMUNOSUPPRESSIVE AGENTS|L4
85949|NOOTROPICS|N6D
85945|WOUND HEALING AGENTS|D3
85936|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
85934|ANTIHYPERTENSIVES|C2
85923|THYROID THERAPY|H3
85920|Ocular antineovascularisation products|S1P
85919|Topical dermatological antifungals|D1A1
85919|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
85918|DRUGS USED IN DIABETES|A10
85918|HUMAN INSULINS AND ANALOGUES|A10C
85918|Human insulins and analogues, fast-acting|A10C1
85902|DRUGS USED IN DIABETES|A10
85902|NOOTROPICS|N6D
85900|ANALGESICS|N2
85897|WOUND HEALING AGENTS|D3
85897|OPHTHALMOLOGICALS|S1
85896|GLUCAGON|H4B
85895|ANTIHYPERTENSIVES|C2
85895|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
85894|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85890|SYSTEMIC ANTIBACTERIALS|J1
85886|DRUGS USED IN DIABETES|A10
85883|ANTIVIRALS FOR SYSTEMIC USE|J5
85881|DRUGS USED IN DIABETES|A10
85879|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
85876|DRUGS USED IN DIABETES|A10
85875|ANTIHYPERTENSIVES|C2
85873|CENTRAL NERVOUS SYSTEM|N
85872|PLATELET AGGREGATION INHIBITORS|B1C
85871|DRUGS USED IN DIABETES|A10
85869|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
85868|ANALGESICS|N2
85867|IMMUNOSUPPRESSIVE AGENTS|L4
85865|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
85849|RADIODIAGNOSTIC AGENTS|T1G
85848|RADIODIAGNOSTIC AGENTS|T1G
85846|ANTI-EPILEPTICS|N3A
85843|SYSTEMIC ANTIBACTERIALS|J1
85841|RADIODIAGNOSTIC AGENTS|T1G
85839|WOUND HEALING AGENTS|D3
85838|RADIODIAGNOSTIC AGENTS|T1G
85837|CENTRAL NERVOUS SYSTEM|N
85835|DIAGNOSTIC AGENTS|T
85834|RADIODIAGNOSTIC AGENTS|T1G
85833|IMMUNOSUPPRESSIVE AGENTS|L4
85832|RADIODIAGNOSTIC AGENTS|T1G
85831|IMMUNOSUPPRESSIVE AGENTS|L4
85830|RADIODIAGNOSTIC AGENTS|T1G
85828|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
85828|IMMUNOSUPPRESSIVE AGENTS|L4
85827|RADIODIAGNOSTIC AGENTS|T1G
85821|ANTIVIRALS FOR SYSTEMIC USE|J5
85817|RADIODIAGNOSTIC AGENTS|T1G
85813|DRUGS USED IN DIABETES|A10
85801|CENTRAL NERVOUS SYSTEM|N
85800|CENTRAL NERVOUS SYSTEM|N
85799|CENTRAL NERVOUS SYSTEM|N
85794|CENTRAL NERVOUS SYSTEM|N
85793|ANTIHYPERTENSIVES|C2
85792|ANTI-ARRHYTHMICS|C1B
85791|RADIODIAGNOSTIC AGENTS|T1G
85787|NOOTROPICS|N6D
85784|SYSTEMIC ANTIBACTERIALS|J1
85780|NOOTROPICS|N6D
85775|ANTIVIRALS FOR SYSTEMIC USE|J5
85774|SYSTEMIC ANTIBACTERIALS|J1
85773|ANALGESICS|N2
85771|IMMUNOSUPPRESSIVE AGENTS|L4
85765|ANTI-EPILEPTICS|N3
85758|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
85757|WOUND HEALING AGENTS|D3
85755|ANTIVIRALS FOR SYSTEMIC USE|J5
85748|CARDIOVASCULAR SYSTEM|C
85747|DERMATOLOGICALS|D
85747|ANTIVIRALS FOR SYSTEMIC USE|J5
85746|ANTIVIRALS FOR SYSTEMIC USE|J5
85743|ANTIHYPERTENSIVES|C2
85742|ANTIHYPERTENSIVES|C2
85740|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85740|DRUGS USED IN DIABETES|A10
85739|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85739|DRUGS USED IN DIABETES|A10
85738|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85738|DRUGS USED IN DIABETES|A10
85737|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85737|DRUGS USED IN DIABETES|A10
85735|ANTIPSYCHOTICS|N5A
85734|ANTIVIRALS FOR SYSTEMIC USE|J5
85734|IMMUNOSTIMULATING AGENTS|L3
85733|ANTIVIRALS FOR SYSTEMIC USE|J5
85732|ANTIVIRALS FOR SYSTEMIC USE|J5
85731|ANAESTHETICS, LOCAL|N1B
85725|APPETITE STIMULANTS|A15
85725|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
85722|IMMUNOSTIMULATING AGENTS|L3
85720|NOOTROPICS|N6D
85711|ANTI-EPILEPTICS|N3A
85710|ANTIHYPERTENSIVES|C2
85710|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
85708|RADIODIAGNOSTIC AGENTS|T1G
85707|RADIODIAGNOSTIC AGENTS|T1G
85705|RADIODIAGNOSTIC AGENTS|T1G
85697|IMMUNOSTIMULATING AGENTS|L3
85694|AMOEBICIDES|P1A
85687|RADIODIAGNOSTIC AGENTS|T1G
85686|OPHTHALMOLOGICALS|S1
85685|ANTI-ACNE PREPARATIONS|D10
85681|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85681|DRUGS USED IN DIABETES|A10
85680|ANTIVIRALS FOR SYSTEMIC USE|J5
85676|NOOTROPICS|N6D
85672|ANTIVIRALS FOR SYSTEMIC USE|J5
85671|ALKYLATING AGENTS|L1A
85667|NOOTROPICS|N6D
85660|Statins (HMG-CoA reductase inhibitors)|C10A1
85656|IMMUNOSTIMULATING AGENTS|L3
85654|IMMUNOSTIMULATING AGENTS|L3
85649|ANALGESICS|N2
85648|HUMAN INSULINS AND ANALOGUES|A10C
85648|Human insulins and analogues, fast-acting|A10C1
85647|ANTIVIRALS FOR SYSTEMIC USE|J5
85647|Interferons, alpha|L3B1
85646|SYSTEMIC ANTIBACTERIALS|J1
85645|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
85644|ANTIHYPERTENSIVES|C2
85634|HYPNOTICS/SEDATIVES|N5B
85631|ANTI-EPILEPTICS|N3A
85630|DRUGS USED IN DIABETES|A10
85629|OPHTHALMOLOGICALS|S1
85628|WOUND HEALING AGENTS|D3
85622|OPHTHALMOLOGICALS|S1
85621|OPHTHALMOLOGICALS|S1
85617|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85615|ANTIHYPERTENSIVES|C2
85612|NOOTROPICS|N6D
85610|ANALGESICS|N2
85605|ANTIPSYCHOTICS|N5A
85602|HUMAN INSULINS AND ANALOGUES|A10C
85602|Human insulins and analogues, long-acting|A10C5
85585|WOUND HEALING AGENTS|D3
85578|CENTRAL NERVOUS SYSTEM|N
85574|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
85573|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
85567|SYSTEMIC ANTIBACTERIALS|J1
85565|ANTIHYPERTENSIVES|C2
85565|OPHTHALMOLOGICALS|S1
85563|IMMUNOSUPPRESSIVE AGENTS|L4
85559|ANTIVIRALS FOR SYSTEMIC USE|J5
85557|IMMUNOSUPPRESSIVE AGENTS|L4
85555|ANTIVIRALS FOR SYSTEMIC USE|J5
85553|ANTI-ARRHYTHMICS|C1B
85552|CENTRAL NERVOUS SYSTEM|N
85551|NOOTROPICS|N6D
85548|ANTI-ACNE PREPARATIONS|D10
85547|ANTIVIRALS FOR SYSTEMIC USE|J5
85544|ANTIPROTOZOALS AND ANTHELMINTICS|P1
85543|ANTIVIRALS FOR SYSTEMIC USE|J5
85542|SYSTEMIC ANTIBACTERIALS|J1
85540|ANALGESICS|N2
85537|Erectile dysfunction products|G4B3
85535|ANTIVIRALS FOR SYSTEMIC USE|J5
85534|OPHTHALMOLOGICALS|S1
85526|IMMUNOSUPPRESSIVE AGENTS|L4
85523|ANALGESICS|N2
85522|ANALGESICS|N2
85521|RESPIRATORY SYSTEM|R
85516|HEPARINS |B1B
85515|IMMUNOSUPPRESSIVE AGENTS|L4
85514|IMMUNOSTIMULATING AGENTS|L3
85513|HUMAN INSULINS AND ANALOGUES|A10C
85513|Human insulins and analogues, long-acting|A10C5
85512|ANTIVIRALS FOR SYSTEMIC USE|J5
85507|CALCIUM ANTAGONISTS|C8
85507|ANALGESICS|N2
85507|ANTI-MIGRAINE PREPARATIONS|N2C
85501|ANTIHYPERTENSIVES|C2
85497|ALKYLATING AGENTS|L1A
85496|ANALGESICS|N2
85484|NOOTROPICS|N6D
85481|PLATELET AGGREGATION INHIBITORS|B1C
85481|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
85476|ANTIVIRALS FOR SYSTEMIC USE|J5
85475|ANTIVIRALS FOR SYSTEMIC USE|J5
85473|PARASITOLOGY|P
85471|PARASITOLOGY|P
85466|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85465|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85463|ANTIVIRALS FOR SYSTEMIC USE|J5
85453|SYSTEMIC ANTIBACTERIALS|J1
85452|Statins (HMG-CoA reductase inhibitors)|C10A1
85450|ANTIVIRALS FOR SYSTEMIC USE|J5
85443|SYSTEMIC ANTIBACTERIALS|J1
85436|ANTIULCERANTS|A2B
85434|RADIODIAGNOSTIC AGENTS|T1G
85433|PARASITOLOGY|P
85419|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
85418|ANTIVIRALS FOR SYSTEMIC USE|J5
85415|ANTI-ACNE PREPARATIONS|D10
85397|Statins (HMG-CoA reductase inhibitors)|C10A1
85397|NOOTROPICS|N6D
85396|ANALGESICS|N2
85395|SYSTEMIC ANTIBACTERIALS|J1
85392|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
85392|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
85392|Statins (HMG-CoA reductase inhibitors)|C10A1
85385|DIAGNOSTIC AGENTS|T
85376|ANTIVIRALS FOR SYSTEMIC USE|J5
85375|ANTIHYPERTENSIVES|C2
85373|ANTI-EPILEPTICS|N3
85362|ANTIVIRALS FOR SYSTEMIC USE|J5
85356|ANTIVIRALS FOR SYSTEMIC USE|J5
85355|ANALGESICS|N2
85354|ANALGESICS|N2
85352|NOOTROPICS|N6D
85352|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
85351|NOOTROPICS|N6D
85351|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
85348|ANTIVIRALS FOR SYSTEMIC USE|J5
85347|ANTI-EPILEPTICS|N3
85346|ANTI-EPILEPTICS|N3
85338|ANTIVIRALS FOR SYSTEMIC USE|J5
85329|ANTIPSYCHOTICS|N5A
85328|SYSTEMIC ANTIBACTERIALS|J1
85327|ANTIVIRALS FOR SYSTEMIC USE|J5
85325|ANTIVIRALS FOR SYSTEMIC USE|J5
85324|ANTIMETABOLITES|L1B
85323|SYSTEMIC ANTIBACTERIALS|J1
85320|ANTI-ACNE PREPARATIONS|D10
85320|SYSTEMIC ANTIBACTERIALS|J1
85317|IMMUNOSUPPRESSIVE AGENTS|L4
85316|ANALGESICS|N2
85312|ANTIVIRALS FOR SYSTEMIC USE|J5
85310|PARASITOLOGY|P
85310|ANTIPROTOZOALS AND ANTHELMINTICS|P1
85309|ANTI-EPILEPTICS|N3
85307|ANTIVIRALS FOR SYSTEMIC USE|J5
85305|ANTI-EPILEPTICS|N3A
85305|ANTIPSYCHOTICS|N5A
85302|ANTIVIRALS FOR SYSTEMIC USE|J5
85298|OPHTHALMOLOGICALS|S1
85297|CARDIAC THERAPY|C1
85297|ANALGESICS|N2
85292|ANTI-EPILEPTICS|N3
85291|IMMUNOSTIMULATING AGENTS|L3
85290|RESPIRATORY SYSTEM|R
85289|IMMUNOSUPPRESSIVE AGENTS|L4
85288|CARDIOVASCULAR SYSTEM|C
85275|ANTIVIRALS FOR SYSTEMIC USE|J5
85274|GROWTH HORMONES|H4C
85264|ANTIVIRALS FOR SYSTEMIC USE|J5
85263|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
85262|ANTIVIRALS FOR SYSTEMIC USE|J5
85261|ANTIVIRALS FOR SYSTEMIC USE|J5
85259|SYSTEMIC ANTIBACTERIALS|J1
85254|ANTI-GOUT PREPARATIONS|M4
85250|ANTIVIRALS FOR SYSTEMIC USE|J5
85249|SYSTEMIC ANTIBACTERIALS|J1
85248|ANTIVIRALS FOR SYSTEMIC USE|J5
85244|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85243|MUSCULO-SKELETAL SYSTEM|M
85235|ANTI-MALARIALS|P1D
85234|OPHTHALMOLOGICALS|S1
85224|MUSCLE RELAXANTS|M3
85224|PARASITOLOGY|P
85224|ANTI-MALARIALS|P1D
85223|PARASITOLOGY|P
85218|CARDIAC THERAPY|C1
85217|PARASITOLOGY|P
85214|ANTIVIRALS FOR SYSTEMIC USE|J5
85214|IMMUNOSTIMULATING AGENTS|L3
85213|ANTIVIRALS FOR SYSTEMIC USE|J5
85212|DERMATOLOGICALS|D
85211|RESPIRATORY SYSTEM|R
85209|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
85208|DERMATOLOGICALS|D
85204|ANTIVIRALS FOR SYSTEMIC USE|J5
85203|ANTIVIRALS FOR SYSTEMIC USE|J5
85200|ANTIHYPERTENSIVES|C2
85199|WOUND HEALING AGENTS|D3
85197|OPHTHALMOLOGICALS|S1
85196|ANTIVIRALS FOR SYSTEMIC USE|J5
85192|ANTIEMETICS AND ANTINAUSEANTS|A4
85192|Vitamin B6 (pyridoxine), plain|A11X2
85192|SYSTEMIC ANTIHISTAMINES|R6
85191|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
85189|IMMUNOSUPPRESSIVE AGENTS|L4
85185|SYSTEMIC ANTIBACTERIALS|J1
85184|OPHTHALMOLOGICALS|S1
85182|ANTI-EPILEPTICS|N3A
85177|ANTI-EPILEPTICS|N3A
85168|ANTIVIRALS FOR SYSTEMIC USE|J5
85167|ANTIVIRALS FOR SYSTEMIC USE|J5
85165|ANTI-EPILEPTICS|N3A
85163|GASTROPROKINETICS|A3F
85162|HUMAN INSULINS AND ANALOGUES|A10C
85162|Human insulins and analogues, fast-acting|A10C1
85162|Human insulins and analogues, intermediate-acting|A10C2
85160|ANTIVIRALS FOR SYSTEMIC USE|J5
85156|SYSTEMIC ANTIBACTERIALS|J1
85155|ANTIVIRALS FOR SYSTEMIC USE|J5
85150|OPHTHALMOLOGICALS|S1
85149|OPHTHALMOLOGICALS|S1
85139|IMMUNOSUPPRESSIVE AGENTS|L4
85138|ANTIVIRALS FOR SYSTEMIC USE|J5
85137|ANTIHYPERTENSIVES|C2
85137|CALCIUM ANTAGONISTS|C8
85136|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
85135|ANTI-EPILEPTICS|N3A
85134|ANTIVIRALS FOR SYSTEMIC USE|J5
85132|DRUGS USED IN DIABETES|A10
85130|DRUGS USED IN DIABETES|A10
85125|OPHTHALMOLOGICAL ANTI-INFECTIVES|S1A
85122|DRUGS USED IN DIABETES|A10
85121|RESPIRATORY SYSTEM|R
85116|ANALGESICS|N2
85113|ANTIVIRALS FOR SYSTEMIC USE|J5
85112|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
85111|SYSTEMIC ANTIBACTERIALS|J1
85108|ANTIVIRALS FOR SYSTEMIC USE|J5
85107|ANTIVIRALS FOR SYSTEMIC USE|J5
85106|ANTIVIRALS FOR SYSTEMIC USE|J5
85106|IMMUNOSTIMULATING AGENTS|L3
85101|ANTIVIRALS FOR SYSTEMIC USE|J5
85098|ANALGESICS|N2
85097|ANALGESICS|N2
85096|PARASITOLOGY|P
85095|PARASITOLOGY|P
85094|TRANQUILLISERS|N5C
85092|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
85087|FIBRINOLYTICS|B1D
85086|FIBRINOLYTICS|B1D
85083|ANTI-EPILEPTICS|N3A
85080|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
85079|ANALGESICS|N2
85077|RADIODIAGNOSTIC AGENTS|T1G
85076|ANTI-EPILEPTICS|N3A
85072|ANTIVIRALS FOR SYSTEMIC USE|J5
85070|FIBRINOLYTICS|B1D
85065|EXPECTORANTS|R5C
85064|SYSTEMIC ANTIBACTERIALS|J1
85059|ANALGESICS|N2
85052|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
85047|DERMATOLOGICALS|D
85047|ANTI-ACNE PREPARATIONS|D10
85046|ANALGESICS|N2
85034|SYSTEMIC ANTIBACTERIALS|J1
85028|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
85026|DRUGS USED IN DIABETES|A10
85021|DRUGS USED IN DIABETES|A10
85021|HUMAN INSULINS AND ANALOGUES|A10C
85021|Human insulins and analogues, intermediate-acting|A10C2
85017|ANTIPSYCHOTICS|N5A
85015|CARDIOVASCULAR SYSTEM|C
85015|WOUND HEALING AGENTS|D3
85012|ANTIPSYCHOTICS|N5A
85011|ANTIPSYCHOTICS|N5A
85008|B2-STIMULANTS|R3A
85005|RESPIRATORY SYSTEM|R
85003|ANTIPSYCHOTICS|N5A
84994|ANALGESICS|N2
84989|PARASITOLOGY|P
84987|ANTIULCERANTS|A2B
84987|PLATELET AGGREGATION INHIBITORS|B1C
84986|OPHTHALMOLOGICALS|S1
84984|OPHTHALMOLOGICALS|S1
84983|ANTIVIRALS FOR SYSTEMIC USE|J5
84978|ANTIPSYCHOTICS|N5A
84975|IMMUNOSTIMULATING AGENTS|L3
84972|PLATELET AGGREGATION INHIBITORS|B1C
84971|PLATELET AGGREGATION INHIBITORS|B1C
84969|ANTIVIRALS FOR SYSTEMIC USE|J5
84964|PLATELET AGGREGATION INHIBITORS|B1C
84964|CARDIOVASCULAR SYSTEM|C
84963|DRUGS USED IN DIABETES|A10
84963|HUMAN INSULINS AND ANALOGUES|A10C
84963|Human insulins and analogues, long-acting|A10C5
84956|ANTIVIRALS FOR SYSTEMIC USE|J5
84955|SYSTEMIC ANTIBACTERIALS|J1
84945|SYSTEMIC ANTIBACTERIALS|J1
84944|PLATELET AGGREGATION INHIBITORS|B1C
84944|DIRECT THROMBIN INHIBITORS|B1E
84943|RESPIRATORY SYSTEM|R
84942|SYSTEMIC ANTIBACTERIALS|J1
84938|CALCIUM ANTAGONISTS|C8
84936|ANTIVIRALS FOR SYSTEMIC USE|J5
84936|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
84933|DPP-IV inhibitor antidiabetics|A10B6
84932|ANTIVIRALS FOR SYSTEMIC USE|J5
84930|ANTIVIRALS FOR SYSTEMIC USE|J5
84930|VACCINES|J7
84921|IMMUNOSUPPRESSIVE AGENTS|L4
84917|OPHTHALMOLOGICALS|S1
84917|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
84916|ANTIVIRALS FOR SYSTEMIC USE|J5
84915|ANTIVIRALS FOR SYSTEMIC USE|J5
84913|ANTIVIRALS FOR SYSTEMIC USE|J5
84911|THYROID THERAPY|H3
84911|OPHTHALMOLOGICALS|S1
84908|HUMAN INSULINS AND ANALOGUES|A10C
84908|Human insulins and analogues, intermediate-acting|A10C2
84907|RESPIRATORY SYSTEM|R
84904|OPHTHALMOLOGICALS|S1
84900|SYSTEMIC ANTIBACTERIALS|J1
84893|SYSTEMIC ANTIBACTERIALS|J1
84891|SYSTEMIC ANTIBACTERIALS|J1
84887|ANTIULCERANTS|A2B
84883|ANALGESICS|N2
84871|ALKYLATING AGENTS|L1A
84870|ALKYLATING AGENTS|L1A
84869|DPP-IV inhibitor antidiabetics|A10B6
84865|Biguanide antidiabetics|A10B2
84863|SYSTEMIC ANTIBACTERIALS|J1
84859|GASTROPROKINETICS|A3F
84858|ANTITUSSIVES|R5D
84849|PARASITOLOGY|P
84849|ANTI-MALARIALS|P1D
84848|ANTI-MALARIALS|P1D
84846|IMMUNOSTIMULATING AGENTS|L3
84845|IMMUNOSTIMULATING AGENTS|L3
84840|FIBRINOLYTICS|B1D
84832|ANTI-EPILEPTICS|N3A
84831|NOOTROPICS|N6D
84826|ANTIVIRALS FOR SYSTEMIC USE|J5
84826|IMMUNOSTIMULATING AGENTS|L3
84825|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
84824|SYSTEMIC ANTIBACTERIALS|J1
84823|SYSTEMIC ANTIBACTERIALS|J1
84822|PLATELET AGGREGATION INHIBITORS|B1C
84821|PLATELET AGGREGATION INHIBITORS|B1C
84820|SYSTEMIC ANTIBACTERIALS|J1
84820|ANTIVIRALS FOR SYSTEMIC USE|J5
84820|PARASITOLOGY|P
84819|ANTIHYPERTENSIVES|C2
84818|ANTIVIRALS FOR SYSTEMIC USE|J5
84817|ANTIVIRALS FOR SYSTEMIC USE|J5
84815|ANTI-ACNE PREPARATIONS|D10
84815|TOPICAL ANTI-ACNE PREPARATIONS|D10A
84813|ANTI-EPILEPTICS|N3
84812|SYSTEMIC ANTIBACTERIALS|J1
84802|SYSTEMIC ANTIBACTERIALS|J1
84800|ANTIVIRALS FOR SYSTEMIC USE|J5
84800|IMMUNOSTIMULATING AGENTS|L3
84795|ANTIEMETICS AND ANTINAUSEANTS|A4
84787|Non-nucleoside reverse transcriptase inhibitors|J5C3
84782|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
84781|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
84780|PLATELET AGGREGATION INHIBITORS|B1C
84780|FIBRINOLYTICS|B1D
84776|OPHTHALMOLOGICALS|S1
84774|OPHTHALMOLOGICALS|S1
84773|OPHTHALMOLOGICALS|S1
84772|MRI AGENTS|T1E
84770|ANTIVIRALS FOR SYSTEMIC USE|J5
84767|ANTIHYPERTENSIVES|C2
84767|CALCIUM ANTAGONISTS|C8
84765|IMMUNOSUPPRESSIVE AGENTS|L4
84755|DIAGNOSTIC AGENTS|T
84751|ANTI-EPILEPTICS|N3A
84750|ANTIVIRALS FOR SYSTEMIC USE|J5
84742|ANTIHYPERTENSIVES|C2
84742|DIURETICS|C3
84742|ACE INHIBITORS, PLAIN|C9A
84740|SYSTEMIC ANTIBACTERIALS|J1
84739|CARDIOVASCULAR SYSTEM|C
84736|ANTIVIRALS FOR SYSTEMIC USE|J5
84732|ANTIHYPERTENSIVES|C2
84731|IMMUNOSUPPRESSIVE AGENTS|L4
84727|OPHTHALMOLOGICALS|S1
84727|Ocular antineovascularisation products|S1P
84723|RADIODIAGNOSTIC AGENTS|T1G
84716|DRUGS USED IN DIABETES|A10
84714|DRUGS USED IN DIABETES|A10
84710|PLATELET AGGREGATION INHIBITORS|B1C
84707|IMMUNOSUPPRESSIVE AGENTS|L4
84703|WOUND HEALING AGENTS|D3
84700|SYSTEMIC ANTIBACTERIALS|J1
84698|SYSTEMIC ANTIBACTERIALS|J1
84696|ANTIVIRALS FOR SYSTEMIC USE|J5
84694|ANTIVIRALS FOR SYSTEMIC USE|J5
84692|ANTIVIRALS FOR SYSTEMIC USE|J5
84689|ANTIVIRALS FOR SYSTEMIC USE|J5
84686|SYSTEMIC ANTIHISTAMINES|R6
84682|ANTIVIRALS FOR SYSTEMIC USE|J5
84677|ANALGESICS|N2
84675|ANTIVIRALS FOR SYSTEMIC USE|J5
84674|SYSTEMIC ANTIBACTERIALS|J1
84673|OPHTHALMOLOGICALS|S1
84672|DERMATOLOGICALS|D
84669|OPHTHALMOLOGICALS|S1
84668|CARDIOVASCULAR SYSTEM|C
84667|CARDIOVASCULAR SYSTEM|C
84666|CARDIOVASCULAR SYSTEM|C
84664|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
84659|ANALGESICS|N2
84658|ANALGESICS|N2
84657|ANTIVIRALS FOR SYSTEMIC USE|J5
84657|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
84654|CARDIOVASCULAR SYSTEM|C
84651|IMMUNOSUPPRESSIVE AGENTS|L4
84650|NOOTROPICS|N6D
84647|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
84646|ANTIVIRALS FOR SYSTEMIC USE|J5
84645|ANTIVIRALS FOR SYSTEMIC USE|J5
84641|ANTIVIRALS FOR SYSTEMIC USE|J5
84639|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
84636|Topical dermatological antifungals|D1A1
84636|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
84635|ANTI-ARRHYTHMICS|C1B
84633|ANTIVIRALS FOR SYSTEMIC USE|J5
84630|SYSTEMIC ANTIBACTERIALS|J1
84623|ANTIVIRALS FOR SYSTEMIC USE|J5
84620|DRUGS USED IN DIABETES|A10
84618|IMMUNOSUPPRESSIVE AGENTS|L4
84616|DIURETICS|C3
84614|ANALGESICS|N2
84613|ANTI-EPILEPTICS|N3
84610|SYSTEMIC ANTIBACTERIALS|J1
84609|ANALGESICS|N2
84608|CARDIOVASCULAR SYSTEM|C
84603|ANDROGENS, EXCLUDING G3E, G3F|G3B
84602|ANTIVIRALS FOR SYSTEMIC USE|J5
84600|VACCINES|J7
84598|ANTIVIRALS FOR SYSTEMIC USE|J5
84593|SYSTEMIC ANTIBACTERIALS|J1
84592|ANTIVIRALS FOR SYSTEMIC USE|J5
84590|ANTIVIRALS FOR SYSTEMIC USE|J5
84589|ANTIVIRALS FOR SYSTEMIC USE|J5
84588|Ocular antineovascularisation products|S1P
84586|Ocular antineovascularisation products|S1P
84585|Ocular antineovascularisation products|S1P
84582|Ocular antineovascularisation products|S1P
84580|SYSTEMIC ANTIBACTERIALS|J1
84579|ANTIVIRALS FOR SYSTEMIC USE|J5
84576|ANTIVIRALS FOR SYSTEMIC USE|J5
84573|WOUND HEALING AGENTS|D3
84572|ANTIPSYCHOTICS|N5A
84565|EXPECTORANTS|R5C
84560|ANTIHYPERTENSIVES|C2
84560|ANALGESICS|N2
84560|TRANQUILLISERS|N5C
84559|ANTIHYPERTENSIVES|C2
84559|ANALGESICS|N2
84559|TRANQUILLISERS|N5C
84558|ANTIVIRALS FOR SYSTEMIC USE|J5
84557|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
84556|MUSCULO-SKELETAL SYSTEM|M
84552|SYSTEMIC ANTIBACTERIALS|J1
84550|IMMUNOSUPPRESSIVE AGENTS|L4
84549|SYSTEMIC ANTIBACTERIALS|J1
84547|CARDIAC THERAPY|C1
84546|SYSTEMIC ANTIBACTERIALS|J1
84545|ANDROGENS, EXCLUDING G3E, G3F|G3B
84544|CARDIOVASCULAR SYSTEM|C
84540|ANTIVIRALS FOR SYSTEMIC USE|J5
84538|RADIODIAGNOSTIC AGENTS|T1G
84537|ANALGESICS|N2
84536|SYSTEMIC ANTIBACTERIALS|J1
84535|IMMUNOSUPPRESSIVE AGENTS|L4
84532|APPETITE STIMULANTS|A15
84530|ANTIVIRALS FOR SYSTEMIC USE|J5
84529|SYSTEMIC ANTIBACTERIALS|J1
84529|CEPHALOSPORINS|J1D
84528|SYSTEMIC ANTIBACTERIALS|J1
84527|ANALGESICS|N2
84525|ANTIVIRALS FOR SYSTEMIC USE|J5
84522|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
84521|ANTIVIRALS FOR SYSTEMIC USE|J5
84516|Ocular antineovascularisation products|S1P
84514|ANTIVIRALS FOR SYSTEMIC USE|J5
84513|ANTI-EPILEPTICS|N3A
84513|NOOTROPICS|N6D
84511|SYSTEMIC ANTIBACTERIALS|J1
84511|ANTIVIRALS FOR SYSTEMIC USE|J5
84511|IMMUNOSTIMULATING AGENTS|L3
84508|ANTIVIRALS FOR SYSTEMIC USE|J5
84507|ANTIVIRALS FOR SYSTEMIC USE|J5
84506|IMMUNOSTIMULATING AGENTS|L3
84503|ANTIVIRALS FOR SYSTEMIC USE|J5
84498|ANTIVIRALS FOR SYSTEMIC USE|J5
84496|ANTI-EPILEPTICS|N3A
84495|Coxibs|M1A3
84494|RESPIRATORY SYSTEM|R
84488|ANTIVIRALS FOR SYSTEMIC USE|J5
84484|ANTI-EPILEPTICS|N3
84483|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
84477|DRUGS USED IN DIABETES|A10
84476|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
84473|ANTIVIRALS FOR SYSTEMIC USE|J5
84472|DIAGNOSTIC AGENTS|T
84471|ANAESTHETICS|N1
84471|ANTI-EPILEPTICS|N3
84470|Alpha-glucosidase inhibitor antidiabetics|A10B5
84468|SYSTEMIC ANTIBACTERIALS|J1
84467|SYSTEMIC ANTIHISTAMINES|R6
84465|WOUND HEALING AGENTS|D3
84462|ANTIVIRALS FOR SYSTEMIC USE|J5
84462|IMMUNOSTIMULATING AGENTS|L3
84454|SYSTEMIC ANTIBACTERIALS|J1
84453|RESPIRATORY SYSTEM|R
84446|ANTIHYPERTENSIVES|C2
84446|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
84446|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
84446|Statins (HMG-CoA reductase inhibitors)|C10A1
84445|ANTIVIRALS FOR SYSTEMIC USE|J5
84443|ANTIVIRALS FOR SYSTEMIC USE|J5
84442|CALCIUM ANTAGONISTS|C8
84442|ANTIVIRALS FOR SYSTEMIC USE|J5
84441|CALCIUM ANTAGONISTS|C8
84441|ANTIVIRALS FOR SYSTEMIC USE|J5
84440|DRUGS USED IN DIABETES|A10
84439|DRUGS USED IN DIABETES|A10
84438|ANTIVIRALS FOR SYSTEMIC USE|J5
84436|VACCINES|J7
84433|ANTIVIRALS FOR SYSTEMIC USE|J5
84432|RESPIRATORY SYSTEM|R
84431|CARDIOVASCULAR SYSTEM|C
84429|DRUGS USED IN DIABETES|A10
84426|VACCINES|J7
84425|ANTIVIRALS FOR SYSTEMIC USE|J5
84424|ANTIVIRALS FOR SYSTEMIC USE|J5
84423|ANTIVIRALS FOR SYSTEMIC USE|J5
84420|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
84414|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
84413|ANTIVIRALS FOR SYSTEMIC USE|J5
84406|DERMATOLOGICALS|D
84404|ANTIVIRALS FOR SYSTEMIC USE|J5
84401|ANTIVIRALS FOR SYSTEMIC USE|J5
84400|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
84400|Statins (HMG-CoA reductase inhibitors)|C10A1
84391|ANTIVIRALS FOR SYSTEMIC USE|J5
84389|PARASITOLOGY|P
84388|ANTIVIRALS FOR SYSTEMIC USE|J5
84385|ANTIVIRALS FOR SYSTEMIC USE|J5
84382|SYSTEMIC ANTIBACTERIALS|J1
84381|SYSTEMIC ANTIBACTERIALS|J1
84374|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
84370|ANTIHYPERTENSIVES|C2
84370|ANDROGENS, EXCLUDING G3E, G3F|G3B
84366|CENTRAL NERVOUS SYSTEM|N
84362|SYSTEMIC ANTIBACTERIALS|J1
84360|ANDROGENS, EXCLUDING G3E, G3F|G3B
84360|TRANQUILLISERS|N5C
84359|DRUGS USED IN DIABETES|A10
84358|SYSTEMIC ANTIBACTERIALS|J1
84357|SYSTEMIC ANTIBACTERIALS|J1
84354|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
84353|SYSTEMIC ANTIBACTERIALS|J1
84349|ANTIVIRALS FOR SYSTEMIC USE|J5
84349|Protease inhibitors|J5C2
84348|DRUGS USED IN DIABETES|A10
84347|ALKYLATING AGENTS|L1A
84345|IMMUNOSUPPRESSIVE AGENTS|L4
84343|ANTIVIRALS FOR SYSTEMIC USE|J5
84340|ANTIVIRALS FOR SYSTEMIC USE|J5
84339|ANTIVIRALS FOR SYSTEMIC USE|J5
84339|IMMUNOSTIMULATING AGENTS|L3
84335|ANTIVIRALS FOR SYSTEMIC USE|J5
84330|OPHTHALMOLOGICALS|S1
84327|NOOTROPICS|N6D
84320|PARASITOLOGY|P
84313|SYSTEMIC ANTIBACTERIALS|J1
84312|ANTIVIRALS FOR SYSTEMIC USE|J5
84301|ANTIVIRALS FOR SYSTEMIC USE|J5
84299|OPHTHALMOLOGICALS|S1
84298|ANALGESICS|N2
84296|ANTIPSYCHOTICS|N5A
84295|PARASITOLOGY|P
84294|SYSTEMIC ANTIBACTERIALS|J1
84293|ANTIVIRALS FOR SYSTEMIC USE|J5
84292|PARASITOLOGY|P
84291|PARASITOLOGY|P
84289|PARASITOLOGY|P
84288|PARASITOLOGY|P
84287|PARASITOLOGY|P
84287|ANTI-MALARIALS|P1D
84285|PARASITOLOGY|P
84283|RESPIRATORY SYSTEM|R
84283|LUNG SURFACTANTS|R7C
84280|ANTIVIRALS FOR SYSTEMIC USE|J5
84278|SYSTEMIC ANTIBACTERIALS|J1
84277|ANTIHYPERTENSIVES|C2
84276|RESPIRATORY SYSTEM|R
84274|ANALGESICS|N2
84273|ANTIVIRALS FOR SYSTEMIC USE|J5
84272|ANTIVIRALS FOR SYSTEMIC USE|J5
84271|ANTIVIRALS FOR SYSTEMIC USE|J5
84270|ANTIVIRALS FOR SYSTEMIC USE|J5
84267|ANTIPSYCHOTICS|N5A
84266|ANTIPSYCHOTICS|N5A
84265|ANTIVIRALS FOR SYSTEMIC USE|J5
84264|ANTIVIRALS FOR SYSTEMIC USE|J5
84263|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
84263|DRUGS USED IN DIABETES|A10
84260|DRUGS USED IN DIABETES|A10
84260|CARDIOVASCULAR SYSTEM|C
84259|ANTIVIRALS FOR SYSTEMIC USE|J5
84258|DRUGS USED IN DIABETES|A10
84258|WOUND HEALING AGENTS|D3
84253|IMMUNOSUPPRESSIVE AGENTS|L4
84252|SYSTEMIC ANTIBACTERIALS|J1
84251|CARDIOVASCULAR SYSTEM|C
84250|CARDIOVASCULAR SYSTEM|C
84249|ANTIPROTOZOALS AND ANTHELMINTICS|P1
84247|CENTRAL NERVOUS SYSTEM|N
84242|DRUGS USED IN DIABETES|A10
84242|HUMAN INSULINS AND ANALOGUES|A10C
84242|Human insulins and analogues, intermediate-acting|A10C2
84241|ANTIVIRALS FOR SYSTEMIC USE|J5
84237|ANTIVIRALS FOR SYSTEMIC USE|J5
84236|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
84235|Vitamin B6 (pyridoxine), plain|A11X2
84235|ANTIVIRALS FOR SYSTEMIC USE|J5
84235|ANTIMETABOLITES|L1B
84234|ANTIVIRALS FOR SYSTEMIC USE|J5
84233|IMMUNOSUPPRESSIVE AGENTS|L4
84232|CARDIAC THERAPY|C1
84232|B2-STIMULANTS|R3A
84230|DERMATOLOGICALS|D
84225|Interferons, beta|L3B2
84222|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
84222|DRUGS USED IN DIABETES|A10
84221|ANTIVIRALS FOR SYSTEMIC USE|J5
84209|CARDIOVASCULAR SYSTEM|C
84204|SYSTEMIC ANTIBACTERIALS|J1
84196|OPHTHALMOLOGICALS|S1
84195|ANTIVIRALS FOR SYSTEMIC USE|J5
84194|Interferons, alpha|L3B1
84187|HUMAN INSULINS AND ANALOGUES|A10C
84187|Human insulins and analogues, fast-acting|A10C1
84186|CARDIOVASCULAR SYSTEM|C
84186|Statins (HMG-CoA reductase inhibitors)|C10A1
84185|CARDIOVASCULAR SYSTEM|C
84185|Statins (HMG-CoA reductase inhibitors)|C10A1
84161|RESPIRATORY SYSTEM|R
84157|WOUND HEALING AGENTS|D3
84154|ANTIVIRALS FOR SYSTEMIC USE|J5
84137|ANTIVIRALS FOR SYSTEMIC USE|J5
84134|ANTIVIRALS FOR SYSTEMIC USE|J5
84119|ANTIVIRALS FOR SYSTEMIC USE|J5
84118|ANTI-EPILEPTICS|N3A
84116|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
84115|ANTIVIRALS FOR SYSTEMIC USE|J5
84114|RADIODIAGNOSTIC AGENTS|T1G
84113|RADIODIAGNOSTIC AGENTS|T1G
84111|IMMUNOSUPPRESSIVE AGENTS|L4
84108|ANALGESICS|N2
84108|RADIODIAGNOSTIC AGENTS|T1G
84106|MRI AGENTS|T1E
84101|CARDIOVASCULAR SYSTEM|C
84100|SYSTEMIC ANTIBACTERIALS|J1
84099|ANTI-ACNE PREPARATIONS|D10
84098|DERMATOLOGICALS|D
84097|CARDIOVASCULAR SYSTEM|C
84096|ANTIHYPERTENSIVES|C2
84095|ANTIPROTOZOALS AND ANTHELMINTICS|P1
84091|ANTIPSYCHOTICS|N5A
84088|ANALGESICS|N2
84087|SYSTEMIC ANTIBACTERIALS|J1
84077|ANTIVIRALS FOR SYSTEMIC USE|J5
84077|ANALGESICS|N2
84074|SYSTEMIC ANTIBACTERIALS|J1
84071|SYSTEMIC ANTIBACTERIALS|J1
84069|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
84064|ANTIVIRALS FOR SYSTEMIC USE|J5
84055|ANTIVIRALS FOR SYSTEMIC USE|J5
84050|ANTIVIRALS FOR SYSTEMIC USE|J5
84047|SYSTEMIC ANTIBACTERIALS|J1
84046|SYSTEMIC ANTIBACTERIALS|J1
84042|ANTIVIRALS FOR SYSTEMIC USE|J5
84039|SYSTEMIC ANTIBACTERIALS|J1
84037|SYSTEMIC ANTIBACTERIALS|J1
84031|PARASITOLOGY|P
84028|ANTIVIRALS FOR SYSTEMIC USE|J5
84026|ANTI-ARRHYTHMICS|C1B
84025|NOOTROPICS|N6D
84006|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
84001|PARASITOLOGY|P
84000|DERMATOLOGICALS|D
83998|PARASITOLOGY|P
83996|SYSTEMIC ANTIBACTERIALS|J1
83994|SYSTEMIC ANTIBACTERIALS|J1
83993|SYSTEMIC ANTIBACTERIALS|J1
83993|ANTIVIRALS FOR SYSTEMIC USE|J5
83992|OPHTHALMOLOGICALS|S1
83991|CENTRAL NERVOUS SYSTEM|N
83991|ANALGESICS|N2
83988|MACROLIDES AND SIMILAR TYPES|J1F
83988|ANALGESICS|N2
83987|RESPIRATORY SYSTEM|R
83987|LUNG SURFACTANTS|R7C
83971|ANTIVIRALS FOR SYSTEMIC USE|J5
83969|NOOTROPICS|N6D
83968|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
83967|ANTIVIRALS FOR SYSTEMIC USE|J5
83963|SYSTEMIC ANTIBACTERIALS|J1
83956|DPP-IV inhibitor antidiabetics|A10B6
83950|GROWTH HORMONES|H4C
83949|GROWTH HORMONES|H4C
83948|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
83946|ANTIVIRALS FOR SYSTEMIC USE|J5
83939|ANTIHYPERTENSIVES|C2
83938|ANTI-ARRHYTHMICS|C1B
83935|ANALGESICS|N2
83925|ANALGESICS|N2
83912|ANTIVIRALS FOR SYSTEMIC USE|J5
83910|CARDIOVASCULAR SYSTEM|C
83909|ANTIHYPERTENSIVES|C2
83899|ANALGESICS|N2
83896|ANTIVIRALS FOR SYSTEMIC USE|J5
83896|IMMUNOSTIMULATING AGENTS|L3
83895|ANTIVIRALS FOR SYSTEMIC USE|J5
83895|IMMUNOSTIMULATING AGENTS|L3
83894|OPHTHALMOLOGICALS|S1
83892|OPHTHALMOLOGICALS|S1
83890|OPHTHALMOLOGICALS|S1
83875|NOOTROPICS|N6D
83872|NOOTROPICS|N6D
83870|PARASITOLOGY|P
83867|IMMUNOSUPPRESSIVE AGENTS|L4
83865|ANALGESICS|N2
83854|ANALGESICS|N2
83852|RESPIRATORY SYSTEM|R
83851|IMMUNOSUPPRESSIVE AGENTS|L4
83851|OPHTHALMOLOGICALS|S1
83849|IMMUNOSUPPRESSIVE AGENTS|L4
83849|OPHTHALMOLOGICALS|S1
83845|DRUGS USED IN DIABETES|A10
83839|WOUND HEALING AGENTS|D3
83836|OPHTHALMOLOGICALS|S1
83835|OPHTHALMOLOGICALS|S1
83834|ANALGESICS|N2
83834|ANTI-EPILEPTICS|N3
83833|CARDIOVASCULAR SYSTEM|C
83833|WOUND HEALING AGENTS|D3
83832|CARDIOVASCULAR SYSTEM|C
83832|WOUND HEALING AGENTS|D3
83831|CENTRAL NERVOUS SYSTEM|N
83831|ANALGESICS|N2
83831|ANTI-MIGRAINE PREPARATIONS|N2C
83830|CENTRAL NERVOUS SYSTEM|N
83830|ANALGESICS|N2
83830|ANTI-MIGRAINE PREPARATIONS|N2C
83820|SYSTEMIC ANTIBACTERIALS|J1
83817|ANTIVIRALS FOR SYSTEMIC USE|J5
83816|ANTIVIRALS FOR SYSTEMIC USE|J5
83812|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
83811|SYSTEMIC ANTIBACTERIALS|J1
83807|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
83806|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
83806|SSRI antidepressants|N6A4
83806|SRNI antidepressants|N6A5
83805|ANALGESICS|N2
83795|ANALGESICS|N2
83794|HYPNOTICS/SEDATIVES|N5B
83794|TRANQUILLISERS|N5C
83788|ANTIVIRALS FOR SYSTEMIC USE|J5
83784|ANTIVIRALS FOR SYSTEMIC USE|J5
83779|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
83773|MACROLIDES AND SIMILAR TYPES|J1F
83771|ANTIVIRALS FOR SYSTEMIC USE|J5
83770|WOUND HEALING AGENTS|D3
83770|RESPIRATORY SYSTEM|R
83769|SYSTEMIC ANTIBACTERIALS|J1
83766|IMMUNOSUPPRESSIVE AGENTS|L4
83764|SYSTEMIC ANTIBACTERIALS|J1
83754|SYSTEMIC ANTIBACTERIALS|J1
83751|B2-STIMULANTS|R3A
83749|ANALGESICS|N2
83749|SSRI antidepressants|N6A4
83749|SRNI antidepressants|N6A5
83748|ANTIVIRALS FOR SYSTEMIC USE|J5
83744|B2-STIMULANTS|R3A
83740|ANTIVIRALS FOR SYSTEMIC USE|J5
83739|ANTIVIRALS FOR SYSTEMIC USE|J5
83728|SYSTEMIC ANTIBACTERIALS|J1
83716|ANTIVIRALS FOR SYSTEMIC USE|J5
83715|ANTIVIRALS FOR SYSTEMIC USE|J5
83712|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
83711|MACROLIDES AND SIMILAR TYPES|J1F
83708|PARASITOLOGY|P
83686|ANTIHYPERTENSIVES|C2
83682|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
83682|ANTIVIRALS FOR SYSTEMIC USE|J5
83679|RESPIRATORY SYSTEM|R
83675|RESPIRATORY SYSTEM|R
83668|ANTIVIRALS FOR SYSTEMIC USE|J5
83667|ANTIVIRALS FOR SYSTEMIC USE|J5
83656|RESPIRATORY SYSTEM|R
83652|RESPIRATORY SYSTEM|R
83651|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
83650|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
83649|SYSTEMIC ANTIBACTERIALS|J1
83648|RESPIRATORY SYSTEM|R
83645|ANTIHYPERTENSIVES|C2
83645|DIURETICS|C3
83645|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
83645|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
83643|ANTIVIRALS FOR SYSTEMIC USE|J5
83641|ANTIVIRALS FOR SYSTEMIC USE|J5
83640|ANTIVIRALS FOR SYSTEMIC USE|J5
83639|ANTIVIRALS FOR SYSTEMIC USE|J5
83632|Sulphonylurea antidiabetics|A10B1
83632|Biguanide antidiabetics|A10B2
83629|Topical dermatological antifungals|D1A1
83629|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
83628|OPHTHALMOLOGICALS|S1
83627|OPHTHALMOLOGICALS|S1
83626|OPHTHALMOLOGICALS|S1
83624|ANTIVIRALS FOR SYSTEMIC USE|J5
83624|ANTITUSSIVES|R5D
83621|OPHTHALMOLOGICALS|S1
83620|ANTIVIRALS FOR SYSTEMIC USE|J5
83619|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
83619|ANTIHYPERTENSIVES|C2
83618|ANALGESICS|N2
83617|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
83613|RADIODIAGNOSTIC AGENTS|T1G
83612|ANTIVIRALS FOR SYSTEMIC USE|J5
83611|CARDIOVASCULAR SYSTEM|C
83611|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
83609|CARDIOVASCULAR SYSTEM|C
83609|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
83603|IMMUNOSTIMULATING AGENTS|L3
83602|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
83599|ANTIVIRALS FOR SYSTEMIC USE|J5
83593|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
83590|ANTI-EPILEPTICS|N3
83586|ANALGESICS|N2
83585|ANALGESICS|N2
83584|HUMAN INSULINS AND ANALOGUES|A10C
83584|Human insulins and analogues, intermediate-acting|A10C2
83581|HUMAN INSULINS AND ANALOGUES|A10C
83581|Human insulins and analogues, intermediate-acting|A10C2
83578|ANDROGENS, EXCLUDING G3E, G3F|G3B
83576|ALKYLATING AGENTS|L1A
83573|ANTIHYPERTENSIVES|C2
83569|RESPIRATORY SYSTEM|R
83567|ALKYLATING AGENTS|L1A
83566|ANTIVIRALS FOR SYSTEMIC USE|J5
83565|IMMUNOSUPPRESSIVE AGENTS|L4
83562|IMMUNOSUPPRESSIVE AGENTS|L4
83559|IMMUNOSUPPRESSIVE AGENTS|L4
83543|PLATELET AGGREGATION INHIBITORS|B1C
83543|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
83539|DRUGS USED IN DIABETES|A10
83539|HUMAN INSULINS AND ANALOGUES|A10C
83539|Human insulins and analogues, long-acting|A10C5
83532|ANTIVIRALS FOR SYSTEMIC USE|J5
83531|SYSTEMIC ANTIBACTERIALS|J1
83526|DRUGS USED IN DIABETES|A10
83526|HUMAN INSULINS AND ANALOGUES|A10C
83526|Human insulins and analogues, intermediate-acting|A10C2
83524|ANTIVIRALS FOR SYSTEMIC USE|J5
83523|ANTIPSYCHOTICS|N5A
83517|ANTIVIRALS FOR SYSTEMIC USE|J5
83510|GROWTH HORMONES|H4C
83508|FIBRINOLYTICS|B1D
83507|FIBRINOLYTICS|B1D
83506|DRUGS USED IN DIABETES|A10
83506|HUMAN INSULINS AND ANALOGUES|A10C
83506|Human insulins and analogues, intermediate-acting|A10C2
83500|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
83497|ANTIHYPERTENSIVES|C2
83497|CALCIUM ANTAGONISTS|C8
83497|ACE INHIBITORS, PLAIN|C9A
83489|ANTIVIRALS FOR SYSTEMIC USE|J5
83484|ANTIVIRALS FOR SYSTEMIC USE|J5
83483|DPP-IV inhibitor antidiabetics|A10B6
83480|SYSTEMIC ANTIBACTERIALS|J1
83479|Factors II, VII, IX and X|B2D2
83476|ANTIVIRALS FOR SYSTEMIC USE|J5
83475|SYSTEMIC ANTIBACTERIALS|J1
83474|SYSTEMIC ANTIBACTERIALS|J1
83469|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
83467|IMMUNOSTIMULATING AGENTS|L3
83464|SYSTEMIC ANTIBACTERIALS|J1
83454|SSRI antidepressants|N6A4
83450|ANALGESICS|N2
83447|HUMAN INSULINS AND ANALOGUES|A10C
83447|Human insulins and analogues, intermediate-acting|A10C2
83446|WOUND HEALING AGENTS|D3
83437|ANALGESICS|N2
83431|ANTIHYPERTENSIVES|C2
83431|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
83422|Ocular decongestants, sympathomimetics|S1G5
83415|Vitamin D|A11C2
83412|ANTIVIRALS FOR SYSTEMIC USE|J5
83410|ANTIVIRALS FOR SYSTEMIC USE|J5
83409|ANTI-EPILEPTICS|N3A
83409|NOOTROPICS|N6D
83407|ANTIVIRALS FOR SYSTEMIC USE|J5
83397|IMMUNOSUPPRESSIVE AGENTS|L4
83388|SYSTEMIC ANTIBACTERIALS|J1
83386|WOUND HEALING AGENTS|D3
83386|SYSTEMIC ANTIBACTERIALS|J1
83369|ANDROGENS, EXCLUDING G3E, G3F|G3B
83368|OPHTHALMOLOGICALS|S1
83367|ANTIVIRALS FOR SYSTEMIC USE|J5
83366|ANALGESICS|N2
83365|ANTI-EPILEPTICS|N3A
83364|SYSTEMIC ANTIBACTERIALS|J1
83361|ANTIEMETICS AND ANTINAUSEANTS|A4
83360|ANTIEMETICS AND ANTINAUSEANTS|A4
83359|ACE INHIBITORS, PLAIN|C9A
83359|OPHTHALMOLOGICALS|S1
83354|VACCINES|J7
83348|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
83345|ANDROGENS, EXCLUDING G3E, G3F|G3B
83344|SYSTEMIC ANTIBACTERIALS|J1
83343|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
83337|ANTIVIRALS FOR SYSTEMIC USE|J5
83335|ANTIVIRALS FOR SYSTEMIC USE|J5
83333|ANTIVIRALS FOR SYSTEMIC USE|J5
83333|IMMUNOSTIMULATING AGENTS|L3
83330|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
83329|NOOTROPICS|N6D
83328|IMMUNOSTIMULATING AGENTS|L3
83323|RADIODIAGNOSTIC AGENTS|T1G
83322|RADIODIAGNOSTIC AGENTS|T1G
83317|ANTIHYPERTENSIVES|C2
83309|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
83308|NOOTROPICS|N6D
83308|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
83289|WOUND HEALING AGENTS|D3
83287|ANTIPSYCHOTICS|N5A
83286|NOOTROPICS|N6D
83278|RESPIRATORY SYSTEM|R
83276|CARDIOVASCULAR SYSTEM|C
83273|Inhibitors of the Kallikrein-kinin-system|B2C2
83273|DERMATOLOGICALS|D
83266|ANTIVIRALS FOR SYSTEMIC USE|J5
83265|ANTI-EPILEPTICS|N3A
83263|NOOTROPICS|N6D
83261|OPHTHALMOLOGICALS|S1
83259|DRUGS USED IN DIABETES|A10
83255|ANTIVIRALS FOR SYSTEMIC USE|J5
83254|ANTIVIRALS FOR SYSTEMIC USE|J5
83253|ANTIVIRALS FOR SYSTEMIC USE|J5
83252|ANTIVIRALS FOR SYSTEMIC USE|J5
83251|ANTIVIRALS FOR SYSTEMIC USE|J5
83250|ANTIVIRALS FOR SYSTEMIC USE|J5
83248|ANALGESICS|N2
83248|ANTI-MIGRAINE PREPARATIONS|N2C
83247|Alpha-glucosidase inhibitor antidiabetics|A10B5
83246|SYSTEMIC ANTIBACTERIALS|J1
83243|HUMAN INSULINS AND ANALOGUES|A10C
83243|Human insulins and analogues, intermediate-acting|A10C2
83241|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
83240|ANTI-ACNE PREPARATIONS|D10
83240|SYSTEMIC ANTIBACTERIALS|J1
83239|PARASITOLOGY|P
83238|SYSTEMIC ANTIBACTERIALS|J1
83237|SYSTEMIC ANTIBACTERIALS|J1
83236|SYSTEMIC ANTIBACTERIALS|J1
83235|SYSTEMIC ANTIBACTERIALS|J1
83231|IMMUNOSTIMULATING AGENTS|L3
83230|DERMATOLOGICALS|D
83229|DERMATOLOGICALS|D
83228|DERMATOLOGICALS|D
83227|DERMATOLOGICALS|D
83224|ANTIVIRALS FOR SYSTEMIC USE|J5
83220|ANALGESICS|N2
83219|ANTIHYPERTENSIVES|C2
83218|ANTIHYPERTENSIVES|C2
83217|Coxibs|M1A3
83216|DRUGS USED IN DIABETES|A10
83216|HUMAN INSULINS AND ANALOGUES|A10C
83216|Human insulins and analogues, intermediate-acting|A10C2
83209|DRUGS USED IN DIABETES|A10
83206|CARDIOVASCULAR SYSTEM|C
83205|ANTIPSYCHOTICS|N5A
83197|ANTIPSYCHOTICS|N5A
83189|ANAESTHETICS|N1
83184|Biguanide antidiabetics|A10B2
83184|DPP-IV inhibitor antidiabetics|A10B6
83183|CARDIAC THERAPY|C1
83183|ANTIHYPERTENSIVES|C2
83183|ACE INHIBITORS, PLAIN|C9A
83182|ANTIHYPERTENSIVES|C2
83169|DRUGS USED IN DIABETES|A10
83167|SYSTEMIC ANTIBACTERIALS|J1
83147|PARASITOLOGY|P
83147|ANTI-MALARIALS|P1D
83146|ANALGESICS|N2
83139|IMMUNOSTIMULATING AGENTS|L3
83138|ANTIULCERANTS|A2B
83134|RESPIRATORY SYSTEM|R
83133|CARDIOVASCULAR SYSTEM|C
83130|ANALGESICS|N2
83130|ANTI-EPILEPTICS|N3
83130|TRANQUILLISERS|N5C
83129|ANTIEMETICS AND ANTINAUSEANTS|A4
83127|VACCINES|J7
83126|RESPIRATORY SYSTEM|R
83125|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
83110|Inhibitors of the Kallikrein-kinin-system|B2C2
83106|TRANQUILLISERS|N5C
83105|TRANQUILLISERS|N5C
83104|ANALGESICS|N2
83104|TRANQUILLISERS|N5C
83100|DRUGS USED IN DIABETES|A10
83098|SYSTEMIC ANTIBACTERIALS|J1
83091|ANALGESICS|N2
83090|ANTIHYPERTENSIVES|C2
83090|CALCIUM ANTAGONISTS|C8
83086|SYSTEMIC ANTIBACTERIALS|J1
83074|OPHTHALMOLOGICALS|S1
83073|DRUGS USED IN DIABETES|A10
83072|DRUGS USED IN DIABETES|A10
83072|HUMAN INSULINS AND ANALOGUES|A10C
83072|Human insulins and analogues, intermediate-acting|A10C2
83071|HUMAN INSULINS AND ANALOGUES|A10C
83071|Human insulins and analogues, fast-acting|A10C1
83067|RESPIRATORY SYSTEM|R
83063|ANTIHYPERTENSIVES|C2
83063|CALCIUM ANTAGONISTS|C8
83062|ANTI-EPILEPTICS|N3A
83060|ANTIVIRALS FOR SYSTEMIC USE|J5
83059|IMMUNOSTIMULATING AGENTS|L3
83058|HUMAN INSULINS AND ANALOGUES|A10C
83058|Human insulins and analogues, intermediate-acting|A10C2
83057|ANTIPSYCHOTICS|N5A
83056|DIRECT THROMBIN INHIBITORS|B1E
83055|DIRECT THROMBIN INHIBITORS|B1E
83053|RADIODIAGNOSTIC AGENTS|T1G
83052|ANTIPSYCHOTICS|N5A
83040|ANALGESICS|N2
83037|ANAESTHETICS, LOCAL|N1B
83037|ANTITUSSIVES|R5D
83034|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
83034|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
83033|DRUGS USED IN DIABETES|A10
83031|SYSTEMIC ANTIBACTERIALS|J1
83031|Carbapenems|J1P2
83005|IMMUNOSTIMULATING AGENTS|L3
82996|DRUGS USED IN DIABETES|A10
82994|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
82991|ANTI-EPILEPTICS|N3A
82990|DRUGS USED IN DIABETES|A10
82989|NOOTROPICS|N6D
82987|ANTIMETABOLITES|L1B
82985|ANTIMETABOLITES|L1B
82983|CARDIAC THERAPY|C1
82977|CARDIAC THERAPY|C1
82973|ANTIVIRALS FOR SYSTEMIC USE|J5
82967|IMMUNOSTIMULATING AGENTS|L3
82966|DRUGS USED IN DIABETES|A10
82965|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
82965|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
82963|ANALGESICS|N2
82960|IMMUNOSTIMULATING AGENTS|L3
82959|ANTIEMETICS AND ANTINAUSEANTS|A4
82959|ANALGESICS|N2
82958|CARDIOVASCULAR SYSTEM|C
82958|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
82957|CARDIAC THERAPY|C1
82955|IMMUNOSTIMULATING AGENTS|L3
82951|ANTIVIRALS FOR SYSTEMIC USE|J5
82948|ANTIVIRALS FOR SYSTEMIC USE|J5
82944|WOUND HEALING AGENTS|D3
82940|ANTI-GOUT PREPARATIONS|M4
82929|FIBRINOLYTICS|B1D
82927|SYSTEMIC ANTIBACTERIALS|J1
82904|ANTIVIRALS FOR SYSTEMIC USE|J5
82904|IMMUNOSTIMULATING AGENTS|L3
82903|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
82903|IMMUNOSUPPRESSIVE AGENTS|L4
82901|IMMUNOSUPPRESSIVE AGENTS|L4
82897|NOOTROPICS|N6D
82896|NOOTROPICS|N6D
82894|NOOTROPICS|N6D
82892|DRUGS USED IN DIABETES|A10
82886|Erectile dysfunction products|G4B3
82885|RADIODIAGNOSTIC AGENTS|T1G
82884|PARASITOLOGY|P
82882|PARASITOLOGY|P
82881|PARASITOLOGY|P
82881|ANTI-MALARIALS|P1D
82880|RADIODIAGNOSTIC AGENTS|T1G
82877|PARASITOLOGY|P
82877|ANTI-MALARIALS|P1D
82876|CENTRAL NERVOUS SYSTEM|N
82874|IMMUNOSUPPRESSIVE AGENTS|L4
82873|ALKYLATING AGENTS|L1A
82865|PARASITOLOGY|P
82863|PARASITOLOGY|P
82862|PARASITOLOGY|P
82862|ANTI-MALARIALS|P1D
82854|SYSTEMIC ANTIBACTERIALS|J1
82848|ANTIVIRALS FOR SYSTEMIC USE|J5
82847|ANTIVIRALS FOR SYSTEMIC USE|J5
82845|CARDIOVASCULAR SYSTEM|C
82844|CARDIOVASCULAR SYSTEM|C
82843|CARDIOVASCULAR SYSTEM|C
82842|NOOTROPICS|N6D
82841|PARASITOLOGY|P
82839|SYSTEMIC ANTIBACTERIALS|J1
82838|ANTIPSYCHOTICS|N5A
82809|GROWTH HORMONES|H4C
82808|Interferons, beta|L3B2
82807|SYSTEMIC ANTIBACTERIALS|J1
82807|CEPHALOSPORINS|J1D
82806|SYSTEMIC ANTIBACTERIALS|J1
82806|CEPHALOSPORINS|J1D
82804|PARASITOLOGY|P
82804|ANTI-MALARIALS|P1D
82803|PARASITOLOGY|P
82803|ANTI-MALARIALS|P1D
82800|ANTIVIRALS FOR SYSTEMIC USE|J5
82799|RESPIRATORY SYSTEM|R
82798|IMMUNOSUPPRESSIVE AGENTS|L4
82790|SYSTEMIC ANTIBACTERIALS|J1
82788|ANTIVIRALS FOR SYSTEMIC USE|J5
82787|ANTIVIRALS FOR SYSTEMIC USE|J5
82785|ANTIVIRALS FOR SYSTEMIC USE|J5
82781|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
82778|ANTIULCERANTS|A2B
82778|SYSTEMIC ANTIBACTERIALS|J1
82776|ANTIVIRALS FOR SYSTEMIC USE|J5
82773|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
82771|GASTROPROKINETICS|A3F
82770|OPHTHALMOLOGICALS|S1
82763|ANTIVIRALS FOR SYSTEMIC USE|J5
82753|HUMAN INSULINS AND ANALOGUES|A10C
82753|Human insulins and analogues, intermediate-acting|A10C2
82750|FIBRINOLYTICS|B1D
82744|IMMUNOSUPPRESSIVE AGENTS|L4
82738|SYSTEMIC ANTIBACTERIALS|J1
82735|OPHTHALMOLOGICALS|S1
82733|ANTIVIRALS FOR SYSTEMIC USE|J5
82730|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
82728|ANTIVIRALS FOR SYSTEMIC USE|J5
82727|ANTIVIRALS FOR SYSTEMIC USE|J5
82724|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
82723|DIRECT THROMBIN INHIBITORS|B1E
82719|IMMUNOSUPPRESSIVE AGENTS|L4
82717|IMMUNOSUPPRESSIVE AGENTS|L4
82716|SYSTEMIC ANTIBACTERIALS|J1
82710|SYSTEMIC ANTIBACTERIALS|J1
82707|DRUGS USED IN DIABETES|A10
82707|HUMAN INSULINS AND ANALOGUES|A10C
82707|Human insulins and analogues, intermediate-acting|A10C2
82705|SYSTEMIC ANTIBACTERIALS|J1
82705|MACROLIDES AND SIMILAR TYPES|J1F
82697|PLATELET AGGREGATION INHIBITORS|B1C
82694|PARASITOLOGY|P
82692|SYSTEMIC ANTIBACTERIALS|J1
82688|ANTIEMETICS AND ANTINAUSEANTS|A4
82686|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
82683|ANALGESICS|N2
82682|SYSTEMIC ANTIBACTERIALS|J1
82682|IMMUNOSTIMULATING AGENTS|L3
82681|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
82675|ANTIVIRALS FOR SYSTEMIC USE|J5
82674|ANTIVIRALS FOR SYSTEMIC USE|J5
82673|ANTIVIRALS FOR SYSTEMIC USE|J5
82672|ANTIVIRALS FOR SYSTEMIC USE|J5
82670|SYSTEMIC ANTIBACTERIALS|J1
82670|CEPHALOSPORINS|J1D
82666|CALCIUM ANTAGONISTS|C8
82663|ALKYLATING AGENTS|L1A
82662|SYSTEMIC ANTIBACTERIALS|J1
82660|SYSTEMIC ANTIBACTERIALS|J1
82659|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
82659|TRANQUILLISERS|N5C
82659|ANTIPROTOZOALS AND ANTHELMINTICS|P1
82657|ANALGESICS|N2
82655|HUMAN INSULINS AND ANALOGUES|A10C
82655|Human insulins and analogues, intermediate-acting|A10C2
82653|HUMAN INSULINS AND ANALOGUES|A10C
82653|Human insulins and analogues, fast-acting|A10C1
82651|ANTIPSYCHOTICS|N5A
82647|IMMUNOSUPPRESSIVE AGENTS|L4
82646|DRUGS USED IN DIABETES|A10
82645|DRUGS USED IN DIABETES|A10
82643|SYSTEMIC ANTIBACTERIALS|J1
82642|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
82641|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
82639|ANTIVIRALS FOR SYSTEMIC USE|J5
82635|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
82634|HUMAN INSULINS AND ANALOGUES|A10C
82634|Human insulins and analogues, intermediate-acting|A10C2
82631|DERMATOLOGICALS|D
82629|ANALGESICS|N2
82627|ANALGESICS|N2
82626|DRUGS USED IN DIABETES|A10
82626|HUMAN INSULINS AND ANALOGUES|A10C
82626|Human insulins and analogues, intermediate-acting|A10C2
82625|DERMATOLOGICALS|D
82624|DERMATOLOGICALS|D
82621|OPHTHALMOLOGICALS|S1
82617|DRUGS USED IN DIABETES|A10
82617|Biguanide antidiabetics|A10B2
82617|Statins (HMG-CoA reductase inhibitors)|C10A1
82616|RADIODIAGNOSTIC AGENTS|T1G
82613|RADIODIAGNOSTIC AGENTS|T1G
82611|ANAESTHETICS, LOCAL|N1B
82611|ANALGESICS|N2
82608|ANTIPSYCHOTICS|N5A
82592|RESPIRATORY SYSTEM|R
82591|ANALGESICS|N2
82589|ANTIVIRALS FOR SYSTEMIC USE|J5
82588|ANTIVIRALS FOR SYSTEMIC USE|J5
82586|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
82586|DRUGS USED IN DIABETES|A10
82586|GLUCAGON|H4B
82584|SYSTEMIC ANTIBACTERIALS|J1
82583|ANALGESICS|N2
82582|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
82582|DRUGS USED IN DIABETES|A10
82581|DRUGS USED IN DIABETES|A10
82581|HUMAN INSULINS AND ANALOGUES|A10C
82581|Human insulins and analogues, intermediate-acting|A10C2
82578|RESPIRATORY SYSTEM|R
82575|SYSTEMIC ANTIBACTERIALS|J1
82569|ANALGESICS|N2
82568|ANDROGENS, EXCLUDING G3E, G3F|G3B
82563|ALKYLATING AGENTS|L1A
82561|ANALGESICS|N2
82561|ANTI-MIGRAINE PREPARATIONS|N2C
82561|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
82561|SSRI antidepressants|N6A4
82561|SRNI antidepressants|N6A5
82560|ANALGESICS|N2
82560|ANTI-MIGRAINE PREPARATIONS|N2C
82560|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
82560|SSRI antidepressants|N6A4
82560|SRNI antidepressants|N6A5
82556|ANTIVIRALS FOR SYSTEMIC USE|J5
82554|ANTI-EPILEPTICS|N3A
82553|ANALGESICS|N2
82552|ANALGESICS|N2
82552|ANTI-EPILEPTICS|N3
82551|DRUGS USED IN DIABETES|A10
82550|ANTI-ARRHYTHMICS|C1B
82549|ANTI-ARRHYTHMICS|C1B
82548|ANALGESICS|N2
82547|Topical dermatological antifungals|D1A1
82547|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
82546|ANTIVIRALS FOR SYSTEMIC USE|J5
82546|RESPIRATORY SYSTEM|R
82544|CARDIOVASCULAR SYSTEM|C
82543|ANALGESICS|N2
82534|ANTIFIBRINOLYTICS|B2A
82532|ANTIFIBRINOLYTICS|B2A
82531|SYSTEMIC ANTIBACTERIALS|J1
82528|ANTIFIBRINOLYTICS|B2A
82527|ANTIHYPERTENSIVES|C2
82526|ANTIFIBRINOLYTICS|B2A
82522|NOOTROPICS|N6D
82520|ANALGESICS|N2
82519|ANALGESICS|N2
82518|ANALGESICS|N2
82517|ANALGESICS|N2
82516|ANTIVIRALS FOR SYSTEMIC USE|J5
82515|SYSTEMIC ANTIBACTERIALS|J1
82515|CEPHALOSPORINS|J1D
82514|DPP-IV inhibitor antidiabetics|A10B6
82513|DPP-IV inhibitor antidiabetics|A10B6
82512|ANALGESICS|N2
82511|RESPIRATORY SYSTEM|R
82506|SYSTEMIC ANTIBACTERIALS|J1
82505|TRANQUILLISERS|N5C
82503|MUSCULO-SKELETAL SYSTEM|M
82503|ANALGESICS|N2
82497|ANTITUSSIVES|R5D
82494|ANTI-GOUT PREPARATIONS|M4
82492|NOOTROPICS|N6D
82488|ANALGESICS|N2
82484|SYSTEMIC ANTIBACTERIALS|J1
82483|SYSTEMIC ANTIBACTERIALS|J1
82482|DRUGS USED IN DIABETES|A10
82456|SYSTEMIC ANTIBACTERIALS|J1
82455|SYSTEMIC ANTIBACTERIALS|J1
82454|OPHTHALMOLOGICALS|S1
82452|DRUGS USED IN DIABETES|A10
82452|HUMAN INSULINS AND ANALOGUES|A10C
82452|Human insulins and analogues, fast-acting|A10C1
82448|ANTIVIRALS FOR SYSTEMIC USE|J5
82445|WOUND HEALING AGENTS|D3
82444|ANALGESICS|N2
82443|BETA-BLOCKING AGENTS|C7
82440|ANALGESICS|N2
82438|ANALGESICS|N2
82437|ANTIHYPERTENSIVES|C2
82437|ANTI-EPILEPTICS|N3A
82436|ANTIVIRALS FOR SYSTEMIC USE|J5
82435|WOUND HEALING AGENTS|D3
82435|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
82434|Factor VIII|B2D1
82431|SYSTEMIC ANTIBACTERIALS|J1
82429|ANTIPROTOZOALS AND ANTHELMINTICS|P1
82428|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
82420|SYSTEMIC ANTIBACTERIALS|J1
82413|CENTRAL NERVOUS SYSTEM|N
82412|ANAESTHETICS, LOCAL|N1B
82411|CENTRAL NERVOUS SYSTEM|N
82410|ANTI-EPILEPTICS|N3
82410|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
82409|ANTI-EPILEPTICS|N3
82409|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
82408|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
82406|ANTIVIRALS FOR SYSTEMIC USE|J5
82403|ANALGESICS|N2
82400|ANTIVIRALS FOR SYSTEMIC USE|J5
82395|Topical dermatological antifungals|D1A1
82395|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
82389|GASTROPROKINETICS|A3F
82387|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
82376|SYSTEMIC ANTIBACTERIALS|J1
82363|MACROLIDES AND SIMILAR TYPES|J1F
82357|SYSTEMIC ANTIBACTERIALS|J1
82355|SYSTEMIC ANTIBACTERIALS|J1
82355|MACROLIDES AND SIMILAR TYPES|J1F
82352|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
82351|ANTIVIRALS FOR SYSTEMIC USE|J5
82351|IMMUNOSUPPRESSIVE AGENTS|L4
82348|ANTIHYPERTENSIVES|C2
82346|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
82346|DRUGS USED IN DIABETES|A10
82345|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
82341|ANTI-GOUT PREPARATIONS|M4
82340|SYSTEMIC ANTIBACTERIALS|J1
82329|DRUGS USED IN DIABETES|A10
82328|OPHTHALMOLOGICALS|S1
82323|ANALGESICS|N2
82321|IMMUNOSTIMULATING AGENTS|L3
82317|ANTI-EPILEPTICS|N3A
82316|RADIODIAGNOSTIC AGENTS|T1G
82314|ANTI-EPILEPTICS|N3
82312|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
82311|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
82311|GLUCAGON|H4B
82307|DPP-IV inhibitor antidiabetics|A10B6
82306|AMINOGLYCOSIDES|J1K
82301|RESPIRATORY SYSTEM|R
82299|SYSTEMIC ANTIBACTERIALS|J1
82294|CARDIOVASCULAR SYSTEM|C
82294|ACE INHIBITORS, PLAIN|C9A
82284|CARDIOVASCULAR SYSTEM|C
82284|NOOTROPICS|N6D
82282|ANTIVIRALS FOR SYSTEMIC USE|J5
82279|WOUND HEALING AGENTS|D3
82277|CARDIOVASCULAR SYSTEM|C
82276|CARDIOVASCULAR SYSTEM|C
82270|Statins (HMG-CoA reductase inhibitors)|C10A1
82268|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
82263|ANTIMETABOLITES|L1B
82262|SYSTEMIC ANTIBACTERIALS|J1
82262|ANTIVIRALS FOR SYSTEMIC USE|J5
82262|RESPIRATORY SYSTEM|R
82246|ANTIVIRALS FOR SYSTEMIC USE|J5
82243|ANTI-EPILEPTICS|N3
82241|ANTIVIRALS FOR SYSTEMIC USE|J5
82233|CARDIOVASCULAR SYSTEM|C
82232|ANTIPROTOZOALS AND ANTHELMINTICS|P1
82229|CARDIOVASCULAR SYSTEM|C
82228|DERMATOLOGICALS|D
82223|ALKYLATING AGENTS|L1A
82223|OPHTHALMOLOGICALS|S1
82221|ALKYLATING AGENTS|L1A
82218|HUMAN INSULINS AND ANALOGUES|A10C
82218|Human insulins and analogues, long-acting|A10C5
82204|ANALGESICS|N2
82197|CENTRAL NERVOUS SYSTEM|N
82196|ANTIVIRALS FOR SYSTEMIC USE|J5
82193|ANTIVIRALS FOR SYSTEMIC USE|J5
82189|DRUGS USED IN DIABETES|A10
82188|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
82188|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
82187|ANALGESICS|N2
82184|ANTI-EPILEPTICS|N3
82184|NOOTROPICS|N6D
82183|ANTI-EPILEPTICS|N3
82182|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
82182|PARASITOLOGY|P
82178|ANALGESICS|N2
82178|ANTI-EPILEPTICS|N3
82175|CARDIOVASCULAR SYSTEM|C
82162|DERMATOLOGICALS|D
82160|ANTIVIRALS FOR SYSTEMIC USE|J5
82151|DRUGS USED IN DIABETES|A10
82148|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
82143|ANTIVIRALS FOR SYSTEMIC USE|J5
82141|PLATELET AGGREGATION INHIBITORS|B1C
82140|PLATELET AGGREGATION INHIBITORS|B1C
82134|GROWTH HORMONES|H4C
82126|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
82122|SYSTEMIC ANTIBACTERIALS|J1
82118|PLATELET AGGREGATION INHIBITORS|B1C
82116|ANTIVIRALS FOR SYSTEMIC USE|J5
82100|DRUGS USED IN DIABETES|A10
82098|ANTIVIRALS FOR SYSTEMIC USE|J5
82097|ANTIVIRALS FOR SYSTEMIC USE|J5
82095|SYSTEMIC ANTIBACTERIALS|J1
82091|SYSTEMIC ANTIBACTERIALS|J1
82088|ANALGESICS|N2
82074|ANALGESICS|N2
82070|PLATELET AGGREGATION INHIBITORS|B1C
82070|CARDIOVASCULAR SYSTEM|C
82068|ANALGESICS|N2
82064|SYSTEMIC ANTIBACTERIALS|J1
82063|WOUND HEALING AGENTS|D3
82062|SYSTEMIC ANTIBACTERIALS|J1
82061|DERMATOLOGICALS|D
82060|ANTIVIRALS FOR SYSTEMIC USE|J5
82059|RESPIRATORY SYSTEM|R
82056|ANDROGENS, EXCLUDING G3E, G3F|G3B
82050|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
82049|FIBRINOLYTICS|B1D
82047|ANTIVIRALS FOR SYSTEMIC USE|J5
82047|INTERFERONS|L3B
82044|CENTRAL NERVOUS SYSTEM|N
82042|ANTIVIRALS FOR SYSTEMIC USE|J5
82040|ANTI-EPILEPTICS|N3A
82035|ANTIVIRALS FOR SYSTEMIC USE|J5
82032|CARDIOVASCULAR SYSTEM|C
82032|Statins (HMG-CoA reductase inhibitors)|C10A1
82031|IMMUNOSTIMULATING AGENTS|L3
82029|SYSTEMIC ANTIBACTERIALS|J1
82028|CARDIOVASCULAR SYSTEM|C
82028|Statins (HMG-CoA reductase inhibitors)|C10A1
82026|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
82026|SRNI antidepressants|N6A5
82024|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
82024|SRNI antidepressants|N6A5
82023|IMMUNOSUPPRESSIVE AGENTS|L4
82019|TRANQUILLISERS|N5C
82019|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
82019|SSRI antidepressants|N6A4
82019|SRNI antidepressants|N6A5
82018|ANTIEMETICS AND ANTINAUSEANTS|A4
82016|SYSTEMIC ANTIBACTERIALS|J1
82015|CARDIOVASCULAR SYSTEM|C
82008|ANTIVIRALS FOR SYSTEMIC USE|J5
82006|WOUND HEALING AGENTS|D3
82006|SYSTEMIC ANTIBACTERIALS|J1
82005|DPP-IV inhibitor antidiabetics|A10B6
82000|SYSTEMIC ANTIBACTERIALS|J1
81998|CALCIUM ANTAGONISTS|C8
81994|ANTIVIRALS FOR SYSTEMIC USE|J5
81993|ANTIVIRALS FOR SYSTEMIC USE|J5
81992|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
81991|OPHTHALMOLOGICALS|S1
81988|OPHTHALMOLOGICALS|S1
81988|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
81988|Ocular antineovascularisation products|S1P
81987|ANDROGENS, EXCLUDING G3E, G3F|G3B
81985|ANTIMETABOLITES|L1B
81980|ANTIVIRALS FOR SYSTEMIC USE|J5
81979|ANTIVIRALS FOR SYSTEMIC USE|J5
81961|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81959|WOUND HEALING AGENTS|D3
81954|DERMATOLOGICALS|D
81951|IMMUNOSTIMULATING AGENTS|L3
81945|Factor VIII|B2D1
81944|ANTIHYPERTENSIVES|C2
81942|ANTIVIRALS FOR SYSTEMIC USE|J5
81937|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81935|ANTIPSYCHOTICS|N5A
81934|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81924|B2-STIMULANTS|R3A
81921|SYSTEMIC ANTIBACTERIALS|J1
81920|ANTIVIRALS FOR SYSTEMIC USE|J5
81918|Factor VIII|B2D1
81917|SYSTEMIC ANTIBACTERIALS|J1
81916|IMMUNOSTIMULATING AGENTS|L3
81914|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
81913|OPHTHALMOLOGICALS|S1
81907|ANTIPSYCHOTICS|N5A
81905|ANTIVIRALS FOR SYSTEMIC USE|J5
81903|OPHTHALMOLOGICALS|S1
81889|MUSCULO-SKELETAL SYSTEM|M
81882|SYSTEMIC ANTIBACTERIALS|J1
81878|ANTIVIRALS FOR SYSTEMIC USE|J5
81878|IMMUNOSTIMULATING AGENTS|L3
81877|RESPIRATORY SYSTEM|R
81874|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81873|SYSTEMIC ANTIBACTERIALS|J1
81872|SYSTEMIC ANTIBACTERIALS|J1
81871|SYSTEMIC ANTIBACTERIALS|J1
81867|CARDIOVASCULAR SYSTEM|C
81867|ANTIHYPERTENSIVES|C2
81865|ANTIVIRALS FOR SYSTEMIC USE|J5
81864|Factor VIII|B2D1
81863|ANTIVIRALS FOR SYSTEMIC USE|J5
81862|ANTIVIRALS FOR SYSTEMIC USE|J5
81855|SYSTEMIC ANTIBACTERIALS|J1
81855|IMMUNOSTIMULATING AGENTS|L3
81854|ANTIVIRALS FOR SYSTEMIC USE|J5
81852|ANTIHYPERTENSIVES|C2
81850|PARASITOLOGY|P
81849|GASTROPROKINETICS|A3F
81849|LAXATIVES|A6
81846|ANTI-EPILEPTICS|N3A
81835|PARASITOLOGY|P
81834|PARASITOLOGY|P
81828|CEPHALOSPORINS|J1D
81827|ANTIVIRALS FOR SYSTEMIC USE|J5
81826|SYSTEMIC ANTIBACTERIALS|J1
81824|SYSTEMIC ANTIBACTERIALS|J1
81821|ANTIVIRALS FOR SYSTEMIC USE|J5
81821|INTERFERONS|L3B
81816|ALKYLATING AGENTS|L1A
81815|DRUGS USED IN DIABETES|A10
81814|CALCIUM ANTAGONISTS|C8
81812|ALKYLATING AGENTS|L1A
81811|ANTIVIRALS FOR SYSTEMIC USE|J5
81810|CARDIOVASCULAR SYSTEM|C
81804|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
81800|ANTIVIRALS FOR SYSTEMIC USE|J5
81796|ANTI-ARRHYTHMICS|C1B
81795|Biguanide antidiabetics|A10B2
81794|ANTIHYPERTENSIVES|C2
81794|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
81794|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
81794|Statins (HMG-CoA reductase inhibitors)|C10A1
81793|PLATELET AGGREGATION INHIBITORS|B1C
81793|CARDIOVASCULAR SYSTEM|C
81789|IMMUNOSTIMULATING AGENTS|L3
81788|ANTIHYPERTENSIVES|C2
81785|ANTIPSYCHOTICS|N5A
81784|MRI AGENTS|T1E
81784|RADIODIAGNOSTIC AGENTS|T1G
81782|ANTIVIRALS FOR SYSTEMIC USE|J5
81778|OPHTHALMOLOGICALS|S1
81777|Antigrowth hormones|H1C2
81775|ACTH|H1A
81775|ANTI-EPILEPTICS|N3
81773|CENTRAL NERVOUS SYSTEM|N
81767|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
81759|ANTIVIRALS FOR SYSTEMIC USE|J5
81758|PLATELET AGGREGATION INHIBITORS|B1C
81758|CARDIOVASCULAR SYSTEM|C
81754|ANTI-ACNE PREPARATIONS|D10
81751|MUSCLE RELAXANTS|M3
81749|ANALGESICS|N2
81733|ANTIHYPERTENSIVES|C2
81732|Human insulins and analogues, long-acting|A10C5
81731|RESPIRATORY SYSTEM|R
81730|RESPIRATORY SYSTEM|R
81729|SYSTEMIC ANTIBACTERIALS|J1
81727|IMMUNOSUPPRESSIVE AGENTS|L4
81726|ANTIHYPERTENSIVES|C2
81726|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
81726|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
81726|Statins (HMG-CoA reductase inhibitors)|C10A1
81724|ANTIVIRALS FOR SYSTEMIC USE|J5
81717|RADIODIAGNOSTIC AGENTS|T1G
81715|ANALGESICS|N2
81714|RADIODIAGNOSTIC AGENTS|T1G
81712|BPH (benign prostatic hypertrophy) products |G4C
81711|ANTIVIRALS FOR SYSTEMIC USE|J5
81711|IMMUNOSTIMULATING AGENTS|L3
81710|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
81708|SYSTEMIC ANTIBACTERIALS|J1
81704|DRUGS USED IN DIABETES|A10
81704|HUMAN INSULINS AND ANALOGUES|A10C
81704|Human insulins and analogues, long-acting|A10C5
81703|IMMUNOSTIMULATING AGENTS|L3
81702|ANTIVIRALS FOR SYSTEMIC USE|J5
81702|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
81698|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
81697|DRUGS USED IN DIABETES|A10
81696|ANTIPSYCHOTICS|N5A
81696|NOOTROPICS|N6D
81695|AMINOGLYCOSIDES|J1K
81694|PSYCHOSTIMULANTS|N6B
81691|DERMATOLOGICALS|D
81685|SYSTEMIC ANTIBACTERIALS|J1
81685|ANTIVIRALS FOR SYSTEMIC USE|J5
81684|CARDIOVASCULAR SYSTEM|C
81681|MACROLIDES AND SIMILAR TYPES|J1F
81680|MUSCLE RELAXANTS|M3
81679|DERMATOLOGICALS|D
81679|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
81679|ANTIVIRALS FOR SYSTEMIC USE|J5
81678|RADIODIAGNOSTIC AGENTS|T1G
81673|CENTRAL NERVOUS SYSTEM|N
81673|RADIODIAGNOSTIC AGENTS|T1G
81671|RADIODIAGNOSTIC AGENTS|T1G
81670|ALKYLATING AGENTS|L1A
81667|Interferons, gamma|L3B3
81666|Interferons, beta|L3B2
81665|MACROLIDES AND SIMILAR TYPES|J1F
81662|GROWTH HORMONES|H4C
81661|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
81652|ANTI-EPILEPTICS|N3
81651|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
81650|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
81650|IMMUNOSUPPRESSIVE AGENTS|L4
81648|ANTIVIRALS FOR SYSTEMIC USE|J5
81646|Vitamin K|B2B1
81637|CENTRAL NERVOUS SYSTEM|N
81637|NOOTROPICS|N6D
81635|SYSTEMIC ANTIBACTERIALS|J1
81634|ANTI-EPILEPTICS|N3
81631|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
81629|ANTI-EPILEPTICS|N3A
81629|NOOTROPICS|N6D
81627|ANTI-EPILEPTICS|N3
81625|SYSTEMIC ANTIBACTERIALS|J1
81624|ANTIVIRALS FOR SYSTEMIC USE|J5
81621|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81619|ANALGESICS|N2
81618|ANALGESICS|N2
81609|FIBRINOLYTICS|B1D
81605|CARDIOVASCULAR SYSTEM|C
81605|ANTIHYPERTENSIVES|C2
81602|MACROLIDES AND SIMILAR TYPES|J1F
81602|RESPIRATORY SYSTEM|R
81596|PARASITOLOGY|P
81592|SYSTEMIC ANTIBACTERIALS|J1
81591|GROWTH HORMONES|H4C
81590|RESPIRATORY SYSTEM|R
81588|ANTIVIRALS FOR SYSTEMIC USE|J5
81587|DRUGS USED IN DIABETES|A10
81587|HUMAN INSULINS AND ANALOGUES|A10C
81587|Human insulins and analogues, long-acting|A10C5
81583|ANTIHYPERTENSIVES|C2
81583|ACE INHIBITORS, PLAIN|C9A
81579|ANTIVIRALS FOR SYSTEMIC USE|J5
81578|ANTIVIRALS FOR SYSTEMIC USE|J5
81575|ANTIVIRALS FOR SYSTEMIC USE|J5
81573|Urinary incontinence products|G4B4
81567|NOOTROPICS|N6D
81567|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
81566|ANTIEMETICS AND ANTINAUSEANTS|A4
81563|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
81562|ANALGESICS|N2
81560|NOOTROPICS|N6D
81559|ANALGESICS|N2
81553|SYSTEMIC ANTIBACTERIALS|J1
81552|B2-STIMULANTS|R3A
81550|ANTIVIRALS FOR SYSTEMIC USE|J5
81545|SYSTEMIC ANTIBACTERIALS|J1
81545|ANTIVIRALS FOR SYSTEMIC USE|J5
81545|IMMUNOSTIMULATING AGENTS|L3
81537|ANALGESICS|N2
81536|ANTIPSYCHOTICS|N5A
81536|NOOTROPICS|N6D
81535|ANTIVIRALS FOR SYSTEMIC USE|J5
81534|ANTIVIRALS FOR SYSTEMIC USE|J5
81533|SYSTEMIC ANTIBACTERIALS|J1
81533|AMINOGLYCOSIDES|J1K
81531|ANALGESICS|N2
81530|NOOTROPICS|N6D
81525|ANALGESICS|N2
81523|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
81508|ANTI-EPILEPTICS|N3A
81505|IMMUNOSTIMULATING AGENTS|L3
81494|ANALGESICS|N2
81492|ANTIVIRALS FOR SYSTEMIC USE|J5
81488|ANTIVIRALS FOR SYSTEMIC USE|J5
81486|ANTIVIRALS FOR SYSTEMIC USE|J5
81481|ANTIPSYCHOTICS|N5A
81478|ANALGESICS|N2
81475|ANALGESICS|N2
81473|SYSTEMIC ANTIBACTERIALS|J1
81472|SYSTEMIC ANTIBACTERIALS|J1
81471|ANTIHYPERTENSIVES|C2
81469|ANTIVIRALS FOR SYSTEMIC USE|J5
81466|SYSTEMIC ANTIBACTERIALS|J1
81464|ANTIVIRALS FOR SYSTEMIC USE|J5
81459|ANTIVIRALS FOR SYSTEMIC USE|J5
81458|ANTIVIRALS FOR SYSTEMIC USE|J5
81456|MUSCULO-SKELETAL SYSTEM|M
81448|ANTIMETABOLITES|L1B
81445|ANTIVIRALS FOR SYSTEMIC USE|J5
81443|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81442|ANTIPSYCHOTICS|N5A
81440|ANALGESICS|N2
81439|ANALGESICS|N2
81438|ANTIVIRALS FOR SYSTEMIC USE|J5
81436|ANTIEMETICS AND ANTINAUSEANTS|A4
81434|MUSCLE RELAXANTS|M3
81433|ANTIVIRALS FOR SYSTEMIC USE|J5
81431|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
81428|PARASITOLOGY|P
81428|AMOEBICIDES|P1A
81426|SYSTEMIC ANTIBACTERIALS|J1
81425|OPHTHALMOLOGICALS|S1
81424|OPHTHALMOLOGICALS|S1
81422|PARASITOLOGY|P
81422|AMOEBICIDES|P1A
81421|PARASITOLOGY|P
81421|ANTIPROTOZOALS AND ANTHELMINTICS|P1
81419|ANALGESICS|N2
81418|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
81417|CARDIOVASCULAR SYSTEM|C
81417|CENTRAL NERVOUS SYSTEM|N
81413|IMMUNOSUPPRESSIVE AGENTS|L4
81410|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
81402|ANALGESICS|N2
81400|ANTIVIRALS FOR SYSTEMIC USE|J5
81397|NOOTROPICS|N6D
81395|TRANQUILLISERS|N5C
81394|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
81392|SYSTEMIC ANTIBACTERIALS|J1
81391|ANTIVIRALS FOR SYSTEMIC USE|J5
81388|ANTIVIRALS FOR SYSTEMIC USE|J5
81388|ANTITUSSIVES|R5D
81387|IMMUNOSUPPRESSIVE AGENTS|L4
81386|IMMUNOSUPPRESSIVE AGENTS|L4
81385|VACCINES|J7
81380|BPH (benign prostatic hypertrophy) products |G4C
81379|VACCINES|J7
81377|VACCINES|J7
81374|RESPIRATORY SYSTEM|R
81373|DRUGS USED IN DIABETES|A10
81372|ANALGESICS|N2
81367|ANTIVIRALS FOR SYSTEMIC USE|J5
81367|VACCINES|J7
81366|ANTI-ARRHYTHMICS|C1B
81362|B2-STIMULANTS|R3A
81361|ANALGESICS|N2
81359|VACCINES|J7
81355|ANTI-EPILEPTICS|N3A
81354|ANTI-EPILEPTICS|N3A
81351|VACCINES|J7
81350|VACCINES|J7
81347|VACCINES|J7
81346|VACCINES|J7
81344|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81344|CARDIOVASCULAR SYSTEM|C
81342|ANTIVIRALS FOR SYSTEMIC USE|J5
81340|ANTIVIRALS FOR SYSTEMIC USE|J5
81340|DIAGNOSTIC AGENTS|T
81332|DRUGS USED IN DIABETES|A10
81319|Ocular antineovascularisation products|S1P
81315|ANTIPROTOZOALS AND ANTHELMINTICS|P1
81315|ANTI-MALARIALS|P1D
81314|DRUGS USED IN DIABETES|A10
81313|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81308|ANTIVIRALS FOR SYSTEMIC USE|J5
81290|ANTIPSYCHOTICS|N5A
81289|SYSTEMIC ANTIBACTERIALS|J1
81287|FIBRINOLYTICS|B1D
81283|IMMUNOSUPPRESSIVE AGENTS|L4
81275|CARDIOVASCULAR SYSTEM|C
81274|DRUGS USED IN DIABETES|A10
81274|HUMAN INSULINS AND ANALOGUES|A10C
81274|Human insulins and analogues, intermediate-acting|A10C2
81273|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81272|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81271|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81270|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81264|SYSTEMIC ANTIBACTERIALS|J1
81264|ANTIVIRALS FOR SYSTEMIC USE|J5
81263|FIBRINOLYTICS|B1D
81262|ANTI-EPILEPTICS|N3
81259|CENTRAL NERVOUS SYSTEM|N
81259|TRANQUILLISERS|N5C
81258|TRANQUILLISERS|N5C
81258|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
81257|ANTIVIRALS FOR SYSTEMIC USE|J5
81255|DRUGS USED IN DIABETES|A10
81255|HUMAN INSULINS AND ANALOGUES|A10C
81255|Human insulins and analogues, intermediate-acting|A10C2
81249|OPHTHALMOLOGICALS|S1
81246|NOOTROPICS|N6D
81240|ANTIVIRALS FOR SYSTEMIC USE|J5
81231|SYSTEMIC ANTIBACTERIALS|J1
81223|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
81221|ANTIVIRALS FOR SYSTEMIC USE|J5
81218|ANTI-ARRHYTHMICS|C1B
81211|SYSTEMIC ANTIBACTERIALS|J1
81210|VACCINES|J7
81209|SYSTEMIC ANTIBACTERIALS|J1
81202|DRUGS USED IN DIABETES|A10
81201|SYSTEMIC ANTIBACTERIALS|J1
81200|DPP-IV inhibitor antidiabetics|A10B6
81197|ANALGESICS|N2
81197|ANTI-MIGRAINE PREPARATIONS|N2C
81196|DRUGS USED IN DIABETES|A10
81188|ANTI-EPILEPTICS|N3A
81186|ANALGESICS|N2
81184|SYSTEMIC ANTIBACTERIALS|J1
81182|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81181|SYSTEMIC ANTIBACTERIALS|J1
81179|CARDIOVASCULAR SYSTEM|C
81174|SYSTEMIC ANTIBACTERIALS|J1
81171|DRUGS USED IN DIABETES|A10
81168|SYSTEMIC ANTIBACTERIALS|J1
81166|ANTIHYPERTENSIVES|C2
81164|SYSTEMIC ANTIBACTERIALS|J1
81163|ANALGESICS|N2
81162|ANALGESICS|N2
81162|SSRI antidepressants|N6A4
81162|SRNI antidepressants|N6A5
81161|CARDIOVASCULAR SYSTEM|C
81161|ANALGESICS|N2
81157|SYSTEMIC ANTIBACTERIALS|J1
81156|ANALGESICS|N2
81155|ANALGESICS|N2
81154|ANTIHYPERTENSIVES|C2
81153|ANALGESICS|N2
81152|ANALGESICS|N2
81142|ANTI-MALARIALS|P1D
81141|SYSTEMIC ANTIBACTERIALS|J1
81139|ANTIVIRALS FOR SYSTEMIC USE|J5
81138|ANTI-MALARIALS|P1D
81136|ANTIVIRALS FOR SYSTEMIC USE|J5
81135|NOOTROPICS|N6D
81133|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81132|ANTI-EPILEPTICS|N3A
81130|CARDIOVASCULAR SYSTEM|C
81123|SYSTEMIC ANTIBACTERIALS|J1
81122|SYSTEMIC ANTIBACTERIALS|J1
81117|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81111|B2-STIMULANTS|R3A
81108|OPHTHALMOLOGICALS|S1
81101|MUSCULO-SKELETAL SYSTEM|M
81099|ANTI-MIGRAINE PREPARATIONS|N2C
81097|SYSTEMIC ANTIBACTERIALS|J1
81096|SYSTEMIC ANTIBACTERIALS|J1
81091|ANALGESICS|N2
81091|ANTI-MIGRAINE PREPARATIONS|N2C
81088|ANALGESICS|N2
81087|ANALGESICS|N2
81083|IMMUNOSTIMULATING AGENTS|L3
81082|RESPIRATORY SYSTEM|R
81081|OPHTHALMOLOGICALS|S1
81080|OPHTHALMOLOGICALS|S1
81077|ANTI-EPILEPTICS|N3A
81071|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81065|ANTIVIRALS FOR SYSTEMIC USE|J5
81060|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
81058|SYSTEMIC ANTIBACTERIALS|J1
81057|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
81056|ANTIVIRALS FOR SYSTEMIC USE|J5
81055|ANTIHYPERTENSIVES|C2
81054|ANTIHYPERTENSIVES|C2
81053|ANTIVIRALS FOR SYSTEMIC USE|J5
81051|CENTRAL NERVOUS SYSTEM|N
81049|ANTIVIRALS FOR SYSTEMIC USE|J5
81048|ANTIVIRALS FOR SYSTEMIC USE|J5
81047|CENTRAL NERVOUS SYSTEM|N
81044|RESPIRATORY SYSTEM|R
81043|RESPIRATORY SYSTEM|R
81040|Interferons, alpha|L3B1
81038|HUMAN INSULINS AND ANALOGUES|A10C
81038|Human insulins and analogues, intermediate-acting|A10C2
81037|SYSTEMIC ANTIBACTERIALS|J1
81034|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
81030|Human insulins and analogues, fast-acting|A10C1
81028|Interferons, beta|L3B2
81027|Interferons, beta|L3B2
81021|ANTIVIRALS FOR SYSTEMIC USE|J5
81020|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
81020|ANTIVIRALS FOR SYSTEMIC USE|J5
81016|DRUGS USED IN DIABETES|A10
81014|ANTI-ACNE PREPARATIONS|D10
81013|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
81012|ANTACIDS, ANTIFLATULENTS, CARMINATIVES|A2A
81012|ANTIULCERANTS|A2B
81008|SYSTEMIC ANTIBACTERIALS|J1
81003|DERMATOLOGICALS|D
81003|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
81002|DERMATOLOGICALS|D
81001|SYSTEMIC ANTIBACTERIALS|J1
81000|SYSTEMIC ANTIBACTERIALS|J1
81000|VACCINES|J7
80999|RESPIRATORY SYSTEM|R
80996|PLATELET AGGREGATION INHIBITORS|B1C
80996|CARDIOVASCULAR SYSTEM|C
80996|ACE INHIBITORS, PLAIN|C9A
80996|Statins (HMG-CoA reductase inhibitors)|C10A1
80992|MRI AGENTS|T1E
80992|ULTRASOUND AGENTS|T1F
80992|RADIODIAGNOSTIC AGENTS|T1G
80987|ANTIVIRALS FOR SYSTEMIC USE|J5
80987|Interferons, alpha|L3B1
80984|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
80981|RADIODIAGNOSTIC AGENTS|T1G
80980|IMMUNOSUPPRESSIVE AGENTS|L4
80977|ANALGESICS|N2
80974|ANALGESICS|N2
80973|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
80970|CARDIOVASCULAR SYSTEM|C
80969|VACCINES|J7
80961|ANTIVIRALS FOR SYSTEMIC USE|J5
80959|ANTI-EPILEPTICS|N3A
80956|IMMUNOSTIMULATING AGENTS|L3
80954|DERMATOLOGICALS|D
80954|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
80952|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
80947|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
80942|SYSTEMIC ANTIBACTERIALS|J1
80936|ANTIVIRALS FOR SYSTEMIC USE|J5
80935|ANTIVIRALS FOR SYSTEMIC USE|J5
80932|CENTRAL NERVOUS SYSTEM|N
80932|RADIODIAGNOSTIC AGENTS|T1G
80931|SYSTEMIC ANTIBACTERIALS|J1
80925|DRUGS USED IN DIABETES|A10
80922|OPHTHALMOLOGICALS|S1
80921|RADIODIAGNOSTIC AGENTS|T1G
80920|ANALGESICS|N2
80919|ANALGESICS|N2
80918|ANALGESICS|N2
80917|SYSTEMIC ANTIBACTERIALS|J1
80916|SYSTEMIC ANTIBACTERIALS|J1
80915|ANTIPSYCHOTICS|N5A
80909|DIRECT THROMBIN INHIBITORS|B1E
80909|CARDIOVASCULAR SYSTEM|C
80908|ANTIVIRALS FOR SYSTEMIC USE|J5
80908|Protease inhibitors|J5C2
80907|DRUGS USED IN DIABETES|A10
80905|DRUGS USED IN DIABETES|A10
80904|Interferons, beta|L3B2
80901|ANTIVIRALS FOR SYSTEMIC USE|J5
80891|Ocular antineovascularisation products|S1P
80890|RADIODIAGNOSTIC AGENTS|T1G
80889|DRUGS USED IN DIABETES|A10
80884|LAXATIVES|A6
80881|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
80880|HYPNOTICS/SEDATIVES|N5B
80879|FIBRINOLYTICS|B1D
80879|CARDIOVASCULAR SYSTEM|C
80878|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
80876|TRANQUILLISERS|N5C
80876|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
80876|SSRI antidepressants|N6A4
80875|FIBRINOLYTICS|B1D
80873|NOOTROPICS|N6D
80872|ANTIVIRALS FOR SYSTEMIC USE|J5
80870|Interferons, beta|L3B2
80869|ANTIMETABOLITES|L1B
80868|Factor VIII|B2D1
80866|ANALGESICS|N2
80865|ANTIVIRALS FOR SYSTEMIC USE|J5
80864|SYSTEMIC ANTIBACTERIALS|J1
80864|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
80864|ANTIVIRALS FOR SYSTEMIC USE|J5
80863|NOOTROPICS|N6D
80859|ANAESTHETICS|N1
80854|DIRECT THROMBIN INHIBITORS|B1E
80853|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80852|RADIODIAGNOSTIC AGENTS|T1G
80851|ANALGESICS|N2
80850|RADIODIAGNOSTIC AGENTS|T1G
80848|RADIODIAGNOSTIC AGENTS|T1G
80847|ANTIVIRALS FOR SYSTEMIC USE|J5
80844|ANTIPROTOZOALS AND ANTHELMINTICS|P1
80843|ANTIVIRALS FOR SYSTEMIC USE|J5
80841|B2-STIMULANTS|R3A
80840|ANTIVIRALS FOR SYSTEMIC USE|J5
80838|SYSTEMIC ANTIBACTERIALS|J1
80836|ANALGESICS|N2
80834|FIBRINOLYTICS|B1D
80833|ANTI-EPILEPTICS|N3A
80833|ANTIPSYCHOTICS|N5A
80832|ANALGESICS|N2
80827|ANTIVIRALS FOR SYSTEMIC USE|J5
80826|HUMAN INSULINS AND ANALOGUES|A10C
80826|Human insulins and analogues, intermediate-acting|A10C2
80824|SYSTEMIC ANTIBACTERIALS|J1
80823|ANTIVIRALS FOR SYSTEMIC USE|J5
80822|DRUGS USED IN DIABETES|A10
80822|HUMAN INSULINS AND ANALOGUES|A10C
80822|Human insulins and analogues, long-acting|A10C5
80819|HYPNOTICS/SEDATIVES|N5B
80819|TRANQUILLISERS|N5C
80814|RADIODIAGNOSTIC AGENTS|T1G
80813|Factors II, VII, IX and X|B2D2
80812|Factor VIII|B2D1
80811|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
80810|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80803|ANTIVIRALS FOR SYSTEMIC USE|J5
80800|ANDROGENS, EXCLUDING G3E, G3F|G3B
80796|SYSTEMIC ANTIBACTERIALS|J1
80796|CEPHALOSPORINS|J1D
80787|TRANQUILLISERS|N5C
80786|ANTIVIRALS FOR SYSTEMIC USE|J5
80784|GROWTH HORMONES|H4C
80783|ANTIPSYCHOTICS|N5A
80776|DRUGS USED IN DIABETES|A10
80776|HUMAN INSULINS AND ANALOGUES|A10C
80776|Human insulins and analogues, fast-acting|A10C1
80775|DRUGS USED IN DIABETES|A10
80775|HUMAN INSULINS AND ANALOGUES|A10C
80775|Human insulins and analogues, fast-acting|A10C1
80772|SYSTEMIC ANTIBACTERIALS|J1
80761|ANTI-EPILEPTICS|N3A
80759|ANTI-GOUT PREPARATIONS|M4
80759|ANALGESICS|N2
80757|ANTIVIRALS FOR SYSTEMIC USE|J5
80753|TOPICAL ANTI-ACNE PREPARATIONS|D10A
80752|ANALGESICS|N2
80748|ANTIVIRALS FOR SYSTEMIC USE|J5
80740|DRUGS USED IN DIABETES|A10
80737|Interferons, beta|L3B2
80736|Interferons, beta|L3B2
80735|Interferons, beta|L3B2
80730|SYSTEMIC ANTIBACTERIALS|J1
80727|CARDIOVASCULAR SYSTEM|C
80723|OPHTHALMOLOGICALS|S1
80718|ANALGESICS|N2
80717|ANTIVIRALS FOR SYSTEMIC USE|J5
80705|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
80705|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
80705|ANALGESICS|N2
80690|ANALGESICS|N2
80689|RESPIRATORY SYSTEM|R
80688|ANTIVIRALS FOR SYSTEMIC USE|J5
80685|CENTRAL NERVOUS SYSTEM|N
80685|NOOTROPICS|N6D
80684|MUSCLE RELAXANTS|M3
80684|ANTI-EPILEPTICS|N3
80683|TRANQUILLISERS|N5C
80683|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
80683|SSRI antidepressants|N6A4
80681|SYSTEMIC ANTIBACTERIALS|J1
80678|SYSTEMIC ANTIBACTERIALS|J1
80678|CEPHALOSPORINS|J1D
80676|SYSTEMIC ANTIBACTERIALS|J1
80671|TRANQUILLISERS|N5C
80671|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
80667|PARASITOLOGY|P
80667|ANTI-MALARIALS|P1D
80665|ANTIVIRALS FOR SYSTEMIC USE|J5
80657|ANTIVIRALS FOR SYSTEMIC USE|J5
80653|ANTI-EPILEPTICS|N3A
80647|ANTIVIRALS FOR SYSTEMIC USE|J5
80644|ALKYLATING AGENTS|L1A
80639|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
80636|CALCITONINS|H4A
80632|CARDIAC THERAPY|C1
80631|CARDIOVASCULAR SYSTEM|C
80630|GROWTH HORMONES|H4C
80629|CARDIOVASCULAR SYSTEM|C
80628|ANTIVIRALS FOR SYSTEMIC USE|J5
80625|CARDIOVASCULAR SYSTEM|C
80622|ANTIVIRALS FOR SYSTEMIC USE|J5
80622|Interferons, alpha|L3B1
80618|FIBRINOLYTICS|B1D
80613|Factors II, VII, IX and X|B2D2
80612|Factors II, VII, IX and X|B2D2
80610|ANTIVIRALS FOR SYSTEMIC USE|J5
80609|ANALGESICS|N2
80608|CARDIOVASCULAR SYSTEM|C
80608|RESPIRATORY SYSTEM|R
80607|SYSTEMIC ANTIBACTERIALS|J1
80590|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
80590|SSRI antidepressants|N6A4
80590|SRNI antidepressants|N6A5
80588|ANTIPSYCHOTICS|N5A
80575|Colony-stimulating factors|L3A1
80572|ANTIVIRALS FOR SYSTEMIC USE|J5
80570|IMMUNOSTIMULATING AGENTS|L3
80568|SYSTEMIC ANTIBACTERIALS|J1
80566|VACCINES|J7
80564|VACCINES|J7
80563|SYSTEMIC ANTIBACTERIALS|J1
80558|SYSTEMIC ANTIBACTERIALS|J1
80557|SYSTEMIC ANTIBACTERIALS|J1
80556|WOUND HEALING AGENTS|D3
80555|ANTIVIRALS FOR SYSTEMIC USE|J5
80553|IMMUNOSTIMULATING AGENTS|L3
80551|ANTIVIRALS FOR SYSTEMIC USE|J5
80548|SYSTEMIC ANTIBACTERIALS|J1
80535|DPP-IV inhibitor antidiabetics|A10B6
80527|Interferons, beta|L3B2
80524|Interferons, alpha|L3B1
80514|Factor VIII|B2D1
80513|GROWTH HORMONES|H4C
80511|GROWTH HORMONES|H4C
80506|IMMUNOSUPPRESSIVE AGENTS|L4
80503|IMMUNOSUPPRESSIVE AGENTS|L4
80495|ANTIVIRALS FOR SYSTEMIC USE|J5
80488|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
80483|SYSTEMIC ANTIBACTERIALS|J1
80482|ANALGESICS|N2
80481|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80481|CARDIOVASCULAR SYSTEM|C
80481|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
80480|OPHTHALMOLOGICALS|S1
80480|Ocular antineovascularisation products|S1P
80477|PLATELET AGGREGATION INHIBITORS|B1C
80477|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
80476|IMMUNOSUPPRESSIVE AGENTS|L4
80474|ANTIVIRALS FOR SYSTEMIC USE|J5
80472|FIBRINOLYTICS|B1D
80467|SYSTEMIC ANTIBACTERIALS|J1
80465|FIBRINOLYTICS|B1D
80465|CARDIOVASCULAR SYSTEM|C
80464|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
80463|ANTIVIRALS FOR SYSTEMIC USE|J5
80463|IMMUNOSTIMULATING AGENTS|L3
80462|SYSTEMIC ANTIBACTERIALS|J1
80462|CEPHALOSPORINS|J1D
80461|ANTIVIRALS FOR SYSTEMIC USE|J5
80460|ANTIVIRALS FOR SYSTEMIC USE|J5
80459|ANTIVIRALS FOR SYSTEMIC USE|J5
80458|SYSTEMIC ANTIBACTERIALS|J1
80453|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
80451|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
80449|Interferons, beta|L3B2
80447|ANTIVIRALS FOR SYSTEMIC USE|J5
80446|ANTIVIRALS FOR SYSTEMIC USE|J5
80442|ANTIVIRALS FOR SYSTEMIC USE|J5
80438|Factors II, VII, IX and X|B2D2
80437|Factor VIII|B2D1
80436|ANTIVIRALS FOR SYSTEMIC USE|J5
80434|ANTIVIRALS FOR SYSTEMIC USE|J5
80433|ANTIVIRALS FOR SYSTEMIC USE|J5
80429|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80429|DRUGS USED IN DIABETES|A10
80426|ANTIVIRALS FOR SYSTEMIC USE|J5
80416|ANTIVIRALS FOR SYSTEMIC USE|J5
80405|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
80405|IMMUNOSUPPRESSIVE AGENTS|L4
80401|FIBRINOLYTICS|B1D
80398|CARDIOVASCULAR SYSTEM|C
80396|ANTIVIRALS FOR SYSTEMIC USE|J5
80393|FIBRINOLYTICS|B1D
80393|CARDIOVASCULAR SYSTEM|C
80391|ANTIVIRALS FOR SYSTEMIC USE|J5
80385|WOUND HEALING AGENTS|D3
80382|FIBRINOLYTICS|B1D
80376|CENTRAL NERVOUS SYSTEM|N
80371|ANTIVIRALS FOR SYSTEMIC USE|J5
80368|ANTIHYPERTENSIVES|C2
80366|ANTIEMETICS AND ANTINAUSEANTS|A4
80365|DRUGS USED IN DIABETES|A10
80364|ANTIVIRALS FOR SYSTEMIC USE|J5
80362|DRUGS USED IN DIABETES|A10
80359|DRUGS USED IN DIABETES|A10
80359|HUMAN INSULINS AND ANALOGUES|A10C
80359|Human insulins and analogues, long-acting|A10C5
80353|ANTIVIRALS FOR SYSTEMIC USE|J5
80343|ANTIVIRALS FOR SYSTEMIC USE|J5
80339|ANALGESICS|N2
80338|ANTIVIRALS FOR SYSTEMIC USE|J5
80333|B2-STIMULANTS|R3A
80330|ANTIVIRALS FOR SYSTEMIC USE|J5
80329|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
80329|ANALGESICS|N2
80329|ANTI-MIGRAINE PREPARATIONS|N2C
80324|FIBRINOLYTICS|B1D
80320|ANTIVIRALS FOR SYSTEMIC USE|J5
80312|Factor VIII|B2D1
80310|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80309|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80308|CARDIOVASCULAR SYSTEM|C
80291|ANTIHYPERTENSIVES|C2
80291|DIURETICS|C3
80291|ACE INHIBITORS, PLAIN|C9A
80284|PARASITOLOGY|P
80283|NOOTROPICS|N6D
80281|ANTIVIRALS FOR SYSTEMIC USE|J5
80280|ANTIVIRALS FOR SYSTEMIC USE|J5
80279|TRANQUILLISERS|N5C
80279|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
80277|DIRECT THROMBIN INHIBITORS|B1E
80276|ANALGESICS|N2
80274|DIRECT THROMBIN INHIBITORS|B1E
80272|ANTIVIRALS FOR SYSTEMIC USE|J5
80271|FIBRINOLYTICS|B1D
80270|CARDIOVASCULAR SYSTEM|C
80269|ANALGESICS|N2
80269|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
80251|ANTIVIRALS FOR SYSTEMIC USE|J5
80238|DRUGS USED IN DIABETES|A10
80238|HUMAN INSULINS AND ANALOGUES|A10C
80238|Human insulins and analogues, intermediate-acting|A10C2
80237|DRUGS USED IN DIABETES|A10
80237|HUMAN INSULINS AND ANALOGUES|A10C
80237|Human insulins and analogues, intermediate-acting|A10C2
80233|WOUND HEALING AGENTS|D3
80233|SYSTEMIC ANTIBACTERIALS|J1
80214|Interferons, beta|L3B2
80212|Interferons, beta|L3B2
80208|SYSTEMIC ANTIBACTERIALS|J1
80208|ANTIVIRALS FOR SYSTEMIC USE|J5
80208|IMMUNOSTIMULATING AGENTS|L3
80207|SYSTEMIC ANTIBACTERIALS|J1
80207|OPHTHALMOLOGICAL ANTI-INFECTIVES|S1A
80206|ANTIVIRALS FOR SYSTEMIC USE|J5
80205|SYSTEMIC ANTIBACTERIALS|J1
80205|ANTIVIRALS FOR SYSTEMIC USE|J5
80205|IMMUNOSTIMULATING AGENTS|L3
80200|IMMUNOSUPPRESSIVE AGENTS|L4
80190|ANALGESICS|N2
80188|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
80186|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80186|DRUGS USED IN DIABETES|A10
80180|ANTIVIRALS FOR SYSTEMIC USE|J5
80179|ANTIVIRALS FOR SYSTEMIC USE|J5
80172|IMMUNOSTIMULATING AGENTS|L3
80171|ANTIVIRALS FOR SYSTEMIC USE|J5
80171|IMMUNOSTIMULATING AGENTS|L3
80166|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80166|DRUGS USED IN DIABETES|A10
80164|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80164|DRUGS USED IN DIABETES|A10
80162|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80162|DRUGS USED IN DIABETES|A10
80152|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
80151|ALKYLATING AGENTS|L1A
80150|BETA-BLOCKING AGENTS|C7
80150|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
80147|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
80146|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
80142|ANTI-ARRHYTHMICS|C1B
80141|OPHTHALMOLOGICALS|S1
80140|ANTIVIRALS FOR SYSTEMIC USE|J5
80137|SYSTEMIC ANTIBACTERIALS|J1
80136|PARASITOLOGY|P
80135|ANTIPSYCHOTICS|N5A
80133|RESPIRATORY SYSTEM|R
80133|LUNG SURFACTANTS|R7C
80129|INTERFERONS|L3B
80127|ANTIVIRALS FOR SYSTEMIC USE|J5
80126|FIBRINOLYTICS|B1D
80124|ANTIVIRALS FOR SYSTEMIC USE|J5
80122|GROWTH HORMONES|H4C
80120|ANTIVIRALS FOR SYSTEMIC USE|J5
80114|Interferons, beta|L3B2
80111|Interferons, beta|L3B2
80110|IMMUNOSTIMULATING AGENTS|L3
80109|Ocular antineovascularisation products|S1P
80108|DRUGS USED IN DIABETES|A10
80107|ANTIHYPERTENSIVES|C2
80106|ANTIVIRALS FOR SYSTEMIC USE|J5
80099|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
80096|IMMUNOSTIMULATING AGENTS|L3
80086|ANTIVIRALS FOR SYSTEMIC USE|J5
80085|ANTIVIRALS FOR SYSTEMIC USE|J5
80083|IMMUNOSTIMULATING AGENTS|L3
80082|OPHTHALMOLOGICALS|S1
80081|ANTIVIRALS FOR SYSTEMIC USE|J5
80074|CENTRAL NERVOUS SYSTEM|N
80063|SYSTEMIC ANTIBACTERIALS|J1
80063|ANTIVIRALS FOR SYSTEMIC USE|J5
80062|SYSTEMIC ANTIBACTERIALS|J1
80062|ANTIVIRALS FOR SYSTEMIC USE|J5
80061|ANTIVIRALS FOR SYSTEMIC USE|J5
80060|CENTRAL NERVOUS SYSTEM|N
80057|Interferons, beta|L3B2
80056|ANTIVIRALS FOR SYSTEMIC USE|J5
80055|ANTIVIRALS FOR SYSTEMIC USE|J5
80054|CARDIOVASCULAR SYSTEM|C
80054|RADIODIAGNOSTIC AGENTS|T1G
80053|ANTIVIRALS FOR SYSTEMIC USE|J5
80051|ANTIVIRALS FOR SYSTEMIC USE|J5
80049|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
80048|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
80047|FIBRINOLYTICS|B1D
80045|ANTIVIRALS FOR SYSTEMIC USE|J5
80044|Interferons, beta|L3B2
80040|ANTIHYPERTENSIVES|C2
80035|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
80035|SRNI antidepressants|N6A5
80033|PLATELET AGGREGATION INHIBITORS|B1C
80030|ANTIVIRALS FOR SYSTEMIC USE|J5
80030|IMMUNOSTIMULATING AGENTS|L3
80030|ANAESTHETICS, LOCAL|N1B
80029|SYSTEMIC ANTIHISTAMINES|R6
80027|ANTIVIRALS FOR SYSTEMIC USE|J5
80027|Protease inhibitors|J5C2
80026|Interferons, beta|L3B2
80023|OPHTHALMOLOGICALS|S1
80013|SYSTEMIC ANTIBACTERIALS|J1
80012|SYSTEMIC ANTIBACTERIALS|J1
80011|ANALGESICS|N2
80007|Factor VIII|B2D1
80006|Coxibs|M1A3
80006|ANALGESICS|N2
80005|PLATELET AGGREGATION INHIBITORS|B1C
80004|CALCIUM ANTAGONISTS|C8
80004|MUSCLE RELAXANTS|M3
80004|ANALGESICS|N2
80000|CARDIOVASCULAR SYSTEM|C
79999|PARASITOLOGY|P
79997|SYSTEMIC ANTIBACTERIALS|J1
79997|RESPIRATORY SYSTEM|R
79995|HUMAN INSULINS AND ANALOGUES|A10C
79995|Human insulins and analogues, long-acting|A10C5
79994|ANTI-ACNE PREPARATIONS|D10
79993|ANTIVIRALS FOR SYSTEMIC USE|J5
79992|ANTI-ACNE PREPARATIONS|D10
79987|FIBRINOLYTICS|B1D
79984|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
79979|SYSTEMIC ANTIBACTERIALS|J1
79975|RESPIRATORY SYSTEM|R
79974|DRUGS USED IN DIABETES|A10
79974|HUMAN INSULINS AND ANALOGUES|A10C
79974|Human insulins and analogues, fast-acting|A10C1
79973|IMMUNOSUPPRESSIVE AGENTS|L4
79972|IMMUNOSUPPRESSIVE AGENTS|L4
79970|ANTIVIRALS FOR SYSTEMIC USE|J5
79969|SYSTEMIC ANTIBACTERIALS|J1
79969|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
79965|DRUGS USED IN DIABETES|A10
79963|ANTIVIRALS FOR SYSTEMIC USE|J5
79962|ANTIVIRALS FOR SYSTEMIC USE|J5
79958|OPHTHALMOLOGICALS|S1
79944|SYSTEMIC ANTIBACTERIALS|J1
79943|IMMUNOSUPPRESSIVE AGENTS|L4
79941|Interferons, beta|L3B2
79928|DRUGS USED IN DIABETES|A10
79928|HUMAN INSULINS AND ANALOGUES|A10C
79928|Human insulins and analogues, intermediate-acting|A10C2
79927|Interferons, beta|L3B2
79923|ANTIVIRALS FOR SYSTEMIC USE|J5
79916|DRUGS USED IN DIABETES|A10
79916|HUMAN INSULINS AND ANALOGUES|A10C
79916|Human insulins and analogues, intermediate-acting|A10C2
79912|ANALGESICS|N2
79911|FIBRINOLYTICS|B1D
79910|Interferons, beta|L3B2
79909|GLUCAGON|H4B
79908|GLUCAGON|H4B
79905|HUMAN INSULINS AND ANALOGUES|A10C
79905|Human insulins and analogues, intermediate-acting|A10C2
79903|HUMAN INSULINS AND ANALOGUES|A10C
79903|Human insulins and analogues, intermediate-acting|A10C2
79901|SYSTEMIC ANTIBACTERIALS|J1
79900|SYSTEMIC ANTIBACTERIALS|J1
79898|TRANQUILLISERS|N5C
79892|PARASITOLOGY|P
79891|PARASITOLOGY|P
79889|GROWTH HORMONES|H4C
79886|ANALGESICS|N2
79885|WOUND HEALING AGENTS|D3
79884|ANTIVIRALS FOR SYSTEMIC USE|J5
79883|ANTIVIRALS FOR SYSTEMIC USE|J5
79882|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
79880|DRUGS USED IN DIABETES|A10
79878|DRUGS USED IN DIABETES|A10
79878|HUMAN INSULINS AND ANALOGUES|A10C
79878|Human insulins and analogues, fast-acting|A10C1
79877|Factor VIII|B2D1
79876|DRUGS USED IN DIABETES|A10
79876|HUMAN INSULINS AND ANALOGUES|A10C
79876|Human insulins and analogues, fast-acting|A10C1
79872|DRUGS USED IN DIABETES|A10
79872|HUMAN INSULINS AND ANALOGUES|A10C
79872|Human insulins and analogues, intermediate-acting|A10C2
79867|ANTIVIRALS FOR SYSTEMIC USE|J5
79866|GROWTH HORMONES|H4C
79864|ANTIVIRALS FOR SYSTEMIC USE|J5
79863|Interferons, beta|L3B2
79862|Interferons, beta|L3B2
79853|DRUGS USED IN DIABETES|A10
79850|ANTI-EPILEPTICS|N3
79850|TRANQUILLISERS|N5C
79848|HYPNOTICS/SEDATIVES|N5B
79839|ANTIVIRALS FOR SYSTEMIC USE|J5
79835|MRI AGENTS|T1E
79832|GROWTH HORMONES|H4C
79825|WOUND HEALING AGENTS|D3
79824|SYSTEMIC ANTIHISTAMINES|R6
79822|ANTIVIRALS FOR SYSTEMIC USE|J5
79818|ANTIVIRALS FOR SYSTEMIC USE|J5
79817|ANTIVIRALS FOR SYSTEMIC USE|J5
79811|ANTIVIRALS FOR SYSTEMIC USE|J5
79810|ANTIVIRALS FOR SYSTEMIC USE|J5
79806|DRUGS USED IN DIABETES|A10
79802|ANTIVIRALS FOR SYSTEMIC USE|J5
79801|ANTIVIRALS FOR SYSTEMIC USE|J5
79793|GROWTH HORMONES|H4C
79792|NOOTROPICS|N6D
79792|DIAGNOSTIC AGENTS|T
79791|NOOTROPICS|N6D
79791|DIAGNOSTIC AGENTS|T
79790|WOUND HEALING AGENTS|D3
79782|Interferons, beta|L3B2
79781|IMMUNOSUPPRESSIVE AGENTS|L4
79778|NOOTROPICS|N6D
79777|Interferons, beta|L3B2
79772|ANTIPSYCHOTICS|N5A
79771|ANTIVIRALS FOR SYSTEMIC USE|J5
79768|Interferons, beta|L3B2
79767|CARDIAC THERAPY|C1
79767|POSITIVE INOTROPIC AGENTS|C1F
79766|CARDIAC THERAPY|C1
79766|POSITIVE INOTROPIC AGENTS|C1F
79765|SYSTEMIC ANTIBACTERIALS|J1
79757|SYSTEMIC ANTIBACTERIALS|J1
79757|ANTIVIRALS FOR SYSTEMIC USE|J5
79756|SYSTEMIC ANTIBACTERIALS|J1
79756|ANTIVIRALS FOR SYSTEMIC USE|J5
79755|DRUGS USED IN DIABETES|A10
79755|HUMAN INSULINS AND ANALOGUES|A10C
79755|Human insulins and analogues, intermediate-acting|A10C2
79751|ANTIPSYCHOTICS|N5A
79750|ANTI-EPILEPTICS|N3A
79750|Ocular antineovascularisation products|S1P
79746|ANTIVIRALS FOR SYSTEMIC USE|J5
79743|ANTIVIRALS FOR SYSTEMIC USE|J5
79742|ANTIHYPERTENSIVES|C2
79741|ANALGESICS|N2
79741|OPHTHALMOLOGICALS|S1
79740|ANALGESICS|N2
79740|OPHTHALMOLOGICALS|S1
79739|ANTIVIRALS FOR SYSTEMIC USE|J5
79736|GROWTH HORMONES|H4C
79735|Interferons, beta|L3B2
79734|Interferons, beta|L3B2
79733|OPHTHALMOLOGICALS|S1
79729|ANALGESICS|N2
79728|ANTIVIRALS FOR SYSTEMIC USE|J5
79727|CENTRAL NERVOUS SYSTEM|N
79722|HUMAN INSULINS AND ANALOGUES|A10C
79722|Human insulins and analogues, long-acting|A10C5
79720|GROWTH HORMONES|H4C
79715|Coxibs|M1A3
79712|Protease inhibitors|J5C2
79711|ANTIVIRALS FOR SYSTEMIC USE|J5
79709|SYSTEMIC ANTIBACTERIALS|J1
79690|ANTIVIRALS FOR SYSTEMIC USE|J5
79688|ANTIVIRALS FOR SYSTEMIC USE|J5
79687|NOOTROPICS|N6D
79683|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
79681|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
79678|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
79675|ANALGESICS|N2
79674|ANTIHYPERTENSIVES|C2
79670|ANALGESICS|N2
79667|CARDIOVASCULAR SYSTEM|C
79666|ANTIPSYCHOTICS|N5A
79665|CARDIOVASCULAR SYSTEM|C
79664|CARDIOVASCULAR SYSTEM|C
79659|WOUND HEALING AGENTS|D3
79656|ANTIVIRALS FOR SYSTEMIC USE|J5
79654|DRUGS USED IN DIABETES|A10
79653|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
79649|NOOTROPICS|N6D
79648|ANTIVIRALS FOR SYSTEMIC USE|J5
79646|ANTIVIRALS FOR SYSTEMIC USE|J5
79644|IMMUNOSUPPRESSIVE AGENTS|L4
79638|ANTIVIRALS FOR SYSTEMIC USE|J5
79637|ANALGESICS|N2
79635|OPHTHALMOLOGICALS|S1
79634|ANALGESICS|N2
79626|BETA-BLOCKING AGENTS|C7
79621|TRANQUILLISERS|N5C
79618|IMMUNOSTIMULATING AGENTS|L3
79617|IMMUNOSUPPRESSIVE AGENTS|L4
79615|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
79615|IMMUNOSUPPRESSIVE AGENTS|L4
79612|IMMUNOSUPPRESSIVE AGENTS|L4
79609|ANTIVIRALS FOR SYSTEMIC USE|J5
79607|ANTIVIRALS FOR SYSTEMIC USE|J5
79603|DRUGS USED IN DIABETES|A10
79603|ANALGESICS|N2
79594|DRUGS USED IN DIABETES|A10
79589|DRUGS USED IN DIABETES|A10
79585|FIBRINOLYTICS|B1D
79584|PARASITOLOGY|P
79584|ANTI-MALARIALS|P1D
79578|ANALGESICS|N2
79575|TRANQUILLISERS|N5C
79559|Interferons, beta|L3B2
79558|ANTIVIRALS FOR SYSTEMIC USE|J5
79557|Interferons, beta|L3B2
79556|Interferons, beta|L3B2
79555|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
79553|PLATELET AGGREGATION INHIBITORS|B1C
79553|Fibrinogen|B2D5
79551|ANTIVIRALS FOR SYSTEMIC USE|J5
79551|INTERFERONS|L3B
79551|Interferons, alpha|L3B1
79547|WOUND HEALING AGENTS|D3
79546|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
79546|DRUGS USED IN DIABETES|A10
79543|CENTRAL NERVOUS SYSTEM|N
79543|NOOTROPICS|N6D
79537|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
79536|RESPIRATORY SYSTEM|R
79535|ANALGESICS|N2
79535|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
79534|ANALGESICS|N2
79534|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
79533|DRUGS USED IN DIABETES|A10
79528|Ocular antineovascularisation products|S1P
79519|SYSTEMIC ANTIBACTERIALS|J1
79505|ANTIVIRALS FOR SYSTEMIC USE|J5
79503|CARDIOVASCULAR SYSTEM|C
79503|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
79503|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
79503|Statins (HMG-CoA reductase inhibitors)|C10A1
79501|ANTIHYPERTENSIVES|C2
79501|CALCIUM ANTAGONISTS|C8
79501|Statins (HMG-CoA reductase inhibitors)|C10A1
79498|CARDIOVASCULAR SYSTEM|C
79498|ANTIHYPERTENSIVES|C2
79498|CALCIUM ANTAGONISTS|C8
79498|ACE INHIBITORS, PLAIN|C9A
79498|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
79498|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
79498|Statins (HMG-CoA reductase inhibitors)|C10A1
79497|CARDIOVASCULAR SYSTEM|C
79497|ANTIHYPERTENSIVES|C2
79497|CALCIUM ANTAGONISTS|C8
79497|ACE INHIBITORS, PLAIN|C9A
79497|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
79497|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
79497|Statins (HMG-CoA reductase inhibitors)|C10A1
79493|IMMUNOSUPPRESSIVE AGENTS|L4
79489|DRUGS USED IN DIABETES|A10
79489|HUMAN INSULINS AND ANALOGUES|A10C
79489|Human insulins and analogues, intermediate-acting|A10C2
79488|DRUGS USED IN DIABETES|A10
79488|HUMAN INSULINS AND ANALOGUES|A10C
79488|Human insulins and analogues, intermediate-acting|A10C2
79487|GROWTH HORMONES|H4C
79485|ANTIVIRALS FOR SYSTEMIC USE|J5
79485|OPHTHALMOLOGICALS|S1
79482|OPHTHALMOLOGICALS|S1
79480|GROWTH HORMONES|H4C
79479|GROWTH HORMONES|H4C
79473|SYSTEMIC ANTIBACTERIALS|J1
79472|ANALGESICS|N2
79469|ANTIVIRALS FOR SYSTEMIC USE|J5
79467|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
79464|ANTIVIRALS FOR SYSTEMIC USE|J5
79462|SYSTEMIC ANTIBACTERIALS|J1
79461|SYSTEMIC ANTIBACTERIALS|J1
79460|ANTI-ACNE PREPARATIONS|D10
79457|SYSTEMIC ANTIBACTERIALS|J1
79453|NOOTROPICS|N6D
79452|NOOTROPICS|N6D
79450|IMMUNOSTIMULATING AGENTS|L3
79449|ANTIVIRALS FOR SYSTEMIC USE|J5
79448|Interferons, beta|L3B2
79444|Interferons, beta|L3B2
79441|Ocular antineovascularisation products|S1P
79440|Interferons, beta|L3B2
79439|DRUGS USED IN DIABETES|A10
79439|WOUND HEALING AGENTS|D3
79432|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
79430|ANALGESICS|N2
79429|DRUGS USED IN DIABETES|A10
79429|HUMAN INSULINS AND ANALOGUES|A10C
79429|Human insulins and analogues, intermediate-acting|A10C2
79427|OPHTHALMOLOGICALS|S1
79426|ANTI-MALARIALS|P1D
79422|TRANQUILLISERS|N5C
79421|SYSTEMIC ANTIBACTERIALS|J1
79417|ANTIVIRALS FOR SYSTEMIC USE|J5
79416|BPH (benign prostatic hypertrophy) products |G4C
79410|IMMUNOSTIMULATING AGENTS|L3
79407|IMMUNOSTIMULATING AGENTS|L3
79400|DRUGS USED IN DIABETES|A10
79400|DPP-IV inhibitor antidiabetics|A10B6
79399|DRUGS USED IN DIABETES|A10
79397|WOUND HEALING AGENTS|D3
79395|SYSTEMIC ANTIBACTERIALS|J1
79386|IMMUNOSUPPRESSIVE AGENTS|L4
79384|ANTIVIRALS FOR SYSTEMIC USE|J5
79374|ALKYLATING AGENTS|L1A
79372|ANTIVIRALS FOR SYSTEMIC USE|J5
79371|ANTIVIRALS FOR SYSTEMIC USE|J5
79369|ANTIVIRALS FOR SYSTEMIC USE|J5
79367|GROWTH HORMONES|H4C
79365|ANTIHYPERTENSIVES|C2
79364|DIRECT THROMBIN INHIBITORS|B1E
79363|ANTIVIRALS FOR SYSTEMIC USE|J5
79362|ANTIVIRALS FOR SYSTEMIC USE|J5
79359|HUMAN INSULINS AND ANALOGUES|A10C
79359|Human insulins and analogues, intermediate-acting|A10C2
79355|ANTIHYPERTENSIVES|C2
79355|OPHTHALMOLOGICALS|S1
79350|ANTIVIRALS FOR SYSTEMIC USE|J5
79346|ANTIVIRALS FOR SYSTEMIC USE|J5
79345|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
79342|ANTIVIRALS FOR SYSTEMIC USE|J5
79340|ANTIVIRALS FOR SYSTEMIC USE|J5
79337|ANALGESICS|N2
79336|CENTRAL NERVOUS SYSTEM|N
79335|DRUGS USED IN DIABETES|A10
79330|GLUCAGON|H4B
79327|HUMAN INSULINS AND ANALOGUES|A10C
79327|Human insulins and analogues, intermediate-acting|A10C2
79321|Carbapenems|J1P2
79319|DRUGS USED IN DIABETES|A10
79319|HUMAN INSULINS AND ANALOGUES|A10C
79316|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
79311|DRUGS USED IN DIABETES|A10
79309|SYSTEMIC ANTIHISTAMINES|R6
79307|HUMAN INSULINS AND ANALOGUES|A10C
79307|Human insulins and analogues, intermediate-acting|A10C2
79305|HUMAN INSULINS AND ANALOGUES|A10C
79305|Human insulins and analogues, intermediate-acting|A10C2
79304|SYSTEMIC ANTIBACTERIALS|J1
79303|PARASITOLOGY|P
79299|CARDIOVASCULAR SYSTEM|C
79291|RESPIRATORY SYSTEM|R
79289|SYSTEMIC ANTIBACTERIALS|J1
79288|PARASITOLOGY|P
79287|ANALGESICS|N2
79284|RADIODIAGNOSTIC AGENTS|T1G
79283|IMMUNOSUPPRESSIVE AGENTS|L4
79277|WOUND HEALING AGENTS|D3
79276|IMMUNOSUPPRESSIVE AGENTS|L4
79275|OPHTHALMOLOGICALS|S1
79271|NOOTROPICS|N6D
79265|RADIODIAGNOSTIC AGENTS|T1G
79263|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
79262|NOOTROPICS|N6D
79260|ANALGESICS|N2
79259|ANALGESICS|N2
79257|Factor VIII|B2D1
79255|CENTRAL NERVOUS SYSTEM|N
79253|SYSTEMIC ANTIBACTERIALS|J1
79251|ANTIVIRALS FOR SYSTEMIC USE|J5
79250|ANTIVIRALS FOR SYSTEMIC USE|J5
79246|CALCITONINS|H4A
79245|ANTIVIRALS FOR SYSTEMIC USE|J5
79243|B2-STIMULANTS|R3A
79242|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
79239|DRUGS USED IN DIABETES|A10
79238|B2-STIMULANTS|R3A
79236|ANTIVIRALS FOR SYSTEMIC USE|J5
79233|ANTIVIRALS FOR SYSTEMIC USE|J5
79232|ANTIVIRALS FOR SYSTEMIC USE|J5
79231|DERMATOLOGICALS|D
79230|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
79228|SYSTEMIC ANTIBACTERIALS|J1
79227|ANTIVIRALS FOR SYSTEMIC USE|J5
79226|ANTI-ARRHYTHMICS|C1B
79225|SYSTEMIC ANTIBACTERIALS|J1
79217|IMMUNOSTIMULATING AGENTS|L3
79210|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
79204|ANTIPSYCHOTICS|N5A
79203|OPHTHALMOLOGICALS|S1
79202|IMMUNOSTIMULATING AGENTS|L3
79201|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
79199|SYSTEMIC ANTIBACTERIALS|J1
79197|ANALGESICS|N2
79196|ANTIVIRALS FOR SYSTEMIC USE|J5
79192|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
79192|SYSTEMIC ANTIBACTERIALS|J1
79188|IMMUNOSUPPRESSIVE AGENTS|L4
79187|ANTIVIRALS FOR SYSTEMIC USE|J5
79181|ANALGESICS|N2
79179|SYSTEMIC ANTIBACTERIALS|J1
79175|ANALGESICS|N2
79171|OPHTHALMOLOGICALS|S1
79168|OPHTHALMOLOGICALS|S1
79166|ANTIVIRALS FOR SYSTEMIC USE|J5
79165|GROWTH HORMONES|H4C
79161|WOUND HEALING AGENTS|D3
79161|GROWTH HORMONES|H4C
79157|ANTIVIRALS FOR SYSTEMIC USE|J5
79156|ANTIVIRALS FOR SYSTEMIC USE|J5
79145|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
79145|Interferons, gamma|L3B3
79128|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
79119|IMMUNOSTIMULATING AGENTS|L3
79113|Factor VIII|B2D1
79112|CENTRAL NERVOUS SYSTEM|N
79109|ANTIVIRALS FOR SYSTEMIC USE|J5
79108|OPHTHALMOLOGICALS|S1
79106|ANTIVIRALS FOR SYSTEMIC USE|J5
79105|ANTIVIRALS FOR SYSTEMIC USE|J5
79100|PARASITOLOGY|P
79099|ANTIVIRALS FOR SYSTEMIC USE|J5
79093|IMMUNOSUPPRESSIVE AGENTS|L4
79089|ANALGESICS|N2
79087|ANALGESICS|N2
79086|ANTIVIRALS FOR SYSTEMIC USE|J5
79086|VACCINES|J7
79085|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
79085|DRUGS USED IN DIABETES|A10
79081|SYSTEMIC ANTIBACTERIALS|J1
79080|Factor VIII|B2D1
79079|OPHTHALMOLOGICALS|S1
79077|ANTIVIRALS FOR SYSTEMIC USE|J5
79074|IMMUNOSUPPRESSIVE AGENTS|L4
79073|WOUND HEALING AGENTS|D3
79072|ANTIVIRALS FOR SYSTEMIC USE|J5
79069|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
79068|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
79068|ANTIPROTOZOALS AND ANTHELMINTICS|P1
79067|ANTIVIRALS FOR SYSTEMIC USE|J5
79065|IMMUNOSUPPRESSIVE AGENTS|L4
79063|IMMUNOSUPPRESSIVE AGENTS|L4
79061|ANTIPSYCHOTICS|N5A
79057|IMMUNOSUPPRESSIVE AGENTS|L4
79055|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
79052|ANTI-EPILEPTICS|N3A
79048|NOOTROPICS|N6D
79041|CARDIAC THERAPY|C1
79038|DRUGS USED IN DIABETES|A10
79033|SYSTEMIC ANTIBACTERIALS|J1
79030|DRUGS USED IN DIABETES|A10
79026|DRUGS USED IN DIABETES|A10
79019|ANTIVIRALS FOR SYSTEMIC USE|J5
79017|OPHTHALMOLOGICALS|S1
79016|ANALGESICS|N2
79015|ANTI-EPILEPTICS|N3A
79012|ANTIVIRALS FOR SYSTEMIC USE|J5
79011|ANTIVIRALS FOR SYSTEMIC USE|J5
79009|ANTIVIRALS FOR SYSTEMIC USE|J5
79008|WOUND HEALING AGENTS|D3
79001|IMMUNOSUPPRESSIVE AGENTS|L4
78999|ANTIVIRALS FOR SYSTEMIC USE|J5
78998|WOUND HEALING AGENTS|D3
78997|FIBRINOLYTICS|B1D
78995|ANTIVIRALS FOR SYSTEMIC USE|J5
78993|ANTIVIRALS FOR SYSTEMIC USE|J5
78988|WOUND HEALING AGENTS|D3
78987|SYSTEMIC ANTIBACTERIALS|J1
78986|ANTIVIRALS FOR SYSTEMIC USE|J5
78986|PARASITOLOGY|P
78984|CARDIOVASCULAR SYSTEM|C
78981|SYSTEMIC ANTIBACTERIALS|J1
78981|CENTRAL NERVOUS SYSTEM|N
78978|ANTIVIRALS FOR SYSTEMIC USE|J5
78976|ANTIVIRALS FOR SYSTEMIC USE|J5
78975|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78975|DRUGS USED IN DIABETES|A10
78974|ANTIVIRALS FOR SYSTEMIC USE|J5
78970|CENTRAL NERVOUS SYSTEM|N
78969|HUMAN INSULINS AND ANALOGUES|A10C
78969|Human insulins and analogues, intermediate-acting|A10C2
78968|RADIODIAGNOSTIC AGENTS|T1G
78967|DRUGS USED IN DIABETES|A10
78967|HUMAN INSULINS AND ANALOGUES|A10C
78967|Human insulins and analogues, intermediate-acting|A10C2
78963|ANTIVIRALS FOR SYSTEMIC USE|J5
78959|ANALGESICS|N2
78958|DRUGS USED IN DIABETES|A10
78958|HUMAN INSULINS AND ANALOGUES|A10C
78958|Human insulins and analogues, intermediate-acting|A10C2
78954|ANTIVIRALS FOR SYSTEMIC USE|J5
78953|ANTIHYPERTENSIVES|C2
78950|ANTIVIRALS FOR SYSTEMIC USE|J5
78945|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
78945|IMMUNOSUPPRESSIVE AGENTS|L4
78940|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
78934|ANTIVIRALS FOR SYSTEMIC USE|J5
78931|ANTIVIRALS FOR SYSTEMIC USE|J5
78929|ANTIVIRALS FOR SYSTEMIC USE|J5
78928|ANTIVIRALS FOR SYSTEMIC USE|J5
78928|Interferons, alpha|L3B1
78927|IMMUNOSTIMULATING AGENTS|L3
78924|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78920|VITAMIN C, INCLUDING COMBINATIONS WITH MINERALS|A11G
78912|IMMUNOSUPPRESSIVE AGENTS|L4
78911|RADIODIAGNOSTIC AGENTS|T1G
78910|RADIODIAGNOSTIC AGENTS|T1G
78909|RADIODIAGNOSTIC AGENTS|T1G
78906|SYSTEMIC ANTIBACTERIALS|J1
78904|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
78901|ANAESTHETICS|N1
78900|ANTI-EPILEPTICS|N3A
78899|ANTIVIRALS FOR SYSTEMIC USE|J5
78896|IMMUNOSUPPRESSIVE AGENTS|L4
78891|ANTIMETABOLITES|L1B
78885|PARASITOLOGY|P
78884|ALKYLATING AGENTS|L1A
78883|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78882|ANTIVIRALS FOR SYSTEMIC USE|J5
78881|SYSTEMIC ANTIBACTERIALS|J1
78878|RADIODIAGNOSTIC AGENTS|T1G
78870|IMMUNOSUPPRESSIVE AGENTS|L4
78869|IMMUNOSUPPRESSIVE AGENTS|L4
78868|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
78867|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
78863|IMMUNOSUPPRESSIVE AGENTS|L4
78863|ANTI-GOUT PREPARATIONS|M4
78862|ALKYLATING AGENTS|L1A
78861|RADIODIAGNOSTIC AGENTS|T1G
78858|ANTI-EPILEPTICS|N3
78857|ANTI-EPILEPTICS|N3
78856|ANTI-EPILEPTICS|N3
78855|ANTI-EPILEPTICS|N3
78854|ANTI-EPILEPTICS|N3
78853|ANTI-EPILEPTICS|N3
78852|RADIODIAGNOSTIC AGENTS|T1G
78851|ACE INHIBITORS, PLAIN|C9A
78850|ACE INHIBITORS, PLAIN|C9A
78849|ACE INHIBITORS, PLAIN|C9A
78848|ACE INHIBITORS, PLAIN|C9A
78847|ACE INHIBITORS, PLAIN|C9A
78846|ACE INHIBITORS, PLAIN|C9A
78844|ANAESTHETICS|N1
78843|ANAESTHETICS|N1
78842|RADIODIAGNOSTIC AGENTS|T1G
78840|CENTRAL NERVOUS SYSTEM|N
78840|RADIODIAGNOSTIC AGENTS|T1G
78839|CENTRAL NERVOUS SYSTEM|N
78839|RADIODIAGNOSTIC AGENTS|T1G
78836|ANTIVIRALS FOR SYSTEMIC USE|J5
78835|ANTIVIRALS FOR SYSTEMIC USE|J5
78831|ANTI-EPILEPTICS|N3A
78830|RADIODIAGNOSTIC AGENTS|T1G
78825|ANTI-EPILEPTICS|N3A
78823|RADIODIAGNOSTIC AGENTS|T1G
78819|NOOTROPICS|N6D
78818|ANALGESICS|N2
78818|ANTI-MIGRAINE PREPARATIONS|N2C
78817|OPHTHALMOLOGICALS|S1
78814|CENTRAL NERVOUS SYSTEM|N
78813|WOUND HEALING AGENTS|D3
78810|RADIODIAGNOSTIC AGENTS|T1G
78808|ANTIVIRALS FOR SYSTEMIC USE|J5
78807|ANTIHYPERTENSIVES|C2
78807|Coxibs|M1A3
78807|ANALGESICS|N2
78806|ANALGESICS|N2
78805|SYSTEMIC ANTIBACTERIALS|J1
78804|ANTIVIRALS FOR SYSTEMIC USE|J5
78799|ANTIVIRALS FOR SYSTEMIC USE|J5
78798|ANTIVIRALS FOR SYSTEMIC USE|J5
78797|ANTIVIRALS FOR SYSTEMIC USE|J5
78793|ANTI-EPILEPTICS|N3A
78791|RADIODIAGNOSTIC AGENTS|T1G
78789|ANALGESICS|N2
78788|RADIODIAGNOSTIC AGENTS|T1G
78787|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78787|DRUGS USED IN DIABETES|A10
78786|FIBRINOLYTICS|B1D
78784|WOUND HEALING AGENTS|D3
78784|GROWTH HORMONES|H4C
78781|ANTIVIRALS FOR SYSTEMIC USE|J5
78778|ANTIEMETICS AND ANTINAUSEANTS|A4
78778|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
78778|ANTIHYPERTENSIVES|C2
78778|ANALGESICS|N2
78777|RADIODIAGNOSTIC AGENTS|T1G
78776|RADIODIAGNOSTIC AGENTS|T1G
78773|RADIODIAGNOSTIC AGENTS|T1G
78767|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
78757|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
78756|ANTIHYPERTENSIVES|C2
78753|CENTRAL NERVOUS SYSTEM|N
78753|ANALGESICS|N2
78752|VACCINES|J7
78747|ANALGESICS|N2
78746|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78743|CENTRAL NERVOUS SYSTEM|N
78737|ANALGESICS|N2
78734|WOUND HEALING AGENTS|D3
78730|PARASITOLOGY|P
78728|IMMUNOSTIMULATING AGENTS|L3
78726|TRANQUILLISERS|N5C
78721|ANTIVIRALS FOR SYSTEMIC USE|J5
78715|DRUGS USED IN DIABETES|A10
78711|SYSTEMIC ANTIBACTERIALS|J1
78710|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78709|FIBRINOLYTICS|B1D
78708|ANTIVIRALS FOR SYSTEMIC USE|J5
78707|RADIODIAGNOSTIC AGENTS|T1G
78705|RESPIRATORY SYSTEM|R
78703|SYSTEMIC ANTIBACTERIALS|J1
78703|ANTIVIRALS FOR SYSTEMIC USE|J5
78701|WOUND HEALING AGENTS|D3
78700|DERMATOLOGICALS|D
78700|ANTIVIRALS FOR SYSTEMIC USE|J5
78700|CENTRAL NERVOUS SYSTEM|N
78696|RADIODIAGNOSTIC AGENTS|T1G
78692|HUMAN INSULINS AND ANALOGUES|A10C
78692|Human insulins and analogues, intermediate-acting|A10C2
78691|ANTIVIRALS FOR SYSTEMIC USE|J5
78689|SYSTEMIC ANTIBACTERIALS|J1
78687|SYSTEMIC ANTIBACTERIALS|J1
78680|WOUND HEALING AGENTS|D3
78680|ANALGESICS|N2
78676|IMMUNOSUPPRESSIVE AGENTS|L4
78675|ANTIVIRALS FOR SYSTEMIC USE|J5
78675|IMMUNOSUPPRESSIVE AGENTS|L4
78673|ANTIVIRALS FOR SYSTEMIC USE|J5
78671|RESPIRATORY SYSTEM|R
78669|RESPIRATORY SYSTEM|R
78666|DRUGS USED IN DIABETES|A10
78664|DRUGS USED IN DIABETES|A10
78663|RESPIRATORY SYSTEM|R
78662|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
78658|NOOTROPICS|N6D
78657|ANTIVIRALS FOR SYSTEMIC USE|J5
78656|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
78655|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
78653|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
78652|ANTIVIRALS FOR SYSTEMIC USE|J5
78647|OPHTHALMOLOGICALS|S1
78645|ANALGESICS|N2
78643|RESPIRATORY SYSTEM|R
78630|ANAESTHETICS, LOCAL|N1B
78630|ANALGESICS|N2
78628|ANTIVIRALS FOR SYSTEMIC USE|J5
78625|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78618|CARDIOVASCULAR SYSTEM|C
78611|CARDIOVASCULAR SYSTEM|C
78608|SYSTEMIC ANTIBACTERIALS|J1
78604|RADIODIAGNOSTIC AGENTS|T1G
78601|ANTIVIRALS FOR SYSTEMIC USE|J5
78599|MRI AGENTS|T1E
78599|RADIODIAGNOSTIC AGENTS|T1G
78590|ANTIHYPERTENSIVES|C2
78586|SYSTEMIC ANTIBACTERIALS|J1
78585|ANTIEMETICS AND ANTINAUSEANTS|A4
78585|TRANQUILLISERS|N5C
78582|APPETITE STIMULANTS|A15
78582|ANTI-EPILEPTICS|N3A
78579|ANTIPSYCHOTICS|N5A
78578|ANALGESICS|N2
78576|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
78575|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
78574|MUSCULO-SKELETAL SYSTEM|M
78574|ANALGESICS|N2
78573|ANTIHYPERTENSIVES|C2
78573|CALCIUM ANTAGONISTS|C8
78571|ANALGESICS|N2
78569|OPHTHALMOLOGICALS|S1
78568|HYPNOTICS/SEDATIVES|N5B
78567|CENTRAL NERVOUS SYSTEM|N
78563|RESPIRATORY SYSTEM|R
78559|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
78558|ANTIVIRALS FOR SYSTEMIC USE|J5
78556|RADIODIAGNOSTIC AGENTS|T1G
78547|B2-STIMULANTS|R3A
78546|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
78545|SYSTEMIC ANTIBACTERIALS|J1
78544|IMMUNOSTIMULATING AGENTS|L3
78542|ANALGESICS|N2
78538|ANALGESICS|N2
78538|SSRI antidepressants|N6A4
78538|SRNI antidepressants|N6A5
78536|IMMUNOSTIMULATING AGENTS|L3
78534|WOUND HEALING AGENTS|D3
78532|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
78531|SYSTEMIC ANTIBACTERIALS|J1
78530|ANTIVIRALS FOR SYSTEMIC USE|J5
78529|PARASITOLOGY|P
78526|ANALGESICS|N2
78525|ANTI-EPILEPTICS|N3
78523|SYSTEMIC ANTIBACTERIALS|J1
78519|ANALGESICS|N2
78514|OPHTHALMOLOGICALS|S1
78511|RESPIRATORY SYSTEM|R
78508|ANALGESICS|N2
78505|IMMUNOSUPPRESSIVE AGENTS|L4
78505|OPHTHALMOLOGICALS|S1
78502|ANTIVIRALS FOR SYSTEMIC USE|J5
78501|ANALGESICS|N2
78501|SSRI antidepressants|N6A4
78501|SRNI antidepressants|N6A5
78496|IMMUNOSUPPRESSIVE AGENTS|L4
78495|SYSTEMIC ANTIBACTERIALS|J1
78495|ANTIPROTOZOALS AND ANTHELMINTICS|P1
78494|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
78494|IMMUNOSUPPRESSIVE AGENTS|L4
78491|ANALGESICS|N2
78489|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
78489|SSRI antidepressants|N6A4
78488|Ocular antineovascularisation products|S1P
78486|IMMUNOSTIMULATING AGENTS|L3
78477|SYSTEMIC ANTIBACTERIALS|J1
78474|WOUND HEALING AGENTS|D3
78473|ANALGESICS|N2
78470|ANTIVIRALS FOR SYSTEMIC USE|J5
78470|IMMUNOSTIMULATING AGENTS|L3
78467|ANALGESICS|N2
78466|ANALGESICS|N2
78464|ANALGESICS|N2
78462|ANALGESICS|N2
78461|NOOTROPICS|N6D
78461|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
78458|ANALGESICS|N2
78457|ANTIEMETICS AND ANTINAUSEANTS|A4
78457|ANTIPSYCHOTICS|N5A
78456|ANTIEMETICS AND ANTINAUSEANTS|A4
78452|ANALGESICS|N2
78449|Factors II, VII, IX and X|B2D2
78447|DRUGS USED IN DIABETES|A10
78447|HUMAN INSULINS AND ANALOGUES|A10C
78445|Factor VIII|B2D1
78444|DERMATOLOGICALS|D
78442|CARDIOVASCULAR SYSTEM|C
78439|ANTIVIRALS FOR SYSTEMIC USE|J5
78437|BPH (benign prostatic hypertrophy) products |G4C
78432|ANTI-GOUT PREPARATIONS|M4
78428|SYSTEMIC ANTIBACTERIALS|J1
78421|ANTIHYPERTENSIVES|C2
78420|ANTIPROTOZOALS AND ANTHELMINTICS|P1
78420|ANTI-MALARIALS|P1D
78414|ANTI-MALARIALS|P1D
78413|HUMAN INSULINS AND ANALOGUES|A10C
78413|Human insulins and analogues, intermediate-acting|A10C2
78409|ANALGESICS|N2
78407|ANTIVIRALS FOR SYSTEMIC USE|J5
78403|ANTIVIRALS FOR SYSTEMIC USE|J5
78401|WOUND HEALING AGENTS|D3
78400|WOUND HEALING AGENTS|D3
78399|ANTIHYPERTENSIVES|C2
78397|WOUND HEALING AGENTS|D3
78396|IMMUNOSTIMULATING AGENTS|L3
78395|IMMUNOSTIMULATING AGENTS|L3
78370|ANTIPROTOZOALS AND ANTHELMINTICS|P1
78368|ANTIVIRALS FOR SYSTEMIC USE|J5
78368|IMMUNOSTIMULATING AGENTS|L3
78367|SYSTEMIC ANTIBACTERIALS|J1
78366|IMMUNOSTIMULATING AGENTS|L3
78365|DPP-IV inhibitor antidiabetics|A10B6
78359|CARDIOVASCULAR SYSTEM|C
78357|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
78355|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78354|ANALGESICS|N2
78350|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
78348|CARDIOVASCULAR SYSTEM|C
78347|Erectile dysfunction products|G4B3
78345|RADIODIAGNOSTIC AGENTS|T1G
78332|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78324|HYPNOTICS/SEDATIVES|N5B
78321|ANALGESICS|N2
78321|TRANQUILLISERS|N5C
78319|SYSTEMIC ANTIBACTERIALS|J1
78318|ALKYLATING AGENTS|L1A
78316|ALKYLATING AGENTS|L1A
78312|DRUGS USED IN DIABETES|A10
78311|CARDIOVASCULAR SYSTEM|C
78310|ANALGESICS|N2
78309|ANTIVIRALS FOR SYSTEMIC USE|J5
78308|WOUND HEALING AGENTS|D3
78306|ALKYLATING AGENTS|L1A
78305|ANTIVIRALS FOR SYSTEMIC USE|J5
78296|CARDIOVASCULAR SYSTEM|C
78295|WOUND HEALING AGENTS|D3
78292|Ocular antineovascularisation products|S1P
78290|SYSTEMIC ANTIBACTERIALS|J1
78290|Carbapenems|J1P2
78288|SYSTEMIC ANTIBACTERIALS|J1
78288|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
78288|ANALGESICS|N2
78287|ANTIVIRALS FOR SYSTEMIC USE|J5
78283|ANTIVIRALS FOR SYSTEMIC USE|J5
78281|ANTIVIRALS FOR SYSTEMIC USE|J5
78279|WOUND HEALING AGENTS|D3
78278|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
78277|ANTIVIRALS FOR SYSTEMIC USE|J5
78276|WOUND HEALING AGENTS|D3
78275|ANTIVIRALS FOR SYSTEMIC USE|J5
78271|CARDIOVASCULAR SYSTEM|C
78270|OPHTHALMOLOGICALS|S1
78269|ANTIHYPERTENSIVES|C2
78268|ANALGESICS|N2
78267|SYSTEMIC ANTIBACTERIALS|J1
78265|FIBRINOLYTICS|B1D
78263|ANTIVIRALS FOR SYSTEMIC USE|J5
78262|FIBRINOLYTICS|B1D
78261|SYSTEMIC ANTIBACTERIALS|J1
78260|ANALGESICS|N2
78259|ANTI-ACNE PREPARATIONS|D10
78256|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
78248|ANTIHYPERTENSIVES|C2
78248|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
78244|ANTI-EPILEPTICS|N3A
78241|ANALGESICS|N2
78239|CARDIOVASCULAR SYSTEM|C
78238|IMMUNOSUPPRESSIVE AGENTS|L4
78235|SYSTEMIC ANTIBACTERIALS|J1
78233|IMMUNOSTIMULATING AGENTS|L3
78230|DRUGS USED IN DIABETES|A10
78227|SYSTEMIC ANTIBACTERIALS|J1
78226|SYSTEMIC ANTIBACTERIALS|J1
78225|NOOTROPICS|N6D
78224|DIAGNOSTIC AGENTS|T
78223|DIAGNOSTIC AGENTS|T
78220|SYSTEMIC ANTIBACTERIALS|J1
78219|ANALGESICS|N2
78217|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
78217|SSRI antidepressants|N6A4
78217|SRNI antidepressants|N6A5
78214|OPHTHALMOLOGICALS|S1
78208|ANTIVIRALS FOR SYSTEMIC USE|J5
78207|RADIODIAGNOSTIC AGENTS|T1G
78206|RADIODIAGNOSTIC AGENTS|T1G
78203|RADIODIAGNOSTIC AGENTS|T1G
78202|IMMUNOSUPPRESSIVE AGENTS|L4
78201|ANALGESICS|N2
78201|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
78179|ANTIEMETICS AND ANTINAUSEANTS|A4
78178|ANALGESICS|N2
78176|ANTIMETABOLITES|L1B
78175|SYSTEMIC ANTIBACTERIALS|J1
78172|Ocular antineovascularisation products|S1P
78168|ANTIMETABOLITES|L1B
78167|ANTIMETABOLITES|L1B
78166|ALKYLATING AGENTS|L1A
78165|ANTIVIRALS FOR SYSTEMIC USE|J5
78163|ANTIVIRALS FOR SYSTEMIC USE|J5
78157|OPHTHALMOLOGICALS|S1
78153|RESPIRATORY SYSTEM|R
78152|ANAESTHETICS, LOCAL|N1B
78152|ANALGESICS|N2
78151|RESPIRATORY SYSTEM|R
78148|RESPIRATORY SYSTEM|R
78147|RESPIRATORY SYSTEM|R
78145|SYSTEMIC ANTIBACTERIALS|J1
78144|DRUGS USED IN DIABETES|A10
78143|PARASITOLOGY|P
78142|ANAESTHETICS, LOCAL|N1B
78140|ANALGESICS|N2
78139|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78137|ANTIVIRALS FOR SYSTEMIC USE|J5
78136|ANTIVIRALS FOR SYSTEMIC USE|J5
78135|WOUND HEALING AGENTS|D3
78135|Ocular antineovascularisation products|S1P
78134|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
78121|ANALGESICS|N2
78120|NOOTROPICS|N6D
78111|SYSTEMIC ANTIBACTERIALS|J1
78110|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
78109|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
78107|CARDIOVASCULAR SYSTEM|C
78107|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
78107|Statins (HMG-CoA reductase inhibitors)|C10A1
78106|CARDIOVASCULAR SYSTEM|C
78106|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
78106|Statins (HMG-CoA reductase inhibitors)|C10A1
78105|CARDIOVASCULAR SYSTEM|C
78105|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
78105|Statins (HMG-CoA reductase inhibitors)|C10A1
78103|MUSCULO-SKELETAL SYSTEM|M
78102|HUMAN INSULINS AND ANALOGUES|A10C
78102|Human insulins and analogues, long-acting|A10C5
78098|ANTIVIRALS FOR SYSTEMIC USE|J5
78097|OPHTHALMOLOGICALS|S1
78096|ANALGESICS|N2
78091|ANTIMETABOLITES|L1B
78087|ANTIVIRALS FOR SYSTEMIC USE|J5
78086|OPHTHALMOLOGICALS|S1
78085|NOOTROPICS|N6D
78081|OPHTHALMOLOGICALS|S1
78080|OPHTHALMOLOGICALS|S1
78079|ANTIHYPERTENSIVES|C2
78075|VITAMIN C, INCLUDING COMBINATIONS WITH MINERALS|A11G
78075|PLATELET AGGREGATION INHIBITORS|B1C
78075|ANTIVIRALS FOR SYSTEMIC USE|J5
78075|ANALGESICS|N2
78074|CARDIOVASCULAR SYSTEM|C
78074|ANTIHYPERTENSIVES|C2
78073|ANTIVIRALS FOR SYSTEMIC USE|J5
78073|IMMUNOSTIMULATING AGENTS|L3
78070|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
78063|ANALGESICS|N2
78062|OPHTHALMOLOGICALS|S1
78062|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
78059|OPHTHALMOLOGICALS|S1
78058|ANTI-EPILEPTICS|N3A
78056|OPHTHALMOLOGICALS|S1
78055|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
78053|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
78052|RESPIRATORY SYSTEM|R
78051|RADIODIAGNOSTIC AGENTS|T1G
78049|SYSTEMIC ANTIBACTERIALS|J1
78047|SYSTEMIC ANTIBACTERIALS|J1
78046|ANTIVIRALS FOR SYSTEMIC USE|J5
78037|ANTIVIRALS FOR SYSTEMIC USE|J5
78036|SYSTEMIC ANTIBACTERIALS|J1
78031|ANTIVIRALS FOR SYSTEMIC USE|J5
78030|ANTIEMETICS AND ANTINAUSEANTS|A4
78029|ANALGESICS|N2
78028|Vitamin A|A11C1
78028|ANTI-ACNE PREPARATIONS|D10
78027|MUSCULO-SKELETAL SYSTEM|M
78024|HUMAN INSULINS AND ANALOGUES|A10C
78024|Human insulins and analogues, intermediate-acting|A10C2
78022|MUSCULO-SKELETAL SYSTEM|M
78016|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
78015|Erectile dysfunction products|G4B3
78013|IMMUNOSUPPRESSIVE AGENTS|L4
78012|ANTIHYPERTENSIVES|C2
78008|DRUGS USED IN DIABETES|A10
78005|ANTIHYPERTENSIVES|C2
78003|ANTIVIRALS FOR SYSTEMIC USE|J5
78002|DRUGS USED IN DIABETES|A10
78000|ANTIVIRALS FOR SYSTEMIC USE|J5
77998|SYSTEMIC ANTIBACTERIALS|J1
77997|Ocular antineovascularisation products|S1P
77995|Ocular antineovascularisation products|S1P
77994|Ocular antineovascularisation products|S1P
77989|NOOTROPICS|N6D
77983|CARDIOVASCULAR SYSTEM|C
77982|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
77972|AMINOGLYCOSIDES|J1K
77966|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
77964|SYSTEMIC ANTIBACTERIALS|J1
77964|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
77961|ANALGESICS|N2
77960|ANTIFIBRINOLYTICS|B2A
77957|ANTIHYPERTENSIVES|C2
77953|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
77945|ANALGESICS|N2
77945|SSRI antidepressants|N6A4
77945|SRNI antidepressants|N6A5
77944|ANALGESICS|N2
77944|SSRI antidepressants|N6A4
77944|SRNI antidepressants|N6A5
77943|ANALGESICS|N2
77943|SSRI antidepressants|N6A4
77943|SRNI antidepressants|N6A5
77941|ANALGESICS|N2
77941|SSRI antidepressants|N6A4
77941|SRNI antidepressants|N6A5
77929|ANALGESICS|N2
77927|ANTIVIRALS FOR SYSTEMIC USE|J5
77924|DRUGS USED IN DIABETES|A10
77923|Miotics and antiglaucoma preparations, topical|S1E2
77921|ANTIHYPERTENSIVES|C2
77921|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
77920|CENTRAL NERVOUS SYSTEM|N
77920|NOOTROPICS|N6D
77916|MUSCULO-SKELETAL SYSTEM|M
77915|WOUND HEALING AGENTS|D3
77914|HYPNOTICS/SEDATIVES|N5B
77913|DERMATOLOGICALS|D
77912|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77911|DRUGS USED IN DIABETES|A10
77910|DRUGS USED IN DIABETES|A10
77907|CALCIUM ANTAGONISTS|C8
77905|ANTITUSSIVES|R5D
77903|Erectile dysfunction products|G4B3
77900|ANTIVIRALS FOR SYSTEMIC USE|J5
77898|ANTIHYPERTENSIVES|C2
77897|Biguanide antidiabetics|A10B2
77897|CARDIOVASCULAR SYSTEM|C
77897|ANTIHYPERTENSIVES|C2
77897|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
77895|CARDIOVASCULAR SYSTEM|C
77895|ANTIHYPERTENSIVES|C2
77895|CALCIUM ANTAGONISTS|C8
77895|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
77894|CARDIOVASCULAR SYSTEM|C
77894|ANTIHYPERTENSIVES|C2
77894|DIURETICS|C3
77894|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
77893|CARDIOVASCULAR SYSTEM|C
77893|ANTIHYPERTENSIVES|C2
77893|DIURETICS|C3
77893|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
77892|RESPIRATORY SYSTEM|R
77890|SYSTEMIC ANTIBACTERIALS|J1
77889|ANALGESICS|N2
77888|ANTIVIRALS FOR SYSTEMIC USE|J5
77887|OPHTHALMOLOGICALS|S1
77886|PARASITOLOGY|P
77886|OPHTHALMOLOGICALS|S1
77885|OPHTHALMOLOGICALS|S1
77882|OPHTHALMOLOGICALS|S1
77882|Ocular antineovascularisation products|S1P
77880|ANTIHYPERTENSIVES|C2
77880|OPHTHALMOLOGICALS|S1
77878|SYSTEMIC ANTIBACTERIALS|J1
77877|ANTIVIRALS FOR SYSTEMIC USE|J5
77875|PLATELET AGGREGATION INHIBITORS|B1C
77872|ANTI-GOUT PREPARATIONS|M4
77870|OPHTHALMOLOGICALS|S1
77865|ANTIVIRALS FOR SYSTEMIC USE|J5
77864|CARDIAC THERAPY|C1
77863|ANTIVIRALS FOR SYSTEMIC USE|J5
77857|Erectile dysfunction products|G4B3
77852|CARDIOVASCULAR SYSTEM|C
77852|DERMATOLOGICALS|D
77852|WOUND HEALING AGENTS|D3
77851|ANTIVIRALS FOR SYSTEMIC USE|J5
77847|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
77846|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
77844|NOOTROPICS|N6D
77843|ANTI-EPILEPTICS|N3A
77843|NOOTROPICS|N6D
77842|NOOTROPICS|N6D
77841|ANTIPSYCHOTICS|N5A
77841|NOOTROPICS|N6D
77839|ANTI-EPILEPTICS|N3A
77839|NOOTROPICS|N6D
77838|ANTI-EPILEPTICS|N3A
77838|NOOTROPICS|N6D
77837|TRANQUILLISERS|N5C
77837|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77837|SSRI antidepressants|N6A4
77836|TRANQUILLISERS|N5C
77836|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77836|SSRI antidepressants|N6A4
77835|B2-STIMULANTS|R3A
77829|ANALGESICS|N2
77829|ANTI-MIGRAINE PREPARATIONS|N2C
77828|ANALGESICS|N2
77828|ANTI-MIGRAINE PREPARATIONS|N2C
77827|ANALGESICS|N2
77827|ANTI-MIGRAINE PREPARATIONS|N2C
77818|ANTIHYPERTENSIVES|C2
77818|CALCIUM ANTAGONISTS|C8
77818|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
77818|Statins (HMG-CoA reductase inhibitors)|C10A1
77817|ANALGESICS|N2
77812|ANTIHYPERTENSIVES|C2
77812|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
77812|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
77812|Statins (HMG-CoA reductase inhibitors)|C10A1
77811|PLATELET AGGREGATION INHIBITORS|B1C
77807|CARDIOVASCULAR SYSTEM|C
77806|ANALGESICS|N2
77802|ANALGESICS|N2
77800|ANTIVIRALS FOR SYSTEMIC USE|J5
77798|Vitamin A|A11C1
77798|ANTI-ACNE PREPARATIONS|D10
77797|ANALGESICS|N2
77796|MUSCULO-SKELETAL SYSTEM|M
77796|ANALGESICS|N2
77794|NOOTROPICS|N6D
77790|ANTIVIRALS FOR SYSTEMIC USE|J5
77789|Antigonadotrophin-releasing hormones|H1C3
77788|MUSCULO-SKELETAL SYSTEM|M
77785|ANTIHYPERTENSIVES|C2
77768|ANTIHYPERTENSIVES|C2
77766|Miotics and antiglaucoma preparations, topical|S1E2
77765|Miotics and antiglaucoma preparations, topical|S1E2
77754|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77753|ANALGESICS|N2
77748|ANALGESICS|N2
77738|SYSTEMIC ANTIBACTERIALS|J1
77737|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77736|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77734|ANTIHYPERTENSIVES|C2
77734|CALCIUM ANTAGONISTS|C8
77734|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
77732|IMMUNOSUPPRESSIVE AGENTS|L4
77725|ALKYLATING AGENTS|L1A
77724|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
77722|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77722|DRUGS USED IN DIABETES|A10
77718|CARDIAC THERAPY|C1
77717|WOUND HEALING AGENTS|D3
77716|DERMATOLOGICALS|D
77715|DERMATOLOGICALS|D
77709|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77708|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77707|ANALGESICS|N2
77706|ANALGESICS|N2
77701|ANALGESICS|N2
77700|ANALGESICS|N2
77699|ANALGESICS|N2
77698|ANALGESICS|N2
77696|ANALGESICS|N2
77690|SYSTEMIC ANTIBACTERIALS|J1
77685|Factor VIII|B2D1
77684|Factor VIII|B2D1
77681|CENTRAL NERVOUS SYSTEM|N
77678|ANTI-GOUT PREPARATIONS|M4
77676|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77676|DRUGS USED IN DIABETES|A10
77671|ANTIVIRALS FOR SYSTEMIC USE|J5
77670|ANTIHYPERTENSIVES|C2
77670|SSRI antidepressants|N6A4
77666|ANTIVIRALS FOR SYSTEMIC USE|J5
77666|IMMUNOSTIMULATING AGENTS|L3
77665|ANTIVIRALS FOR SYSTEMIC USE|J5
77664|PLATELET AGGREGATION INHIBITORS|B1C
77663|ALKYLATING AGENTS|L1A
77661|ANTIVIRALS FOR SYSTEMIC USE|J5
77656|ANAESTHETICS, LOCAL|N1B
77656|ANALGESICS|N2
77646|ANTIPSYCHOTICS|N5A
77645|ANTIPSYCHOTICS|N5A
77644|ANTIPSYCHOTICS|N5A
77636|ANTIVIRALS FOR SYSTEMIC USE|J5
77635|ANTIVIRALS FOR SYSTEMIC USE|J5
77614|DRUGS USED IN DIABETES|A10
77612|DRUGS USED IN DIABETES|A10
77602|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
77601|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
77601|Statins (HMG-CoA reductase inhibitors)|C10A1
77600|ANALGESICS|N2
77598|PLATELET AGGREGATION INHIBITORS|B1C
77594|CARDIAC THERAPY|C1
77593|ANTIHYPERTENSIVES|C2
77593|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
77590|ANTI-EPILEPTICS|N3A
77590|TRANQUILLISERS|N5C
77590|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77589|ANTI-EPILEPTICS|N3A
77589|TRANQUILLISERS|N5C
77589|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77588|IMMUNOSTIMULATING AGENTS|L3
77585|OPHTHALMOLOGICALS|S1
77583|SYSTEMIC ANTIBACTERIALS|J1
77582|ANTIVIRALS FOR SYSTEMIC USE|J5
77579|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
77578|ANTIVIRALS FOR SYSTEMIC USE|J5
77575|ANTIPSYCHOTICS|N5A
77573|THYROID THERAPY|H3
77571|ANTIVIRALS FOR SYSTEMIC USE|J5
77564|DERMATOLOGICALS|D
77561|ANTIVIRALS FOR SYSTEMIC USE|J5
77559|Factor VIII|B2D1
77558|DERMATOLOGICALS|D
77556|WOUND HEALING AGENTS|D3
77553|DERMATOLOGICALS|D
77552|DERMATOLOGICALS|D
77549|DERMATOLOGICALS|D
77544|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77539|ANALGESICS|N2
77535|Ocular antineovascularisation products|S1P
77530|OPHTHALMOLOGICALS|S1
77528|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77528|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
77522|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77522|DRUGS USED IN DIABETES|A10
77522|GLUCAGON|H4B
77511|ANALGESICS|N2
77511|ANTI-MIGRAINE PREPARATIONS|N2C
77511|ANTI-EPILEPTICS|N3
77510|SYSTEMIC ANTIBACTERIALS|J1
77509|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77509|DRUGS USED IN DIABETES|A10
77503|CENTRAL NERVOUS SYSTEM|N
77501|CARDIOVASCULAR SYSTEM|C
77499|IMMUNOSTIMULATING AGENTS|L3
77494|ANTIVIRALS FOR SYSTEMIC USE|J5
77493|ANTIVIRALS FOR SYSTEMIC USE|J5
77492|ANTIVIRALS FOR SYSTEMIC USE|J5
77488|Coxibs|M1A3
77488|ANALGESICS|N2
77486|SYSTEMIC ANTIBACTERIALS|J1
77482|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
77481|SYSTEMIC ANTIBACTERIALS|J1
77475|ANTIMETABOLITES|L1B
77474|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
77474|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
77471|ANTIVIRALS FOR SYSTEMIC USE|J5
77470|ANTI-EPILEPTICS|N3A
77469|SYSTEMIC ANTIBACTERIALS|J1
77466|ANTI-EPILEPTICS|N3A
77465|RADIODIAGNOSTIC AGENTS|T1G
77458|DERMATOLOGICALS|D
77457|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77445|WOUND HEALING AGENTS|D3
77444|WOUND HEALING AGENTS|D3
77440|RESPIRATORY SYSTEM|R
77438|ANTIHYPERTENSIVES|C2
77434|IMMUNOSTIMULATING AGENTS|L3
77429|IMMUNOSTIMULATING AGENTS|L3
77428|IMMUNOSTIMULATING AGENTS|L3
77427|IMMUNOSTIMULATING AGENTS|L3
77426|IMMUNOSTIMULATING AGENTS|L3
77414|ANTIVIRALS FOR SYSTEMIC USE|J5
77409|CARDIOVASCULAR SYSTEM|C
77402|ANTIHYPERTENSIVES|C2
77402|CALCIUM ANTAGONISTS|C8
77395|ANTIVIRALS FOR SYSTEMIC USE|J5
77394|ANALGESICS|N2
77392|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77391|ANALGESICS|N2
77390|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77386|ANTI-EPILEPTICS|N3
77385|ANTI-EPILEPTICS|N3A
77383|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77378|WOUND HEALING AGENTS|D3
77371|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
77364|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77363|DIURETICS|C3
77360|ANTIHYPERTENSIVES|C2
77357|RESPIRATORY SYSTEM|R
77356|WOUND HEALING AGENTS|D3
77351|ANTIVIRALS FOR SYSTEMIC USE|J5
77350|RESPIRATORY SYSTEM|R
77348|SYSTEMIC ANTIBACTERIALS|J1
77339|ANTIVIRALS FOR SYSTEMIC USE|J5
77337|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
77336|SYSTEMIC ANTIBACTERIALS|J1
77335|ANTIVIRALS FOR SYSTEMIC USE|J5
77334|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77327|ANALGESICS|N2
77324|ANTIVIRALS FOR SYSTEMIC USE|J5
77323|ANTIVIRALS FOR SYSTEMIC USE|J5
77321|ANTIVIRALS FOR SYSTEMIC USE|J5
77319|ANTIVIRALS FOR SYSTEMIC USE|J5
77318|ANTIVIRALS FOR SYSTEMIC USE|J5
77318|Interferons, alpha|L3B1
77315|SYSTEMIC ANTIBACTERIALS|J1
77314|ANTIVIRALS FOR SYSTEMIC USE|J5
77313|ANTIVIRALS FOR SYSTEMIC USE|J5
77310|SYSTEMIC ANTIBACTERIALS|J1
77301|ANTI-EPILEPTICS|N3
77301|NOOTROPICS|N6D
77299|ANALGESICS|N2
77299|SSRI antidepressants|N6A4
77299|SRNI antidepressants|N6A5
77298|ANALGESICS|N2
77298|SSRI antidepressants|N6A4
77298|SRNI antidepressants|N6A5
77297|ANTIHYPERTENSIVES|C2
77288|ANALGESICS|N2
77288|SSRI antidepressants|N6A4
77288|SRNI antidepressants|N6A5
77286|ANALGESICS|N2
77286|SSRI antidepressants|N6A4
77286|SRNI antidepressants|N6A5
77276|ANTI-EPILEPTICS|N3A
77275|NOOTROPICS|N6D
77271|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77271|DRUGS USED IN DIABETES|A10
77267|ANTIVIRALS FOR SYSTEMIC USE|J5
77259|RADIODIAGNOSTIC AGENTS|T1G
77250|IMMUNOSTIMULATING AGENTS|L3
77248|ANTIPSYCHOTICS|N5A
77247|SYSTEMIC ANTIBACTERIALS|J1
77243|ANTIHYPERTENSIVES|C2
77242|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77232|ANTIVIRALS FOR SYSTEMIC USE|J5
77231|SYSTEMIC ANTIBACTERIALS|J1
77230|TRANQUILLISERS|N5C
77230|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77229|ANTIPSYCHOTICS|N5A
77212|PARASITOLOGY|P
77210|RADIODIAGNOSTIC AGENTS|T1G
77208|RADIODIAGNOSTIC AGENTS|T1G
77207|ANTI-MIGRAINE PREPARATIONS|N2C
77203|DRUGS USED IN DIABETES|A10
77195|B2-STIMULANTS|R3A
77194|ANTIPSYCHOTICS|N5A
77191|ANTIVIRALS FOR SYSTEMIC USE|J5
77188|GROWTH HORMONES|H4C
77183|CARDIOVASCULAR SYSTEM|C
77179|IMMUNOSTIMULATING AGENTS|L3
77175|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
77175|IMMUNOSUPPRESSIVE AGENTS|L4
77174|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
77174|IMMUNOSUPPRESSIVE AGENTS|L4
77172|IMMUNOSUPPRESSIVE AGENTS|L4
77172|OPHTHALMOLOGICALS|S1
77171|ANAESTHETICS, GENERAL|N1A
77169|CARDIOVASCULAR SYSTEM|C
77164|ANTIVIRALS FOR SYSTEMIC USE|J5
77160|Ocular antineovascularisation products|S1P
77159|ANTI-EPILEPTICS|N3A
77159|SRNI antidepressants|N6A5
77155|ANTI-EPILEPTICS|N3A
77152|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77152|DRUGS USED IN DIABETES|A10
77151|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
77150|IMMUNOSUPPRESSIVE AGENTS|L4
77149|SYSTEMIC ANTIBACTERIALS|J1
77145|SYSTEMIC ANTIBACTERIALS|J1
77144|OPHTHALMOLOGICALS|S1
77143|OPHTHALMOLOGICALS|S1
77142|OPHTHALMOLOGICALS|S1
77132|ANALGESICS|N2
77131|ANALGESICS|N2
77128|CARDIOVASCULAR SYSTEM|C
77127|SYSTEMIC ANTIBACTERIALS|J1
77126|RESPIRATORY SYSTEM|R
77125|WOUND HEALING AGENTS|D3
77125|SYSTEMIC ANTIBACTERIALS|J1
77124|SYSTEMIC ANTIBACTERIALS|J1
77120|CENTRAL NERVOUS SYSTEM|N
77117|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77116|SYSTEMIC ANTIBACTERIALS|J1
77115|ANTIVIRALS FOR SYSTEMIC USE|J5
77109|ANALGESICS|N2
77105|ANTIEMETICS AND ANTINAUSEANTS|A4
77100|ANTIVIRALS FOR SYSTEMIC USE|J5
77099|ANTIVIRALS FOR SYSTEMIC USE|J5
77098|ANTIVIRALS FOR SYSTEMIC USE|J5
77097|PLATELET AGGREGATION INHIBITORS|B1C
77097|CARDIOVASCULAR SYSTEM|C
77093|ANTIVIRALS FOR SYSTEMIC USE|J5
77091|ANTIVIRALS FOR SYSTEMIC USE|J5
77090|CARDIAC THERAPY|C1
77089|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77088|ANTIVIRALS FOR SYSTEMIC USE|J5
77087|OPHTHALMOLOGICALS|S1
77087|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
77086|WOUND HEALING AGENTS|D3
77084|ANTIVIRALS FOR SYSTEMIC USE|J5
77081|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77073|ANTIVIRALS FOR SYSTEMIC USE|J5
77070|DRUGS USED IN DIABETES|A10
77070|HUMAN INSULINS AND ANALOGUES|A10C
77066|IMMUNOSUPPRESSIVE AGENTS|L4
77065|OPHTHALMOLOGICALS|S1
77050|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77050|DRUGS USED IN DIABETES|A10
77050|GLUCAGON|H4B
77048|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
77048|DRUGS USED IN DIABETES|A10
77048|GLUCAGON|H4B
77046|ANALGESICS|N2
77045|ANALGESICS|N2
77040|ANALGESICS|N2
77039|ANALGESICS|N2
77038|Factors II, VII, IX and X|B2D2
77036|CARDIOVASCULAR SYSTEM|C
77036|Statins (HMG-CoA reductase inhibitors)|C10A1
77035|CARDIOVASCULAR SYSTEM|C
77035|Statins (HMG-CoA reductase inhibitors)|C10A1
77034|CARDIOVASCULAR SYSTEM|C
77034|Statins (HMG-CoA reductase inhibitors)|C10A1
77031|ANTIVIRALS FOR SYSTEMIC USE|J5
77014|CARDIOVASCULAR SYSTEM|C
77007|ANTIHYPERTENSIVES|C2
77005|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
77005|SSRI antidepressants|N6A4
77005|SRNI antidepressants|N6A5
77004|CARDIOVASCULAR SYSTEM|C
77003|CARDIOVASCULAR SYSTEM|C
77002|CARDIOVASCULAR SYSTEM|C
76991|SYSTEMIC ANTIBACTERIALS|J1
76987|DRUGS USED IN DIABETES|A10
76987|NOOTROPICS|N6D
76982|ANTIVIRALS FOR SYSTEMIC USE|J5
76981|SYSTEMIC ANTIBACTERIALS|J1
76980|SYSTEMIC ANTIBACTERIALS|J1
76978|ANALGESICS|N2
76977|RADIODIAGNOSTIC AGENTS|T1G
76975|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
76974|SYSTEMIC ANTIBACTERIALS|J1
76973|ANTIVIRALS FOR SYSTEMIC USE|J5
76971|IMMUNOSUPPRESSIVE AGENTS|L4
76967|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
76967|NOOTROPICS|N6D
76965|SYSTEMIC ANTIBACTERIALS|J1
76962|SYSTEMIC ANTIBACTERIALS|J1
76961|SYSTEMIC ANTIBACTERIALS|J1
76957|DRUGS USED IN DIABETES|A10
76957|CARDIOVASCULAR SYSTEM|C
76953|DRUGS USED IN DIABETES|A10
76942|CENTRAL NERVOUS SYSTEM|N
76939|NOOTROPICS|N6D
76937|DRUGS USED IN DIABETES|A10
76935|ANALGESICS|N2
76923|ANTIVIRALS FOR SYSTEMIC USE|J5
76923|ANALGESICS|N2
76915|NOOTROPICS|N6D
76914|SYSTEMIC ANTIBACTERIALS|J1
76908|TRANQUILLISERS|N5C
76908|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
76905|RADIODIAGNOSTIC AGENTS|T1G
76901|ANTIPSYCHOTICS|N5A
76900|ANTI-EPILEPTICS|N3A
76900|ANTIPSYCHOTICS|N5A
76900|TRANQUILLISERS|N5C
76899|DRUGS USED IN DIABETES|A10
76898|MACROLIDES AND SIMILAR TYPES|J1F
76895|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
76892|ANTIPSYCHOTICS|N5A
76889|DRUGS USED IN DIABETES|A10
76888|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
76885|SYSTEMIC ANTIBACTERIALS|J1
76884|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
76883|CARDIOVASCULAR SYSTEM|C
76881|ANTIVIRALS FOR SYSTEMIC USE|J5
76876|ANTIVIRALS FOR SYSTEMIC USE|J5
76874|Ocular antineovascularisation products|S1P
76859|TRANQUILLISERS|N5C
76858|ANTIVIRALS FOR SYSTEMIC USE|J5
76856|CARDIOVASCULAR SYSTEM|C
76852|ANTIHYPERTENSIVES|C2
76849|DRUGS USED IN DIABETES|A10
76844|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76844|DRUGS USED IN DIABETES|A10
76839|RESPIRATORY SYSTEM|R
76838|SYSTEMIC ANTIBACTERIALS|J1
76835|ANTIVIRALS FOR SYSTEMIC USE|J5
76833|ANTIVIRALS FOR SYSTEMIC USE|J5
76832|ANALGESICS|N2
76831|NOOTROPICS|N6D
76830|DRUGS USED IN DIABETES|A10
76830|DPP-IV inhibitor antidiabetics|A10B6
76819|SYSTEMIC ANTIBACTERIALS|J1
76818|ANTIMETABOLITES|L1B
76815|ANALGESICS|N2
76814|HUMAN INSULINS AND ANALOGUES|A10C
76813|HUMAN INSULINS AND ANALOGUES|A10C
76812|ANALGESICS|N2
76802|B2-STIMULANTS|R3A
76796|SYSTEMIC ANTIBACTERIALS|J1
76795|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
76794|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
76793|ANTIVIRALS FOR SYSTEMIC USE|J5
76789|NOOTROPICS|N6D
76787|ANTI-EPILEPTICS|N3A
76785|SYSTEMIC ANTIBACTERIALS|J1
76785|ANTIVIRALS FOR SYSTEMIC USE|J5
76783|SYSTEMIC ANTIBACTERIALS|J1
76782|B2-STIMULANTS|R3A
76780|ANTIVIRALS FOR SYSTEMIC USE|J5
76779|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
76778|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
76775|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
76774|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
76773|OPHTHALMOLOGICALS|S1
76770|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
76767|NOOTROPICS|N6D
76767|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
76764|ANTI-EPILEPTICS|N3A
76763|ANTI-MIGRAINE PREPARATIONS|N2C
76763|TRANQUILLISERS|N5C
76760|ANTI-MIGRAINE PREPARATIONS|N2C
76760|TRANQUILLISERS|N5C
76755|Erectile dysfunction products|G4B3
76754|Erectile dysfunction products|G4B3
76751|Coxibs|M1A3
76748|SYSTEMIC ANTIBACTERIALS|J1
76747|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76747|ANTIHYPERTENSIVES|C2
76742|ANTIVIRALS FOR SYSTEMIC USE|J5
76741|DRUGS USED IN DIABETES|A10
76739|PARASITOLOGY|P
76738|CARDIOVASCULAR SYSTEM|C
76737|ANTIPSYCHOTICS|N5A
76734|DRUGS USED IN DIABETES|A10
76733|ANTIVIRALS FOR SYSTEMIC USE|J5
76732|SYSTEMIC ANTIBACTERIALS|J1
76730|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76729|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76728|SYSTEMIC ANTIBACTERIALS|J1
76722|MACROLIDES AND SIMILAR TYPES|J1F
76721|SYSTEMIC ANTIBACTERIALS|J1
76720|SYSTEMIC ANTIBACTERIALS|J1
76719|SYSTEMIC ANTIBACTERIALS|J1
76718|SYSTEMIC ANTIBACTERIALS|J1
76717|SYSTEMIC ANTIBACTERIALS|J1
76709|ANTIVIRALS FOR SYSTEMIC USE|J5
76708|SYSTEMIC ANTIBACTERIALS|J1
76706|Factors II, VII, IX and X|B2D2
76705|DRUGS USED IN DIABETES|A10
76703|SYSTEMIC ANTIBACTERIALS|J1
76702|OPHTHALMOLOGICALS|S1
76701|SYSTEMIC ANTIBACTERIALS|J1
76700|OPHTHALMOLOGICALS|S1
76698|ANTIVIRALS FOR SYSTEMIC USE|J5
76696|ANTIVIRALS FOR SYSTEMIC USE|J5
76694|SYSTEMIC ANTIBACTERIALS|J1
76693|SYSTEMIC ANTIBACTERIALS|J1
76692|ANALGESICS|N2
76691|PARASITOLOGY|P
76690|ANTIVIRALS FOR SYSTEMIC USE|J5
76689|ANTIVIRALS FOR SYSTEMIC USE|J5
76688|SYSTEMIC ANTIBACTERIALS|J1
76686|ANALGESICS|N2
76678|RESPIRATORY SYSTEM|R
76675|RESPIRATORY SYSTEM|R
76674|IMMUNOSUPPRESSIVE AGENTS|L4
76672|DPP-IV inhibitor antidiabetics|A10B6
76670|ANALGESICS|N2
76668|ANTI-EPILEPTICS|N3
76666|ANTIVIRALS FOR SYSTEMIC USE|J5
76665|IMMUNOSTIMULATING AGENTS|L3
76661|ANTIHYPERTENSIVES|C2
76660|WOUND HEALING AGENTS|D3
76653|RESPIRATORY SYSTEM|R
76647|ANTIVIRALS FOR SYSTEMIC USE|J5
76647|DIAGNOSTIC AGENTS|T
76645|PARASITOLOGY|P
76645|ANTI-MALARIALS|P1D
76638|SYSTEMIC ANTIBACTERIALS|J1
76634|SYSTEMIC ANTIBACTERIALS|J1
76633|SYSTEMIC ANTIBACTERIALS|J1
76622|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
76614|OPHTHALMOLOGICALS|S1
76612|IMMUNOSUPPRESSIVE AGENTS|L4
76611|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
76610|IMMUNOSUPPRESSIVE AGENTS|L4
76610|OPHTHALMOLOGICALS|S1
76609|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
76606|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76599|ANTIVIRALS FOR SYSTEMIC USE|J5
76598|ANTIVIRALS FOR SYSTEMIC USE|J5
76597|ANTIVIRALS FOR SYSTEMIC USE|J5
76596|SYSTEMIC ANTIBACTERIALS|J1
76593|ANTIPSYCHOTICS|N5A
76592|ANALGESICS|N2
76552|OPHTHALMOLOGICALS|S1
76549|WOUND HEALING AGENTS|D3
76543|SYSTEMIC ANTIBACTERIALS|J1
76543|Carbapenems|J1P2
76542|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76540|ANTIVIRALS FOR SYSTEMIC USE|J5
76538|ANTIHYPERTENSIVES|C2
76537|ANTIHYPERTENSIVES|C2
76533|SYSTEMIC ANTIBACTERIALS|J1
76532|ANTIULCERANTS|A2B
76532|SYSTEMIC ANTIBACTERIALS|J1
76531|SYSTEMIC ANTIBACTERIALS|J1
76530|ANTI-EPILEPTICS|N3A
76530|NOOTROPICS|N6D
76513|ANALGESICS|N2
76513|ANTI-EPILEPTICS|N3
76512|ANALGESICS|N2
76512|ANTI-EPILEPTICS|N3
76510|ANTIVIRALS FOR SYSTEMIC USE|J5
76510|IMMUNOSTIMULATING AGENTS|L3
76508|IMMUNOSTIMULATING AGENTS|L3
76507|ANTIVIRALS FOR SYSTEMIC USE|J5
76499|MRI AGENTS|T1E
76496|ANTI-MIGRAINE PREPARATIONS|N2C
76494|ANTI-EPILEPTICS|N3A
76493|DERMATOLOGICALS|D
76492|NOOTROPICS|N6D
76490|NOOTROPICS|N6D
76486|ANTIVIRALS FOR SYSTEMIC USE|J5
76485|ANTIVIRALS FOR SYSTEMIC USE|J5
76482|ANTI-EPILEPTICS|N3A
76482|NOOTROPICS|N6D
76475|IMMUNOSUPPRESSIVE AGENTS|L4
76471|ANTI-EPILEPTICS|N3A
76467|AMINOGLYCOSIDES|J1K
76467|RESPIRATORY SYSTEM|R
76450|PLATELET AGGREGATION INHIBITORS|B1C
76448|NOOTROPICS|N6D
76447|ANTIVIRALS FOR SYSTEMIC USE|J5
76446|ANTHELMINTICS, EXCLUDING SCHISTOSOMICIDES|P1B
76445|ANTIVIRALS FOR SYSTEMIC USE|J5
76439|ANTIPSYCHOTICS|N5A
76438|DRUGS USED IN DIABETES|A10
76438|CARDIOVASCULAR SYSTEM|C
76436|ANTIVIRALS FOR SYSTEMIC USE|J5
76435|ANTIVIRALS FOR SYSTEMIC USE|J5
76433|DERMATOLOGICALS|D
76432|ANTIVIRALS FOR SYSTEMIC USE|J5
76425|ANTIVIRALS FOR SYSTEMIC USE|J5
76421|ANTIVIRALS FOR SYSTEMIC USE|J5
76420|DRUGS USED IN DIABETES|A10
76418|PARASITOLOGY|P
76417|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76415|RESPIRATORY SYSTEM|R
76414|RESPIRATORY SYSTEM|R
76413|RESPIRATORY SYSTEM|R
76412|RESPIRATORY SYSTEM|R
76410|RESPIRATORY SYSTEM|R
76409|RESPIRATORY SYSTEM|R
76407|RESPIRATORY SYSTEM|R
76406|RESPIRATORY SYSTEM|R
76406|B2-STIMULANTS|R3A
76401|CENTRAL NERVOUS SYSTEM|N
76401|ANTIPSYCHOTICS|N5A
76400|CENTRAL NERVOUS SYSTEM|N
76400|ANTIPSYCHOTICS|N5A
76395|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
76394|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
76391|RESPIRATORY SYSTEM|R
76390|RESPIRATORY SYSTEM|R
76389|RESPIRATORY SYSTEM|R
76387|RESPIRATORY SYSTEM|R
76386|RESPIRATORY SYSTEM|R
76385|RESPIRATORY SYSTEM|R
76383|RESPIRATORY SYSTEM|R
76382|RESPIRATORY SYSTEM|R
76378|ANTIVIRALS FOR SYSTEMIC USE|J5
76377|ANTIVIRALS FOR SYSTEMIC USE|J5
76376|NOOTROPICS|N6D
76373|ANALGESICS|N2
76372|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
76371|ANTIPSYCHOTICS|N5A
76362|ANTIPSYCHOTICS|N5A
76350|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
76348|ANALGESICS|N2
76348|B2-STIMULANTS|R3A
76344|APPETITE STIMULANTS|A15
76343|Erectile dysfunction products|G4B3
76339|ANALGESICS|N2
76335|WOUND HEALING AGENTS|D3
76334|DRUGS USED IN DIABETES|A10
76333|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
76332|ANTIHYPERTENSIVES|C2
76331|Factor VIII|B2D1
76330|PARASITOLOGY|P
76327|ANAESTHETICS, LOCAL|N1B
76325|PLATELET AGGREGATION INHIBITORS|B1C
76321|ANTIVIRALS FOR SYSTEMIC USE|J5
76318|CENTRAL NERVOUS SYSTEM|N
76307|SYSTEMIC ANTIBACTERIALS|J1
76292|WOUND HEALING AGENTS|D3
76281|SYSTEMIC ANTIBACTERIALS|J1
76276|NOOTROPICS|N6D
76275|OPHTHALMOLOGICALS|S1
76275|Ocular antineovascularisation products|S1P
76270|SYSTEMIC ANTIBACTERIALS|J1
76263|ANTIHYPERTENSIVES|C2
76261|ANTIHYPERTENSIVES|C2
76257|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76257|DRUGS USED IN DIABETES|A10
76256|ANALGESICS|N2
76255|DRUGS USED IN DIABETES|A10
76254|DRUGS USED IN DIABETES|A10
76252|ANALGESICS|N2
76251|ANALGESICS|N2
76248|ANTIPSYCHOTICS|N5A
76248|NOOTROPICS|N6D
76244|ANTIVIRALS FOR SYSTEMIC USE|J5
76233|ANALGESICS|N2
76232|ANALGESICS|N2
76231|ANALGESICS|N2
76230|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76218|ANTIPSYCHOTICS|N5A
76218|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
76217|DRUGS USED IN DIABETES|A10
76215|DRUGS USED IN DIABETES|A10
76213|CARDIOVASCULAR SYSTEM|C
76212|CARDIOVASCULAR SYSTEM|C
76206|WOUND HEALING AGENTS|D3
76201|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76196|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
76194|ANTIPSYCHOTICS|N5A
76193|ANTIPSYCHOTICS|N5A
76192|ANALGESICS|N2
76187|Ocular antineovascularisation products|S1P
76186|WOUND HEALING AGENTS|D3
76185|WOUND HEALING AGENTS|D3
76183|ANTI-EPILEPTICS|N3A
76177|ANTIVIRALS FOR SYSTEMIC USE|J5
76175|ANTI-EPILEPTICS|N3A
76173|OPHTHALMOLOGICALS|S1
76172|OPHTHALMOLOGICALS|S1
76170|ANTI-EPILEPTICS|N3A
76165|CENTRAL NERVOUS SYSTEM|N
76164|WOUND HEALING AGENTS|D3
76160|WOUND HEALING AGENTS|D3
76155|CARDIOVASCULAR SYSTEM|C
76154|RESPIRATORY SYSTEM|R
76151|ANTIHYPERTENSIVES|C2
76148|DRUGS USED IN DIABETES|A10
76147|DRUGS USED IN DIABETES|A10
76142|ANALGESICS|N2
76132|ANTI-EPILEPTICS|N3A
76130|ANDROGENS, EXCLUDING G3E, G3F|G3B
76129|ANDROGENS, EXCLUDING G3E, G3F|G3B
76128|SYSTEMIC ANTIBACTERIALS|J1
76128|SYSTEMIC ANTIBACTERIALS|J1
76123|NOOTROPICS|N6D
76119|WOUND HEALING AGENTS|D3
76117|CARDIOVASCULAR SYSTEM|C
76117|DERMATOLOGICALS|D
76117|CENTRAL NERVOUS SYSTEM|N
76115|ANTIHYPERTENSIVES|C2
76113|BPH (benign prostatic hypertrophy) products |G4C
76112|Coxibs|M1A3
76112|ANALGESICS|N2
76111|CARDIOVASCULAR SYSTEM|C
76111|EXPECTORANTS|R5C
76111|ANTITUSSIVES|R5D
76110|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
76108|MUSCLE RELAXANTS|M3
76108|ANALGESICS|N2
76106|CARDIOVASCULAR SYSTEM|C
76105|ANTIVIRALS FOR SYSTEMIC USE|J5
76104|ANTI-EPILEPTICS|N3
76103|ANTI-EPILEPTICS|N3
76102|ANTI-EPILEPTICS|N3
76101|ANTIHYPERTENSIVES|C2
76101|DIURETICS|C3
76101|CALCIUM ANTAGONISTS|C8
76095|DERMATOLOGICALS|D
76091|ANALGESICS|N2
76087|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76085|PARASITOLOGY|P
76083|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
76083|Statins (HMG-CoA reductase inhibitors)|C10A1
76082|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
76082|Statins (HMG-CoA reductase inhibitors)|C10A1
76080|RESPIRATORY SYSTEM|R
76079|GASTROPROKINETICS|A3F
76076|SYSTEMIC ANTIBACTERIALS|J1
76073|OPHTHALMOLOGICALS|S1
76069|ANTI-MIGRAINE PREPARATIONS|N2C
76068|Inhibitors of the Kallikrein-kinin-system|B2C2
76063|Coxibs|M1A3
76062|BETA-BLOCKING AGENTS|C7
76061|NOOTROPICS|N6D
76060|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
76057|NOOTROPICS|N6D
76056|ANALGESICS|N2
76054|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
76041|SYSTEMIC ANTIBACTERIALS|J1
76040|SYSTEMIC ANTIBACTERIALS|J1
76035|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
76034|RESPIRATORY SYSTEM|R
76028|SYSTEMIC ANTIBACTERIALS|J1
76027|CENTRAL NERVOUS SYSTEM|N
76025|ANTIVIRALS FOR SYSTEMIC USE|J5
76025|Ocular antineovascularisation products|S1P
76022|ANTIPSYCHOTICS|N5A
76021|PLATELET AGGREGATION INHIBITORS|B1C
76014|ANTIVIRALS FOR SYSTEMIC USE|J5
76013|ANALGESICS|N2
76004|NOOTROPICS|N6D
76002|WOUND HEALING AGENTS|D3
76002|SYSTEMIC ANTIBACTERIALS|J1
75996|ANTIVIRALS FOR SYSTEMIC USE|J5
75995|ANTIPROTOZOALS AND ANTHELMINTICS|P1
75992|ANTIVIRALS FOR SYSTEMIC USE|J5
75991|DERMATOLOGICALS|D
75982|ANTIHYPERTENSIVES|C2
75982|OPHTHALMOLOGICALS|S1
75982|Miotics and antiglaucoma preparations, topical|S1E2
75981|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
75981|ANTIVIRALS FOR SYSTEMIC USE|J5
75975|WOUND HEALING AGENTS|D3
75974|Alpha-glucosidase inhibitor antidiabetics|A10B5
75973|Alpha-glucosidase inhibitor antidiabetics|A10B5
75971|RESPIRATORY SYSTEM|R
75969|SYSTEMIC ANTIBACTERIALS|J1
75964|ANTI-EPILEPTICS|N3
75961|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75961|SSRI antidepressants|N6A4
75961|SRNI antidepressants|N6A5
75960|ANALGESICS|N2
75960|SSRI antidepressants|N6A4
75960|SRNI antidepressants|N6A5
75959|ANALGESICS|N2
75959|SSRI antidepressants|N6A4
75959|SRNI antidepressants|N6A5
75958|ANALGESICS|N2
75958|SSRI antidepressants|N6A4
75958|SRNI antidepressants|N6A5
75957|Erectile dysfunction products|G4B3
75956|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75953|ANTI-EPILEPTICS|N3A
75952|ANTIHYPERTENSIVES|C2
75952|OPHTHALMOLOGICALS|S1
75952|Miotics and antiglaucoma preparations, topical|S1E2
75938|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75930|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
75929|ANTI-EPILEPTICS|N3A
75929|OPHTHALMOLOGICALS|S1
75925|DIURETICS|C3
75924|IMMUNOSTIMULATING AGENTS|L3
75923|WOUND HEALING AGENTS|D3
75923|IMMUNOSTIMULATING AGENTS|L3
75921|ANTIVIRALS FOR SYSTEMIC USE|J5
75915|ANTI-EPILEPTICS|N3
75914|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
75914|OPHTHALMOLOGICALS|S1
75910|SYSTEMIC ANTIBACTERIALS|J1
75908|CARDIOVASCULAR SYSTEM|C
75905|ANTI-MALARIALS|P1D
75904|CARDIOVASCULAR SYSTEM|C
75899|ANTIVIRALS FOR SYSTEMIC USE|J5
75895|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
75894|IMMUNOSUPPRESSIVE AGENTS|L4
75893|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
75889|IMMUNOSUPPRESSIVE AGENTS|L4
75889|OPHTHALMOLOGICALS|S1
75887|SYSTEMIC ANTIBACTERIALS|J1
75885|SYSTEMIC ANTIBACTERIALS|J1
75884|SYSTEMIC ANTIBACTERIALS|J1
75883|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75883|SSRI antidepressants|N6A4
75882|DRUGS USED IN DIABETES|A10
75881|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75881|SSRI antidepressants|N6A4
75881|SRNI antidepressants|N6A5
75880|DRUGS USED IN DIABETES|A10
75878|DRUGS USED IN DIABETES|A10
75876|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75876|DRUGS USED IN DIABETES|A10
75873|CARDIOVASCULAR SYSTEM|C
75870|CARDIOVASCULAR SYSTEM|C
75868|HEPARINS |B1B
75867|ACE INHIBITORS, PLAIN|C9A
75857|ANTIHYPERTENSIVES|C2
75852|WOUND HEALING AGENTS|D3
75852|ANTI-ACNE PREPARATIONS|D10
75852|SYSTEMIC ANTIBACTERIALS|J1
75851|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75850|PARASITOLOGY|P
75848|CARDIOVASCULAR SYSTEM|C
75847|ANTI-EPILEPTICS|N3A
75847|Ocular antineovascularisation products|S1P
75843|ANALGESICS|N2
75841|ANTIVIRALS FOR SYSTEMIC USE|J5
75835|SYSTEMIC ANTIBACTERIALS|J1
75834|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
75834|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
75834|OPHTHALMOLOGICALS|S1
75833|ANTIVIRALS FOR SYSTEMIC USE|J5
75832|IMMUNOSTIMULATING AGENTS|L3
75829|NOOTROPICS|N6D
75828|ANTIVIRALS FOR SYSTEMIC USE|J5
75827|PARASITOLOGY|P
75827|ANTI-MALARIALS|P1D
75821|ANALGESICS|N2
75818|Factor VIII|B2D1
75811|OPHTHALMOLOGICALS|S1
75809|OPHTHALMOLOGICALS|S1
75809|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
75807|ANALGESICS|N2
75806|ANTIVIRALS FOR SYSTEMIC USE|J5
75801|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
75797|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75796|CARDIOVASCULAR SYSTEM|C
75789|CARDIOVASCULAR SYSTEM|C
75789|CENTRAL NERVOUS SYSTEM|N
75788|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75787|ANTIVIRALS FOR SYSTEMIC USE|J5
75785|CARDIOVASCULAR SYSTEM|C
75785|ANTIHYPERTENSIVES|C2
75785|Erectile dysfunction products|G4B3
75784|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
75781|ANTIVIRALS FOR SYSTEMIC USE|J5
75780|ANTIVIRALS FOR SYSTEMIC USE|J5
75773|ANTIVIRALS FOR SYSTEMIC USE|J5
75773|IMMUNOSTIMULATING AGENTS|L3
75769|ANTIHYPERTENSIVES|C2
75766|ANTIFIBRINOLYTICS|B2A
75760|SYSTEMIC ANTIBACTERIALS|J1
75759|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
75758|RADIODIAGNOSTIC AGENTS|T1G
75755|CARDIOVASCULAR SYSTEM|C
75751|IMMUNOSUPPRESSIVE AGENTS|L4
75750|PARASITOLOGY|P
75750|ANTI-MALARIALS|P1D
75747|SYSTEMIC ANTIBACTERIALS|J1
75746|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
75738|ANTIVIRALS FOR SYSTEMIC USE|J5
75732|Erectile dysfunction products|G4B3
75731|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75729|ANTIPSYCHOTICS|N5A
75728|NOOTROPICS|N6D
75726|RADIODIAGNOSTIC AGENTS|T1G
75725|ANTIPSYCHOTICS|N5A
75724|NOOTROPICS|N6D
75723|IMMUNOSTIMULATING AGENTS|L3
75721|ANALGESICS|N2
75720|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75716|ANTIEMETICS AND ANTINAUSEANTS|A4
75713|ANTIPSYCHOTICS|N5A
75711|ANTIVIRALS FOR SYSTEMIC USE|J5
75707|SYSTEMIC ANTIBACTERIALS|J1
75703|ANALGESICS|N2
75699|WOUND HEALING AGENTS|D3
75691|ANTI-EPILEPTICS|N3
75685|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
75681|SYSTEMIC ANTIBACTERIALS|J1
75674|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
75668|ANALGESICS|N2
75664|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75658|RADIODIAGNOSTIC AGENTS|T1G
75654|RADIODIAGNOSTIC AGENTS|T1G
75647|ANTIHYPERTENSIVES|C2
75647|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
75646|ANTIHYPERTENSIVES|C2
75646|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
75641|SYSTEMIC ANTIBACTERIALS|J1
75636|ANALGESICS|N2
75634|ANTIHYPERTENSIVES|C2
75632|BPH (benign prostatic hypertrophy) products |G4C
75631|BPH (benign prostatic hypertrophy) products |G4C
75630|ANALGESICS|N2
75626|ANALGESICS|N2
75625|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
75625|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
75625|ANALGESICS|N2
75623|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75619|SYSTEMIC ANTIBACTERIALS|J1
75618|DRUGS USED IN DIABETES|A10
75617|ANTIHYPERTENSIVES|C2
75615|ANALGESICS|N2
75614|ANTIHYPERTENSIVES|C2
75613|SYSTEMIC ANTIBACTERIALS|J1
75612|Coxibs|M1A3
75612|ANALGESICS|N2
75610|TRANQUILLISERS|N5C
75607|ANALGESICS|N2
75603|HYPNOTICS/SEDATIVES|N5B
75597|NOOTROPICS|N6D
75593|SYSTEMIC ANTIBACTERIALS|J1
75593|MACROLIDES AND SIMILAR TYPES|J1F
75584|ANTI-GOUT PREPARATIONS|M4
75583|ANTI-GOUT PREPARATIONS|M4
75581|ANTIVIRALS FOR SYSTEMIC USE|J5
75574|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
75573|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75570|OPHTHALMOLOGICALS|S1
75568|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
75564|ANTIMETABOLITES|L1B
75558|ANTIHYPERTENSIVES|C2
75558|CALCIUM ANTAGONISTS|C8
75551|IMMUNOSTIMULATING AGENTS|L3
75550|ANALGESICS|N2
75549|ANTIEMETICS AND ANTINAUSEANTS|A4
75548|ANTIEMETICS AND ANTINAUSEANTS|A4
75546|ANIMAL INSULINS|A10D
75545|ANIMAL INSULINS|A10D
75544|ANTIVIRALS FOR SYSTEMIC USE|J5
75539|ANTI-EPILEPTICS|N3
75538|ANALGESICS|N2
75537|ANTIVIRALS FOR SYSTEMIC USE|J5
75532|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75532|DRUGS USED IN DIABETES|A10
75530|RESPIRATORY SYSTEM|R
75528|Ocular antineovascularisation products|S1P
75527|ANTIHYPERTENSIVES|C2
75526|ANTIHYPERTENSIVES|C2
75525|CENTRAL NERVOUS SYSTEM|N
75524|ANTIHYPERTENSIVES|C2
75521|DRUGS USED IN DIABETES|A10
75518|ANTIVIRALS FOR SYSTEMIC USE|J5
75516|DERMATOLOGICALS|D
75515|RADIODIAGNOSTIC AGENTS|T1G
75513|PLATELET AGGREGATION INHIBITORS|B1C
75506|DRUGS USED IN DIABETES|A10
75505|DRUGS USED IN DIABETES|A10
75504|DRUGS USED IN DIABETES|A10
75499|Ocular antineovascularisation products|S1P
75497|B2-STIMULANTS|R3A
75496|CARDIOVASCULAR SYSTEM|C
75492|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
75490|HUMAN INSULINS AND ANALOGUES|A10C
75490|Human insulins and analogues, long-acting|A10C5
75488|CARDIOVASCULAR SYSTEM|C
75488|RESPIRATORY SYSTEM|R
75487|WOUND HEALING AGENTS|D3
75477|MUSCULO-SKELETAL SYSTEM|M
75476|CENTRAL NERVOUS SYSTEM|N
75468|NOOTROPICS|N6D
75462|ANTIVIRALS FOR SYSTEMIC USE|J5
75461|ANTIVIRALS FOR SYSTEMIC USE|J5
75454|IMMUNOSTIMULATING AGENTS|L3
75449|ANTIVIRALS FOR SYSTEMIC USE|J5
75445|SYSTEMIC ANTIBACTERIALS|J1
75436|Coxibs|M1A3
75436|ANALGESICS|N2
75434|Coxibs|M1A3
75434|ANALGESICS|N2
75433|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
75433|ANTIVIRALS FOR SYSTEMIC USE|J5
75428|OPHTHALMOLOGICALS|S1
75428|Ocular antineovascularisation products|S1P
75423|RESPIRATORY SYSTEM|R
75421|NOOTROPICS|N6D
75421|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
75420|CENTRAL NERVOUS SYSTEM|N
75419|NOOTROPICS|N6D
75418|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75413|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
75411|ANTI-EPILEPTICS|N3A
75411|NOOTROPICS|N6D
75406|PARASITOLOGY|P
75405|PLATELET AGGREGATION INHIBITORS|B1C
75403|IMMUNOSTIMULATING AGENTS|L3
75399|Factor VIII|B2D1
75398|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75397|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75397|NOOTROPICS|N6D
75396|ANTI-ACNE PREPARATIONS|D10
75396|ANTI-GOUT PREPARATIONS|M4
75396|RESPIRATORY SYSTEM|R
75393|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75392|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75391|IMMUNOSUPPRESSIVE AGENTS|L4
75390|IMMUNOSUPPRESSIVE AGENTS|L4
75389|Coxibs|M1A3
75389|ANALGESICS|N2
75384|ANTIVIRALS FOR SYSTEMIC USE|J5
75380|CENTRAL NERVOUS SYSTEM|N
75379|DRUGS USED IN DIABETES|A10
75379|HUMAN INSULINS AND ANALOGUES|A10C
75379|Human insulins and analogues, intermediate-acting|A10C2
75378|ANTI-EPILEPTICS|N3A
75376|OPHTHALMOLOGICALS|S1
75374|ANTIVIRALS FOR SYSTEMIC USE|J5
75371|CENTRAL NERVOUS SYSTEM|N
75370|CARDIOVASCULAR SYSTEM|C
75368|CARDIOVASCULAR SYSTEM|C
75367|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75364|ANTIVIRALS FOR SYSTEMIC USE|J5
75363|Sulphonylurea antidiabetics|A10B1
75363|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
75363|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
75363|Statins (HMG-CoA reductase inhibitors)|C10A1
75359|CENTRAL NERVOUS SYSTEM|N
75359|NOOTROPICS|N6D
75355|ANTIVIRALS FOR SYSTEMIC USE|J5
75352|CENTRAL NERVOUS SYSTEM|N
75352|HYPNOTICS/SEDATIVES|N5B
75352|TRANQUILLISERS|N5C
75348|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
75346|CARDIOVASCULAR SYSTEM|C
75346|TRANQUILLISERS|N5C
75342|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75341|DRUGS USED IN DIABETES|A10
75340|NOOTROPICS|N6D
75339|ALKYLATING AGENTS|L1A
75337|NOOTROPICS|N6D
75336|WOUND HEALING AGENTS|D3
75330|PSYCHOSTIMULANTS|N6B
75329|PSYCHOSTIMULANTS|N6B
75328|ALKYLATING AGENTS|L1A
75327|ALKYLATING AGENTS|L1A
75326|ANTITUSSIVES|R5D
75325|ANTITUSSIVES|R5D
75323|VACCINES|J7
75320|ANTIVIRALS FOR SYSTEMIC USE|J5
75319|ANTIVIRALS FOR SYSTEMIC USE|J5
75317|PLATELET AGGREGATION INHIBITORS|B1C
75317|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
75316|ANTIVIRALS FOR SYSTEMIC USE|J5
75310|ANTIHYPERTENSIVES|C2
75305|ANTI-ARRHYTHMICS|C1B
75298|ANTI-EPILEPTICS|N3A
75297|ANTI-EPILEPTICS|N3A
75292|ANALGESICS|N2
75290|ANALGESICS|N2
75287|ANALGESICS|N2
75284|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
75283|CARDIOVASCULAR SYSTEM|C
75281|Systemic dermatological antifungals|D1A2
75281|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
75280|HUMAN INSULINS AND ANALOGUES|A10C
75280|Human insulins and analogues, long-acting|A10C5
75276|ANTI-EPILEPTICS|N3A
75272|OPHTHALMOLOGICALS|S1
75271|OPHTHALMOLOGICALS|S1
75270|OPHTHALMOLOGICALS|S1
75268|ANALGESICS|N2
75268|OPHTHALMOLOGICALS|S1
75266|PARASITOLOGY|P
75263|ANALGESICS|N2
75248|ANTIPSYCHOTICS|N5A
75247|ANTIPSYCHOTICS|N5A
75246|ANALGESICS|N2
75245|NOOTROPICS|N6D
75243|ANALGESICS|N2
75242|ANTIVIRALS FOR SYSTEMIC USE|J5
75241|ANTIVIRALS FOR SYSTEMIC USE|J5
75230|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
75228|SYSTEMIC ANTIBACTERIALS|J1
75226|DRUGS USED IN DIABETES|A10
75226|HUMAN INSULINS AND ANALOGUES|A10C
75212|Ocular antineovascularisation products|S1P
75206|ANALGESICS|N2
75205|ANALGESICS|N2
75202|DRUGS USED IN DIABETES|A10
75200|PARASITOLOGY|P
75194|OPHTHALMOLOGICALS|S1
75192|B2-STIMULANTS|R3A
75187|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
75183|ANTI-MALARIALS|P1D
75179|ANTIMETABOLITES|L1B
75177|ANTI-EPILEPTICS|N3A
75175|OPHTHALMOLOGICALS|S1
75171|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
75164|DRUGS USED IN DIABETES|A10
75160|ANALGESICS|N2
75159|ANALGESICS|N2
75159|ANTI-MIGRAINE PREPARATIONS|N2C
75159|ANTI-EPILEPTICS|N3A
75159|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75158|SYSTEMIC ANTIBACTERIALS|J1
75151|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
75150|NOOTROPICS|N6D
75149|PARASITOLOGY|P
75142|HEPARINS |B1B
75142|WOUND HEALING AGENTS|D3
75141|HEPARINS |B1B
75140|HEPARINS |B1B
75136|CARDIOVASCULAR SYSTEM|C
75135|ANTIHYPERTENSIVES|C2
75135|BETA-BLOCKING AGENTS|C7
75135|CALCIUM ANTAGONISTS|C8
75130|ANTIHYPERTENSIVES|C2
75130|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
75130|Statins (HMG-CoA reductase inhibitors)|C10A1
75126|ANTIVIRALS FOR SYSTEMIC USE|J5
75120|ANTI-EPILEPTICS|N3A
75114|ANALGESICS|N2
75114|ANTIPSYCHOTICS|N5A
75107|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
75104|IMMUNOSUPPRESSIVE AGENTS|L4
75103|IMMUNOSUPPRESSIVE AGENTS|L4
75095|ANTIVIRALS FOR SYSTEMIC USE|J5
75094|ANTIVIRALS FOR SYSTEMIC USE|J5
75089|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
75089|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
75089|Statins (HMG-CoA reductase inhibitors)|C10A1
75087|SYSTEMIC ANTIBACTERIALS|J1
75086|IMMUNOSTIMULATING AGENTS|L3
75081|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75076|ANTIVIRALS FOR SYSTEMIC USE|J5
75074|SYSTEMIC ANTIBACTERIALS|J1
75070|ANTIVIRALS FOR SYSTEMIC USE|J5
75068|RESPIRATORY SYSTEM|R
75064|ANALGESICS|N2
75063|NOOTROPICS|N6D
75061|ANALGESICS|N2
75061|ANTI-MIGRAINE PREPARATIONS|N2C
75061|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
75054|NOOTROPICS|N6D
75054|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
75053|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
75052|ANALGESICS|N2
75050|CARDIOVASCULAR SYSTEM|C
75048|ANTIPSYCHOTICS|N5A
75045|ANTI-EPILEPTICS|N3A
75044|GROWTH HORMONES|H4C
75043|NOOTROPICS|N6D
75041|ANTIVIRALS FOR SYSTEMIC USE|J5
75041|Interferons, alpha|L3B1
75039|ANTIVIRALS FOR SYSTEMIC USE|J5
75038|ANTIPSYCHOTICS|N5A
75036|ANALGESICS|N2
75035|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
75030|CARDIOVASCULAR SYSTEM|C
75029|CARDIOVASCULAR SYSTEM|C
75028|NOOTROPICS|N6D
75028|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
75026|IMMUNOSTIMULATING AGENTS|L3
75024|ANTI-EPILEPTICS|N3A
75010|ANALGESICS|N2
75009|SYSTEMIC ANTIBACTERIALS|J1
75008|ANTIVIRALS FOR SYSTEMIC USE|J5
75007|SYSTEMIC ANTIBACTERIALS|J1
74989|ANTIHYPERTENSIVES|C2
74989|CALCIUM ANTAGONISTS|C8
74988|PLATELET AGGREGATION INHIBITORS|B1C
74986|ANALGESICS|N2
74973|ANTIPSYCHOTICS|N5A
74971|ANTITUSSIVES|R5D
74964|ANTIVIRALS FOR SYSTEMIC USE|J5
74962|ANTIVIRALS FOR SYSTEMIC USE|J5
74950|CARDIOVASCULAR SYSTEM|C
74948|ANDROGENS, EXCLUDING G3E, G3F|G3B
74947|OPHTHALMOLOGICALS|S1
74946|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
74945|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
74941|IMMUNOSTIMULATING AGENTS|L3
74938|ANTIVIRALS FOR SYSTEMIC USE|J5
74932|ANTI-EPILEPTICS|N3A
74930|ANTI-EPILEPTICS|N3A
74929|NOOTROPICS|N6D
74925|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74924|TRANQUILLISERS|N5C
74923|IMMUNOSUPPRESSIVE AGENTS|L4
74921|NOOTROPICS|N6D
74920|ANTIVIRALS FOR SYSTEMIC USE|J5
74919|ANTIVIRALS FOR SYSTEMIC USE|J5
74915|ANALGESICS|N2
74914|MRI AGENTS|T1E
74913|ANAESTHETICS|N1
74913|ANTI-EPILEPTICS|N3
74913|TRANQUILLISERS|N5C
74912|PARASITOLOGY|P
74911|RESPIRATORY SYSTEM|R
74910|DERMATOLOGICALS|D
74906|DRUGS USED IN DIABETES|A10
74906|HUMAN INSULINS AND ANALOGUES|A10C
74906|Human insulins and analogues, intermediate-acting|A10C2
74898|ANALGESICS|N2
74895|ANALGESICS|N2
74892|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74890|BPH (benign prostatic hypertrophy) products |G4C
74887|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
74881|ANTIVIRALS FOR SYSTEMIC USE|J5
74881|Protease inhibitors|J5C2
74880|Factor VIII|B2D1
74878|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74878|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
74878|GLUCAGON|H4B
74876|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
74870|ANTI-ARRHYTHMICS|C1B
74868|ANTIVIRALS FOR SYSTEMIC USE|J5
74864|DRUGS USED IN DIABETES|A10
74863|ANALGESICS|N2
74862|ANALGESICS|N2
74862|OPHTHALMOLOGICALS|S1
74860|PLATELET AGGREGATION INHIBITORS|B1C
74859|ANTI-MIGRAINE PREPARATIONS|N2C
74857|ANTI-EPILEPTICS|N3A
74857|NOOTROPICS|N6D
74856|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
74854|ANTIMETABOLITES|L1B
74852|ANTIVIRALS FOR SYSTEMIC USE|J5
74846|RESPIRATORY SYSTEM|R
74844|TRANQUILLISERS|N5C
74842|IMMUNOSUPPRESSIVE AGENTS|L4
74840|BPH (benign prostatic hypertrophy) products |G4C
74839|ANTIVIRALS FOR SYSTEMIC USE|J5
74838|ANTI-EPILEPTICS|N3A
74832|CARDIOVASCULAR SYSTEM|C
74831|SYSTEMIC ANTIBACTERIALS|J1
74830|CARDIOVASCULAR SYSTEM|C
74829|SYSTEMIC ANTIBACTERIALS|J1
74828|NOOTROPICS|N6D
74827|HYPNOTICS/SEDATIVES|N5B
74826|FIBRINOLYTICS|B1D
74824|CARDIOVASCULAR SYSTEM|C
74823|ANTIMETABOLITES|L1B
74822|ANDROGENS, EXCLUDING G3E, G3F|G3B
74821|WOUND HEALING AGENTS|D3
74820|ANTI-EPILEPTICS|N3A
74816|Ocular antineovascularisation products|S1P
74815|ANTIVIRALS FOR SYSTEMIC USE|J5
74814|SYSTEMIC ANTIBACTERIALS|J1
74813|OPHTHALMOLOGICALS|S1
74812|OPHTHALMOLOGICALS|S1
74809|NOOTROPICS|N6D
74806|ANTI-EPILEPTICS|N3
74801|ALKYLATING AGENTS|L1A
74799|ANTIVIRALS FOR SYSTEMIC USE|J5
74797|WOUND HEALING AGENTS|D3
74793|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74787|ANALGESICS|N2
74781|ANALGESICS|N2
74780|ANALGESICS|N2
74775|ANTIVIRALS FOR SYSTEMIC USE|J5
74774|PARASITOLOGY|P
74773|ANTIVIRALS FOR SYSTEMIC USE|J5
74768|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74768|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
74760|ANTIVIRALS FOR SYSTEMIC USE|J5
74759|ANTIVIRALS FOR SYSTEMIC USE|J5
74759|PARASITOLOGY|P
74758|RESPIRATORY SYSTEM|R
74757|NOOTROPICS|N6D
74752|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
74752|NOOTROPICS|N6D
74750|ANTIEMETICS AND ANTINAUSEANTS|A4
74747|IMMUNOSUPPRESSIVE AGENTS|L4
74746|IMMUNOSUPPRESSIVE AGENTS|L4
74743|PLATELET AGGREGATION INHIBITORS|B1C
74743|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
74742|SYSTEMIC ANTIBACTERIALS|J1
74741|ANALGESICS|N2
74740|ANALGESICS|N2
74738|ANALGESICS|N2
74736|ANALGESICS|N2
74721|ANALGESICS|N2
74716|SYSTEMIC ANTIHISTAMINES|R6
74714|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74712|ANALGESICS|N2
74711|IMMUNOSTIMULATING AGENTS|L3
74705|ANTIPSYCHOTICS|N5A
74702|ANTI-EPILEPTICS|N3A
74701|ANTIVIRALS FOR SYSTEMIC USE|J5
74701|Non-nucleoside reverse transcriptase inhibitors|J5C3
74698|ANALGESICS|N2
74691|ANALGESICS|N2
74690|ANTIPSYCHOTICS|N5A
74689|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74688|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
74688|NOOTROPICS|N6D
74687|ANALGESICS|N2
74686|ANALGESICS|N2
74677|NOOTROPICS|N6D
74676|IMMUNOSTIMULATING AGENTS|L3
74675|ALKYLATING AGENTS|L1A
74667|RESPIRATORY SYSTEM|R
74664|ANTIVIRALS FOR SYSTEMIC USE|J5
74663|PLATELET AGGREGATION INHIBITORS|B1C
74658|ANTIVIRALS FOR SYSTEMIC USE|J5
74658|Non-nucleoside reverse transcriptase inhibitors|J5C3
74657|ANTIVIRALS FOR SYSTEMIC USE|J5
74656|ANTIVIRALS FOR SYSTEMIC USE|J5
74655|IMMUNOSUPPRESSIVE AGENTS|L4
74652|ANTIVIRALS FOR SYSTEMIC USE|J5
74651|ANTIVIRALS FOR SYSTEMIC USE|J5
74649|ANTIPSYCHOTICS|N5A
74639|RADIODIAGNOSTIC AGENTS|T1G
74635|ANTIHYPERTENSIVES|C2
74634|ANTIVIRALS FOR SYSTEMIC USE|J5
74633|ANTIVIRALS FOR SYSTEMIC USE|J5
74620|ANTI-EPILEPTICS|N3A
74619|ANTI-EPILEPTICS|N3A
74618|Erectile dysfunction products|G4B3
74617|ANALGESICS|N2
74616|ANTIVIRALS FOR SYSTEMIC USE|J5
74614|ANALGESICS|N2
74604|ANTI-EPILEPTICS|N3
74600|Coxibs|M1A3
74599|Coxibs|M1A3
74595|PARASITOLOGY|P
74586|ANALGESICS|N2
74586|NOOTROPICS|N6D
74585|WOUND HEALING AGENTS|D3
74584|WOUND HEALING AGENTS|D3
74582|ANALGESICS|N2
74581|DRUGS USED IN DIABETES|A10
74578|CARDIAC THERAPY|C1
74573|ANTIPROTOZOALS AND ANTHELMINTICS|P1
74572|ANTIPROTOZOALS AND ANTHELMINTICS|P1
74571|ANTIPROTOZOALS AND ANTHELMINTICS|P1
74570|ANTIMETABOLITES|L1B
74568|NOOTROPICS|N6D
74551|ANTI-EPILEPTICS|N3
74547|CENTRAL NERVOUS SYSTEM|N
74541|ANTIVIRALS FOR SYSTEMIC USE|J5
74541|Non-nucleoside reverse transcriptase inhibitors|J5C3
74534|PARASITOLOGY|P
74533|ANAESTHETICS|N1
74533|ANALGESICS|N2
74526|ANTIVIRALS FOR SYSTEMIC USE|J5
74523|DRUGS USED IN DIABETES|A10
74523|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
74521|DRUGS USED IN DIABETES|A10
74520|IMMUNOSUPPRESSIVE AGENTS|L4
74519|DRUGS USED IN DIABETES|A10
74517|DRUGS USED IN DIABETES|A10
74516|ANALGESICS|N2
74512|ANTI-EPILEPTICS|N3A
74508|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
74507|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
74505|ANTI-EPILEPTICS|N3A
74500|ANTIVIRALS FOR SYSTEMIC USE|J5
74500|RESPIRATORY SYSTEM|R
74496|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74496|CALCITONINS|H4A
74495|ANALGESICS|N2
74495|ANTI-EPILEPTICS|N3
74494|ANTIVIRALS FOR SYSTEMIC USE|J5
74491|Ocular antineovascularisation products|S1P
74489|ANTIVIRALS FOR SYSTEMIC USE|J5
74489|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
74489|Non-nucleoside reverse transcriptase inhibitors|J5C3
74487|ANDROGENS, EXCLUDING G3E, G3F|G3B
74480|Non-nucleoside reverse transcriptase inhibitors|J5C3
74478|ANALGESICS|N2
74468|ANTI-ACNE PREPARATIONS|D10
74466|WOUND HEALING AGENTS|D3
74463|OPHTHALMOLOGICALS|S1
74460|OPHTHALMOLOGICALS|S1
74459|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
74457|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
74456|ANALGESICS|N2
74454|WOUND HEALING AGENTS|D3
74453|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
74449|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
74448|DPP-IV inhibitor antidiabetics|A10B6
74448|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
74448|Statins (HMG-CoA reductase inhibitors)|C10A1
74444|ANTI-EPILEPTICS|N3A
74443|SYSTEMIC ANTIBACTERIALS|J1
74442|ANTIVIRALS FOR SYSTEMIC USE|J5
74440|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74437|SYSTEMIC ANTIBACTERIALS|J1
74435|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74433|SYSTEMIC ANTIBACTERIALS|J1
74432|SYSTEMIC ANTIBACTERIALS|J1
74427|SYSTEMIC ANTIBACTERIALS|J1
74423|SYSTEMIC ANTIBACTERIALS|J1
74422|IMMUNOSUPPRESSIVE AGENTS|L4
74421|ANTI-EPILEPTICS|N3A
74419|ANTIVIRALS FOR SYSTEMIC USE|J5
74416|ANTIPSYCHOTICS|N5A
74416|NOOTROPICS|N6D
74415|CENTRAL NERVOUS SYSTEM|N
74415|NOOTROPICS|N6D
74413|SYSTEMIC ANTIBACTERIALS|J1
74412|ANTIVIRALS FOR SYSTEMIC USE|J5
74412|IMMUNOSTIMULATING AGENTS|L3
74411|IMMUNOSTIMULATING AGENTS|L3
74403|ANTIVIRALS FOR SYSTEMIC USE|J5
74403|Non-nucleoside reverse transcriptase inhibitors|J5C3
74402|IMMUNOSUPPRESSIVE AGENTS|L4
74401|CALCIUM ANTAGONISTS|C8
74400|RESPIRATORY SYSTEM|R
74397|CENTRAL NERVOUS SYSTEM|N
74397|RADIODIAGNOSTIC AGENTS|T1G
74396|SYSTEMIC ANTIBACTERIALS|J1
74395|ANTIVIRALS FOR SYSTEMIC USE|J5
74394|ANTIVIRALS FOR SYSTEMIC USE|J5
74389|ANALGESICS|N2
74388|ANALGESICS|N2
74387|ANTIHYPERTENSIVES|C2
74387|CALCIUM ANTAGONISTS|C8
74387|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
74384|ANALGESICS|N2
74381|DRUGS USED IN DIABETES|A10
74380|CENTRAL NERVOUS SYSTEM|N
74380|ANTIPSYCHOTICS|N5A
74374|ANTIVIRALS FOR SYSTEMIC USE|J5
74373|SYSTEMIC ANTIBACTERIALS|J1
74371|ANALGESICS|N2
74367|OPHTHALMOLOGICALS|S1
74366|NOOTROPICS|N6D
74365|MUSCULO-SKELETAL SYSTEM|M
74362|ANTIPSYCHOTICS|N5A
74360|ANTIVIRALS FOR SYSTEMIC USE|J5
74357|GASTROPROKINETICS|A3F
74352|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74352|DRUGS USED IN DIABETES|A10
74347|HYPNOTICS/SEDATIVES|N5B
74345|ANTI-EPILEPTICS|N3A
74344|ANTIVIRALS FOR SYSTEMIC USE|J5
74339|ANTIVIRALS FOR SYSTEMIC USE|J5
74337|DRUGS USED IN DIABETES|A10
74327|SYSTEMIC ANTIBACTERIALS|J1
74326|DRUGS USED IN DIABETES|A10
74325|ANTI-ARRHYTHMICS|C1B
74323|ANTIPSYCHOTICS|N5A
74321|OPHTHALMOLOGICALS|S1
74319|ANTI-EPILEPTICS|N3A
74318|Urinary incontinence products|G4B4
74314|CARDIOVASCULAR SYSTEM|C
74313|MUSCLE RELAXANTS|M3
74313|ANALGESICS|N2
74311|NOOTROPICS|N6D
74307|Ocular antineovascularisation products|S1P
74299|RADIODIAGNOSTIC AGENTS|T1G
74297|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74295|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
74291|CARDIOVASCULAR SYSTEM|C
74290|MUSCLE RELAXANTS|M3
74290|ANALGESICS|N2
74285|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
74285|ANALGESICS|N2
74284|PARASITOLOGY|P
74282|ANTIHYPERTENSIVES|C2
74280|MUSCULO-SKELETAL SYSTEM|M
74274|ANTIVIRALS FOR SYSTEMIC USE|J5
74269|ANTIPSYCHOTICS|N5A
74268|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74263|ANTIVIRALS FOR SYSTEMIC USE|J5
74263|Protease inhibitors|J5C2
74261|NOOTROPICS|N6D
74261|OPHTHALMOLOGICALS|S1
74260|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
74259|ANALGESICS|N2
74258|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
74258|ANTI-ACNE PREPARATIONS|D10
74256|ANTIVIRALS FOR SYSTEMIC USE|J5
74252|ANALGESICS|N2
74249|ANTIPSYCHOTICS|N5A
74242|DRUGS USED IN DIABETES|A10
74241|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
74240|OPHTHALMOLOGICALS|S1
74239|SYSTEMIC ANTIBACTERIALS|J1
74238|OPHTHALMOLOGICALS|S1
74234|SYSTEMIC ANTIBACTERIALS|J1
74233|RADIODIAGNOSTIC AGENTS|T1G
74228|OPHTHALMOLOGICALS|S1
74226|DRUGS USED IN DIABETES|A10
74224|ANTI-ACNE PREPARATIONS|D10
74224|SYSTEMIC ANTIBACTERIALS|J1
74224|PARASITOLOGY|P
74224|ANTI-MALARIALS|P1D
74223|RADIODIAGNOSTIC AGENTS|T1G
74222|WOUND HEALING AGENTS|D3
74220|SYSTEMIC ANTIBACTERIALS|J1
74219|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
74215|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74214|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74208|CARDIOVASCULAR SYSTEM|C
74208|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
74207|ANTIVIRALS FOR SYSTEMIC USE|J5
74198|Biguanide antidiabetics|A10B2
74194|RADIODIAGNOSTIC AGENTS|T1G
74191|ANTIVIRALS FOR SYSTEMIC USE|J5
74189|Ocular antineovascularisation products|S1P
74188|SYSTEMIC ANTIBACTERIALS|J1
74187|ANTIVIRALS FOR SYSTEMIC USE|J5
74184|SYSTEMIC ANTIBACTERIALS|J1
74184|Ocular antineovascularisation products|S1P
74182|CARDIOVASCULAR SYSTEM|C
74182|CALCIUM ANTAGONISTS|C8
74182|ANALGESICS|N2
74180|IMMUNOSTIMULATING AGENTS|L3
74180|ANTIPSYCHOTICS|N5A
74179|AMINOGLYCOSIDES|J1K
74172|IMMUNOSTIMULATING AGENTS|L3
74168|CENTRAL NERVOUS SYSTEM|N
74167|ANALGESICS|N2
74166|ANTIVIRALS FOR SYSTEMIC USE|J5
74165|SYSTEMIC ANTIBACTERIALS|J1
74162|ANTIVIRALS FOR SYSTEMIC USE|J5
74160|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74159|ANALGESICS|N2
74156|ANTI-EPILEPTICS|N3A
74150|RADIODIAGNOSTIC AGENTS|T1G
74149|ANALGESICS|N2
74146|Coxibs|M1A3
74146|ANALGESICS|N2
74145|ANTI-EPILEPTICS|N3A
74144|OPHTHALMOLOGICALS|S1
74142|CARDIOVASCULAR SYSTEM|C
74140|CENTRAL NERVOUS SYSTEM|N
74138|CENTRAL NERVOUS SYSTEM|N
74138|ANTI-EPILEPTICS|N3
74137|ANTIPSYCHOTICS|N5A
74136|ANALGESICS|N2
74131|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74126|RESPIRATORY SYSTEM|R
74126|B2-STIMULANTS|R3A
74125|GASTROPROKINETICS|A3F
74123|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74118|ANTI-ARRHYTHMICS|C1B
74118|CALCIUM ANTAGONISTS|C8
74117|ANTIVIRALS FOR SYSTEMIC USE|J5
74116|DIURETICS|C3
74115|RADIODIAGNOSTIC AGENTS|T1G
74113|ANTIPSYCHOTICS|N5A
74113|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
74113|SSRI antidepressants|N6A4
74112|ANTIVIRALS FOR SYSTEMIC USE|J5
74110|ANTIVIRALS FOR SYSTEMIC USE|J5
74109|IMMUNOSTIMULATING AGENTS|L3
74108|ANTIHYPERTENSIVES|C2
74108|BETA-BLOCKING AGENTS|C7
74103|Miotics and antiglaucoma preparations, topical|S1E2
74101|ANTI-EPILEPTICS|N3A
74100|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
74099|CARDIAC THERAPY|C1
74099|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
74095|ANTIVIRALS FOR SYSTEMIC USE|J5
74088|ANALGESICS|N2
74088|ANTI-EPILEPTICS|N3
74087|RADIODIAGNOSTIC AGENTS|T1G
74084|NOOTROPICS|N6D
74082|SYSTEMIC ANTIBACTERIALS|J1
74079|SYSTEMIC ANTIBACTERIALS|J1
74076|ANTIPSYCHOTICS|N5A
74069|MUSCULO-SKELETAL SYSTEM|M
74068|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
74068|ANTIVIRALS FOR SYSTEMIC USE|J5
74065|PARASITOLOGY|P
74063|CALCIUM ANTAGONISTS|C8
74060|SYSTEMIC ANTIHISTAMINES|R6
74050|CARDIAC THERAPY|C1
74049|CARDIAC THERAPY|C1
74046|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
74045|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
74044|Factor VIII|B2D1
74043|Factor VIII|B2D1
74036|PLATELET AGGREGATION INHIBITORS|B1C
74036|CARDIOVASCULAR SYSTEM|C
74035|PARASITOLOGY|P
74035|ANTI-MALARIALS|P1D
74031|ANALGESICS|N2
74030|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
74027|ANTI-EPILEPTICS|N3
74022|CENTRAL NERVOUS SYSTEM|N
74021|ANTIVIRALS FOR SYSTEMIC USE|J5
74020|ANTIVIRALS FOR SYSTEMIC USE|J5
74019|ANTIVIRALS FOR SYSTEMIC USE|J5
74018|CENTRAL NERVOUS SYSTEM|N
74015|Interferons, gamma|L3B3
74012|ANTIVIRALS FOR SYSTEMIC USE|J5
74009|CARDIOVASCULAR SYSTEM|C
74007|CARDIOVASCULAR SYSTEM|C
74005|BPH (benign prostatic hypertrophy) products |G4C
74004|ANTIHYPERTENSIVES|C2
74004|CALCIUM ANTAGONISTS|C8
74003|BPH (benign prostatic hypertrophy) products |G4C
74002|BPH (benign prostatic hypertrophy) products |G4C
73999|CARDIOVASCULAR SYSTEM|C
73996|OPHTHALMOLOGICALS|S1
73996|Miotics and antiglaucoma preparations, topical|S1E2
73993|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
73982|NOOTROPICS|N6D
73982|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
73980|HYPNOTICS/SEDATIVES|N5B
73977|ANTIVIRALS FOR SYSTEMIC USE|J5
73976|DERMATOLOGICALS|D
73976|WOUND HEALING AGENTS|D3
73972|SYSTEMIC ANTIBACTERIALS|J1
73972|RESPIRATORY SYSTEM|R
73971|Vitamin D|A11C2
73970|Vitamin D|A11C2
73969|PLATELET AGGREGATION INHIBITORS|B1C
73968|ANTIVIRALS FOR SYSTEMIC USE|J5
73963|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73962|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73961|PARASITOLOGY|P
73961|ANTI-MALARIALS|P1D
73956|WOUND HEALING AGENTS|D3
73954|ANTIVIRALS FOR SYSTEMIC USE|J5
73953|ANTIVIRALS FOR SYSTEMIC USE|J5
73951|Biguanide antidiabetics|A10B2
73950|RESPIRATORY SYSTEM|R
73938|DRUGS USED IN DIABETES|A10
73938|CENTRAL NERVOUS SYSTEM|N
73936|ANTIPSYCHOTICS|N5A
73924|ANTIEMETICS AND ANTINAUSEANTS|A4
73923|ANALGESICS|N2
73921|WOUND HEALING AGENTS|D3
73918|ANALGESICS|N2
73915|SYSTEMIC ANTIBACTERIALS|J1
73911|WOUND HEALING AGENTS|D3
73909|WOUND HEALING AGENTS|D3
73905|ANTI-MALARIALS|P1D
73904|ANTIVIRALS FOR SYSTEMIC USE|J5
73904|ANAESTHETICS, LOCAL|N1B
73903|SYSTEMIC ANTIBACTERIALS|J1
73901|TRANQUILLISERS|N5C
73892|MRI AGENTS|T1E
73891|MRI AGENTS|T1E
73890|PARASITOLOGY|P
73887|PARASITOLOGY|P
73881|SYSTEMIC ANTIBACTERIALS|J1
73871|SYSTEMIC ANTIBACTERIALS|J1
73870|WOUND HEALING AGENTS|D3
73870|OPHTHALMOLOGICALS|S1
73868|ANTIVIRALS FOR SYSTEMIC USE|J5
73867|DRUGS USED IN DIABETES|A10
73866|DRUGS USED IN DIABETES|A10
73863|B2-STIMULANTS|R3A
73857|ANTIVIRALS FOR SYSTEMIC USE|J5
73851|Erectile dysfunction products|G4B3
73850|ANTIVIRALS FOR SYSTEMIC USE|J5
73850|Interferons, alpha|L3B1
73849|NOOTROPICS|N6D
73848|NOOTROPICS|N6D
73841|Erectile dysfunction products|G4B3
73840|ANTI-MIGRAINE PREPARATIONS|N2C
73840|ANTIPSYCHOTICS|N5A
73838|SYSTEMIC ANTIBACTERIALS|J1
73838|MACROLIDES AND SIMILAR TYPES|J1F
73836|Interferons, alpha|L3B1
73829|ANALGESICS|N2
73828|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
73828|SSRI antidepressants|N6A4
73827|Erectile dysfunction products|G4B3
73824|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73821|ANTIPROTOZOALS AND ANTHELMINTICS|P1
73821|ANTI-MALARIALS|P1D
73820|SYSTEMIC ANTIBACTERIALS|J1
73818|ANALGESICS|N2
73817|ANTI-EPILEPTICS|N3
73816|ANTIPSYCHOTICS|N5A
73813|ANTI-EPILEPTICS|N3
73813|ANTI-EPILEPTICS|N3A
73813|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
73813|NOOTROPICS|N6D
73811|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73811|DRUGS USED IN DIABETES|A10
73810|OPHTHALMOLOGICALS|S1
73810|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
73808|Ocular antineovascularisation products|S1P
73806|SYSTEMIC ANTIBACTERIALS|J1
73805|ANTIVIRALS FOR SYSTEMIC USE|J5
73805|Protease inhibitors|J5C2
73804|ANTIVIRALS FOR SYSTEMIC USE|J5
73804|Protease inhibitors|J5C2
73801|ANALGESICS|N2
73800|ANTIVIRALS FOR SYSTEMIC USE|J5
73799|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
73798|ANTIVIRALS FOR SYSTEMIC USE|J5
73796|SYSTEMIC ANTIBACTERIALS|J1
73795|SYSTEMIC ANTIBACTERIALS|J1
73794|DRUGS USED IN DIABETES|A10
73793|Topical dermatological antifungals|D1A1
73793|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73784|SYSTEMIC ANTIBACTERIALS|J1
73779|ANTIVIRALS FOR SYSTEMIC USE|J5
73778|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73777|ANTIVIRALS FOR SYSTEMIC USE|J5
73775|SYSTEMIC ANTIBACTERIALS|J1
73774|SYSTEMIC ANTIBACTERIALS|J1
73772|DRUGS USED IN DIABETES|A10
73770|ANTIPROTOZOALS AND ANTHELMINTICS|P1
73770|ANTI-MALARIALS|P1D
73769|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73767|SYSTEMIC ANTIBACTERIALS|J1
73766|CARDIAC THERAPY|C1
73766|OPHTHALMOLOGICALS|S1
73762|Interferons, gamma|L3B3
73757|Factors II, VII, IX and X|B2D2
73754|IMMUNOSTIMULATING AGENTS|L3
73749|SYSTEMIC ANTIBACTERIALS|J1
73748|SYSTEMIC ANTIBACTERIALS|J1
73747|SYSTEMIC ANTIBACTERIALS|J1
73745|Carbapenems|J1P2
73743|ANTIVIRALS FOR SYSTEMIC USE|J5
73740|ANALGESICS|N2
73740|ANTI-MIGRAINE PREPARATIONS|N2C
73739|SYSTEMIC ANTIBACTERIALS|J1
73739|AMINOGLYCOSIDES|J1K
73734|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
73733|IMMUNOSTIMULATING AGENTS|L3
73732|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
73729|ANTIVIRALS FOR SYSTEMIC USE|J5
73728|ANTIHYPERTENSIVES|C2
73728|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
73712|MUSCULO-SKELETAL SYSTEM|M
73710|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73708|ANALGESICS|N2
73706|SYSTEMIC ANTIBACTERIALS|J1
73704|Ocular antineovascularisation products|S1P
73702|ANTI-EPILEPTICS|N3A
73699|ANTIVIRALS FOR SYSTEMIC USE|J5
73698|ANTIVIRALS FOR SYSTEMIC USE|J5
73697|SYSTEMIC ANTIBACTERIALS|J1
73696|SYSTEMIC ANTIBACTERIALS|J1
73695|ANTIVIRALS FOR SYSTEMIC USE|J5
73694|SYSTEMIC ANTIBACTERIALS|J1
73693|SYSTEMIC ANTIBACTERIALS|J1
73692|SYSTEMIC ANTIBACTERIALS|J1
73689|ANTIVIRALS FOR SYSTEMIC USE|J5
73688|RADIODIAGNOSTIC AGENTS|T1G
73681|ANTIVIRALS FOR SYSTEMIC USE|J5
73672|ANTITUSSIVES|R5D
73671|DRUGS USED IN DIABETES|A10
73663|PLATELET AGGREGATION INHIBITORS|B1C
73660|ANTIVIRALS FOR SYSTEMIC USE|J5
73653|SYSTEMIC ANTIBACTERIALS|J1
73652|ANALGESICS|N2
73651|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
73649|MUSCLE RELAXANTS|M3
73649|ANALGESICS|N2
73648|LUNG SURFACTANTS|R7C
73647|SYSTEMIC ANTIBACTERIALS|J1
73646|ANTI-EPILEPTICS|N3A
73646|PSYCHOSTIMULANTS|N6B
73646|NOOTROPICS|N6D
73644|SYSTEMIC ANTIBACTERIALS|J1
73644|RESPIRATORY SYSTEM|R
73641|ANTI-EPILEPTICS|N3A
73640|LUNG SURFACTANTS|R7C
73637|ANTIHYPERTENSIVES|C2
73634|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73633|SYSTEMIC ANTIBACTERIALS|J1
73632|SYSTEMIC ANTIBACTERIALS|J1
73625|ANTIVIRALS FOR SYSTEMIC USE|J5
73624|ANTIVIRALS FOR SYSTEMIC USE|J5
73623|SYSTEMIC ANTIBACTERIALS|J1
73622|SYSTEMIC ANTIBACTERIALS|J1
73621|NOOTROPICS|N6D
73620|SYSTEMIC ANTIBACTERIALS|J1
73619|RESPIRATORY SYSTEM|R
73616|ANALGESICS|N2
73611|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73611|CARDIOVASCULAR SYSTEM|C
73609|ANTIVIRALS FOR SYSTEMIC USE|J5
73607|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73605|B2-STIMULANTS|R3A
73602|SYSTEMIC ANTIBACTERIALS|J1
73600|SYSTEMIC ANTIBACTERIALS|J1
73580|SYSTEMIC ANTIBACTERIALS|J1
73580|OPHTHALMOLOGICALS|S1
73579|SYSTEMIC ANTIBACTERIALS|J1
73579|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73579|ANTIVIRALS FOR SYSTEMIC USE|J5
73579|IMMUNOSTIMULATING AGENTS|L3
73578|ANALGESICS|N2
73577|ANTIVIRALS FOR SYSTEMIC USE|J5
73572|WOUND HEALING AGENTS|D3
73571|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
73566|B2-STIMULANTS|R3A
73564|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73563|SYSTEMIC ANTIBACTERIALS|J1
73553|ANTIVIRALS FOR SYSTEMIC USE|J5
73551|PLATELET AGGREGATION INHIBITORS|B1C
73551|CARDIOVASCULAR SYSTEM|C
73543|RESPIRATORY SYSTEM|R
73541|CARDIAC THERAPY|C1
73539|OPHTHALMOLOGICALS|S1
73526|TOPICAL ANTI-ACNE PREPARATIONS|D10A
73526|SYSTEMIC ANTIBACTERIALS|J1
73525|SYSTEMIC ANTIBACTERIALS|J1
73524|CENTRAL NERVOUS SYSTEM|N
73523|ANTIPSYCHOTICS|N5A
73522|ANTIPSYCHOTICS|N5A
73521|ANTIPSYCHOTICS|N5A
73520|ANTIPSYCHOTICS|N5A
73517|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73516|ANTIVIRALS FOR SYSTEMIC USE|J5
73510|SYSTEMIC ANTIBACTERIALS|J1
73510|ANTIVIRALS FOR SYSTEMIC USE|J5
73509|RADIODIAGNOSTIC AGENTS|T1G
73508|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73507|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73506|OPHTHALMOLOGICALS|S1
73505|IMMUNOSTIMULATING AGENTS|L3
73503|IMMUNOSTIMULATING AGENTS|L3
73499|SYSTEMIC ANTIBACTERIALS|J1
73499|ANTIVIRALS FOR SYSTEMIC USE|J5
73497|IMMUNOSTIMULATING AGENTS|L3
73496|ANTIVIRALS FOR SYSTEMIC USE|J5
73495|ANTIPSYCHOTICS|N5A
73495|NOOTROPICS|N6D
73494|ANTIPSYCHOTICS|N5A
73493|ANTITUSSIVES|R5D
73492|B2-STIMULANTS|R3A
73491|ANTIVIRALS FOR SYSTEMIC USE|J5
73488|ANTIVIRALS FOR SYSTEMIC USE|J5
73481|ANALGESICS|N2
73481|ANTI-MIGRAINE PREPARATIONS|N2C
73479|OPHTHALMOLOGICALS|S1
73476|ANTIPSYCHOTICS|N5A
73468|ANTIVIRALS FOR SYSTEMIC USE|J5
73468|ANALGESICS|N2
73459|RESPIRATORY SYSTEM|R
73458|ANTIVIRALS FOR SYSTEMIC USE|J5
73457|ANTIVIRALS FOR SYSTEMIC USE|J5
73456|ANTIVIRALS FOR SYSTEMIC USE|J5
73455|ANTIVIRALS FOR SYSTEMIC USE|J5
73454|ANTIVIRALS FOR SYSTEMIC USE|J5
73453|ANTIVIRALS FOR SYSTEMIC USE|J5
73451|ANTI-EPILEPTICS|N3A
73450|DRUGS USED IN DIABETES|A10
73450|CARDIOVASCULAR SYSTEM|C
73449|DIRECT THROMBIN INHIBITORS|B1E
73448|ANTIVIRALS FOR SYSTEMIC USE|J5
73447|ANTIHYPERTENSIVES|C2
73444|SYSTEMIC ANTIBACTERIALS|J1
73443|CARDIOVASCULAR SYSTEM|C
73443|ANTI-ARRHYTHMICS|C1B
73441|OPHTHALMOLOGICALS|S1
73441|Miotics and antiglaucoma preparations, topical|S1E2
73440|ANAESTHETICS|N1
73440|HYPNOTICS/SEDATIVES|N5B
73440|TRANQUILLISERS|N5C
73438|DRUGS USED IN DIABETES|A10
73438|ANTIVIRALS FOR SYSTEMIC USE|J5
73433|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
73432|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73430|SSRI antidepressants|N6A4
73428|SYSTEMIC ANTIBACTERIALS|J1
73427|SYSTEMIC ANTIBACTERIALS|J1
73427|CEPHALOSPORINS|J1D
73426|ANTIVIRALS FOR SYSTEMIC USE|J5
73420|PARASITOLOGY|P
73420|ANTI-MALARIALS|P1D
73416|SYSTEMIC ANTIBACTERIALS|J1
73416|MACROLIDES AND SIMILAR TYPES|J1F
73409|SYSTEMIC ANTIBACTERIALS|J1
73408|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
73406|PLATELET AGGREGATION INHIBITORS|B1C
73405|ANALGESICS|N2
73404|PARASITOLOGY|P
73404|ANTI-MALARIALS|P1D
73403|ANTIHYPERTENSIVES|C2
73402|ANTIPROTOZOALS AND ANTHELMINTICS|P1
73400|WOUND HEALING AGENTS|D3
73396|Erectile dysfunction products|G4B3
73394|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
73393|ANTIHYPERTENSIVES|C2
73391|DPP-IV inhibitor antidiabetics|A10B6
73384|DRUGS USED IN DIABETES|A10
73381|OPHTHALMOLOGICALS|S1
73377|CARDIOVASCULAR SYSTEM|C
73375|NOOTROPICS|N6D
73371|ANALGESICS|N2
73371|ANTI-EPILEPTICS|N3
73361|CARDIOVASCULAR SYSTEM|C
73361|ANTIVIRALS FOR SYSTEMIC USE|J5
73358|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
73357|ANALGESICS|N2
73351|ANTIVIRALS FOR SYSTEMIC USE|J5
73351|NOOTROPICS|N6D
73348|ANTIVIRALS FOR SYSTEMIC USE|J5
73343|CARDIAC THERAPY|C1
73338|DRUGS USED IN DIABETES|A10
73337|ANTI-EPILEPTICS|N3A
73335|ANTIVIRALS FOR SYSTEMIC USE|J5
73334|HUMAN INSULINS AND ANALOGUES|A10C
73334|Human insulins and analogues, intermediate-acting|A10C2
73334|Human insulins and analogues, long-acting|A10C5
73332|DERMATOLOGICALS|D
73332|IMMUNOSUPPRESSIVE AGENTS|L4
73326|SYSTEMIC ANTIBACTERIALS|J1
73319|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
73316|ANTI-EPILEPTICS|N3A
73314|ANTI-EPILEPTICS|N3A
73311|IMMUNOSTIMULATING AGENTS|L3
73310|SYSTEMIC ANTIBACTERIALS|J1
73310|VACCINES|J7
73307|WOUND HEALING AGENTS|D3
73306|CENTRAL NERVOUS SYSTEM|N
73304|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73303|PARASITOLOGY|P
73303|ANTI-MALARIALS|P1D
73302|LAXATIVES|A6
73299|DRUGS USED IN DIABETES|A10
73296|CENTRAL NERVOUS SYSTEM|N
73296|TRANQUILLISERS|N5C
73294|RESPIRATORY SYSTEM|R
73292|ANTIVIRALS FOR SYSTEMIC USE|J5
73289|ANTIHYPERTENSIVES|C2
73289|DIURETICS|C3
73285|ANALGESICS|N2
73285|TRANQUILLISERS|N5C
73284|ANTIVIRALS FOR SYSTEMIC USE|J5
73282|RESPIRATORY SYSTEM|R
73277|ANALGESICS|N2
73276|SYSTEMIC ANTIBACTERIALS|J1
73276|ANTI-EPILEPTICS|N3
73275|HUMAN INSULINS AND ANALOGUES|A10C
73275|Human insulins and analogues, long-acting|A10C5
73274|SYSTEMIC ANTIBACTERIALS|J1
73273|HUMAN INSULINS AND ANALOGUES|A10C
73273|Human insulins and analogues, fast-acting|A10C1
73272|ANTIHYPERTENSIVES|C2
73272|CALCIUM ANTAGONISTS|C8
73272|ACE INHIBITORS, PLAIN|C9A
73270|IMMUNOSTIMULATING AGENTS|L3
73269|NOOTROPICS|N6D
73268|SYSTEMIC ANTIBACTERIALS|J1
73267|ALKYLATING AGENTS|L1A
73266|Erectile dysfunction products|G4B3
73265|ANTI-EPILEPTICS|N3A
73262|WOUND HEALING AGENTS|D3
73261|ANTI-EPILEPTICS|N3A
73261|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
73261|NOOTROPICS|N6D
73257|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
73256|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
73255|ANALGESICS|N2
73255|OPHTHALMOLOGICALS|S1
73254|PLATELET AGGREGATION INHIBITORS|B1C
73250|ANALGESICS|N2
73240|ANTIPSYCHOTICS|N5A
73240|TRANQUILLISERS|N5C
73230|NOOTROPICS|N6D
73222|NOOTROPICS|N6D
73221|NOOTROPICS|N6D
73213|NOOTROPICS|N6D
73209|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73208|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73208|CARDIAC THERAPY|C1
73208|ANTIHYPERTENSIVES|C2
73207|OPHTHALMOLOGICALS|S1
73202|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73202|ANALGESICS|N2
73202|ANTIPSYCHOTICS|N5A
73202|NOOTROPICS|N6D
73192|CARDIOVASCULAR SYSTEM|C
73191|TRANQUILLISERS|N5C
73191|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
73188|SYSTEMIC ANTIBACTERIALS|J1
73182|SYSTEMIC ANTIBACTERIALS|J1
73181|ANALGESICS|N2
73180|IMMUNOSTIMULATING AGENTS|L3
73179|ANTI-EPILEPTICS|N3A
73178|SYSTEMIC ANTIBACTERIALS|J1
73175|WOUND HEALING AGENTS|D3
73174|ANALGESICS|N2
73173|ANALGESICS|N2
73172|PLATELET AGGREGATION INHIBITORS|B1C
73171|ANALGESICS|N2
73170|ANALGESICS|N2
73169|GROWTH HORMONES|H4C
73168|RESPIRATORY SYSTEM|R
73160|ANALGESICS|N2
73157|DRUGS USED IN DIABETES|A10
73156|ANALGESICS|N2
73152|DRUGS USED IN DIABETES|A10
73146|PLATELET AGGREGATION INHIBITORS|B1C
73144|IMMUNOSTIMULATING AGENTS|L3
73141|IMMUNOSUPPRESSIVE AGENTS|L4
73136|IMMUNOSTIMULATING AGENTS|L3
73135|Inhibitors of the Kallikrein-kinin-system|B2C2
73135|OPHTHALMOLOGICALS|S1
73134|Inhibitors of the Kallikrein-kinin-system|B2C2
73134|OPHTHALMOLOGICALS|S1
73128|DRUGS USED IN DIABETES|A10
73125|NOOTROPICS|N6D
73123|ANTI-ACNE PREPARATIONS|D10
73119|DRUGS USED IN DIABETES|A10
73117|ANTITUSSIVES|R5D
73114|ANTITUSSIVES|R5D
73112|RESPIRATORY SYSTEM|R
73111|ANTIVIRALS FOR SYSTEMIC USE|J5
73109|IMMUNOSTIMULATING AGENTS|L3
73106|RESPIRATORY SYSTEM|R
73101|ANALGESICS|N2
73098|ANTIVIRALS FOR SYSTEMIC USE|J5
73096|SYSTEMIC ANTIBACTERIALS|J1
73095|Vitamin D|A11C2
73095|CARDIOVASCULAR SYSTEM|C
73092|NOOTROPICS|N6D
73091|VACCINES|J7
73089|Vitamin K|B2B1
73082|RESPIRATORY SYSTEM|R
73081|CARDIAC THERAPY|C1
73078|ANTIVIRALS FOR SYSTEMIC USE|J5
73077|ANTIVIRALS FOR SYSTEMIC USE|J5
73076|ANTIVIRALS FOR SYSTEMIC USE|J5
73072|SYSTEMIC ANTIBACTERIALS|J1
73068|ANTIVIRALS FOR SYSTEMIC USE|J5
73066|IMMUNOSUPPRESSIVE AGENTS|L4
73065|CENTRAL NERVOUS SYSTEM|N
73065|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
73064|SYSTEMIC ANTIBACTERIALS|J1
73064|Carbapenems|J1P2
73063|Ocular antineovascularisation products|S1P
73062|ANTIVIRALS FOR SYSTEMIC USE|J5
73050|SYSTEMIC ANTIBACTERIALS|J1
73049|ANTIVIRALS FOR SYSTEMIC USE|J5
73045|ANALGESICS|N2
73044|HUMAN INSULINS AND ANALOGUES|A10C
73044|Human insulins and analogues, intermediate-acting|A10C2
73042|IMMUNOSTIMULATING AGENTS|L3
73041|PARASITOLOGY|P
73038|SYSTEMIC ANTIBACTERIALS|J1
73035|DRUGS USED IN DIABETES|A10
73031|VACCINES|J7
73030|SYSTEMIC ANTIBACTERIALS|J1
73028|ANTIVIRALS FOR SYSTEMIC USE|J5
73026|ANTIVIRALS FOR SYSTEMIC USE|J5
73025|ANTIVIRALS FOR SYSTEMIC USE|J5
73024|VACCINES|J7
73023|CARDIOVASCULAR SYSTEM|C
73022|CENTRAL NERVOUS SYSTEM|N
73016|DRUGS USED IN DIABETES|A10
73013|OPHTHALMOLOGICALS|S1
73012|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
73012|HUMAN INSULINS AND ANALOGUES|A10C
73012|Human insulins and analogues, long-acting|A10C5
73006|Biguanide antidiabetics|A10B2
73001|ANTIVIRALS FOR SYSTEMIC USE|J5
73000|ANALGESICS|N2
72997|ANTIVIRALS FOR SYSTEMIC USE|J5
72993|DRUGS USED IN DIABETES|A10
72990|CARDIOVASCULAR SYSTEM|C
72986|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72982|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
72976|IMMUNOSUPPRESSIVE AGENTS|L4
72975|ANTIVIRALS FOR SYSTEMIC USE|J5
72973|ANTIVIRALS FOR SYSTEMIC USE|J5
72972|ANTIVIRALS FOR SYSTEMIC USE|J5
72971|ANTIVIRALS FOR SYSTEMIC USE|J5
72970|ANTIVIRALS FOR SYSTEMIC USE|J5
72954|ANTIVIRALS FOR SYSTEMIC USE|J5
72953|ACE INHIBITORS, PLAIN|C9A
72949|CENTRAL NERVOUS SYSTEM|N
72947|IMMUNOSUPPRESSIVE AGENTS|L4
72945|CARDIOVASCULAR SYSTEM|C
72944|ANALGESICS|N2
72941|ANALGESICS|N2
72938|ANTIVIRALS FOR SYSTEMIC USE|J5
72937|IMMUNOSTIMULATING AGENTS|L3
72936|ANTI-MALARIALS|P1D
72932|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72931|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72930|ANALGESICS|N2
72926|SYSTEMIC ANTIBACTERIALS|J1
72925|IMMUNOSTIMULATING AGENTS|L3
72924|ANTI-MALARIALS|P1D
72923|CARDIOVASCULAR SYSTEM|C
72922|OPHTHALMOLOGICALS|S1
72914|ANTIVIRALS FOR SYSTEMIC USE|J5
72914|IMMUNOSTIMULATING AGENTS|L3
72913|ANTI-MALARIALS|P1D
72912|SYSTEMIC ANTIBACTERIALS|J1
72910|ANALGESICS|N2
72909|ANTIVIRALS FOR SYSTEMIC USE|J5
72908|ANTIVIRALS FOR SYSTEMIC USE|J5
72904|OPHTHALMOLOGICALS|S1
72901|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72899|DRUGS USED IN DIABETES|A10
72899|Alpha-glucosidase inhibitor antidiabetics|A10B5
72894|ANTI-EPILEPTICS|N3A
72891|ANTI-EPILEPTICS|N3A
72886|ANTIVIRALS FOR SYSTEMIC USE|J5
72883|SYSTEMIC ANTIBACTERIALS|J1
72882|ANAESTHETICS, LOCAL|N1B
72879|Interferons, beta|L3B2
72877|PARASITOLOGY|P
72873|PLATELET AGGREGATION INHIBITORS|B1C
72873|ANTIHYPERTENSIVES|C2
72872|PLATELET AGGREGATION INHIBITORS|B1C
72872|ANTIHYPERTENSIVES|C2
72871|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
72866|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
72861|IMMUNOSTIMULATING AGENTS|L3
72855|ANTIVIRALS FOR SYSTEMIC USE|J5
72855|ANALGESICS|N2
72851|SYSTEMIC ANTIBACTERIALS|J1
72849|GASTROPROKINETICS|A3F
72847|ANALGESICS|N2
72846|ANALGESICS|N2
72845|ANALGESICS|N2
72843|ANALGESICS|N2
72842|SYSTEMIC ANTIBACTERIALS|J1
72842|ANTIPROTOZOALS AND ANTHELMINTICS|P1
72841|SYSTEMIC ANTIBACTERIALS|J1
72841|ANTIPROTOZOALS AND ANTHELMINTICS|P1
72840|SYSTEMIC ANTIBACTERIALS|J1
72840|ANTIPROTOZOALS AND ANTHELMINTICS|P1
72839|Coxibs|M1A3
72839|ANALGESICS|N2
72824|ANALGESICS|N2
72817|SYSTEMIC ANTIBACTERIALS|J1
72812|ANTIVIRALS FOR SYSTEMIC USE|J5
72811|OPHTHALMOLOGICALS|S1
72807|AMINOGLYCOSIDES|J1K
72805|RESPIRATORY SYSTEM|R
72800|ANTIVIRALS FOR SYSTEMIC USE|J5
72799|ANTIVIRALS FOR SYSTEMIC USE|J5
72798|ANTIVIRALS FOR SYSTEMIC USE|J5
72796|ANTIVIRALS FOR SYSTEMIC USE|J5
72793|ANTIVIRALS FOR SYSTEMIC USE|J5
72788|ANTIVIRALS FOR SYSTEMIC USE|J5
72786|ANTIVIRALS FOR SYSTEMIC USE|J5
72771|CARDIOVASCULAR SYSTEM|C
72770|SYSTEMIC ANTIBACTERIALS|J1
72769|SYSTEMIC ANTIBACTERIALS|J1
72768|SYSTEMIC ANTIBACTERIALS|J1
72767|SYSTEMIC ANTIBACTERIALS|J1
72763|SYSTEMIC ANTIBACTERIALS|J1
72763|CEPHALOSPORINS|J1D
72758|IMMUNOSUPPRESSIVE AGENTS|L4
72758|OPHTHALMOLOGICALS|S1
72755|ANTIVIRALS FOR SYSTEMIC USE|J5
72749|MUSCULO-SKELETAL SYSTEM|M
72747|SYSTEMIC ANTIBACTERIALS|J1
72747|ANTIVIRALS FOR SYSTEMIC USE|J5
72739|ANALGESICS|N2
72738|ANTIVIRALS FOR SYSTEMIC USE|J5
72736|ANTI-ACNE PREPARATIONS|D10
72735|ANALGESICS|N2
72730|Ocular antineovascularisation products|S1P
72729|ANTIHYPERTENSIVES|C2
72721|Ocular antineovascularisation products|S1P
72717|DRUGS USED IN DIABETES|A10
72716|CENTRAL NERVOUS SYSTEM|N
72715|ANTIVIRALS FOR SYSTEMIC USE|J5
72714|RESPIRATORY SYSTEM|R
72713|ANALGESICS|N2
72711|ANALGESICS|N2
72709|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72709|DRUGS USED IN DIABETES|A10
72706|ANTIVIRALS FOR SYSTEMIC USE|J5
72703|SYSTEMIC ANTIBACTERIALS|J1
72702|SYSTEMIC ANTIBACTERIALS|J1
72700|IMMUNOSUPPRESSIVE AGENTS|L4
72699|IMMUNOSTIMULATING AGENTS|L3
72694|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
72691|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72691|DRUGS USED IN DIABETES|A10
72691|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
72688|Ocular antineovascularisation products|S1P
72687|Ocular antineovascularisation products|S1P
72686|Ocular antineovascularisation products|S1P
72685|OPHTHALMOLOGICALS|S1
72684|Ocular antineovascularisation products|S1P
72683|CENTRAL NERVOUS SYSTEM|N
72682|ANTIVIRALS FOR SYSTEMIC USE|J5
72679|ANTIVIRALS FOR SYSTEMIC USE|J5
72676|ANTIHYPERTENSIVES|C2
72675|ANTIVIRALS FOR SYSTEMIC USE|J5
72670|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72669|CALCIUM ANTAGONISTS|C8
72669|ANALGESICS|N2
72669|SSRI antidepressants|N6A4
72669|SRNI antidepressants|N6A5
72667|CALCIUM ANTAGONISTS|C8
72667|ANALGESICS|N2
72660|ANALGESICS|N2
72657|ANALGESICS|N2
72656|ANTIVIRALS FOR SYSTEMIC USE|J5
72655|ANTI-MIGRAINE PREPARATIONS|N2C
72650|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
72647|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
72647|NOOTROPICS|N6D
72645|NOOTROPICS|N6D
72639|WOUND HEALING AGENTS|D3
72637|ANALGESICS|N2
72631|ANTIVIRALS FOR SYSTEMIC USE|J5
72628|ANTIVIRALS FOR SYSTEMIC USE|J5
72616|DIRECT THROMBIN INHIBITORS|B1E
72616|CARDIOVASCULAR SYSTEM|C
72615|ANTIEMETICS AND ANTINAUSEANTS|A4
72615|APPETITE STIMULANTS|A15
72615|ANALGESICS|N2
72613|RESPIRATORY SYSTEM|R
72612|OPHTHALMOLOGICALS|S1
72611|NOOTROPICS|N6D
72609|Ocular antineovascularisation products|S1P
72608|CARDIOVASCULAR SYSTEM|C
72605|CARDIOVASCULAR SYSTEM|C
72604|CENTRAL NERVOUS SYSTEM|N
72601|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
72600|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
72600|SSRI antidepressants|N6A4
72597|ANTIVIRALS FOR SYSTEMIC USE|J5
72593|RESPIRATORY SYSTEM|R
72592|ANALGESICS|N2
72590|ANTIVIRALS FOR SYSTEMIC USE|J5
72588|ALKYLATING AGENTS|L1A
72586|ANTIVIRALS FOR SYSTEMIC USE|J5
72584|SYSTEMIC ANTIBACTERIALS|J1
72584|ANTIVIRALS FOR SYSTEMIC USE|J5
72584|PARASITOLOGY|P
72576|ANTIVIRALS FOR SYSTEMIC USE|J5
72569|ANTIVIRALS FOR SYSTEMIC USE|J5
72567|ANTI-EPILEPTICS|N3
72559|NOOTROPICS|N6D
72551|ANTITUSSIVES|R5D
72550|DRUGS USED IN DIABETES|A10
72550|DPP-IV inhibitor antidiabetics|A10B6
72549|ANALGESICS|N2
72549|SSRI antidepressants|N6A4
72549|SRNI antidepressants|N6A5
72547|ANTI-MIGRAINE PREPARATIONS|N2C
72546|ANALGESICS|N2
72544|ANTIVIRALS FOR SYSTEMIC USE|J5
72537|SYSTEMIC ANTIBACTERIALS|J1
72536|WOUND HEALING AGENTS|D3
72528|IMMUNOSUPPRESSIVE AGENTS|L4
72523|SYSTEMIC ANTIBACTERIALS|J1
72521|ANTIVIRALS FOR SYSTEMIC USE|J5
72520|OPHTHALMOLOGICALS|S1
72519|Urinary incontinence products|G4B4
72518|ANALGESICS|N2
72514|NOOTROPICS|N6D
72511|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72510|ANTIVIRALS FOR SYSTEMIC USE|J5
72508|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72503|RESPIRATORY SYSTEM|R
72493|CARDIOVASCULAR SYSTEM|C
72493|RADIODIAGNOSTIC AGENTS|T1G
72491|RADIODIAGNOSTIC AGENTS|T1G
72490|ANTIVIRALS FOR SYSTEMIC USE|J5
72489|ANTIVIRALS FOR SYSTEMIC USE|J5
72484|ANTIVIRALS FOR SYSTEMIC USE|J5
72482|SYSTEMIC ANTIBACTERIALS|J1
72482|ANTIVIRALS FOR SYSTEMIC USE|J5
72480|ANTIVIRALS FOR SYSTEMIC USE|J5
72478|Coxibs|M1A3
72478|ANALGESICS|N2
72476|ANTIVIRALS FOR SYSTEMIC USE|J5
72475|SYSTEMIC ANTIBACTERIALS|J1
72472|MRI AGENTS|T1E
72464|CARDIAC THERAPY|C1
72458|ANTIPSYCHOTICS|N5A
72457|ANTI-EPILEPTICS|N3A
72455|ANTIVIRALS FOR SYSTEMIC USE|J5
72453|WOUND HEALING AGENTS|D3
72451|ANTIPROTOZOALS AND ANTHELMINTICS|P1
72450|ANTI-EPILEPTICS|N3A
72442|OPHTHALMOLOGICALS|S1
72438|IMMUNOSUPPRESSIVE AGENTS|L4
72436|PLATELET AGGREGATION INHIBITORS|B1C
72436|ANTIHYPERTENSIVES|C2
72435|CENTRAL NERVOUS SYSTEM|N
72435|ANTIPSYCHOTICS|N5A
72429|IMMUNOSUPPRESSIVE AGENTS|L4
72423|CARDIOVASCULAR SYSTEM|C
72416|DERMATOLOGICALS|D
72416|Ocular antineovascularisation products|S1P
72413|ANALGESICS|N2
72411|SYSTEMIC ANTIBACTERIALS|J1
72407|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
72407|Statins (HMG-CoA reductase inhibitors)|C10A1
72404|ANTIHYPERTENSIVES|C2
72402|HUMAN INSULINS AND ANALOGUES|A10C
72402|Human insulins and analogues, intermediate-acting|A10C2
72401|ANTI-EPILEPTICS|N3A
72398|ALKYLATING AGENTS|L1A
72396|ANTI-ACNE PREPARATIONS|D10
72395|ANALGESICS|N2
72394|ANALGESICS|N2
72392|PARASITOLOGY|P
72390|OPHTHALMOLOGICALS|S1
72389|ANALGESICS|N2
72388|ANTIVIRALS FOR SYSTEMIC USE|J5
72388|IMMUNOSTIMULATING AGENTS|L3
72387|ANTIVIRALS FOR SYSTEMIC USE|J5
72386|DRUGS USED IN DIABETES|A10
72386|PARASITOLOGY|P
72379|SYSTEMIC ANTIBACTERIALS|J1
72378|SYSTEMIC ANTIBACTERIALS|J1
72377|ANALGESICS|N2
72377|SSRI antidepressants|N6A4
72377|SRNI antidepressants|N6A5
72376|ANTIVIRALS FOR SYSTEMIC USE|J5
72373|PLATELET AGGREGATION INHIBITORS|B1C
72367|ANALGESICS|N2
72366|ANTIVIRALS FOR SYSTEMIC USE|J5
72365|CARDIOVASCULAR SYSTEM|C
72365|WOUND HEALING AGENTS|D3
72364|Non-nucleoside reverse transcriptase inhibitors|J5C3
72360|ANALGESICS|N2
72358|HUMAN INSULINS AND ANALOGUES|A10C
72358|Human insulins and analogues, intermediate-acting|A10C2
72357|DRUGS USED IN DIABETES|A10
72356|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72346|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72345|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72345|DRUGS USED IN DIABETES|A10
72343|ANTIVIRALS FOR SYSTEMIC USE|J5
72340|ANTI-EPILEPTICS|N3
72339|ANTI-EPILEPTICS|N3A
72338|ANTI-EPILEPTICS|N3A
72332|RESPIRATORY SYSTEM|R
72331|SYSTEMIC ANTIBACTERIALS|J1
72319|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
72313|SYSTEMIC ANTIBACTERIALS|J1
72312|SYSTEMIC ANTIBACTERIALS|J1
72311|ANTIVIRALS FOR SYSTEMIC USE|J5
72311|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
72308|ANTIPSYCHOTICS|N5A
72307|SYSTEMIC ANTIBACTERIALS|J1
72306|Interferons, gamma|L3B3
72305|SYSTEMIC ANTIBACTERIALS|J1
72297|ANTIVIRALS FOR SYSTEMIC USE|J5
72294|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
72293|ANTIVIRALS FOR SYSTEMIC USE|J5
72290|DIAGNOSTIC AGENTS|T
72289|ANALGESICS|N2
72288|ANTIVIRALS FOR SYSTEMIC USE|J5
72280|BPH (benign prostatic hypertrophy) products |G4C
72279|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
72279|Statins (HMG-CoA reductase inhibitors)|C10A1
72278|GROWTH HORMONES|H4C
72277|ANALGESICS|N2
72276|ANALGESICS|N2
72275|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
72272|ANALGESICS|N2
72271|ANALGESICS|N2
72271|ANTI-EPILEPTICS|N3A
72268|ANTIVIRALS FOR SYSTEMIC USE|J5
72267|ANTIVIRALS FOR SYSTEMIC USE|J5
72258|ANTIVIRALS FOR SYSTEMIC USE|J5
72256|ANTIPSYCHOTICS|N5A
72256|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
72256|SRNI antidepressants|N6A5
72255|WOUND HEALING AGENTS|D3
72253|WOUND HEALING AGENTS|D3
72252|WOUND HEALING AGENTS|D3
72251|WOUND HEALING AGENTS|D3
72249|WOUND HEALING AGENTS|D3
72247|DRUGS USED IN DIABETES|A10
72245|SYSTEMIC ANTIBACTERIALS|J1
72245|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
72245|PARASITOLOGY|P
72236|ANTIVIRALS FOR SYSTEMIC USE|J5
72236|IMMUNOSTIMULATING AGENTS|L3
72234|ANTIVIRALS FOR SYSTEMIC USE|J5
72232|ANALGESICS|N2
72221|IMMUNOSUPPRESSIVE AGENTS|L4
72214|OPHTHALMOLOGICALS|S1
72213|ANAESTHETICS, LOCAL|N1B
72213|ANALGESICS|N2
72212|SYSTEMIC ANTIBACTERIALS|J1
72209|ALKYLATING AGENTS|L1A
72208|SYSTEMIC ANTIBACTERIALS|J1
72204|DRUGS USED IN DIABETES|A10
72198|ANTIVIRALS FOR SYSTEMIC USE|J5
72197|DRUGS USED IN DIABETES|A10
72195|ANALGESICS|N2
72193|ANTI-MIGRAINE PREPARATIONS|N2C
72190|SYSTEMIC ANTIBACTERIALS|J1
72189|SYSTEMIC ANTIBACTERIALS|J1
72187|SYSTEMIC ANTIBACTERIALS|J1
72181|ANTIVIRALS FOR SYSTEMIC USE|J5
72174|WOUND HEALING AGENTS|D3
72174|MUSCULO-SKELETAL SYSTEM|M
72168|ANTIVIRALS FOR SYSTEMIC USE|J5
72167|OPHTHALMOLOGICALS|S1
72165|ANTIVIRALS FOR SYSTEMIC USE|J5
72164|SYSTEMIC ANTIBACTERIALS|J1
72163|SYSTEMIC ANTIBACTERIALS|J1
72162|SYSTEMIC ANTIBACTERIALS|J1
72161|SYSTEMIC ANTIBACTERIALS|J1
72160|SYSTEMIC ANTIBACTERIALS|J1
72159|RESPIRATORY SYSTEM|R
72156|OPHTHALMOLOGICALS|S1
72155|ANTIVIRALS FOR SYSTEMIC USE|J5
72153|ANTIVIRALS FOR SYSTEMIC USE|J5
72152|ANTIVIRALS FOR SYSTEMIC USE|J5
72149|DRUGS USED IN DIABETES|A10
72147|BETA-BLOCKING AGENTS|C7
72145|GASTROPROKINETICS|A3F
72140|ANTIVIRALS FOR SYSTEMIC USE|J5
72139|Factors II, VII, IX and X|B2D2
72138|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
72137|ANTIVIRALS FOR SYSTEMIC USE|J5
72136|ANTIVIRALS FOR SYSTEMIC USE|J5
72134|ANTIVIRALS FOR SYSTEMIC USE|J5
72132|IMMUNOSUPPRESSIVE AGENTS|L4
72127|SYSTEMIC ANTIBACTERIALS|J1
72126|ANALGESICS|N2
72125|IMMUNOSUPPRESSIVE AGENTS|L4
72124|ANALGESICS|N2
72123|ANTIVIRALS FOR SYSTEMIC USE|J5
72120|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72120|DRUGS USED IN DIABETES|A10
72119|ANTIHYPERTENSIVES|C2
72119|DIURETICS|C3
72115|CARDIOVASCULAR SYSTEM|C
72115|CENTRAL NERVOUS SYSTEM|N
72114|PLATELET AGGREGATION INHIBITORS|B1C
72114|CARDIOVASCULAR SYSTEM|C
72111|RADIODIAGNOSTIC AGENTS|T1G
72108|ANALGESICS|N2
72105|CARDIOVASCULAR SYSTEM|C
72102|ANTIVIRALS FOR SYSTEMIC USE|J5
72101|ANTIVIRALS FOR SYSTEMIC USE|J5
72097|ANTIVIRALS FOR SYSTEMIC USE|J5
72092|DRUGS USED IN DIABETES|A10
72091|ANALGESICS|N2
72090|SYSTEMIC ANTIBACTERIALS|J1
72090|CEPHALOSPORINS|J1D
72089|SYSTEMIC ANTIBACTERIALS|J1
72086|APPETITE STIMULANTS|A15
72086|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
72074|SYSTEMIC ANTIBACTERIALS|J1
72070|IMMUNOSUPPRESSIVE AGENTS|L4
72068|Factor VIII|B2D1
72067|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
72066|IMMUNOSTIMULATING AGENTS|L3
72061|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72053|ALKYLATING AGENTS|L1A
72052|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
72047|CARDIAC THERAPY|C1
72047|RADIODIAGNOSTIC AGENTS|T1G
72042|ANTIVIRALS FOR SYSTEMIC USE|J5
72040|SYSTEMIC ANTIBACTERIALS|J1
72039|MUSCULO-SKELETAL SYSTEM|M
72039|RESPIRATORY SYSTEM|R
72037|ANTIVIRALS FOR SYSTEMIC USE|J5
72037|IMMUNOSTIMULATING AGENTS|L3
72034|ANALGESICS|N2
72033|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72032|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
72032|DRUGS USED IN DIABETES|A10
72030|Coxibs|M1A3
72030|ANALGESICS|N2
72023|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
72020|GASTROPROKINETICS|A3F
72014|MUSCLE RELAXANTS|M3
72011|PARASITOLOGY|P
72008|ANALGESICS|N2
72008|ANTIPSYCHOTICS|N5A
72008|TRANQUILLISERS|N5C
72008|NOOTROPICS|N6D
72006|ANTI-MALARIALS|P1D
72004|PARASITOLOGY|P
72002|OPHTHALMOLOGICALS|S1
72002|Ocular antineovascularisation products|S1P
71991|RESPIRATORY SYSTEM|R
71988|Miotics and antiglaucoma preparations, systemic|S1E1
71987|ANALGESICS|N2
71985|PARASITOLOGY|P
71981|IMMUNOSTIMULATING AGENTS|L3
71977|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
71976|ANTIVIRALS FOR SYSTEMIC USE|J5
71964|RESPIRATORY SYSTEM|R
71960|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
71957|SYSTEMIC ANTIBACTERIALS|J1
71951|ANALGESICS|N2
71951|TRANQUILLISERS|N5C
71944|ANTIHYPERTENSIVES|C2
71943|DRUGS USED IN DIABETES|A10
71942|DRUGS USED IN DIABETES|A10
71941|DIAGNOSTIC AGENTS|T
71935|ANTIVIRALS FOR SYSTEMIC USE|J5
71935|IMMUNOSTIMULATING AGENTS|L3
71934|ANTIVIRALS FOR SYSTEMIC USE|J5
71934|IMMUNOSTIMULATING AGENTS|L3
71926|ANTIHYPERTENSIVES|C2
71926|DIURETICS|C3
71925|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
71920|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
71916|IMMUNOSTIMULATING AGENTS|L3
71915|ANALGESICS|N2
71912|ANTIHYPERTENSIVES|C2
71907|ANTIVIRALS FOR SYSTEMIC USE|J5
71906|WOUND HEALING AGENTS|D3
71903|NOOTROPICS|N6D
71902|SYSTEMIC ANTIBACTERIALS|J1
71899|SYSTEMIC ANTIBACTERIALS|J1
71898|ANTIHYPERTENSIVES|C2
71897|SYSTEMIC ANTIBACTERIALS|J1
71896|IMMUNOSUPPRESSIVE AGENTS|L4
71895|SYSTEMIC ANTIBACTERIALS|J1
71894|SYSTEMIC ANTIBACTERIALS|J1
71893|WOUND HEALING AGENTS|D3
71891|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
71889|OPHTHALMOLOGICAL ANTI-INFECTIVES|S1A
71888|OPHTHALMOLOGICAL ANTI-INFECTIVES|S1A
71887|RADIODIAGNOSTIC AGENTS|T1G
71886|ANTIVIRALS FOR SYSTEMIC USE|J5
71884|ANTIVIRALS FOR SYSTEMIC USE|J5
71882|ANALGESICS|N2
71880|ANTI-EPILEPTICS|N3A
71871|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71870|Interferons, alpha|L3B1
71868|ANTIHYPERTENSIVES|C2
71866|CARDIOVASCULAR SYSTEM|C
71866|CENTRAL NERVOUS SYSTEM|N
71864|ANTIVIRALS FOR SYSTEMIC USE|J5
71859|TRANQUILLISERS|N5C
71857|ANTIPSYCHOTICS|N5A
71856|ANTIPSYCHOTICS|N5A
71855|HYPNOTICS/SEDATIVES|N5B
71854|ANTI-EPILEPTICS|N3A
71853|ANALGESICS|N2
71852|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71847|ANTIHYPERTENSIVES|C2
71845|ANTIPSYCHOTICS|N5A
71845|TRANQUILLISERS|N5C
71845|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71845|SSRI antidepressants|N6A4
71841|ANALGESICS|N2
71837|ANTI-ACNE PREPARATIONS|D10
71836|SYSTEMIC ANTIBACTERIALS|J1
71831|WOUND HEALING AGENTS|D3
71825|ANTIVIRALS FOR SYSTEMIC USE|J5
71823|SYSTEMIC ANTIBACTERIALS|J1
71821|RADIODIAGNOSTIC AGENTS|T1G
71820|SYSTEMIC ANTIBACTERIALS|J1
71819|SYSTEMIC ANTIBACTERIALS|J1
71818|SYSTEMIC ANTIBACTERIALS|J1
71813|SYSTEMIC ANTIBACTERIALS|J1
71812|SYSTEMIC ANTIBACTERIALS|J1
71810|SYSTEMIC ANTIBACTERIALS|J1
71807|ANTI-ACNE PREPARATIONS|D10
71807|SYSTEMIC ANTIBACTERIALS|J1
71806|SYSTEMIC ANTIBACTERIALS|J1
71805|SYSTEMIC ANTIBACTERIALS|J1
71800|ANTIVIRALS FOR SYSTEMIC USE|J5
71792|CARDIOVASCULAR SYSTEM|C
71792|ANALGESICS|N2
71789|ANTIVIRALS FOR SYSTEMIC USE|J5
71787|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
71787|DRUGS USED IN DIABETES|A10
71786|DRUGS USED IN DIABETES|A10
71786|RADIODIAGNOSTIC AGENTS|T1G
71785|WOUND HEALING AGENTS|D3
71784|RADIODIAGNOSTIC AGENTS|T1G
71782|RESPIRATORY SYSTEM|R
71780|ANTIVIRALS FOR SYSTEMIC USE|J5
71779|ANTIVIRALS FOR SYSTEMIC USE|J5
71778|ANTIVIRALS FOR SYSTEMIC USE|J5
71775|ANTIVIRALS FOR SYSTEMIC USE|J5
71773|WOUND HEALING AGENTS|D3
71772|ANTIVIRALS FOR SYSTEMIC USE|J5
71771|ANTIVIRALS FOR SYSTEMIC USE|J5
71770|SSRI antidepressants|N6A4
71770|SRNI antidepressants|N6A5
71770|PSYCHOSTIMULANTS|N6B
71769|OPHTHALMOLOGICALS|S1
71768|IMMUNOSUPPRESSIVE AGENTS|L4
71767|ANAESTHETICS, LOCAL|N1B
71767|ANALGESICS|N2
71766|ANTI-EPILEPTICS|N3A
71764|ANALGESICS|N2
71763|ANALGESICS|N2
71757|IMMUNOSUPPRESSIVE AGENTS|L4
71756|ANTIPSYCHOTICS|N5A
71756|SSRI antidepressants|N6A4
71756|SRNI antidepressants|N6A5
71755|ANTIPSYCHOTICS|N5A
71755|SSRI antidepressants|N6A4
71755|SRNI antidepressants|N6A5
71754|ANTIPSYCHOTICS|N5A
71753|ANTIPSYCHOTICS|N5A
71751|CENTRAL NERVOUS SYSTEM|N
71747|NOOTROPICS|N6D
71744|ANALGESICS|N2
71743|SYSTEMIC ANTIBACTERIALS|J1
71742|SYSTEMIC ANTIBACTERIALS|J1
71741|SYSTEMIC ANTIBACTERIALS|J1
71740|SYSTEMIC ANTIBACTERIALS|J1
71735|ANTI-EPILEPTICS|N3A
71732|RADIODIAGNOSTIC AGENTS|T1G
71730|ANTIPSYCHOTICS|N5A
71725|ANALGESICS|N2
71725|ANTIPSYCHOTICS|N5A
71722|ANTI-EPILEPTICS|N3A
71722|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71721|ANTIPSYCHOTICS|N5A
71721|SRNI antidepressants|N6A5
71719|ANALGESICS|N2
71719|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71718|ANTIPSYCHOTICS|N5A
71718|SRNI antidepressants|N6A5
71717|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
71711|ANTIPSYCHOTICS|N5A
71711|SRNI antidepressants|N6A5
71708|ANALGESICS|N2
71706|SYSTEMIC ANTIBACTERIALS|J1
71706|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
71705|DERMATOLOGICALS|D
71700|SYSTEMIC ANTIBACTERIALS|J1
71699|SYSTEMIC ANTIBACTERIALS|J1
71698|SYSTEMIC ANTIBACTERIALS|J1
71697|DRUGS USED IN DIABETES|A10
71695|DRUGS USED IN DIABETES|A10
71694|DRUGS USED IN DIABETES|A10
71693|SYSTEMIC ANTIBACTERIALS|J1
71690|PARASITOLOGY|P
71689|Coxibs|M1A3
71689|ANALGESICS|N2
71689|SSRI antidepressants|N6A4
71689|SRNI antidepressants|N6A5
71686|RADIODIAGNOSTIC AGENTS|T1G
71684|RADIODIAGNOSTIC AGENTS|T1G
71682|DRUGS USED IN DIABETES|A10
71682|RADIODIAGNOSTIC AGENTS|T1G
71677|OPHTHALMOLOGICALS|S1
71671|WOUND HEALING AGENTS|D3
71667|SYSTEMIC ANTIBACTERIALS|J1
71665|RADIODIAGNOSTIC AGENTS|T1G
71664|RADIODIAGNOSTIC AGENTS|T1G
71662|RADIODIAGNOSTIC AGENTS|T1G
71661|RADIODIAGNOSTIC AGENTS|T1G
71659|RADIODIAGNOSTIC AGENTS|T1G
71656|SYSTEMIC ANTIBACTERIALS|J1
71653|RESPIRATORY SYSTEM|R
71651|ANALGESICS|N2
71651|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71649|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
71649|DRUGS USED IN DIABETES|A10
71648|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71648|SSRI antidepressants|N6A4
71646|SYSTEMIC ANTIBACTERIALS|J1
71644|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71644|SSRI antidepressants|N6A4
71644|SRNI antidepressants|N6A5
71643|ANALGESICS|N2
71643|SSRI antidepressants|N6A4
71643|SRNI antidepressants|N6A5
71642|ANALGESICS|N2
71638|CARDIOVASCULAR SYSTEM|C
71634|ANTIPSYCHOTICS|N5A
71625|Vitamin D|A11C2
71621|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
71616|Factors II, VII, IX and X|B2D2
71615|SYSTEMIC ANTIBACTERIALS|J1
71614|SYSTEMIC ANTIBACTERIALS|J1
71613|SYSTEMIC ANTIBACTERIALS|J1
71612|SYSTEMIC ANTIBACTERIALS|J1
71610|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
71609|ANTIVIRALS FOR SYSTEMIC USE|J5
71608|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
71606|ANTIPSYCHOTICS|N5A
71605|ANTIPSYCHOTICS|N5A
71601|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
71596|CARDIOVASCULAR SYSTEM|C
71595|SYSTEMIC ANTIBACTERIALS|J1
71594|ANTIHYPERTENSIVES|C2
71594|RESPIRATORY SYSTEM|R
71591|VACCINES|J7
71587|IMMUNOSTIMULATING AGENTS|L3
71582|IMMUNOSUPPRESSIVE AGENTS|L4
71581|Factors II, VII, IX and X|B2D2
71580|RADIODIAGNOSTIC AGENTS|T1G
71576|Interferons, beta|L3B2
71575|ANTI-ARRHYTHMICS|C1B
71574|THYROID THERAPY|H3
71572|ANTIVIRALS FOR SYSTEMIC USE|J5
71570|RESPIRATORY SYSTEM|R
71569|NOOTROPICS|N6D
71569|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
71567|ANTIVIRALS FOR SYSTEMIC USE|J5
71562|ANTIVIRALS FOR SYSTEMIC USE|J5
71561|ANTIVIRALS FOR SYSTEMIC USE|J5
71560|ANTIVIRALS FOR SYSTEMIC USE|J5
71556|ANTIVIRALS FOR SYSTEMIC USE|J5
71553|ANTIVIRALS FOR SYSTEMIC USE|J5
71551|IMMUNOSTIMULATING AGENTS|L3
71549|ANTIHYPERTENSIVES|C2
71549|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
71547|CARDIAC THERAPY|C1
71545|ANTIHYPERTENSIVES|C2
71545|CALCIUM ANTAGONISTS|C8
71545|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
71545|Statins (HMG-CoA reductase inhibitors)|C10A1
71544|ANTIVIRALS FOR SYSTEMIC USE|J5
71544|Interferons, alpha|L3B1
71537|IMMUNOSTIMULATING AGENTS|L3
71534|ANTIVIRALS FOR SYSTEMIC USE|J5
71534|Interferons, alpha|L3B1
71532|ANALGESICS|N2
71531|ANALGESICS|N2
71518|IMMUNOSUPPRESSIVE AGENTS|L4
71517|Ocular antineovascularisation products|S1P
71515|TRANQUILLISERS|N5C
71509|ANTIVIRALS FOR SYSTEMIC USE|J5
71504|NOOTROPICS|N6D
71499|ANTIHYPERTENSIVES|C2
71495|SYSTEMIC ANTIBACTERIALS|J1
71492|ANTIVIRALS FOR SYSTEMIC USE|J5
71491|ANTIVIRALS FOR SYSTEMIC USE|J5
71489|DRUGS USED IN DIABETES|A10
71488|IMMUNOSTIMULATING AGENTS|L3
71475|ANTIPROTOZOALS AND ANTHELMINTICS|P1
71474|Ocular antineovascularisation products|S1P
71472|DRUGS USED IN DIABETES|A10
71471|RESPIRATORY SYSTEM|R
71470|ANTIPSYCHOTICS|N5A
71469|ANTIVIRALS FOR SYSTEMIC USE|J5
71469|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
71456|DRUGS USED IN DIABETES|A10
71452|WOUND HEALING AGENTS|D3
71449|SYSTEMIC ANTIBACTERIALS|J1
71447|ANTI-EPILEPTICS|N3A
71446|ANTIVIRALS FOR SYSTEMIC USE|J5
71440|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
71434|Ocular antineovascularisation products|S1P
71433|SYSTEMIC ANTIBACTERIALS|J1
71431|ANTIHYPERTENSIVES|C2
71430|SYSTEMIC ANTIBACTERIALS|J1
71425|ANTIPROTOZOALS AND ANTHELMINTICS|P1
71418|ANTIPROTOZOALS AND ANTHELMINTICS|P1
71418|ANTI-MALARIALS|P1D
71412|GASTROPROKINETICS|A3F
71411|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
71410|RESPIRATORY SYSTEM|R
71409|ANTIVIRALS FOR SYSTEMIC USE|J5
71408|OPHTHALMOLOGICALS|S1
71408|Ocular antineovascularisation products|S1P
71407|ANTIVIRALS FOR SYSTEMIC USE|J5
71400|SYSTEMIC ANTIBACTERIALS|J1
71399|ANTIVIRALS FOR SYSTEMIC USE|J5
71398|ANTIVIRALS FOR SYSTEMIC USE|J5
71397|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
71392|PLATELET AGGREGATION INHIBITORS|B1C
71391|ANTIVIRALS FOR SYSTEMIC USE|J5
71390|PLATELET AGGREGATION INHIBITORS|B1C
71388|Vitamin E, plain|A11X3
71387|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
71387|ANTIVIRALS FOR SYSTEMIC USE|J5
71384|PLATELET AGGREGATION INHIBITORS|B1C
71382|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
71381|PLATELET AGGREGATION INHIBITORS|B1C
71380|ANTIVIRALS FOR SYSTEMIC USE|J5
71379|ANTI-MALARIALS|P1D
71377|PARASITOLOGY|P
71377|ANTI-MALARIALS|P1D
71375|NOOTROPICS|N6D
71375|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
71374|SYSTEMIC ANTIBACTERIALS|J1
71373|OPHTHALMOLOGICALS|S1
71369|SYSTEMIC ANTIBACTERIALS|J1
71368|IMMUNOSUPPRESSIVE AGENTS|L4
71363|OPHTHALMOLOGICALS|S1
71361|SYSTEMIC ANTIBACTERIALS|J1
71359|IMMUNOSTIMULATING AGENTS|L3
71358|ANALGESICS|N2
71355|ANTIVIRALS FOR SYSTEMIC USE|J5
71350|RESPIRATORY SYSTEM|R
71348|OPHTHALMOLOGICALS|S1
71346|ANTIVIRALS FOR SYSTEMIC USE|J5
71342|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71342|SSRI antidepressants|N6A4
71341|ANTIVIRALS FOR SYSTEMIC USE|J5
71335|Factor VIII|B2D1
71332|PARASITOLOGY|P
71331|ANTIVIRALS FOR SYSTEMIC USE|J5
71324|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
71320|ANTIVIRALS FOR SYSTEMIC USE|J5
71319|ANTIVIRALS FOR SYSTEMIC USE|J5
71319|RESPIRATORY SYSTEM|R
71317|RESPIRATORY SYSTEM|R
71316|ANTIHYPERTENSIVES|C2
71316|RESPIRATORY SYSTEM|R
71315|GLUCAGON|H4B
71314|PARASITOLOGY|P
71313|SYSTEMIC ANTIBACTERIALS|J1
71313|RESPIRATORY SYSTEM|R
71312|OPHTHALMOLOGICALS|S1
71311|SYSTEMIC ANTIBACTERIALS|J1
71311|RESPIRATORY SYSTEM|R
71308|DRUGS USED IN DIABETES|A10
71308|HUMAN INSULINS AND ANALOGUES|A10C
71308|Human insulins and analogues, long-acting|A10C5
71307|IMMUNOSUPPRESSIVE AGENTS|L4
71306|RESPIRATORY SYSTEM|R
71304|SYSTEMIC ANTIBACTERIALS|J1
71304|RESPIRATORY SYSTEM|R
71303|SYSTEMIC ANTIBACTERIALS|J1
71303|RESPIRATORY SYSTEM|R
71301|CARDIOVASCULAR SYSTEM|C
71301|CENTRAL NERVOUS SYSTEM|N
71300|ANTIPROTOZOALS AND ANTHELMINTICS|P1
71300|ANTI-MALARIALS|P1D
71299|ANTIVIRALS FOR SYSTEMIC USE|J5
71296|GROWTH HORMONES|H4C
71295|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
71294|ANTIVIRALS FOR SYSTEMIC USE|J5
71293|OPHTHALMOLOGICALS|S1
71292|ANTI-EPILEPTICS|N3
71290|Ocular antineovascularisation products|S1P
71288|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
71288|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
71287|ANTI-EPILEPTICS|N3
71286|SYSTEMIC ANTIBACTERIALS|J1
71286|MACROLIDES AND SIMILAR TYPES|J1F
71284|WOUND HEALING AGENTS|D3
71282|IMMUNOSUPPRESSIVE AGENTS|L4
71276|SYSTEMIC ANTIBACTERIALS|J1
71276|ANTIVIRALS FOR SYSTEMIC USE|J5
71275|SYSTEMIC ANTIBACTERIALS|J1
71275|ANTIVIRALS FOR SYSTEMIC USE|J5
71274|SYSTEMIC ANTIBACTERIALS|J1
71274|ANTIVIRALS FOR SYSTEMIC USE|J5
71274|OPHTHALMOLOGICALS|S1
71273|SYSTEMIC ANTIBACTERIALS|J1
71271|SYSTEMIC ANTIBACTERIALS|J1
71264|ANTIHYPERTENSIVES|C2
71261|SYSTEMIC ANTIBACTERIALS|J1
71260|SYSTEMIC ANTIBACTERIALS|J1
71259|ANTIVIRALS FOR SYSTEMIC USE|J5
71258|ANTIVIRALS FOR SYSTEMIC USE|J5
71249|NOOTROPICS|N6D
71248|OPHTHALMOLOGICALS|S1
71244|GASTROPROKINETICS|A3F
71238|ANALGESICS|N2
71237|ANTIHYPERTENSIVES|C2
71237|ANALGESICS|N2
71237|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71237|NOOTROPICS|N6D
71236|WOUND HEALING AGENTS|D3
71236|OPHTHALMOLOGICALS|S1
71235|OPHTHALMOLOGICALS|S1
71231|WOUND HEALING AGENTS|D3
71229|RESPIRATORY SYSTEM|R
71228|ANTIPSYCHOTICS|N5A
71225|ANTIVIRALS FOR SYSTEMIC USE|J5
71225|EXPECTORANTS|R5C
71225|ANTITUSSIVES|R5D
71219|CARDIOVASCULAR SYSTEM|C
71218|CARDIOVASCULAR SYSTEM|C
71216|ANALGESICS|N2
71215|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
71215|ANALGESICS|N2
71214|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
71214|ANALGESICS|N2
71213|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
71212|OPHTHALMOLOGICALS|S1
71208|OPHTHALMOLOGICALS|S1
71208|Ocular antineovascularisation products|S1P
71207|OPHTHALMOLOGICALS|S1
71204|SYSTEMIC ANTIBACTERIALS|J1
71203|OPHTHALMOLOGICALS|S1
71201|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
71201|DRUGS USED IN DIABETES|A10
71196|Coxibs|M1A3
71196|ANALGESICS|N2
71194|ANALGESICS|N2
71187|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
71180|ANTIVIRALS FOR SYSTEMIC USE|J5
71180|IMMUNOSTIMULATING AGENTS|L3
71179|IMMUNOSUPPRESSIVE AGENTS|L4
71177|ANTI-EPILEPTICS|N3A
71171|ANTIHYPERTENSIVES|C2
71171|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
71169|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
71168|ANALGESICS|N2
71165|PARASITOLOGY|P
71163|ANTIVIRALS FOR SYSTEMIC USE|J5
71162|RADIODIAGNOSTIC AGENTS|T1G
71161|RADIODIAGNOSTIC AGENTS|T1G
71157|ANALGESICS|N2
71156|IMMUNOSUPPRESSIVE AGENTS|L4
71155|IMMUNOSTIMULATING AGENTS|L3
71152|CENTRAL NERVOUS SYSTEM|N
71152|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
71144|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
71144|DRUGS USED IN DIABETES|A10
71144|ANTIHYPERTENSIVES|C2
71143|ANTI-EPILEPTICS|N3A
71141|NOOTROPICS|N6D
71140|NOOTROPICS|N6D
71139|ANTIVIRALS FOR SYSTEMIC USE|J5
71139|VACCINES|J7
71138|WOUND HEALING AGENTS|D3
71137|RADIODIAGNOSTIC AGENTS|T1G
71136|DRUGS USED IN DIABETES|A10
71136|HUMAN INSULINS AND ANALOGUES|A10C
71136|Human insulins and analogues, intermediate-acting|A10C2
71128|Interferons, alpha|L3B1
71127|SYSTEMIC ANTIBACTERIALS|J1
71115|SYSTEMIC ANTIBACTERIALS|J1
71112|PLATELET AGGREGATION INHIBITORS|B1C
71112|Coxibs|M1A3
71111|Coxibs|M1A3
71108|SYSTEMIC ANTIBACTERIALS|J1
71104|Coxibs|M1A3
71103|ANTIVIRALS FOR SYSTEMIC USE|J5
71102|Coxibs|M1A3
71100|IMMUNOSTIMULATING AGENTS|L3
71100|RESPIRATORY SYSTEM|R
71097|NOOTROPICS|N6D
71091|GASTROPROKINETICS|A3F
71088|ANTIVIRALS FOR SYSTEMIC USE|J5
71082|SYSTEMIC ANTIBACTERIALS|J1
71081|ANALGESICS|N2
71081|SRNI antidepressants|N6A5
71077|ANALGESICS|N2
71077|SRNI antidepressants|N6A5
71076|ANALGESICS|N2
71076|SRNI antidepressants|N6A5
71075|ANALGESICS|N2
71074|ANALGESICS|N2
71073|ANALGESICS|N2
71072|SYSTEMIC ANTIBACTERIALS|J1
71071|ANALGESICS|N2
71070|ANALGESICS|N2
71069|ANALGESICS|N2
71067|PSYCHOSTIMULANTS|N6B
71064|ANALGESICS|N2
71063|ANALGESICS|N2
71061|ANALGESICS|N2
71060|ANALGESICS|N2
71056|PARASITOLOGY|P
71054|NOOTROPICS|N6D
71052|ANTI-MALARIALS|P1D
71051|GASTROPROKINETICS|A3F
71050|IMMUNOSUPPRESSIVE AGENTS|L4
71048|ANALGESICS|N2
71045|ANALGESICS|N2
71044|ANALGESICS|N2
71043|ANALGESICS|N2
71039|DERMATOLOGICALS|D
71039|IMMUNOSUPPRESSIVE AGENTS|L4
71037|SYSTEMIC ANTIBACTERIALS|J1
71036|SYSTEMIC ANTIBACTERIALS|J1
71035|ANALGESICS|N2
71033|ANALGESICS|N2
71032|ANTI-MALARIALS|P1D
71027|ANTIVIRALS FOR SYSTEMIC USE|J5
71021|ANALGESICS|N2
71019|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
71019|NOOTROPICS|N6D
71018|ANALGESICS|N2
71013|DRUGS USED IN DIABETES|A10
71013|HUMAN INSULINS AND ANALOGUES|A10C
71013|Human insulins and analogues, long-acting|A10C5
71011|ANTI-MALARIALS|P1D
71009|IMMUNOSTIMULATING AGENTS|L3
71006|SYSTEMIC ANTIBACTERIALS|J1
71004|ANTI-EPILEPTICS|N3
70997|GROWTH HORMONES|H4C
70996|DRUGS USED IN DIABETES|A10
70996|HUMAN INSULINS AND ANALOGUES|A10C
70996|Human insulins and analogues, intermediate-acting|A10C2
70992|CALCITONINS|H4A
70992|ANALGESICS|N2
70991|OPHTHALMOLOGICALS|S1
70988|OPHTHALMOLOGICALS|S1
70987|PARASITOLOGY|P
70985|RADIODIAGNOSTIC AGENTS|T1G
70984|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
70982|ANTI-MALARIALS|P1D
70978|SYSTEMIC ANTIBACTERIALS|J1
70970|ANTI-ACNE PREPARATIONS|D10
70970|SYSTEMIC ANTIBACTERIALS|J1
70969|SYSTEMIC ANTIBACTERIALS|J1
70952|SYSTEMIC ANTIBACTERIALS|J1
70946|CENTRAL NERVOUS SYSTEM|N
70945|CENTRAL NERVOUS SYSTEM|N
70938|SYSTEMIC ANTIBACTERIALS|J1
70937|CALCIUM ANTAGONISTS|C8
70936|ANTIVIRALS FOR SYSTEMIC USE|J5
70934|SYSTEMIC ANTIBACTERIALS|J1
70930|PLATELET AGGREGATION INHIBITORS|B1C
70926|ANTIHYPERTENSIVES|C2
70926|BETA-BLOCKING AGENTS|C7
70919|ANTIVIRALS FOR SYSTEMIC USE|J5
70919|Interferons, alpha|L3B1
70916|PARASITOLOGY|P
70916|ANTI-MALARIALS|P1D
70915|ANTIVIRALS FOR SYSTEMIC USE|J5
70912|ANTIVIRALS FOR SYSTEMIC USE|J5
70910|ANALGESICS|N2
70909|ANTIVIRALS FOR SYSTEMIC USE|J5
70906|SYSTEMIC ANTIBACTERIALS|J1
70901|SYSTEMIC ANTIBACTERIALS|J1
70900|ANTIVIRALS FOR SYSTEMIC USE|J5
70897|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70896|ANTIVIRALS FOR SYSTEMIC USE|J5
70893|CARDIOVASCULAR SYSTEM|C
70892|CARDIOVASCULAR SYSTEM|C
70890|CARDIOVASCULAR SYSTEM|C
70887|SYSTEMIC ANTIBACTERIALS|J1
70886|SYSTEMIC ANTIBACTERIALS|J1
70885|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70885|DRUGS USED IN DIABETES|A10
70883|Urinary incontinence products|G4B4
70883|ANALGESICS|N2
70882|NOOTROPICS|N6D
70880|ANALGESICS|N2
70879|NOOTROPICS|N6D
70875|PARASITOLOGY|P
70875|ANTIPROTOZOALS AND ANTHELMINTICS|P1
70875|ANTI-MALARIALS|P1D
70873|HYPNOTICS/SEDATIVES|N5B
70871|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
70870|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
70869|WOUND HEALING AGENTS|D3
70868|SYSTEMIC ANTIBACTERIALS|J1
70866|RESPIRATORY SYSTEM|R
70862|ANALGESICS|N2
70859|WOUND HEALING AGENTS|D3
70858|CARDIOVASCULAR SYSTEM|C
70858|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
70857|ANTIVIRALS FOR SYSTEMIC USE|J5
70856|ANAESTHETICS, GENERAL|N1A
70856|HYPNOTICS/SEDATIVES|N5B
70853|ANTHELMINTICS, EXCLUDING SCHISTOSOMICIDES|P1B
70850|ANTIPSYCHOTICS|N5A
70849|SYSTEMIC ANTIBACTERIALS|J1
70847|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
70844|ANTIVIRALS FOR SYSTEMIC USE|J5
70841|NOOTROPICS|N6D
70840|SYSTEMIC ANTIBACTERIALS|J1
70838|SYSTEMIC ANTIBACTERIALS|J1
70836|SYSTEMIC ANTIBACTERIALS|J1
70836|PARASITOLOGY|P
70835|IMMUNOSUPPRESSIVE AGENTS|L4
70834|PARASITOLOGY|P
70834|ANTIPROTOZOALS AND ANTHELMINTICS|P1
70834|ANTI-MALARIALS|P1D
70832|ANALGESICS|N2
70829|SYSTEMIC ANTIBACTERIALS|J1
70827|SYSTEMIC ANTIBACTERIALS|J1
70825|PLATELET AGGREGATION INHIBITORS|B1C
70816|ANTIVIRALS FOR SYSTEMIC USE|J5
70803|ANTI-ACNE PREPARATIONS|D10
70803|TOPICAL ANTI-ACNE PREPARATIONS|D10A
70802|ANALGESICS|N2
70802|SRNI antidepressants|N6A5
70800|ANALGESICS|N2
70799|CARDIOVASCULAR SYSTEM|C
70799|ANALGESICS|N2
70797|ANTIVIRALS FOR SYSTEMIC USE|J5
70795|VACCINES|J7
70789|ANALGESICS|N2
70789|ANTI-MIGRAINE PREPARATIONS|N2C
70788|PARASITOLOGY|P
70787|MACROLIDES AND SIMILAR TYPES|J1F
70785|NOOTROPICS|N6D
70784|PARASITOLOGY|P
70780|NOOTROPICS|N6D
70779|CALCIUM ANTAGONISTS|C8
70777|CALCIUM ANTAGONISTS|C8
70776|NOOTROPICS|N6D
70772|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
70767|NOOTROPICS|N6D
70766|NOOTROPICS|N6D
70765|NOOTROPICS|N6D
70763|SYSTEMIC ANTIBACTERIALS|J1
70762|ANTIVIRALS FOR SYSTEMIC USE|J5
70759|SYSTEMIC ANTIBACTERIALS|J1
70755|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
70754|CARDIOVASCULAR SYSTEM|C
70753|IMMUNOSTIMULATING AGENTS|L3
70751|PARASITOLOGY|P
70749|ANTIPROTOZOALS AND ANTHELMINTICS|P1
70743|ANALGESICS|N2
70740|PARASITOLOGY|P
70736|PARASITOLOGY|P
70733|Ocular antineovascularisation products|S1P
70729|ANTIHYPERTENSIVES|C2
70729|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
70728|DRUGS USED IN DIABETES|A10
70726|ANTIHYPERTENSIVES|C2
70725|ANTI-ACNE PREPARATIONS|D10
70724|ANTI-MIGRAINE PREPARATIONS|N2C
70723|ANALGESICS|N2
70722|ANALGESICS|N2
70720|ANALGESICS|N2
70715|ANTIVIRALS FOR SYSTEMIC USE|J5
70712|RESPIRATORY SYSTEM|R
70709|ANTIHYPERTENSIVES|C2
70709|BETA-BLOCKING AGENTS|C7
70709|Miotics and antiglaucoma preparations, topical|S1E2
70705|PARASITOLOGY|P
70705|ANTI-MALARIALS|P1D
70699|PARASITOLOGY|P
70691|ANALGESICS|N2
70690|PARASITOLOGY|P
70689|ANALGESICS|N2
70685|Interferons, alpha|L3B1
70680|ANTIVIRALS FOR SYSTEMIC USE|J5
70674|ANTIVIRALS FOR SYSTEMIC USE|J5
70669|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70655|NOOTROPICS|N6D
70653|ANTIHYPERTENSIVES|C2
70652|ANTIVIRALS FOR SYSTEMIC USE|J5
70651|Antigonadotrophin-releasing hormones|H1C3
70650|PARASITOLOGY|P
70649|PARASITOLOGY|P
70647|PARASITOLOGY|P
70647|ANTI-MALARIALS|P1D
70645|ANTIPROTOZOALS AND ANTHELMINTICS|P1
70645|ANTI-MALARIALS|P1D
70643|ANALGESICS|N2
70640|RESPIRATORY SYSTEM|R
70639|PARASITOLOGY|P
70638|OPHTHALMOLOGICALS|S1
70636|RESPIRATORY SYSTEM|R
70634|IMMUNOSTIMULATING AGENTS|L3
70632|ANTI-ACNE PREPARATIONS|D10
70632|ANALGESICS|N2
70632|ANTI-MIGRAINE PREPARATIONS|N2C
70630|NOOTROPICS|N6D
70630|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
70627|RADIODIAGNOSTIC AGENTS|T1G
70624|ANALGESICS|N2
70620|ANTIVIRALS FOR SYSTEMIC USE|J5
70614|ANTIVIRALS FOR SYSTEMIC USE|J5
70612|ANALGESICS|N2
70610|MUSCLE RELAXANTS|M3
70607|RESPIRATORY SYSTEM|R
70604|ANTIVIRALS FOR SYSTEMIC USE|J5
70590|ANTI-EPILEPTICS|N3A
70587|ANTI-ARRHYTHMICS|C1B
70586|DRUGS USED IN DIABETES|A10
70585|SYSTEMIC ANTIBACTERIALS|J1
70584|ANTI-EPILEPTICS|N3A
70581|SYSTEMIC ANTIBACTERIALS|J1
70579|SYSTEMIC ANTIBACTERIALS|J1
70578|PARASITOLOGY|P
70576|SYSTEMIC ANTIBACTERIALS|J1
70575|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
70573|ANALGESICS|N2
70572|Miotics and antiglaucoma preparations, topical|S1E2
70570|ANALGESICS|N2
70567|SYSTEMIC ANTIBACTERIALS|J1
70564|IMMUNOSUPPRESSIVE AGENTS|L4
70563|MUSCLE RELAXANTS|M3
70563|ANALGESICS|N2
70561|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
70556|DRUGS USED IN DIABETES|A10
70554|ANTIVIRALS FOR SYSTEMIC USE|J5
70551|ANTIVIRALS FOR SYSTEMIC USE|J5
70551|Non-nucleoside reverse transcriptase inhibitors|J5C3
70549|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
70548|DIAGNOSTIC AGENTS|T
70545|DRUGS USED IN DIABETES|A10
70545|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
70543|PARASITOLOGY|P
70529|ANTI-GOUT PREPARATIONS|M4
70529|ANALGESICS|N2
70525|ANTIHYPERTENSIVES|C2
70525|DIURETICS|C3
70525|CALCIUM ANTAGONISTS|C8
70525|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
70516|ANALGESICS|N2
70511|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
70510|Human insulins and analogues, fast-acting|A10C1
70507|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
70506|PARASITOLOGY|P
70503|ANTIVIRALS FOR SYSTEMIC USE|J5
70499|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
70498|RESPIRATORY SYSTEM|R
70497|RESPIRATORY SYSTEM|R
70486|SYSTEMIC ANTIBACTERIALS|J1
70484|SYSTEMIC ANTIBACTERIALS|J1
70481|PLATELET AGGREGATION INHIBITORS|B1C
70480|PLATELET AGGREGATION INHIBITORS|B1C
70479|ANTIVIRALS FOR SYSTEMIC USE|J5
70471|WOUND HEALING AGENTS|D3
70470|ANALGESICS|N2
70469|ANALGESICS|N2
70465|ANTI-EPILEPTICS|N3
70463|ANTIVIRALS FOR SYSTEMIC USE|J5
70462|ANTIPSYCHOTICS|N5A
70462|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
70461|ANALGESICS|N2
70454|OPHTHALMOLOGICALS|S1
70451|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70451|DRUGS USED IN DIABETES|A10
70450|SYSTEMIC ANTIBACTERIALS|J1
70446|NOOTROPICS|N6D
70444|ANTIVIRALS FOR SYSTEMIC USE|J5
70439|IMMUNOSUPPRESSIVE AGENTS|L4
70435|ANALGESICS|N2
70432|ANALGESICS|N2
70426|GASTROPROKINETICS|A3F
70425|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
70425|Statins (HMG-CoA reductase inhibitors)|C10A1
70424|ANALGESICS|N2
70419|DERMATOLOGICALS|D
70415|ALKYLATING AGENTS|L1A
70414|ANTIVIRALS FOR SYSTEMIC USE|J5
70409|MUSCULO-SKELETAL SYSTEM|M
70408|ANALGESICS|N2
70406|ANTIVIRALS FOR SYSTEMIC USE|J5
70402|SYSTEMIC ANTIBACTERIALS|J1
70401|ANTIVIRALS FOR SYSTEMIC USE|J5
70399|CARDIOVASCULAR SYSTEM|C
70399|ACE INHIBITORS, PLAIN|C9A
70391|Urinary incontinence products|G4B4
70391|BPH (benign prostatic hypertrophy) products |G4C
70373|ANTIVIRALS FOR SYSTEMIC USE|J5
70369|CARDIOVASCULAR SYSTEM|C
70367|RESPIRATORY SYSTEM|R
70365|ANTIVIRALS FOR SYSTEMIC USE|J5
70359|VACCINES|J7
70358|ANTIVIRALS FOR SYSTEMIC USE|J5
70358|IMMUNOSTIMULATING AGENTS|L3
70356|CALCIUM ANTAGONISTS|C8
70355|ANTIEMETICS AND ANTINAUSEANTS|A4
70355|ANALGESICS|N2
70355|ANTI-MIGRAINE PREPARATIONS|N2C
70351|Ocular antineovascularisation products|S1P
70350|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
70342|ANTIHYPERTENSIVES|C2
70342|DIURETICS|C3
70342|ACE INHIBITORS, PLAIN|C9A
70341|ANTIHYPERTENSIVES|C2
70341|DIURETICS|C3
70341|ACE INHIBITORS, PLAIN|C9A
70340|ANTIHYPERTENSIVES|C2
70340|DIURETICS|C3
70340|ACE INHIBITORS, PLAIN|C9A
70339|MRI AGENTS|T1E
70339|RADIODIAGNOSTIC AGENTS|T1G
70338|ANTIHYPERTENSIVES|C2
70338|DIURETICS|C3
70337|ANTIHYPERTENSIVES|C2
70337|DIURETICS|C3
70337|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
70334|ANTIHYPERTENSIVES|C2
70334|DIURETICS|C3
70332|ANTIHYPERTENSIVES|C2
70332|DIURETICS|C3
70330|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70330|NOOTROPICS|N6D
70329|CARDIOVASCULAR SYSTEM|C
70326|RADIODIAGNOSTIC AGENTS|T1G
70325|ANTIVIRALS FOR SYSTEMIC USE|J5
70324|ANTI-EPILEPTICS|N3
70323|DERMATOLOGICALS|D
70323|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
70319|SYSTEMIC ANTIBACTERIALS|J1
70302|ANTIVIRALS FOR SYSTEMIC USE|J5
70302|ANTI-EPILEPTICS|N3
70298|ANALGESICS|N2
70296|OPHTHALMOLOGICALS|S1
70295|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
70294|ANTI-EPILEPTICS|N3A
70294|NOOTROPICS|N6D
70293|DRUGS USED IN DIABETES|A10
70292|ANTIULCERANTS|A2B
70291|Ocular antineovascularisation products|S1P
70290|NOOTROPICS|N6D
70288|OPHTHALMOLOGICALS|S1
70287|CARDIAC THERAPY|C1
70286|OPHTHALMOLOGICALS|S1
70283|PSYCHOSTIMULANTS|N6B
70282|ANALGESICS|N2
70279|B2-STIMULANTS|R3A
70273|ANTI-GOUT PREPARATIONS|M4
70269|WOUND HEALING AGENTS|D3
70265|Vitamin A|A11C1
70263|OPHTHALMOLOGICALS|S1
70260|Coxibs|M1A3
70260|ANALGESICS|N2
70259|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
70255|ANTIVIRALS FOR SYSTEMIC USE|J5
70247|RESPIRATORY SYSTEM|R
70243|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70243|DRUGS USED IN DIABETES|A10
70242|ANTIVIRALS FOR SYSTEMIC USE|J5
70235|ANTIPSYCHOTICS|N5A
70229|ANTIVIRALS FOR SYSTEMIC USE|J5
70228|ANTIHYPERTENSIVES|C2
70228|DIURETICS|C3
70228|CALCIUM ANTAGONISTS|C8
70221|SYSTEMIC ANTIBACTERIALS|J1
70208|SYSTEMIC ANTIBACTERIALS|J1
70203|PARASITOLOGY|P
70203|ANTI-MALARIALS|P1D
70202|ANALGESICS|N2
70200|ANALGESICS|N2
70200|TRANQUILLISERS|N5C
70200|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
70199|ANALGESICS|N2
70199|TRANQUILLISERS|N5C
70199|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
70198|ANALGESICS|N2
70191|SYSTEMIC ANTIBACTERIALS|J1
70191|Carbapenems|J1P2
70190|ANALGESICS|N2
70189|NOOTROPICS|N6D
70175|SYSTEMIC ANTIBACTERIALS|J1
70174|SYSTEMIC ANTIBACTERIALS|J1
70172|Ocular antineovascularisation products|S1P
70170|ANALGESICS|N2
70167|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
70167|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
70164|SYSTEMIC ANTIBACTERIALS|J1
70161|MUSCULO-SKELETAL SYSTEM|M
70160|IMMUNOSTIMULATING AGENTS|L3
70155|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70152|SYSTEMIC ANTIBACTERIALS|J1
70151|RADIODIAGNOSTIC AGENTS|T1G
70144|IMMUNOSTIMULATING AGENTS|L3
70143|B2-STIMULANTS|R3A
70142|SYSTEMIC ANTIBACTERIALS|J1
70140|ANALGESICS|N2
70135|SYSTEMIC ANTIBACTERIALS|J1
70135|PARASITOLOGY|P
70135|ANTI-MALARIALS|P1D
70134|OPHTHALMOLOGICALS|S1
70133|Vitamin E, plain|A11X3
70133|ANTI-EPILEPTICS|N3A
70132|Ocular antineovascularisation products|S1P
70131|B2-STIMULANTS|R3A
70129|SYSTEMIC ANTIBACTERIALS|J1
70129|IMMUNOSTIMULATING AGENTS|L3
70128|NOOTROPICS|N6D
70127|OPHTHALMOLOGICALS|S1
70121|ANTIVIRALS FOR SYSTEMIC USE|J5
70120|ANTIVIRALS FOR SYSTEMIC USE|J5
70118|WOUND HEALING AGENTS|D3
70117|ANTIVIRALS FOR SYSTEMIC USE|J5
70114|RADIODIAGNOSTIC AGENTS|T1G
70111|ANALGESICS|N2
70110|ANALGESICS|N2
70102|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70102|CARDIOVASCULAR SYSTEM|C
70100|SYSTEMIC ANTIBACTERIALS|J1
70099|SYSTEMIC ANTIBACTERIALS|J1
70099|OPHTHALMOLOGICALS|S1
70097|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70096|OPHTHALMOLOGICALS|S1
70093|CENTRAL NERVOUS SYSTEM|N
70091|ANTIPSYCHOTICS|N5A
70089|CARDIOVASCULAR SYSTEM|C
70088|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
70085|ANTIVIRALS FOR SYSTEMIC USE|J5
70081|ANTIVIRALS FOR SYSTEMIC USE|J5
70074|NOOTROPICS|N6D
70073|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70068|SYSTEMIC ANTIBACTERIALS|J1
70065|ANTI-ACNE PREPARATIONS|D10
70065|SYSTEMIC ANTIBACTERIALS|J1
70064|B2-STIMULANTS|R3A
70055|NOOTROPICS|N6D
70054|ANTIPSYCHOTICS|N5A
70052|ANTIPSYCHOTICS|N5A
70051|ANTI-EPILEPTICS|N3A
70049|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70049|DRUGS USED IN DIABETES|A10
70045|ANTIHYPERTENSIVES|C2
70045|CALCIUM ANTAGONISTS|C8
70045|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
70042|SYSTEMIC ANTIBACTERIALS|J1
70039|ANTI-EPILEPTICS|N3A
70038|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70038|DRUGS USED IN DIABETES|A10
70033|SYSTEMIC ANTIBACTERIALS|J1
70029|ANTIPROTOZOALS AND ANTHELMINTICS|P1
70026|SYSTEMIC ANTIBACTERIALS|J1
70020|HYPNOTICS/SEDATIVES|N5B
70019|SYSTEMIC ANTIBACTERIALS|J1
70014|Factor VIII|B2D1
70013|ANTIPSYCHOTICS|N5A
70008|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
70008|NOOTROPICS|N6D
70007|ANALGESICS|N2
70005|SYSTEMIC ANTIBACTERIALS|J1
70002|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
70001|ANTIVIRALS FOR SYSTEMIC USE|J5
69998|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69998|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69993|ANTIVIRALS FOR SYSTEMIC USE|J5
69985|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69985|ANTIPSYCHOTICS|N5A
69985|NOOTROPICS|N6D
69985|SYSTEMIC ANTIHISTAMINES|R6
69978|ANTIHYPERTENSIVES|C2
69973|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
69963|RESPIRATORY SYSTEM|R
69962|OPHTHALMOLOGICALS|S1
69961|IMMUNOSUPPRESSIVE AGENTS|L4
69961|OPHTHALMOLOGICALS|S1
69960|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
69958|ANALGESICS|N2
69958|ANTI-EPILEPTICS|N3
69958|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69957|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69957|DRUGS USED IN DIABETES|A10
69957|NOOTROPICS|N6D
69957|SYSTEMIC ANTIHISTAMINES|R6
69955|SYSTEMIC ANTIBACTERIALS|J1
69955|IMMUNOSTIMULATING AGENTS|L3
69951|NOOTROPICS|N6D
69948|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69943|SYSTEMIC ANTIBACTERIALS|J1
69938|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69935|ANALGESICS|N2
69931|SYSTEMIC ANTIBACTERIALS|J1
69927|ANALGESICS|N2
69924|ANTIHYPERTENSIVES|C2
69924|DIURETICS|C3
69924|ACE INHIBITORS, PLAIN|C9A
69921|ANTIPSYCHOTICS|N5A
69921|NOOTROPICS|N6D
69918|ANALGESICS|N2
69916|ANTIVIRALS FOR SYSTEMIC USE|J5
69911|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
69911|Ocular antineovascularisation products|S1P
69909|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
69909|Ocular antineovascularisation products|S1P
69907|SYSTEMIC ANTIBACTERIALS|J1
69906|SYSTEMIC ANTIBACTERIALS|J1
69906|IMMUNOSTIMULATING AGENTS|L3
69903|LUNG SURFACTANTS|R7C
69902|ANTIVIRALS FOR SYSTEMIC USE|J5
69900|ANALGESICS|N2
69891|ANTIVIRALS FOR SYSTEMIC USE|J5
69887|ANALGESICS|N2
69885|ANTIPSYCHOTICS|N5A
69884|CARDIOVASCULAR SYSTEM|C
69884|MUSCULO-SKELETAL SYSTEM|M
69879|LUNG SURFACTANTS|R7C
69878|ANTI-EPILEPTICS|N3A
69875|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
69872|ANALGESICS|N2
69871|Miotics and antiglaucoma preparations, systemic|S1E1
69860|ANTIVIRALS FOR SYSTEMIC USE|J5
69859|WOUND HEALING AGENTS|D3
69859|IMMUNOSTIMULATING AGENTS|L3
69857|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
69839|ANALGESICS|N2
69838|DRUGS USED IN DIABETES|A10
69837|Antigrowth hormones|H1C2
69837|GROWTH HORMONES|H4C
69826|IMMUNOSTIMULATING AGENTS|L3
69823|PARASITOLOGY|P
69821|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69820|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69818|TRANQUILLISERS|N5C
69817|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69817|SSRI antidepressants|N6A4
69816|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69812|CARDIOVASCULAR SYSTEM|C
69812|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
69804|ANTIVIRALS FOR SYSTEMIC USE|J5
69801|SYSTEMIC ANTIBACTERIALS|J1
69798|ANTITUSSIVES|R5D
69798|SYSTEMIC ANTIHISTAMINES|R6
69796|SYSTEMIC ANTIBACTERIALS|J1
69788|ANTIHYPERTENSIVES|C2
69787|ANALGESICS|N2
69784|OPHTHALMOLOGICALS|S1
69783|OPHTHALMOLOGICALS|S1
69780|DRUGS USED IN DIABETES|A10
69777|ANTIHYPERTENSIVES|C2
69777|BETA-BLOCKING AGENTS|C7
69775|IMMUNOSTIMULATING AGENTS|L3
69773|PLATELET AGGREGATION INHIBITORS|B1C
69773|CARDIOVASCULAR SYSTEM|C
69773|Coxibs|M1A3
69772|ANTIEMETICS AND ANTINAUSEANTS|A4
69770|CARDIOVASCULAR SYSTEM|C
69769|ANALGESICS|N2
69768|PLATELET AGGREGATION INHIBITORS|B1C
69768|CARDIOVASCULAR SYSTEM|C
69768|Coxibs|M1A3
69765|PLATELET AGGREGATION INHIBITORS|B1C
69765|CARDIOVASCULAR SYSTEM|C
69765|Coxibs|M1A3
69758|ANTIEMETICS AND ANTINAUSEANTS|A4
69757|NOOTROPICS|N6D
69755|ANALGESICS|N2
69752|ANTIVIRALS FOR SYSTEMIC USE|J5
69749|IMMUNOSTIMULATING AGENTS|L3
69743|ANTIVIRALS FOR SYSTEMIC USE|J5
69736|Factor VIII|B2D1
69735|ANTIHYPERTENSIVES|C2
69735|DIURETICS|C3
69735|CALCIUM ANTAGONISTS|C8
69733|PLATELET AGGREGATION INHIBITORS|B1C
69732|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69732|SSRI antidepressants|N6A4
69732|SRNI antidepressants|N6A5
69731|DRUGS USED IN DIABETES|A10
69731|DPP-IV inhibitor antidiabetics|A10B6
69728|ANALGESICS|N2
69727|ANALGESICS|N2
69726|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
69724|DPP-IV inhibitor antidiabetics|A10B6
69718|ANTI-EPILEPTICS|N3
69716|WOUND HEALING AGENTS|D3
69714|PLATELET AGGREGATION INHIBITORS|B1C
69712|IMMUNOSUPPRESSIVE AGENTS|L4
69704|IMMUNOSUPPRESSIVE AGENTS|L4
69702|MUSCLE RELAXANTS|M3
69702|ANALGESICS|N2
69702|TRANQUILLISERS|N5C
69699|ANTIVIRALS FOR SYSTEMIC USE|J5
69699|EXPECTORANTS|R5C
69699|ANTITUSSIVES|R5D
69697|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69694|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
69693|ANTI-EPILEPTICS|N3A
69693|NOOTROPICS|N6D
69690|DRUGS USED IN DIABETES|A10
69690|HUMAN INSULINS AND ANALOGUES|A10C
69690|Human insulins and analogues, long-acting|A10C5
69689|ANTIVIRALS FOR SYSTEMIC USE|J5
69687|ANTIFIBRINOLYTICS|B2A
69685|HYPNOTICS/SEDATIVES|N5B
69683|ANTIVIRALS FOR SYSTEMIC USE|J5
69681|Coxibs|M1A3
69681|OPHTHALMOLOGICALS|S1
69679|ALKYLATING AGENTS|L1A
69677|ANTI-EPILEPTICS|N3A
69672|ANTIVIRALS FOR SYSTEMIC USE|J5
69671|WOUND HEALING AGENTS|D3
69665|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69663|ANTIVIRALS FOR SYSTEMIC USE|J5
69662|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
69660|Inhibitors of the Kallikrein-kinin-system|B2C2
69660|DERMATOLOGICALS|D
69657|SYSTEMIC ANTIBACTERIALS|J1
69657|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69656|ANALGESICS|N2
69655|ANTIEMETICS AND ANTINAUSEANTS|A4
69654|CARDIOVASCULAR SYSTEM|C
69653|OPHTHALMOLOGICALS|S1
69651|ANTIVIRALS FOR SYSTEMIC USE|J5
69650|SYSTEMIC ANTIBACTERIALS|J1
69650|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69650|ANTIVIRALS FOR SYSTEMIC USE|J5
69646|CENTRAL NERVOUS SYSTEM|N
69646|ANTIPSYCHOTICS|N5A
69645|SYSTEMIC ANTIBACTERIALS|J1
69643|ANTI-EPILEPTICS|N3A
69641|ANALGESICS|N2
69639|SYSTEMIC ANTIBACTERIALS|J1
69636|ANALGESICS|N2
69633|SYSTEMIC ANTIBACTERIALS|J1
69629|ANALGESICS|N2
69626|ANTIHYPERTENSIVES|C2
69623|ANTIVIRALS FOR SYSTEMIC USE|J5
69622|CENTRAL NERVOUS SYSTEM|N
69621|SYSTEMIC ANTIBACTERIALS|J1
69620|ANTIPSYCHOTICS|N5A
69619|DERMATOLOGICALS|D
69617|CENTRAL NERVOUS SYSTEM|N
69616|CARDIOVASCULAR SYSTEM|C
69615|ANTIVIRALS FOR SYSTEMIC USE|J5
69614|SYSTEMIC ANTIBACTERIALS|J1
69613|ANTIVIRALS FOR SYSTEMIC USE|J5
69611|CARDIOVASCULAR SYSTEM|C
69610|Coxibs|M1A3
69610|ANALGESICS|N2
69608|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69603|ANTIVIRALS FOR SYSTEMIC USE|J5
69603|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
69602|ANTIVIRALS FOR SYSTEMIC USE|J5
69602|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
69598|ANTIVIRALS FOR SYSTEMIC USE|J5
69597|ANTIVIRALS FOR SYSTEMIC USE|J5
69597|Non-nucleoside reverse transcriptase inhibitors|J5C3
69594|ANTIFIBRINOLYTICS|B2A
69593|ANTIVIRALS FOR SYSTEMIC USE|J5
69591|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69589|ANTIVIRALS FOR SYSTEMIC USE|J5
69585|SYSTEMIC ANTIBACTERIALS|J1
69585|ANTIVIRALS FOR SYSTEMIC USE|J5
69584|ANTIVIRALS FOR SYSTEMIC USE|J5
69583|SYSTEMIC ANTIBACTERIALS|J1
69582|HEPARINS |B1B
69577|IMMUNOSUPPRESSIVE AGENTS|L4
69571|SYSTEMIC ANTIBACTERIALS|J1
69570|DRUGS USED IN DIABETES|A10
69567|ANTIVIRALS FOR SYSTEMIC USE|J5
69564|ANTIVIRALS FOR SYSTEMIC USE|J5
69563|ANTIVIRALS FOR SYSTEMIC USE|J5
69562|ANTIVIRALS FOR SYSTEMIC USE|J5
69561|Factor VIII|B2D1
69558|ANTI-EPILEPTICS|N3A
69558|NOOTROPICS|N6D
69556|ANTI-EPILEPTICS|N3A
69556|NOOTROPICS|N6D
69553|SYSTEMIC ANTIBACTERIALS|J1
69552|ANTI-EPILEPTICS|N3A
69550|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69548|DPP-IV inhibitor antidiabetics|A10B6
69547|SSRI antidepressants|N6A4
69546|Erectile dysfunction products|G4B3
69545|IMMUNOSUPPRESSIVE AGENTS|L4
69542|ANTIVIRALS FOR SYSTEMIC USE|J5
69541|PLATELET AGGREGATION INHIBITORS|B1C
69541|CARDIOVASCULAR SYSTEM|C
69539|SYSTEMIC ANTIBACTERIALS|J1
69538|SYSTEMIC ANTIBACTERIALS|J1
69536|ANTI-GOUT PREPARATIONS|M4
69531|OPHTHALMOLOGICALS|S1
69530|Coxibs|M1A3
69529|ANTIHYPERTENSIVES|C2
69529|BETA-BLOCKING AGENTS|C7
69529|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
69527|RADIODIAGNOSTIC AGENTS|T1G
69526|RADIODIAGNOSTIC AGENTS|T1G
69521|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69518|PLATELET AGGREGATION INHIBITORS|B1C
69517|ANTIVIRALS FOR SYSTEMIC USE|J5
69506|ANTIVIRALS FOR SYSTEMIC USE|J5
69505|ANTIPROTOZOALS AND ANTHELMINTICS|P1
69502|PARASITOLOGY|P
69501|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
69500|ANTIVIRALS FOR SYSTEMIC USE|J5
69499|SYSTEMIC ANTIBACTERIALS|J1
69497|OPHTHALMOLOGICALS|S1
69492|ANTIVIRALS FOR SYSTEMIC USE|J5
69491|ANTI-EPILEPTICS|N3A
69486|WOUND HEALING AGENTS|D3
69486|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
69484|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69484|ANALGESICS|N2
69483|WOUND HEALING AGENTS|D3
69482|SYSTEMIC ANTIBACTERIALS|J1
69476|IMMUNOSUPPRESSIVE AGENTS|L4
69474|IMMUNOSTIMULATING AGENTS|L3
69469|CARDIOVASCULAR SYSTEM|C
69468|CARDIOVASCULAR SYSTEM|C
69467|WOUND HEALING AGENTS|D3
69462|ANTIPSYCHOTICS|N5A
69462|NOOTROPICS|N6D
69459|ANALGESICS|N2
69459|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69459|SSRI antidepressants|N6A4
69459|SRNI antidepressants|N6A5
69457|ANTI-EPILEPTICS|N3A
69456|ANTI-EPILEPTICS|N3A
69454|ANALGESICS|N2
69453|GASTROPROKINETICS|A3F
69452|OPHTHALMOLOGICALS|S1
69450|OPHTHALMOLOGICALS|S1
69449|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
69448|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
69447|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
69445|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
69444|OPHTHALMOLOGICALS|S1
69443|OPHTHALMOLOGICALS|S1
69442|OPHTHALMOLOGICALS|S1
69440|OPHTHALMOLOGICALS|S1
69438|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
69437|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69435|OPHTHALMOLOGICALS|S1
69434|OPHTHALMOLOGICALS|S1
69433|NOOTROPICS|N6D
69431|ANALGESICS|N2
69429|CARDIOVASCULAR SYSTEM|C
69429|WOUND HEALING AGENTS|D3
69428|ANTIVIRALS FOR SYSTEMIC USE|J5
69426|B2-STIMULANTS|R3A
69418|ANALGESICS|N2
69417|ANALGESICS|N2
69415|SYSTEMIC ANTIBACTERIALS|J1
69413|SYSTEMIC ANTIBACTERIALS|J1
69410|SYSTEMIC ANTIBACTERIALS|J1
69408|ANTIVIRALS FOR SYSTEMIC USE|J5
69406|ANALGESICS|N2
69404|ANTIEMETICS AND ANTINAUSEANTS|A4
69404|ANALGESICS|N2
69400|ANTIVIRALS FOR SYSTEMIC USE|J5
69399|ANALGESICS|N2
69398|OPHTHALMOLOGICALS|S1
69397|SYSTEMIC ANTIBACTERIALS|J1
69396|ANTIVIRALS FOR SYSTEMIC USE|J5
69383|ANTIVIRALS FOR SYSTEMIC USE|J5
69376|ANTI-MIGRAINE PREPARATIONS|N2C
69371|ANALGESICS|N2
69370|ANTIVIRALS FOR SYSTEMIC USE|J5
69367|ANAESTHETICS, LOCAL|N1B
69362|DRUGS USED IN DIABETES|A10
69362|HUMAN INSULINS AND ANALOGUES|A10C
69362|Human insulins and analogues, intermediate-acting|A10C2
69361|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
69358|ANTIPSYCHOTICS|N5A
69358|NOOTROPICS|N6D
69355|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
69354|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
69352|ANALGESICS|N2
69351|SYSTEMIC ANTIBACTERIALS|J1
69346|SYSTEMIC ANTIBACTERIALS|J1
69344|ANTIPSYCHOTICS|N5A
69344|NOOTROPICS|N6D
69340|ANTIVIRALS FOR SYSTEMIC USE|J5
69338|SYSTEMIC ANTIBACTERIALS|J1
69338|ANTIVIRALS FOR SYSTEMIC USE|J5
69335|ANALGESICS|N2
69333|NOOTROPICS|N6D
69330|RESPIRATORY SYSTEM|R
69327|SYSTEMIC ANTIBACTERIALS|J1
69327|MACROLIDES AND SIMILAR TYPES|J1F
69327|PARASITOLOGY|P
69326|SYSTEMIC ANTIBACTERIALS|J1
69326|MACROLIDES AND SIMILAR TYPES|J1F
69326|PARASITOLOGY|P
69325|OPHTHALMOLOGICALS|S1
69322|Factors II, VII, IX and X|B2D2
69319|ANTIVIRALS FOR SYSTEMIC USE|J5
69317|CENTRAL NERVOUS SYSTEM|N
69308|ANALGESICS|N2
69306|BPH (benign prostatic hypertrophy) products |G4C
69305|FIBRINOLYTICS|B1D
69305|CARDIOVASCULAR SYSTEM|C
69302|OPHTHALMOLOGICALS|S1
69292|IMMUNOSTIMULATING AGENTS|L3
69289|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
69288|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
69286|ANALGESICS|N2
69282|ANTI-EPILEPTICS|N3A
69281|ANTIVIRALS FOR SYSTEMIC USE|J5
69280|RESPIRATORY SYSTEM|R
69273|ANTIHYPERTENSIVES|C2
69269|WOUND HEALING AGENTS|D3
69265|ANTIHYPERTENSIVES|C2
69264|ANTIEMETICS AND ANTINAUSEANTS|A4
69264|SYSTEMIC ANTIBACTERIALS|J1
69264|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69264|PARASITOLOGY|P
69262|CENTRAL NERVOUS SYSTEM|N
69257|IMMUNOSTIMULATING AGENTS|L3
69256|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69254|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69247|ANTIVIRALS FOR SYSTEMIC USE|J5
69242|ANTIVIRALS FOR SYSTEMIC USE|J5
69238|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69236|ANTIHYPERTENSIVES|C2
69223|ANALGESICS|N2
69221|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
69218|ANTIVIRALS FOR SYSTEMIC USE|J5
69218|Interferons, alpha|L3B1
69217|SYSTEMIC ANTIBACTERIALS|J1
69215|WOUND HEALING AGENTS|D3
69210|SYSTEMIC ANTIBACTERIALS|J1
69210|ANTIVIRALS FOR SYSTEMIC USE|J5
69209|ANTI-EPILEPTICS|N3A
69208|PARASITOLOGY|P
69206|ANTIVIRALS FOR SYSTEMIC USE|J5
69202|ANTIVIRALS FOR SYSTEMIC USE|J5
69189|ACE INHIBITORS, PLAIN|C9A
69189|WOUND HEALING AGENTS|D3
69188|Antigonadotrophin-releasing hormones|H1C3
69178|ANALGESICS|N2
69175|ANTI-MIGRAINE PREPARATIONS|N2C
69174|DRUGS USED IN DIABETES|A10
69173|HYPNOTICS/SEDATIVES|N5B
69172|ANALGESICS|N2
69167|ANTIPSYCHOTICS|N5A
69167|NOOTROPICS|N6D
69165|SYSTEMIC ANTIBACTERIALS|J1
69164|SYSTEMIC ANTIBACTERIALS|J1
69162|SYSTEMIC ANTIBACTERIALS|J1
69158|IMMUNOSUPPRESSIVE AGENTS|L4
69149|RESPIRATORY SYSTEM|R
69139|ANTI-MALARIALS|P1D
69136|ANTIPSYCHOTICS|N5A
69136|NOOTROPICS|N6D
69129|ANALGESICS|N2
69126|HYPNOTICS/SEDATIVES|N5B
69123|ANALGESICS|N2
69122|ANTIPSYCHOTICS|N5A
69121|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69120|ANTIPSYCHOTICS|N5A
69116|Factor VIII|B2D1
69114|ANTIPSYCHOTICS|N5A
69112|ANTI-ARRHYTHMICS|C1B
69105|ANALGESICS|N2
69104|ANALGESICS|N2
69103|ANTIVIRALS FOR SYSTEMIC USE|J5
69102|ANALGESICS|N2
69094|ANTIHYPERTENSIVES|C2
69093|CENTRAL NERVOUS SYSTEM|N
69093|ANTIPSYCHOTICS|N5A
69084|ANTIVIRALS FOR SYSTEMIC USE|J5
69082|ANALGESICS|N2
69082|ANTIPSYCHOTICS|N5A
69082|SSRI antidepressants|N6A4
69082|SRNI antidepressants|N6A5
69081|ANTIPSYCHOTICS|N5A
69079|RESPIRATORY SYSTEM|R
69078|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69078|SSRI antidepressants|N6A4
69078|SRNI antidepressants|N6A5
69078|NOOTROPICS|N6D
69074|SYSTEMIC ANTIBACTERIALS|J1
69072|CALCIUM ANTAGONISTS|C8
69072|MUSCLE RELAXANTS|M3
69071|ANTIVIRALS FOR SYSTEMIC USE|J5
69071|IMMUNOSTIMULATING AGENTS|L3
69070|Topical dermatological antifungals|D1A1
69070|EMOLLIENTS, PROTECTIVES|D2
69070|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
69069|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
69068|Non-nucleoside reverse transcriptase inhibitors|J5C3
69067|ANALGESICS|N2
69065|Human insulins and analogues, intermediate-acting|A10C2
69064|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69062|ANALGESICS|N2
69061|SYSTEMIC ANTIBACTERIALS|J1
69060|CARDIOVASCULAR SYSTEM|C
69058|RESPIRATORY SYSTEM|R
69057|CARDIOVASCULAR SYSTEM|C
69055|ANTI-EPILEPTICS|N3A
69054|IMMUNOSUPPRESSIVE AGENTS|L4
69053|IMMUNOSUPPRESSIVE AGENTS|L4
69050|LAXATIVES|A6
69045|TRANQUILLISERS|N5C
69045|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
69043|ANTIPSYCHOTICS|N5A
69043|NOOTROPICS|N6D
69042|LABOUR INHIBITORS|G2E
69041|ANALGESICS|N2
69037|Urinary incontinence products|G4B4
69036|Coxibs|M1A3
69036|ANALGESICS|N2
69035|ANTIHYPERTENSIVES|C2
69033|SYSTEMIC ANTIBACTERIALS|J1
69032|ANTIVIRALS FOR SYSTEMIC USE|J5
69029|NOOTROPICS|N6D
69028|ANALGESICS|N2
69027|NOOTROPICS|N6D
69025|ANALGESICS|N2
69024|DRUGS USED IN DIABETES|A10
69024|HUMAN INSULINS AND ANALOGUES|A10C
69024|Human insulins and analogues, long-acting|A10C5
69023|CENTRAL NERVOUS SYSTEM|N
69021|DERMATOLOGICALS|D
69020|CENTRAL NERVOUS SYSTEM|N
69019|CARDIOVASCULAR SYSTEM|C
69008|NOOTROPICS|N6D
69007|ANTIVIRALS FOR SYSTEMIC USE|J5
69006|IMMUNOSUPPRESSIVE AGENTS|L4
69006|OPHTHALMOLOGICALS|S1
69005|DPP-IV inhibitor antidiabetics|A10B6
69004|ANTIVIRALS FOR SYSTEMIC USE|J5
69003|ANTIVIRALS FOR SYSTEMIC USE|J5
69001|ANTI-EPILEPTICS|N3A
69001|NOOTROPICS|N6D
69000|ANTIVIRALS FOR SYSTEMIC USE|J5
68997|ANALGESICS|N2
68992|ANTIPSYCHOTICS|N5A
68991|ANTIHYPERTENSIVES|C2
68991|BETA-BLOCKING AGENTS|C7
68989|HYPNOTICS/SEDATIVES|N5B
68988|NOOTROPICS|N6D
68986|ANTIVIRALS FOR SYSTEMIC USE|J5
68984|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
68982|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
68982|ANTIPSYCHOTICS|N5A
68979|IMMUNOSUPPRESSIVE AGENTS|L4
68976|SYSTEMIC ANTIBACTERIALS|J1
68976|ANTIVIRALS FOR SYSTEMIC USE|J5
68974|ANTI-EPILEPTICS|N3A
68972|ANTIVIRALS FOR SYSTEMIC USE|J5
68968|IMMUNOSTIMULATING AGENTS|L3
68963|ANTIPSYCHOTICS|N5A
68958|CARDIOVASCULAR SYSTEM|C
68955|CARDIOVASCULAR SYSTEM|C
68954|CARDIOVASCULAR SYSTEM|C
68952|ANTIHYPERTENSIVES|C2
68951|SYSTEMIC ANTIBACTERIALS|J1
68946|CARDIOVASCULAR SYSTEM|C
68946|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
68942|CARDIOVASCULAR SYSTEM|C
68940|PLATELET AGGREGATION INHIBITORS|B1C
68940|OPHTHALMOLOGICALS|S1
68924|WOUND HEALING AGENTS|D3
68918|CARDIOVASCULAR SYSTEM|C
68917|CARDIOVASCULAR SYSTEM|C
68914|CARDIOVASCULAR SYSTEM|C
68913|WOUND HEALING AGENTS|D3
68911|CARDIOVASCULAR SYSTEM|C
68909|WOUND HEALING AGENTS|D3
68908|CARDIOVASCULAR SYSTEM|C
68904|CARDIOVASCULAR SYSTEM|C
68902|CARDIOVASCULAR SYSTEM|C
68898|WOUND HEALING AGENTS|D3
68897|WOUND HEALING AGENTS|D3
68896|CARDIOVASCULAR SYSTEM|C
68887|CARDIOVASCULAR SYSTEM|C
68885|ANTI-EPILEPTICS|N3A
68882|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
68877|CARDIOVASCULAR SYSTEM|C
68875|DRUGS USED IN DIABETES|A10
68870|CARDIOVASCULAR SYSTEM|C
68869|CARDIOVASCULAR SYSTEM|C
68855|CARDIOVASCULAR SYSTEM|C
68854|CARDIOVASCULAR SYSTEM|C
68853|Ocular antineovascularisation products|S1P
68852|ANALGESICS|N2
68842|WOUND HEALING AGENTS|D3
68837|CARDIOVASCULAR SYSTEM|C
68834|WOUND HEALING AGENTS|D3
68827|ANALGESICS|N2
68826|ANALGESICS|N2
68824|ANTIFIBRINOLYTICS|B2A
68822|CARDIOVASCULAR SYSTEM|C
68821|Interferons, beta|L3B2
68815|ANTIVIRALS FOR SYSTEMIC USE|J5
68814|WOUND HEALING AGENTS|D3
68813|SYSTEMIC ANTIBACTERIALS|J1
68813|CEPHALOSPORINS|J1D
68807|WOUND HEALING AGENTS|D3
68804|CARDIOVASCULAR SYSTEM|C
68801|WOUND HEALING AGENTS|D3
68800|CARDIOVASCULAR SYSTEM|C
68799|Inhibitors of the Kallikrein-kinin-system|B2C2
68798|WOUND HEALING AGENTS|D3
68796|WOUND HEALING AGENTS|D3
68795|DRUGS USED IN DIABETES|A10
68792|CARDIOVASCULAR SYSTEM|C
68788|CARDIOVASCULAR SYSTEM|C
68786|ANALGESICS|N2
68785|ANALGESICS|N2
68784|ANALGESICS|N2
68764|ANTI-ARRHYTHMICS|C1B
68757|ANALGESICS|N2
68757|ANTI-EPILEPTICS|N3
68755|MRI AGENTS|T1E
68750|ANALGESICS|N2
68744|IMMUNOSTIMULATING AGENTS|L3
68741|ANTIHYPERTENSIVES|C2
68740|CALCITONINS|H4A
68726|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
68713|DERMATOLOGICALS|D
68710|SYSTEMIC ANTIBACTERIALS|J1
68704|ANALGESICS|N2
68701|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68700|TRANQUILLISERS|N5C
68700|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68697|RADIODIAGNOSTIC AGENTS|T1G
68687|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
68686|ANTI-EPILEPTICS|N3A
68677|CARDIOVASCULAR SYSTEM|C
68674|SSRI antidepressants|N6A4
68673|TRANQUILLISERS|N5C
68673|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68673|SSRI antidepressants|N6A4
68670|RESPIRATORY SYSTEM|R
68669|BPH (benign prostatic hypertrophy) products |G4C
68667|ANTI-ACNE PREPARATIONS|D10
68666|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
68665|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
68660|ULTRASOUND AGENTS|T1F
68656|ANTI-EPILEPTICS|N3A
68654|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
68651|ANTI-ACNE PREPARATIONS|D10
68649|SYSTEMIC ANTIBACTERIALS|J1
68648|ANTIVIRALS FOR SYSTEMIC USE|J5
68646|SYSTEMIC ANTIBACTERIALS|J1
68641|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
68640|ANTIVIRALS FOR SYSTEMIC USE|J5
68639|SSRI antidepressants|N6A4
68639|SRNI antidepressants|N6A5
68638|SSRI antidepressants|N6A4
68638|SRNI antidepressants|N6A5
68635|NOOTROPICS|N6D
68634|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
68627|SYSTEMIC ANTIBACTERIALS|J1
68625|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
68620|SYSTEMIC ANTIBACTERIALS|J1
68617|SYSTEMIC ANTIBACTERIALS|J1
68615|SYSTEMIC ANTIBACTERIALS|J1
68612|ANTI-ARRHYTHMICS|C1B
68608|SYSTEMIC ANTIBACTERIALS|J1
68607|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
68604|ANTIVIRALS FOR SYSTEMIC USE|J5
68601|ANTIVIRALS FOR SYSTEMIC USE|J5
68600|ANTIHYPERTENSIVES|C2
68600|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
68600|Statins (HMG-CoA reductase inhibitors)|C10A1
68598|Biguanide antidiabetics|A10B2
68596|ANTIVIRALS FOR SYSTEMIC USE|J5
68594|SYSTEMIC ANTIBACTERIALS|J1
68593|SYSTEMIC ANTIBACTERIALS|J1
68589|RADIODIAGNOSTIC AGENTS|T1G
68588|ANALGESICS|N2
68588|ANTI-EPILEPTICS|N3
68587|ANALGESICS|N2
68587|ANTI-EPILEPTICS|N3A
68586|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68584|ANALGESICS|N2
68582|ANALGESICS|N2
68581|ANALGESICS|N2
68580|ANTIPSYCHOTICS|N5A
68579|ANALGESICS|N2
68578|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
68578|ANTI-EPILEPTICS|N3A
68577|DRUGS USED IN DIABETES|A10
68575|ANTIHYPERTENSIVES|C2
68575|OPHTHALMOLOGICALS|S1
68574|DRUGS USED IN DIABETES|A10
68574|RADIODIAGNOSTIC AGENTS|T1G
68573|ANALGESICS|N2
68573|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68571|ANTI-EPILEPTICS|N3A
68571|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68571|RADIODIAGNOSTIC AGENTS|T1G
68570|ANALGESICS|N2
68569|RADIODIAGNOSTIC AGENTS|T1G
68567|Biguanide antidiabetics|A10B2
68567|DPP-IV inhibitor antidiabetics|A10B6
68561|ANTIVIRALS FOR SYSTEMIC USE|J5
68560|IMMUNOSUPPRESSIVE AGENTS|L4
68555|IMMUNOSUPPRESSIVE AGENTS|L4
68536|ANTIVIRALS FOR SYSTEMIC USE|J5
68529|ANTIVIRALS FOR SYSTEMIC USE|J5
68522|SYSTEMIC ANTIBACTERIALS|J1
68521|SYSTEMIC ANTIBACTERIALS|J1
68515|CARDIOVASCULAR SYSTEM|C
68515|CENTRAL NERVOUS SYSTEM|N
68512|SYSTEMIC ANTIBACTERIALS|J1
68509|OPHTHALMOLOGICALS|S1
68509|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
68505|DRUGS USED IN DIABETES|A10
68504|OPHTHALMOLOGICALS|S1
68503|OPHTHALMOLOGICALS|S1
68499|ANTIVIRALS FOR SYSTEMIC USE|J5
68496|ANTI-EPILEPTICS|N3A
68495|NOOTROPICS|N6D
68494|IMMUNOSUPPRESSIVE AGENTS|L4
68493|ANTIVIRALS FOR SYSTEMIC USE|J5
68492|ANTIVIRALS FOR SYSTEMIC USE|J5
68484|SYSTEMIC ANTIBACTERIALS|J1
68484|ANTIVIRALS FOR SYSTEMIC USE|J5
68483|ANTIVIRALS FOR SYSTEMIC USE|J5
68482|ANTIVIRALS FOR SYSTEMIC USE|J5
68480|ANTIHYPERTENSIVES|C2
68475|CENTRAL NERVOUS SYSTEM|N
68475|NOOTROPICS|N6D
68472|DRUGS USED IN DIABETES|A10
68464|DRUGS USED IN DIABETES|A10
68463|ANTIHYPERTENSIVES|C2
68463|Miotics and antiglaucoma preparations, topical|S1E2
68462|ANTIVIRALS FOR SYSTEMIC USE|J5
68460|Antigrowth hormones|H1C2
68456|ANALGESICS|N2
68455|ANALGESICS|N2
68446|ANALGESICS|N2
68445|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
68445|DRUGS USED IN DIABETES|A10
68443|DRUGS USED IN DIABETES|A10
68442|ANALGESICS|N2
68442|ANTI-EPILEPTICS|N3
68436|ANALGESICS|N2
68430|RESPIRATORY SYSTEM|R
68429|ANALGESICS|N2
68426|ANTIVIRALS FOR SYSTEMIC USE|J5
68423|ANALGESICS|N2
68415|ANALGESICS|N2
68410|ANTIVIRALS FOR SYSTEMIC USE|J5
68409|ANTI-EPILEPTICS|N3A
68408|ANALGESICS|N2
68407|RESPIRATORY SYSTEM|R
68406|ANALGESICS|N2
68405|ANTIVIRALS FOR SYSTEMIC USE|J5
68404|IMMUNOSUPPRESSIVE AGENTS|L4
68402|IMMUNOSTIMULATING AGENTS|L3
68398|DRUGS USED IN DIABETES|A10
68397|IMMUNOSUPPRESSIVE AGENTS|L4
68396|IMMUNOSUPPRESSIVE AGENTS|L4
68395|CARDIOVASCULAR SYSTEM|C
68395|CENTRAL NERVOUS SYSTEM|N
68395|RESPIRATORY SYSTEM|R
68395|OPHTHALMOLOGICALS|S1
68394|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68394|NOOTROPICS|N6D
68393|SYSTEMIC ANTIBACTERIALS|J1
68392|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
68391|ANTIHYPERTENSIVES|C2
68390|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
68390|Statins (HMG-CoA reductase inhibitors)|C10A1
68389|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
68388|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
68387|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
68386|ANTIHYPERTENSIVES|C2
68386|DIURETICS|C3
68382|ANTIHYPERTENSIVES|C2
68381|SYSTEMIC ANTIBACTERIALS|J1
68379|ANTIVIRALS FOR SYSTEMIC USE|J5
68375|ANTIVIRALS FOR SYSTEMIC USE|J5
68373|ANTIVIRALS FOR SYSTEMIC USE|J5
68371|SYSTEMIC ANTIBACTERIALS|J1
68370|SYSTEMIC ANTIBACTERIALS|J1
68369|SYSTEMIC ANTIBACTERIALS|J1
68368|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
68366|SYSTEMIC ANTIBACTERIALS|J1
68364|IMMUNOSUPPRESSIVE AGENTS|L4
68362|NOOTROPICS|N6D
68346|B2-STIMULANTS|R3A
68342|ANALGESICS|N2
68342|ANTI-EPILEPTICS|N3
68340|OPHTHALMOLOGICALS|S1
68337|CENTRAL NERVOUS SYSTEM|N
68330|Factor VIII|B2D1
68319|PARASITOLOGY|P
68319|ANTI-MALARIALS|P1D
68317|IMMUNOSUPPRESSIVE AGENTS|L4
68316|SYSTEMIC ANTIBACTERIALS|J1
68312|ANTIVIRALS FOR SYSTEMIC USE|J5
68310|SYSTEMIC ANTIBACTERIALS|J1
68308|WOUND HEALING AGENTS|D3
68304|ANALGESICS|N2
68300|ANALGESICS|N2
68298|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
68297|DRUGS USED IN DIABETES|A10
68297|HUMAN INSULINS AND ANALOGUES|A10C
68297|Human insulins and analogues, fast-acting|A10C1
68296|DRUGS USED IN DIABETES|A10
68296|HUMAN INSULINS AND ANALOGUES|A10C
68296|Human insulins and analogues, fast-acting|A10C1
68294|NOOTROPICS|N6D
68291|PARASITOLOGY|P
68291|ANTI-MALARIALS|P1D
68290|PARASITOLOGY|P
68290|ANTI-MALARIALS|P1D
68288|SYSTEMIC ANTIBACTERIALS|J1
68288|CEPHALOSPORINS|J1D
68287|PARASITOLOGY|P
68287|ANTI-MALARIALS|P1D
68286|RESPIRATORY SYSTEM|R
68285|ANTIPROTOZOALS AND ANTHELMINTICS|P1
68285|ANTI-MALARIALS|P1D
68283|PARASITOLOGY|P
68283|ANTI-MALARIALS|P1D
68281|IMMUNOSTIMULATING AGENTS|L3
68280|IMMUNOSTIMULATING AGENTS|L3
68278|PARASITOLOGY|P
68278|ANTI-MALARIALS|P1D
68277|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68275|PARASITOLOGY|P
68275|ANTI-MALARIALS|P1D
68274|ANTIVIRALS FOR SYSTEMIC USE|J5
68273|PARASITOLOGY|P
68273|ANTI-MALARIALS|P1D
68268|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
68266|PARASITOLOGY|P
68266|ANTI-MALARIALS|P1D
68263|Factors II, VII, IX and X|B2D2
68262|PARASITOLOGY|P
68262|ANTI-MALARIALS|P1D
68261|MACROLIDES AND SIMILAR TYPES|J1F
68261|PARASITOLOGY|P
68260|SYSTEMIC ANTIBACTERIALS|J1
68259|PARASITOLOGY|P
68259|ANTI-MALARIALS|P1D
68258|PARASITOLOGY|P
68258|ANTI-MALARIALS|P1D
68257|PARASITOLOGY|P
68257|ANTI-MALARIALS|P1D
68255|PARASITOLOGY|P
68255|ANTI-MALARIALS|P1D
68249|ANALGESICS|N2
68247|CARDIOVASCULAR SYSTEM|C
68247|ANTIHYPERTENSIVES|C2
68246|Factors II, VII, IX and X|B2D2
68245|ANTI-EPILEPTICS|N3A
68244|SYSTEMIC ANTIBACTERIALS|J1
68235|ANALGESICS|N2
68234|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
68232|SYSTEMIC ANTIBACTERIALS|J1
68229|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
68228|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
68228|GLUCAGON|H4B
68227|IMMUNOSUPPRESSIVE AGENTS|L4
68225|ANTIVIRALS FOR SYSTEMIC USE|J5
68223|ANTIHYPERTENSIVES|C2
68217|CARDIOVASCULAR SYSTEM|C
68215|WOUND HEALING AGENTS|D3
68211|SYSTEMIC ANTIBACTERIALS|J1
68209|IMMUNOSUPPRESSIVE AGENTS|L4
68200|PARASITOLOGY|P
68200|ANTI-MALARIALS|P1D
68199|PARASITOLOGY|P
68199|ANTI-MALARIALS|P1D
68197|ANALGESICS|N2
68195|SYSTEMIC ANTIBACTERIALS|J1
68195|ANTIVIRALS FOR SYSTEMIC USE|J5
68192|HUMAN INSULINS AND ANALOGUES|A10C
68192|Human insulins and analogues, long-acting|A10C5
68188|IMMUNOSTIMULATING AGENTS|L3
68180|Statins (HMG-CoA reductase inhibitors)|C10A1
68179|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
68178|ANALGESICS|N2
68174|ANTIVIRALS FOR SYSTEMIC USE|J5
68170|ANALGESICS|N2
68169|TRANQUILLISERS|N5C
68166|ANTI-EPILEPTICS|N3A
68165|ANTIVIRALS FOR SYSTEMIC USE|J5
68163|Vitamin E, plain|A11X3
68161|IMMUNOSUPPRESSIVE AGENTS|L4
68158|ANTI-EPILEPTICS|N3A
68157|CARDIOVASCULAR SYSTEM|C
68153|PARASITOLOGY|P
68153|ANTI-MALARIALS|P1D
68151|NOOTROPICS|N6D
68148|NOOTROPICS|N6D
68141|CARDIOVASCULAR SYSTEM|C
68136|Systemic dermatological antifungals|D1A2
68136|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
68133|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
68128|CENTRAL NERVOUS SYSTEM|N
68128|ANALGESICS|N2
68128|NOOTROPICS|N6D
68125|ANTI-EPILEPTICS|N3A
68123|Urinary incontinence products|G4B4
68118|ANTI-EPILEPTICS|N3A
68116|SYSTEMIC ANTIBACTERIALS|J1
68092|ANTIVIRALS FOR SYSTEMIC USE|J5
68054|ALKYLATING AGENTS|L1A
68052|NOOTROPICS|N6D
68052|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
68038|NOOTROPICS|N6D
68037|IMMUNOSTIMULATING AGENTS|L3
68035|ANTIVIRALS FOR SYSTEMIC USE|J5
68032|ANTIVIRALS FOR SYSTEMIC USE|J5
68015|Protease inhibitors|J5C2
68001|ANTIVIRALS FOR SYSTEMIC USE|J5
67997|ANALGESICS|N2
67996|ANALGESICS|N2
67995|ANTI-GOUT PREPARATIONS|M4
67994|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
67992|ANTIPSYCHOTICS|N5A
67972|ANTIVIRALS FOR SYSTEMIC USE|J5
67953|DPP-IV inhibitor antidiabetics|A10B6
67952|ANTIVIRALS FOR SYSTEMIC USE|J5
67947|ANALGESICS|N2
67945|ANALGESICS|N2
67944|ANALGESICS|N2
67943|ANALGESICS|N2
67942|NOOTROPICS|N6D
67941|TRANQUILLISERS|N5C
67941|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
67937|SYSTEMIC ANTIBACTERIALS|J1
67934|ANTIPSYCHOTICS|N5A
67934|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
67933|ANTIPSYCHOTICS|N5A
67923|ANTIVIRALS FOR SYSTEMIC USE|J5
67922|PARASITOLOGY|P
67921|ANTI-MALARIALS|P1D
67914|ANTIPSYCHOTICS|N5A
67913|TRANQUILLISERS|N5C
67895|ANTI-MIGRAINE PREPARATIONS|N2C
67894|DERMATOLOGICALS|D
67871|ANTIVIRALS FOR SYSTEMIC USE|J5
67866|CENTRAL NERVOUS SYSTEM|N
67866|ANTI-EPILEPTICS|N3
67866|ANTI-EPILEPTICS|N3A
67860|ANTIVIRALS FOR SYSTEMIC USE|J5
67857|CARDIOVASCULAR SYSTEM|C
67857|RADIODIAGNOSTIC AGENTS|T1G
67855|ANTI-EPILEPTICS|N3
67853|ANTIVIRALS FOR SYSTEMIC USE|J5
67851|ANTIVIRALS FOR SYSTEMIC USE|J5
67849|DRUGS USED IN DIABETES|A10
67842|ANTI-EPILEPTICS|N3
67839|ANTIVIRALS FOR SYSTEMIC USE|J5
67838|ANALGESICS|N2
67831|ANALGESICS|N2
67828|ANALGESICS|N2
67826|ANTIMETABOLITES|L1B
67825|ANTIVIRALS FOR SYSTEMIC USE|J5
67820|SYSTEMIC ANTIBACTERIALS|J1
67815|B2-STIMULANTS|R3A
67814|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
67812|NOOTROPICS|N6D
67810|DRUGS USED IN DIABETES|A10
67802|CENTRAL NERVOUS SYSTEM|N
67789|ANALGESICS|N2
67784|CARDIOVASCULAR SYSTEM|C
67778|WOUND HEALING AGENTS|D3
67774|ANALGESICS|N2
67769|NOOTROPICS|N6D
67768|ANTIULCERANTS|A2B
67766|ANAESTHETICS, GENERAL|N1A
67766|HYPNOTICS/SEDATIVES|N5B
67765|ANTIHYPERTENSIVES|C2
67765|BETA-BLOCKING AGENTS|C7
67763|CARDIOVASCULAR SYSTEM|C
67763|ANTI-ARRHYTHMICS|C1B
67762|SYSTEMIC ANTIBACTERIALS|J1
67745|WOUND HEALING AGENTS|D3
67744|CARDIOVASCULAR SYSTEM|C
67739|SYSTEMIC ANTIBACTERIALS|J1
67736|ANTI-ARRHYTHMICS|C1B
67733|OPHTHALMOLOGICALS|S1
67729|ANTIVIRALS FOR SYSTEMIC USE|J5
67729|CENTRAL NERVOUS SYSTEM|N
67727|SYSTEMIC ANTIBACTERIALS|J1
67723|DRUGS USED IN DIABETES|A10
67722|ANALGESICS|N2
67719|B2-STIMULANTS|R3A
67715|WOUND HEALING AGENTS|D3
67713|OPHTHALMOLOGICALS|S1
67712|MUSCULO-SKELETAL SYSTEM|M
67708|WOUND HEALING AGENTS|D3
67706|WOUND HEALING AGENTS|D3
67703|WOUND HEALING AGENTS|D3
67701|DERMATOLOGICALS|D
67700|IMMUNOSUPPRESSIVE AGENTS|L4
67699|IMMUNOSUPPRESSIVE AGENTS|L4
67698|IMMUNOSUPPRESSIVE AGENTS|L4
67697|IMMUNOSUPPRESSIVE AGENTS|L4
67696|IMMUNOSUPPRESSIVE AGENTS|L4
67684|ANTIMETABOLITES|L1B
67683|SYSTEMIC ANTIBACTERIALS|J1
67682|NOOTROPICS|N6D
67678|ANTIMETABOLITES|L1B
67676|NOOTROPICS|N6D
67669|CARDIOVASCULAR SYSTEM|C
67668|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
67658|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
67651|Statins (HMG-CoA reductase inhibitors)|C10A1
67647|Coxibs|M1A3
67644|CARDIOVASCULAR SYSTEM|C
67644|WOUND HEALING AGENTS|D3
67641|CARDIOVASCULAR SYSTEM|C
67641|WOUND HEALING AGENTS|D3
67637|ANTIVIRALS FOR SYSTEMIC USE|J5
67636|ANTIVIRALS FOR SYSTEMIC USE|J5
67633|DRUGS USED IN DIABETES|A10
67632|RESPIRATORY SYSTEM|R
67630|DRUGS USED IN DIABETES|A10
67628|DRUGS USED IN DIABETES|A10
67625|ANTI-MALARIALS|P1D
67623|ANTIPSYCHOTICS|N5A
67619|ANTIVIRALS FOR SYSTEMIC USE|J5
67619|ANTITUSSIVES|R5D
67617|ANTIVIRALS FOR SYSTEMIC USE|J5
67615|ANTIVIRALS FOR SYSTEMIC USE|J5
67611|SYSTEMIC ANTIBACTERIALS|J1
67610|ANALGESICS|N2
67607|ANTIVIRALS FOR SYSTEMIC USE|J5
67602|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
67599|PLATELET AGGREGATION INHIBITORS|B1C
67599|FIBRINOLYTICS|B1D
67599|Coxibs|M1A3
67595|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
67590|TRANQUILLISERS|N5C
67587|ANTIVIRALS FOR SYSTEMIC USE|J5
67586|ANTI-EPILEPTICS|N3A
67585|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
67584|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
67582|SYSTEMIC ANTIBACTERIALS|J1
67580|ANALGESICS|N2
67580|ANTI-MIGRAINE PREPARATIONS|N2C
67580|ANTI-EPILEPTICS|N3
67580|ANTIPSYCHOTICS|N5A
67580|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
67579|ANTI-EPILEPTICS|N3
67578|GASTROPROKINETICS|A3F
67577|ANTIVIRALS FOR SYSTEMIC USE|J5
67577|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
67576|ANTIHYPERTENSIVES|C2
67574|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
67574|CARDIOVASCULAR SYSTEM|C
67574|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
67573|ANTIVIRALS FOR SYSTEMIC USE|J5
67572|MUSCULO-SKELETAL SYSTEM|M
67569|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
67561|Antigonadotrophin-releasing hormones|H1C3
67560|IMMUNOSTIMULATING AGENTS|L3
67559|B2-STIMULANTS|R3A
67557|ANALGESICS|N2
67549|ANTIVIRALS FOR SYSTEMIC USE|J5
67542|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
67542|GROWTH HORMONES|H4C
67541|SYSTEMIC ANTIBACTERIALS|J1
67533|CENTRAL NERVOUS SYSTEM|N
67524|CARDIOVASCULAR SYSTEM|C
67521|PARASITOLOGY|P
67520|PARASITOLOGY|P
67519|PARASITOLOGY|P
67513|CARDIOVASCULAR SYSTEM|C
67513|ANTIHYPERTENSIVES|C2
67512|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
67511|CALCIUM ANTAGONISTS|C8
67510|ANTIPSYCHOTICS|N5A
67510|NOOTROPICS|N6D
67509|ANTIPSYCHOTICS|N5A
67509|NOOTROPICS|N6D
67506|ANALGESICS|N2
67505|ANALGESICS|N2
67503|ANALGESICS|N2
67501|NOOTROPICS|N6D
67500|Ocular antineovascularisation products|S1P
67497|ANALGESICS|N2
67493|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
67485|SYSTEMIC ANTIBACTERIALS|J1
67483|MUSCULO-SKELETAL SYSTEM|M
67474|PARASITOLOGY|P
67473|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
67472|ANALGESICS|N2
67471|CENTRAL NERVOUS SYSTEM|N
67469|OPHTHALMOLOGICALS|S1
67464|ANALGESICS|N2
67457|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
67457|Statins (HMG-CoA reductase inhibitors)|C10A1
67455|NOOTROPICS|N6D
67451|DPP-IV inhibitor antidiabetics|A10B6
67449|SYSTEMIC ANTIBACTERIALS|J1
67446|NOOTROPICS|N6D
67443|PARASITOLOGY|P
67443|ANTI-MALARIALS|P1D
67442|HYPNOTICS/SEDATIVES|N5B
67440|OPHTHALMOLOGICALS|S1
67439|OPHTHALMOLOGICALS|S1
67434|SYSTEMIC ANTIBACTERIALS|J1
67431|SYSTEMIC ANTIBACTERIALS|J1
67429|Erectile dysfunction products|G4B3
67428|ANTIVIRALS FOR SYSTEMIC USE|J5
67426|CALCIUM ANTAGONISTS|C8
67426|ANALGESICS|N2
67424|MACROLIDES AND SIMILAR TYPES|J1F
67424|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
67422|PARASITOLOGY|P
67421|NOOTROPICS|N6D
67417|ANTI-GOUT PREPARATIONS|M4
67416|SYSTEMIC ANTIBACTERIALS|J1
67415|MUSCULO-SKELETAL SYSTEM|M
67413|SYSTEMIC ANTIBACTERIALS|J1
67412|NOOTROPICS|N6D
67411|ANALGESICS|N2
67410|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
67409|PLATELET AGGREGATION INHIBITORS|B1C
67408|GASTROPROKINETICS|A3F
67404|ANTIVIRALS FOR SYSTEMIC USE|J5
67403|RESPIRATORY SYSTEM|R
67402|RADIODIAGNOSTIC AGENTS|T1G
67401|SYSTEMIC ANTIBACTERIALS|J1
67400|SYSTEMIC ANTIBACTERIALS|J1
67399|ANTIVIRALS FOR SYSTEMIC USE|J5
67398|ANTIVIRALS FOR SYSTEMIC USE|J5
67397|RESPIRATORY SYSTEM|R
67396|ANTIVIRALS FOR SYSTEMIC USE|J5
67394|ANTIVIRALS FOR SYSTEMIC USE|J5
67393|SYSTEMIC ANTIBACTERIALS|J1
67392|SYSTEMIC ANTIBACTERIALS|J1
67387|ANALGESICS|N2
67386|ANTIPSYCHOTICS|N5A
67384|ANALGESICS|N2
67383|ANALGESICS|N2
67381|ANTIVIRALS FOR SYSTEMIC USE|J5
67378|ANTIVIRALS FOR SYSTEMIC USE|J5
67377|NOOTROPICS|N6D
67376|ANTIVIRALS FOR SYSTEMIC USE|J5
67374|ANTIVIRALS FOR SYSTEMIC USE|J5
67372|ANALGESICS|N2
67371|Systemic dermatological antifungals|D1A2
67371|SYSTEMIC ANTIBACTERIALS|J1
67371|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
67370|ANTIVIRALS FOR SYSTEMIC USE|J5
67364|ANTI-EPILEPTICS|N3
67357|ANTIVIRALS FOR SYSTEMIC USE|J5
67355|ANTI-EPILEPTICS|N3A
67351|ANALGESICS|N2
67348|OPHTHALMOLOGICALS|S1
67336|ANALGESICS|N2
67334|SYSTEMIC ANTIBACTERIALS|J1
67334|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
67334|ANAESTHETICS, LOCAL|N1B
67333|SYSTEMIC ANTIBACTERIALS|J1
67333|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
67333|ANAESTHETICS, LOCAL|N1B
67333|PARASITOLOGY|P
67332|ANTIVIRALS FOR SYSTEMIC USE|J5
67329|ANTIVIRALS FOR SYSTEMIC USE|J5
67328|ANTIVIRALS FOR SYSTEMIC USE|J5
67326|ANTIVIRALS FOR SYSTEMIC USE|J5
67324|ANTIPSYCHOTICS|N5A
67322|MUSCULO-SKELETAL SYSTEM|M
67320|HUMAN INSULINS AND ANALOGUES|A10C
67320|Human insulins and analogues, intermediate-acting|A10C2
67319|ANALGESICS|N2
67318|ANALGESICS|N2
67317|ANALGESICS|N2
67316|SYSTEMIC ANTIBACTERIALS|J1
67315|DERMATOLOGICALS|D
67314|ACE INHIBITORS, PLAIN|C9A
67312|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
67309|WOUND HEALING AGENTS|D3
67299|SYSTEMIC ANTIBACTERIALS|J1
67298|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
67295|SYSTEMIC ANTIBACTERIALS|J1
67288|ANTIVIRALS FOR SYSTEMIC USE|J5
67285|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
67284|Ocular antineovascularisation products|S1P
67283|Ocular antineovascularisation products|S1P
67282|Ocular antineovascularisation products|S1P
67281|OPHTHALMOLOGICALS|S1
67279|CARDIOVASCULAR SYSTEM|C
67274|ANTIVIRALS FOR SYSTEMIC USE|J5
67271|ANTIVIRALS FOR SYSTEMIC USE|J5
67270|ANTIVIRALS FOR SYSTEMIC USE|J5
67264|SYSTEMIC ANTIBACTERIALS|J1
67264|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
67264|PARASITOLOGY|P
67263|SYSTEMIC ANTIBACTERIALS|J1
67263|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
67263|PARASITOLOGY|P
67260|ANTIVIRALS FOR SYSTEMIC USE|J5
67254|SYSTEMIC ANTIBACTERIALS|J1
67254|MACROLIDES AND SIMILAR TYPES|J1F
67248|DERMATOLOGICALS|D
67247|DERMATOLOGICALS|D
67246|ANALGESICS|N2
67245|ANALGESICS|N2
67244|NOOTROPICS|N6D
67242|ANALGESICS|N2
67240|ANALGESICS|N2
67239|CARDIAC THERAPY|C1
67238|ANALGESICS|N2
67237|CARDIOVASCULAR SYSTEM|C
67236|MUSCULO-SKELETAL SYSTEM|M
67235|ANALGESICS|N2
67229|ANALGESICS|N2
67228|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
67228|DRUGS USED IN DIABETES|A10
67227|DRUGS USED IN DIABETES|A10
67227|HUMAN INSULINS AND ANALOGUES|A10C
67227|Human insulins and analogues, fast-acting|A10C1
67225|DRUGS USED IN DIABETES|A10
67225|DPP-IV inhibitor antidiabetics|A10B6
67223|DERMATOLOGICALS|D
67219|ANTIVIRALS FOR SYSTEMIC USE|J5
67218|DRUGS USED IN DIABETES|A10
67213|ANALGESICS|N2
67206|ANTIPSYCHOTICS|N5A
67206|SSRI antidepressants|N6A4
67206|SRNI antidepressants|N6A5
67203|Ocular antineovascularisation products|S1P
67202|PARASITOLOGY|P
67202|ANTIPROTOZOALS AND ANTHELMINTICS|P1
67201|TRANQUILLISERS|N5C
67200|IMMUNOSUPPRESSIVE AGENTS|L4
67195|DRUGS USED IN DIABETES|A10
67192|ANTI-EPILEPTICS|N3A
67190|NOOTROPICS|N6D
67188|ANTIVIRALS FOR SYSTEMIC USE|J5
67187|OPHTHALMOLOGICALS|S1
67186|SYSTEMIC ANTIBACTERIALS|J1
67183|ANTIHYPERTENSIVES|C2
67182|ANTIHYPERTENSIVES|C2
67182|ACE INHIBITORS, PLAIN|C9A
67178|RESPIRATORY SYSTEM|R
67174|IMMUNOSUPPRESSIVE AGENTS|L4
67169|Inhibitors of the Kallikrein-kinin-system|B2C2
67169|OPHTHALMOLOGICALS|S1
67167|DRUGS USED IN DIABETES|A10
67165|ANTI-EPILEPTICS|N3A
67164|SYSTEMIC ANTIBACTERIALS|J1
67155|RESPIRATORY SYSTEM|R
67149|NOOTROPICS|N6D
67148|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
67147|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
67146|Statins (HMG-CoA reductase inhibitors)|C10A1
67139|ANTIHYPERTENSIVES|C2
67139|CALCIUM ANTAGONISTS|C8
67139|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
67137|Non-nucleoside reverse transcriptase inhibitors|J5C3
67135|ANTIHYPERTENSIVES|C2
67134|OPHTHALMOLOGICALS|S1
67130|ANTIHYPERTENSIVES|C2
67130|OPHTHALMOLOGICALS|S1
67130|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
67129|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
67129|GLUCAGON|H4B
67126|ANALGESICS|N2
67125|ANTI-EPILEPTICS|N3A
67124|ANALGESICS|N2
67119|IMMUNOSUPPRESSIVE AGENTS|L4
67115|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
67113|WOUND HEALING AGENTS|D3
67110|RESPIRATORY SYSTEM|R
67109|IMMUNOSTIMULATING AGENTS|L3
67104|ANALGESICS|N2
67101|DIRECT THROMBIN INHIBITORS|B1E
67100|GASTROPROKINETICS|A3F
67099|WOUND HEALING AGENTS|D3
67093|Factor VIII|B2D1
67092|SYSTEMIC ANTIBACTERIALS|J1
67091|PARASITOLOGY|P
67090|SYSTEMIC ANTIBACTERIALS|J1
67089|WOUND HEALING AGENTS|D3
67089|ANTI-ACNE PREPARATIONS|D10
67087|SYSTEMIC ANTIBACTERIALS|J1
67083|ANALGESICS|N2
67079|TRANQUILLISERS|N5C
67079|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
67078|ANALGESICS|N2
67074|IMMUNOSUPPRESSIVE AGENTS|L4
67072|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
67071|OPHTHALMOLOGICALS|S1
67070|PARASITOLOGY|P
67070|ANTI-MALARIALS|P1D
67066|DERMATOLOGICALS|D
67066|ANALGESICS|N2
67065|ANALGESICS|N2
67063|ANTIVIRALS FOR SYSTEMIC USE|J5
67062|ANTIVIRALS FOR SYSTEMIC USE|J5
67059|ANTIVIRALS FOR SYSTEMIC USE|J5
67058|ANTIVIRALS FOR SYSTEMIC USE|J5
67055|SYSTEMIC ANTIBACTERIALS|J1
67054|ANALGESICS|N2
67054|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
67050|ANALGESICS|N2
67045|WOUND HEALING AGENTS|D3
67045|OPHTHALMOLOGICALS|S1
67040|IMMUNOSTIMULATING AGENTS|L3
67029|RESPIRATORY SYSTEM|R
67025|ANALGESICS|N2
67024|ANTHELMINTICS, EXCLUDING SCHISTOSOMICIDES|P1B
67018|WOUND HEALING AGENTS|D3
67018|ANALGESICS|N2
67017|DERMATOLOGICALS|D
67015|ANALGESICS|N2
67014|ANAESTHETICS, LOCAL|N1B
67014|ANALGESICS|N2
67013|ANALGESICS|N2
67013|SSRI antidepressants|N6A4
67013|SRNI antidepressants|N6A5
67012|ANTI-ACNE PREPARATIONS|D10
67011|DERMATOLOGICALS|D
67011|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
67011|IMMUNOSUPPRESSIVE AGENTS|L4
67008|WOUND HEALING AGENTS|D3
67005|ANTIVIRALS FOR SYSTEMIC USE|J5
67005|IMMUNOSTIMULATING AGENTS|L3
67001|ANTIVIRALS FOR SYSTEMIC USE|J5
67000|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
66998|DRUGS USED IN DIABETES|A10
66996|ANTIVIRALS FOR SYSTEMIC USE|J5
66992|ANALGESICS|N2
66990|ANALGESICS|N2
66987|ANALGESICS|N2
66985|ANTIVIRALS FOR SYSTEMIC USE|J5
66984|ANTIVIRALS FOR SYSTEMIC USE|J5
66983|SYSTEMIC ANTIBACTERIALS|J1
66975|ANTIPSYCHOTICS|N5A
66975|NOOTROPICS|N6D
66970|ANTIVIRALS FOR SYSTEMIC USE|J5
66970|IMMUNOSTIMULATING AGENTS|L3
66966|ANTI-MALARIALS|P1D
66965|ANTIHYPERTENSIVES|C2
66965|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66965|Statins (HMG-CoA reductase inhibitors)|C10A1
66962|EMOLLIENTS, PROTECTIVES|D2
66962|TOPICAL ANTI-ACNE PREPARATIONS|D10A
66960|ANTIHYPERTENSIVES|C2
66958|ANTIHYPERTENSIVES|C2
66958|Erectile dysfunction products|G4B3
66953|ANALGESICS|N2
66946|DRUGS USED IN DIABETES|A10
66938|DRUGS USED IN DIABETES|A10
66934|DRUGS USED IN DIABETES|A10
66931|ANTIHYPERTENSIVES|C2
66931|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66930|ANTIHYPERTENSIVES|C2
66930|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66930|Statins (HMG-CoA reductase inhibitors)|C10A1
66927|EMOLLIENTS, PROTECTIVES|D2
66923|ANTIVIRALS FOR SYSTEMIC USE|J5
66922|SYSTEMIC ANTIBACTERIALS|J1
66921|SYSTEMIC ANTIBACTERIALS|J1
66920|SYSTEMIC ANTIBACTERIALS|J1
66919|LABOUR INHIBITORS|G2E
66913|PARASITOLOGY|P
66913|ANTI-MALARIALS|P1D
66912|ANTIHYPERTENSIVES|C2
66911|DRUGS USED IN DIABETES|A10
66910|DRUGS USED IN DIABETES|A10
66909|ANTIVIRALS FOR SYSTEMIC USE|J5
66909|IMMUNOSTIMULATING AGENTS|L3
66901|ANTIVIRALS FOR SYSTEMIC USE|J5
66900|ANTIHYPERTENSIVES|C2
66897|ANTIHYPERTENSIVES|C2
66895|RESPIRATORY SYSTEM|R
66893|ANALGESICS|N2
66893|SSRI antidepressants|N6A4
66893|SRNI antidepressants|N6A5
66892|ANALGESICS|N2
66889|PLATELET AGGREGATION INHIBITORS|B1C
66888|SYSTEMIC ANTIBACTERIALS|J1
66886|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
66885|ANTI-GOUT PREPARATIONS|M4
66884|ANTIULCERANTS|A2B
66883|NOOTROPICS|N6D
66882|ANTIHYPERTENSIVES|C2
66882|DIURETICS|C3
66881|Bile stone therapy|A5A2
66878|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66877|ANALGESICS|N2
66876|ANTIVIRALS FOR SYSTEMIC USE|J5
66873|Statins (HMG-CoA reductase inhibitors)|C10A1
66872|DRUGS USED IN DIABETES|A10
66872|ANTIVIRALS FOR SYSTEMIC USE|J5
66871|DRUGS USED IN DIABETES|A10
66871|ANTIVIRALS FOR SYSTEMIC USE|J5
66870|DRUGS USED IN DIABETES|A10
66870|ANTIVIRALS FOR SYSTEMIC USE|J5
66869|DRUGS USED IN DIABETES|A10
66869|ANTIVIRALS FOR SYSTEMIC USE|J5
66868|SYSTEMIC ANTIBACTERIALS|J1
66867|DRUGS USED IN DIABETES|A10
66867|ANTIVIRALS FOR SYSTEMIC USE|J5
66865|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66865|DRUGS USED IN DIABETES|A10
66865|ANTIVIRALS FOR SYSTEMIC USE|J5
66863|ANTIVIRALS FOR SYSTEMIC USE|J5
66861|ANTIVIRALS FOR SYSTEMIC USE|J5
66858|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66858|NOOTROPICS|N6D
66851|DPP-IV inhibitor antidiabetics|A10B6
66850|RADIODIAGNOSTIC AGENTS|T1G
66849|DRUGS USED IN DIABETES|A10
66849|ANTIHYPERTENSIVES|C2
66849|ANTIVIRALS FOR SYSTEMIC USE|J5
66849|RESPIRATORY SYSTEM|R
66846|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66846|ANTIHYPERTENSIVES|C2
66846|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66845|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66842|ANTI-EPILEPTICS|N3A
66841|ANTIHYPERTENSIVES|C2
66840|ANTIVIRALS FOR SYSTEMIC USE|J5
66839|ANALGESICS|N2
66833|ANALGESICS|N2
66823|ANTIVIRALS FOR SYSTEMIC USE|J5
66816|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
66813|ANTIVIRALS FOR SYSTEMIC USE|J5
66812|ANTIHYPERTENSIVES|C2
66808|IMMUNOSTIMULATING AGENTS|L3
66808|DIAGNOSTIC AGENTS|T
66801|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
66798|ANTIEMETICS AND ANTINAUSEANTS|A4
66796|ANTIEMETICS AND ANTINAUSEANTS|A4
66796|ANALGESICS|N2
66794|ANTIVIRALS FOR SYSTEMIC USE|J5
66787|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66781|ANALGESICS|N2
66771|ANTIPSYCHOTICS|N5A
66771|NOOTROPICS|N6D
66767|SYSTEMIC ANTIBACTERIALS|J1
66767|ANTIVIRALS FOR SYSTEMIC USE|J5
66760|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66759|IMMUNOSUPPRESSIVE AGENTS|L4
66757|RESPIRATORY SYSTEM|R
66755|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66749|ANTIVIRALS FOR SYSTEMIC USE|J5
66747|ANTIVIRALS FOR SYSTEMIC USE|J5
66744|NOOTROPICS|N6D
66743|IMMUNOSUPPRESSIVE AGENTS|L4
66742|ANTIVIRALS FOR SYSTEMIC USE|J5
66740|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
66740|RESPIRATORY SYSTEM|R
66738|RADIODIAGNOSTIC AGENTS|T1G
66735|OPHTHALMOLOGICALS|S1
66731|RESPIRATORY SYSTEM|R
66728|HUMAN INSULINS AND ANALOGUES|A10C
66728|Human insulins and analogues, intermediate-acting|A10C2
66725|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66725|GLUCAGON|H4B
66718|NOOTROPICS|N6D
66713|ANALGESICS|N2
66710|ANTI-EPILEPTICS|N3
66708|NOOTROPICS|N6D
66687|ANTIMETABOLITES|L1B
66686|ANTIPSYCHOTICS|N5A
66686|NOOTROPICS|N6D
66682|SYSTEMIC ANTIBACTERIALS|J1
66678|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66677|SYSTEMIC ANTIBACTERIALS|J1
66676|SYSTEMIC ANTIBACTERIALS|J1
66675|SYSTEMIC ANTIBACTERIALS|J1
66674|SYSTEMIC ANTIBACTERIALS|J1
66673|SYSTEMIC ANTIBACTERIALS|J1
66671|WOUND HEALING AGENTS|D3
66669|ANTIVIRALS FOR SYSTEMIC USE|J5
66661|ANALGESICS|N2
66653|OPHTHALMOLOGICALS|S1
66652|ANTIVIRALS FOR SYSTEMIC USE|J5
66651|ANTIVIRALS FOR SYSTEMIC USE|J5
66650|ANALGESICS|N2
66648|OPHTHALMOLOGICALS|S1
66647|ANTIVIRALS FOR SYSTEMIC USE|J5
66646|GASTROPROKINETICS|A3F
66644|DRUGS USED IN DIABETES|A10
66640|CENTRAL NERVOUS SYSTEM|N
66640|ANALGESICS|N2
66639|ANTIVIRALS FOR SYSTEMIC USE|J5
66637|ANALGESICS|N2
66636|ANALGESICS|N2
66634|ALKYLATING AGENTS|L1A
66633|SYSTEMIC ANTIBACTERIALS|J1
66631|ANTIVIRALS FOR SYSTEMIC USE|J5
66630|ANALGESICS|N2
66629|ANALGESICS|N2
66628|SYSTEMIC ANTIBACTERIALS|J1
66628|PARASITOLOGY|P
66627|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
66626|ANALGESICS|N2
66625|ALKYLATING AGENTS|L1A
66624|CALCIUM ANTAGONISTS|C8
66624|ANALGESICS|N2
66624|ANTI-EPILEPTICS|N3
66623|CALCIUM ANTAGONISTS|C8
66623|ANALGESICS|N2
66622|SYSTEMIC ANTIBACTERIALS|J1
66621|NOOTROPICS|N6D
66616|ANTIEMETICS AND ANTINAUSEANTS|A4
66609|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66609|DRUGS USED IN DIABETES|A10
66607|ANTIVIRALS FOR SYSTEMIC USE|J5
66604|PLATELET AGGREGATION INHIBITORS|B1C
66600|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66600|DRUGS USED IN DIABETES|A10
66600|ANTIHYPERTENSIVES|C2
66600|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
66580|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
66578|OPHTHALMOLOGICALS|S1
66573|ANALGESICS|N2
66571|CARDIOVASCULAR SYSTEM|C
66571|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
66570|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
66569|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
66567|ANALGESICS|N2
66564|OPHTHALMOLOGICAL ANTI-INFECTIVES|S1A
66558|SYSTEMIC ANTIBACTERIALS|J1
66556|CARDIOVASCULAR SYSTEM|C
66556|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66556|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
66555|ANTIHYPERTENSIVES|C2
66554|TRANQUILLISERS|N5C
66554|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
66553|PLATELET AGGREGATION INHIBITORS|B1C
66553|CARDIOVASCULAR SYSTEM|C
66553|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66553|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
66553|Statins (HMG-CoA reductase inhibitors)|C10A1
66553|ANALGESICS|N2
66552|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66552|DRUGS USED IN DIABETES|A10
66551|ANALGESICS|N2
66550|ANALGESICS|N2
66546|ANTI-EPILEPTICS|N3
66544|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66540|ANTIHYPERTENSIVES|C2
66540|DIURETICS|C3
66538|ANALGESICS|N2
66537|ANALGESICS|N2
66533|ANTIPROTOZOALS AND ANTHELMINTICS|P1
66533|OPHTHALMOLOGICALS|S1
66526|CARDIOVASCULAR SYSTEM|C
66525|OPHTHALMOLOGICALS|S1
66522|Vitamin B6 (pyridoxine), plain|A11X2
66519|HUMAN INSULINS AND ANALOGUES|A10C
66519|Human insulins and analogues, fast-acting|A10C1
66509|ANALGESICS|N2
66507|RESPIRATORY SYSTEM|R
66506|ANTIPSYCHOTICS|N5A
66506|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
66505|ANTI-MALARIALS|P1D
66503|ANALGESICS|N2
66503|NOOTROPICS|N6D
66500|DERMATOLOGICALS|D
66500|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
66498|ANTIVIRALS FOR SYSTEMIC USE|J5
66495|TRANQUILLISERS|N5C
66493|IMMUNOSUPPRESSIVE AGENTS|L4
66492|IMMUNOSUPPRESSIVE AGENTS|L4
66487|ANTIPSYCHOTICS|N5A
66485|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
66483|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
66464|ANALGESICS|N2
66463|ANTIHYPERTENSIVES|C2
66463|Miotics and antiglaucoma preparations, topical|S1E2
66451|NOOTROPICS|N6D
66444|RESPIRATORY SYSTEM|R
66443|LUNG SURFACTANTS|R7C
66436|ANTIMETABOLITES|L1B
66435|WOUND HEALING AGENTS|D3
66435|SYSTEMIC ANTIBACTERIALS|J1
66433|OPHTHALMOLOGICALS|S1
66431|OPHTHALMOLOGICALS|S1
66429|CENTRAL NERVOUS SYSTEM|N
66428|CARDIOVASCULAR SYSTEM|C
66426|NOOTROPICS|N6D
66425|NOOTROPICS|N6D
66421|OPHTHALMOLOGICALS|S1
66420|IMMUNOSUPPRESSIVE AGENTS|L4
66418|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
66418|CENTRAL NERVOUS SYSTEM|N
66409|SYSTEMIC ANTIBACTERIALS|J1
66402|WOUND HEALING AGENTS|D3
66401|WOUND HEALING AGENTS|D3
66400|WOUND HEALING AGENTS|D3
66398|ANTIMETABOLITES|L1B
66395|ANTIHYPERTENSIVES|C2
66395|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
66394|WOUND HEALING AGENTS|D3
66391|ANTIHYPERTENSIVES|C2
66390|PARASITOLOGY|P
66386|ANTIVIRALS FOR SYSTEMIC USE|J5
66386|Interferons, alpha|L3B1
66385|ANTI-MALARIALS|P1D
66372|IMMUNOSUPPRESSIVE AGENTS|L4
66370|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
66369|CARDIAC THERAPY|C1
66366|IMMUNOSTIMULATING AGENTS|L3
66365|DRUGS USED IN DIABETES|A10
66351|Miotics and antiglaucoma preparations, topical|S1E2
66348|TRANQUILLISERS|N5C
66348|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
66344|SYSTEMIC ANTIBACTERIALS|J1
66342|Ocular antineovascularisation products|S1P
66338|ANTIVIRALS FOR SYSTEMIC USE|J5
66335|ANTIVIRALS FOR SYSTEMIC USE|J5
66319|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
66316|CARDIOVASCULAR SYSTEM|C
66316|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66315|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66314|SYSTEMIC ANTIBACTERIALS|J1
66311|TRANQUILLISERS|N5C
66309|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66306|WOUND HEALING AGENTS|D3
66304|ANTIHYPERTENSIVES|C2
66304|CENTRAL NERVOUS SYSTEM|N
66302|WOUND HEALING AGENTS|D3
66301|IMMUNOSUPPRESSIVE AGENTS|L4
66298|RESPIRATORY SYSTEM|R
66292|RADIODIAGNOSTIC AGENTS|T1G
66291|IMMUNOSTIMULATING AGENTS|L3
66282|SYSTEMIC ANTIBACTERIALS|J1
66281|SYSTEMIC ANTIBACTERIALS|J1
66277|ANTIPSYCHOTICS|N5A
66276|SYSTEMIC ANTIBACTERIALS|J1
66275|SYSTEMIC ANTIBACTERIALS|J1
66274|SYSTEMIC ANTIBACTERIALS|J1
66273|ALKYLATING AGENTS|L1A
66272|Factor VIII|B2D1
66271|ALKYLATING AGENTS|L1A
66269|ANTIVIRALS FOR SYSTEMIC USE|J5
66266|Factor VIII|B2D1
66265|ANTIVIRALS FOR SYSTEMIC USE|J5
66264|ANTIVIRALS FOR SYSTEMIC USE|J5
66262|ANTIVIRALS FOR SYSTEMIC USE|J5
66259|SYSTEMIC ANTIBACTERIALS|J1
66258|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
66256|ANTIPSYCHOTICS|N5A
66256|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
66254|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
66253|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
66251|RADIODIAGNOSTIC AGENTS|T1G
66250|ANTIPROTOZOALS AND ANTHELMINTICS|P1
66250|ANTI-MALARIALS|P1D
66244|ALKYLATING AGENTS|L1A
66241|ANTIPSYCHOTICS|N5A
66238|RESPIRATORY SYSTEM|R
66238|LUNG SURFACTANTS|R7C
66236|BPH (benign prostatic hypertrophy) products |G4C
66236|ANTIPSYCHOTICS|N5A
66235|SYSTEMIC ANTIBACTERIALS|J1
66233|ANALGESICS|N2
66232|DRUGS USED IN DIABETES|A10
66232|HUMAN INSULINS AND ANALOGUES|A10C
66232|Human insulins and analogues, intermediate-acting|A10C2
66231|RESPIRATORY SYSTEM|R
66229|ANTI-GOUT PREPARATIONS|M4
66225|ANALGESICS|N2
66225|ANTI-MIGRAINE PREPARATIONS|N2C
66219|IMMUNOSTIMULATING AGENTS|L3
66215|CARDIOVASCULAR SYSTEM|C
66208|WOUND HEALING AGENTS|D3
66206|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
66205|WOUND HEALING AGENTS|D3
66202|IMMUNOSUPPRESSIVE AGENTS|L4
66195|ANTIPSYCHOTICS|N5A
66195|NOOTROPICS|N6D
66189|MUSCLE RELAXANTS|M3
66185|ANTI-EPILEPTICS|N3
66176|ANTI-EPILEPTICS|N3A
66174|ANTIVIRALS FOR SYSTEMIC USE|J5
66172|SYSTEMIC ANTIBACTERIALS|J1
66169|ANTIEMETICS AND ANTINAUSEANTS|A4
66169|ANTITUSSIVES|R5D
66168|RADIODIAGNOSTIC AGENTS|T1G
66165|IMMUNOSTIMULATING AGENTS|L3
66164|ANTIVIRALS FOR SYSTEMIC USE|J5
66160|IMMUNOSTIMULATING AGENTS|L3
66159|ANTIVIRALS FOR SYSTEMIC USE|J5
66159|EXPECTORANTS|R5C
66159|ANTITUSSIVES|R5D
66158|ANTIVIRALS FOR SYSTEMIC USE|J5
66158|ANTITUSSIVES|R5D
66158|SYSTEMIC ANTIHISTAMINES|R6
66157|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
66156|ANDROGENS, EXCLUDING G3E, G3F|G3B
66155|DRUGS USED IN DIABETES|A10
66154|ANTIVIRALS FOR SYSTEMIC USE|J5
66152|PARASITOLOGY|P
66151|CENTRAL NERVOUS SYSTEM|N
66149|ANTIHYPERTENSIVES|C2
66143|IMMUNOSTIMULATING AGENTS|L3
66142|IMMUNOSTIMULATING AGENTS|L3
66141|Factors II, VII, IX and X|B2D2
66140|IMMUNOSTIMULATING AGENTS|L3
66139|SYSTEMIC ANTIBACTERIALS|J1
66138|ANTIPROTOZOALS AND ANTHELMINTICS|P1
66138|ANTI-MALARIALS|P1D
66137|ANALGESICS|N2
66133|ANTIPSYCHOTICS|N5A
66132|ANTIPSYCHOTICS|N5A
66129|SYSTEMIC ANTIBACTERIALS|J1
66128|ANTI-EPILEPTICS|N3A
66125|SYSTEMIC ANTIBACTERIALS|J1
66124|SYSTEMIC ANTIBACTERIALS|J1
66121|ANTIVIRALS FOR SYSTEMIC USE|J5
66119|IMMUNOSTIMULATING AGENTS|L3
66118|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
66117|PARASITOLOGY|P
66117|ANTI-MALARIALS|P1D
66116|ANTIVIRALS FOR SYSTEMIC USE|J5
66115|IMMUNOSTIMULATING AGENTS|L3
66110|IMMUNOSTIMULATING AGENTS|L3
66109|MUSCULO-SKELETAL SYSTEM|M
66107|TRANQUILLISERS|N5C
66107|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
66103|ANTIHYPERTENSIVES|C2
66101|CENTRAL NERVOUS SYSTEM|N
66099|WOUND HEALING AGENTS|D3
66098|IMMUNOSUPPRESSIVE AGENTS|L4
66085|ANALGESICS|N2
66084|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66084|Statins (HMG-CoA reductase inhibitors)|C10A1
66078|ANTI-ACNE PREPARATIONS|D10
66077|NOOTROPICS|N6D
66075|ANTIVIRALS FOR SYSTEMIC USE|J5
66072|PLATELET AGGREGATION INHIBITORS|B1C
66069|SYSTEMIC ANTIBACTERIALS|J1
66068|ANTIPSYCHOTICS|N5A
66068|NOOTROPICS|N6D
66067|PLATELET AGGREGATION INHIBITORS|B1C
66062|ANTIVIRALS FOR SYSTEMIC USE|J5
66061|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
66058|SYSTEMIC ANTIBACTERIALS|J1
66055|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
66054|WOUND HEALING AGENTS|D3
66053|WOUND HEALING AGENTS|D3
66050|SYSTEMIC ANTIBACTERIALS|J1
66049|CENTRAL NERVOUS SYSTEM|N
66048|CENTRAL NERVOUS SYSTEM|N
66046|NOOTROPICS|N6D
66041|ANTIVIRALS FOR SYSTEMIC USE|J5
66040|IMMUNOSTIMULATING AGENTS|L3
66036|ANTI-EPILEPTICS|N3A
66035|SYSTEMIC ANTIBACTERIALS|J1
66034|NOOTROPICS|N6D
66033|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
66024|ANALGESICS|N2
66023|ANTIPSYCHOTICS|N5A
66021|ANTIHYPERTENSIVES|C2
66021|OPHTHALMOLOGICALS|S1
66021|Miotics and antiglaucoma preparations, topical|S1E2
66019|PLATELET AGGREGATION INHIBITORS|B1C
66019|CARDIOVASCULAR SYSTEM|C
66018|PARASITOLOGY|P
66018|ANTI-MALARIALS|P1D
66013|ANTIHYPERTENSIVES|C2
66009|DRUGS USED IN DIABETES|A10
66009|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
66008|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
66008|DRUGS USED IN DIABETES|A10
66003|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
66000|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65996|ANALGESICS|N2
65995|NOOTROPICS|N6D
65993|ANALGESICS|N2
65993|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65991|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65990|CENTRAL NERVOUS SYSTEM|N
65988|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
65984|RESPIRATORY SYSTEM|R
65982|ANTIPROTOZOALS AND ANTHELMINTICS|P1
65979|ANALGESICS|N2
65976|TRANQUILLISERS|N5C
65976|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65976|SRNI antidepressants|N6A5
65974|DRUGS USED IN DIABETES|A10
65974|ANTIHYPERTENSIVES|C2
65970|ANTIVIRALS FOR SYSTEMIC USE|J5
65967|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65966|IMMUNOSUPPRESSIVE AGENTS|L4
65965|DRUGS USED IN DIABETES|A10
65965|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
65963|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
65962|ANTIHYPERTENSIVES|C2
65961|ANTIHYPERTENSIVES|C2
65961|ACE INHIBITORS, PLAIN|C9A
65955|RESPIRATORY SYSTEM|R
65953|ANTIVIRALS FOR SYSTEMIC USE|J5
65953|RESPIRATORY SYSTEM|R
65950|ANTIPSYCHOTICS|N5A
65947|GASTROPROKINETICS|A3F
65947|LAXATIVES|A6
65947|ANALGESICS|N2
65942|DRUGS USED IN DIABETES|A10
65940|RESPIRATORY SYSTEM|R
65939|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
65937|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
65932|DRUGS USED IN DIABETES|A10
65926|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
65925|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
65924|ANTIVIRALS FOR SYSTEMIC USE|J5
65920|ANALGESICS|N2
65916|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65916|SSRI antidepressants|N6A4
65916|SRNI antidepressants|N6A5
65914|ANTIVIRALS FOR SYSTEMIC USE|J5
65913|Combinations of sulphonylureas and biguanide antidiabetics|A10B3
65911|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65905|SYSTEMIC ANTIBACTERIALS|J1
65902|ANTIVIRALS FOR SYSTEMIC USE|J5
65901|PLATELET AGGREGATION INHIBITORS|B1C
65900|DIRECT THROMBIN INHIBITORS|B1E
65894|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65893|ANALGESICS|N2
65886|ANALGESICS|N2
65882|DPP-IV inhibitor antidiabetics|A10B6
65881|WOUND HEALING AGENTS|D3
65880|Statins (HMG-CoA reductase inhibitors)|C10A1
65880|ANTI-EPILEPTICS|N3
65880|NOOTROPICS|N6D
65879|IMMUNOSTIMULATING AGENTS|L3
65876|B2-STIMULANTS|R3A
65868|ANTI-EPILEPTICS|N3A
65864|TRANQUILLISERS|N5C
65857|THYROID THERAPY|H3
65856|ANDROGENS, EXCLUDING G3E, G3F|G3B
65854|ANTIVIRALS FOR SYSTEMIC USE|J5
65847|IMMUNOSUPPRESSIVE AGENTS|L4
65842|SYSTEMIC ANTIBACTERIALS|J1
65842|MACROLIDES AND SIMILAR TYPES|J1F
65838|NOOTROPICS|N6D
65837|ANTIVIRALS FOR SYSTEMIC USE|J5
65837|IMMUNOSTIMULATING AGENTS|L3
65834|CARDIOVASCULAR SYSTEM|C
65834|ANTIHYPERTENSIVES|C2
65832|ANTIHYPERTENSIVES|C2
65832|RESPIRATORY SYSTEM|R
65829|Erectile dysfunction products|G4B3
65828|CARDIOVASCULAR SYSTEM|C
65827|Ocular antineovascularisation products|S1P
65823|ANTIVIRALS FOR SYSTEMIC USE|J5
65819|IMMUNOSUPPRESSIVE AGENTS|L4
65818|IMMUNOSUPPRESSIVE AGENTS|L4
65816|RESPIRATORY SYSTEM|R
65812|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
65811|ANTIEMETICS AND ANTINAUSEANTS|A4
65809|WOUND HEALING AGENTS|D3
65804|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65804|DRUGS USED IN DIABETES|A10
65804|GLUCAGON|H4B
65801|ANALGESICS|N2
65801|ANTI-MIGRAINE PREPARATIONS|N2C
65801|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65801|SSRI antidepressants|N6A4
65799|ANTIVIRALS FOR SYSTEMIC USE|J5
65792|ANTIVIRALS FOR SYSTEMIC USE|J5
65791|NOOTROPICS|N6D
65791|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
65789|ANTIVIRALS FOR SYSTEMIC USE|J5
65786|NOOTROPICS|N6D
65785|ANTI-EPILEPTICS|N3A
65783|HYPNOTICS/SEDATIVES|N5B
65782|ANTI-EPILEPTICS|N3A
65779|CARDIAC THERAPY|C1
65778|ANALGESICS|N2
65777|ANTI-EPILEPTICS|N3A
65777|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65776|SYSTEMIC ANTIBACTERIALS|J1
65774|ANALGESICS|N2
65771|Factor VIII|B2D1
65768|ANTI-EPILEPTICS|N3A
65767|ANTI-EPILEPTICS|N3A
65764|NOOTROPICS|N6D
65762|PLATELET AGGREGATION INHIBITORS|B1C
65761|IMMUNOSUPPRESSIVE AGENTS|L4
65756|ANTIHYPERTENSIVES|C2
65755|Ocular antineovascularisation products|S1P
65749|ANTI-EPILEPTICS|N3A
65748|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
65743|ANTI-EPILEPTICS|N3
65742|ANTI-EPILEPTICS|N3A
65741|IMMUNOSUPPRESSIVE AGENTS|L4
65740|WOUND HEALING AGENTS|D3
65740|SYSTEMIC ANTIBACTERIALS|J1
65740|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
65740|ANTIVIRALS FOR SYSTEMIC USE|J5
65736|PARASITOLOGY|P
65734|ANALGESICS|N2
65732|ANALGESICS|N2
65731|DRUGS USED IN DIABETES|A10
65730|CARDIOVASCULAR SYSTEM|C
65728|CARDIOVASCULAR SYSTEM|C
65726|WOUND HEALING AGENTS|D3
65726|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
65725|OPHTHALMOLOGICALS|S1
65723|OPHTHALMOLOGICALS|S1
65719|OPHTHALMOLOGICALS|S1
65718|OPHTHALMOLOGICALS|S1
65717|ANTIVIRALS FOR SYSTEMIC USE|J5
65716|OPHTHALMOLOGICALS|S1
65714|CARDIOVASCULAR SYSTEM|C
65712|ANTI-EPILEPTICS|N3A
65711|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65709|ALKYLATING AGENTS|L1A
65706|SYSTEMIC ANTIBACTERIALS|J1
65703|SYSTEMIC ANTIBACTERIALS|J1
65694|ANALGESICS|N2
65691|ANALGESICS|N2
65689|ANALGESICS|N2
65688|CARDIAC THERAPY|C1
65687|WOUND HEALING AGENTS|D3
65686|NOOTROPICS|N6D
65684|ANTI-EPILEPTICS|N3A
65684|OPHTHALMOLOGICALS|S1
65682|ANTIVIRALS FOR SYSTEMIC USE|J5
65680|ANTIVIRALS FOR SYSTEMIC USE|J5
65679|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65674|ANALGESICS|N2
65673|ANTIVIRALS FOR SYSTEMIC USE|J5
65673|IMMUNOSTIMULATING AGENTS|L3
65672|IMMUNOSUPPRESSIVE AGENTS|L4
65671|NOOTROPICS|N6D
65670|NOOTROPICS|N6D
65669|NOOTROPICS|N6D
65665|OPHTHALMOLOGICALS|S1
65660|Interferons, beta|L3B2
65659|RADIODIAGNOSTIC AGENTS|T1G
65657|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65653|SYSTEMIC ANTIBACTERIALS|J1
65652|RESPIRATORY SYSTEM|R
65651|ANALGESICS|N2
65649|DRUGS USED IN DIABETES|A10
65647|OPHTHALMOLOGICALS|S1
65645|WOUND HEALING AGENTS|D3
65644|ANTIVIRALS FOR SYSTEMIC USE|J5
65642|WOUND HEALING AGENTS|D3
65641|WOUND HEALING AGENTS|D3
65637|Biguanide antidiabetics|A10B2
65637|DPP-IV inhibitor antidiabetics|A10B6
65636|SYSTEMIC ANTIBACTERIALS|J1
65629|CARDIOVASCULAR SYSTEM|C
65628|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
65627|ALKYLATING AGENTS|L1A
65625|ANALGESICS|N2
65624|ANALGESICS|N2
65623|ANALGESICS|N2
65622|ANTI-ARRHYTHMICS|C1B
65621|ANTI-ARRHYTHMICS|C1B
65620|ANTIHYPERTENSIVES|C2
65620|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
65619|Statins (HMG-CoA reductase inhibitors)|C10A1
65619|ANTI-EPILEPTICS|N3
65617|DRUGS USED IN DIABETES|A10
65617|ANTI-GOUT PREPARATIONS|M4
65614|OPHTHALMOLOGICALS|S1
65613|ANTI-ARRHYTHMICS|C1B
65612|CENTRAL NERVOUS SYSTEM|N
65610|IMMUNOSTIMULATING AGENTS|L3
65609|Ocular antineovascularisation products|S1P
65608|ANTI-EPILEPTICS|N3A
65607|SYSTEMIC ANTIBACTERIALS|J1
65606|IMMUNOSTIMULATING AGENTS|L3
65605|SYSTEMIC ANTIBACTERIALS|J1
65604|CARDIOVASCULAR SYSTEM|C
65603|DRUGS USED IN DIABETES|A10
65603|ANTIHYPERTENSIVES|C2
65603|ANTIVIRALS FOR SYSTEMIC USE|J5
65603|ANTI-EPILEPTICS|N3
65603|NOOTROPICS|N6D
65600|CENTRAL NERVOUS SYSTEM|N
65600|ANALGESICS|N2
65600|OPHTHALMOLOGICALS|S1
65599|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65599|Statins (HMG-CoA reductase inhibitors)|C10A1
65599|ANTI-EPILEPTICS|N3
65598|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65598|ANALGESICS|N2
65597|NOOTROPICS|N6D
65594|ANALGESICS|N2
65593|ANALGESICS|N2
65593|ANTI-MIGRAINE PREPARATIONS|N2C
65587|Vitamin K|B2B1
65586|CENTRAL NERVOUS SYSTEM|N
65586|ANALGESICS|N2
65586|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65585|HYPNOTICS/SEDATIVES|N5B
65585|TRANQUILLISERS|N5C
65584|ANALGESICS|N2
65580|PARASITOLOGY|P
65574|ANTIVIRALS FOR SYSTEMIC USE|J5
65574|Interferons, alpha|L3B1
65573|ANTI-EPILEPTICS|N3A
65572|ANTIPSYCHOTICS|N5A
65568|ANTIPSYCHOTICS|N5A
65568|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65567|SYSTEMIC ANTIBACTERIALS|J1
65566|RESPIRATORY SYSTEM|R
65565|MUSCULO-SKELETAL SYSTEM|M
65564|CALCIUM ANTAGONISTS|C8
65564|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
65561|CARDIOVASCULAR SYSTEM|C
65560|LUNG SURFACTANTS|R7C
65556|DRUGS USED IN DIABETES|A10
65554|ANTIVIRALS FOR SYSTEMIC USE|J5
65551|IMMUNOSTIMULATING AGENTS|L3
65536|ANALGESICS|N2
65535|ANTITUSSIVES|R5D
65533|RESPIRATORY SYSTEM|R
65528|DRUGS USED IN DIABETES|A10
65528|DPP-IV inhibitor antidiabetics|A10B6
65527|ANTIVIRALS FOR SYSTEMIC USE|J5
65526|ANTI-EPILEPTICS|N3A
65523|ANTIPSYCHOTICS|N5A
65522|DRUGS USED IN DIABETES|A10
65522|HUMAN INSULINS AND ANALOGUES|A10C
65522|Human insulins and analogues, intermediate-acting|A10C2
65521|RESPIRATORY SYSTEM|R
65516|SYSTEMIC ANTIBACTERIALS|J1
65514|NOOTROPICS|N6D
65511|DERMATOLOGICALS|D
65510|DRUGS USED IN DIABETES|A10
65506|ANTIVIRALS FOR SYSTEMIC USE|J5
65499|PLATELET AGGREGATION INHIBITORS|B1C
65498|PLATELET AGGREGATION INHIBITORS|B1C
65498|CARDIOVASCULAR SYSTEM|C
65498|ANTIHYPERTENSIVES|C2
65498|DIURETICS|C3
65498|ACE INHIBITORS, PLAIN|C9A
65498|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65498|Statins (HMG-CoA reductase inhibitors)|C10A1
65497|CARDIOVASCULAR SYSTEM|C
65495|HUMAN INSULINS AND ANALOGUES|A10C
65495|Human insulins and analogues, intermediate-acting|A10C2
65494|SYSTEMIC ANTIBACTERIALS|J1
65494|ANTIVIRALS FOR SYSTEMIC USE|J5
65491|ANALGESICS|N2
65491|NOOTROPICS|N6D
65486|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
65486|OPHTHALMOLOGICALS|S1
65482|WOUND HEALING AGENTS|D3
65480|WOUND HEALING AGENTS|D3
65479|WOUND HEALING AGENTS|D3
65477|IMMUNOSUPPRESSIVE AGENTS|L4
65476|ANALGESICS|N2
65473|Non-nucleoside reverse transcriptase inhibitors|J5C3
65472|ANTIVIRALS FOR SYSTEMIC USE|J5
65471|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65470|ANTIVIRALS FOR SYSTEMIC USE|J5
65469|SYSTEMIC ANTIBACTERIALS|J1
65469|AMINOGLYCOSIDES|J1K
65468|CARDIOVASCULAR SYSTEM|C
65468|POSITIVE INOTROPIC AGENTS|C1F
65466|VITAMIN C, INCLUDING COMBINATIONS WITH MINERALS|A11G
65464|NOOTROPICS|N6D
65463|ANALGESICS|N2
65463|ANTIPSYCHOTICS|N5A
65457|HUMAN INSULINS AND ANALOGUES|A10C
65457|Human insulins and analogues, intermediate-acting|A10C2
65455|IMMUNOSTIMULATING AGENTS|L3
65453|ANTIHYPERTENSIVES|C2
65451|ANTIVIRALS FOR SYSTEMIC USE|J5
65447|ANTIPSYCHOTICS|N5A
65445|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65445|DRUGS USED IN DIABETES|A10
65444|RESPIRATORY SYSTEM|R
65441|PLATELET AGGREGATION INHIBITORS|B1C
65441|CARDIOVASCULAR SYSTEM|C
65441|ANTIHYPERTENSIVES|C2
65441|DIURETICS|C3
65441|ACE INHIBITORS, PLAIN|C9A
65441|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
65441|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65441|Statins (HMG-CoA reductase inhibitors)|C10A1
65440|Factor VIII|B2D1
65438|Factor VIII|B2D1
65437|Factors II, VII, IX and X|B2D2
65436|PLATELET AGGREGATION INHIBITORS|B1C
65436|CARDIOVASCULAR SYSTEM|C
65436|ANTIHYPERTENSIVES|C2
65436|ACE INHIBITORS, PLAIN|C9A
65436|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65436|Statins (HMG-CoA reductase inhibitors)|C10A1
65435|CARDIOVASCULAR SYSTEM|C
65431|SYSTEMIC ANTIBACTERIALS|J1
65430|SYSTEMIC ANTIBACTERIALS|J1
65429|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
65425|Interferons, beta|L3B2
65422|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65421|ALKYLATING AGENTS|L1A
65414|ANALGESICS|N2
65411|SYSTEMIC ANTIBACTERIALS|J1
65409|ANALGESICS|N2
65407|ANTIHYPERTENSIVES|C2
65407|CALCIUM ANTAGONISTS|C8
65405|Systemic dermatological antifungals|D1A2
65405|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
65403|ANTIVIRALS FOR SYSTEMIC USE|J5
65394|OPHTHALMOLOGICALS|S1
65392|SYSTEMIC ANTIBACTERIALS|J1
65388|NOOTROPICS|N6D
65383|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
65380|ANALGESICS|N2
65379|ANALGESICS|N2
65378|ANALGESICS|N2
65375|ANTI-EPILEPTICS|N3
65374|NOOTROPICS|N6D
65366|RESPIRATORY SYSTEM|R
65366|ANTITUSSIVES|R5D
65365|ANTIVIRALS FOR SYSTEMIC USE|J5
65364|ANALGESICS|N2
65362|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65358|PROLACTIN INHIBITORS|G2D
65350|ANTIVIRALS FOR SYSTEMIC USE|J5
65349|PLATELET AGGREGATION INHIBITORS|B1C
65348|ANALGESICS|N2
65347|ANALGESICS|N2
65344|TRANQUILLISERS|N5C
65341|ANALGESICS|N2
65341|ANTI-MIGRAINE PREPARATIONS|N2C
65339|ANTIVIRALS FOR SYSTEMIC USE|J5
65338|TRANQUILLISERS|N5C
65338|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65337|ANTIEMETICS AND ANTINAUSEANTS|A4
65335|CENTRAL NERVOUS SYSTEM|N
65335|ANTIPSYCHOTICS|N5A
65334|CENTRAL NERVOUS SYSTEM|N
65334|ANTIPSYCHOTICS|N5A
65333|CENTRAL NERVOUS SYSTEM|N
65333|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65326|ANTIVIRALS FOR SYSTEMIC USE|J5
65325|OPHTHALMOLOGICALS|S1
65322|Coxibs|M1A3
65322|ANALGESICS|N2
65321|Coxibs|M1A3
65321|ANALGESICS|N2
65314|TRANQUILLISERS|N5C
65314|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65310|CENTRAL NERVOUS SYSTEM|N
65310|ANTIPSYCHOTICS|N5A
65310|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65306|RESPIRATORY SYSTEM|R
65305|WOUND HEALING AGENTS|D3
65304|CENTRAL NERVOUS SYSTEM|N
65303|Interferons, beta|L3B2
65301|RESPIRATORY SYSTEM|R
65300|SYSTEMIC ANTIBACTERIALS|J1
65299|SYSTEMIC ANTIBACTERIALS|J1
65291|Interferons, alpha|L3B1
65286|OPHTHALMOLOGICALS|S1
65284|SYSTEMIC ANTIBACTERIALS|J1
65282|ANALGESICS|N2
65279|RADIODIAGNOSTIC AGENTS|T1G
65277|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
65270|IMMUNOSTIMULATING AGENTS|L3
65268|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65268|DRUGS USED IN DIABETES|A10
65267|SYSTEMIC ANTIBACTERIALS|J1
65253|FIBRINOLYTICS|B1D
65250|CENTRAL NERVOUS SYSTEM|N
65250|NOOTROPICS|N6D
65248|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
65247|ANTIVIRALS FOR SYSTEMIC USE|J5
65241|ANALGESICS|N2
65240|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65238|IMMUNOSUPPRESSIVE AGENTS|L4
65234|ANALGESICS|N2
65233|NOOTROPICS|N6D
65232|ANALGESICS|N2
65225|ANTIULCERANTS|A2B
65224|DERMATOLOGICALS|D
65223|ANTIEMETICS AND ANTINAUSEANTS|A4
65219|ANTIVIRALS FOR SYSTEMIC USE|J5
65218|ANALGESICS|N2
65215|ANTIVIRALS FOR SYSTEMIC USE|J5
65208|ANTI-MALARIALS|P1D
65206|ANTI-ACNE PREPARATIONS|D10
65206|ANTIVIRALS FOR SYSTEMIC USE|J5
65204|ANTI-EPILEPTICS|N3
65202|B2-STIMULANTS|R3A
65200|ANTIVIRALS FOR SYSTEMIC USE|J5
65197|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65196|ANTIVIRALS FOR SYSTEMIC USE|J5
65196|INTERFERONS|L3B
65194|SYSTEMIC ANTIBACTERIALS|J1
65193|SYSTEMIC ANTIBACTERIALS|J1
65191|DRUGS USED IN DIABETES|A10
65190|ANTIHYPERTENSIVES|C2
65190|RESPIRATORY SYSTEM|R
65189|TRANQUILLISERS|N5C
65189|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65182|ANTIVIRALS FOR SYSTEMIC USE|J5
65180|Erectile dysfunction products|G4B3
65173|ANTIVIRALS FOR SYSTEMIC USE|J5
65171|CENTRAL NERVOUS SYSTEM|N
65171|ANALGESICS|N2
65171|TRANQUILLISERS|N5C
65171|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65170|CARDIOVASCULAR SYSTEM|C
65159|WOUND HEALING AGENTS|D3
65156|SYSTEMIC ANTIBACTERIALS|J1
65155|ANTIVIRALS FOR SYSTEMIC USE|J5
65152|ANALGESICS|N2
65134|SYSTEMIC ANTIBACTERIALS|J1
65127|SYSTEMIC ANTIBACTERIALS|J1
65126|TRANQUILLISERS|N5C
65126|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65125|ANTIVIRALS FOR SYSTEMIC USE|J5
65124|DRUGS USED IN DIABETES|A10
65124|HUMAN INSULINS AND ANALOGUES|A10C
65124|Human insulins and analogues, intermediate-acting|A10C2
65122|DRUGS USED IN DIABETES|A10
65122|HUMAN INSULINS AND ANALOGUES|A10C
65122|Human insulins and analogues, intermediate-acting|A10C2
65121|OPHTHALMOLOGICALS|S1
65116|ANTI-EPILEPTICS|N3A
65116|NOOTROPICS|N6D
65115|Topical dermatological antifungals|D1A1
65115|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
65111|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
65111|RESPIRATORY SYSTEM|R
65109|ANTIPSYCHOTICS|N5A
65108|ANTIHYPERTENSIVES|C2
65108|DIURETICS|C3
65095|ANTIHYPERTENSIVES|C2
65095|OPHTHALMOLOGICALS|S1
65092|RADIODIAGNOSTIC AGENTS|T1G
65085|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
65085|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
65084|SYSTEMIC ANTIBACTERIALS|J1
65083|ANTIHYPERTENSIVES|C2
65082|ANTIHYPERTENSIVES|C2
65077|ANTIVIRALS FOR SYSTEMIC USE|J5
65069|ANTIVIRALS FOR SYSTEMIC USE|J5
65069|Non-nucleoside reverse transcriptase inhibitors|J5C3
65068|ANTIVIRALS FOR SYSTEMIC USE|J5
65066|DRUGS USED IN DIABETES|A10
65066|ANTIHYPERTENSIVES|C2
65066|SYSTEMIC ANTIBACTERIALS|J1
65066|ANTIVIRALS FOR SYSTEMIC USE|J5
65066|CENTRAL NERVOUS SYSTEM|N
65064|DERMATOLOGICALS|D
65064|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
65063|DERMATOLOGICALS|D
65061|ANALGESICS|N2
65060|WOUND HEALING AGENTS|D3
65059|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
65054|ALKYLATING AGENTS|L1A
65046|NOOTROPICS|N6D
65046|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
65044|RESPIRATORY SYSTEM|R
65040|ANALGESICS|N2
65037|NOOTROPICS|N6D
65035|ANTIVIRALS FOR SYSTEMIC USE|J5
65027|ALKYLATING AGENTS|L1A
65023|ANALGESICS|N2
65017|PLATELET AGGREGATION INHIBITORS|B1C
65016|PLATELET AGGREGATION INHIBITORS|B1C
65007|WOUND HEALING AGENTS|D3
64998|NOOTROPICS|N6D
64997|ANTIFIBRINOLYTICS|B2A
64994|DRUGS USED IN DIABETES|A10
64992|DRUGS USED IN DIABETES|A10
64992|HUMAN INSULINS AND ANALOGUES|A10C
64992|Human insulins and analogues, intermediate-acting|A10C2
64983|ANTIVIRALS FOR SYSTEMIC USE|J5
64983|IMMUNOSTIMULATING AGENTS|L3
64977|ANALGESICS|N2
64967|ANTI-EPILEPTICS|N3A
64964|ALKYLATING AGENTS|L1A
64963|ANALGESICS|N2
64962|ANTIVIRALS FOR SYSTEMIC USE|J5
64959|ANTI-EPILEPTICS|N3A
64959|ANTIPSYCHOTICS|N5A
64959|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64949|ANALGESICS|N2
64949|ANTI-EPILEPTICS|N3
64948|ANALGESICS|N2
64948|ANTI-EPILEPTICS|N3
64942|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64935|ANTIVIRALS FOR SYSTEMIC USE|J5
64934|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64932|WOUND HEALING AGENTS|D3
64931|RADIODIAGNOSTIC AGENTS|T1G
64923|ANTIHYPERTENSIVES|C2
64923|CALCIUM ANTAGONISTS|C8
64917|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
64916|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
64915|SYSTEMIC ANTIBACTERIALS|J1
64908|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
64903|NOOTROPICS|N6D
64901|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
64901|Statins (HMG-CoA reductase inhibitors)|C10A1
64900|PLATELET AGGREGATION INHIBITORS|B1C
64899|ANTIULCERANTS|A2B
64899|SYSTEMIC ANTIBACTERIALS|J1
64898|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64898|SSRI antidepressants|N6A4
64898|SRNI antidepressants|N6A5
64897|ANTIHYPERTENSIVES|C2
64897|CALCIUM ANTAGONISTS|C8
64896|ANTIHYPERTENSIVES|C2
64896|CALCIUM ANTAGONISTS|C8
64894|ANTIHYPERTENSIVES|C2
64893|PLATELET AGGREGATION INHIBITORS|B1C
64893|CARDIOVASCULAR SYSTEM|C
64893|ANTIHYPERTENSIVES|C2
64893|ACE INHIBITORS, PLAIN|C9A
64893|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
64893|Statins (HMG-CoA reductase inhibitors)|C10A1
64892|TOPICAL ANTI-ACNE PREPARATIONS|D10A
64890|SYSTEMIC ANTIBACTERIALS|J1
64884|NOOTROPICS|N6D
64881|ANTIPSYCHOTICS|N5A
64881|NOOTROPICS|N6D
64879|ANTIPSYCHOTICS|N5A
64879|NOOTROPICS|N6D
64878|ANTIPSYCHOTICS|N5A
64878|NOOTROPICS|N6D
64874|ANALGESICS|N2
64873|DRUGS USED IN DIABETES|A10
64872|ANALGESICS|N2
64868|ANTIVIRALS FOR SYSTEMIC USE|J5
64867|ANTIVIRALS FOR SYSTEMIC USE|J5
64862|ANALGESICS|N2
64856|IMMUNOSUPPRESSIVE AGENTS|L4
64854|NOOTROPICS|N6D
64854|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
64853|RESPIRATORY SYSTEM|R
64852|DRUGS USED IN DIABETES|A10
64850|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64849|ANTI-MIGRAINE PREPARATIONS|N2C
64843|OPHTHALMOLOGICALS|S1
64841|PLATELET AGGREGATION INHIBITORS|B1C
64841|DIRECT THROMBIN INHIBITORS|B1E
64841|Fibrinogen|B2D5
64840|OPHTHALMOLOGICALS|S1
64831|OPHTHALMOLOGICALS|S1
64830|ALKYLATING AGENTS|L1A
64829|DRUGS USED IN DIABETES|A10
64829|HUMAN INSULINS AND ANALOGUES|A10C
64829|Human insulins and analogues, intermediate-acting|A10C2
64817|ANTI-ARRHYTHMICS|C1B
64817|ANTI-EPILEPTICS|N3
64815|IMMUNOSTIMULATING AGENTS|L3
64814|IMMUNOSUPPRESSIVE AGENTS|L4
64811|NOOTROPICS|N6D
64810|NOOTROPICS|N6D
64807|IMMUNOSUPPRESSIVE AGENTS|L4
64806|RESPIRATORY SYSTEM|R
64805|RESPIRATORY SYSTEM|R
64800|ANTIHYPERTENSIVES|C2
64799|ANALGESICS|N2
64799|ANTI-EPILEPTICS|N3A
64799|ANTIPSYCHOTICS|N5A
64799|TRANQUILLISERS|N5C
64798|OPHTHALMOLOGICALS|S1
64797|NOOTROPICS|N6D
64794|ANTIVIRALS FOR SYSTEMIC USE|J5
64791|IMMUNOSTIMULATING AGENTS|L3
64788|IMMUNOSTIMULATING AGENTS|L3
64787|DRUGS USED IN DIABETES|A10
64785|NOOTROPICS|N6D
64779|IMMUNOSUPPRESSIVE AGENTS|L4
64778|RESPIRATORY SYSTEM|R
64777|Alpha-glucosidase inhibitor antidiabetics|A10B5
64774|ANTIVIRALS FOR SYSTEMIC USE|J5
64774|IMMUNOSTIMULATING AGENTS|L3
64773|ANALGESICS|N2
64773|ANTI-MIGRAINE PREPARATIONS|N2C
64771|ANTIPSYCHOTICS|N5A
64769|ANALGESICS|N2
64768|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
64768|CENTRAL NERVOUS SYSTEM|N
64765|ANTI-EPILEPTICS|N3A
64761|Erectile dysfunction products|G4B3
64760|TRANQUILLISERS|N5C
64760|NOOTROPICS|N6D
64759|ANTIVIRALS FOR SYSTEMIC USE|J5
64758|RADIODIAGNOSTIC AGENTS|T1G
64757|ANALGESICS|N2
64757|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64757|SSRI antidepressants|N6A4
64757|SRNI antidepressants|N6A5
64756|PARASITOLOGY|P
64756|ANTI-MALARIALS|P1D
64752|HUMAN INSULINS AND ANALOGUES|A10C
64752|Human insulins and analogues, long-acting|A10C5
64751|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64751|NOOTROPICS|N6D
64747|SYSTEMIC ANTIBACTERIALS|J1
64746|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
64735|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
64734|ANTIHYPERTENSIVES|C2
64734|CALCIUM ANTAGONISTS|C8
64733|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64732|DRUGS USED IN DIABETES|A10
64726|ANTI-EPILEPTICS|N3A
64725|ANTI-EPILEPTICS|N3
64724|ANALGESICS|N2
64717|ANTIMETABOLITES|L1B
64714|ANTI-EPILEPTICS|N3A
64711|ANTI-MIGRAINE PREPARATIONS|N2C
64711|RADIODIAGNOSTIC AGENTS|T1G
64709|ANTIVIRALS FOR SYSTEMIC USE|J5
64708|ANTIVIRALS FOR SYSTEMIC USE|J5
64705|DRUGS USED IN DIABETES|A10
64704|ANTIVIRALS FOR SYSTEMIC USE|J5
64703|ALKYLATING AGENTS|L1A
64700|ANALGESICS|N2
64696|NOOTROPICS|N6D
64695|OPHTHALMOLOGICALS|S1
64693|BPH (benign prostatic hypertrophy) products |G4C
64692|ANTIPSYCHOTICS|N5A
64689|ANTIPSYCHOTICS|N5A
64686|SYSTEMIC ANTIBACTERIALS|J1
64684|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
64683|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
64682|OPHTHALMOLOGICALS|S1
64681|NOOTROPICS|N6D
64680|ANTI-EPILEPTICS|N3A
64679|OPHTHALMOLOGICALS|S1
64679|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
64678|ANTIHYPERTENSIVES|C2
64678|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
64677|SYSTEMIC ANTIBACTERIALS|J1
64676|ANTIVIRALS FOR SYSTEMIC USE|J5
64675|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64672|NOOTROPICS|N6D
64670|ANTIVIRALS FOR SYSTEMIC USE|J5
64667|SYSTEMIC ANTIBACTERIALS|J1
64664|NOOTROPICS|N6D
64661|NOOTROPICS|N6D
64659|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
64657|ANALGESICS|N2
64654|ANALGESICS|N2
64651|ANTIVIRALS FOR SYSTEMIC USE|J5
64650|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
64649|ANTIVIRALS FOR SYSTEMIC USE|J5
64647|ANALGESICS|N2
64646|ANALGESICS|N2
64645|ANDROGENS, EXCLUDING G3E, G3F|G3B
64644|ANALGESICS|N2
64640|ANTIMETABOLITES|L1B
64637|PARASITOLOGY|P
64634|ANTI-EPILEPTICS|N3
64631|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64631|DRUGS USED IN DIABETES|A10
64629|CARDIOVASCULAR SYSTEM|C
64629|Statins (HMG-CoA reductase inhibitors)|C10A1
64625|ANTI-EPILEPTICS|N3A
64620|ANTIVIRALS FOR SYSTEMIC USE|J5
64613|ANTIVIRALS FOR SYSTEMIC USE|J5
64613|IMMUNOSUPPRESSIVE AGENTS|L4
64612|ANTIVIRALS FOR SYSTEMIC USE|J5
64608|OPHTHALMOLOGICALS|S1
64601|ANTIVIRALS FOR SYSTEMIC USE|J5
64594|Ocular antineovascularisation products|S1P
64589|ANTIHYPERTENSIVES|C2
64586|Coxibs|M1A3
64586|ANALGESICS|N2
64585|ANALGESICS|N2
64583|ANALGESICS|N2
64579|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
64577|ANTI-EPILEPTICS|N3A
64574|NOOTROPICS|N6D
64571|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
64570|RESPIRATORY SYSTEM|R
64567|ANTIVIRALS FOR SYSTEMIC USE|J5
64561|RESPIRATORY SYSTEM|R
64560|ANTIVIRALS FOR SYSTEMIC USE|J5
64554|NOOTROPICS|N6D
64547|Urinary incontinence products|G4B4
64546|ANALGESICS|N2
64545|IMMUNOSUPPRESSIVE AGENTS|L4
64541|ANTIVIRALS FOR SYSTEMIC USE|J5
64540|CARDIOVASCULAR SYSTEM|C
64540|ANTIHYPERTENSIVES|C2
64538|NOOTROPICS|N6D
64537|NOOTROPICS|N6D
64536|NOOTROPICS|N6D
64531|SYSTEMIC ANTIBACTERIALS|J1
64530|SYSTEMIC ANTIBACTERIALS|J1
64529|ANTIVIRALS FOR SYSTEMIC USE|J5
64528|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
64527|SYSTEMIC ANTIBACTERIALS|J1
64526|DERMATOLOGICALS|D
64526|SYSTEMIC ANTIBACTERIALS|J1
64525|ANTIVIRALS FOR SYSTEMIC USE|J5
64523|ANTI-EPILEPTICS|N3A
64513|HUMAN INSULINS AND ANALOGUES|A10C
64513|Human insulins and analogues, long-acting|A10C5
64512|ANTIVIRALS FOR SYSTEMIC USE|J5
64511|DRUGS USED IN DIABETES|A10
64506|ANALGESICS|N2
64505|WOUND HEALING AGENTS|D3
64505|SYSTEMIC ANTIBACTERIALS|J1
64504|RESPIRATORY SYSTEM|R
64503|SYSTEMIC ANTIBACTERIALS|J1
64503|ANTIVIRALS FOR SYSTEMIC USE|J5
64500|ANTI-EPILEPTICS|N3A
64497|OPHTHALMOLOGICALS|S1
64496|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
64494|ANALGESICS|N2
64492|TOPICAL ANTI-ACNE PREPARATIONS|D10A
64492|SYSTEMIC ANTIBACTERIALS|J1
64486|ANTIFIBRINOLYTICS|B2A
64483|SYSTEMIC ANTIBACTERIALS|J1
64482|ANTIVIRALS FOR SYSTEMIC USE|J5
64481|Biguanide antidiabetics|A10B2
64480|ALKYLATING AGENTS|L1A
64479|ANALGESICS|N2
64479|ANTI-MIGRAINE PREPARATIONS|N2C
64479|ANTI-EPILEPTICS|N3
64477|ANTI-EPILEPTICS|N3
64473|SYSTEMIC ANTIBACTERIALS|J1
64472|ANALGESICS|N2
64472|ANTI-EPILEPTICS|N3
64470|SYSTEMIC ANTIBACTERIALS|J1
64470|ANTIVIRALS FOR SYSTEMIC USE|J5
64466|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
64462|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
64459|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64459|DRUGS USED IN DIABETES|A10
64457|ANTI-ACNE PREPARATIONS|D10
64457|SYSTEMIC ANTIBACTERIALS|J1
64456|SYSTEMIC ANTIBACTERIALS|J1
64453|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64450|Systemic dermatological antifungals|D1A2
64450|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
64446|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
64441|DRUGS USED IN DIABETES|A10
64438|ANALGESICS|N2
64433|ANALGESICS|N2
64428|ANALGESICS|N2
64427|Factor VIII|B2D1
64425|ANTIVIRALS FOR SYSTEMIC USE|J5
64424|Topical dermatological antifungals|D1A1
64424|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
64420|WOUND HEALING AGENTS|D3
64420|SYSTEMIC ANTIBACTERIALS|J1
64419|OPHTHALMOLOGICALS|S1
64416|SYSTEMIC ANTIBACTERIALS|J1
64413|SYSTEMIC ANTIBACTERIALS|J1
64412|ANTIVIRALS FOR SYSTEMIC USE|J5
64412|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
64411|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
64407|ANTIVIRALS FOR SYSTEMIC USE|J5
64404|SYSTEMIC ANTIBACTERIALS|J1
64403|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
64402|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64400|ANTIVIRALS FOR SYSTEMIC USE|J5
64397|SYSTEMIC ANTIBACTERIALS|J1
64387|ANTIVIRALS FOR SYSTEMIC USE|J5
64374|ANTIVIRALS FOR SYSTEMIC USE|J5
64373|ANTIVIRALS FOR SYSTEMIC USE|J5
64371|ANTIHYPERTENSIVES|C2
64371|CALCIUM ANTAGONISTS|C8
64368|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
64366|Biguanide antidiabetics|A10B2
64366|Alpha-glucosidase inhibitor antidiabetics|A10B5
64364|ANTI-MIGRAINE PREPARATIONS|N2C
64362|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64362|NOOTROPICS|N6D
64361|ALKYLATING AGENTS|L1A
64360|OPHTHALMOLOGICALS|S1
64358|PLATELET AGGREGATION INHIBITORS|B1C
64358|CARDIOVASCULAR SYSTEM|C
64357|IMMUNOSUPPRESSIVE AGENTS|L4
64355|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64348|ANTIVIRALS FOR SYSTEMIC USE|J5
64345|RADIODIAGNOSTIC AGENTS|T1G
64344|RADIODIAGNOSTIC AGENTS|T1G
64342|ANTIVIRALS FOR SYSTEMIC USE|J5
64339|ANALGESICS|N2
64334|DRUGS USED IN DIABETES|A10
64334|Biguanide antidiabetics|A10B2
64334|DPP-IV inhibitor antidiabetics|A10B6
64328|ANTIPSYCHOTICS|N5A
64326|ANALGESICS|N2
64316|ANALGESICS|N2
64316|ANTI-EPILEPTICS|N3
64316|TRANQUILLISERS|N5C
64315|ANTIVIRALS FOR SYSTEMIC USE|J5
64313|ANTIVIRALS FOR SYSTEMIC USE|J5
64313|IMMUNOSUPPRESSIVE AGENTS|L4
64310|IMMUNOSTIMULATING AGENTS|L3
64309|SYSTEMIC ANTIBACTERIALS|J1
64308|SYSTEMIC ANTIBACTERIALS|J1
64305|ANTIHYPERTENSIVES|C2
64305|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
64302|NOOTROPICS|N6D
64300|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
64300|PARASITOLOGY|P
64293|IMMUNOSTIMULATING AGENTS|L3
64292|ANTIPSYCHOTICS|N5A
64291|GASTROPROKINETICS|A3F
64288|PARASITOLOGY|P
64288|ANTI-MALARIALS|P1D
64286|ANTIVIRALS FOR SYSTEMIC USE|J5
64285|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64284|WOUND HEALING AGENTS|D3
64282|Factor VIII|B2D1
64281|ANTIHYPERTENSIVES|C2
64280|ANTI-EPILEPTICS|N3A
64279|Topical dermatological antifungals|D1A1
64279|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
64278|WOUND HEALING AGENTS|D3
64275|ANALGESICS|N2
64275|SSRI antidepressants|N6A4
64275|SRNI antidepressants|N6A5
64274|ANTIVIRALS FOR SYSTEMIC USE|J5
64272|ANALGESICS|N2
64270|ANALGESICS|N2
64267|RADIODIAGNOSTIC AGENTS|T1G
64263|ANTIVIRALS FOR SYSTEMIC USE|J5
64261|CENTRAL NERVOUS SYSTEM|N
64260|ANTIHYPERTENSIVES|C2
64259|SYSTEMIC ANTIBACTERIALS|J1
64258|PARASITOLOGY|P
64255|ANALGESICS|N2
64253|CARDIOVASCULAR SYSTEM|C
64251|ANTIVIRALS FOR SYSTEMIC USE|J5
64247|CENTRAL NERVOUS SYSTEM|N
64247|NOOTROPICS|N6D
64245|ANTIVIRALS FOR SYSTEMIC USE|J5
64244|ANTI-EPILEPTICS|N3
64242|ANALGESICS|N2
64241|ANTIVIRALS FOR SYSTEMIC USE|J5
64240|NOOTROPICS|N6D
64238|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
64236|ANTIEMETICS AND ANTINAUSEANTS|A4
64236|ANAESTHETICS, GENERAL|N1A
64236|HYPNOTICS/SEDATIVES|N5B
64234|ANTIVIRALS FOR SYSTEMIC USE|J5
64229|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64229|SSRI antidepressants|N6A4
64229|SRNI antidepressants|N6A5
64226|NOOTROPICS|N6D
64225|HYPNOTICS/SEDATIVES|N5B
64224|RESPIRATORY SYSTEM|R
64223|ANTI-EPILEPTICS|N3A
64212|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64211|NOOTROPICS|N6D
64210|DRUGS USED IN DIABETES|A10
64201|IMMUNOSUPPRESSIVE AGENTS|L4
64199|IMMUNOSTIMULATING AGENTS|L3
64194|TRANQUILLISERS|N5C
64192|ANTI-MIGRAINE PREPARATIONS|N2C
64187|ANTIVIRALS FOR SYSTEMIC USE|J5
64183|NOOTROPICS|N6D
64182|ANTIHYPERTENSIVES|C2
64182|Erectile dysfunction products|G4B3
64180|NOOTROPICS|N6D
64179|DRUGS USED IN DIABETES|A10
64179|DPP-IV inhibitor antidiabetics|A10B6
64174|ANTIVIRALS FOR SYSTEMIC USE|J5
64172|RESPIRATORY SYSTEM|R
64171|CARDIOVASCULAR SYSTEM|C
64171|ANALGESICS|N2
64169|ANTIVIRALS FOR SYSTEMIC USE|J5
64168|ANALGESICS|N2
64167|ANALGESICS|N2
64164|ANTI-EPILEPTICS|N3A
64163|ANTI-EPILEPTICS|N3A
64160|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64160|SSRI antidepressants|N6A4
64153|SYSTEMIC ANTIBACTERIALS|J1
64151|RESPIRATORY SYSTEM|R
64150|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
64149|RESPIRATORY SYSTEM|R
64148|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64147|RESPIRATORY SYSTEM|R
64146|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64145|DRUGS USED IN DIABETES|A10
64145|ANALGESICS|N2
64142|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64142|SSRI antidepressants|N6A4
64142|SRNI antidepressants|N6A5
64141|ANTIVIRALS FOR SYSTEMIC USE|J5
64132|OPHTHALMOLOGICALS|S1
64126|ANALGESICS|N2
64121|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
64121|OPHTHALMOLOGICALS|S1
64120|Ocular antineovascularisation products|S1P
64118|IMMUNOSTIMULATING AGENTS|L3
64112|ANTIVIRALS FOR SYSTEMIC USE|J5
64106|CARDIOVASCULAR SYSTEM|C
64106|CALCIUM ANTAGONISTS|C8
64105|HYPNOTICS/SEDATIVES|N5B
64103|ANTI-EPILEPTICS|N3
64102|TRANQUILLISERS|N5C
64102|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
64099|RADIODIAGNOSTIC AGENTS|T1G
64098|ANTIVIRALS FOR SYSTEMIC USE|J5
64098|IMMUNOSTIMULATING AGENTS|L3
64095|SYSTEMIC ANTIBACTERIALS|J1
64095|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
64089|ANTIVIRALS FOR SYSTEMIC USE|J5
64081|ANTIVIRALS FOR SYSTEMIC USE|J5
64081|VACCINES|J7
64080|VACCINES|J7
64079|ANTIVIRALS FOR SYSTEMIC USE|J5
64073|OPHTHALMOLOGICALS|S1
64068|OPHTHALMOLOGICALS|S1
64067|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
64067|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
64066|ANTIVIRALS FOR SYSTEMIC USE|J5
64064|ANALGESICS|N2
64063|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
64060|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
64057|GASTROPROKINETICS|A3F
64057|ANTIEMETICS AND ANTINAUSEANTS|A4
64056|CARDIOVASCULAR SYSTEM|C
64053|ANTIVIRALS FOR SYSTEMIC USE|J5
64052|NOOTROPICS|N6D
64051|ANAESTHETICS, LOCAL|N1B
64048|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64047|WOUND HEALING AGENTS|D3
64046|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
64045|ANTIPSYCHOTICS|N5A
64045|NOOTROPICS|N6D
64044|TRANQUILLISERS|N5C
64043|ANALGESICS|N2
64043|RESPIRATORY SYSTEM|R
64042|PLATELET AGGREGATION INHIBITORS|B1C
64041|NOOTROPICS|N6D
64040|NOOTROPICS|N6D
64039|DRUGS USED IN DIABETES|A10
64039|ANTI-EPILEPTICS|N3A
64039|OPHTHALMOLOGICALS|S1
64037|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
64037|ANTI-ACNE PREPARATIONS|D10
64037|SYSTEMIC ANTIBACTERIALS|J1
64034|ANTIPSYCHOTICS|N5A
64032|PARASITOLOGY|P
64030|NOOTROPICS|N6D
64028|WOUND HEALING AGENTS|D3
64027|RADIODIAGNOSTIC AGENTS|T1G
64026|ANDROGENS, EXCLUDING G3E, G3F|G3B
64023|SYSTEMIC ANTIBACTERIALS|J1
64022|ANTI-GOUT PREPARATIONS|M4
64019|ANALGESICS|N2
64016|ANTIVIRALS FOR SYSTEMIC USE|J5
64015|ANTIVIRALS FOR SYSTEMIC USE|J5
64014|ANTIVIRALS FOR SYSTEMIC USE|J5
64013|ANALGESICS|N2
64012|ANALGESICS|N2
64011|ANALGESICS|N2
64008|ANTIVIRALS FOR SYSTEMIC USE|J5
64006|GASTROPROKINETICS|A3F
64002|ANTIHYPERTENSIVES|C2
64001|WOUND HEALING AGENTS|D3
64000|RESPIRATORY SYSTEM|R
64000|EXPECTORANTS|R5C
64000|ANTITUSSIVES|R5D
63999|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
63996|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
63995|ANALGESICS|N2
63994|ANALGESICS|N2
63990|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63988|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
63988|Non-nucleoside reverse transcriptase inhibitors|J5C3
63982|ANTIHYPERTENSIVES|C2
63980|NOOTROPICS|N6D
63980|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
63979|NOOTROPICS|N6D
63975|ANTIVIRALS FOR SYSTEMIC USE|J5
63974|CARDIOVASCULAR SYSTEM|C
63970|LUNG SURFACTANTS|R7C
63969|ANTIHYPERTENSIVES|C2
63965|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63962|RESPIRATORY SYSTEM|R
63962|LUNG SURFACTANTS|R7C
63958|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63958|DRUGS USED IN DIABETES|A10
63955|NOOTROPICS|N6D
63954|ANTIVIRALS FOR SYSTEMIC USE|J5
63952|BPH (benign prostatic hypertrophy) products |G4C
63951|ANTIVIRALS FOR SYSTEMIC USE|J5
63950|ANALGESICS|N2
63947|OPHTHALMOLOGICALS|S1
63946|RESPIRATORY SYSTEM|R
63945|RESPIRATORY SYSTEM|R
63944|NOOTROPICS|N6D
63943|PARASITOLOGY|P
63942|PLATELET AGGREGATION INHIBITORS|B1C
63942|Coxibs|M1A3
63935|ANTIVIRALS FOR SYSTEMIC USE|J5
63931|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
63927|ANTIPROTOZOALS AND ANTHELMINTICS|P1
63927|ANTI-MALARIALS|P1D
63925|ANTI-GOUT PREPARATIONS|M4
63914|NOOTROPICS|N6D
63913|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
63913|ANTIVIRALS FOR SYSTEMIC USE|J5
63912|ANALGESICS|N2
63912|SRNI antidepressants|N6A5
63911|SYSTEMIC ANTIBACTERIALS|J1
63908|ANTIVIRALS FOR SYSTEMIC USE|J5
63906|ANTIVIRALS FOR SYSTEMIC USE|J5
63902|SYSTEMIC ANTIBACTERIALS|J1
63898|WOUND HEALING AGENTS|D3
63896|ULTRASOUND AGENTS|T1F
63895|ANTIHYPERTENSIVES|C2
63894|Interferons, beta|L3B2
63893|ANTIVIRALS FOR SYSTEMIC USE|J5
63892|ANTIVIRALS FOR SYSTEMIC USE|J5
63891|OPHTHALMOLOGICALS|S1
63890|Coxibs|M1A3
63890|ANALGESICS|N2
63890|OPHTHALMOLOGICALS|S1
63888|ANTIVIRALS FOR SYSTEMIC USE|J5
63886|GROWTH HORMONES|H4C
63885|ANTIVIRALS FOR SYSTEMIC USE|J5
63885|Interferons, beta|L3B2
63881|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63880|ANTI-EPILEPTICS|N3A
63880|NOOTROPICS|N6D
63874|RESPIRATORY SYSTEM|R
63873|ANALGESICS|N2
63863|ANTI-ACNE PREPARATIONS|D10
63857|GASTROPROKINETICS|A3F
63853|OPHTHALMOLOGICALS|S1
63852|OPHTHALMOLOGICALS|S1
63851|ANTI-EPILEPTICS|N3A
63850|OPHTHALMOLOGICALS|S1
63847|OPHTHALMOLOGICALS|S1
63847|Ocular antineovascularisation products|S1P
63846|CENTRAL NERVOUS SYSTEM|N
63841|SYSTEMIC ANTIBACTERIALS|J1
63838|TRANQUILLISERS|N5C
63833|DERMATOLOGICALS|D
63831|DERMATOLOGICALS|D
63826|Erectile dysfunction products|G4B3
63824|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63823|ANALGESICS|N2
63822|IMMUNOSUPPRESSIVE AGENTS|L4
63822|ANALGESICS|N2
63821|ANTIVIRALS FOR SYSTEMIC USE|J5
63817|DERMATOLOGICALS|D
63807|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63805|ANALGESICS|N2
63803|RADIODIAGNOSTIC AGENTS|T1G
63800|TRANQUILLISERS|N5C
63797|IMMUNOSTIMULATING AGENTS|L3
63795|OPHTHALMOLOGICALS|S1
63793|ANALGESICS|N2
63792|MUSCULO-SKELETAL SYSTEM|M
63791|RADIODIAGNOSTIC AGENTS|T1G
63790|ANTI-EPILEPTICS|N3
63788|OPHTHALMOLOGICALS|S1
63787|Interferons, beta|L3B2
63784|Interferons, beta|L3B2
63769|TRANQUILLISERS|N5C
63768|ANALGESICS|N2
63768|HYPNOTICS/SEDATIVES|N5B
63767|HYPNOTICS/SEDATIVES|N5B
63766|MUSCLE RELAXANTS|M3
63761|NOOTROPICS|N6D
63759|CENTRAL NERVOUS SYSTEM|N
63758|ANTIVIRALS FOR SYSTEMIC USE|J5
63756|RESPIRATORY SYSTEM|R
63754|ANTIVIRALS FOR SYSTEMIC USE|J5
63753|ANTI-EPILEPTICS|N3
63751|CENTRAL NERVOUS SYSTEM|N
63747|RADIODIAGNOSTIC AGENTS|T1G
63742|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
63740|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
63739|WOUND HEALING AGENTS|D3
63736|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
63736|NOOTROPICS|N6D
63735|OPHTHALMOLOGICALS|S1
63734|OPHTHALMOLOGICALS|S1
63730|ANTIVIRALS FOR SYSTEMIC USE|J5
63729|RADIODIAGNOSTIC AGENTS|T1G
63725|RADIODIAGNOSTIC AGENTS|T1G
63724|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
63722|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
63721|ANALGESICS|N2
63720|ANALGESICS|N2
63719|PARASITOLOGY|P
63719|ANTI-MALARIALS|P1D
63711|ANTIHYPERTENSIVES|C2
63706|DIAGNOSTIC AGENTS|T
63706|RADIODIAGNOSTIC AGENTS|T1G
63703|ANTIHYPERTENSIVES|C2
63703|CALCIUM ANTAGONISTS|C8
63702|B2-STIMULANTS|R3A
63700|RADIODIAGNOSTIC AGENTS|T1G
63698|RADIODIAGNOSTIC AGENTS|T1G
63697|B2-STIMULANTS|R3A
63696|ANTIVIRALS FOR SYSTEMIC USE|J5
63695|ANALGESICS|N2
63692|WOUND HEALING AGENTS|D3
63690|ANTIVIRALS FOR SYSTEMIC USE|J5
63687|NOOTROPICS|N6D
63684|ANTIHYPERTENSIVES|C2
63681|ANTIEMETICS AND ANTINAUSEANTS|A4
63680|IMMUNOSTIMULATING AGENTS|L3
63673|SYSTEMIC ANTIBACTERIALS|J1
63672|SYSTEMIC ANTIBACTERIALS|J1
63671|SYSTEMIC ANTIBACTERIALS|J1
63668|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63666|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63664|RADIODIAGNOSTIC AGENTS|T1G
63662|HYPNOTICS/SEDATIVES|N5B
63660|ANTIVIRALS FOR SYSTEMIC USE|J5
63660|ANALGESICS|N2
63657|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63657|DRUGS USED IN DIABETES|A10
63655|NOOTROPICS|N6D
63652|ANTI-EPILEPTICS|N3A
63643|IMMUNOSTIMULATING AGENTS|L3
63641|ANTIVIRALS FOR SYSTEMIC USE|J5
63631|ANTIHYPERTENSIVES|C2
63631|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
63631|Statins (HMG-CoA reductase inhibitors)|C10A1
63629|BETA-BLOCKING AGENTS|C7
63623|FIBRINOLYTICS|B1D
63623|OPHTHALMOLOGICALS|S1
63620|ANTIPSYCHOTICS|N5A
63620|NOOTROPICS|N6D
63610|ANTIULCERANTS|A2B
63602|RESPIRATORY SYSTEM|R
63599|DPP-IV inhibitor antidiabetics|A10B6
63598|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63594|WOUND HEALING AGENTS|D3
63590|GLUCAGON|H4B
63586|WOUND HEALING AGENTS|D3
63585|ANTIPSYCHOTICS|N5A
63585|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63582|ANTIVIRALS FOR SYSTEMIC USE|J5
63581|ANTIVIRALS FOR SYSTEMIC USE|J5
63580|ANTIVIRALS FOR SYSTEMIC USE|J5
63562|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63561|PARASITOLOGY|P
63559|ANTIVIRALS FOR SYSTEMIC USE|J5
63557|GASTROPROKINETICS|A3F
63552|ANTIVIRALS FOR SYSTEMIC USE|J5
63551|SYSTEMIC ANTIBACTERIALS|J1
63548|CARDIOVASCULAR SYSTEM|C
63548|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
63547|DRUGS USED IN DIABETES|A10
63545|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63542|CARDIOVASCULAR SYSTEM|C
63538|GROWTH HORMONES|H4C
63537|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
63535|ANTIVIRALS FOR SYSTEMIC USE|J5
63528|CARDIOVASCULAR SYSTEM|C
63525|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
63524|SYSTEMIC ANTIBACTERIALS|J1
63523|SYSTEMIC ANTIBACTERIALS|J1
63522|SYSTEMIC ANTIBACTERIALS|J1
63521|IMMUNOSUPPRESSIVE AGENTS|L4
63517|Topical dermatological antifungals|D1A1
63517|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
63516|ANTIVIRALS FOR SYSTEMIC USE|J5
63514|OPHTHALMOLOGICALS|S1
63513|OPHTHALMOLOGICALS|S1
63512|IMMUNOSTIMULATING AGENTS|L3
63511|IMMUNOSUPPRESSIVE AGENTS|L4
63510|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
63507|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63506|OPHTHALMOLOGICALS|S1
63502|CARDIOVASCULAR SYSTEM|C
63502|ANTIHYPERTENSIVES|C2
63498|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63498|SSRI antidepressants|N6A4
63498|SRNI antidepressants|N6A5
63497|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63494|IMMUNOSUPPRESSIVE AGENTS|L4
63493|IMMUNOSUPPRESSIVE AGENTS|L4
63492|IMMUNOSUPPRESSIVE AGENTS|L4
63490|ANTI-EPILEPTICS|N3
63489|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63487|ANTIVIRALS FOR SYSTEMIC USE|J5
63486|IMMUNOSUPPRESSIVE AGENTS|L4
63485|CENTRAL NERVOUS SYSTEM|N
63484|DRUGS USED IN DIABETES|A10
63484|CARDIOVASCULAR SYSTEM|C
63484|OPHTHALMOLOGICALS|S1
63481|DERMATOLOGICALS|D
63480|CARDIOVASCULAR SYSTEM|C
63480|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
63479|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
63478|ANTIVIRALS FOR SYSTEMIC USE|J5
63477|VACCINES|J7
63471|ANALGESICS|N2
63465|Antigonadotrophin-releasing hormones|H1C3
63461|ANTIVIRALS FOR SYSTEMIC USE|J5
63455|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63455|ANTIHYPERTENSIVES|C2
63453|ANTIVIRALS FOR SYSTEMIC USE|J5
63452|RESPIRATORY SYSTEM|R
63446|WOUND HEALING AGENTS|D3
63445|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63445|DRUGS USED IN DIABETES|A10
63442|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63442|DRUGS USED IN DIABETES|A10
63440|WOUND HEALING AGENTS|D3
63435|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63435|DRUGS USED IN DIABETES|A10
63433|WOUND HEALING AGENTS|D3
63432|NOOTROPICS|N6D
63429|DRUGS USED IN DIABETES|A10
63426|ANTIFIBRINOLYTICS|B2A
63421|SYSTEMIC ANTIBACTERIALS|J1
63420|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
63417|IMMUNOSUPPRESSIVE AGENTS|L4
63415|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63415|DRUGS USED IN DIABETES|A10
63407|PLATELET AGGREGATION INHIBITORS|B1C
63406|Ocular antineovascularisation products|S1P
63405|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
63402|ANTIHYPERTENSIVES|C2
63396|CARDIOVASCULAR SYSTEM|C
63395|OPHTHALMOLOGICALS|S1
63394|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
63393|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
63393|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
63392|CARDIOVASCULAR SYSTEM|C
63391|CARDIOVASCULAR SYSTEM|C
63390|CARDIOVASCULAR SYSTEM|C
63389|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
63387|ANTIHYPERTENSIVES|C2
63387|OPHTHALMOLOGICALS|S1
63387|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
63386|OPHTHALMOLOGICALS|S1
63384|PLATELET AGGREGATION INHIBITORS|B1C
63384|Coxibs|M1A3
63383|OPHTHALMOLOGICALS|S1
63382|Ocular antineovascularisation products|S1P
63381|IMMUNOSTIMULATING AGENTS|L3
63377|RESPIRATORY SYSTEM|R
63376|OPHTHALMOLOGICALS|S1
63376|Ocular antineovascularisation products|S1P
63375|ANTIVIRALS FOR SYSTEMIC USE|J5
63372|ANTIVIRALS FOR SYSTEMIC USE|J5
63371|OPHTHALMOLOGICALS|S1
63361|ANTIVIRALS FOR SYSTEMIC USE|J5
63360|ANALGESICS|N2
63359|ANTIVIRALS FOR SYSTEMIC USE|J5
63358|DIURETICS|C3
63356|ANTIHYPERTENSIVES|C2
63356|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
63353|TRANQUILLISERS|N5C
63353|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63349|ANTIVIRALS FOR SYSTEMIC USE|J5
63349|VACCINES|J7
63348|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63348|ANTIPSYCHOTICS|N5A
63346|OPHTHALMOLOGICALS|S1
63346|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
63344|NOOTROPICS|N6D
63342|SYSTEMIC ANTIBACTERIALS|J1
63342|OPHTHALMOLOGICALS|S1
63341|ANTIEMETICS AND ANTINAUSEANTS|A4
63340|ANTIVIRALS FOR SYSTEMIC USE|J5
63340|VACCINES|J7
63339|OPHTHALMOLOGICALS|S1
63338|Ocular antineovascularisation products|S1P
63337|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
63337|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
63336|BETA-BLOCKING AGENTS|C7
63335|IMMUNOSUPPRESSIVE AGENTS|L4
63334|ANTIVIRALS FOR SYSTEMIC USE|J5
63332|ANTIHYPERTENSIVES|C2
63331|Miotics and antiglaucoma preparations, topical|S1E2
63330|OPHTHALMOLOGICALS|S1
63329|ANTIPSYCHOTICS|N5A
63328|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
63327|ANTI-EPILEPTICS|N3
63324|ANTIVIRALS FOR SYSTEMIC USE|J5
63323|PARASITOLOGY|P
63323|ANTI-MALARIALS|P1D
63320|ANDROGENS, EXCLUDING G3E, G3F|G3B
63318|GASTROPROKINETICS|A3F
63318|ANTIEMETICS AND ANTINAUSEANTS|A4
63317|ANTIVIRALS FOR SYSTEMIC USE|J5
63316|ANTIVIRALS FOR SYSTEMIC USE|J5
63315|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
63313|CARDIOVASCULAR SYSTEM|C
63312|IMMUNOSTIMULATING AGENTS|L3
63312|RESPIRATORY SYSTEM|R
63306|SYSTEMIC ANTIBACTERIALS|J1
63304|Factors II, VII, IX and X|B2D2
63292|CARDIOVASCULAR SYSTEM|C
63290|ANTIVIRALS FOR SYSTEMIC USE|J5
63289|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63289|ANTIHYPERTENSIVES|C2
63288|ANTI-EPILEPTICS|N3A
63287|TRANQUILLISERS|N5C
63283|Ocular antineovascularisation products|S1P
63282|OPHTHALMOLOGICALS|S1
63280|IMMUNOSUPPRESSIVE AGENTS|L4
63278|IMMUNOSUPPRESSIVE AGENTS|L4
63268|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
63268|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
63262|ANTIVIRALS FOR SYSTEMIC USE|J5
63262|RESPIRATORY SYSTEM|R
63259|WOUND HEALING AGENTS|D3
63247|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
63247|SYSTEMIC ANTIBACTERIALS|J1
63237|SYSTEMIC ANTIBACTERIALS|J1
63224|Non-nucleoside reverse transcriptase inhibitors|J5C3
63218|SYSTEMIC ANTIBACTERIALS|J1
63214|ANTIVIRALS FOR SYSTEMIC USE|J5
63203|ANTIPSYCHOTICS|N5A
63201|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
63194|ANTI-EPILEPTICS|N3A
63192|ANTIPSYCHOTICS|N5A
63190|ANTI-ARRHYTHMICS|C1B
63188|OPHTHALMOLOGICALS|S1
63186|ANTIEMETICS AND ANTINAUSEANTS|A4
63184|Vitamin D|A11C2
63176|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63172|IMMUNOSUPPRESSIVE AGENTS|L4
63170|IMMUNOSUPPRESSIVE AGENTS|L4
63147|ANTIMETABOLITES|L1B
63146|CENTRAL NERVOUS SYSTEM|N
63133|ANALGESICS|N2
63131|ANTI-EPILEPTICS|N3A
63130|ANTIHYPERTENSIVES|C2
63128|PLATELET AGGREGATION INHIBITORS|B1C
63128|CARDIOVASCULAR SYSTEM|C
63126|CARDIOVASCULAR SYSTEM|C
63124|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
63124|SYSTEMIC ANTIBACTERIALS|J1
63119|ANTIVIRALS FOR SYSTEMIC USE|J5
63119|Protease inhibitors|J5C2
63117|Factor VIII|B2D1
63116|ANTIPSYCHOTICS|N5A
63114|CARDIOVASCULAR SYSTEM|C
63112|ALKYLATING AGENTS|L1A
63110|IMMUNOSTIMULATING AGENTS|L3
63102|ANALGESICS|N2
63101|SYSTEMIC ANTIBACTERIALS|J1
63100|ANALGESICS|N2
63092|GASTROPROKINETICS|A3F
63092|ANALGESICS|N2
63091|SYSTEMIC ANTIBACTERIALS|J1
63090|NOOTROPICS|N6D
63087|SYSTEMIC ANTIBACTERIALS|J1
63080|ANALGESICS|N2
63079|ANTIPROTOZOALS AND ANTHELMINTICS|P1
63079|ANTHELMINTICS, EXCLUDING SCHISTOSOMICIDES|P1B
63077|ANTIVIRALS FOR SYSTEMIC USE|J5
63077|SYSTEMIC ANTIHISTAMINES|R6
63075|ANTIVIRALS FOR SYSTEMIC USE|J5
63072|OPHTHALMOLOGICALS|S1
63070|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63067|SYSTEMIC ANTIBACTERIALS|J1
63066|Ocular antineovascularisation products|S1P
63065|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
63063|MUSCULO-SKELETAL SYSTEM|M
63061|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
63056|PARASITOLOGY|P
63053|CENTRAL NERVOUS SYSTEM|N
63053|HYPNOTICS/SEDATIVES|N5B
63052|ANTI-EPILEPTICS|N3
63050|ANTIFIBRINOLYTICS|B2A
63049|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63048|ANTIPSYCHOTICS|N5A
63048|NOOTROPICS|N6D
63047|ALKYLATING AGENTS|L1A
63046|BPH (benign prostatic hypertrophy) products |G4C
63041|IMMUNOSTIMULATING AGENTS|L3
63037|ANTIVIRALS FOR SYSTEMIC USE|J5
63036|ANTIVIRALS FOR SYSTEMIC USE|J5
63034|ANTI-EPILEPTICS|N3
63032|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
63029|ANALGESICS|N2
63029|HYPNOTICS/SEDATIVES|N5B
63028|PARASITOLOGY|P
63027|OPHTHALMOLOGICALS|S1
63026|OPHTHALMOLOGICALS|S1
63022|PARASITOLOGY|P
63021|CARDIOVASCULAR SYSTEM|C
63021|ANTIHYPERTENSIVES|C2
63017|PARASITOLOGY|P
63016|SYSTEMIC ANTIBACTERIALS|J1
63016|CEPHALOSPORINS|J1D
63014|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
63013|PARASITOLOGY|P
63012|SYSTEMIC ANTIBACTERIALS|J1
63012|CEPHALOSPORINS|J1D
63010|ANTI-EPILEPTICS|N3A
63010|NOOTROPICS|N6D
63006|IMMUNOSTIMULATING AGENTS|L3
63005|NOOTROPICS|N6D
63004|ANTIVIRALS FOR SYSTEMIC USE|J5
63003|TRANQUILLISERS|N5C
63003|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
63001|ANALGESICS|N2
63000|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62998|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
62996|ANTI-EPILEPTICS|N3A
62992|BPH (benign prostatic hypertrophy) products |G4C
62990|RESPIRATORY SYSTEM|R
62989|SYSTEMIC ANTIBACTERIALS|J1
62988|RESPIRATORY SYSTEM|R
62985|DRUGS USED IN DIABETES|A10
62983|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
62982|ANTIHYPERTENSIVES|C2
62982|OPHTHALMOLOGICALS|S1
62980|ANALGESICS|N2
62977|ANTIVIRALS FOR SYSTEMIC USE|J5
62970|Topical dermatological antifungals|D1A1
62970|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62968|SYSTEMIC ANTIBACTERIALS|J1
62968|PARASITOLOGY|P
62968|ANTI-MALARIALS|P1D
62967|WOUND HEALING AGENTS|D3
62967|SYSTEMIC ANTIBACTERIALS|J1
62964|ANALGESICS|N2
62961|ANALGESICS|N2
62960|PLATELET AGGREGATION INHIBITORS|B1C
62960|CARDIOVASCULAR SYSTEM|C
62958|NOOTROPICS|N6D
62955|ANALGESICS|N2
62953|SYSTEMIC ANTIBACTERIALS|J1
62946|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62946|DRUGS USED IN DIABETES|A10
62942|CENTRAL NERVOUS SYSTEM|N
62942|MRI AGENTS|T1E
62941|ANALGESICS|N2
62940|ANALGESICS|N2
62939|ANALGESICS|N2
62936|SYSTEMIC ANTIBACTERIALS|J1
62935|ANTIVIRALS FOR SYSTEMIC USE|J5
62935|Non-nucleoside reverse transcriptase inhibitors|J5C3
62932|OPHTHALMOLOGICALS|S1
62931|ANALGESICS|N2
62924|ANTIHYPERTENSIVES|C2
62924|DIURETICS|C3
62924|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
62923|IMMUNOSUPPRESSIVE AGENTS|L4
62921|PARASITOLOGY|P
62920|CENTRAL NERVOUS SYSTEM|N
62919|IMMUNOSUPPRESSIVE AGENTS|L4
62918|ANTIPROTOZOALS AND ANTHELMINTICS|P1
62917|SYSTEMIC ANTIBACTERIALS|J1
62916|CENTRAL NERVOUS SYSTEM|N
62915|TRANQUILLISERS|N5C
62915|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62912|MACROLIDES AND SIMILAR TYPES|J1F
62911|PARASITOLOGY|P
62911|ANTI-MALARIALS|P1D
62908|SYSTEMIC ANTIBACTERIALS|J1
62905|ANALGESICS|N2
62905|ANTI-EPILEPTICS|N3
62900|WOUND HEALING AGENTS|D3
62896|CARDIOVASCULAR SYSTEM|C
62887|MRI AGENTS|T1E
62882|ANTIVIRALS FOR SYSTEMIC USE|J5
62881|ANTIVIRALS FOR SYSTEMIC USE|J5
62880|Protease inhibitors|J5C2
62879|ANALGESICS|N2
62875|SYSTEMIC ANTIBACTERIALS|J1
62874|ANTIPSYCHOTICS|N5A
62870|ANTIVIRALS FOR SYSTEMIC USE|J5
62869|ANTIVIRALS FOR SYSTEMIC USE|J5
62863|DRUGS USED IN DIABETES|A10
62863|HUMAN INSULINS AND ANALOGUES|A10C
62863|Human insulins and analogues, intermediate-acting|A10C2
62858|SYSTEMIC ANTIBACTERIALS|J1
62857|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62856|SYSTEMIC ANTIBACTERIALS|J1
62853|ANTI-EPILEPTICS|N3A
62853|NOOTROPICS|N6D
62850|SYSTEMIC ANTIBACTERIALS|J1
62847|SYSTEMIC ANTIBACTERIALS|J1
62846|SYSTEMIC ANTIBACTERIALS|J1
62845|SYSTEMIC ANTIBACTERIALS|J1
62843|Topical dermatological antifungals|D1A1
62843|Systemic dermatological antifungals|D1A2
62843|SYSTEMIC ANTIBACTERIALS|J1
62843|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62840|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
62839|ANTIVIRALS FOR SYSTEMIC USE|J5
62833|ANALGESICS|N2
62832|ANALGESICS|N2
62831|ANALGESICS|N2
62831|NOOTROPICS|N6D
62830|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62830|ANALGESICS|N2
62827|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62826|OPHTHALMOLOGICALS|S1
62825|OPHTHALMOLOGICALS|S1
62820|Inhibitors of the Kallikrein-kinin-system|B2C2
62818|ANTIVIRALS FOR SYSTEMIC USE|J5
62816|DRUGS USED IN DIABETES|A10
62816|DPP-IV inhibitor antidiabetics|A10B6
62815|CARDIAC THERAPY|C1
62814|ANTIVIRALS FOR SYSTEMIC USE|J5
62813|SYSTEMIC ANTIBACTERIALS|J1
62810|ANALGESICS|N2
62807|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62805|ANALGESICS|N2
62802|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62800|SYSTEMIC ANTIBACTERIALS|J1
62798|ANTIPSYCHOTICS|N5A
62796|ANTIVIRALS FOR SYSTEMIC USE|J5
62794|ANTIVIRALS FOR SYSTEMIC USE|J5
62789|DRUGS USED IN DIABETES|A10
62788|ANTIVIRALS FOR SYSTEMIC USE|J5
62785|SYSTEMIC ANTIBACTERIALS|J1
62784|CARDIOVASCULAR SYSTEM|C
62782|RESPIRATORY SYSTEM|R
62776|ANTIVIRALS FOR SYSTEMIC USE|J5
62775|SYSTEMIC ANTIBACTERIALS|J1
62774|IMMUNOSTIMULATING AGENTS|L3
62771|ANTIFIBRINOLYTICS|B2A
62761|ANTIVIRALS FOR SYSTEMIC USE|J5
62758|ANTIVIRALS FOR SYSTEMIC USE|J5
62757|ANTIVIRALS FOR SYSTEMIC USE|J5
62756|ANALGESICS|N2
62749|IMMUNOSUPPRESSIVE AGENTS|L4
62747|ANTIVIRALS FOR SYSTEMIC USE|J5
62746|FIBRINOLYTICS|B1D
62743|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62738|MACROLIDES AND SIMILAR TYPES|J1F
62736|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
62736|SYSTEMIC ANTIBACTERIALS|J1
62735|ANTIMETABOLITES|L1B
62731|OPHTHALMOLOGICALS|S1
62728|SYSTEMIC ANTIBACTERIALS|J1
62727|ANTI-ARRHYTHMICS|C1B
62727|ANALGESICS|N2
62725|OPHTHALMOLOGICALS|S1
62724|ANALGESICS|N2
62723|WOUND HEALING AGENTS|D3
62721|ANTIVIRALS FOR SYSTEMIC USE|J5
62715|HUMAN INSULINS AND ANALOGUES|A10C
62715|Human insulins and analogues, intermediate-acting|A10C2
62714|WOUND HEALING AGENTS|D3
62711|OPHTHALMOLOGICALS|S1
62707|FIBRINOLYTICS|B1D
62706|ANTIHYPERTENSIVES|C2
62705|WOUND HEALING AGENTS|D3
62705|IMMUNOSTIMULATING AGENTS|L3
62703|RESPIRATORY SYSTEM|R
62702|RESPIRATORY SYSTEM|R
62699|ANALGESICS|N2
62699|ANTI-MIGRAINE PREPARATIONS|N2C
62697|BETA-BLOCKING AGENTS|C7
62696|IMMUNOSUPPRESSIVE AGENTS|L4
62696|SYSTEMIC ANTIHISTAMINES|R6
62695|ANTIVIRALS FOR SYSTEMIC USE|J5
62694|OPHTHALMOLOGICALS|S1
62692|BETA-BLOCKING AGENTS|C7
62691|CENTRAL NERVOUS SYSTEM|N
62690|PARASITOLOGY|P
62690|ANTI-MALARIALS|P1D
62689|ANTIPSYCHOTICS|N5A
62689|NOOTROPICS|N6D
62686|ANTIVIRALS FOR SYSTEMIC USE|J5
62685|ANTIPSYCHOTICS|N5A
62685|NOOTROPICS|N6D
62683|ANALGESICS|N2
62681|PARASITOLOGY|P
62680|ANTI-EPILEPTICS|N3
62679|ANTI-EPILEPTICS|N3A
62678|ANALGESICS|N2
62675|ANTIVIRALS FOR SYSTEMIC USE|J5
62674|NOOTROPICS|N6D
62673|APPETITE STIMULANTS|A15
62672|DRUGS USED IN DIABETES|A10
62666|ANALGESICS|N2
62663|SYSTEMIC ANTIBACTERIALS|J1
62655|SYSTEMIC ANTIBACTERIALS|J1
62654|PARASITOLOGY|P
62652|ANTIVIRALS FOR SYSTEMIC USE|J5
62651|Interferons, beta|L3B2
62648|ANALGESICS|N2
62646|ANTIVIRALS FOR SYSTEMIC USE|J5
62638|Erectile dysfunction products|G4B3
62638|ANTI-EPILEPTICS|N3A
62637|ANTI-EPILEPTICS|N3A
62637|NOOTROPICS|N6D
62636|ANTI-EPILEPTICS|N3A
62636|NOOTROPICS|N6D
62635|TRANQUILLISERS|N5C
62632|CARDIOVASCULAR SYSTEM|C
62632|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
62629|BPH (benign prostatic hypertrophy) products |G4C
62628|ANTIPROTOZOALS AND ANTHELMINTICS|P1
62627|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62626|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62625|SYSTEMIC ANTIBACTERIALS|J1
62624|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62624|SSRI antidepressants|N6A4
62619|IMMUNOSTIMULATING AGENTS|L3
62618|RESPIRATORY SYSTEM|R
62617|IMMUNOSUPPRESSIVE AGENTS|L4
62616|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
62615|OPHTHALMOLOGICALS|S1
62614|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62613|BETA-BLOCKING AGENTS|C7
62613|WOUND HEALING AGENTS|D3
62607|ANALGESICS|N2
62606|ANTIEMETICS AND ANTINAUSEANTS|A4
62606|ANTI-MIGRAINE PREPARATIONS|N2C
62605|ANTIEMETICS AND ANTINAUSEANTS|A4
62605|ANALGESICS|N2
62603|TRANQUILLISERS|N5C
62603|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62602|TRANQUILLISERS|N5C
62602|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62601|TRANQUILLISERS|N5C
62601|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62600|RADIODIAGNOSTIC AGENTS|T1G
62596|ANTIVIRALS FOR SYSTEMIC USE|J5
62591|SYSTEMIC ANTIBACTERIALS|J1
62591|ANTIVIRALS FOR SYSTEMIC USE|J5
62587|ANTIVIRALS FOR SYSTEMIC USE|J5
62586|ANTIVIRALS FOR SYSTEMIC USE|J5
62584|SYSTEMIC ANTIBACTERIALS|J1
62583|SYSTEMIC ANTIBACTERIALS|J1
62581|ANTIVIRALS FOR SYSTEMIC USE|J5
62577|IMMUNOSTIMULATING AGENTS|L3
62576|SYSTEMIC ANTIBACTERIALS|J1
62574|Systemic dermatological antifungals|D1A2
62574|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62573|SYSTEMIC ANTIBACTERIALS|J1
62572|IMMUNOSTIMULATING AGENTS|L3
62571|ANTIPROTOZOALS AND ANTHELMINTICS|P1
62545|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62545|NOOTROPICS|N6D
62542|WOUND HEALING AGENTS|D3
62540|TRANQUILLISERS|N5C
62539|ANTIHYPERTENSIVES|C2
62536|ANTIVIRALS FOR SYSTEMIC USE|J5
62534|ANTIVIRALS FOR SYSTEMIC USE|J5
62533|Coxibs|M1A3
62533|ANALGESICS|N2
62530|OPHTHALMOLOGICALS|S1
62529|BETA-BLOCKING AGENTS|C7
62529|OPHTHALMOLOGICALS|S1
62528|RESPIRATORY SYSTEM|R
62526|ANTIEMETICS AND ANTINAUSEANTS|A4
62525|ANALGESICS|N2
62524|ANTI-MIGRAINE PREPARATIONS|N2C
62520|ANTIVIRALS FOR SYSTEMIC USE|J5
62517|ANALGESICS|N2
62514|ANTIVIRALS FOR SYSTEMIC USE|J5
62513|CARDIOVASCULAR SYSTEM|C
62512|SYSTEMIC ANTIBACTERIALS|J1
62509|CENTRAL NERVOUS SYSTEM|N
62505|ANAESTHETICS, LOCAL|N1B
62505|ANALGESICS|N2
62504|ANTIVIRALS FOR SYSTEMIC USE|J5
62503|PARASITOLOGY|P
62500|OPHTHALMOLOGICALS|S1
62499|NOOTROPICS|N6D
62498|ANTIVIRALS FOR SYSTEMIC USE|J5
62494|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62494|DRUGS USED IN DIABETES|A10
62492|CARDIOVASCULAR SYSTEM|C
62492|ANTIHYPERTENSIVES|C2
62491|CENTRAL NERVOUS SYSTEM|N
62489|WOUND HEALING AGENTS|D3
62487|WOUND HEALING AGENTS|D3
62486|Inhibitors of the Kallikrein-kinin-system|B2C2
62486|OPHTHALMOLOGICALS|S1
62477|ANTIVIRALS FOR SYSTEMIC USE|J5
62476|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62473|GASTROPROKINETICS|A3F
62468|ANTIVIRALS FOR SYSTEMIC USE|J5
62467|ANTIVIRALS FOR SYSTEMIC USE|J5
62465|PLATELET AGGREGATION INHIBITORS|B1C
62465|CARDIOVASCULAR SYSTEM|C
62465|ANTIHYPERTENSIVES|C2
62462|ANTI-EPILEPTICS|N3A
62461|ANTIVIRALS FOR SYSTEMIC USE|J5
62459|OPHTHALMOLOGICALS|S1
62459|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
62458|IMMUNOSUPPRESSIVE AGENTS|L4
62458|NOOTROPICS|N6D
62455|SYSTEMIC ANTIBACTERIALS|J1
62455|PARASITOLOGY|P
62452|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62451|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62450|ANTIVIRALS FOR SYSTEMIC USE|J5
62450|IMMUNOSTIMULATING AGENTS|L3
62449|Factors II, VII, IX and X|B2D2
62443|ANTIVIRALS FOR SYSTEMIC USE|J5
62442|MUSCULO-SKELETAL SYSTEM|M
62441|ANTIVIRALS FOR SYSTEMIC USE|J5
62440|ANTIPSYCHOTICS|N5A
62432|WOUND HEALING AGENTS|D3
62431|RESPIRATORY SYSTEM|R
62427|ANTIVIRALS FOR SYSTEMIC USE|J5
62426|IMMUNOSTIMULATING AGENTS|L3
62424|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62423|IMMUNOSTIMULATING AGENTS|L3
62421|ANALGESICS|N2
62419|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
62418|IMMUNOSUPPRESSIVE AGENTS|L4
62417|IMMUNOSUPPRESSIVE AGENTS|L4
62415|ANTIFIBRINOLYTICS|B2A
62415|ANTITUSSIVES|R5D
62414|DRUGS USED IN DIABETES|A10
62414|ANTIHYPERTENSIVES|C2
62413|WOUND HEALING AGENTS|D3
62413|OPHTHALMOLOGICALS|S1
62412|ANTIHYPERTENSIVES|C2
62412|Erectile dysfunction products|G4B3
62406|SYSTEMIC ANTIBACTERIALS|J1
62400|ANALGESICS|N2
62399|ANTIHYPERTENSIVES|C2
62397|IMMUNOSTIMULATING AGENTS|L3
62393|RADIODIAGNOSTIC AGENTS|T1G
62391|OPHTHALMOLOGICALS|S1
62386|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62385|ANTIVIRALS FOR SYSTEMIC USE|J5
62383|ANTI-EPILEPTICS|N3A
62382|OPHTHALMOLOGICALS|S1
62381|OPHTHALMOLOGICALS|S1
62374|ANTIVIRALS FOR SYSTEMIC USE|J5
62370|IMMUNOSUPPRESSIVE AGENTS|L4
62368|Factor VIII|B2D1
62367|TRANQUILLISERS|N5C
62366|IMMUNOSUPPRESSIVE AGENTS|L4
62365|ANTIVIRALS FOR SYSTEMIC USE|J5
62365|IMMUNOSUPPRESSIVE AGENTS|L4
62358|ANALGESICS|N2
62351|ANALGESICS|N2
62351|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62347|ANTIVIRALS FOR SYSTEMIC USE|J5
62346|ANTIVIRALS FOR SYSTEMIC USE|J5
62345|NOOTROPICS|N6D
62343|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62343|DRUGS USED IN DIABETES|A10
62340|AMINOGLYCOSIDES|J1K
62339|SYSTEMIC ANTIBACTERIALS|J1
62337|ANTIVIRALS FOR SYSTEMIC USE|J5
62336|ANTIVIRALS FOR SYSTEMIC USE|J5
62332|SYSTEMIC ANTIBACTERIALS|J1
62328|OPHTHALMOLOGICALS|S1
62327|ANTI-EPILEPTICS|N3A
62327|NOOTROPICS|N6D
62326|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62325|NOOTROPICS|N6D
62321|ANTI-EPILEPTICS|N3A
62321|OPHTHALMOLOGICALS|S1
62316|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62312|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62310|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62305|ANALGESICS|N2
62302|HUMAN INSULINS AND ANALOGUES|A10C
62302|Human insulins and analogues, intermediate-acting|A10C2
62300|IMMUNOSTIMULATING AGENTS|L3
62296|ANTIMETABOLITES|L1B
62291|ANALGESICS|N2
62290|MRI AGENTS|T1E
62282|HYALURONIDASE|B6B
62279|SYSTEMIC ANTIBACTERIALS|J1
62277|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
62276|HYPNOTICS/SEDATIVES|N5B
62275|ANTIVIRALS FOR SYSTEMIC USE|J5
62273|ANTIVIRALS FOR SYSTEMIC USE|J5
62273|IMMUNOSTIMULATING AGENTS|L3
62269|ANTIVIRALS FOR SYSTEMIC USE|J5
62263|Interferons, beta|L3B2
62262|OPHTHALMOLOGICALS|S1
62261|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62261|NOOTROPICS|N6D
62260|PLATELET AGGREGATION INHIBITORS|B1C
62260|CARDIOVASCULAR SYSTEM|C
62258|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62258|DRUGS USED IN DIABETES|A10
62256|HYPNOTICS/SEDATIVES|N5B
62255|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
62255|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
62254|ANTIVIRALS FOR SYSTEMIC USE|J5
62253|DPP-IV inhibitor antidiabetics|A10B6
62252|ANTIEMETICS AND ANTINAUSEANTS|A4
62252|ANALGESICS|N2
62250|ANTISEPTICS AND DISINFECTANTS|D8
62250|SYSTEMIC ANTIBACTERIALS|J1
62250|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62250|ANTIVIRALS FOR SYSTEMIC USE|J5
62249|ANALGESICS|N2
62246|Topical dermatological antifungals|D1A1
62246|ANTI-ACNE PREPARATIONS|D10
62246|SYSTEMIC ANTIBACTERIALS|J1
62246|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62245|Interferons, beta|L3B2
62244|ANALGESICS|N2
62243|ANTIVIRALS FOR SYSTEMIC USE|J5
62242|SYSTEMIC ANTIBACTERIALS|J1
62241|ANALGESICS|N2
62241|ANTI-EPILEPTICS|N3
62239|NOOTROPICS|N6D
62238|CENTRAL NERVOUS SYSTEM|N
62237|ANALGESICS|N2
62237|ANTI-EPILEPTICS|N3
62236|RESPIRATORY SYSTEM|R
62234|AMINOGLYCOSIDES|J1K
62226|ANTIVIRALS FOR SYSTEMIC USE|J5
62223|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
62220|ANTIPSYCHOTICS|N5A
62217|ANTI-ACNE PREPARATIONS|D10
62217|TOPICAL ANTI-ACNE PREPARATIONS|D10A
62217|SYSTEMIC ANTIBACTERIALS|J1
62216|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62214|ANTIULCERANTS|A2B
62211|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62207|OPHTHALMOLOGICALS|S1
62206|ANTIHYPERTENSIVES|C2
62206|OPHTHALMOLOGICALS|S1
62206|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
62201|ANALGESICS|N2
62201|ANTI-MIGRAINE PREPARATIONS|N2C
62201|HYPNOTICS/SEDATIVES|N5B
62201|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62200|ANTIVIRALS FOR SYSTEMIC USE|J5
62199|ANTIVIRALS FOR SYSTEMIC USE|J5
62199|Non-nucleoside reverse transcriptase inhibitors|J5C3
62198|ANTIVIRALS FOR SYSTEMIC USE|J5
62198|Non-nucleoside reverse transcriptase inhibitors|J5C3
62197|ANALGESICS|N2
62197|OPHTHALMOLOGICALS|S1
62196|DRUGS USED IN DIABETES|A10
62195|SYSTEMIC ANTIBACTERIALS|J1
62193|PLATELET AGGREGATION INHIBITORS|B1C
62192|ANTIHYPERTENSIVES|C2
62192|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
62192|Statins (HMG-CoA reductase inhibitors)|C10A1
62191|Statins (HMG-CoA reductase inhibitors)|C10A1
62190|DRUGS USED IN DIABETES|A10
62190|Biguanide antidiabetics|A10B2
62188|ANTIHYPERTENSIVES|C2
62188|CALCIUM ANTAGONISTS|C8
62187|ANTIHYPERTENSIVES|C2
62187|CALCIUM ANTAGONISTS|C8
62187|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
62187|Statins (HMG-CoA reductase inhibitors)|C10A1
62186|PLATELET AGGREGATION INHIBITORS|B1C
62186|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
62185|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62184|DRUGS USED IN DIABETES|A10
62184|Biguanide antidiabetics|A10B2
62183|IMMUNOSTIMULATING AGENTS|L3
62182|CENTRAL NERVOUS SYSTEM|N
62181|DRUGS USED IN DIABETES|A10
62179|RESPIRATORY SYSTEM|R
62177|IMMUNOSUPPRESSIVE AGENTS|L4
62173|OPHTHALMOLOGICALS|S1
62171|DERMATOLOGICALS|D
62170|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62170|NOOTROPICS|N6D
62169|DPP-IV inhibitor antidiabetics|A10B6
62169|Statins (HMG-CoA reductase inhibitors)|C10A1
62168|Statins (HMG-CoA reductase inhibitors)|C10A1
62166|DRUGS USED IN DIABETES|A10
62166|HUMAN INSULINS AND ANALOGUES|A10C
62166|Human insulins and analogues, intermediate-acting|A10C2
62164|ANTIVIRALS FOR SYSTEMIC USE|J5
62161|ANTIVIRALS FOR SYSTEMIC USE|J5
62161|Non-nucleoside reverse transcriptase inhibitors|J5C3
62153|ANTIVIRALS FOR SYSTEMIC USE|J5
62146|IMMUNOSUPPRESSIVE AGENTS|L4
62142|SYSTEMIC ANTIBACTERIALS|J1
62142|ANTIVIRALS FOR SYSTEMIC USE|J5
62141|SYSTEMIC ANTIBACTERIALS|J1
62136|DERMATOLOGICALS|D
62136|OPHTHALMOLOGICALS|S1
62134|ANTI-EPILEPTICS|N3A
62128|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62127|ANDROGENS, EXCLUDING G3E, G3F|G3B
62127|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
62127|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
62126|Ocular antineovascularisation products|S1P
62123|ANALGESICS|N2
62123|ANTI-MIGRAINE PREPARATIONS|N2C
62121|OPHTHALMOLOGICALS|S1
62110|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
62110|SSRI antidepressants|N6A4
62098|ANALGESICS|N2
62095|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
62095|IMMUNOSUPPRESSIVE AGENTS|L4
62091|ANALGESICS|N2
62085|IMMUNOSTIMULATING AGENTS|L3
62083|ANTIVIRALS FOR SYSTEMIC USE|J5
62082|ANTIVIRALS FOR SYSTEMIC USE|J5
62078|SYSTEMIC ANTIBACTERIALS|J1
62067|DIRECT THROMBIN INHIBITORS|B1E
62067|ANTI-ARRHYTHMICS|C1B
62065|DPP-IV inhibitor antidiabetics|A10B6
62063|Coxibs|M1A3
62063|ANALGESICS|N2
62061|RESPIRATORY SYSTEM|R
62058|ANTIPSYCHOTICS|N5A
62056|SYSTEMIC ANTIBACTERIALS|J1
62055|ANTIHYPERTENSIVES|C2
62054|ANTIHYPERTENSIVES|C2
62053|CARDIOVASCULAR SYSTEM|C
62053|ANTIHYPERTENSIVES|C2
62048|ANTI-EPILEPTICS|N3A
62044|ANALGESICS|N2
62035|SYSTEMIC ANTIBACTERIALS|J1
62030|ANALGESICS|N2
62028|ANALGESICS|N2
62027|RESPIRATORY SYSTEM|R
62025|OPHTHALMOLOGICALS|S1
62021|ANALGESICS|N2
62019|ANTIVIRALS FOR SYSTEMIC USE|J5
62018|NOOTROPICS|N6D
62016|ANTIVIRALS FOR SYSTEMIC USE|J5
62014|IMMUNOSUPPRESSIVE AGENTS|L4
62013|DRUGS USED IN DIABETES|A10
62012|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
62011|GROWTH HORMONES|H4C
62007|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
62007|ANTIVIRALS FOR SYSTEMIC USE|J5
62006|DIURETICS|C3
62005|NOOTROPICS|N6D
62003|ANTI-GOUT PREPARATIONS|M4
62003|ANALGESICS|N2
62001|ANTIPSYCHOTICS|N5A
62001|TRANQUILLISERS|N5C
62001|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61999|RESPIRATORY SYSTEM|R
61996|CARDIOVASCULAR SYSTEM|C
61996|ANTIHYPERTENSIVES|C2
61994|CARDIAC THERAPY|C1
61994|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
61992|CENTRAL NERVOUS SYSTEM|N
61990|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61988|ANALGESICS|N2
61987|ANALGESICS|N2
61983|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61983|DRUGS USED IN DIABETES|A10
61982|APPETITE STIMULANTS|A15
61980|MACROLIDES AND SIMILAR TYPES|J1F
61979|APPETITE STIMULANTS|A15
61977|TRANQUILLISERS|N5C
61977|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61972|Alpha-glucosidase inhibitor antidiabetics|A10B5
61971|ANTIVIRALS FOR SYSTEMIC USE|J5
61970|WOUND HEALING AGENTS|D3
61969|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61963|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61962|Topical dermatological antifungals|D1A1
61962|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61959|NOOTROPICS|N6D
61959|OPHTHALMOLOGICALS|S1
61957|WOUND HEALING AGENTS|D3
61952|NOOTROPICS|N6D
61951|ANTI-EPILEPTICS|N3A
61948|ANALGESICS|N2
61946|DPP-IV inhibitor antidiabetics|A10B6
61944|ANALGESICS|N2
61943|ANALGESICS|N2
61942|ANALGESICS|N2
61941|ANTIVIRALS FOR SYSTEMIC USE|J5
61940|TRANQUILLISERS|N5C
61939|ANTI-EPILEPTICS|N3A
61938|NOOTROPICS|N6D
61937|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61933|TRANQUILLISERS|N5C
61933|NOOTROPICS|N6D
61932|ANTIPSYCHOTICS|N5A
61932|NOOTROPICS|N6D
61931|SYSTEMIC ANTIBACTERIALS|J1
61931|IMMUNOSTIMULATING AGENTS|L3
61923|ANTI-EPILEPTICS|N3A
61916|NOOTROPICS|N6D
61915|Coxibs|M1A3
61915|ANALGESICS|N2
61913|ANTI-EPILEPTICS|N3
61912|SYSTEMIC ANTIBACTERIALS|J1
61911|NOOTROPICS|N6D
61909|ANALGESICS|N2
61908|ANTIHYPERTENSIVES|C2
61908|CALCIUM ANTAGONISTS|C8
61906|ANTIHYPERTENSIVES|C2
61906|CALCIUM ANTAGONISTS|C8
61900|ANTIVIRALS FOR SYSTEMIC USE|J5
61899|ANTIVIRALS FOR SYSTEMIC USE|J5
61898|ANTIVIRALS FOR SYSTEMIC USE|J5
61892|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
61889|ANTIVIRALS FOR SYSTEMIC USE|J5
61888|SYSTEMIC ANTIBACTERIALS|J1
61887|RESPIRATORY SYSTEM|R
61885|TRANQUILLISERS|N5C
61885|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61882|NOOTROPICS|N6D
61880|RESPIRATORY SYSTEM|R
61876|Coxibs|M1A3
61876|ANALGESICS|N2
61872|ANTIVIRALS FOR SYSTEMIC USE|J5
61872|Interferons, alpha|L3B1
61869|GASTROPROKINETICS|A3F
61866|ANALGESICS|N2
61862|ANTIPSYCHOTICS|N5A
61862|SSRI antidepressants|N6A4
61857|ANTIPSYCHOTICS|N5A
61857|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61857|SSRI antidepressants|N6A4
61857|NOOTROPICS|N6D
61854|NOOTROPICS|N6D
61853|SYSTEMIC ANTIBACTERIALS|J1
61852|CARDIOVASCULAR SYSTEM|C
61851|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
61850|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
61845|DERMATOLOGICALS|D
61843|APPETITE STIMULANTS|A15
61840|OPHTHALMOLOGICALS|S1
61839|ANTIPSYCHOTICS|N5A
61838|ANTIVIRALS FOR SYSTEMIC USE|J5
61835|HYALURONIDASE|B6B
61834|SYSTEMIC ANTIBACTERIALS|J1
61830|SYSTEMIC ANTIBACTERIALS|J1
61828|ANALGESICS|N2
61827|Coxibs|M1A3
61827|ANALGESICS|N2
61826|Coxibs|M1A3
61826|ANALGESICS|N2
61823|IMMUNOSTIMULATING AGENTS|L3
61822|SYSTEMIC ANTIBACTERIALS|J1
61821|ANTIPROTOZOALS AND ANTHELMINTICS|P1
61815|AMINOGLYCOSIDES|J1K
61814|CARDIOVASCULAR SYSTEM|C
61814|DIURETICS|C3
61813|HYALURONIDASE|B6B
61813|ALKYLATING AGENTS|L1A
61812|CARDIOVASCULAR SYSTEM|C
61809|ANALGESICS|N2
61803|SYSTEMIC ANTIBACTERIALS|J1
61803|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61800|ANTIVIRALS FOR SYSTEMIC USE|J5
61799|SYSTEMIC ANTIBACTERIALS|J1
61797|TRANQUILLISERS|N5C
61794|SYSTEMIC ANTIBACTERIALS|J1
61792|DRUGS USED IN DIABETES|A10
61792|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61791|ANDROGENS, EXCLUDING G3E, G3F|G3B
61791|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
61788|IMMUNOSUPPRESSIVE AGENTS|L4
61786|ANALGESICS|N2
61784|ANTIVIRALS FOR SYSTEMIC USE|J5
61783|ANALGESICS|N2
61782|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61781|ANALGESICS|N2
61780|B2-STIMULANTS|R3A
61778|CARDIOVASCULAR SYSTEM|C
61778|ANTIHYPERTENSIVES|C2
61778|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
61778|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61776|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61775|NOOTROPICS|N6D
61773|SYSTEMIC ANTIHISTAMINES|R6
61772|SYSTEMIC ANTIBACTERIALS|J1
61770|SYSTEMIC ANTIBACTERIALS|J1
61769|ANTIVIRALS FOR SYSTEMIC USE|J5
61768|SYSTEMIC ANTIBACTERIALS|J1
61767|IMMUNOSTIMULATING AGENTS|L3
61764|SYSTEMIC ANTIBACTERIALS|J1
61761|THYROID THERAPY|H3
61760|ANTIVIRALS FOR SYSTEMIC USE|J5
61760|ANTITUSSIVES|R5D
61760|SYSTEMIC ANTIHISTAMINES|R6
61758|NOOTROPICS|N6D
61757|SYSTEMIC ANTIHISTAMINES|R6
61756|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61755|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61755|NOOTROPICS|N6D
61753|ANTIVIRALS FOR SYSTEMIC USE|J5
61750|TRANQUILLISERS|N5C
61750|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61750|NOOTROPICS|N6D
61748|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61747|ALKYLATING AGENTS|L1A
61747|ANTIMETABOLITES|L1B
61742|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61741|OPHTHALMOLOGICALS|S1
61739|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61737|SYSTEMIC ANTIBACTERIALS|J1
61731|ANTI-EPILEPTICS|N3A
61730|IMMUNOSTIMULATING AGENTS|L3
61729|ANALGESICS|N2
61729|OPHTHALMOLOGICALS|S1
61726|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61726|CARDIOVASCULAR SYSTEM|C
61726|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
61722|IMMUNOSUPPRESSIVE AGENTS|L4
61721|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61720|SYSTEMIC ANTIBACTERIALS|J1
61720|CEPHALOSPORINS|J1D
61714|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
61714|ANTI-ACNE PREPARATIONS|D10
61712|ANALGESICS|N2
61711|ANTIEMETICS AND ANTINAUSEANTS|A4
61711|APPETITE STIMULANTS|A15
61711|ANALGESICS|N2
61709|Topical dermatological antifungals|D1A1
61709|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61708|ANALGESICS|N2
61708|TRANQUILLISERS|N5C
61703|ANALGESICS|N2
61699|ANTIVIRALS FOR SYSTEMIC USE|J5
61696|NOOTROPICS|N6D
61694|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61694|ANTIPSYCHOTICS|N5A
61694|TRANQUILLISERS|N5C
61692|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61692|DRUGS USED IN DIABETES|A10
61684|ANTIVIRALS FOR SYSTEMIC USE|J5
61683|SYSTEMIC ANTIBACTERIALS|J1
61682|SYSTEMIC ANTIBACTERIALS|J1
61677|OPHTHALMOLOGICALS|S1
61673|ANALGESICS|N2
61672|SYSTEMIC ANTIBACTERIALS|J1
61669|Monobactams|J1P1
61666|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61665|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61664|ANALGESICS|N2
61663|NOOTROPICS|N6D
61662|ANTI-ARRHYTHMICS|C1B
61661|NOOTROPICS|N6D
61658|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61657|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61656|ANALGESICS|N2
61656|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61656|SSRI antidepressants|N6A4
61656|SRNI antidepressants|N6A5
61655|ALKYLATING AGENTS|L1A
61652|Urinary incontinence products|G4B4
61652|RESPIRATORY SYSTEM|R
61647|ANTIVIRALS FOR SYSTEMIC USE|J5
61646|ANTIVIRALS FOR SYSTEMIC USE|J5
61643|ANTIVIRALS FOR SYSTEMIC USE|J5
61643|Interferons, alpha|L3B1
61641|SYSTEMIC ANTIBACTERIALS|J1
61641|ANTIVIRALS FOR SYSTEMIC USE|J5
61640|Interferons, beta|L3B2
61638|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
61638|ANTIVIRALS FOR SYSTEMIC USE|J5
61633|ANTIHYPERTENSIVES|C2
61630|SYSTEMIC ANTIBACTERIALS|J1
61630|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61627|SYSTEMIC ANTIBACTERIALS|J1
61626|PLATELET AGGREGATION INHIBITORS|B1C
61623|ANTIFIBRINOLYTICS|B2A
61619|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61618|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61615|OPHTHALMOLOGICALS|S1
61614|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61614|CENTRAL NERVOUS SYSTEM|N
61614|ANALGESICS|N2
61613|RESPIRATORY SYSTEM|R
61612|DERMATOLOGICALS|D
61604|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
61601|RESPIRATORY SYSTEM|R
61600|ANALGESICS|N2
61595|IMMUNOSTIMULATING AGENTS|L3
61593|BPH (benign prostatic hypertrophy) products |G4C
61593|CENTRAL NERVOUS SYSTEM|N
61592|IMMUNOSUPPRESSIVE AGENTS|L4
61590|ANALGESICS|N2
61589|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61587|Topical dermatological antifungals|D1A1
61587|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61583|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61579|OPHTHALMOLOGICALS|S1
61576|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61575|ANTI-EPILEPTICS|N3
61574|IMMUNOSUPPRESSIVE AGENTS|L4
61573|SYSTEMIC ANTIBACTERIALS|J1
61563|ANTIVIRALS FOR SYSTEMIC USE|J5
61563|IMMUNOSTIMULATING AGENTS|L3
61562|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61562|Statins (HMG-CoA reductase inhibitors)|C10A1
61556|ANALGESICS|N2
61555|ANALGESICS|N2
61554|ANALGESICS|N2
61554|ANTI-MIGRAINE PREPARATIONS|N2C
61554|TRANQUILLISERS|N5C
61554|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61552|ANALGESICS|N2
61551|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
61550|ANALGESICS|N2
61550|ANTI-MIGRAINE PREPARATIONS|N2C
61550|ANTI-EPILEPTICS|N3A
61548|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
61545|SYSTEMIC ANTIBACTERIALS|J1
61544|SYSTEMIC ANTIBACTERIALS|J1
61543|ANTI-EPILEPTICS|N3A
61543|NOOTROPICS|N6D
61535|ANTIVIRALS FOR SYSTEMIC USE|J5
61534|RESPIRATORY SYSTEM|R
61531|Interferons, beta|L3B2
61528|ANTIVIRALS FOR SYSTEMIC USE|J5
61527|ANTIVIRALS FOR SYSTEMIC USE|J5
61523|ALKYLATING AGENTS|L1A
61522|IMMUNOSTIMULATING AGENTS|L3
61517|OPHTHALMOLOGICALS|S1
61515|ANTIVIRALS FOR SYSTEMIC USE|J5
61515|IMMUNOSTIMULATING AGENTS|L3
61506|ANTIVIRALS FOR SYSTEMIC USE|J5
61503|ANTIVIRALS FOR SYSTEMIC USE|J5
61501|ANTIVIRALS FOR SYSTEMIC USE|J5
61499|ANTIVIRALS FOR SYSTEMIC USE|J5
61498|ANTIVIRALS FOR SYSTEMIC USE|J5
61495|ANTIVIRALS FOR SYSTEMIC USE|J5
61494|ANTIVIRALS FOR SYSTEMIC USE|J5
61492|ANTIVIRALS FOR SYSTEMIC USE|J5
61490|ANTIVIRALS FOR SYSTEMIC USE|J5
61487|OPHTHALMOLOGICALS|S1
61485|CARDIOVASCULAR SYSTEM|C
61483|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61481|ANALGESICS|N2
61481|TRANQUILLISERS|N5C
61479|SYSTEMIC ANTIBACTERIALS|J1
61478|NOOTROPICS|N6D
61475|NOOTROPICS|N6D
61474|WOUND HEALING AGENTS|D3
61465|ANALGESICS|N2
61464|RESPIRATORY SYSTEM|R
61462|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61461|Coxibs|M1A3
61461|ANALGESICS|N2
61460|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61460|CENTRAL NERVOUS SYSTEM|N
61456|ANALGESICS|N2
61452|ANTIVIRALS FOR SYSTEMIC USE|J5
61451|DRUGS USED IN DIABETES|A10
61449|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61449|NOOTROPICS|N6D
61443|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61442|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61442|SRNI antidepressants|N6A5
61441|WOUND HEALING AGENTS|D3
61431|ANTIVIRALS FOR SYSTEMIC USE|J5
61428|VACCINES|J7
61425|ANTIPSYCHOTICS|N5A
61422|ANTIVIRALS FOR SYSTEMIC USE|J5
61419|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61413|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
61412|IMMUNOSTIMULATING AGENTS|L3
61411|ANTIPSYCHOTICS|N5A
61409|CARDIOVASCULAR SYSTEM|C
61403|ANALGESICS|N2
61401|ANALGESICS|N2
61400|ANALGESICS|N2
61399|ANALGESICS|N2
61397|OPHTHALMOLOGICALS|S1
61393|ANALGESICS|N2
61392|Non-nucleoside reverse transcriptase inhibitors|J5C3
61390|Topical dermatological antifungals|D1A1
61390|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61387|NOOTROPICS|N6D
61387|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
61384|ANTIVIRALS FOR SYSTEMIC USE|J5
61383|Bile stone therapy|A5A2
61382|Bile stone therapy|A5A2
61380|ANTIVIRALS FOR SYSTEMIC USE|J5
61379|SYSTEMIC ANTIBACTERIALS|J1
61378|IMMUNOSUPPRESSIVE AGENTS|L4
61374|ANTIVIRALS FOR SYSTEMIC USE|J5
61363|ANAESTHETICS|N1
61363|HYPNOTICS/SEDATIVES|N5B
61360|ANALGESICS|N2
61358|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61357|ANTIHYPERTENSIVES|C2
61357|OPHTHALMOLOGICALS|S1
61356|BPH (benign prostatic hypertrophy) products |G4C
61355|ANALGESICS|N2
61355|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61351|ANALGESICS|N2
61350|ANTIPSYCHOTICS|N5A
61349|WOUND HEALING AGENTS|D3
61344|RADIODIAGNOSTIC AGENTS|T1G
61342|SYSTEMIC ANTIBACTERIALS|J1
61341|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61341|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
61340|SYSTEMIC ANTIBACTERIALS|J1
61340|RESPIRATORY SYSTEM|R
61339|DRUGS USED IN DIABETES|A10
61334|CARDIOVASCULAR SYSTEM|C
61334|OPHTHALMOLOGICALS|S1
61325|MACROLIDES AND SIMILAR TYPES|J1F
61322|B2-STIMULANTS|R3A
61312|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61311|ANALGESICS|N2
61310|ANALGESICS|N2
61308|ANALGESICS|N2
61303|DRUGS USED IN DIABETES|A10
61303|DPP-IV inhibitor antidiabetics|A10B6
61302|DRUGS USED IN DIABETES|A10
61301|ANTIPSYCHOTICS|N5A
61300|DRUGS USED IN DIABETES|A10
61298|ANTIPSYCHOTICS|N5A
61297|ANALGESICS|N2
61297|ANTI-MIGRAINE PREPARATIONS|N2C
61296|OPHTHALMOLOGICALS|S1
61295|ANALGESICS|N2
61294|ANTI-EPILEPTICS|N3A
61294|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61294|NOOTROPICS|N6D
61292|BPH (benign prostatic hypertrophy) products |G4C
61289|ANALGESICS|N2
61288|ANTIVIRALS FOR SYSTEMIC USE|J5
61284|ANALGESICS|N2
61281|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61276|DERMATOLOGICALS|D
61276|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
61272|SYSTEMIC ANTIBACTERIALS|J1
61269|ALKYLATING AGENTS|L1A
61267|IMMUNOSTIMULATING AGENTS|L3
61260|GASTROPROKINETICS|A3F
61259|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61258|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61257|ANALGESICS|N2
61256|NOOTROPICS|N6D
61255|NOOTROPICS|N6D
61244|SYSTEMIC ANTIBACTERIALS|J1
61242|ANALGESICS|N2
61238|NOOTROPICS|N6D
61237|NOOTROPICS|N6D
61236|IMMUNOSTIMULATING AGENTS|L3
61235|NOOTROPICS|N6D
61234|NOOTROPICS|N6D
61233|OPHTHALMOLOGICALS|S1
61231|RESPIRATORY SYSTEM|R
61230|ANALGESICS|N2
61229|IMMUNOSTIMULATING AGENTS|L3
61221|NOOTROPICS|N6D
61220|IMMUNOSUPPRESSIVE AGENTS|L4
61220|OPHTHALMOLOGICALS|S1
61219|TRANQUILLISERS|N5C
61219|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61217|OPHTHALMOLOGICALS|S1
61215|ANTIVIRALS FOR SYSTEMIC USE|J5
61214|ANALGESICS|N2
61210|ANALGESICS|N2
61209|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
61207|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
61203|ANTIVIRALS FOR SYSTEMIC USE|J5
61201|ANTIVIRALS FOR SYSTEMIC USE|J5
61200|ANTIVIRALS FOR SYSTEMIC USE|J5
61199|ANTIPSYCHOTICS|N5A
61198|ANALGESICS|N2
61197|ANALGESICS|N2
61195|ANALGESICS|N2
61193|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
61193|RESPIRATORY SYSTEM|R
61192|CENTRAL NERVOUS SYSTEM|N
61190|GASTROPROKINETICS|A3F
61188|ANTIVIRALS FOR SYSTEMIC USE|J5
61187|HYPNOTICS/SEDATIVES|N5B
61185|GASTROPROKINETICS|A3F
61184|ANTI-EPILEPTICS|N3A
61183|SYSTEMIC ANTIBACTERIALS|J1
61179|NOOTROPICS|N6D
61178|Miotics and antiglaucoma preparations, topical|S1E2
61177|IMMUNOSUPPRESSIVE AGENTS|L4
61175|DERMATOLOGICALS|D
61175|IMMUNOSUPPRESSIVE AGENTS|L4
61174|ANTIVIRALS FOR SYSTEMIC USE|J5
61171|SYSTEMIC ANTIBACTERIALS|J1
61170|ANTIVIRALS FOR SYSTEMIC USE|J5
61167|ANTIVIRALS FOR SYSTEMIC USE|J5
61166|ANTIVIRALS FOR SYSTEMIC USE|J5
61165|ANTIVIRALS FOR SYSTEMIC USE|J5
61163|CARDIOVASCULAR SYSTEM|C
61162|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
61161|SYSTEMIC ANTIBACTERIALS|J1
61155|DERMATOLOGICALS|D
61153|ANALGESICS|N2
61153|ANTI-MIGRAINE PREPARATIONS|N2C
61152|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61147|CENTRAL NERVOUS SYSTEM|N
61147|OPHTHALMOLOGICALS|S1
61140|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
61139|IMMUNOSUPPRESSIVE AGENTS|L4
61130|SYSTEMIC ANTIBACTERIALS|J1
61130|ANTIVIRALS FOR SYSTEMIC USE|J5
61126|ANALGESICS|N2
61126|ANTI-MIGRAINE PREPARATIONS|N2C
61125|Urinary incontinence products|G4B4
61125|MUSCLE RELAXANTS|M3
61124|ANTIPSYCHOTICS|N5A
61123|PARASITOLOGY|P
61123|ANTI-MALARIALS|P1D
61121|ANALGESICS|N2
61120|RADIODIAGNOSTIC AGENTS|T1G
61115|SYSTEMIC ANTIBACTERIALS|J1
61111|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
61111|SRNI antidepressants|N6A5
61109|ALKYLATING AGENTS|L1A
61103|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61098|SYSTEMIC ANTIBACTERIALS|J1
61097|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
61097|IMMUNOSUPPRESSIVE AGENTS|L4
61096|ANTIHYPERTENSIVES|C2
61094|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
61093|ANALGESICS|N2
61093|HYPNOTICS/SEDATIVES|N5B
61091|ANTIHYPERTENSIVES|C2
61091|DIURETICS|C3
61091|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
61090|ANTIHYPERTENSIVES|C2
61090|CALCIUM ANTAGONISTS|C8
61089|DIURETICS|C3
61084|NOOTROPICS|N6D
61081|ANTIVIRALS FOR SYSTEMIC USE|J5
61077|NOOTROPICS|N6D
61073|RESPIRATORY SYSTEM|R
61071|CENTRAL NERVOUS SYSTEM|N
61071|TRANQUILLISERS|N5C
61067|CENTRAL NERVOUS SYSTEM|N
61065|HEPARINS |B1B
61065|FIBRINOLYTICS|B1D
61057|ANTIVIRALS FOR SYSTEMIC USE|J5
61057|IMMUNOSUPPRESSIVE AGENTS|L4
61056|ANTIHYPERTENSIVES|C2
61056|CALCIUM ANTAGONISTS|C8
61056|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
61054|SYSTEMIC ANTIBACTERIALS|J1
61052|SYSTEMIC ANTIBACTERIALS|J1
61051|SYSTEMIC ANTIBACTERIALS|J1
61047|RESPIRATORY SYSTEM|R
61047|B2-STIMULANTS|R3A
61045|IMMUNOSUPPRESSIVE AGENTS|L4
61042|SYSTEMIC ANTIBACTERIALS|J1
61041|SYSTEMIC ANTIBACTERIALS|J1
61040|SYSTEMIC ANTIBACTERIALS|J1
61039|ANTIVIRALS FOR SYSTEMIC USE|J5
61038|SYSTEMIC ANTIBACTERIALS|J1
61037|ANTIVIRALS FOR SYSTEMIC USE|J5
61035|IMMUNOSUPPRESSIVE AGENTS|L4
61032|IMMUNOSUPPRESSIVE AGENTS|L4
61031|NOOTROPICS|N6D
61030|DIRECT THROMBIN INHIBITORS|B1E
61029|ANTIHYPERTENSIVES|C2
61029|OPHTHALMOLOGICALS|S1
61029|Miotics and antiglaucoma preparations, topical|S1E2
61027|RESPIRATORY SYSTEM|R
61026|OPHTHALMOLOGICALS|S1
61025|DRUGS USED IN DIABETES|A10
61019|CARDIOVASCULAR SYSTEM|C
61018|ANAESTHETICS, LOCAL|N1B
61018|ANALGESICS|N2
61017|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61015|Coxibs|M1A3
61007|NOOTROPICS|N6D
61006|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
61005|ANALGESICS|N2
61002|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60998|SYSTEMIC ANTIBACTERIALS|J1
60998|Carbapenems|J1P2
60997|DRUGS USED IN DIABETES|A10
60997|HUMAN INSULINS AND ANALOGUES|A10C
60997|Human insulins and analogues, intermediate-acting|A10C2
60997|HYALURONIDASE|B6B
60995|DRUGS USED IN DIABETES|A10
60985|DIRECT THROMBIN INHIBITORS|B1E
60983|OPHTHALMOLOGICALS|S1
60979|ANTI-EPILEPTICS|N3A
60977|ANTI-EPILEPTICS|N3A
60975|ANTIVIRALS FOR SYSTEMIC USE|J5
60973|ANTI-GOUT PREPARATIONS|M4
60971|ANTIHYPERTENSIVES|C2
60967|NOOTROPICS|N6D
60967|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
60966|TRANQUILLISERS|N5C
60964|RESPIRATORY SYSTEM|R
60963|ANTIVIRALS FOR SYSTEMIC USE|J5
60963|Non-nucleoside reverse transcriptase inhibitors|J5C3
60962|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
60960|DRUGS USED IN DIABETES|A10
60958|ANTIVIRALS FOR SYSTEMIC USE|J5
60954|ANTIFIBRINOLYTICS|B2A
60953|OPHTHALMOLOGICALS|S1
60950|ANTIFIBRINOLYTICS|B2A
60949|CENTRAL NERVOUS SYSTEM|N
60949|ANTI-EPILEPTICS|N3
60948|RESPIRATORY SYSTEM|R
60948|ANTITUSSIVES|R5D
60947|ANTIVIRALS FOR SYSTEMIC USE|J5
60942|ANTI-MALARIALS|P1D
60940|ANTIEMETICS AND ANTINAUSEANTS|A4
60939|ANTIVIRALS FOR SYSTEMIC USE|J5
60939|INTERFERONS|L3B
60938|ANTIVIRALS FOR SYSTEMIC USE|J5
60938|INTERFERONS|L3B
60935|ANTIHYPERTENSIVES|C2
60935|CALCIUM ANTAGONISTS|C8
60934|ANTIDIURETIC HORMONES|H4D
60933|TRANQUILLISERS|N5C
60933|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60933|SSRI antidepressants|N6A4
60931|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
60927|CALCITONINS|H4A
60926|PARASITOLOGY|P
60926|ANTI-MALARIALS|P1D
60924|PARASITOLOGY|P
60924|ANTI-MALARIALS|P1D
60923|ANALGESICS|N2
60922|ANALGESICS|N2
60921|ANTIVIRALS FOR SYSTEMIC USE|J5
60919|ANALGESICS|N2
60918|Statins (HMG-CoA reductase inhibitors)|C10A1
60917|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
60916|CARDIOVASCULAR SYSTEM|C
60916|CENTRAL NERVOUS SYSTEM|N
60915|ANTIEMETICS AND ANTINAUSEANTS|A4
60911|ANTIVIRALS FOR SYSTEMIC USE|J5
60903|ANTIPSYCHOTICS|N5A
60903|TRANQUILLISERS|N5C
60903|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60903|NOOTROPICS|N6D
60901|PARASITOLOGY|P
60900|PARASITOLOGY|P
60895|SYSTEMIC ANTIBACTERIALS|J1
60889|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
60888|ANALGESICS|N2
60887|Topical dermatological antifungals|D1A1
60887|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
60886|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60886|ANTIHYPERTENSIVES|C2
60885|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
60884|ANTIHYPERTENSIVES|C2
60884|BETA-BLOCKING AGENTS|C7
60882|ANTIMETABOLITES|L1B
60876|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
60874|Urinary incontinence products|G4B4
60874|ANALGESICS|N2
60873|Urinary incontinence products|G4B4
60873|ANALGESICS|N2
60865|IMMUNOSUPPRESSIVE AGENTS|L4
60863|ANTIPSYCHOTICS|N5A
60863|NOOTROPICS|N6D
60862|ANALGESICS|N2
60862|ANTI-MIGRAINE PREPARATIONS|N2C
60860|WOUND HEALING AGENTS|D3
60857|ANTIPSYCHOTICS|N5A
60857|NOOTROPICS|N6D
60852|RADIODIAGNOSTIC AGENTS|T1G
60849|RADIODIAGNOSTIC AGENTS|T1G
60838|ANTIPSYCHOTICS|N5A
60830|Topical dermatological antifungals|D1A1
60830|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
60829|SYSTEMIC ANTIBACTERIALS|J1
60828|SYSTEMIC ANTIBACTERIALS|J1
60826|SYSTEMIC ANTIBACTERIALS|J1
60823|PARASITOLOGY|P
60819|NOOTROPICS|N6D
60814|DIRECT THROMBIN INHIBITORS|B1E
60813|IMMUNOSUPPRESSIVE AGENTS|L4
60811|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60810|CARDIAC THERAPY|C1
60810|RADIODIAGNOSTIC AGENTS|T1G
60809|CARDIAC THERAPY|C1
60809|RADIODIAGNOSTIC AGENTS|T1G
60802|ANTIHYPERTENSIVES|C2
60802|ACE INHIBITORS, PLAIN|C9A
60802|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
60802|Statins (HMG-CoA reductase inhibitors)|C10A1
60801|IMMUNOSUPPRESSIVE AGENTS|L4
60800|ANTIHYPERTENSIVES|C2
60797|WOUND HEALING AGENTS|D3
60794|Coxibs|M1A3
60794|ANALGESICS|N2
60793|ANTIHYPERTENSIVES|C2
60791|SYSTEMIC ANTIBACTERIALS|J1
60790|SYSTEMIC ANTIBACTERIALS|J1
60790|MACROLIDES AND SIMILAR TYPES|J1F
60788|CARDIOVASCULAR SYSTEM|C
60780|WOUND HEALING AGENTS|D3
60775|SYSTEMIC ANTIBACTERIALS|J1
60773|NOOTROPICS|N6D
60772|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
60764|Ocular antineovascularisation products|S1P
60763|ANTIVIRALS FOR SYSTEMIC USE|J5
60762|ANTIVIRALS FOR SYSTEMIC USE|J5
60761|ANTIHYPERTENSIVES|C2
60759|ANTIHYPERTENSIVES|C2
60758|ANALGESICS|N2
60758|SSRI antidepressants|N6A4
60758|SRNI antidepressants|N6A5
60757|ANTIVIRALS FOR SYSTEMIC USE|J5
60756|ANTIHYPERTENSIVES|C2
60753|GASTROPROKINETICS|A3F
60750|DRUGS USED IN DIABETES|A10
60750|DPP-IV inhibitor antidiabetics|A10B6
60745|IMMUNOSUPPRESSIVE AGENTS|L4
60739|CALCIUM ANTAGONISTS|C8
60737|VACCINES|J7
60732|ANTI-EPILEPTICS|N3A
60731|IMMUNOSUPPRESSIVE AGENTS|L4
60729|RESPIRATORY SYSTEM|R
60723|B2-STIMULANTS|R3A
60718|ANTI-EPILEPTICS|N3A
60713|NOOTROPICS|N6D
60711|ANTIPSYCHOTICS|N5A
60704|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60703|ANTIVIRALS FOR SYSTEMIC USE|J5
60703|IMMUNOSTIMULATING AGENTS|L3
60700|DERMATOLOGICALS|D
60699|DERMATOLOGICALS|D
60697|ANALGESICS|N2
60696|ANTIHYPERTENSIVES|C2
60696|MRI AGENTS|T1E
60696|RADIODIAGNOSTIC AGENTS|T1G
60694|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60691|ANTI-MIGRAINE PREPARATIONS|N2C
60690|DPP-IV inhibitor antidiabetics|A10B6
60681|Coxibs|M1A3
60681|ANALGESICS|N2
60677|Coxibs|M1A3
60677|MUSCLE RELAXANTS|M3
60677|ANALGESICS|N2
60676|IMMUNOSTIMULATING AGENTS|L3
60675|NOOTROPICS|N6D
60674|ANTI-EPILEPTICS|N3A
60674|NOOTROPICS|N6D
60673|SYSTEMIC ANTIBACTERIALS|J1
60672|GASTROPROKINETICS|A3F
60672|LAXATIVES|A6
60671|IMMUNOSTIMULATING AGENTS|L3
60670|ANALGESICS|N2
60668|ANALGESICS|N2
60666|CENTRAL NERVOUS SYSTEM|N
60665|PARASITOLOGY|P
60664|ANTIVIRALS FOR SYSTEMIC USE|J5
60663|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60661|NOOTROPICS|N6D
60657|Statins (HMG-CoA reductase inhibitors)|C10A1
60656|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
60654|IMMUNOSTIMULATING AGENTS|L3
60652|ANTIVIRALS FOR SYSTEMIC USE|J5
60650|PARASITOLOGY|P
60649|DRUGS USED IN DIABETES|A10
60649|ANTIHYPERTENSIVES|C2
60649|ACE INHIBITORS, PLAIN|C9A
60647|ANALGESICS|N2
60644|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60642|SYSTEMIC ANTIBACTERIALS|J1
60641|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60638|ANTIHYPERTENSIVES|C2
60637|PARASITOLOGY|P
60636|RADIODIAGNOSTIC AGENTS|T1G
60634|ANALGESICS|N2
60627|RESPIRATORY SYSTEM|R
60624|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60623|CARDIOVASCULAR SYSTEM|C
60622|ANALGESICS|N2
60622|ANTI-EPILEPTICS|N3
60622|TRANQUILLISERS|N5C
60621|RESPIRATORY SYSTEM|R
60620|ANTI-EPILEPTICS|N3
60619|ANALGESICS|N2
60618|SYSTEMIC ANTIBACTERIALS|J1
60617|ANTI-EPILEPTICS|N3A
60617|RADIODIAGNOSTIC AGENTS|T1G
60616|ANTIVIRALS FOR SYSTEMIC USE|J5
60615|Interferons, alpha|L3B1
60614|ANTIPSYCHOTICS|N5A
60614|NOOTROPICS|N6D
60613|RADIODIAGNOSTIC AGENTS|T1G
60612|RADIODIAGNOSTIC AGENTS|T1G
60611|RESPIRATORY SYSTEM|R
60607|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
60605|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60605|CENTRAL NERVOUS SYSTEM|N
60603|ANALGESICS|N2
60602|ANALGESICS|N2
60598|ANTIHYPERTENSIVES|C2
60594|ANTI-EPILEPTICS|N3A
60593|SYSTEMIC ANTIBACTERIALS|J1
60590|RADIODIAGNOSTIC AGENTS|T1G
60588|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60588|SSRI antidepressants|N6A4
60586|NOOTROPICS|N6D
60585|HUMAN INSULINS AND ANALOGUES|A10C
60585|Human insulins and analogues, intermediate-acting|A10C2
60582|PLATELET AGGREGATION INHIBITORS|B1C
60581|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
60575|SYSTEMIC ANTIBACTERIALS|J1
60574|ANTIHYPERTENSIVES|C2
60574|RESPIRATORY SYSTEM|R
60571|DRUGS USED IN DIABETES|A10
60565|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60564|DRUGS USED IN DIABETES|A10
60562|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60562|DRUGS USED IN DIABETES|A10
60561|SYSTEMIC ANTIBACTERIALS|J1
60560|NOOTROPICS|N6D
60559|NOOTROPICS|N6D
60558|CARDIOVASCULAR SYSTEM|C
60558|ANTIHYPERTENSIVES|C2
60558|DIURETICS|C3
60554|DERMATOLOGICALS|D
60554|ANALGESICS|N2
60553|SYSTEMIC ANTIBACTERIALS|J1
60550|DRUGS USED IN DIABETES|A10
60550|CENTRAL NERVOUS SYSTEM|N
60550|ANTI-EPILEPTICS|N3A
60548|HUMAN INSULINS AND ANALOGUES|A10C
60548|Human insulins and analogues, intermediate-acting|A10C2
60547|ANTI-EPILEPTICS|N3A
60544|SSRI antidepressants|N6A4
60543|ANTIPSYCHOTICS|N5A
60542|DERMATOLOGICALS|D
60532|ANTIHYPERTENSIVES|C2
60532|DIURETICS|C3
60532|CALCIUM ANTAGONISTS|C8
60529|ANTIHYPERTENSIVES|C2
60529|DIURETICS|C3
60525|RADIODIAGNOSTIC AGENTS|T1G
60524|DRUGS USED IN DIABETES|A10
60522|RADIODIAGNOSTIC AGENTS|T1G
60520|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
60518|DRUGS USED IN DIABETES|A10
60518|RADIODIAGNOSTIC AGENTS|T1G
60517|ANALGESICS|N2
60516|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
60510|RADIODIAGNOSTIC AGENTS|T1G
60507|SYSTEMIC ANTIBACTERIALS|J1
60501|RESPIRATORY SYSTEM|R
60500|ANALGESICS|N2
60498|ANALGESICS|N2
60490|RESPIRATORY SYSTEM|R
60489|BPH (benign prostatic hypertrophy) products |G4C
60488|SYSTEMIC ANTIBACTERIALS|J1
60482|B2-STIMULANTS|R3A
60481|NOOTROPICS|N6D
60481|Ocular antineovascularisation products|S1P
60480|IMMUNOSTIMULATING AGENTS|L3
60479|B2-STIMULANTS|R3A
60475|ANTI-EPILEPTICS|N3
60474|B2-STIMULANTS|R3A
60473|IMMUNOSUPPRESSIVE AGENTS|L4
60469|ANTIPSYCHOTICS|N5A
60468|ANALGESICS|N2
60467|DRUGS USED IN DIABETES|A10
60467|HUMAN INSULINS AND ANALOGUES|A10C
60467|Human insulins and analogues, intermediate-acting|A10C2
60462|HEPARINS |B1B
60461|ANALGESICS|N2
60461|ANTI-MIGRAINE PREPARATIONS|N2C
60459|Factors II, VII, IX and X|B2D2
60456|ANALGESICS|N2
60454|DRUGS USED IN DIABETES|A10
60449|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
60448|ANALGESICS|N2
60445|ANTIVIRALS FOR SYSTEMIC USE|J5
60443|Urinary incontinence products|G4B4
60442|CALCIUM ANTAGONISTS|C8
60440|DRUGS USED IN DIABETES|A10
60440|HUMAN INSULINS AND ANALOGUES|A10C
60440|Human insulins and analogues, intermediate-acting|A10C2
60439|MUSCULO-SKELETAL SYSTEM|M
60438|THYROID THERAPY|H3
60437|FIBRINOLYTICS|B1D
60436|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
60436|Statins (HMG-CoA reductase inhibitors)|C10A1
60435|DRUGS USED IN DIABETES|A10
60431|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60428|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60422|ANTIHYPERTENSIVES|C2
60422|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
60422|ANTI-EPILEPTICS|N3A
60421|ANTIPSYCHOTICS|N5A
60420|PLATELET AGGREGATION INHIBITORS|B1C
60418|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60418|DRUGS USED IN DIABETES|A10
60417|CARDIAC THERAPY|C1
60417|ANTI-ARRHYTHMICS|C1B
60416|ANTIVIRALS FOR SYSTEMIC USE|J5
60415|ANTIVIRALS FOR SYSTEMIC USE|J5
60413|ANALGESICS|N2
60412|OPHTHALMOLOGICALS|S1
60408|SYSTEMIC ANTIBACTERIALS|J1
60407|IMMUNOSUPPRESSIVE AGENTS|L4
60405|RESPIRATORY SYSTEM|R
60405|B2-STIMULANTS|R3A
60404|IMMUNOSUPPRESSIVE AGENTS|L4
60403|ANALGESICS|N2
60401|SYSTEMIC ANTIBACTERIALS|J1
60399|ANTIVIRALS FOR SYSTEMIC USE|J5
60395|RESPIRATORY SYSTEM|R
60394|RESPIRATORY SYSTEM|R
60392|SYSTEMIC ANTIBACTERIALS|J1
60391|ANTIVIRALS FOR SYSTEMIC USE|J5
60390|SYSTEMIC ANTIBACTERIALS|J1
60387|ANTI-EPILEPTICS|N3A
60382|RESPIRATORY SYSTEM|R
60381|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60380|ANTIVIRALS FOR SYSTEMIC USE|J5
60379|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
60378|CARDIAC THERAPY|C1
60376|SYSTEMIC ANTIBACTERIALS|J1
60374|ANTIHYPERTENSIVES|C2
60372|Erectile dysfunction products|G4B3
60369|ANTI-EPILEPTICS|N3A
60365|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60363|OPHTHALMOLOGICALS|S1
60361|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
60358|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60357|ANALGESICS|N2
60355|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
60354|ANALGESICS|N2
60352|DRUGS USED IN DIABETES|A10
60351|DRUGS USED IN DIABETES|A10
60350|DRUGS USED IN DIABETES|A10
60336|ANTIVIRALS FOR SYSTEMIC USE|J5
60332|ANALGESICS|N2
60332|OPHTHALMOLOGICALS|S1
60332|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
60331|IMMUNOSTIMULATING AGENTS|L3
60325|ANTI-EPILEPTICS|N3
60322|SYSTEMIC ANTIBACTERIALS|J1
60320|ANTIVIRALS FOR SYSTEMIC USE|J5
60316|PLATELET AGGREGATION INHIBITORS|B1C
60312|ANTIVIRALS FOR SYSTEMIC USE|J5
60311|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60310|MUSCULO-SKELETAL SYSTEM|M
60308|DRUGS USED IN DIABETES|A10
60306|SYSTEMIC ANTIBACTERIALS|J1
60305|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60305|SSRI antidepressants|N6A4
60305|SRNI antidepressants|N6A5
60304|ANALGESICS|N2
60298|ANTI-EPILEPTICS|N3A
60297|ANTI-EPILEPTICS|N3A
60296|SYSTEMIC ANTIBACTERIALS|J1
60293|WOUND HEALING AGENTS|D3
60293|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
60293|ANTIVIRALS FOR SYSTEMIC USE|J5
60292|CENTRAL NERVOUS SYSTEM|N
60288|ANALGESICS|N2
60285|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
60285|IMMUNOSUPPRESSIVE AGENTS|L4
60281|ANTIVIRALS FOR SYSTEMIC USE|J5
60276|ANTIPSYCHOTICS|N5A
60274|CARDIAC THERAPY|C1
60274|OPHTHALMOLOGICALS|S1
60273|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
60271|RESPIRATORY SYSTEM|R
60266|RESPIRATORY SYSTEM|R
60265|CENTRAL NERVOUS SYSTEM|N
60264|TRANQUILLISERS|N5C
60264|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60263|WOUND HEALING AGENTS|D3
60263|SYSTEMIC ANTIBACTERIALS|J1
60262|IMMUNOSUPPRESSIVE AGENTS|L4
60260|ANALGESICS|N2
60259|CENTRAL NERVOUS SYSTEM|N
60258|NOOTROPICS|N6D
60257|CARDIOVASCULAR SYSTEM|C
60255|ANTI-ACNE PREPARATIONS|D10
60255|SYSTEMIC ANTIBACTERIALS|J1
60253|CENTRAL NERVOUS SYSTEM|N
60253|NOOTROPICS|N6D
60252|ANTIVIRALS FOR SYSTEMIC USE|J5
60250|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60250|DRUGS USED IN DIABETES|A10
60249|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
60242|ANALGESICS|N2
60242|SRNI antidepressants|N6A5
60241|ANTIVIRALS FOR SYSTEMIC USE|J5
60239|ANTIVIRALS FOR SYSTEMIC USE|J5
60236|ANTI-GOUT PREPARATIONS|M4
60235|SYSTEMIC ANTIBACTERIALS|J1
60234|DERMATOLOGICALS|D
60233|NOOTROPICS|N6D
60232|CARDIOVASCULAR SYSTEM|C
60232|ANALGESICS|N2
60231|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60229|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60229|ANALGESICS|N2
60228|DRUGS USED IN DIABETES|A10
60227|DRUGS USED IN DIABETES|A10
60224|DRUGS USED IN DIABETES|A10
60224|CENTRAL NERVOUS SYSTEM|N
60221|DRUGS USED IN DIABETES|A10
60219|ANALGESICS|N2
60219|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60219|SSRI antidepressants|N6A4
60219|SRNI antidepressants|N6A5
60218|ANALGESICS|N2
60218|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60218|SSRI antidepressants|N6A4
60218|SRNI antidepressants|N6A5
60216|ANTIVIRALS FOR SYSTEMIC USE|J5
60214|Factor VIII|B2D1
60213|SYSTEMIC ANTIBACTERIALS|J1
60213|IMMUNOSTIMULATING AGENTS|L3
60212|CARDIOVASCULAR SYSTEM|C
60206|SYSTEMIC ANTIBACTERIALS|J1
60205|CARDIOVASCULAR SYSTEM|C
60204|CENTRAL NERVOUS SYSTEM|N
60203|HYPNOTICS/SEDATIVES|N5B
60203|TRANQUILLISERS|N5C
60201|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
60201|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
60199|HEPARINS |B1B
60199|PARASITOLOGY|P
60199|ANTIPROTOZOALS AND ANTHELMINTICS|P1
60199|ANTI-MALARIALS|P1D
60197|CARDIOVASCULAR SYSTEM|C
60196|HEPARINS |B1B
60191|ANTIVIRALS FOR SYSTEMIC USE|J5
60184|ANALGESICS|N2
60182|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60177|ANALGESICS|N2
60171|SYSTEMIC ANTIBACTERIALS|J1
60168|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
60164|OPHTHALMOLOGICALS|S1
60163|IMMUNOSTIMULATING AGENTS|L3
60162|ANDROGENS, EXCLUDING G3E, G3F|G3B
60162|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
60162|OPHTHALMOLOGICALS|S1
60161|CARDIOVASCULAR SYSTEM|C
60157|ANTIVIRALS FOR SYSTEMIC USE|J5
60156|ANALGESICS|N2
60155|DRUGS USED IN DIABETES|A10
60155|IMMUNOSTIMULATING AGENTS|L3
60150|DRUGS USED IN DIABETES|A10
60150|IMMUNOSTIMULATING AGENTS|L3
60146|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
60144|RESPIRATORY SYSTEM|R
60142|NOOTROPICS|N6D
60140|SRNI antidepressants|N6A5
60139|TRANQUILLISERS|N5C
60138|TRANQUILLISERS|N5C
60137|CENTRAL NERVOUS SYSTEM|N
60137|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60137|SRNI antidepressants|N6A5
60136|OPHTHALMOLOGICALS|S1
60135|ANTI-EPILEPTICS|N3A
60134|ANTI-EPILEPTICS|N3
60134|NOOTROPICS|N6D
60133|ANTI-EPILEPTICS|N3
60129|NOOTROPICS|N6D
60128|HYPNOTICS/SEDATIVES|N5B
60128|NOOTROPICS|N6D
60127|ANALGESICS|N2
60126|OPHTHALMOLOGICALS|S1
60124|TRANQUILLISERS|N5C
60124|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60123|Protease inhibitors|J5C2
60122|OPHTHALMOLOGICALS|S1
60121|ANTIVIRALS FOR SYSTEMIC USE|J5
60121|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
60121|Non-nucleoside reverse transcriptase inhibitors|J5C3
60118|Erectile dysfunction products|G4B3
60115|SYSTEMIC ANTIBACTERIALS|J1
60110|ANTIEMETICS AND ANTINAUSEANTS|A4
60108|CENTRAL NERVOUS SYSTEM|N
60107|PARASITOLOGY|P
60106|SSRI antidepressants|N6A4
60103|OPHTHALMOLOGICALS|S1
60102|ANTIVIRALS FOR SYSTEMIC USE|J5
60102|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
60099|ANTI-EPILEPTICS|N3A
60097|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
60096|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
60091|SYSTEMIC ANTIBACTERIALS|J1
60079|NOOTROPICS|N6D
60078|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
60077|NOOTROPICS|N6D
60076|Vitamin E, plain|A11X3
60073|ANTIHYPERTENSIVES|C2
60070|SYSTEMIC ANTIHISTAMINES|R6
60069|ANTIHYPERTENSIVES|C2
60068|ALKYLATING AGENTS|L1A
60067|B2-STIMULANTS|R3A
60065|ANTIHYPERTENSIVES|C2
60065|OPHTHALMOLOGICALS|S1
60063|DRUGS USED IN DIABETES|A10
60063|DPP-IV inhibitor antidiabetics|A10B6
60061|ANALGESICS|N2
60057|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
60056|ANTIVIRALS FOR SYSTEMIC USE|J5
60053|Urinary incontinence products|G4B4
60051|Urinary incontinence products|G4B4
60050|ANTI-GOUT PREPARATIONS|M4
60049|ANTI-GOUT PREPARATIONS|M4
60048|ANTIMETABOLITES|L1B
60045|SYSTEMIC ANTIBACTERIALS|J1
60043|SYSTEMIC ANTIBACTERIALS|J1
60042|Vitamin A|A11C1
60042|OPHTHALMOLOGICALS|S1
60041|OPHTHALMOLOGICALS|S1
60040|ANAESTHETICS, LOCAL|N1B
60040|ANALGESICS|N2
60039|Urinary incontinence products|G4B4
60039|ANTIDIURETIC HORMONES|H4D
60035|ANTIVIRALS FOR SYSTEMIC USE|J5
60031|DERMATOLOGICALS|D
60030|SYSTEMIC ANTIBACTERIALS|J1
60028|OPHTHALMOLOGICALS|S1
60026|ANAESTHETICS|N1
60026|ANALGESICS|N2
60025|ANALGESICS|N2
60024|ANALGESICS|N2
60021|ANALGESICS|N2
60009|OPHTHALMOLOGICALS|S1
60006|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
60005|SYSTEMIC ANTIBACTERIALS|J1
60004|DIRECT THROMBIN INHIBITORS|B1E
60000|NOOTROPICS|N6D
59985|IMMUNOSUPPRESSIVE AGENTS|L4
59984|RADIODIAGNOSTIC AGENTS|T1G
59980|WOUND HEALING AGENTS|D3
59980|SYSTEMIC ANTIBACTERIALS|J1
59978|ANTIEMETICS AND ANTINAUSEANTS|A4
59978|ANALGESICS|N2
59978|NOOTROPICS|N6D
59976|ANALGESICS|N2
59965|ANTIVIRALS FOR SYSTEMIC USE|J5
59938|CARDIOVASCULAR SYSTEM|C
59937|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59930|WOUND HEALING AGENTS|D3
59926|OPHTHALMOLOGICALS|S1
59918|OPHTHALMOLOGICALS|S1
59914|NOOTROPICS|N6D
59912|CENTRAL NERVOUS SYSTEM|N
59912|ANTIPSYCHOTICS|N5A
59912|NOOTROPICS|N6D
59911|CENTRAL NERVOUS SYSTEM|N
59911|ANALGESICS|N2
59911|ANTIPSYCHOTICS|N5A
59911|TRANQUILLISERS|N5C
59911|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59911|SSRI antidepressants|N6A4
59911|SRNI antidepressants|N6A5
59909|SYSTEMIC ANTIBACTERIALS|J1
59908|ANALGESICS|N2
59906|Erectile dysfunction products|G4B3
59904|MUSCULO-SKELETAL SYSTEM|M
59899|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59898|NOOTROPICS|N6D
59897|MACROLIDES AND SIMILAR TYPES|J1F
59896|ANTIPSYCHOTICS|N5A
59896|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59895|SYSTEMIC ANTIBACTERIALS|J1
59894|NOOTROPICS|N6D
59892|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59890|ANTIMETABOLITES|L1B
59886|ANTIVIRALS FOR SYSTEMIC USE|J5
59885|SYSTEMIC ANTIBACTERIALS|J1
59874|DPP-IV inhibitor antidiabetics|A10B6
59871|ANTIVIRALS FOR SYSTEMIC USE|J5
59870|CENTRAL NERVOUS SYSTEM|N
59870|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59868|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59868|GLUCAGON|H4B
59866|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59865|PARASITOLOGY|P
59863|ANTIVIRALS FOR SYSTEMIC USE|J5
59862|SYSTEMIC ANTIBACTERIALS|J1
59859|ANTIVIRALS FOR SYSTEMIC USE|J5
59856|RADIODIAGNOSTIC AGENTS|T1G
59850|NOOTROPICS|N6D
59849|DRUGS USED IN DIABETES|A10
59846|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
59845|ANTIVIRALS FOR SYSTEMIC USE|J5
59844|IMMUNOSUPPRESSIVE AGENTS|L4
59842|SYSTEMIC ANTIBACTERIALS|J1
59842|CEPHALOSPORINS|J1D
59841|SYSTEMIC ANTIBACTERIALS|J1
59839|DPP-IV inhibitor antidiabetics|A10B6
59836|ANTIHYPERTENSIVES|C2
59836|CALCIUM ANTAGONISTS|C8
59834|ANTIVIRALS FOR SYSTEMIC USE|J5
59833|ANALGESICS|N2
59832|SYSTEMIC ANTIBACTERIALS|J1
59828|NOOTROPICS|N6D
59827|ANALGESICS|N2
59825|ANTIHYPERTENSIVES|C2
59825|DIURETICS|C3
59823|AMINOGLYCOSIDES|J1K
59822|CARDIOVASCULAR SYSTEM|C
59820|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59819|SYSTEMIC ANTIBACTERIALS|J1
59817|SYSTEMIC ANTIBACTERIALS|J1
59817|Carbapenems|J1P2
59816|ANALGESICS|N2
59813|RESPIRATORY SYSTEM|R
59811|ANTIVIRALS FOR SYSTEMIC USE|J5
59810|SYSTEMIC ANTIBACTERIALS|J1
59806|Ocular antineovascularisation products|S1P
59805|ANTIPSYCHOTICS|N5A
59804|ANAESTHETICS|N1
59803|ANALGESICS|N2
59799|ANTIVIRALS FOR SYSTEMIC USE|J5
59797|Interferons, beta|L3B2
59796|SYSTEMIC ANTIBACTERIALS|J1
59796|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59796|ANTIVIRALS FOR SYSTEMIC USE|J5
59795|DRUGS USED IN DIABETES|A10
59795|DPP-IV inhibitor antidiabetics|A10B6
59787|SYSTEMIC ANTIBACTERIALS|J1
59787|IMMUNOSTIMULATING AGENTS|L3
59786|ANALGESICS|N2
59785|OPHTHALMOLOGICALS|S1
59784|SYSTEMIC ANTIBACTERIALS|J1
59783|ANTIVIRALS FOR SYSTEMIC USE|J5
59782|ANTI-ARRHYTHMICS|C1B
59780|ANTIVIRALS FOR SYSTEMIC USE|J5
59778|ANTI-MALARIALS|P1D
59777|SYSTEMIC ANTIBACTERIALS|J1
59776|SYSTEMIC ANTIBACTERIALS|J1
59774|ANTIVIRALS FOR SYSTEMIC USE|J5
59771|ANTIVIRALS FOR SYSTEMIC USE|J5
59770|ANALGESICS|N2
59765|TRANQUILLISERS|N5C
59765|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59765|SSRI antidepressants|N6A4
59757|ANTI-EPILEPTICS|N3A
59756|ANALGESICS|N2
59755|ANTIVIRALS FOR SYSTEMIC USE|J5
59754|DRUGS USED IN DIABETES|A10
59752|ANALGESICS|N2
59751|CARDIOVASCULAR SYSTEM|C
59749|OPHTHALMOLOGICALS|S1
59746|ANTIVIRALS FOR SYSTEMIC USE|J5
59746|RESPIRATORY SYSTEM|R
59740|ANTIVIRALS FOR SYSTEMIC USE|J5
59739|ANTIVIRALS FOR SYSTEMIC USE|J5
59737|RADIODIAGNOSTIC AGENTS|T1G
59733|PSYCHOSTIMULANTS|N6B
59730|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
59729|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
59728|LAXATIVES|A6
59725|IMMUNOSTIMULATING AGENTS|L3
59724|ANALGESICS|N2
59721|RESPIRATORY SYSTEM|R
59715|ANTIVIRALS FOR SYSTEMIC USE|J5
59714|DRUGS USED IN DIABETES|A10
59713|CARDIOVASCULAR SYSTEM|C
59708|IMMUNOSUPPRESSIVE AGENTS|L4
59707|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59703|ANTIVIRALS FOR SYSTEMIC USE|J5
59703|Interferons, alpha|L3B1
59700|B2-STIMULANTS|R3A
59693|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
59692|ANALGESICS|N2
59689|TRANQUILLISERS|N5C
59689|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59689|SSRI antidepressants|N6A4
59685|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
59683|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59683|DRUGS USED IN DIABETES|A10
59682|ANALGESICS|N2
59681|Biguanide antidiabetics|A10B2
59681|DPP-IV inhibitor antidiabetics|A10B6
59678|RESPIRATORY SYSTEM|R
59677|CARDIOVASCULAR SYSTEM|C
59677|ANTIHYPERTENSIVES|C2
59677|CALCIUM ANTAGONISTS|C8
59674|PARASITOLOGY|P
59673|ANTIPSYCHOTICS|N5A
59669|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
59668|NOOTROPICS|N6D
59666|PARASITOLOGY|P
59662|WOUND HEALING AGENTS|D3
59654|SYSTEMIC ANTIBACTERIALS|J1
59654|AMINOGLYCOSIDES|J1K
59652|ANTI-GOUT PREPARATIONS|M4
59646|ANTI-ARRHYTHMICS|C1B
59638|IMMUNOSTIMULATING AGENTS|L3
59638|Interferons, gamma|L3B3
59637|PSYCHOSTIMULANTS|N6B
59629|ANTIVIRALS FOR SYSTEMIC USE|J5
59628|OPHTHALMOLOGICALS|S1
59627|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59622|ANALGESICS|N2
59616|IMMUNOSUPPRESSIVE AGENTS|L4
59615|ANTI-MALARIALS|P1D
59614|LUNG SURFACTANTS|R7C
59612|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59612|DRUGS USED IN DIABETES|A10
59610|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59610|DRUGS USED IN DIABETES|A10
59607|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
59607|ANTI-ACNE PREPARATIONS|D10
59607|IMMUNOSUPPRESSIVE AGENTS|L4
59606|RESPIRATORY SYSTEM|R
59605|DRUGS USED IN DIABETES|A10
59604|ANALGESICS|N2
59603|RESPIRATORY SYSTEM|R
59602|ANTI-EPILEPTICS|N3
59602|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59594|IMMUNOSUPPRESSIVE AGENTS|L4
59592|ANTIVIRALS FOR SYSTEMIC USE|J5
59591|CENTRAL NERVOUS SYSTEM|N
59590|DERMATOLOGICALS|D
59589|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
59585|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
59584|SYSTEMIC ANTIBACTERIALS|J1
59583|SYSTEMIC ANTIBACTERIALS|J1
59582|WOUND HEALING AGENTS|D3
59579|ANTIVIRALS FOR SYSTEMIC USE|J5
59576|SYSTEMIC ANTIBACTERIALS|J1
59572|GASTROPROKINETICS|A3F
59571|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59569|ANTIEMETICS AND ANTINAUSEANTS|A4
59566|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59562|OPHTHALMOLOGICALS|S1
59561|DRUGS USED IN DIABETES|A10
59561|CARDIOVASCULAR SYSTEM|C
59561|DERMATOLOGICALS|D
59561|Ocular antineovascularisation products|S1P
59560|SYSTEMIC ANTIHISTAMINES|R6
59559|CARDIOVASCULAR SYSTEM|C
59559|ANTIPSYCHOTICS|N5A
59559|TRANQUILLISERS|N5C
59559|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59556|RESPIRATORY SYSTEM|R
59555|ANALGESICS|N2
59553|ANTIHYPERTENSIVES|C2
59553|DIURETICS|C3
59553|CALCIUM ANTAGONISTS|C8
59548|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
59547|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
59546|AMINOGLYCOSIDES|J1K
59543|ANTIEMETICS AND ANTINAUSEANTS|A4
59542|ANTIVIRALS FOR SYSTEMIC USE|J5
59540|CARDIOVASCULAR SYSTEM|C
59540|IMMUNOSUPPRESSIVE AGENTS|L4
59538|SYSTEMIC ANTIHISTAMINES|R6
59538|OPHTHALMOLOGICALS|S1
59537|OPHTHALMOLOGICALS|S1
59535|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59534|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
59532|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
59530|Ocular antineovascularisation products|S1P
59529|VACCINES|J7
59527|RESPIRATORY SYSTEM|R
59526|ANTIVIRALS FOR SYSTEMIC USE|J5
59524|ANTIVIRALS FOR SYSTEMIC USE|J5
59518|DRUGS USED IN DIABETES|A10
59518|ANTIVIRALS FOR SYSTEMIC USE|J5
59513|Interferons, beta|L3B2
59511|ANTIVIRALS FOR SYSTEMIC USE|J5
59507|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
59507|Statins (HMG-CoA reductase inhibitors)|C10A1
59506|PLATELET AGGREGATION INHIBITORS|B1C
59506|CARDIOVASCULAR SYSTEM|C
59506|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
59506|Statins (HMG-CoA reductase inhibitors)|C10A1
59505|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
59505|ANTI-ACNE PREPARATIONS|D10
59504|PLATELET AGGREGATION INHIBITORS|B1C
59504|CARDIOVASCULAR SYSTEM|C
59504|ANTIHYPERTENSIVES|C2
59503|DRUGS USED IN DIABETES|A10
59503|HUMAN INSULINS AND ANALOGUES|A10C
59503|Human insulins and analogues, intermediate-acting|A10C2
59502|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59502|ANTIVIRALS FOR SYSTEMIC USE|J5
59502|ANTIPROTOZOALS AND ANTHELMINTICS|P1
59501|ANTI-EPILEPTICS|N3
59500|ANTIMETABOLITES|L1B
59499|ANTIVIRALS FOR SYSTEMIC USE|J5
59498|CARDIOVASCULAR SYSTEM|C
59498|NOOTROPICS|N6D
59494|ANTIVIRALS FOR SYSTEMIC USE|J5
59494|Protease inhibitors|J5C2
59491|ANALGESICS|N2
59490|WOUND HEALING AGENTS|D3
59490|OPHTHALMOLOGICALS|S1
59486|DIRECT THROMBIN INHIBITORS|B1E
59485|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
59485|Statins (HMG-CoA reductase inhibitors)|C10A1
59483|NOOTROPICS|N6D
59478|ANTIVIRALS FOR SYSTEMIC USE|J5
59477|IMMUNOSUPPRESSIVE AGENTS|L4
59473|ANTIVIRALS FOR SYSTEMIC USE|J5
59473|Non-nucleoside reverse transcriptase inhibitors|J5C3
59472|ANTIVIRALS FOR SYSTEMIC USE|J5
59471|PLATELET AGGREGATION INHIBITORS|B1C
59471|CARDIOVASCULAR SYSTEM|C
59471|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
59471|Statins (HMG-CoA reductase inhibitors)|C10A1
59470|ANTIVIRALS FOR SYSTEMIC USE|J5
59469|DERMATOLOGICALS|D
59467|CARDIOVASCULAR SYSTEM|C
59467|ANTIHYPERTENSIVES|C2
59465|ANTIVIRALS FOR SYSTEMIC USE|J5
59464|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
59462|NOOTROPICS|N6D
59461|DPP-IV inhibitor antidiabetics|A10B6
59458|ANALGESICS|N2
59457|CARDIOVASCULAR SYSTEM|C
59455|NOOTROPICS|N6D
59444|ANTIVIRALS FOR SYSTEMIC USE|J5
59443|ANTIVIRALS FOR SYSTEMIC USE|J5
59442|ANTI-EPILEPTICS|N3
59441|ANTIVIRALS FOR SYSTEMIC USE|J5
59435|Coxibs|M1A3
59435|ANALGESICS|N2
59432|Non-nucleoside reverse transcriptase inhibitors|J5C3
59430|BETA-BLOCKING AGENTS|C7
59430|OPHTHALMOLOGICALS|S1
59425|Factors II, VII, IX and X|B2D2
59423|SYSTEMIC ANTIBACTERIALS|J1
59422|RADIODIAGNOSTIC AGENTS|T1G
59420|SYSTEMIC ANTIBACTERIALS|J1
59419|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59417|Coxibs|M1A3
59417|MUSCLE RELAXANTS|M3
59417|ANALGESICS|N2
59416|Coxibs|M1A3
59416|ANALGESICS|N2
59414|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59413|TRANQUILLISERS|N5C
59413|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59410|AMINOGLYCOSIDES|J1K
59407|ANTIVIRALS FOR SYSTEMIC USE|J5
59407|PARASITOLOGY|P
59406|ANTIVIRALS FOR SYSTEMIC USE|J5
59403|ANTIVIRALS FOR SYSTEMIC USE|J5
59402|SYSTEMIC ANTIBACTERIALS|J1
59401|ANALGESICS|N2
59400|ANALGESICS|N2
59398|ANALGESICS|N2
59397|WOUND HEALING AGENTS|D3
59396|WOUND HEALING AGENTS|D3
59395|WOUND HEALING AGENTS|D3
59394|WOUND HEALING AGENTS|D3
59391|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59391|SSRI antidepressants|N6A4
59390|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59390|SSRI antidepressants|N6A4
59389|CARDIOVASCULAR SYSTEM|C
59377|Coxibs|M1A3
59376|Coxibs|M1A3
59374|CENTRAL NERVOUS SYSTEM|N
59372|Coxibs|M1A3
59371|Coxibs|M1A3
59370|Coxibs|M1A3
59369|OPHTHALMOLOGICALS|S1
59368|OPHTHALMOLOGICALS|S1
59367|OPHTHALMOLOGICALS|S1
59364|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59363|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59362|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59356|SYSTEMIC ANTIBACTERIALS|J1
59355|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59339|ANTIVIRALS FOR SYSTEMIC USE|J5
59338|HUMAN INSULINS AND ANALOGUES|A10C
59338|Human insulins and analogues, intermediate-acting|A10C2
59333|Topical dermatological antifungals|D1A1
59333|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59321|ANTIVIRALS FOR SYSTEMIC USE|J5
59319|WOUND HEALING AGENTS|D3
59318|WOUND HEALING AGENTS|D3
59316|PARASITOLOGY|P
59316|ANTI-MALARIALS|P1D
59315|PARASITOLOGY|P
59315|ANTI-MALARIALS|P1D
59314|RESPIRATORY SYSTEM|R
59312|RESPIRATORY SYSTEM|R
59311|RESPIRATORY SYSTEM|R
59310|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59310|NOOTROPICS|N6D
59309|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59309|NOOTROPICS|N6D
59308|Miotics and antiglaucoma preparations, topical|S1E2
59307|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
59304|TRANQUILLISERS|N5C
59304|NOOTROPICS|N6D
59304|OPHTHALMOLOGICALS|S1
59303|PARASITOLOGY|P
59299|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59297|MACROLIDES AND SIMILAR TYPES|J1F
59297|PARASITOLOGY|P
59297|ANTI-MALARIALS|P1D
59295|ANALGESICS|N2
59293|RESPIRATORY SYSTEM|R
59292|OPHTHALMOLOGICALS|S1
59290|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
59284|DRUGS USED IN DIABETES|A10
59281|IMMUNOSUPPRESSIVE AGENTS|L4
59280|ANTI-EPILEPTICS|N3A
59280|NOOTROPICS|N6D
59279|ANTIVIRALS FOR SYSTEMIC USE|J5
59276|SYSTEMIC ANTIBACTERIALS|J1
59272|CEPHALOSPORINS|J1D
59269|HUMAN INSULINS AND ANALOGUES|A10C
59269|Human insulins and analogues, long-acting|A10C5
59268|ANTI-EPILEPTICS|N3A
59267|DERMATOLOGICALS|D
59265|ACTH|H1A
59262|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
59261|ANTIVIRALS FOR SYSTEMIC USE|J5
59257|ANTIVIRALS FOR SYSTEMIC USE|J5
59257|Interferons, beta|L3B2
59256|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59255|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59254|DRUGS USED IN DIABETES|A10
59253|ANTIVIRALS FOR SYSTEMIC USE|J5
59249|IMMUNOSUPPRESSIVE AGENTS|L4
59248|SYSTEMIC ANTIBACTERIALS|J1
59243|ANTIVIRALS FOR SYSTEMIC USE|J5
59238|CARDIOVASCULAR SYSTEM|C
59236|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
59234|GASTROPROKINETICS|A3F
59231|HUMAN INSULINS AND ANALOGUES|A10C
59231|Human insulins and analogues, intermediate-acting|A10C2
59230|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
59228|HUMAN INSULINS AND ANALOGUES|A10C
59215|ALKYLATING AGENTS|L1A
59210|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59210|NOOTROPICS|N6D
59209|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59206|BPH (benign prostatic hypertrophy) products |G4C
59204|ANTIHYPERTENSIVES|C2
59204|Miotics and antiglaucoma preparations, topical|S1E2
59202|ANALGESICS|N2
59200|ANTIVIRALS FOR SYSTEMIC USE|J5
59199|ALKYLATING AGENTS|L1A
59195|CARDIOVASCULAR SYSTEM|C
59195|MUSCULO-SKELETAL SYSTEM|M
59194|ANALGESICS|N2
59193|ANALGESICS|N2
59192|AMINOGLYCOSIDES|J1K
59192|RESPIRATORY SYSTEM|R
59183|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
59183|ANTI-MIGRAINE PREPARATIONS|N2C
59182|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59180|ANTIVIRALS FOR SYSTEMIC USE|J5
59176|ANTI-EPILEPTICS|N3A
59175|SYSTEMIC ANTIBACTERIALS|J1
59169|Coxibs|M1A3
59167|NOOTROPICS|N6D
59167|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
59166|PLATELET AGGREGATION INHIBITORS|B1C
59162|RESPIRATORY SYSTEM|R
59160|IMMUNOSTIMULATING AGENTS|L3
59158|ANTI-EPILEPTICS|N3
59147|SYSTEMIC ANTIBACTERIALS|J1
59147|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
59139|ANTIHYPERTENSIVES|C2
59135|ANTIVIRALS FOR SYSTEMIC USE|J5
59134|ANTIPSYCHOTICS|N5A
59132|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59131|Factors II, VII, IX and X|B2D2
59128|TRANQUILLISERS|N5C
59128|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59127|ANALGESICS|N2
59126|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
59122|SYSTEMIC ANTIHISTAMINES|R6
59119|HYPNOTICS/SEDATIVES|N5B
59116|ANALGESICS|N2
59115|NOOTROPICS|N6D
59113|RESPIRATORY SYSTEM|R
59110|RESPIRATORY SYSTEM|R
59109|RESPIRATORY SYSTEM|R
59108|RESPIRATORY SYSTEM|R
59107|ANTIVIRALS FOR SYSTEMIC USE|J5
59101|PLATELET AGGREGATION INHIBITORS|B1C
59100|Biguanide antidiabetics|A10B2
59100|DPP-IV inhibitor antidiabetics|A10B6
59098|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
59097|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59097|DRUGS USED IN DIABETES|A10
59095|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59095|CALCIUM ANTAGONISTS|C8
59092|MUSCLE RELAXANTS|M3
59089|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
59088|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59088|DRUGS USED IN DIABETES|A10
59087|OPHTHALMOLOGICALS|S1
59086|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
59083|IMMUNOSUPPRESSIVE AGENTS|L4
59081|ANALGESICS|N2
59081|ANTIPSYCHOTICS|N5A
59081|ANTITUSSIVES|R5D
59078|SSRI antidepressants|N6A4
59077|ANTIVIRALS FOR SYSTEMIC USE|J5
59076|ANALGESICS|N2
59076|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59074|DERMATOLOGICALS|D
59072|Interferons, beta|L3B2
59071|OPHTHALMOLOGICALS|S1
59070|DRUGS USED IN DIABETES|A10
59069|OPHTHALMOLOGICALS|S1
59067|SYSTEMIC ANTIBACTERIALS|J1
59066|Ocular antineovascularisation products|S1P
59065|Ocular antineovascularisation products|S1P
59061|IMMUNOSUPPRESSIVE AGENTS|L4
59060|B2-STIMULANTS|R3A
59055|Inhibitors of the Kallikrein-kinin-system|B2C2
59055|OPHTHALMOLOGICALS|S1
59054|ANALGESICS|N2
59054|TRANQUILLISERS|N5C
59054|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59051|SYSTEMIC ANTIBACTERIALS|J1
59048|Ocular antineovascularisation products|S1P
59047|GASTROPROKINETICS|A3F
59045|DPP-IV inhibitor antidiabetics|A10B6
59044|ANTIVIRALS FOR SYSTEMIC USE|J5
59044|Interferons, alpha|L3B1
59043|PLATELET AGGREGATION INHIBITORS|B1C
59043|CARDIOVASCULAR SYSTEM|C
59043|SSRI antidepressants|N6A4
59041|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59041|SSRI antidepressants|N6A4
59041|SRNI antidepressants|N6A5
59036|WOUND HEALING AGENTS|D3
59033|ANTIVIRALS FOR SYSTEMIC USE|J5
59031|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
59031|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
59030|ANALGESICS|N2
59028|PLATELET AGGREGATION INHIBITORS|B1C
59028|CARDIAC THERAPY|C1
59025|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
59024|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
59023|Other oral antidiabetics|A10B9
59020|ANTIVIRALS FOR SYSTEMIC USE|J5
59020|OPHTHALMOLOGICALS|S1
59020|Ocular antineovascularisation products|S1P
59015|ANTIPSYCHOTICS|N5A
59012|Erectile dysfunction products|G4B3
59010|SYSTEMIC ANTIBACTERIALS|J1
59006|OPHTHALMOLOGICALS|S1
59002|ANTIPSYCHOTICS|N5A
58998|ANTIVIRALS FOR SYSTEMIC USE|J5
58997|ANTI-EPILEPTICS|N3A
58992|AMINOGLYCOSIDES|J1K
58989|CARDIOVASCULAR SYSTEM|C
58988|RESPIRATORY SYSTEM|R
58987|RESPIRATORY SYSTEM|R
58986|RESPIRATORY SYSTEM|R
58985|ANTIHYPERTENSIVES|C2
58985|ANTI-MIGRAINE PREPARATIONS|N2C
58980|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58978|SYSTEMIC ANTIBACTERIALS|J1
58974|PLATELET AGGREGATION INHIBITORS|B1C
58972|ANTI-EPILEPTICS|N3A
58971|ANALGESICS|N2
58962|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58962|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
58961|ANTIHYPERTENSIVES|C2
58961|OPHTHALMOLOGICALS|S1
58961|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
58959|CARDIOVASCULAR SYSTEM|C
58956|ANALGESICS|N2
58956|NOOTROPICS|N6D
58955|ANALGESICS|N2
58955|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58955|SSRI antidepressants|N6A4
58955|SRNI antidepressants|N6A5
58954|ANALGESICS|N2
58954|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58954|SSRI antidepressants|N6A4
58954|SRNI antidepressants|N6A5
58952|CARDIOVASCULAR SYSTEM|C
58950|ANTIVIRALS FOR SYSTEMIC USE|J5
58943|ANALGESICS|N2
58942|IMMUNOSTIMULATING AGENTS|L3
58937|ANTI-EPILEPTICS|N3
58924|RESPIRATORY SYSTEM|R
58921|HYPNOTICS/SEDATIVES|N5B
58918|DRUGS USED IN DIABETES|A10
58917|DRUGS USED IN DIABETES|A10
58916|CARDIOVASCULAR SYSTEM|C
58915|ANALGESICS|N2
58915|ANTI-MIGRAINE PREPARATIONS|N2C
58915|ANTI-EPILEPTICS|N3
58911|ANTI-EPILEPTICS|N3
58907|RADIODIAGNOSTIC AGENTS|T1G
58905|Ocular antineovascularisation products|S1P
58903|ANALGESICS|N2
58901|ANTIVIRALS FOR SYSTEMIC USE|J5
58896|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58895|ANTIVIRALS FOR SYSTEMIC USE|J5
58894|IMMUNOSTIMULATING AGENTS|L3
58891|ANTIVIRALS FOR SYSTEMIC USE|J5
58890|ANALGESICS|N2
58888|ANTIVIRALS FOR SYSTEMIC USE|J5
58887|ANALGESICS|N2
58884|ANALGESICS|N2
58884|ANTIPSYCHOTICS|N5A
58884|NOOTROPICS|N6D
58883|PARASITOLOGY|P
58883|ANTIPROTOZOALS AND ANTHELMINTICS|P1
58882|ANALGESICS|N2
58879|IMMUNOSUPPRESSIVE AGENTS|L4
58878|IMMUNOSTIMULATING AGENTS|L3
58877|IMMUNOSTIMULATING AGENTS|L3
58876|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58875|ANTIVIRALS FOR SYSTEMIC USE|J5
58874|IMMUNOSUPPRESSIVE AGENTS|L4
58872|ANTIPSYCHOTICS|N5A
58871|IMMUNOSUPPRESSIVE AGENTS|L4
58870|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58869|ANTI-EPILEPTICS|N3A
58869|TRANQUILLISERS|N5C
58859|ANTIPSYCHOTICS|N5A
58855|ANTIVIRALS FOR SYSTEMIC USE|J5
58855|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
58847|ANALGESICS|N2
58842|IMMUNOSUPPRESSIVE AGENTS|L4
58841|ANTIHYPERTENSIVES|C2
58841|CALCIUM ANTAGONISTS|C8
58840|CALCIUM ANTAGONISTS|C8
58840|Ocular antineovascularisation products|S1P
58833|DRUGS USED IN DIABETES|A10
58833|HUMAN INSULINS AND ANALOGUES|A10C
58833|Human insulins and analogues, long-acting|A10C5
58830|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
58829|NOOTROPICS|N6D
58828|CARDIOVASCULAR SYSTEM|C
58827|TRANQUILLISERS|N5C
58827|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58824|WOUND HEALING AGENTS|D3
58822|OPHTHALMOLOGICALS|S1
58821|ANDROGENS, EXCLUDING G3E, G3F|G3B
58820|ANDROGENS, EXCLUDING G3E, G3F|G3B
58819|CARDIOVASCULAR SYSTEM|C
58817|RESPIRATORY SYSTEM|R
58814|ANALGESICS|N2
58814|ANTI-MIGRAINE PREPARATIONS|N2C
58813|OPHTHALMOLOGICALS|S1
58808|OPHTHALMOLOGICALS|S1
58808|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
58800|CENTRAL NERVOUS SYSTEM|N
58796|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
58795|AMINOGLYCOSIDES|J1K
58794|DPP-IV inhibitor antidiabetics|A10B6
58793|ANALGESICS|N2
58788|ANALGESICS|N2
58787|ANALGESICS|N2
58785|NOOTROPICS|N6D
58783|ANALGESICS|N2
58782|ANTIHYPERTENSIVES|C2
58779|Interferons, beta|L3B2
58779|RESPIRATORY SYSTEM|R
58777|OPHTHALMOLOGICALS|S1
58770|CALCITONINS|H4A
58769|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58763|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
58760|PLATELET AGGREGATION INHIBITORS|B1C
58760|CARDIOVASCULAR SYSTEM|C
58758|ANTIVIRALS FOR SYSTEMIC USE|J5
58758|VACCINES|J7
58757|ANTIVIRALS FOR SYSTEMIC USE|J5
58757|VACCINES|J7
58756|CARDIOVASCULAR SYSTEM|C
58755|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58754|NOOTROPICS|N6D
58753|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58751|ANTIPSYCHOTICS|N5A
58749|Vitamin D|A11C2
58747|IMMUNOSUPPRESSIVE AGENTS|L4
58746|ANTI-EPILEPTICS|N3A
58741|ANTIVIRALS FOR SYSTEMIC USE|J5
58739|BPH (benign prostatic hypertrophy) products |G4C
58738|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58731|NOOTROPICS|N6D
58730|ANTIVIRALS FOR SYSTEMIC USE|J5
58725|ANTIVIRALS FOR SYSTEMIC USE|J5
58719|CARDIOVASCULAR SYSTEM|C
58717|PLATELET AGGREGATION INHIBITORS|B1C
58716|ANTIHYPERTENSIVES|C2
58716|ANALGESICS|N2
58715|TRANQUILLISERS|N5C
58715|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58714|NOOTROPICS|N6D
58706|ANTI-EPILEPTICS|N3
58704|OPHTHALMOLOGICALS|S1
58702|DRUGS USED IN DIABETES|A10
58701|WOUND HEALING AGENTS|D3
58700|CENTRAL NERVOUS SYSTEM|N
58700|ANTI-EPILEPTICS|N3A
58698|ANALGESICS|N2
58697|TRANQUILLISERS|N5C
58694|IMMUNOSTIMULATING AGENTS|L3
58694|ANALGESICS|N2
58692|TRANQUILLISERS|N5C
58691|ANALGESICS|N2
58689|OPHTHALMOLOGICAL ANTI-INFLAMMATORY/ANTI-INFECTIVE COMBINATIONS|S1C
58688|Factors II, VII, IX and X|B2D2
58687|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58684|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58684|SSRI antidepressants|N6A4
58683|NOOTROPICS|N6D
58682|ANTI-EPILEPTICS|N3A
58676|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
58676|Statins (HMG-CoA reductase inhibitors)|C10A1
58675|MUSCLE RELAXANTS|M3
58674|ANTI-EPILEPTICS|N3
58672|ANTI-EPILEPTICS|N3
58672|ANTIPSYCHOTICS|N5A
58672|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58671|Vitamin A|A11C1
58670|Vitamin A|A11C1
58667|ANTIVIRALS FOR SYSTEMIC USE|J5
58664|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58664|SSRI antidepressants|N6A4
58664|SRNI antidepressants|N6A5
58661|ANALGESICS|N2
58659|CARDIOVASCULAR SYSTEM|C
58658|CENTRAL NERVOUS SYSTEM|N
58657|ANALGESICS|N2
58656|ANALGESICS|N2
58655|FIBRINOLYTICS|B1D
58654|ANTI-EPILEPTICS|N3
58654|TRANQUILLISERS|N5C
58653|GLUCAGON|H4B
58651|ANTI-EPILEPTICS|N3A
58651|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58651|NOOTROPICS|N6D
58650|ALKYLATING AGENTS|L1A
58649|ANALGESICS|N2
58648|ANTIHYPERTENSIVES|C2
58648|OPHTHALMOLOGICALS|S1
58648|Miotics and antiglaucoma preparations, topical|S1E2
58647|DIRECT THROMBIN INHIBITORS|B1E
58636|HYALURONIDASE|B6B
58635|ANTIHYPERTENSIVES|C2
58635|ANALGESICS|N2
58635|HYPNOTICS/SEDATIVES|N5B
58635|TRANQUILLISERS|N5C
58635|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58635|NOOTROPICS|N6D
58634|ANTIHYPERTENSIVES|C2
58633|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58633|SSRI antidepressants|N6A4
58633|SRNI antidepressants|N6A5
58628|ANTIVIRALS FOR SYSTEMIC USE|J5
58623|ANTIPSYCHOTICS|N5A
58623|NOOTROPICS|N6D
58622|NOOTROPICS|N6D
58617|SYSTEMIC ANTIBACTERIALS|J1
58612|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
58602|SYSTEMIC ANTIBACTERIALS|J1
58600|CARDIOVASCULAR SYSTEM|C
58598|CEPHALOSPORINS|J1D
58595|ANALGESICS|N2
58588|SYSTEMIC ANTIBACTERIALS|J1
58587|ANTIPSYCHOTICS|N5A
58583|SYSTEMIC ANTIBACTERIALS|J1
58582|ANTIVIRALS FOR SYSTEMIC USE|J5
58577|ANTI-EPILEPTICS|N3
58576|ANALGESICS|N2
58575|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58573|SYSTEMIC ANTIBACTERIALS|J1
58573|Carbapenems|J1P2
58571|ANTIPSYCHOTICS|N5A
58569|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
58562|Topical dermatological antifungals|D1A1
58562|SYSTEMIC ANTIBACTERIALS|J1
58562|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
58559|ANTIVIRALS FOR SYSTEMIC USE|J5
58556|ANTIPSYCHOTICS|N5A
58553|DIRECT THROMBIN INHIBITORS|B1E
58549|ANTI-EPILEPTICS|N3A
58541|ANTIPSYCHOTICS|N5A
58534|ANTIVIRALS FOR SYSTEMIC USE|J5
58533|ANTIVIRALS FOR SYSTEMIC USE|J5
58529|INSECTICIDES AND REPELLENTS|P3B
58525|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58525|IMMUNOSUPPRESSIVE AGENTS|L4
58524|ANTIHYPERTENSIVES|C2
58523|ANTI-EPILEPTICS|N3A
58521|ANTIVIRALS FOR SYSTEMIC USE|J5
58518|ANTIVIRALS FOR SYSTEMIC USE|J5
58514|ALKYLATING AGENTS|L1A
58513|ALKYLATING AGENTS|L1A
58511|DRUGS USED IN DIABETES|A10
58510|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58509|Biguanide antidiabetics|A10B2
58509|Other oral antidiabetics|A10B9
58502|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
58502|ANTIVIRALS FOR SYSTEMIC USE|J5
58502|IMMUNOSTIMULATING AGENTS|L3
58501|ACE INHIBITORS, PLAIN|C9A
58500|ANTI-ACNE PREPARATIONS|D10
58500|SYSTEMIC ANTIBACTERIALS|J1
58497|ANALGESICS|N2
58486|CARDIAC THERAPY|C1
58484|VACCINES|J7
58483|ANTITUSSIVES|R5D
58475|ANTI-EPILEPTICS|N3A
58462|HYPNOTICS/SEDATIVES|N5B
58461|OPHTHALMOLOGICALS|S1
58439|CENTRAL NERVOUS SYSTEM|N
58439|ANTI-EPILEPTICS|N3A
58438|PARASITOLOGY|P
58437|ANALGESICS|N2
58435|ANALGESICS|N2
58434|DRUGS USED IN DIABETES|A10
58434|HUMAN INSULINS AND ANALOGUES|A10C
58434|Human insulins and analogues, long-acting|A10C5
58432|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
58427|TRANQUILLISERS|N5C
58422|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
58420|CENTRAL NERVOUS SYSTEM|N
58420|ANTI-EPILEPTICS|N3
58418|SYSTEMIC ANTIBACTERIALS|J1
58417|WOUND HEALING AGENTS|D3
58409|ANALGESICS|N2
58407|PLATELET AGGREGATION INHIBITORS|B1C
58407|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58405|B2-STIMULANTS|R3A
58403|ANTIVIRALS FOR SYSTEMIC USE|J5
58403|VACCINES|J7
58401|ANTIVIRALS FOR SYSTEMIC USE|J5
58397|Ocular antineovascularisation products|S1P
58396|DRUGS USED IN DIABETES|A10
58396|HUMAN INSULINS AND ANALOGUES|A10C
58396|Human insulins and analogues, intermediate-acting|A10C2
58395|DRUGS USED IN DIABETES|A10
58395|HUMAN INSULINS AND ANALOGUES|A10C
58395|Human insulins and analogues, intermediate-acting|A10C2
58394|OPHTHALMOLOGICALS|S1
58394|Ocular antineovascularisation products|S1P
58393|OPHTHALMOLOGICALS|S1
58393|Ocular antineovascularisation products|S1P
58392|PARASITOLOGY|P
58391|PARASITOLOGY|P
58390|PARASITOLOGY|P
58381|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58372|IMMUNOSUPPRESSIVE AGENTS|L4
58370|RESPIRATORY SYSTEM|R
58369|RESPIRATORY SYSTEM|R
58367|Interferons, beta|L3B2
58363|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58362|ANALGESICS|N2
58361|WOUND HEALING AGENTS|D3
58361|SYSTEMIC ANTIBACTERIALS|J1
58360|OPHTHALMOLOGICALS|S1
58359|AMINOGLYCOSIDES|J1K
58359|RESPIRATORY SYSTEM|R
58355|SYSTEMIC ANTIBACTERIALS|J1
58354|RESPIRATORY SYSTEM|R
58353|DRUGS USED IN DIABETES|A10
58353|GLUCAGON|H4B
58349|NOOTROPICS|N6D
58348|ANTIVIRALS FOR SYSTEMIC USE|J5
58346|ANTIVIRALS FOR SYSTEMIC USE|J5
58343|ANTIVIRALS FOR SYSTEMIC USE|J5
58341|WOUND HEALING AGENTS|D3
58341|SYSTEMIC ANTIBACTERIALS|J1
58341|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
58337|ANALGESICS|N2
58332|ANTIPSYCHOTICS|N5A
58332|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58329|IMMUNOSTIMULATING AGENTS|L3
58327|ANTIPSYCHOTICS|N5A
58326|NOOTROPICS|N6D
58324|FIBRINOLYTICS|B1D
58323|ANTIVIRALS FOR SYSTEMIC USE|J5
58318|SYSTEMIC ANTIBACTERIALS|J1
58314|NOOTROPICS|N6D
58312|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58311|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58311|DERMATOLOGICALS|D
58310|ANTIVIRALS FOR SYSTEMIC USE|J5
58309|DPP-IV inhibitor antidiabetics|A10B6
58308|APPETITE STIMULANTS|A15
58307|ANTIHYPERTENSIVES|C2
58304|ANTI-EPILEPTICS|N3A
58303|ANALGESICS|N2
58302|WOUND HEALING AGENTS|D3
58296|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
58295|DRUGS USED IN DIABETES|A10
58294|WOUND HEALING AGENTS|D3
58294|ANALGESICS|N2
58293|ANALGESICS|N2
58292|ANALGESICS|N2
58288|OPHTHALMOLOGICALS|S1
58287|ANTIVIRALS FOR SYSTEMIC USE|J5
58286|ANTI-ARRHYTHMICS|C1B
58286|CALCIUM ANTAGONISTS|C8
58284|Coxibs|M1A3
58284|ANALGESICS|N2
58283|TRANQUILLISERS|N5C
58283|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58261|IMMUNOSUPPRESSIVE AGENTS|L4
58255|SYSTEMIC ANTIBACTERIALS|J1
58253|ANTIVIRALS FOR SYSTEMIC USE|J5
58253|IMMUNOSTIMULATING AGENTS|L3
58251|SYSTEMIC ANTIBACTERIALS|J1
58249|SYSTEMIC ANTIBACTERIALS|J1
58244|ANALGESICS|N2
58243|SYSTEMIC ANTIBACTERIALS|J1
58242|SYSTEMIC ANTIBACTERIALS|J1
58240|ANTI-EPILEPTICS|N3
58239|ANTIVIRALS FOR SYSTEMIC USE|J5
58234|ANTIVIRALS FOR SYSTEMIC USE|J5
58230|ANTIMETABOLITES|L1B
58228|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
58227|IMMUNOSUPPRESSIVE AGENTS|L4
58226|SYSTEMIC ANTIBACTERIALS|J1
58223|RESPIRATORY SYSTEM|R
58222|SYSTEMIC ANTIBACTERIALS|J1
58221|SYSTEMIC ANTIBACTERIALS|J1
58220|SYSTEMIC ANTIBACTERIALS|J1
58219|SYSTEMIC ANTIBACTERIALS|J1
58218|ANTIPSYCHOTICS|N5A
58216|SYSTEMIC ANTIBACTERIALS|J1
58214|SYSTEMIC ANTIBACTERIALS|J1
58210|SYSTEMIC ANTIBACTERIALS|J1
58209|SYSTEMIC ANTIBACTERIALS|J1
58207|SYSTEMIC ANTIBACTERIALS|J1
58204|NOOTROPICS|N6D
58201|Urinary incontinence products|G4B4
58201|ANALGESICS|N2
58197|DIURETICS|C3
58195|NOOTROPICS|N6D
58194|TRANQUILLISERS|N5C
58194|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
58193|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
58192|IMMUNOSUPPRESSIVE AGENTS|L4
58182|WOUND HEALING AGENTS|D3
58180|ANTI-EPILEPTICS|N3A
58178|GROWTH HORMONES|H4C
58172|Interferons, beta|L3B2
58170|ANTIHYPERTENSIVES|C2
58166|ANTIVIRALS FOR SYSTEMIC USE|J5
58165|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58165|DRUGS USED IN DIABETES|A10
58158|SYSTEMIC ANTIBACTERIALS|J1
58156|ANTI-EPILEPTICS|N3A
58154|SYSTEMIC ANTIBACTERIALS|J1
58152|FIBRINOLYTICS|B1D
58150|ANTIPSYCHOTICS|N5A
58144|ANALGESICS|N2
58143|ANALGESICS|N2
58131|ANALGESICS|N2
58128|SYSTEMIC ANTIBACTERIALS|J1
58126|GROWTH HORMONES|H4C
58123|ANTIVIRALS FOR SYSTEMIC USE|J5
58122|SYSTEMIC ANTIBACTERIALS|J1
58121|IMMUNOSTIMULATING AGENTS|L3
58120|ANTI-EPILEPTICS|N3A
58117|SYSTEMIC ANTIBACTERIALS|J1
58113|Other oral antidiabetics|A10B9
58112|DRUGS USED IN DIABETES|A10
58111|DRUGS USED IN DIABETES|A10
58110|DRUGS USED IN DIABETES|A10
58110|HUMAN INSULINS AND ANALOGUES|A10C
58110|Human insulins and analogues, long-acting|A10C5
58109|ANTIVIRALS FOR SYSTEMIC USE|J5
58109|INTERFERONS|L3B
58107|DERMATOLOGICALS|D
58104|MUSCLE RELAXANTS|M3
58103|ANTIVIRALS FOR SYSTEMIC USE|J5
58092|ANTIVIRALS FOR SYSTEMIC USE|J5
58091|WOUND HEALING AGENTS|D3
58090|HYPNOTICS/SEDATIVES|N5B
58088|SSRI antidepressants|N6A4
58087|ANALGESICS|N2
58086|NOOTROPICS|N6D
58085|SYSTEMIC ANTIBACTERIALS|J1
58084|Monobactams|J1P1
58083|NOOTROPICS|N6D
58080|VACCINES|J7
58064|CENTRAL NERVOUS SYSTEM|N
58064|ANTIPSYCHOTICS|N5A
58064|NOOTROPICS|N6D
58062|ANTI-ACNE PREPARATIONS|D10
58062|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
58062|PARASITOLOGY|P
58053|ANTI-EPILEPTICS|N3A
58053|NOOTROPICS|N6D
58050|ANTIVIRALS FOR SYSTEMIC USE|J5
58045|ANTI-MALARIALS|P1D
58044|WOUND HEALING AGENTS|D3
58042|SYSTEMIC ANTIBACTERIALS|J1
58040|ANALGESICS|N2
58037|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58036|ANALGESICS|N2
58035|ANTIVIRALS FOR SYSTEMIC USE|J5
58034|OPHTHALMOLOGICALS|S1
58033|SRNI antidepressants|N6A5
58028|ANALGESICS|N2
58028|ANTI-MIGRAINE PREPARATIONS|N2C
58028|ANTI-EPILEPTICS|N3
58025|ANALGESICS|N2
58024|CENTRAL NERVOUS SYSTEM|N
58024|ANALGESICS|N2
58024|OPHTHALMOLOGICALS|S1
58022|ANALGESICS|N2
58022|ANTI-MIGRAINE PREPARATIONS|N2C
58017|ANTI-EPILEPTICS|N3A
58011|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58003|ALKYLATING AGENTS|L1A
58002|ANALGESICS|N2
58001|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
58001|DRUGS USED IN DIABETES|A10
58001|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
57999|ANTIHYPERTENSIVES|C2
57998|ANALGESICS|N2
57998|ANTI-EPILEPTICS|N3
57998|ANTIPSYCHOTICS|N5A
57997|ANALGESICS|N2
57997|ANTI-EPILEPTICS|N3
57997|ANTIPSYCHOTICS|N5A
57996|ANALGESICS|N2
57996|ANTI-EPILEPTICS|N3
57996|ANTIPSYCHOTICS|N5A
57993|DRUGS USED IN DIABETES|A10
57990|ANTIVIRALS FOR SYSTEMIC USE|J5
57987|MUSCULO-SKELETAL SYSTEM|M
57982|ANTI-EPILEPTICS|N3A
57979|SRNI antidepressants|N6A5
57976|ANTIHYPERTENSIVES|C2
57975|WOUND HEALING AGENTS|D3
57972|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57972|PARASITOLOGY|P
57971|PSYCHOSTIMULANTS|N6B
57970|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
57968|SYSTEMIC ANTIBACTERIALS|J1
57966|ANTI-EPILEPTICS|N3A
57963|ANTIVIRALS FOR SYSTEMIC USE|J5
57960|NOOTROPICS|N6D
57959|Non-nucleoside reverse transcriptase inhibitors|J5C3
57958|DRUGS USED IN DIABETES|A10
57958|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
57954|ANALGESICS|N2
57953|THYROID THERAPY|H3
57952|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
57951|ANTIVIRALS FOR SYSTEMIC USE|J5
57949|DRUGS USED IN DIABETES|A10
57948|ANTIVIRALS FOR SYSTEMIC USE|J5
57947|RESPIRATORY SYSTEM|R
57946|NOOTROPICS|N6D
57944|NOOTROPICS|N6D
57943|ANTI-ARRHYTHMICS|C1B
57941|ANTI-ARRHYTHMICS|C1B
57940|NOOTROPICS|N6D
57937|ANTIPSYCHOTICS|N5A
57937|NOOTROPICS|N6D
57932|SYSTEMIC ANTIBACTERIALS|J1
57931|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57928|DRUGS USED IN DIABETES|A10
57928|Glitazone antidiabetics|A10B4
57927|ANTIVIRALS FOR SYSTEMIC USE|J5
57926|ANTI-MIGRAINE PREPARATIONS|N2C
57924|Ocular antineovascularisation products|S1P
57919|ALKYLATING AGENTS|L1A
57914|ANTIPROTOZOALS AND ANTHELMINTICS|P1
57913|DRUGS USED IN DIABETES|A10
57911|ANALGESICS|N2
57910|Ocular antineovascularisation products|S1P
57909|ANTI-ACNE PREPARATIONS|D10
57905|CALCIUM ANTAGONISTS|C8
57902|ANTIVIRALS FOR SYSTEMIC USE|J5
57901|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
57901|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57900|ANALGESICS|N2
57900|ANTI-MIGRAINE PREPARATIONS|N2C
57899|ANALGESICS|N2
57898|ANTIEMETICS AND ANTINAUSEANTS|A4
57897|ANTI-EPILEPTICS|N3
57897|NOOTROPICS|N6D
57896|ANTITUSSIVES|R5D
57895|ANTIVIRALS FOR SYSTEMIC USE|J5
57884|SYSTEMIC ANTIBACTERIALS|J1
57883|PARASITOLOGY|P
57882|PARASITOLOGY|P
57881|ANALGESICS|N2
57880|ANALGESICS|N2
57879|ANALGESICS|N2
57878|ANTIVIRALS FOR SYSTEMIC USE|J5
57878|Non-nucleoside reverse transcriptase inhibitors|J5C3
57878|ANTI-GOUT PREPARATIONS|M4
57877|MACROLIDES AND SIMILAR TYPES|J1F
57873|ANTIHYPERTENSIVES|C2
57869|CARDIOVASCULAR SYSTEM|C
57868|CALCITONINS|H4A
57867|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57867|VACCINES|J7
57866|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57866|VACCINES|J7
57865|ANALGESICS|N2
57861|PARASITOLOGY|P
57860|ANTI-MIGRAINE PREPARATIONS|N2C
57857|ANALGESICS|N2
57855|Coxibs|M1A3
57855|ANALGESICS|N2
57855|SSRI antidepressants|N6A4
57855|SRNI antidepressants|N6A5
57854|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57854|NOOTROPICS|N6D
57853|ANTIVIRALS FOR SYSTEMIC USE|J5
57853|Non-nucleoside reverse transcriptase inhibitors|J5C3
57852|CARDIOVASCULAR SYSTEM|C
57851|ANTIHYPERTENSIVES|C2
57851|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
57847|ANALGESICS|N2
57846|ANTIEMETICS AND ANTINAUSEANTS|A4
57845|ANALGESICS|N2
57844|ANALGESICS|N2
57843|CENTRAL NERVOUS SYSTEM|N
57843|ANALGESICS|N2
57843|SRNI antidepressants|N6A5
57842|ANALGESICS|N2
57841|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57832|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57830|ANTIPSYCHOTICS|N5A
57829|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
57828|SYSTEMIC ANTIBACTERIALS|J1
57821|ANALGESICS|N2
57818|ANALGESICS|N2
57817|ANALGESICS|N2
57815|NOOTROPICS|N6D
57814|PARASITOLOGY|P
57814|INSECTICIDES AND REPELLENTS|P3B
57813|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57809|ANTIVIRALS FOR SYSTEMIC USE|J5
57808|ANTIPSYCHOTICS|N5A
57803|ANTIHYPERTENSIVES|C2
57799|IMMUNOSUPPRESSIVE AGENTS|L4
57798|SYSTEMIC ANTIBACTERIALS|J1
57797|ANTIHYPERTENSIVES|C2
57797|CALCIUM ANTAGONISTS|C8
57797|CENTRAL NERVOUS SYSTEM|N
57792|ANTI-ARRHYTHMICS|C1B
57791|IMMUNOSUPPRESSIVE AGENTS|L4
57790|SYSTEMIC ANTIBACTERIALS|J1
57788|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57787|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57786|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
57786|TRANQUILLISERS|N5C
57785|ANDROGENS, EXCLUDING G3E, G3F|G3B
57785|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57783|ANALGESICS|N2
57782|ANDROGENS, EXCLUDING G3E, G3F|G3B
57779|ANAESTHETICS, LOCAL|N1B
57779|ANALGESICS|N2
57773|ANTIVIRALS FOR SYSTEMIC USE|J5
57772|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57770|WOUND HEALING AGENTS|D3
57768|ANTIVIRALS FOR SYSTEMIC USE|J5
57766|HUMAN INSULINS AND ANALOGUES|A10C
57766|Human insulins and analogues, long-acting|A10C5
57765|SYSTEMIC ANTIBACTERIALS|J1
57765|VACCINES|J7
57763|ANALGESICS|N2
57762|ANTIHYPERTENSIVES|C2
57760|ANTI-ARRHYTHMICS|C1B
57760|ANTI-GOUT PREPARATIONS|M4
57759|BPH (benign prostatic hypertrophy) products |G4C
57756|ANALGESICS|N2
57755|IMMUNOSUPPRESSIVE AGENTS|L4
57755|OPHTHALMOLOGICALS|S1
57753|ALKYLATING AGENTS|L1A
57752|ANALGESICS|N2
57752|ANTI-MIGRAINE PREPARATIONS|N2C
57751|ANALGESICS|N2
57751|ANTI-MIGRAINE PREPARATIONS|N2C
57749|CARDIOVASCULAR SYSTEM|C
57748|ANTI-MIGRAINE PREPARATIONS|N2C
57744|ANTIVIRALS FOR SYSTEMIC USE|J5
57740|ANALGESICS|N2
57739|ANALGESICS|N2
57739|ANTI-EPILEPTICS|N3
57737|SYSTEMIC ANTIBACTERIALS|J1
57733|SYSTEMIC ANTIBACTERIALS|J1
57731|TRANQUILLISERS|N5C
57730|SYSTEMIC ANTIBACTERIALS|J1
57729|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57727|ANTIVIRALS FOR SYSTEMIC USE|J5
57727|RESPIRATORY SYSTEM|R
57725|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57723|ANALGESICS|N2
57722|Coxibs|M1A3
57722|ANALGESICS|N2
57714|ANALGESICS|N2
57711|SYSTEMIC ANTIBACTERIALS|J1
57709|ANALGESICS|N2
57708|IMMUNOSTIMULATING AGENTS|L3
57706|ANTI-EPILEPTICS|N3A
57705|DERMATOLOGICALS|D
57705|ANTIVIRALS FOR SYSTEMIC USE|J5
57692|ANTI-EPILEPTICS|N3A
57689|SSRI antidepressants|N6A4
57688|Topical dermatological antifungals|D1A1
57687|Topical dermatological antifungals|D1A1
57687|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57686|ANTIVIRALS FOR SYSTEMIC USE|J5
57684|RESPIRATORY SYSTEM|R
57683|ANTI-EPILEPTICS|N3
57681|ANALGESICS|N2
57680|TRANQUILLISERS|N5C
57679|ANTIEMETICS AND ANTINAUSEANTS|A4
57677|APPETITE STIMULANTS|A15
57677|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57677|B2-STIMULANTS|R3A
57675|ANTIVIRALS FOR SYSTEMIC USE|J5
57673|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57673|NOOTROPICS|N6D
57669|Topical dermatological antifungals|D1A1
57669|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57668|ANALGESICS|N2
57665|ANALGESICS|N2
57661|PLATELET AGGREGATION INHIBITORS|B1C
57658|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
57658|IMMUNOSUPPRESSIVE AGENTS|L4
57656|MUSCLE RELAXANTS|M3
57654|ANTI-MIGRAINE PREPARATIONS|N2C
57653|ANTIPSYCHOTICS|N5A
57652|ANTIPSYCHOTICS|N5A
57644|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
57644|SRNI antidepressants|N6A5
57644|PSYCHOSTIMULANTS|N6B
57639|ANTHELMINTICS, EXCLUDING SCHISTOSOMICIDES|P1B
57638|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57637|PLATELET AGGREGATION INHIBITORS|B1C
57627|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
57624|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
57620|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
57619|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
57618|OPHTHALMOLOGICALS|S1
57610|ANTI-ACNE PREPARATIONS|D10
57609|WOUND HEALING AGENTS|D3
57606|PLATELET AGGREGATION INHIBITORS|B1C
57606|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
57605|Antigonadotrophin-releasing hormones|H1C3
57604|TRANQUILLISERS|N5C
57604|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
57603|RESPIRATORY SYSTEM|R
57600|ANTIPSYCHOTICS|N5A
57598|Coxibs|M1A3
57598|ANALGESICS|N2
57597|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57596|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57595|SYSTEMIC ANTIBACTERIALS|J1
57592|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57591|ANTI-EPILEPTICS|N3
57591|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
57590|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
57589|DRUGS USED IN DIABETES|A10
57583|ANTIHYPERTENSIVES|C2
57582|WOUND HEALING AGENTS|D3
57579|ANTIVIRALS FOR SYSTEMIC USE|J5
57578|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
57577|TRANQUILLISERS|N5C
57575|SYSTEMIC ANTIBACTERIALS|J1
57573|ANTI-ACNE PREPARATIONS|D10
57573|SYSTEMIC ANTIBACTERIALS|J1
57572|SYSTEMIC ANTIBACTERIALS|J1
57571|ANTI-EPILEPTICS|N3
57569|ANTI-EPILEPTICS|N3
57566|Urinary incontinence products|G4B4
57565|ALKYLATING AGENTS|L1A
57564|ALKYLATING AGENTS|L1A
57563|ANALGESICS|N2
57562|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57561|NOOTROPICS|N6D
57559|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57558|ANDROGENS, EXCLUDING G3E, G3F|G3B
57557|ANALGESICS|N2
57556|HYPNOTICS/SEDATIVES|N5B
57554|TOPICAL ANTI-ACNE PREPARATIONS|D10A
57553|DRUGS USED IN DIABETES|A10
57549|CARDIOVASCULAR SYSTEM|C
57549|IMMUNOSUPPRESSIVE AGENTS|L4
57548|ANALGESICS|N2
57547|ANALGESICS|N2
57538|Ocular antineovascularisation products|S1P
57536|Ocular antineovascularisation products|S1P
57534|HYPNOTICS/SEDATIVES|N5B
57533|ANTIPSYCHOTICS|N5A
57533|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
57531|IMMUNOSTIMULATING AGENTS|L3
57530|ANDROGENS, EXCLUDING G3E, G3F|G3B
57530|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
57530|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57528|ANALGESICS|N2
57528|ANTI-MIGRAINE PREPARATIONS|N2C
57524|IMMUNOSUPPRESSIVE AGENTS|L4
57516|ANALGESICS|N2
57515|ANTIVIRALS FOR SYSTEMIC USE|J5
57514|DIRECT THROMBIN INHIBITORS|B1E
57511|IMMUNOSUPPRESSIVE AGENTS|L4
57510|DRUGS USED IN DIABETES|A10
57509|DRUGS USED IN DIABETES|A10
57508|DRUGS USED IN DIABETES|A10
57503|RADIODIAGNOSTIC AGENTS|T1G
57499|RADIODIAGNOSTIC AGENTS|T1G
57495|RADIODIAGNOSTIC AGENTS|T1G
57491|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57491|RADIODIAGNOSTIC AGENTS|T1G
57488|RADIODIAGNOSTIC AGENTS|T1G
57485|ANALGESICS|N2
57483|PSYCHOSTIMULANTS|N6B
57483|NOOTROPICS|N6D
57481|CARDIOVASCULAR SYSTEM|C
57479|ANALGESICS|N2
57478|AMINOGLYCOSIDES|J1K
57476|SYSTEMIC ANTIBACTERIALS|J1
57476|AMINOGLYCOSIDES|J1K
57474|GASTROPROKINETICS|A3F
57473|GASTROPROKINETICS|A3F
57472|ANTIHYPERTENSIVES|C2
57472|DIURETICS|C3
57467|ANALGESICS|N2
57466|ANTIHYPERTENSIVES|C2
57466|BETA-BLOCKING AGENTS|C7
57464|OPHTHALMOLOGICALS|S1
57463|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
57461|ANTIVIRALS FOR SYSTEMIC USE|J5
57458|ANTI-EPILEPTICS|N3A
57457|ANTI-EPILEPTICS|N3
57457|ANTIPSYCHOTICS|N5A
57450|RESPIRATORY SYSTEM|R
57450|B2-STIMULANTS|R3A
57449|RESPIRATORY SYSTEM|R
57449|B2-STIMULANTS|R3A
57448|ANTIVIRALS FOR SYSTEMIC USE|J5
57447|ANTIVIRALS FOR SYSTEMIC USE|J5
57444|ANTIPSYCHOTICS|N5A
57444|NOOTROPICS|N6D
57441|ANTI-MIGRAINE PREPARATIONS|N2C
57441|ANTI-EPILEPTICS|N3
57438|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
57437|ANAESTHETICS, LOCAL|N1B
57437|ANALGESICS|N2
57435|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57427|NOOTROPICS|N6D
57426|SYSTEMIC ANTIBACTERIALS|J1
57425|IMMUNOSUPPRESSIVE AGENTS|L4
57423|IMMUNOSUPPRESSIVE AGENTS|L4
57417|WOUND HEALING AGENTS|D3
57416|ANALGESICS|N2
57415|DIRECT THROMBIN INHIBITORS|B1E
57410|IMMUNOSTIMULATING AGENTS|L3
57409|IMMUNOSTIMULATING AGENTS|L3
57408|IMMUNOSTIMULATING AGENTS|L3
57406|IMMUNOSTIMULATING AGENTS|L3
57405|IMMUNOSTIMULATING AGENTS|L3
57404|IMMUNOSTIMULATING AGENTS|L3
57403|NOOTROPICS|N6D
57401|ANDROGENS, EXCLUDING G3E, G3F|G3B
57381|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57379|ANTI-ARRHYTHMICS|C1B
57377|ANTIVIRALS FOR SYSTEMIC USE|J5
57374|ANTI-EPILEPTICS|N3A
57372|CARDIOVASCULAR SYSTEM|C
57371|ANALGESICS|N2
57370|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
57368|ANALGESICS|N2
57366|B2-STIMULANTS|R3A
57358|NOOTROPICS|N6D
57357|ANTIEMETICS AND ANTINAUSEANTS|A4
57354|OPHTHALMOLOGICALS|S1
57353|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57352|LAXATIVES|A6
57349|ANALGESICS|N2
57349|OPHTHALMOLOGICALS|S1
57347|Ocular antineovascularisation products|S1P
57345|ANALGESICS|N2
57344|Topical dermatological antifungals|D1A1
57344|ANTI-ACNE PREPARATIONS|D10
57344|TOPICAL ANTI-ACNE PREPARATIONS|D10A
57344|SYSTEMIC ANTIBACTERIALS|J1
57344|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57341|IMMUNOSUPPRESSIVE AGENTS|L4
57341|OPHTHALMOLOGICALS|S1
57338|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
57338|ANTIVIRALS FOR SYSTEMIC USE|J5
57336|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
57332|ANTIVIRALS FOR SYSTEMIC USE|J5
57328|ANTIVIRALS FOR SYSTEMIC USE|J5
57328|Non-nucleoside reverse transcriptase inhibitors|J5C3
57327|ANTIVIRALS FOR SYSTEMIC USE|J5
57327|Non-nucleoside reverse transcriptase inhibitors|J5C3
57326|EXPECTORANTS|R5C
57326|ANTITUSSIVES|R5D
57324|ANALGESICS|N2
57323|HYPNOTICS/SEDATIVES|N5B
57322|ANTIVIRALS FOR SYSTEMIC USE|J5
57320|ANTIPSYCHOTICS|N5A
57319|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
57313|Ocular antineovascularisation products|S1P
57309|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57309|ANTIPSYCHOTICS|N5A
57309|TRANQUILLISERS|N5C
57308|SYSTEMIC ANTIBACTERIALS|J1
57306|IMMUNOSUPPRESSIVE AGENTS|L4
57305|DRUGS USED IN DIABETES|A10
57305|DPP-IV inhibitor antidiabetics|A10B6
57302|WOUND HEALING AGENTS|D3
57298|NOOTROPICS|N6D
57297|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57297|IMMUNOSUPPRESSIVE AGENTS|L4
57294|IMMUNOSUPPRESSIVE AGENTS|L4
57292|TRANQUILLISERS|N5C
57289|ANTIVIRALS FOR SYSTEMIC USE|J5
57286|ANTIVIRALS FOR SYSTEMIC USE|J5
57283|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
57279|ANTIVIRALS FOR SYSTEMIC USE|J5
57273|Erectile dysfunction products|G4B3
57270|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57268|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57267|OPHTHALMOLOGICALS|S1
57266|ANTIHYPERTENSIVES|C2
57266|OPHTHALMOLOGICALS|S1
57265|OPHTHALMOLOGICALS|S1
57264|RESPIRATORY SYSTEM|R
57262|SYSTEMIC ANTIBACTERIALS|J1
57261|ANTIVIRALS FOR SYSTEMIC USE|J5
57261|Protease inhibitors|J5C2
57258|CARDIOVASCULAR SYSTEM|C
57258|ANTIVIRALS FOR SYSTEMIC USE|J5
57255|RESPIRATORY SYSTEM|R
57254|OPHTHALMOLOGICALS|S1
57252|Ocular antineovascularisation products|S1P
57251|ANALGESICS|N2
57250|Ocular antineovascularisation products|S1P
57246|Vitamin E, plain|A11X3
57240|Coxibs|M1A3
57238|DRUGS USED IN DIABETES|A10
57234|SYSTEMIC ANTIBACTERIALS|J1
57233|Topical dermatological antifungals|D1A1
57233|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
57229|OPHTHALMOLOGICALS|S1
57228|DRUGS USED IN DIABETES|A10
57228|DPP-IV inhibitor antidiabetics|A10B6
57225|ANTIFIBRINOLYTICS|B2A
57222|ANTI-EPILEPTICS|N3A
57219|SYSTEMIC ANTIBACTERIALS|J1
57212|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
57208|NOOTROPICS|N6D
57200|PARASITOLOGY|P
57198|ANALGESICS|N2
57195|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
57193|ANTIPSYCHOTICS|N5A
57193|HYPNOTICS/SEDATIVES|N5B
57191|DRUGS USED IN DIABETES|A10
57176|IMMUNOSTIMULATING AGENTS|L3
57174|ALKYLATING AGENTS|L1A
57159|CARDIOVASCULAR SYSTEM|C
57155|NOOTROPICS|N6D
57151|NOOTROPICS|N6D
57146|ANTIVIRALS FOR SYSTEMIC USE|J5
57142|ANALGESICS|N2
57141|CARDIOVASCULAR SYSTEM|C
57140|ANTIVIRALS FOR SYSTEMIC USE|J5
57137|IMMUNOSTIMULATING AGENTS|L3
57137|Ocular antineovascularisation products|S1P
57134|ANTIHYPERTENSIVES|C2
57131|ANTI-EPILEPTICS|N3A
57127|OPHTHALMOLOGICALS|S1
57126|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57124|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57124|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
57122|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57120|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
57117|ANTIHYPERTENSIVES|C2
57112|RESPIRATORY SYSTEM|R
57107|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
57106|B2-STIMULANTS|R3A
57102|ANTI-EPILEPTICS|N3
57101|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57099|ANTI-EPILEPTICS|N3
57099|ANTI-EPILEPTICS|N3A
57099|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
57099|NOOTROPICS|N6D
57098|ANTIVIRALS FOR SYSTEMIC USE|J5
57097|RESPIRATORY SYSTEM|R
57093|OPHTHALMOLOGICALS|S1
57092|ANTIVIRALS FOR SYSTEMIC USE|J5
57091|CARDIOVASCULAR SYSTEM|C
57091|OPHTHALMOLOGICALS|S1
57090|IMMUNOSTIMULATING AGENTS|L3
57089|ANTIVIRALS FOR SYSTEMIC USE|J5
57088|ANALGESICS|N2
57087|ANTIVIRALS FOR SYSTEMIC USE|J5
57086|ANTIVIRALS FOR SYSTEMIC USE|J5
57082|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57081|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57079|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57078|ANTIVIRALS FOR SYSTEMIC USE|J5
57076|ANTIVIRALS FOR SYSTEMIC USE|J5
57075|GASTROPROKINETICS|A3F
57074|CARDIOVASCULAR SYSTEM|C
57073|SYSTEMIC ANTIBACTERIALS|J1
57073|CEPHALOSPORINS|J1D
57071|ANTIVIRALS FOR SYSTEMIC USE|J5
57070|DRUGS USED IN DIABETES|A10
57070|HUMAN INSULINS AND ANALOGUES|A10C
57070|Human insulins and analogues, long-acting|A10C5
57068|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
57066|NOOTROPICS|N6D
57065|ANTIVIRALS FOR SYSTEMIC USE|J5
57064|ANTIVIRALS FOR SYSTEMIC USE|J5
57063|SYSTEMIC ANTIBACTERIALS|J1
57062|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
57062|RESPIRATORY SYSTEM|R
57054|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
57054|Statins (HMG-CoA reductase inhibitors)|C10A1
57052|ANTIVIRALS FOR SYSTEMIC USE|J5
57052|OPHTHALMOLOGICALS|S1
57049|SSRI antidepressants|N6A4
57049|SRNI antidepressants|N6A5
57046|ANALGESICS|N2
57045|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
57042|ANTI-EPILEPTICS|N3A
57041|ANTI-EPILEPTICS|N3A
57039|ANALGESICS|N2
57038|DRUGS USED IN DIABETES|A10
57037|ANALGESICS|N2
57035|ANTI-EPILEPTICS|N3
57031|DRUGS USED IN DIABETES|A10
57030|ANTIVIRALS FOR SYSTEMIC USE|J5
57029|SYSTEMIC ANTIBACTERIALS|J1
57028|ANALGESICS|N2
57026|ANALGESICS|N2
57025|ANTIHYPERTENSIVES|C2
57023|TRANQUILLISERS|N5C
57023|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
57022|RADIODIAGNOSTIC AGENTS|T1G
57021|RADIODIAGNOSTIC AGENTS|T1G
57012|ANTIPSYCHOTICS|N5A
57011|TRANQUILLISERS|N5C
57011|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
57006|ANTIFIBRINOLYTICS|B2A
57006|WOUND HEALING AGENTS|D3
57005|BPH (benign prostatic hypertrophy) products |G4C
57001|VACCINES|J7
57001|IMMUNOSTIMULATING AGENTS|L3
56999|ANTIPSYCHOTICS|N5A
56998|NOOTROPICS|N6D
56989|ANTIVIRALS FOR SYSTEMIC USE|J5
56988|Systemic dermatological antifungals|D1A2
56988|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56987|RESPIRATORY SYSTEM|R
56986|ANTIPSYCHOTICS|N5A
56986|NOOTROPICS|N6D
56984|ANTIHYPERTENSIVES|C2
56984|BETA-BLOCKING AGENTS|C7
56984|ACE INHIBITORS, PLAIN|C9A
56981|ANALGESICS|N2
56980|CARDIOVASCULAR SYSTEM|C
56979|ANTIVIRALS FOR SYSTEMIC USE|J5
56978|ANTIVIRALS FOR SYSTEMIC USE|J5
56977|ANTIHYPERTENSIVES|C2
56976|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56974|SYSTEMIC ANTIBACTERIALS|J1
56973|ANTI-EPILEPTICS|N3A
56973|ANTIPSYCHOTICS|N5A
56972|CARDIOVASCULAR SYSTEM|C
56970|CENTRAL NERVOUS SYSTEM|N
56968|Ocular antineovascularisation products|S1P
56962|TRANQUILLISERS|N5C
56962|SSRI antidepressants|N6A4
56961|ANTI-EPILEPTICS|N3
56959|CENTRAL NERVOUS SYSTEM|N
56958|CARDIOVASCULAR SYSTEM|C
56956|HYPNOTICS/SEDATIVES|N5B
56954|GROWTH HORMONES|H4C
56952|CENTRAL NERVOUS SYSTEM|N
56952|ANALGESICS|N2
56952|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56950|Combinations of sulphonylureas and biguanide antidiabetics|A10B3
56945|ANTIEMETICS AND ANTINAUSEANTS|A4
56944|ANTIHYPERTENSIVES|C2
56943|ANTIVIRALS FOR SYSTEMIC USE|J5
56938|ANTIVIRALS FOR SYSTEMIC USE|J5
56936|CENTRAL NERVOUS SYSTEM|N
56936|ANTI-EPILEPTICS|N3
56935|Protease inhibitors|J5C2
56930|ANTI-ACNE PREPARATIONS|D10
56922|PARASITOLOGY|P
56921|ANALGESICS|N2
56920|NOOTROPICS|N6D
56919|TRANQUILLISERS|N5C
56919|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56918|HYPNOTICS/SEDATIVES|N5B
56916|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
56914|SYSTEMIC ANTIBACTERIALS|J1
56907|CENTRAL NERVOUS SYSTEM|N
56906|ANTIPROTOZOALS AND ANTHELMINTICS|P1
56905|TRANQUILLISERS|N5C
56903|WOUND HEALING AGENTS|D3
56900|DRUGS USED IN DIABETES|A10
56900|HUMAN INSULINS AND ANALOGUES|A10C
56900|Human insulins and analogues, long-acting|A10C5
56899|DRUGS USED IN DIABETES|A10
56899|IMMUNOSUPPRESSIVE AGENTS|L4
56898|PLATELET AGGREGATION INHIBITORS|B1C
56897|ANALGESICS|N2
56895|ANALGESICS|N2
56894|AMINOGLYCOSIDES|J1K
56892|ANTIHYPERTENSIVES|C2
56892|Erectile dysfunction products|G4B3
56892|ANALGESICS|N2
56886|ANTIPSYCHOTICS|N5A
56886|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56882|SYSTEMIC ANTIBACTERIALS|J1
56880|SYSTEMIC ANTIBACTERIALS|J1
56878|DRUGS USED IN DIABETES|A10
56876|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56876|MUSCULO-SKELETAL SYSTEM|M
56875|ANTIVIRALS FOR SYSTEMIC USE|J5
56873|ANTIVIRALS FOR SYSTEMIC USE|J5
56870|Factors II, VII, IX and X|B2D2
56867|TRANQUILLISERS|N5C
56866|DRUGS USED IN DIABETES|A10
56866|HUMAN INSULINS AND ANALOGUES|A10C
56866|Human insulins and analogues, intermediate-acting|A10C2
56864|RESPIRATORY SYSTEM|R
56864|ANTITUSSIVES|R5D
56859|B2-STIMULANTS|R3A
56858|RESPIRATORY SYSTEM|R
56852|ANALGESICS|N2
56852|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56849|TRANQUILLISERS|N5C
56848|ANALGESICS|N2
56847|ANTIPSYCHOTICS|N5A
56846|ANALGESICS|N2
56838|SYSTEMIC ANTIBACTERIALS|J1
56836|SYSTEMIC ANTIBACTERIALS|J1
56835|ANTIHYPERTENSIVES|C2
56833|ANTIVIRALS FOR SYSTEMIC USE|J5
56828|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56828|DRUGS USED IN DIABETES|A10
56827|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
56827|Statins (HMG-CoA reductase inhibitors)|C10A1
56826|ANTIVIRALS FOR SYSTEMIC USE|J5
56826|PARASITOLOGY|P
56825|ANALGESICS|N2
56822|ANTIVIRALS FOR SYSTEMIC USE|J5
56820|ANTI-EPILEPTICS|N3A
56819|ANALGESICS|N2
56818|ANTI-EPILEPTICS|N3A
56818|TRANQUILLISERS|N5C
56818|NOOTROPICS|N6D
56817|MRI AGENTS|T1E
56816|NOOTROPICS|N6D
56813|TRANQUILLISERS|N5C
56812|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56812|DRUGS USED IN DIABETES|A10
56808|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56807|DRUGS USED IN DIABETES|A10
56807|ANTI-EPILEPTICS|N3
56807|ANTI-EPILEPTICS|N3A
56807|NOOTROPICS|N6D
56805|IMMUNOSTIMULATING AGENTS|L3
56804|ANALGESICS|N2
56803|ANALGESICS|N2
56802|ANTI-MIGRAINE PREPARATIONS|N2C
56798|NOOTROPICS|N6D
56796|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
56794|SYSTEMIC ANTIBACTERIALS|J1
56791|ANALGESICS|N2
56791|SRNI antidepressants|N6A5
56790|ANTIPSYCHOTICS|N5A
56787|ANALGESICS|N2
56786|SYSTEMIC ANTIBACTERIALS|J1
56786|VACCINES|J7
56783|TRANQUILLISERS|N5C
56779|WOUND HEALING AGENTS|D3
56779|ANTIVIRALS FOR SYSTEMIC USE|J5
56778|Non-nucleoside reverse transcriptase inhibitors|J5C3
56777|IMMUNOSTIMULATING AGENTS|L3
56774|ANTI-ACNE PREPARATIONS|D10
56772|DERMATOLOGICALS|D
56771|SYSTEMIC ANTIBACTERIALS|J1
56770|DPP-IV inhibitor antidiabetics|A10B6
56767|CENTRAL NERVOUS SYSTEM|N
56767|ANTIPSYCHOTICS|N5A
56766|RESPIRATORY SYSTEM|R
56764|ANALGESICS|N2
56763|ANALGESICS|N2
56762|Erectile dysfunction products|G4B3
56762|ANALGESICS|N2
56760|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
56760|ANTIVIRALS FOR SYSTEMIC USE|J5
56751|ANTI-EPILEPTICS|N3
56750|WOUND HEALING AGENTS|D3
56744|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
56744|IMMUNOSUPPRESSIVE AGENTS|L4
56743|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56743|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
56742|TRANQUILLISERS|N5C
56742|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56735|TRANQUILLISERS|N5C
56734|NOOTROPICS|N6D
56733|ANTIPSYCHOTICS|N5A
56731|ANTIPSYCHOTICS|N5A
56731|NOOTROPICS|N6D
56729|ANTIPSYCHOTICS|N5A
56725|ANALGESICS|N2
56722|SYSTEMIC ANTIBACTERIALS|J1
56719|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
56717|Urinary incontinence products|G4B4
56712|Ocular antineovascularisation products|S1P
56704|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56703|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56702|ANTIHYPERTENSIVES|C2
56702|ANALGESICS|N2
56699|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56697|RESPIRATORY SYSTEM|R
56697|B2-STIMULANTS|R3A
56692|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56691|ANTIVIRALS FOR SYSTEMIC USE|J5
56690|SYSTEMIC ANTIBACTERIALS|J1
56689|SYSTEMIC ANTIBACTERIALS|J1
56688|SYSTEMIC ANTIBACTERIALS|J1
56687|ANALGESICS|N2
56680|SYSTEMIC ANTIBACTERIALS|J1
56674|ANTI-ARRHYTHMICS|C1B
56667|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56664|ANTIPSYCHOTICS|N5A
56664|NOOTROPICS|N6D
56663|ANTIPSYCHOTICS|N5A
56660|CARDIAC THERAPY|C1
56659|Antigonadotrophin-releasing hormones|H1C3
56657|CENTRAL NERVOUS SYSTEM|N
56657|ANALGESICS|N2
56655|DRUGS USED IN DIABETES|A10
56654|Vitamin D|A11C2
56652|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
56651|ANDROGENS, EXCLUDING G3E, G3F|G3B
56651|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
56651|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
56650|ANTI-EPILEPTICS|N3A
56650|NOOTROPICS|N6D
56648|RADIODIAGNOSTIC AGENTS|T1G
56647|RADIODIAGNOSTIC AGENTS|T1G
56646|RADIODIAGNOSTIC AGENTS|T1G
56644|ANTIVIRALS FOR SYSTEMIC USE|J5
56643|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
56643|OPHTHALMOLOGICALS|S1
56642|BETA-BLOCKING AGENTS|C7
56641|ANTIHYPERTENSIVES|C2
56640|ANALGESICS|N2
56638|ANALGESICS|N2
56636|ANTACIDS, ANTIFLATULENTS, CARMINATIVES|A2A
56636|ANALGESICS|N2
56635|ANTIULCERANTS|A2B
56635|ANTIEMETICS AND ANTINAUSEANTS|A4
56631|WOUND HEALING AGENTS|D3
56631|OPHTHALMOLOGICALS|S1
56630|ANTIEMETICS AND ANTINAUSEANTS|A4
56628|DIRECT THROMBIN INHIBITORS|B1E
56623|NOOTROPICS|N6D
56623|OPHTHALMOLOGICALS|S1
56610|CARDIAC THERAPY|C1
56607|WOUND HEALING AGENTS|D3
56605|PARASITOLOGY|P
56605|ANTI-MALARIALS|P1D
56603|ANALGESICS|N2
56602|RESPIRATORY SYSTEM|R
56596|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
56592|PARASITOLOGY|P
56589|ANTIVIRALS FOR SYSTEMIC USE|J5
56588|ANTIVIRALS FOR SYSTEMIC USE|J5
56586|ANTIVIRALS FOR SYSTEMIC USE|J5
56584|NOOTROPICS|N6D
56580|ANTACIDS, ANTIFLATULENTS, CARMINATIVES|A2A
56580|Coxibs|M1A3
56580|ANALGESICS|N2
56579|ANTACIDS, ANTIFLATULENTS, CARMINATIVES|A2A
56579|Coxibs|M1A3
56579|ANALGESICS|N2
56576|ANTACIDS, ANTIFLATULENTS, CARMINATIVES|A2A
56576|ANALGESICS|N2
56575|AMINOGLYCOSIDES|J1K
56570|ALKYLATING AGENTS|L1A
56567|SYSTEMIC ANTIBACTERIALS|J1
56566|DPP-IV inhibitor antidiabetics|A10B6
56566|Other oral antidiabetics|A10B9
56565|ANTIVIRALS FOR SYSTEMIC USE|J5
56562|SYSTEMIC ANTIBACTERIALS|J1
56555|Other oral antidiabetics|A10B9
56546|ANTIVIRALS FOR SYSTEMIC USE|J5
56545|ANTIHYPERTENSIVES|C2
56545|ANTI-EPILEPTICS|N3A
56539|WOUND HEALING AGENTS|D3
56537|CARDIAC THERAPY|C1
56537|ANTIHYPERTENSIVES|C2
56537|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
56535|ANTI-EPILEPTICS|N3A
56534|ANTI-EPILEPTICS|N3
56527|Erectile dysfunction products|G4B3
56527|IMMUNOSUPPRESSIVE AGENTS|L4
56526|ANTIPSYCHOTICS|N5A
56526|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56525|Interferons, beta|L3B2
56521|ANALGESICS|N2
56521|ANTI-EPILEPTICS|N3A
56521|TRANQUILLISERS|N5C
56521|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56517|ANALGESICS|N2
56515|IMMUNOSUPPRESSIVE AGENTS|L4
56513|ANTIHYPERTENSIVES|C2
56512|ANTI-ARRHYTHMICS|C1B
56512|WOUND HEALING AGENTS|D3
56511|PLATELET AGGREGATION INHIBITORS|B1C
56510|IMMUNOSUPPRESSIVE AGENTS|L4
56508|ANTIVIRALS FOR SYSTEMIC USE|J5
56505|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56498|ANTIHYPERTENSIVES|C2
56498|ACE INHIBITORS, PLAIN|C9A
56497|ANTIHYPERTENSIVES|C2
56497|ACE INHIBITORS, PLAIN|C9A
56496|FIBRINOLYTICS|B1D
56495|ANTITUSSIVES|R5D
56492|ANALGESICS|N2
56492|PSYCHOSTIMULANTS|N6B
56491|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
56487|ANALGESICS|N2
56485|ANTIPSYCHOTICS|N5A
56485|TRANQUILLISERS|N5C
56482|CARDIOVASCULAR SYSTEM|C
56481|ANALGESICS|N2
56475|ANTI-ARRHYTHMICS|C1B
56473|Topical dermatological antifungals|D1A1
56473|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56472|ANALGESICS|N2
56465|MRI AGENTS|T1E
56462|MRI AGENTS|T1E
56461|ANTI-ARRHYTHMICS|C1B
56458|ANTIHYPERTENSIVES|C2
56455|ANTIHYPERTENSIVES|C2
56455|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
56449|ANTIVIRALS FOR SYSTEMIC USE|J5
56447|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
56445|NOOTROPICS|N6D
56443|FIBRINOLYTICS|B1D
56443|OPHTHALMOLOGICALS|S1
56442|FIBRINOLYTICS|B1D
56442|OPHTHALMOLOGICALS|S1
56439|IMMUNOSTIMULATING AGENTS|L3
56434|MACROLIDES AND SIMILAR TYPES|J1F
56431|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
56430|ANTIEMETICS AND ANTINAUSEANTS|A4
56430|ANALGESICS|N2
56428|CARDIOVASCULAR SYSTEM|C
56427|IMMUNOSUPPRESSIVE AGENTS|L4
56422|ANTIMETABOLITES|L1B
56421|FIBRINOLYTICS|B1D
56421|NOOTROPICS|N6D
56415|ANTIPSYCHOTICS|N5A
56415|NOOTROPICS|N6D
56413|SYSTEMIC ANTIBACTERIALS|J1
56410|SYSTEMIC ANTIBACTERIALS|J1
56403|ANALGESICS|N2
56401|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56397|ANALGESICS|N2
56396|PLATELET AGGREGATION INHIBITORS|B1C
56396|CARDIOVASCULAR SYSTEM|C
56394|CENTRAL NERVOUS SYSTEM|N
56394|ANALGESICS|N2
56394|ANTI-EPILEPTICS|N3
56392|ANALGESICS|N2
56385|SYSTEMIC ANTIBACTERIALS|J1
56377|ANALGESICS|N2
56377|ANTIPSYCHOTICS|N5A
56377|SRNI antidepressants|N6A5
56376|ANALGESICS|N2
56375|ANALGESICS|N2
56373|SYSTEMIC ANTIBACTERIALS|J1
56371|SYSTEMIC ANTIBACTERIALS|J1
56370|OPHTHALMOLOGICALS|S1
56369|IMMUNOSUPPRESSIVE AGENTS|L4
56367|RESPIRATORY SYSTEM|R
56365|WOUND HEALING AGENTS|D3
56364|ANTIVIRALS FOR SYSTEMIC USE|J5
56364|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
56363|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
56363|PARASITOLOGY|P
56361|IMMUNOSUPPRESSIVE AGENTS|L4
56357|Ocular antineovascularisation products|S1P
56356|SYSTEMIC ANTIBACTERIALS|J1
56355|PLATELET AGGREGATION INHIBITORS|B1C
56351|SYSTEMIC ANTIBACTERIALS|J1
56351|ANTIVIRALS FOR SYSTEMIC USE|J5
56350|MACROLIDES AND SIMILAR TYPES|J1F
56349|ANTIVIRALS FOR SYSTEMIC USE|J5
56348|SYSTEMIC ANTIBACTERIALS|J1
56347|NOOTROPICS|N6D
56346|HYPNOTICS/SEDATIVES|N5B
56345|Erectile dysfunction products|G4B3
56344|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
56344|ANALGESICS|N2
56341|ANTI-EPILEPTICS|N3A
56337|ANTI-EPILEPTICS|N3A
56335|ANALGESICS|N2
56333|ANTIPSYCHOTICS|N5A
56333|HYPNOTICS/SEDATIVES|N5B
56333|TRANQUILLISERS|N5C
56333|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56331|ANTI-EPILEPTICS|N3A
56327|NOOTROPICS|N6D
56326|IMMUNOSUPPRESSIVE AGENTS|L4
56321|ANTI-EPILEPTICS|N3A
56320|NOOTROPICS|N6D
56319|DRUGS USED IN DIABETES|A10
56319|HUMAN INSULINS AND ANALOGUES|A10C
56319|Human insulins and analogues, intermediate-acting|A10C2
56316|ANAESTHETICS, LOCAL|N1B
56312|NOOTROPICS|N6D
56308|SYSTEMIC ANTIBACTERIALS|J1
56305|ANTIPSYCHOTICS|N5A
56305|NOOTROPICS|N6D
56304|ANTIPSYCHOTICS|N5A
56304|NOOTROPICS|N6D
56300|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
56299|PARASITOLOGY|P
56298|ANTIPSYCHOTICS|N5A
56298|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56297|ANTIPSYCHOTICS|N5A
56297|TRANQUILLISERS|N5C
56297|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56296|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56295|SYSTEMIC ANTIBACTERIALS|J1
56293|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
56292|ANTI-EPILEPTICS|N3A
56292|NOOTROPICS|N6D
56290|ANALGESICS|N2
56290|ANTI-MIGRAINE PREPARATIONS|N2C
56288|Urinary incontinence products|G4B4
56288|ANTIDIURETIC HORMONES|H4D
56286|ANTIVIRALS FOR SYSTEMIC USE|J5
56284|TRANQUILLISERS|N5C
56280|ANTIVIRALS FOR SYSTEMIC USE|J5
56276|PLATELET AGGREGATION INHIBITORS|B1C
56276|CARDIOVASCULAR SYSTEM|C
56276|ANALGESICS|N2
56275|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
56273|ANTIVIRALS FOR SYSTEMIC USE|J5
56268|Coxibs|M1A3
56268|ANALGESICS|N2
56265|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56264|IMMUNOSUPPRESSIVE AGENTS|L4
56263|IMMUNOSUPPRESSIVE AGENTS|L4
56262|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56259|Vitamin E, plain|A11X3
56259|TRANQUILLISERS|N5C
56259|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56258|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56256|CENTRAL NERVOUS SYSTEM|N
56256|ANTI-EPILEPTICS|N3A
56256|ANTIPSYCHOTICS|N5A
56253|HYPNOTICS/SEDATIVES|N5B
56250|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56250|SSRI antidepressants|N6A4
56250|SRNI antidepressants|N6A5
56249|ANALGESICS|N2
56248|ANALGESICS|N2
56246|ANALGESICS|N2
56245|CENTRAL NERVOUS SYSTEM|N
56244|ANTIPSYCHOTICS|N5A
56244|NOOTROPICS|N6D
56243|ANALGESICS|N2
56242|CALCIUM ANTAGONISTS|C8
56242|ANALGESICS|N2
56239|ANALGESICS|N2
56238|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
56236|IMMUNOSUPPRESSIVE AGENTS|L4
56235|ANTIVIRALS FOR SYSTEMIC USE|J5
56234|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
56234|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56232|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
56232|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56230|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56230|ANTIPSYCHOTICS|N5A
56229|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
56227|ANALGESICS|N2
56226|CENTRAL NERVOUS SYSTEM|N
56225|SYSTEMIC ANTIBACTERIALS|J1
56224|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56224|VACCINES|J7
56223|ANTIVIRALS FOR SYSTEMIC USE|J5
56222|SYSTEMIC ANTIBACTERIALS|J1
56220|SYSTEMIC ANTIHISTAMINES|R6
56219|SYSTEMIC ANTIBACTERIALS|J1
56218|ANTIHYPERTENSIVES|C2
56218|ACE INHIBITORS, PLAIN|C9A
56217|ANTI-MIGRAINE PREPARATIONS|N2C
56216|SYSTEMIC ANTIBACTERIALS|J1
56214|SYSTEMIC ANTIBACTERIALS|J1
56211|SYSTEMIC ANTIBACTERIALS|J1
56208|SYSTEMIC ANTIBACTERIALS|J1
56206|MUSCLE RELAXANTS|M3
56205|SYSTEMIC ANTIBACTERIALS|J1
56204|SYSTEMIC ANTIBACTERIALS|J1
56203|SYSTEMIC ANTIBACTERIALS|J1
56202|OPHTHALMOLOGICALS|S1
56201|SYSTEMIC ANTIBACTERIALS|J1
56199|ANTIVIRALS FOR SYSTEMIC USE|J5
56193|ANTIVIRALS FOR SYSTEMIC USE|J5
56193|Interferons, alpha|L3B1
56192|SYSTEMIC ANTIBACTERIALS|J1
56189|OPHTHALMOLOGICALS|S1
56188|OPHTHALMOLOGICALS|S1
56185|CALCIUM ANTAGONISTS|C8
56185|OPHTHALMOLOGICALS|S1
56184|OPHTHALMOLOGICALS|S1
56183|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
56182|SYSTEMIC ANTIBACTERIALS|J1
56181|OPHTHALMOLOGICALS|S1
56179|SYSTEMIC ANTIBACTERIALS|J1
56178|WOUND HEALING AGENTS|D3
56176|IMMUNOSTIMULATING AGENTS|L3
56173|Erectile dysfunction products|G4B3
56172|SYSTEMIC ANTIBACTERIALS|J1
56171|SYSTEMIC ANTIBACTERIALS|J1
56170|NOOTROPICS|N6D
56170|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
56168|ANTIVIRALS FOR SYSTEMIC USE|J5
56168|VACCINES|J7
56167|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56162|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56162|SSRI antidepressants|N6A4
56158|Interferons, beta|L3B2
56156|HUMAN INSULINS AND ANALOGUES|A10C
56156|Human insulins and analogues, long-acting|A10C5
56155|ANALGESICS|N2
56154|FIBRINOLYTICS|B1D
56151|DPP-IV inhibitor antidiabetics|A10B6
56149|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56148|DRUGS USED IN DIABETES|A10
56148|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
56147|ANTI-ACNE PREPARATIONS|D10
56145|ANTIHYPERTENSIVES|C2
56144|ANALGESICS|N2
56142|ANTIVIRALS FOR SYSTEMIC USE|J5
56141|BPH (benign prostatic hypertrophy) products |G4C
56140|ANTIVIRALS FOR SYSTEMIC USE|J5
56139|CENTRAL NERVOUS SYSTEM|N
56138|ANTIHYPERTENSIVES|C2
56135|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
56134|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
56134|ANTIVIRALS FOR SYSTEMIC USE|J5
56133|CENTRAL NERVOUS SYSTEM|N
56133|ANTI-EPILEPTICS|N3
56133|TRANQUILLISERS|N5C
56133|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56131|ANTIPSYCHOTICS|N5A
56127|NOOTROPICS|N6D
56122|RESPIRATORY SYSTEM|R
56121|NOOTROPICS|N6D
56120|ANTIVIRALS FOR SYSTEMIC USE|J5
56120|IMMUNOSTIMULATING AGENTS|L3
56120|INTERFERONS|L3B
56114|ANALGESICS|N2
56111|ANTI-EPILEPTICS|N3A
56108|OPHTHALMOLOGICALS|S1
56107|ANALGESICS|N2
56104|IMMUNOSUPPRESSIVE AGENTS|L4
56102|IMMUNOSUPPRESSIVE AGENTS|L4
56101|ANTIVIRALS FOR SYSTEMIC USE|J5
56099|RESPIRATORY SYSTEM|R
56098|ANTIPSYCHOTICS|N5A
56097|ANTIVIRALS FOR SYSTEMIC USE|J5
56095|ANALGESICS|N2
56094|ANTI-EPILEPTICS|N3A
56093|IMMUNOSTIMULATING AGENTS|L3
56092|MUSCLE RELAXANTS|M3
56091|ANTIVIRALS FOR SYSTEMIC USE|J5
56090|B2-STIMULANTS|R3A
56089|OPHTHALMOLOGICALS|S1
56085|ANTI-EPILEPTICS|N3
56085|ANTI-EPILEPTICS|N3A
56084|ANTI-EPILEPTICS|N3
56084|ANTI-EPILEPTICS|N3A
56083|ANALGESICS|N2
56083|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56083|SRNI antidepressants|N6A5
56082|ANTIVIRALS FOR SYSTEMIC USE|J5
56080|ANTI-MALARIALS|P1D
56076|Urinary incontinence products|G4B4
56076|ANALGESICS|N2
56076|TRANQUILLISERS|N5C
56076|ANTITUSSIVES|R5D
56072|ANTIPSYCHOTICS|N5A
56072|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56066|ALKYLATING AGENTS|L1A
56066|IMMUNOSTIMULATING AGENTS|L3
56064|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56062|OPHTHALMOLOGICALS|S1
56061|SYSTEMIC ANTIBACTERIALS|J1
56061|VACCINES|J7
56060|Ocular antineovascularisation products|S1P
56057|OPHTHALMOLOGICALS|S1
56055|OPHTHALMOLOGICALS|S1
56053|TRANQUILLISERS|N5C
56053|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
56048|CARDIOVASCULAR SYSTEM|C
56048|ANTIHYPERTENSIVES|C2
56046|RESPIRATORY SYSTEM|R
56045|SYSTEMIC ANTIBACTERIALS|J1
56045|ANTIVIRALS FOR SYSTEMIC USE|J5
56039|IMMUNOSUPPRESSIVE AGENTS|L4
56038|SYSTEMIC ANTIBACTERIALS|J1
56034|DRUGS USED IN DIABETES|A10
56032|PLATELET AGGREGATION INHIBITORS|B1C
56031|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56029|Urinary incontinence products|G4B4
56022|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56020|CENTRAL NERVOUS SYSTEM|N
56020|NOOTROPICS|N6D
56019|ANTI-ARRHYTHMICS|C1B
56017|ANTIVIRALS FOR SYSTEMIC USE|J5
56017|IMMUNOSTIMULATING AGENTS|L3
56014|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
56014|ANTI-ACNE PREPARATIONS|D10
56013|ANTIHYPERTENSIVES|C2
56012|RESPIRATORY SYSTEM|R
56012|B2-STIMULANTS|R3A
56009|SYSTEMIC ANTIBACTERIALS|J1
56007|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
56006|OPHTHALMOLOGICALS|S1
56006|Ocular antineovascularisation products|S1P
56005|ANALGESICS|N2
56003|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
56002|CARDIOVASCULAR SYSTEM|C
55999|ALKYLATING AGENTS|L1A
55997|IMMUNOSUPPRESSIVE AGENTS|L4
55988|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
55985|VACCINES|J7
55982|OPHTHALMOLOGICALS|S1
55976|ANTIVIRALS FOR SYSTEMIC USE|J5
55975|PARASITOLOGY|P
55975|ANTI-MALARIALS|P1D
55974|Systemic dermatological antifungals|D1A2
55974|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
55971|NOOTROPICS|N6D
55970|ANTI-ACNE PREPARATIONS|D10
55970|SYSTEMIC ANTIBACTERIALS|J1
55966|DRUGS USED IN DIABETES|A10
55965|ANTIVIRALS FOR SYSTEMIC USE|J5
55962|ANTIVIRALS FOR SYSTEMIC USE|J5
55962|Protease inhibitors|J5C2
55960|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55960|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
55959|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
55954|ANTITUSSIVES|R5D
55953|DERMATOLOGICALS|D
55953|WOUND HEALING AGENTS|D3
55952|IMMUNOSUPPRESSIVE AGENTS|L4
55949|NOOTROPICS|N6D
55946|ANTIVIRALS FOR SYSTEMIC USE|J5
55943|CARDIAC THERAPY|C1
55943|CENTRAL NERVOUS SYSTEM|N
55942|ANTIPSYCHOTICS|N5A
55941|ANTI-EPILEPTICS|N3A
55924|WOUND HEALING AGENTS|D3
55921|B2-STIMULANTS|R3A
55920|ANTIHYPERTENSIVES|C2
55917|B2-STIMULANTS|R3A
55916|RESPIRATORY SYSTEM|R
55909|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
55908|PLATELET AGGREGATION INHIBITORS|B1C
55908|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
55907|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
55902|ANTIVIRALS FOR SYSTEMIC USE|J5
55900|RESPIRATORY SYSTEM|R
55898|DRUGS USED IN DIABETES|A10
55898|HUMAN INSULINS AND ANALOGUES|A10C
55898|Human insulins and analogues, intermediate-acting|A10C2
55896|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
55896|OPHTHALMOLOGICALS|S1
55895|CENTRAL NERVOUS SYSTEM|N
55895|NOOTROPICS|N6D
55893|ANTIVIRALS FOR SYSTEMIC USE|J5
55892|Coxibs|M1A3
55892|ANALGESICS|N2
55885|RADIODIAGNOSTIC AGENTS|T1G
55884|OPHTHALMOLOGICALS|S1
55882|IMMUNOSUPPRESSIVE AGENTS|L4
55882|OPHTHALMOLOGICALS|S1
55881|ANTIVIRALS FOR SYSTEMIC USE|J5
55878|IMMUNOSUPPRESSIVE AGENTS|L4
55877|IMMUNOSUPPRESSIVE AGENTS|L4
55876|ANTI-ARRHYTHMICS|C1B
55860|DRUGS USED IN DIABETES|A10
55860|HUMAN INSULINS AND ANALOGUES|A10C
55860|Human insulins and analogues, fast-acting|A10C1
55857|SYSTEMIC ANTIBACTERIALS|J1
55854|SYSTEMIC ANTIBACTERIALS|J1
55854|MACROLIDES AND SIMILAR TYPES|J1F
55852|DPP-IV inhibitor antidiabetics|A10B6
55852|WOUND HEALING AGENTS|D3
55832|ANALGESICS|N2
55828|ANTIULCERANTS|A2B
55828|Coxibs|M1A3
55828|ANALGESICS|N2
55827|ANALGESICS|N2
55825|DRUGS USED IN DIABETES|A10
55825|HUMAN INSULINS AND ANALOGUES|A10C
55825|Human insulins and analogues, fast-acting|A10C1
55824|ANALGESICS|N2
55823|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
55822|OPHTHALMOLOGICALS|S1
55821|ANTI-ARRHYTHMICS|C1B
55820|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55819|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55818|Erectile dysfunction products|G4B3
55816|SYSTEMIC ANTIBACTERIALS|J1
55815|SYSTEMIC ANTIBACTERIALS|J1
55811|OPHTHALMOLOGICALS|S1
55810|OPHTHALMOLOGICALS|S1
55809|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55808|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55807|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55806|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55803|IMMUNOSTIMULATING AGENTS|L3
55802|DPP-IV inhibitor antidiabetics|A10B6
55800|SYSTEMIC ANTIBACTERIALS|J1
55789|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55789|NOOTROPICS|N6D
55788|OPHTHALMOLOGICALS|S1
55785|ANTIPSYCHOTICS|N5A
55783|ANTIPSYCHOTICS|N5A
55779|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55779|DRUGS USED IN DIABETES|A10
55776|IMMUNOSTIMULATING AGENTS|L3
55773|ANTIMETABOLITES|L1B
55772|ANTIHYPERTENSIVES|C2
55772|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
55770|ANTIHYPERTENSIVES|C2
55764|DRUGS USED IN DIABETES|A10
55763|ANTIULCERANTS|A2B
55763|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55762|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55757|OPHTHALMOLOGICALS|S1
55750|SYSTEMIC ANTIBACTERIALS|J1
55750|AMINOGLYCOSIDES|J1K
55749|RESPIRATORY SYSTEM|R
55748|DRUGS USED IN DIABETES|A10
55746|ANALGESICS|N2
55744|ANTIVIRALS FOR SYSTEMIC USE|J5
55740|ANTIPSYCHOTICS|N5A
55740|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55739|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55738|ANTIVIRALS FOR SYSTEMIC USE|J5
55735|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55733|ANTIVIRALS FOR SYSTEMIC USE|J5
55733|VACCINES|J7
55732|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55730|CENTRAL NERVOUS SYSTEM|N
55728|ANTI-ARRHYTHMICS|C1B
55726|IMMUNOSTIMULATING AGENTS|L3
55723|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55722|TRANQUILLISERS|N5C
55722|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55721|SYSTEMIC ANTIBACTERIALS|J1
55721|PARASITOLOGY|P
55718|NOOTROPICS|N6D
55717|NOOTROPICS|N6D
55714|ANTIHYPERTENSIVES|C2
55714|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
55712|ANDROGENS, EXCLUDING G3E, G3F|G3B
55712|OPHTHALMOLOGICALS|S1
55711|ANALGESICS|N2
55710|ANALGESICS|N2
55709|ANALGESICS|N2
55708|ANTIPSYCHOTICS|N5A
55707|ANALGESICS|N2
55707|ANTI-MIGRAINE PREPARATIONS|N2C
55706|ANTIVIRALS FOR SYSTEMIC USE|J5
55705|ANTIVIRALS FOR SYSTEMIC USE|J5
55701|ANAESTHETICS, LOCAL|N1B
55700|ANALGESICS|N2
55699|ANALGESICS|N2
55699|ANTI-MIGRAINE PREPARATIONS|N2C
55698|ANALGESICS|N2
55694|ANALGESICS|N2
55692|Urinary incontinence products|G4B4
55692|ANALGESICS|N2
55690|LUNG SURFACTANTS|R7C
55687|Urinary incontinence products|G4B4
55687|SRNI antidepressants|N6A5
55686|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55685|RESPIRATORY SYSTEM|R
55683|NOOTROPICS|N6D
55681|Protease inhibitors|J5C2
55679|IMMUNOSUPPRESSIVE AGENTS|L4
55677|SYSTEMIC ANTIBACTERIALS|J1
55675|ANTIVIRALS FOR SYSTEMIC USE|J5
55672|ANTIHYPERTENSIVES|C2
55672|OPHTHALMOLOGICALS|S1
55670|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
55670|Statins (HMG-CoA reductase inhibitors)|C10A1
55666|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
55666|Statins (HMG-CoA reductase inhibitors)|C10A1
55664|ANTIHYPERTENSIVES|C2
55663|ANALGESICS|N2
55661|ANALGESICS|N2
55659|Factor VIII|B2D1
55658|Vitamin A|A11C1
55657|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
55656|CALCIUM ANTAGONISTS|C8
55653|WOUND HEALING AGENTS|D3
55653|ANTI-EPILEPTICS|N3A
55647|ANTIVIRALS FOR SYSTEMIC USE|J5
55646|OPHTHALMOLOGICALS|S1
55645|OPHTHALMOLOGICALS|S1
55644|ANTI-EPILEPTICS|N3
55643|ANTI-ACNE PREPARATIONS|D10
55643|TOPICAL ANTI-ACNE PREPARATIONS|D10A
55640|ANTIVIRALS FOR SYSTEMIC USE|J5
55639|ANTIVIRALS FOR SYSTEMIC USE|J5
55635|ANALGESICS|N2
55634|OPHTHALMOLOGICALS|S1
55633|ANTI-EPILEPTICS|N3A
55633|NOOTROPICS|N6D
55630|ANTI-ACNE PREPARATIONS|D10
55629|Topical dermatological antifungals|D1A1
55629|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
55625|CARDIOVASCULAR SYSTEM|C
55623|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
55622|TRANQUILLISERS|N5C
55618|ANALGESICS|N2
55617|PARASITOLOGY|P
55617|ANTI-MALARIALS|P1D
55613|ANALGESICS|N2
55611|ANALGESICS|N2
55610|IMMUNOSTIMULATING AGENTS|L3
55609|IMMUNOSTIMULATING AGENTS|L3
55604|ANALGESICS|N2
55602|SYSTEMIC ANTIBACTERIALS|J1
55601|DRUGS USED IN DIABETES|A10
55599|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
55594|ANTIVIRALS FOR SYSTEMIC USE|J5
55592|ANALGESICS|N2
55590|ANTIHYPERTENSIVES|C2
55590|OPHTHALMOLOGICALS|S1
55589|ANTIHYPERTENSIVES|C2
55589|CALCIUM ANTAGONISTS|C8
55589|OPHTHALMOLOGICALS|S1
55586|CARDIOVASCULAR SYSTEM|C
55586|WOUND HEALING AGENTS|D3
55585|SYSTEMIC ANTIBACTERIALS|J1
55583|ANALGESICS|N2
55582|ANALGESICS|N2
55581|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
55580|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
55578|ANTIHYPERTENSIVES|C2
55578|OPHTHALMOLOGICALS|S1
55578|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
55576|RADIODIAGNOSTIC AGENTS|T1G
55571|RADIODIAGNOSTIC AGENTS|T1G
55570|IMMUNOSTIMULATING AGENTS|L3
55569|IMMUNOSTIMULATING AGENTS|L3
55568|IMMUNOSUPPRESSIVE AGENTS|L4
55561|DRUGS USED IN DIABETES|A10
55561|HUMAN INSULINS AND ANALOGUES|A10C
55561|Human insulins and analogues, intermediate-acting|A10C2
55560|ANTIVIRALS FOR SYSTEMIC USE|J5
55559|RADIODIAGNOSTIC AGENTS|T1G
55556|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
55552|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55549|DPP-IV inhibitor antidiabetics|A10B6
55547|DRUGS USED IN DIABETES|A10
55546|DPP-IV inhibitor antidiabetics|A10B6
55543|RADIODIAGNOSTIC AGENTS|T1G
55542|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
55541|RADIODIAGNOSTIC AGENTS|T1G
55538|IMMUNOSUPPRESSIVE AGENTS|L4
55537|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
55537|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
55534|ANALGESICS|N2
55532|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55524|DRUGS USED IN DIABETES|A10
55521|SYSTEMIC ANTIBACTERIALS|J1
55521|IMMUNOSTIMULATING AGENTS|L3
55517|RADIODIAGNOSTIC AGENTS|T1G
55516|PARASITOLOGY|P
55516|ANTI-MALARIALS|P1D
55488|NOOTROPICS|N6D
55487|OPHTHALMOLOGICALS|S1
55486|Coxibs|M1A3
55486|ANALGESICS|N2
55486|OPHTHALMOLOGICALS|S1
55485|OPHTHALMOLOGICALS|S1
55484|WOUND HEALING AGENTS|D3
55483|ANTI-EPILEPTICS|N3A
55482|OPHTHALMOLOGICALS|S1
55481|ANTIVIRALS FOR SYSTEMIC USE|J5
55481|Interferons, beta|L3B2
55480|ALKYLATING AGENTS|L1A
55476|GASTROPROKINETICS|A3F
55475|B2-STIMULANTS|R3A
55474|B2-STIMULANTS|R3A
55470|ANTIEMETICS AND ANTINAUSEANTS|A4
55469|ANALGESICS|N2
55468|ANALGESICS|N2
55467|CARDIOVASCULAR SYSTEM|C
55467|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
55455|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55455|SSRI antidepressants|N6A4
55454|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55454|DRUGS USED IN DIABETES|A10
55454|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55453|ANTIVIRALS FOR SYSTEMIC USE|J5
55453|VACCINES|J7
55448|APPETITE STIMULANTS|A15
55447|IMMUNOSTIMULATING AGENTS|L3
55446|ANTIPSYCHOTICS|N5A
55444|NOOTROPICS|N6D
55439|ANTIHYPERTENSIVES|C2
55439|CALCIUM ANTAGONISTS|C8
55437|IMMUNOSUPPRESSIVE AGENTS|L4
55433|Vitamin D|A11C2
55433|IMMUNOSUPPRESSIVE AGENTS|L4
55426|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55424|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
55416|ANTI-EPILEPTICS|N3A
55415|ANTIVIRALS FOR SYSTEMIC USE|J5
55414|ANTIVIRALS FOR SYSTEMIC USE|J5
55413|WOUND HEALING AGENTS|D3
55413|IMMUNOSTIMULATING AGENTS|L3
55411|Antigonadotrophin-releasing hormones|H1C3
55407|ANTIVIRALS FOR SYSTEMIC USE|J5
55406|ANTIVIRALS FOR SYSTEMIC USE|J5
55405|DERMATOLOGICALS|D
55404|ANTIVIRALS FOR SYSTEMIC USE|J5
55403|CARDIOVASCULAR SYSTEM|C
55402|ANALGESICS|N2
55402|NOOTROPICS|N6D
55402|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
55401|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
55401|ANTIVIRALS FOR SYSTEMIC USE|J5
55400|ANTIVIRALS FOR SYSTEMIC USE|J5
55400|Ocular antineovascularisation products|S1P
55399|IMMUNOSUPPRESSIVE AGENTS|L4
55398|IMMUNOSTIMULATING AGENTS|L3
55396|ANALGESICS|N2
55395|ANALGESICS|N2
55392|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55391|ANALGESICS|N2
55391|ANTI-MIGRAINE PREPARATIONS|N2C
55385|ANTI-EPILEPTICS|N3A
55385|NOOTROPICS|N6D
55381|ANTI-EPILEPTICS|N3A
55379|ANTI-EPILEPTICS|N3A
55377|ANTIPSYCHOTICS|N5A
55375|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
55374|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
55372|ANTIVIRALS FOR SYSTEMIC USE|J5
55370|ANALGESICS|N2
55369|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55369|PSYCHOSTIMULANTS|N6B
55368|SYSTEMIC ANTIBACTERIALS|J1
55357|ANTIVIRALS FOR SYSTEMIC USE|J5
55356|CARDIOVASCULAR SYSTEM|C
55356|SYSTEMIC ANTIBACTERIALS|J1
55354|ANTIVIRALS FOR SYSTEMIC USE|J5
55353|ANALGESICS|N2
55352|ANALGESICS|N2
55342|ANALGESICS|N2
55341|OPHTHALMOLOGICALS|S1
55340|Erectile dysfunction products|G4B3
55336|ANALGESICS|N2
55332|ANALGESICS|N2
55327|NOOTROPICS|N6D
55326|CENTRAL NERVOUS SYSTEM|N
55326|SSRI antidepressants|N6A4
55325|CENTRAL NERVOUS SYSTEM|N
55325|NOOTROPICS|N6D
55324|OPHTHALMOLOGICALS|S1
55323|ANTITUSSIVES|R5D
55322|ANTITUSSIVES|R5D
55321|ANTIPSYCHOTICS|N5A
55320|CARDIOVASCULAR SYSTEM|C
55319|ANDROGENS, EXCLUDING G3E, G3F|G3B
55312|SYSTEMIC ANTIBACTERIALS|J1
55311|PARASITOLOGY|P
55310|ANTIVIRALS FOR SYSTEMIC USE|J5
55301|ANTIVIRALS FOR SYSTEMIC USE|J5
55301|Interferons, alpha|L3B1
55300|DRUGS USED IN DIABETES|A10
55299|CENTRAL NERVOUS SYSTEM|N
55299|ANALGESICS|N2
55297|SYSTEMIC ANTIBACTERIALS|J1
55295|RADIODIAGNOSTIC AGENTS|T1G
55292|SYSTEMIC ANTIBACTERIALS|J1
55291|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
55290|WOUND HEALING AGENTS|D3
55289|ANALGESICS|N2
55287|ANTIVIRALS FOR SYSTEMIC USE|J5
55287|IMMUNOSTIMULATING AGENTS|L3
55286|SYSTEMIC ANTIBACTERIALS|J1
55285|SYSTEMIC ANTIBACTERIALS|J1
55284|SYSTEMIC ANTIBACTERIALS|J1
55284|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
55284|ANTIVIRALS FOR SYSTEMIC USE|J5
55284|PARASITOLOGY|P
55275|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
55273|OPHTHALMOLOGICALS|S1
55261|DRUGS USED IN DIABETES|A10
55261|Antigrowth hormones|H1C2
55260|DRUGS USED IN DIABETES|A10
55260|Antigrowth hormones|H1C2
55259|DRUGS USED IN DIABETES|A10
55259|Antigrowth hormones|H1C2
55257|Human insulins and analogues, intermediate-acting|A10C2
55256|Human insulins and analogues, intermediate-acting|A10C2
55254|ANTIVIRALS FOR SYSTEMIC USE|J5
55250|ALKYLATING AGENTS|L1A
55249|ALKYLATING AGENTS|L1A
55248|PLATELET AGGREGATION INHIBITORS|B1C
55246|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
55245|RESPIRATORY SYSTEM|R
55244|Urinary incontinence products|G4B4
55242|DRUGS USED IN DIABETES|A10
55242|SYSTEMIC ANTIBACTERIALS|J1
55239|CARDIOVASCULAR SYSTEM|C
55235|ANALGESICS|N2
55229|DRUGS USED IN DIABETES|A10
55228|IMMUNOSTIMULATING AGENTS|L3
55221|DRUGS USED IN DIABETES|A10
55219|DRUGS USED IN DIABETES|A10
55219|CARDIOVASCULAR SYSTEM|C
55219|IMMUNOSUPPRESSIVE AGENTS|L4
55219|ANTI-EPILEPTICS|N3A
55218|DRUGS USED IN DIABETES|A10
55209|ANTIVIRALS FOR SYSTEMIC USE|J5
55208|ANTIVIRALS FOR SYSTEMIC USE|J5
55207|SYSTEMIC ANTIBACTERIALS|J1
55200|ANALGESICS|N2
55198|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55196|IMMUNOSTIMULATING AGENTS|L3
55195|ANALGESICS|N2
55194|ANALGESICS|N2
55193|CENTRAL NERVOUS SYSTEM|N
55191|ANTIVIRALS FOR SYSTEMIC USE|J5
55190|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55190|DRUGS USED IN DIABETES|A10
55183|ANTIHYPERTENSIVES|C2
55183|OPHTHALMOLOGICALS|S1
55181|Non-nucleoside reverse transcriptase inhibitors|J5C3
55177|Combinations of glitazones with other oral antidiabetics|A10B8
55173|SYSTEMIC ANTIBACTERIALS|J1
55173|Interferons, gamma|L3B3
55169|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
55166|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
55165|ALKYLATING AGENTS|L1A
55163|OPHTHALMOLOGICALS|S1
55162|OPHTHALMOLOGICALS|S1
55161|OPHTHALMOLOGICALS|S1
55159|CARDIOVASCULAR SYSTEM|C
55158|ANALGESICS|N2
55155|WOUND HEALING AGENTS|D3
55155|MACROLIDES AND SIMILAR TYPES|J1F
55153|ALKYLATING AGENTS|L1A
55150|THYROID THERAPY|H3
55143|WOUND HEALING AGENTS|D3
55142|OPHTHALMOLOGICALS|S1
55138|TRANQUILLISERS|N5C
55138|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55136|SYSTEMIC ANTIBACTERIALS|J1
55131|SYSTEMIC ANTIBACTERIALS|J1
55126|ANTIHYPERTENSIVES|C2
55126|BETA-BLOCKING AGENTS|C7
55122|ANTIHYPERTENSIVES|C2
55119|ANTI-EPILEPTICS|N3A
55113|ANTIVIRALS FOR SYSTEMIC USE|J5
55112|ANTIPSYCHOTICS|N5A
55112|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55110|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
55109|NOOTROPICS|N6D
55109|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
55108|OPHTHALMOLOGICALS|S1
55106|ANTIVIRALS FOR SYSTEMIC USE|J5
55106|IMMUNOSTIMULATING AGENTS|L3
55106|INTERFERONS|L3B
55097|WOUND HEALING AGENTS|D3
55095|DPP-IV inhibitor antidiabetics|A10B6
55094|CARDIOVASCULAR SYSTEM|C
55093|ANTIVIRALS FOR SYSTEMIC USE|J5
55092|DRUGS USED IN DIABETES|A10
55092|HUMAN INSULINS AND ANALOGUES|A10C
55092|Human insulins and analogues, intermediate-acting|A10C2
55091|DRUGS USED IN DIABETES|A10
55091|HUMAN INSULINS AND ANALOGUES|A10C
55091|Human insulins and analogues, intermediate-acting|A10C2
55086|ANTI-MIGRAINE PREPARATIONS|N2C
55083|OPHTHALMOLOGICALS|S1
55082|CENTRAL NERVOUS SYSTEM|N
55080|CENTRAL NERVOUS SYSTEM|N
55079|ANTIPSYCHOTICS|N5A
55078|CARDIOVASCULAR SYSTEM|C
55077|CARDIOVASCULAR SYSTEM|C
55077|RESPIRATORY SYSTEM|R
55075|ANTIVIRALS FOR SYSTEMIC USE|J5
55072|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55066|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55066|DERMATOLOGICALS|D
55063|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
55061|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
55061|NOOTROPICS|N6D
55060|ANTIVIRALS FOR SYSTEMIC USE|J5
55058|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55055|ANTIHYPERTENSIVES|C2
55055|OPHTHALMOLOGICALS|S1
55055|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
55049|ANTIHYPERTENSIVES|C2
55049|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
55048|Non-nucleoside reverse transcriptase inhibitors|J5C3
55047|ANTI-MALARIALS|P1D
55043|RESPIRATORY SYSTEM|R
55042|RESPIRATORY SYSTEM|R
55041|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
55039|SYSTEMIC ANTIBACTERIALS|J1
55036|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55036|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
55035|ANTIVIRALS FOR SYSTEMIC USE|J5
55033|ANALGESICS|N2
55031|SYSTEMIC ANTIBACTERIALS|J1
55030|SYSTEMIC ANTIBACTERIALS|J1
55029|RESPIRATORY SYSTEM|R
55028|ANTI-ARRHYTHMICS|C1B
55026|ANALGESICS|N2
55024|ANALGESICS|N2
55023|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
55021|DPP-IV inhibitor antidiabetics|A10B6
55015|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55014|ANALGESICS|N2
55010|ANALGESICS|N2
55006|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
55006|NOOTROPICS|N6D
54990|HYPNOTICS/SEDATIVES|N5B
54989|ANTIHYPERTENSIVES|C2
54987|DRUGS USED IN DIABETES|A10
54986|DRUGS USED IN DIABETES|A10
54985|DRUGS USED IN DIABETES|A10
54984|CARDIOVASCULAR SYSTEM|C
54982|SYSTEMIC ANTIBACTERIALS|J1
54978|HYPNOTICS/SEDATIVES|N5B
54977|ANALGESICS|N2
54975|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
54974|ANTIPSYCHOTICS|N5A
54972|Non-nucleoside reverse transcriptase inhibitors|J5C3
54971|ANTIPSYCHOTICS|N5A
54969|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54968|ANALGESICS|N2
54968|ANTITUSSIVES|R5D
54967|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54967|ACTH|H1A
54966|ANTIVIRALS FOR SYSTEMIC USE|J5
54965|ANTIHYPERTENSIVES|C2
54962|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54960|CENTRAL NERVOUS SYSTEM|N
54960|ANALGESICS|N2
54953|ANTIVIRALS FOR SYSTEMIC USE|J5
54952|CENTRAL NERVOUS SYSTEM|N
54952|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54952|SSRI antidepressants|N6A4
54952|SRNI antidepressants|N6A5
54947|RESPIRATORY SYSTEM|R
54946|RESPIRATORY SYSTEM|R
54945|RESPIRATORY SYSTEM|R
54943|RESPIRATORY SYSTEM|R
54942|RESPIRATORY SYSTEM|R
54941|RESPIRATORY SYSTEM|R
54933|ANTI-EPILEPTICS|N3A
54932|ANALGESICS|N2
54930|ANALGESICS|N2
54929|TRANQUILLISERS|N5C
54929|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54926|DRUGS USED IN DIABETES|A10
54925|ANTI-ARRHYTHMICS|C1B
54923|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54923|DRUGS USED IN DIABETES|A10
54922|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54922|DRUGS USED IN DIABETES|A10
54921|ANALGESICS|N2
54920|HYPNOTICS/SEDATIVES|N5B
54920|TRANQUILLISERS|N5C
54914|ANDROGENS, EXCLUDING G3E, G3F|G3B
54910|ANALGESICS|N2
54907|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
54905|ANTIVIRALS FOR SYSTEMIC USE|J5
54904|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
54903|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
54903|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
54902|NOOTROPICS|N6D
54901|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
54899|ANTIVIRALS FOR SYSTEMIC USE|J5
54898|ANTIVIRALS FOR SYSTEMIC USE|J5
54897|ANTIVIRALS FOR SYSTEMIC USE|J5
54895|ANTIHYPERTENSIVES|C2
54895|CALCIUM ANTAGONISTS|C8
54894|NOOTROPICS|N6D
54891|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54889|Urinary incontinence products|G4B4
54889|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54889|SSRI antidepressants|N6A4
54889|SRNI antidepressants|N6A5
54888|ANTIPSYCHOTICS|N5A
54884|ANTI-EPILEPTICS|N3A
54881|ANTIVIRALS FOR SYSTEMIC USE|J5
54880|ANTI-EPILEPTICS|N3A
54878|ANTIEMETICS AND ANTINAUSEANTS|A4
54876|MUSCLE RELAXANTS|M3
54874|Ocular antineovascularisation products|S1P
54873|ANALGESICS|N2
54872|RESPIRATORY SYSTEM|R
54871|ANTI-EPILEPTICS|N3
54867|ANTI-EPILEPTICS|N3
54866|ANTI-EPILEPTICS|N3
54864|ANALGESICS|N2
54863|ANTI-EPILEPTICS|N3A
54862|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54862|SSRI antidepressants|N6A4
54862|SRNI antidepressants|N6A5
54861|ANALGESICS|N2
54858|ANTI-EPILEPTICS|N3A
54857|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
54857|Statins (HMG-CoA reductase inhibitors)|C10A1
54856|DRUGS USED IN DIABETES|A10
54856|HUMAN INSULINS AND ANALOGUES|A10C
54856|Human insulins and analogues, long-acting|A10C5
54852|SYSTEMIC ANTIBACTERIALS|J1
54848|HYPNOTICS/SEDATIVES|N5B
54844|Systemic dermatological antifungals|D1A2
54844|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54843|Factors II, VII, IX and X|B2D2
54841|SYSTEMIC ANTIBACTERIALS|J1
54839|TRANQUILLISERS|N5C
54838|TRANQUILLISERS|N5C
54832|ANALGESICS|N2
54830|IMMUNOSUPPRESSIVE AGENTS|L4
54828|SYSTEMIC ANTIBACTERIALS|J1
54828|PARASITOLOGY|P
54828|ANTI-MALARIALS|P1D
54825|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54825|DRUGS USED IN DIABETES|A10
54825|NOOTROPICS|N6D
54822|IMMUNOSTIMULATING AGENTS|L3
54819|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
54818|Ocular antineovascularisation products|S1P
54814|IMMUNOSUPPRESSIVE AGENTS|L4
54812|ANALGESICS|N2
54812|ANTI-MIGRAINE PREPARATIONS|N2C
54804|ANTIVIRALS FOR SYSTEMIC USE|J5
54792|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54791|MACROLIDES AND SIMILAR TYPES|J1F
54791|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54790|B2-STIMULANTS|R3A
54788|WOUND HEALING AGENTS|D3
54788|SYSTEMIC ANTIBACTERIALS|J1
54764|CENTRAL NERVOUS SYSTEM|N
54762|IMMUNOSUPPRESSIVE AGENTS|L4
54762|ANALGESICS|N2
54761|ANTI-EPILEPTICS|N3
54758|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54757|ANALGESICS|N2
54755|PSYCHOSTIMULANTS|N6B
54754|HYPNOTICS/SEDATIVES|N5B
54754|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54753|ANTIPSYCHOTICS|N5A
54750|ANTIVIRALS FOR SYSTEMIC USE|J5
54750|IMMUNOSTIMULATING AGENTS|L3
54750|INTERFERONS|L3B
54748|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54747|ANTIVIRALS FOR SYSTEMIC USE|J5
54741|ANTIVIRALS FOR SYSTEMIC USE|J5
54740|ANAESTHETICS, LOCAL|N1B
54740|ANALGESICS|N2
54738|ANAESTHETICS, LOCAL|N1B
54738|ANALGESICS|N2
54737|ANTIEMETICS AND ANTINAUSEANTS|A4
54736|TRANQUILLISERS|N5C
54734|ANALGESICS|N2
54725|CALCITONINS|H4A
54723|CALCITONINS|H4A
54722|SYSTEMIC ANTIBACTERIALS|J1
54718|CENTRAL NERVOUS SYSTEM|N
54717|IMMUNOSTIMULATING AGENTS|L3
54716|SYSTEMIC ANTIBACTERIALS|J1
54714|DIURETICS|C3
54706|PARASITOLOGY|P
54705|ANTIVIRALS FOR SYSTEMIC USE|J5
54702|ANTI-EPILEPTICS|N3A
54701|ANTI-EPILEPTICS|N3A
54701|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54699|PLATELET AGGREGATION INHIBITORS|B1C
54699|CARDIOVASCULAR SYSTEM|C
54697|ANTIHYPERTENSIVES|C2
54697|CALCIUM ANTAGONISTS|C8
54697|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
54695|DRUGS USED IN DIABETES|A10
54692|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54691|SYSTEMIC ANTIBACTERIALS|J1
54688|LAXATIVES|A6
54688|CENTRAL NERVOUS SYSTEM|N
54688|NOOTROPICS|N6D
54685|ANTIPSYCHOTICS|N5A
54682|SYSTEMIC ANTIBACTERIALS|J1
54682|ANTIVIRALS FOR SYSTEMIC USE|J5
54679|SYSTEMIC ANTIBACTERIALS|J1
54675|SYSTEMIC ANTIBACTERIALS|J1
54673|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
54671|IMMUNOSUPPRESSIVE AGENTS|L4
54669|ANTIVIRALS FOR SYSTEMIC USE|J5
54667|HYPNOTICS/SEDATIVES|N5B
54665|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54664|PLATELET AGGREGATION INHIBITORS|B1C
54657|DPP-IV inhibitor antidiabetics|A10B6
54656|ANALGESICS|N2
54648|SYSTEMIC ANTIBACTERIALS|J1
54648|CEPHALOSPORINS|J1D
54647|SYSTEMIC ANTIBACTERIALS|J1
54647|CEPHALOSPORINS|J1D
54642|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54641|ANALGESICS|N2
54641|SSRI antidepressants|N6A4
54641|SRNI antidepressants|N6A5
54640|VACCINES|J7
54635|PARASITOLOGY|P
54633|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
54631|ANALGESICS|N2
54626|ANTIHYPERTENSIVES|C2
54623|DRUGS USED IN DIABETES|A10
54622|DRUGS USED IN DIABETES|A10
54622|CARDIOVASCULAR SYSTEM|C
54622|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54620|ANTIMETABOLITES|L1B
54618|ANTIVIRALS FOR SYSTEMIC USE|J5
54618|IMMUNOSTIMULATING AGENTS|L3
54614|ANTIHYPERTENSIVES|C2
54611|TRANQUILLISERS|N5C
54611|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54610|Statins (HMG-CoA reductase inhibitors)|C10A1
54599|ANTIVIRALS FOR SYSTEMIC USE|J5
54598|ANTIVIRALS FOR SYSTEMIC USE|J5
54595|Erectile dysfunction products|G4B3
54595|IMMUNOSTIMULATING AGENTS|L3
54593|ANTIVIRALS FOR SYSTEMIC USE|J5
54590|PARASITOLOGY|P
54587|SYSTEMIC ANTIBACTERIALS|J1
54586|ANDROGENS, EXCLUDING G3E, G3F|G3B
54584|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54584|IMMUNOSUPPRESSIVE AGENTS|L4
54583|PLATELET AGGREGATION INHIBITORS|B1C
54583|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
54582|HEPARINS |B1B
54582|CARDIOVASCULAR SYSTEM|C
54581|Interferons, beta|L3B2
54579|ANTIEMETICS AND ANTINAUSEANTS|A4
54579|APPETITE STIMULANTS|A15
54577|ANTI-EPILEPTICS|N3
54577|TRANQUILLISERS|N5C
54574|DRUGS USED IN DIABETES|A10
54574|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
54573|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
54572|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
54572|ANALGESICS|N2
54564|ALKYLATING AGENTS|L1A
54562|DERMATOLOGICALS|D
54562|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
54562|ANTI-ACNE PREPARATIONS|D10
54561|SYSTEMIC ANTIBACTERIALS|J1
54558|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54557|IMMUNOSUPPRESSIVE AGENTS|L4
54553|ANTIHYPERTENSIVES|C2
54553|DIURETICS|C3
54552|APPETITE STIMULANTS|A15
54551|RESPIRATORY SYSTEM|R
54550|RESPIRATORY SYSTEM|R
54549|ANALGESICS|N2
54549|ANTI-EPILEPTICS|N3
54549|ANTI-EPILEPTICS|N3A
54549|TRANQUILLISERS|N5C
54549|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54548|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54542|VACCINES|J7
54539|ANTIVIRALS FOR SYSTEMIC USE|J5
54525|IMMUNOSTIMULATING AGENTS|L3
54522|ANTI-EPILEPTICS|N3A
54520|CARDIOVASCULAR SYSTEM|C
54515|ANTIPSYCHOTICS|N5A
54513|ANTI-EPILEPTICS|N3A
54508|ANTIPSYCHOTICS|N5A
54506|ANTIPSYCHOTICS|N5A
54505|ANALGESICS|N2
54496|IMMUNOSTIMULATING AGENTS|L3
54493|ANTIPSYCHOTICS|N5A
54493|HYPNOTICS/SEDATIVES|N5B
54491|ANTIVIRALS FOR SYSTEMIC USE|J5
54490|ANALGESICS|N2
54487|ANTIPSYCHOTICS|N5A
54487|TRANQUILLISERS|N5C
54486|NOOTROPICS|N6D
54479|ANALGESICS|N2
54474|IMMUNOSTIMULATING AGENTS|L3
54455|DRUGS USED IN DIABETES|A10
54455|HUMAN INSULINS AND ANALOGUES|A10C
54455|Human insulins and analogues, intermediate-acting|A10C2
54448|ANTI-ARRHYTHMICS|C1B
54443|ANALGESICS|N2
54443|ANTI-MIGRAINE PREPARATIONS|N2C
54442|ANALGESICS|N2
54442|ANTI-MIGRAINE PREPARATIONS|N2C
54440|ANALGESICS|N2
54440|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54439|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54439|SSRI antidepressants|N6A4
54439|SRNI antidepressants|N6A5
54433|RADIODIAGNOSTIC AGENTS|T1G
54431|ANTIEMETICS AND ANTINAUSEANTS|A4
54431|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54428|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54427|ANTIVIRALS FOR SYSTEMIC USE|J5
54424|ANALGESICS|N2
54424|ANTIPSYCHOTICS|N5A
54421|DPP-IV inhibitor antidiabetics|A10B6
54413|IMMUNOSUPPRESSIVE AGENTS|L4
54412|ANALGESICS|N2
54410|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
54410|Ocular antineovascularisation products|S1P
54409|CARDIOVASCULAR SYSTEM|C
54409|NOOTROPICS|N6D
54405|ANTIVIRALS FOR SYSTEMIC USE|J5
54405|VACCINES|J7
54404|ANTIVIRALS FOR SYSTEMIC USE|J5
54404|VACCINES|J7
54400|ANTI-EPILEPTICS|N3A
54399|ANTI-EPILEPTICS|N3A
54398|PLATELET AGGREGATION INHIBITORS|B1C
54398|CARDIOVASCULAR SYSTEM|C
54394|ANTIVIRALS FOR SYSTEMIC USE|J5
54393|ANALGESICS|N2
54392|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54391|Erectile dysfunction products|G4B3
54390|SYSTEMIC ANTIBACTERIALS|J1
54389|Coxibs|M1A3
54389|ANALGESICS|N2
54389|OPHTHALMOLOGICALS|S1
54385|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
54382|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54382|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
54381|ANALGESICS|N2
54377|SYSTEMIC ANTIBACTERIALS|J1
54376|ANALGESICS|N2
54374|DRUGS USED IN DIABETES|A10
54374|CARDIOVASCULAR SYSTEM|C
54374|ANTI-GOUT PREPARATIONS|M4
54374|OPHTHALMOLOGICALS|S1
54372|ANTIEMETICS AND ANTINAUSEANTS|A4
54372|ANAESTHETICS|N1
54372|ANTI-MIGRAINE PREPARATIONS|N2C
54371|ANTI-EPILEPTICS|N3A
54370|ANTIVIRALS FOR SYSTEMIC USE|J5
54368|NOOTROPICS|N6D
54367|ANTIVIRALS FOR SYSTEMIC USE|J5
54365|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54365|IMMUNOSUPPRESSIVE AGENTS|L4
54363|ANTIHYPERTENSIVES|C2
54363|DIURETICS|C3
54361|ANTIVIRALS FOR SYSTEMIC USE|J5
54360|ANTI-ARRHYTHMICS|C1B
54358|ANTIVIRALS FOR SYSTEMIC USE|J5
54354|ANTI-EPILEPTICS|N3A
54350|IMMUNOSUPPRESSIVE AGENTS|L4
54345|CALCIUM ANTAGONISTS|C8
54345|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54344|IMMUNOSTIMULATING AGENTS|L3
54341|ANALGESICS|N2
54336|GASTROPROKINETICS|A3F
54326|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
54324|Urinary incontinence products|G4B4
54323|ANTIVIRALS FOR SYSTEMIC USE|J5
54322|OPHTHALMOLOGICALS|S1
54322|Ocular antineovascularisation products|S1P
54321|OPHTHALMOLOGICALS|S1
54321|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
54312|ANALGESICS|N2
54311|ANTIHYPERTENSIVES|C2
54308|WOUND HEALING AGENTS|D3
54308|ANTI-EPILEPTICS|N3A
54307|NOOTROPICS|N6D
54305|NOOTROPICS|N6D
54305|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
54302|ANALGESICS|N2
54301|HYPNOTICS/SEDATIVES|N5B
54298|CARDIOVASCULAR SYSTEM|C
54298|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
54294|WOUND HEALING AGENTS|D3
54294|MUSCULO-SKELETAL SYSTEM|M
54292|WOUND HEALING AGENTS|D3
54291|ANTIHYPERTENSIVES|C2
54291|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
54289|DRUGS USED IN DIABETES|A10
54289|HUMAN INSULINS AND ANALOGUES|A10C
54289|Human insulins and analogues, intermediate-acting|A10C2
54288|ANTIHYPERTENSIVES|C2
54288|CALCIUM ANTAGONISTS|C8
54288|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
54287|SYSTEMIC ANTIBACTERIALS|J1
54287|ANTIVIRALS FOR SYSTEMIC USE|J5
54287|INTERFERONS|L3B
54287|ANALGESICS|N2
54285|SYSTEMIC ANTIBACTERIALS|J1
54284|ANTIVIRALS FOR SYSTEMIC USE|J5
54279|SYSTEMIC ANTIBACTERIALS|J1
54277|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
54276|ANTIVIRALS FOR SYSTEMIC USE|J5
54274|CARDIOVASCULAR SYSTEM|C
54274|MRI AGENTS|T1E
54273|CARDIOVASCULAR SYSTEM|C
54273|MRI AGENTS|T1E
54271|OPHTHALMOLOGICALS|S1
54270|ANTIVIRALS FOR SYSTEMIC USE|J5
54269|ANTIVIRALS FOR SYSTEMIC USE|J5
54268|PLATELET AGGREGATION INHIBITORS|B1C
54268|CARDIOVASCULAR SYSTEM|C
54268|ANTIVIRALS FOR SYSTEMIC USE|J5
54266|PLATELET AGGREGATION INHIBITORS|B1C
54266|CARDIOVASCULAR SYSTEM|C
54266|ANTIVIRALS FOR SYSTEMIC USE|J5
54264|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54264|RESPIRATORY SYSTEM|R
54260|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
54259|SYSTEMIC ANTIBACTERIALS|J1
54258|PLATELET AGGREGATION INHIBITORS|B1C
54258|DIRECT THROMBIN INHIBITORS|B1E
54257|RESPIRATORY SYSTEM|R
54256|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54255|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54254|ANALGESICS|N2
54253|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54252|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54251|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
54251|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
54251|Statins (HMG-CoA reductase inhibitors)|C10A1
54245|ANALGESICS|N2
54245|ANTI-MIGRAINE PREPARATIONS|N2C
54244|ANALGESICS|N2
54243|ANALGESICS|N2
54242|ANTIHYPERTENSIVES|C2
54242|ANALGESICS|N2
54242|OPHTHALMOLOGICALS|S1
54241|ANALGESICS|N2
54238|CARDIOVASCULAR SYSTEM|C
54234|ANTIVIRALS FOR SYSTEMIC USE|J5
54230|ANTI-ACNE PREPARATIONS|D10
54230|TOPICAL ANTI-ACNE PREPARATIONS|D10A
54230|SYSTEMIC ANTIBACTERIALS|J1
54230|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54229|ANTIVIRALS FOR SYSTEMIC USE|J5
54228|ANTIVIRALS FOR SYSTEMIC USE|J5
54226|ANTIVIRALS FOR SYSTEMIC USE|J5
54225|Topical dermatological antifungals|D1A1
54225|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54223|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54222|IMMUNOSUPPRESSIVE AGENTS|L4
54221|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54219|MRI AGENTS|T1E
54210|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
54209|ANALGESICS|N2
54209|ANTI-EPILEPTICS|N3
54206|DIAGNOSTIC AGENTS|T
54205|ANALGESICS|N2
54205|ANTI-EPILEPTICS|N3
54204|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
54203|IMMUNOSTIMULATING AGENTS|L3
54196|ANTIVIRALS FOR SYSTEMIC USE|J5
54194|VACCINES|J7
54194|IMMUNOSTIMULATING AGENTS|L3
54192|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
54188|BPH (benign prostatic hypertrophy) products |G4C
54187|WOUND HEALING AGENTS|D3
54187|ANTI-ACNE PREPARATIONS|D10
54186|ANALGESICS|N2
54184|IMMUNOSTIMULATING AGENTS|L3
54179|Interferons, gamma|L3B3
54177|HEPARINS |B1B
54177|Urinary incontinence products|G4B4
54177|ANAESTHETICS, LOCAL|N1B
54177|ANALGESICS|N2
54176|ANTIVIRALS FOR SYSTEMIC USE|J5
54170|ANTIEMETICS AND ANTINAUSEANTS|A4
54168|ANTI-MIGRAINE PREPARATIONS|N2C
54168|ANTI-EPILEPTICS|N3
54167|ANTIVIRALS FOR SYSTEMIC USE|J5
54162|ANTIVIRALS FOR SYSTEMIC USE|J5
54161|Systemic dermatological antifungals|D1A2
54161|ANTI-ACNE PREPARATIONS|D10
54161|SYSTEMIC ANTIBACTERIALS|J1
54161|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54160|ANTIPSYCHOTICS|N5A
54157|OPHTHALMOLOGICALS|S1
54152|ANTIVIRALS FOR SYSTEMIC USE|J5
54150|WOUND HEALING AGENTS|D3
54149|RADIODIAGNOSTIC AGENTS|T1G
54146|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54145|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54144|SYSTEMIC ANTIBACTERIALS|J1
54144|AMINOGLYCOSIDES|J1K
54143|SYSTEMIC ANTIBACTERIALS|J1
54143|AMINOGLYCOSIDES|J1K
54142|ANTIVIRALS FOR SYSTEMIC USE|J5
54141|ANTIPSYCHOTICS|N5A
54133|BETA-BLOCKING AGENTS|C7
54132|ANTIVIRALS FOR SYSTEMIC USE|J5
54132|Interferons, beta|L3B2
54130|SYSTEMIC ANTIHISTAMINES|R6
54130|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
54128|ANTI-ARRHYTHMICS|C1B
54127|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
54126|ANTIEMETICS AND ANTINAUSEANTS|A4
54126|SYSTEMIC ANTIHISTAMINES|R6
54125|VACCINES|J7
54121|ANALGESICS|N2
54120|ANALGESICS|N2
54119|ANALGESICS|N2
54118|ANALGESICS|N2
54118|ANTI-MIGRAINE PREPARATIONS|N2C
54116|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
54114|GLUCAGON|H4B
54112|GLUCAGON|H4B
54100|NOOTROPICS|N6D
54099|NOOTROPICS|N6D
54098|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
54094|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54090|RESPIRATORY SYSTEM|R
54087|SYSTEMIC ANTIBACTERIALS|J1
54087|ANTIVIRALS FOR SYSTEMIC USE|J5
54086|CENTRAL NERVOUS SYSTEM|N
54086|ANALGESICS|N2
54086|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54086|NOOTROPICS|N6D
54085|CENTRAL NERVOUS SYSTEM|N
54085|ANALGESICS|N2
54085|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
54085|NOOTROPICS|N6D
54084|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54082|ANALGESICS|N2
54082|ANTI-MIGRAINE PREPARATIONS|N2C
54080|ANALGESICS|N2
54080|ANTI-MIGRAINE PREPARATIONS|N2C
54079|ANTIVIRALS FOR SYSTEMIC USE|J5
54071|ANTIVIRALS FOR SYSTEMIC USE|J5
54068|ANTIVIRALS FOR SYSTEMIC USE|J5
54066|IMMUNOSTIMULATING AGENTS|L3
54065|SYSTEMIC ANTIBACTERIALS|J1
54063|ANTIVIRALS FOR SYSTEMIC USE|J5
54060|ANTIVIRALS FOR SYSTEMIC USE|J5
54060|VACCINES|J7
54058|ANALGESICS|N2
54058|ANTI-MIGRAINE PREPARATIONS|N2C
54057|SYSTEMIC ANTIBACTERIALS|J1
54053|WOUND HEALING AGENTS|D3
54052|WOUND HEALING AGENTS|D3
54049|OPHTHALMOLOGICALS|S1
54048|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
54047|NOOTROPICS|N6D
54047|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
54044|NOOTROPICS|N6D
54042|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54041|ANTIVIRALS FOR SYSTEMIC USE|J5
54040|ANALGESICS|N2
54039|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
54037|OPHTHALMOLOGICALS|S1
54037|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
54033|CARDIAC THERAPY|C1
54029|ANTIHYPERTENSIVES|C2
54029|CALCIUM ANTAGONISTS|C8
54029|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
54028|WOUND HEALING AGENTS|D3
54012|ANDROGENS, EXCLUDING G3E, G3F|G3B
54011|OPHTHALMOLOGICALS|S1
54010|ANTIPSYCHOTICS|N5A
54009|ANTIPSYCHOTICS|N5A
54007|NOOTROPICS|N6D
53997|ANALGESICS|N2
53996|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
53996|PARASITOLOGY|P
53995|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
53994|DPP-IV inhibitor antidiabetics|A10B6
53993|CALCIUM ANTAGONISTS|C8
53993|PARASITOLOGY|P
53992|PARASITOLOGY|P
53992|ANTI-MALARIALS|P1D
53991|CARDIOVASCULAR SYSTEM|C
53990|ANTIHYPERTENSIVES|C2
53988|ANALGESICS|N2
53988|ANTI-MIGRAINE PREPARATIONS|N2C
53988|TRANQUILLISERS|N5C
53985|IMMUNOSTIMULATING AGENTS|L3
53984|IMMUNOSTIMULATING AGENTS|L3
53980|NOOTROPICS|N6D
53978|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
53977|ANTIVIRALS FOR SYSTEMIC USE|J5
53974|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53973|ANALGESICS|N2
53968|TRANQUILLISERS|N5C
53960|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53960|DRUGS USED IN DIABETES|A10
53952|ANTI-ARRHYTHMICS|C1B
53951|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53951|NOOTROPICS|N6D
53950|Topical dermatological antifungals|D1A1
53950|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
53949|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
53943|Coxibs|M1A3
53943|ANALGESICS|N2
53940|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
53939|ANTI-MIGRAINE PREPARATIONS|N2C
53939|ANTI-EPILEPTICS|N3
53938|Antigonadotrophin-releasing hormones|H1C3
53937|Antigonadotrophin-releasing hormones|H1C3
53936|ANALGESICS|N2
53931|ANDROGENS, EXCLUDING G3E, G3F|G3B
53930|CARDIOVASCULAR SYSTEM|C
53929|CARDIOVASCULAR SYSTEM|C
53928|FIBRINOLYTICS|B1D
53926|FIBRINOLYTICS|B1D
53925|FIBRINOLYTICS|B1D
53922|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53920|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53919|ANTI-ARRHYTHMICS|C1B
53914|ANTIPSYCHOTICS|N5A
53914|TRANQUILLISERS|N5C
53912|ANALGESICS|N2
53910|CENTRAL NERVOUS SYSTEM|N
53910|ANALGESICS|N2
53910|ANTI-EPILEPTICS|N3
53910|TRANQUILLISERS|N5C
53909|ANAESTHETICS, LOCAL|N1B
53909|ANALGESICS|N2
53908|IMMUNOSTIMULATING AGENTS|L3
53907|ANALGESICS|N2
53907|ANTI-MIGRAINE PREPARATIONS|N2C
53906|ANTIVIRALS FOR SYSTEMIC USE|J5
53905|SYSTEMIC ANTIBACTERIALS|J1
53905|CEPHALOSPORINS|J1D
53899|ANALGESICS|N2
53898|ANTIPSYCHOTICS|N5A
53895|NOOTROPICS|N6D
53895|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
53894|SYSTEMIC ANTIBACTERIALS|J1
53893|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53891|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
53890|DRUGS USED IN DIABETES|A10
53885|SYSTEMIC ANTIBACTERIALS|J1
53885|ANTIVIRALS FOR SYSTEMIC USE|J5
53883|ANTIVIRALS FOR SYSTEMIC USE|J5
53883|IMMUNOSTIMULATING AGENTS|L3
53882|FIBRINOLYTICS|B1D
53879|DRUGS USED IN DIABETES|A10
53878|DRUGS USED IN DIABETES|A10
53878|CENTRAL NERVOUS SYSTEM|N
53875|ANTIVIRALS FOR SYSTEMIC USE|J5
53875|IMMUNOSTIMULATING AGENTS|L3
53874|ANTIPSYCHOTICS|N5A
53871|PARASITOLOGY|P
53870|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53869|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
53868|ANTIPSYCHOTICS|N5A
53864|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53858|SSRI antidepressants|N6A4
53853|ANTIEMETICS AND ANTINAUSEANTS|A4
53853|ANALGESICS|N2
53851|DRUGS USED IN DIABETES|A10
53851|OPHTHALMOLOGICALS|S1
53850|Glitazone antidiabetics|A10B4
53850|CARDIOVASCULAR SYSTEM|C
53848|ANALGESICS|N2
53848|ANTI-EPILEPTICS|N3
53838|ANTIVIRALS FOR SYSTEMIC USE|J5
53837|ANTIVIRALS FOR SYSTEMIC USE|J5
53836|DERMATOLOGICALS|D
53836|ANTI-ACNE PREPARATIONS|D10
53835|DERMATOLOGICALS|D
53835|ANTI-ACNE PREPARATIONS|D10
53833|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
53827|GASTROPROKINETICS|A3F
53822|ANAESTHETICS|N1
53822|TRANQUILLISERS|N5C
53821|ANTI-ACNE PREPARATIONS|D10
53818|ANDROGENS, EXCLUDING G3E, G3F|G3B
53815|SYSTEMIC ANTIBACTERIALS|J1
53815|MACROLIDES AND SIMILAR TYPES|J1F
53814|Topical dermatological antifungals|D1A1
53814|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
53809|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
53809|ANTI-ACNE PREPARATIONS|D10
53809|SYSTEMIC ANTIBACTERIALS|J1
53808|IMMUNOSTIMULATING AGENTS|L3
53804|DRUGS USED IN DIABETES|A10
53804|HUMAN INSULINS AND ANALOGUES|A10C
53804|Human insulins and analogues, intermediate-acting|A10C2
53804|Human insulins and analogues, long-acting|A10C5
53800|IMMUNOSTIMULATING AGENTS|L3
53799|ANAESTHETICS|N1
53799|HYPNOTICS/SEDATIVES|N5B
53799|TRANQUILLISERS|N5C
53798|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53794|ANALGESICS|N2
53794|ANTI-EPILEPTICS|N3A
53791|SYSTEMIC ANTIBACTERIALS|J1
53791|AMINOGLYCOSIDES|J1K
53790|SYSTEMIC ANTIBACTERIALS|J1
53785|CENTRAL NERVOUS SYSTEM|N
53783|ANALGESICS|N2
53779|SYSTEMIC ANTIBACTERIALS|J1
53777|SYSTEMIC ANTIBACTERIALS|J1
53773|ANTIVIRALS FOR SYSTEMIC USE|J5
53772|WOUND HEALING AGENTS|D3
53770|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
53767|TRANQUILLISERS|N5C
53757|CENTRAL NERVOUS SYSTEM|N
53756|WOUND HEALING AGENTS|D3
53753|ANTIVIRALS FOR SYSTEMIC USE|J5
53752|ANTIVIRALS FOR SYSTEMIC USE|J5
53751|PARASITOLOGY|P
53751|ANTI-MALARIALS|P1D
53750|PARASITOLOGY|P
53750|ANTI-MALARIALS|P1D
53742|CALCITONINS|H4A
53740|CALCITONINS|H4A
53738|ANAESTHETICS|N1
53735|RESPIRATORY SYSTEM|R
53733|ANTIPSYCHOTICS|N5A
53732|ANTIVIRALS FOR SYSTEMIC USE|J5
53731|IMMUNOSTIMULATING AGENTS|L3
53731|Interferons, gamma|L3B3
53730|ANTIVIRALS FOR SYSTEMIC USE|J5
53727|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53727|IMMUNOSUPPRESSIVE AGENTS|L4
53724|PARASITOLOGY|P
53724|ANTI-MALARIALS|P1D
53705|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53704|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53703|Vitamin E, plain|A11X3
53701|THYROID THERAPY|H3
53700|ANALGESICS|N2
53699|ANALGESICS|N2
53696|SYSTEMIC ANTIBACTERIALS|J1
53695|Factor VIII|B2D1
53694|Ocular antineovascularisation products|S1P
53693|ANTI-EPILEPTICS|N3A
53692|CENTRAL NERVOUS SYSTEM|N
53690|ANTIPSYCHOTICS|N5A
53680|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53680|IMMUNOSUPPRESSIVE AGENTS|L4
53679|CALCITONINS|H4A
53676|ANALGESICS|N2
53676|ANTI-EPILEPTICS|N3
53676|TRANQUILLISERS|N5C
53672|GASTROPROKINETICS|A3F
53672|APPETITE STIMULANTS|A15
53671|CALCITONINS|H4A
53670|CALCITONINS|H4A
53669|PLATELET AGGREGATION INHIBITORS|B1C
53668|ANTIVIRALS FOR SYSTEMIC USE|J5
53652|SYSTEMIC ANTIBACTERIALS|J1
53651|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53648|WOUND HEALING AGENTS|D3
53647|WOUND HEALING AGENTS|D3
53646|ANTIVIRALS FOR SYSTEMIC USE|J5
53645|Ocular antineovascularisation products|S1P
53642|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
53641|DIURETICS|C3
53637|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
53636|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
53634|Urinary incontinence products|G4B4
53633|Urinary incontinence products|G4B4
53632|ANTIVIRALS FOR SYSTEMIC USE|J5
53628|ANTIVIRALS FOR SYSTEMIC USE|J5
53627|ANTIHYPERTENSIVES|C2
53627|CALCIUM ANTAGONISTS|C8
53627|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
53624|ANTIVIRALS FOR SYSTEMIC USE|J5
53622|ANTIMETABOLITES|L1B
53621|ANTIMETABOLITES|L1B
53619|DRUGS USED IN DIABETES|A10
53618|DRUGS USED IN DIABETES|A10
53614|ANTI-EPILEPTICS|N3A
53607|AMINOGLYCOSIDES|J1K
53606|SYSTEMIC ANTIBACTERIALS|J1
53606|AMINOGLYCOSIDES|J1K
53605|SYSTEMIC ANTIBACTERIALS|J1
53604|ANALGESICS|N2
53603|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
53602|SYSTEMIC ANTIBACTERIALS|J1
53595|ANTIEMETICS AND ANTINAUSEANTS|A4
53594|SYSTEMIC ANTIBACTERIALS|J1
53592|DIAGNOSTIC AGENTS|T
53589|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53584|ANTIEMETICS AND ANTINAUSEANTS|A4
53584|ANALGESICS|N2
53582|ANTIEMETICS AND ANTINAUSEANTS|A4
53582|ANALGESICS|N2
53581|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
53579|ANTIVIRALS FOR SYSTEMIC USE|J5
53578|ANTIVIRALS FOR SYSTEMIC USE|J5
53574|IMMUNOSTIMULATING AGENTS|L3
53573|WOUND HEALING AGENTS|D3
53572|ANALGESICS|N2
53571|ANALGESICS|N2
53570|ANTIVIRALS FOR SYSTEMIC USE|J5
53567|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53563|CENTRAL NERVOUS SYSTEM|N
53562|Coxibs|M1A3
53562|ANALGESICS|N2
53557|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
53554|Coxibs|M1A3
53554|ANALGESICS|N2
53548|Erectile dysfunction products|G4B3
53547|Ocular antineovascularisation products|S1P
53542|IMMUNOSUPPRESSIVE AGENTS|L4
53541|ANTIVIRALS FOR SYSTEMIC USE|J5
53539|ANTIVIRALS FOR SYSTEMIC USE|J5
53539|Interferons, alpha|L3B1
53538|MUSCULO-SKELETAL SYSTEM|M
53537|DPP-IV inhibitor antidiabetics|A10B6
53535|DRUGS USED IN DIABETES|A10
53535|HUMAN INSULINS AND ANALOGUES|A10C
53535|Human insulins and analogues, long-acting|A10C5
53531|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
53528|CARDIAC THERAPY|C1
53528|RADIODIAGNOSTIC AGENTS|T1G
53527|RESPIRATORY SYSTEM|R
53525|SYSTEMIC ANTIBACTERIALS|J1
53524|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
53523|HYPNOTICS/SEDATIVES|N5B
53523|TRANQUILLISERS|N5C
53515|RADIODIAGNOSTIC AGENTS|T1G
53512|ANALGESICS|N2
53511|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53511|RADIODIAGNOSTIC AGENTS|T1G
53508|RESPIRATORY SYSTEM|R
53506|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53504|SYSTEMIC ANTIBACTERIALS|J1
53502|ANTI-EPILEPTICS|N3A
53492|CENTRAL NERVOUS SYSTEM|N
53490|SYSTEMIC ANTIBACTERIALS|J1
53490|ANTIVIRALS FOR SYSTEMIC USE|J5
53489|SYSTEMIC ANTIBACTERIALS|J1
53489|ANTIVIRALS FOR SYSTEMIC USE|J5
53487|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53487|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
53485|ANALGESICS|N2
53484|ANALGESICS|N2
53483|ANALGESICS|N2
53481|SYSTEMIC ANTIBACTERIALS|J1
53481|RADIODIAGNOSTIC AGENTS|T1G
53475|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
53475|Statins (HMG-CoA reductase inhibitors)|C10A1
53474|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
53474|Statins (HMG-CoA reductase inhibitors)|C10A1
53464|NOOTROPICS|N6D
53463|ANTIVIRALS FOR SYSTEMIC USE|J5
53462|RESPIRATORY SYSTEM|R
53460|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
53458|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
53457|HUMAN INSULINS AND ANALOGUES|A10C
53457|Human insulins and analogues, long-acting|A10C5
53456|OPHTHALMOLOGICALS|S1
53455|RADIODIAGNOSTIC AGENTS|T1G
53454|ANTIVIRALS FOR SYSTEMIC USE|J5
53453|ANTIVIRALS FOR SYSTEMIC USE|J5
53452|RADIODIAGNOSTIC AGENTS|T1G
53451|SYSTEMIC ANTIBACTERIALS|J1
53451|ANTIVIRALS FOR SYSTEMIC USE|J5
53448|ANTIPSYCHOTICS|N5A
53448|NOOTROPICS|N6D
53447|ANTIVIRALS FOR SYSTEMIC USE|J5
53445|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
53444|DRUGS USED IN DIABETES|A10
53443|ANTIVIRALS FOR SYSTEMIC USE|J5
53442|DPP-IV inhibitor antidiabetics|A10B6
53440|RADIODIAGNOSTIC AGENTS|T1G
53437|RADIODIAGNOSTIC AGENTS|T1G
53435|ANTIVIRALS FOR SYSTEMIC USE|J5
53433|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53433|ANTIHYPERTENSIVES|C2
53433|ACE INHIBITORS, PLAIN|C9A
53429|VACCINES|J7
53427|B2-STIMULANTS|R3A
53426|RADIODIAGNOSTIC AGENTS|T1G
53425|RADIODIAGNOSTIC AGENTS|T1G
53422|ANTIVIRALS FOR SYSTEMIC USE|J5
53421|RADIODIAGNOSTIC AGENTS|T1G
53394|DRUGS USED IN DIABETES|A10
53394|HUMAN INSULINS AND ANALOGUES|A10C
53394|Human insulins and analogues, intermediate-acting|A10C2
53393|ANTIVIRALS FOR SYSTEMIC USE|J5
53389|ANALGESICS|N2
53387|SYSTEMIC ANTIBACTERIALS|J1
53383|ANALGESICS|N2
53377|RESPIRATORY SYSTEM|R
53376|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53375|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
53374|ANTIVIRALS FOR SYSTEMIC USE|J5
53373|IMMUNOSTIMULATING AGENTS|L3
53371|IMMUNOSTIMULATING AGENTS|L3
53370|DPP-IV inhibitor antidiabetics|A10B6
53368|DRUGS USED IN DIABETES|A10
53366|SRNI antidepressants|N6A5
53363|IMMUNOSTIMULATING AGENTS|L3
53359|DPP-IV inhibitor antidiabetics|A10B6
53357|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
53352|ANTIVIRALS FOR SYSTEMIC USE|J5
53345|ANAESTHETICS, LOCAL|N1B
53345|ANALGESICS|N2
53343|SYSTEMIC ANTIBACTERIALS|J1
53343|MACROLIDES AND SIMILAR TYPES|J1F
53338|CARDIOVASCULAR SYSTEM|C
53338|ANTIHYPERTENSIVES|C2
53338|Erectile dysfunction products|G4B3
53335|SYSTEMIC ANTIHISTAMINES|R6
53332|RESPIRATORY SYSTEM|R
53330|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53328|ANTIVIRALS FOR SYSTEMIC USE|J5
53324|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
53323|NOOTROPICS|N6D
53321|ANTIVIRALS FOR SYSTEMIC USE|J5
53320|ANTIVIRALS FOR SYSTEMIC USE|J5
53320|Protease inhibitors|J5C2
53316|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
53316|OPHTHALMOLOGICALS|S1
53310|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
53309|DRUGS USED IN DIABETES|A10
53299|PLATELET AGGREGATION INHIBITORS|B1C
53295|DRUGS USED IN DIABETES|A10
53295|HUMAN INSULINS AND ANALOGUES|A10C
53295|Human insulins and analogues, intermediate-acting|A10C2
53293|PLATELET AGGREGATION INHIBITORS|B1C
53279|WOUND HEALING AGENTS|D3
53269|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53266|HUMAN INSULINS AND ANALOGUES|A10C
53266|Human insulins and analogues, intermediate-acting|A10C2
53265|NOOTROPICS|N6D
53263|ANTIVIRALS FOR SYSTEMIC USE|J5
53262|ANTIVIRALS FOR SYSTEMIC USE|J5
53262|IMMUNOSTIMULATING AGENTS|L3
53260|SYSTEMIC ANTIBACTERIALS|J1
53256|CARDIOVASCULAR SYSTEM|C
53255|RESPIRATORY SYSTEM|R
53250|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53248|DRUGS USED IN DIABETES|A10
53247|ANTIVIRALS FOR SYSTEMIC USE|J5
53246|DPP-IV inhibitor antidiabetics|A10B6
53245|ANTIVIRALS FOR SYSTEMIC USE|J5
53243|Urinary incontinence products|G4B4
53240|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
53240|SSRI antidepressants|N6A4
53238|AMOEBICIDES|P1A
53236|B2-STIMULANTS|R3A
53231|ANTIPROTOZOALS AND ANTHELMINTICS|P1
53229|ANTIVIRALS FOR SYSTEMIC USE|J5
53229|Protease inhibitors|J5C2
53223|SYSTEMIC ANTIBACTERIALS|J1
53220|Factors II, VII, IX and X|B2D2
53218|ANTIVIRALS FOR SYSTEMIC USE|J5
53217|ANTIVIRALS FOR SYSTEMIC USE|J5
53216|Carbapenems|J1P2
53215|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
53212|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53210|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53208|ANTIVIRALS FOR SYSTEMIC USE|J5
53207|ANTIVIRALS FOR SYSTEMIC USE|J5
53202|ANTIHYPERTENSIVES|C2
53199|WOUND HEALING AGENTS|D3
53196|WOUND HEALING AGENTS|D3
53195|DERMATOLOGICALS|D
53193|ANTI-EPILEPTICS|N3A
53193|NOOTROPICS|N6D
53193|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
53192|ANALGESICS|N2
53190|WOUND HEALING AGENTS|D3
53190|OPHTHALMOLOGICALS|S1
53186|BPH (benign prostatic hypertrophy) products |G4C
53179|ANTIVIRALS FOR SYSTEMIC USE|J5
53176|ANALGESICS|N2
53170|ALKYLATING AGENTS|L1A
53166|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
53161|ANTIPSYCHOTICS|N5A
53158|IMMUNOSTIMULATING AGENTS|L3
53152|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
53152|IMMUNOSUPPRESSIVE AGENTS|L4
53152|OPHTHALMOLOGICALS|S1
53148|ANALGESICS|N2
53140|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
53135|RESPIRATORY SYSTEM|R
53134|AMINOGLYCOSIDES|J1K
53130|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
53125|ANALGESICS|N2
53100|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
53100|SSRI antidepressants|N6A4
53100|SRNI antidepressants|N6A5
53094|ALKYLATING AGENTS|L1A
53090|ANTIMETABOLITES|L1B
53072|DIURETICS|C3
53069|CARDIOVASCULAR SYSTEM|C
53069|ANTIHYPERTENSIVES|C2
53069|BPH (benign prostatic hypertrophy) products |G4C
53068|CARDIOVASCULAR SYSTEM|C
53068|ANTIHYPERTENSIVES|C2
53068|BPH (benign prostatic hypertrophy) products |G4C
53067|ANTIHYPERTENSIVES|C2
53066|ANTIVIRALS FOR SYSTEMIC USE|J5
53065|ANTIVIRALS FOR SYSTEMIC USE|J5
53064|Factor VIII|B2D1
53062|IMMUNOSUPPRESSIVE AGENTS|L4
53061|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53060|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
53055|ANTIVIRALS FOR SYSTEMIC USE|J5
53055|IMMUNOSTIMULATING AGENTS|L3
53051|PARASITOLOGY|P
53051|ANTI-MALARIALS|P1D
53045|ANTIVIRALS FOR SYSTEMIC USE|J5
53044|ANTIHYPERTENSIVES|C2
53041|PARASITOLOGY|P
53041|ANTI-MALARIALS|P1D
53040|ALKYLATING AGENTS|L1A
53039|ALKYLATING AGENTS|L1A
53033|DRUGS USED IN DIABETES|A10
53032|ANTIVIRALS FOR SYSTEMIC USE|J5
53031|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
53027|SYSTEMIC ANTIBACTERIALS|J1
53026|ANTI-ACNE PREPARATIONS|D10
53026|SYSTEMIC ANTIBACTERIALS|J1
53022|ANTIVIRALS FOR SYSTEMIC USE|J5
53020|PLATELET AGGREGATION INHIBITORS|B1C
53019|SYSTEMIC ANTIBACTERIALS|J1
53012|MACROLIDES AND SIMILAR TYPES|J1F
53006|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
53005|ANTIVIRALS FOR SYSTEMIC USE|J5
53000|ANTIHYPERTENSIVES|C2
52994|ANALGESICS|N2
52993|SYSTEMIC ANTIBACTERIALS|J1
52988|ANTIVIRALS FOR SYSTEMIC USE|J5
52987|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
52985|IMMUNOSUPPRESSIVE AGENTS|L4
52983|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52983|SRNI antidepressants|N6A5
52981|ANALGESICS|N2
52971|SYSTEMIC ANTIBACTERIALS|J1
52970|DRUGS USED IN DIABETES|A10
52968|ANALGESICS|N2
52967|ANTI-ARRHYTHMICS|C1B
52960|ANTIPROTOZOALS AND ANTHELMINTICS|P1
52957|ANTIVIRALS FOR SYSTEMIC USE|J5
52956|ANTIVIRALS FOR SYSTEMIC USE|J5
52954|ANTIHYPERTENSIVES|C2
52945|RESPIRATORY SYSTEM|R
52944|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
52941|ANTIVIRALS FOR SYSTEMIC USE|J5
52938|ANTIMETABOLITES|L1B
52935|ANALGESICS|N2
52933|DRUGS USED IN DIABETES|A10
52932|DRUGS USED IN DIABETES|A10
52931|ANTIHYPERTENSIVES|C2
52928|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
52928|ANALGESICS|N2
52928|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52922|DRUGS USED IN DIABETES|A10
52920|WOUND HEALING AGENTS|D3
52919|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
52919|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
52918|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
52918|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
52917|ANTI-EPILEPTICS|N3A
52914|ANTIVIRALS FOR SYSTEMIC USE|J5
52913|Inhibitors of the Kallikrein-kinin-system|B2C2
52913|ANALGESICS|N2
52912|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
52911|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
52910|TRANQUILLISERS|N5C
52907|ANTIVIRALS FOR SYSTEMIC USE|J5
52905|IMMUNOSTIMULATING AGENTS|L3
52902|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
52901|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
52899|CENTRAL NERVOUS SYSTEM|N
52899|NOOTROPICS|N6D
52898|CENTRAL NERVOUS SYSTEM|N
52898|NOOTROPICS|N6D
52896|SYSTEMIC ANTIBACTERIALS|J1
52894|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
52893|CENTRAL NERVOUS SYSTEM|N
52893|ANTI-EPILEPTICS|N3A
52893|TRANQUILLISERS|N5C
52893|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52892|SYSTEMIC ANTIHISTAMINES|R6
52892|OPHTHALMOLOGICALS|S1
52890|PLATELET AGGREGATION INHIBITORS|B1C
52889|ANTIVIRALS FOR SYSTEMIC USE|J5
52886|ANTIVIRALS FOR SYSTEMIC USE|J5
52886|IMMUNOSTIMULATING AGENTS|L3
52883|ANTI-EPILEPTICS|N3A
52883|NOOTROPICS|N6D
52882|TRANQUILLISERS|N5C
52882|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52879|HYPNOTICS/SEDATIVES|N5B
52878|ANTIVIRALS FOR SYSTEMIC USE|J5
52874|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
52874|ANTI-ACNE PREPARATIONS|D10
52869|RESPIRATORY SYSTEM|R
52867|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
52865|ANALGESICS|N2
52864|ANALGESICS|N2
52861|IMMUNOSTIMULATING AGENTS|L3
52860|IMMUNOSTIMULATING AGENTS|L3
52859|IMMUNOSTIMULATING AGENTS|L3
52859|Ocular antineovascularisation products|S1P
52858|IMMUNOSTIMULATING AGENTS|L3
52857|Non-nucleoside reverse transcriptase inhibitors|J5C3
52856|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
52854|ANTIHYPERTENSIVES|C2
52853|GROWTH HORMONES|H4C
52850|ANTIVIRALS FOR SYSTEMIC USE|J5
52850|IMMUNOSTIMULATING AGENTS|L3
52849|ANTIPSYCHOTICS|N5A
52842|DERMATOLOGICALS|D
52841|Systemic dermatological antifungals|D1A2
52841|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
52840|Systemic dermatological antifungals|D1A2
52840|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
52839|Systemic dermatological antifungals|D1A2
52839|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
52836|ANTIHYPERTENSIVES|C2
52836|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
52833|RESPIRATORY SYSTEM|R
52830|Erectile dysfunction products|G4B3
52828|SYSTEMIC ANTIBACTERIALS|J1
52823|ANALGESICS|N2
52822|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
52819|ANTITUSSIVES|R5D
52813|HEPARINS |B1B
52808|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
52806|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
52805|ANALGESICS|N2
52805|SSRI antidepressants|N6A4
52805|SRNI antidepressants|N6A5
52804|ANALGESICS|N2
52804|SSRI antidepressants|N6A4
52804|SRNI antidepressants|N6A5
52801|NOOTROPICS|N6D
52800|ANTI-EPILEPTICS|N3A
52800|ANTIPSYCHOTICS|N5A
52800|TRANQUILLISERS|N5C
52800|NOOTROPICS|N6D
52799|ANTIPSYCHOTICS|N5A
52799|TRANQUILLISERS|N5C
52799|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52799|NOOTROPICS|N6D
52797|Urinary incontinence products|G4B4
52797|ANALGESICS|N2
52797|ANTIPSYCHOTICS|N5A
52797|TRANQUILLISERS|N5C
52797|NOOTROPICS|N6D
52796|CALCIUM ANTAGONISTS|C8
52795|APPETITE STIMULANTS|A15
52794|DPP-IV inhibitor antidiabetics|A10B6
52793|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
52793|ANTI-ACNE PREPARATIONS|D10
52793|ANALGESICS|N2
52792|ANALGESICS|N2
52791|ANALGESICS|N2
52790|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52790|SSRI antidepressants|N6A4
52790|SYSTEMIC ANTIHISTAMINES|R6
52789|SSRI antidepressants|N6A4
52789|SYSTEMIC ANTIHISTAMINES|R6
52788|ANALGESICS|N2
52788|ANTI-MIGRAINE PREPARATIONS|N2C
52787|ANTIHYPERTENSIVES|C2
52787|CALCIUM ANTAGONISTS|C8
52787|ACE INHIBITORS, PLAIN|C9A
52786|TRANQUILLISERS|N5C
52786|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52786|SSRI antidepressants|N6A4
52785|HEPARINS |B1B
52784|ANALGESICS|N2
52784|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
52782|ANTIEMETICS AND ANTINAUSEANTS|A4
52780|ANTIEMETICS AND ANTINAUSEANTS|A4
52780|ANALGESICS|N2
52780|TRANQUILLISERS|N5C
52779|NOOTROPICS|N6D
52776|RESPIRATORY SYSTEM|R
52774|ANALGESICS|N2
52773|Urinary incontinence products|G4B4
52772|ANTI-MIGRAINE PREPARATIONS|N2C
52772|ANTI-EPILEPTICS|N3
52765|ANALGESICS|N2
52759|ANALGESICS|N2
52757|ANALGESICS|N2
52755|ANALGESICS|N2
52754|ANALGESICS|N2
52750|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
52749|DPP-IV inhibitor antidiabetics|A10B6
52735|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
52734|PARASITOLOGY|P
52732|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
52731|PARASITOLOGY|P
52727|ANTIVIRALS FOR SYSTEMIC USE|J5
52726|ANALGESICS|N2
52725|SYSTEMIC ANTIBACTERIALS|J1
52724|SYSTEMIC ANTIBACTERIALS|J1
52723|NOOTROPICS|N6D
52717|ANALGESICS|N2
52716|ANALGESICS|N2
52715|ANTIVIRALS FOR SYSTEMIC USE|J5
52714|ANTIHYPERTENSIVES|C2
52714|IMMUNOSUPPRESSIVE AGENTS|L4
52713|ANTIHYPERTENSIVES|C2
52713|IMMUNOSUPPRESSIVE AGENTS|L4
52711|ANALGESICS|N2
52710|ANTIPSYCHOTICS|N5A
52704|ANTIVIRALS FOR SYSTEMIC USE|J5
52687|DRUGS USED IN DIABETES|A10
52686|ANALGESICS|N2
52685|DRUGS USED IN DIABETES|A10
52684|DRUGS USED IN DIABETES|A10
52683|ANTIHYPERTENSIVES|C2
52682|ANTIHYPERTENSIVES|C2
52681|ANTIVIRALS FOR SYSTEMIC USE|J5
52678|ANTIVIRALS FOR SYSTEMIC USE|J5
52677|SYSTEMIC ANTIBACTERIALS|J1
52676|SYSTEMIC ANTIBACTERIALS|J1
52669|IMMUNOSTIMULATING AGENTS|L3
52668|ANALGESICS|N2
52668|SSRI antidepressants|N6A4
52668|SRNI antidepressants|N6A5
52667|ANTIVIRALS FOR SYSTEMIC USE|J5
52666|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
52665|ANALGESICS|N2
52662|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
52661|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
52656|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
52654|NOOTROPICS|N6D
52649|SYSTEMIC ANTIBACTERIALS|J1
52648|ANTIVIRALS FOR SYSTEMIC USE|J5
52646|ANTIVIRALS FOR SYSTEMIC USE|J5
52639|SYSTEMIC ANTIBACTERIALS|J1
52638|ANTIVIRALS FOR SYSTEMIC USE|J5
52636|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
52635|SYSTEMIC ANTIBACTERIALS|J1
52624|SYSTEMIC ANTIBACTERIALS|J1
52623|SYSTEMIC ANTIBACTERIALS|J1
52621|ANTIVIRALS FOR SYSTEMIC USE|J5
52618|SYSTEMIC ANTIBACTERIALS|J1
52617|HYPNOTICS/SEDATIVES|N5B
52610|MUSCULO-SKELETAL SYSTEM|M
52609|MUSCULO-SKELETAL SYSTEM|M
52608|MUSCULO-SKELETAL SYSTEM|M
52605|ANTI-EPILEPTICS|N3A
52605|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52604|ANALGESICS|N2
52598|ANALGESICS|N2
52595|OPHTHALMOLOGICALS|S1
52591|IMMUNOSTIMULATING AGENTS|L3
52590|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
52589|SYSTEMIC ANTIBACTERIALS|J1
52577|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
52573|SYSTEMIC ANTIBACTERIALS|J1
52572|BPH (benign prostatic hypertrophy) products |G4C
52571|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
52567|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
52564|ANALGESICS|N2
52563|ANTIPSYCHOTICS|N5A
52562|ANTIPSYCHOTICS|N5A
52557|PLATELET AGGREGATION INHIBITORS|B1C
52557|ANTIHYPERTENSIVES|C2
52556|PLATELET AGGREGATION INHIBITORS|B1C
52556|ANTIHYPERTENSIVES|C2
52409|ANTIULCERANTS|A2B
52256|Factor VIII|B2D1
52252|SYSTEMIC ANTIBACTERIALS|J1
52252|ANTIVIRALS FOR SYSTEMIC USE|J5
52249|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52249|SSRI antidepressants|N6A4
52247|Ocular antineovascularisation products|S1P
52239|HYPNOTICS/SEDATIVES|N5B
52234|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
52228|ANTIVIRALS FOR SYSTEMIC USE|J5
52213|ANTIVIRALS FOR SYSTEMIC USE|J5
52209|CEPHALOSPORINS|J1D
52203|RESPIRATORY SYSTEM|R
52199|B2-STIMULANTS|R3A
52193|B2-STIMULANTS|R3A
52191|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
52190|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
52186|ANTIVIRALS FOR SYSTEMIC USE|J5
52184|SYSTEMIC ANTIBACTERIALS|J1
52184|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
52183|ANTI-EPILEPTICS|N3A
52183|TRANQUILLISERS|N5C
52182|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
52180|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
52179|ANTI-MIGRAINE PREPARATIONS|N2C
52176|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
52175|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
52139|SYSTEMIC ANTIBACTERIALS|J1
52092|ANTIHYPERTENSIVES|C2
52092|DIURETICS|C3
52092|ACE INHIBITORS, PLAIN|C9A
51409|ANALGESICS|N2
51405|ANTIPSYCHOTICS|N5A
51405|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51404|TRANQUILLISERS|N5C
51404|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51402|ANTIPSYCHOTICS|N5A
51401|TRANQUILLISERS|N5C
51401|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51401|SSRI antidepressants|N6A4
51400|TRANQUILLISERS|N5C
51400|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51399|TRANQUILLISERS|N5C
51399|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51398|TRANQUILLISERS|N5C
51398|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51397|TRANQUILLISERS|N5C
51397|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51396|ANALGESICS|N2
51395|ANALGESICS|N2
51394|ANALGESICS|N2
51393|OPHTHALMOLOGICALS|S1
51391|Factor VIII|B2D1
51386|MRI AGENTS|T1E
51382|ANTIHYPERTENSIVES|C2
51381|ANTIHYPERTENSIVES|C2
51375|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
51374|BPH (benign prostatic hypertrophy) products |G4C
51373|DRUGS USED IN DIABETES|A10
51372|DRUGS USED IN DIABETES|A10
51370|ANTIFIBRINOLYTICS|B2A
51368|ANDROGENS, EXCLUDING G3E, G3F|G3B
51361|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
51360|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
51351|ANTIVIRALS FOR SYSTEMIC USE|J5
51350|ANTI-EPILEPTICS|N3A
51345|ANALGESICS|N2
51342|ANALGESICS|N2
51341|PARASITOLOGY|P
51336|HYPNOTICS/SEDATIVES|N5B
51336|TRANQUILLISERS|N5C
51335|GASTROPROKINETICS|A3F
51333|ANTI-EPILEPTICS|N3A
51327|ANTIVIRALS FOR SYSTEMIC USE|J5
51327|IMMUNOSTIMULATING AGENTS|L3
51323|BETA-BLOCKING AGENTS|C7
51322|RADIODIAGNOSTIC AGENTS|T1G
51321|ANTIEMETICS AND ANTINAUSEANTS|A4
51319|SYSTEMIC ANTIBACTERIALS|J1
51318|CARDIOVASCULAR SYSTEM|C
51317|ANTIVIRALS FOR SYSTEMIC USE|J5
51313|SYSTEMIC ANTIBACTERIALS|J1
51309|ANTIVIRALS FOR SYSTEMIC USE|J5
51309|PARASITOLOGY|P
51308|ANTI-MIGRAINE PREPARATIONS|N2C
51307|SYSTEMIC ANTIBACTERIALS|J1
51306|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
51304|CARDIOVASCULAR SYSTEM|C
51302|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
51301|SYSTEMIC ANTIBACTERIALS|J1
51295|SYSTEMIC ANTIBACTERIALS|J1
51295|MACROLIDES AND SIMILAR TYPES|J1F
51295|RESPIRATORY SYSTEM|R
51294|SYSTEMIC ANTIBACTERIALS|J1
51292|MACROLIDES AND SIMILAR TYPES|J1F
51291|DRUGS USED IN DIABETES|A10
51290|MRI AGENTS|T1E
51289|ANTIPSYCHOTICS|N5A
51288|ANDROGENS, EXCLUDING G3E, G3F|G3B
51286|ANTIEMETICS AND ANTINAUSEANTS|A4
51286|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51284|ANTI-ACNE PREPARATIONS|D10
51284|MACROLIDES AND SIMILAR TYPES|J1F
51283|ANTIVIRALS FOR SYSTEMIC USE|J5
51281|SYSTEMIC ANTIBACTERIALS|J1
51281|AMINOGLYCOSIDES|J1K
51279|ANTI-EPILEPTICS|N3A
51279|NOOTROPICS|N6D
51276|VACCINES|J7
51275|ANTIVIRALS FOR SYSTEMIC USE|J5
51275|IMMUNOSTIMULATING AGENTS|L3
51269|ANTIVIRALS FOR SYSTEMIC USE|J5
51265|TRANQUILLISERS|N5C
51265|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51264|ANALGESICS|N2
51263|SYSTEMIC ANTIBACTERIALS|J1
51261|ANALGESICS|N2
51259|ALKYLATING AGENTS|L1A
51258|ANTI-EPILEPTICS|N3A
51257|ANALGESICS|N2
51256|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51256|SSRI antidepressants|N6A4
51256|SRNI antidepressants|N6A5
51255|ANTI-ARRHYTHMICS|C1B
51254|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
51253|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
51253|Glitazone antidiabetics|A10B4
51252|ANALGESICS|N2
51250|ANALGESICS|N2
51249|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
51248|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
51248|DRUGS USED IN DIABETES|A10
51247|CENTRAL NERVOUS SYSTEM|N
51247|ANALGESICS|N2
51247|TRANQUILLISERS|N5C
51247|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51246|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
51243|ANALGESICS|N2
51242|IMMUNOSUPPRESSIVE AGENTS|L4
51241|WOUND HEALING AGENTS|D3
51240|ANALGESICS|N2
51237|ANALGESICS|N2
51237|ANTI-EPILEPTICS|N3A
51236|CARDIOVASCULAR SYSTEM|C
51233|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
51229|NOOTROPICS|N6D
51229|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
51224|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
51221|SYSTEMIC ANTIBACTERIALS|J1
51206|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
51204|DERMATOLOGICALS|D
51204|ANTIVIRALS FOR SYSTEMIC USE|J5
51201|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
51195|PLATELET AGGREGATION INHIBITORS|B1C
51195|DIRECT THROMBIN INHIBITORS|B1E
51193|RESPIRATORY SYSTEM|R
51186|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
51186|Statins (HMG-CoA reductase inhibitors)|C10A1
51185|OPHTHALMOLOGICALS|S1
51175|ANALGESICS|N2
51167|SYSTEMIC ANTIBACTERIALS|J1
51166|SYSTEMIC ANTIBACTERIALS|J1
51164|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
51162|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
51159|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
51156|SYSTEMIC ANTIBACTERIALS|J1
51154|CARDIOVASCULAR SYSTEM|C
51154|ANTIHYPERTENSIVES|C2
51152|ANTI-EPILEPTICS|N3
51150|ANTIPSYCHOTICS|N5A
51145|ANTIEMETICS AND ANTINAUSEANTS|A4
51143|HYPNOTICS/SEDATIVES|N5B
51143|TRANQUILLISERS|N5C
51135|SYSTEMIC ANTIBACTERIALS|J1
51132|SYSTEMIC ANTIBACTERIALS|J1
51127|CARDIOVASCULAR SYSTEM|C
51126|Urinary incontinence products|G4B4
51126|RESPIRATORY SYSTEM|R
51125|DPP-IV inhibitor antidiabetics|A10B6
51112|ANTIVIRALS FOR SYSTEMIC USE|J5
51110|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
51108|ANTIHYPERTENSIVES|C2
51108|CALCIUM ANTAGONISTS|C8
51108|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
51100|ANALGESICS|N2
51092|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
51081|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51080|ANTI-EPILEPTICS|N3A
51080|ANTIPSYCHOTICS|N5A
51077|ANTI-EPILEPTICS|N3A
51075|CARDIOVASCULAR SYSTEM|C
51075|SYSTEMIC ANTIBACTERIALS|J1
51069|DPP-IV inhibitor antidiabetics|A10B6
51066|ANALGESICS|N2
51064|DIRECT THROMBIN INHIBITORS|B1E
51063|IMMUNOSUPPRESSIVE AGENTS|L4
51062|ANALGESICS|N2
51061|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51061|SSRI antidepressants|N6A4
51061|SRNI antidepressants|N6A5
51054|RESPIRATORY SYSTEM|R
51053|Coxibs|M1A3
51051|ANTIVIRALS FOR SYSTEMIC USE|J5
51048|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
51048|Antigrowth hormones|H1C2
51047|ANALGESICS|N2
51047|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
51047|SRNI antidepressants|N6A5
51047|PSYCHOSTIMULANTS|N6B
51047|NOOTROPICS|N6D
51044|PLATELET AGGREGATION INHIBITORS|B1C
51041|ANTIEMETICS AND ANTINAUSEANTS|A4
51040|GROWTH HORMONES|H4C
51039|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
51039|Statins (HMG-CoA reductase inhibitors)|C10A1
51037|HUMAN INSULINS AND ANALOGUES|A10C
51037|Human insulins and analogues, intermediate-acting|A10C2
51036|SYSTEMIC ANTIBACTERIALS|J1
51035|SYSTEMIC ANTIBACTERIALS|J1
51033|Coxibs|M1A3
51033|ANALGESICS|N2
51031|RESPIRATORY SYSTEM|R
51029|Ocular antineovascularisation products|S1P
51025|ANALGESICS|N2
51025|ANTITUSSIVES|R5D
51024|ANTIVIRALS FOR SYSTEMIC USE|J5
51021|IMMUNOSUPPRESSIVE AGENTS|L4
51021|RESPIRATORY SYSTEM|R
51019|BPH (benign prostatic hypertrophy) products |G4C
51015|VACCINES|J7
51014|ANALGESICS|N2
51011|B2-STIMULANTS|R3A
51009|ANALGESICS|N2
51007|SYSTEMIC ANTIBACTERIALS|J1
51006|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
51004|ANTIHYPERTENSIVES|C2
51004|BETA-BLOCKING AGENTS|C7
51004|OPHTHALMOLOGICALS|S1
51001|ANTIPSYCHOTICS|N5A
51001|NOOTROPICS|N6D
50999|ANTI-EPILEPTICS|N3
50997|Preparations to prevent cataract and anticataractogenics, topical|S1N2
50991|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
50990|ANTIPSYCHOTICS|N5A
50989|ANTIVIRALS FOR SYSTEMIC USE|J5
50989|OPHTHALMOLOGICALS|S1
50988|DRUGS USED IN DIABETES|A10
50988|DPP-IV inhibitor antidiabetics|A10B6
50987|ANTIPSYCHOTICS|N5A
50986|DPP-IV inhibitor antidiabetics|A10B6
50984|CENTRAL NERVOUS SYSTEM|N
50980|RESPIRATORY SYSTEM|R
50976|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
50976|SSRI antidepressants|N6A4
50975|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
50974|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
50972|ANALGESICS|N2
50971|SYSTEMIC ANTIBACTERIALS|J1
50971|ANTIVIRALS FOR SYSTEMIC USE|J5
50970|SYSTEMIC ANTIBACTERIALS|J1
50969|CENTRAL NERVOUS SYSTEM|N
50969|ANALGESICS|N2
50968|CENTRAL NERVOUS SYSTEM|N
50967|SYSTEMIC ANTIBACTERIALS|J1
50967|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
50965|ANTI-EPILEPTICS|N3A
50965|NOOTROPICS|N6D
50964|ANTI-EPILEPTICS|N3A
50962|ALKYLATING AGENTS|L1A
50961|WOUND HEALING AGENTS|D3
50961|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
50959|HYPNOTICS/SEDATIVES|N5B
50959|TRANQUILLISERS|N5C
50958|ANTIPSYCHOTICS|N5A
50950|ANTIVIRALS FOR SYSTEMIC USE|J5
50947|IMMUNOSUPPRESSIVE AGENTS|L4
50946|CENTRAL NERVOUS SYSTEM|N
50934|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
50927|ANTIVIRALS FOR SYSTEMIC USE|J5
50926|SYSTEMIC ANTIBACTERIALS|J1
50923|CARDIAC THERAPY|C1
50920|ANALGESICS|N2
50907|OPHTHALMOLOGICALS|S1
50906|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
50905|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
50904|ANTIVIRALS FOR SYSTEMIC USE|J5
50903|OPHTHALMOLOGICALS|S1
50900|ANTI-EPILEPTICS|N3A
50899|DERMATOLOGICALS|D
50891|ANTI-EPILEPTICS|N3
50891|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
50883|ANTI-EPILEPTICS|N3A
50882|NOOTROPICS|N6D
50880|ANALGESICS|N2
50879|ANALGESICS|N2
50878|Coxibs|M1A3
50878|ANALGESICS|N2
50872|DRUGS USED IN DIABETES|A10
50869|ANTIVIRALS FOR SYSTEMIC USE|J5
50866|CARDIOVASCULAR SYSTEM|C
50866|ANTIHYPERTENSIVES|C2
50863|CENTRAL NERVOUS SYSTEM|N
50863|NOOTROPICS|N6D
50861|IMMUNOSTIMULATING AGENTS|L3
50858|ANTIVIRALS FOR SYSTEMIC USE|J5
50856|DRUGS USED IN DIABETES|A10
50855|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
50854|ANALGESICS|N2
50853|SYSTEMIC ANTIBACTERIALS|J1
50850|NOOTROPICS|N6D
50848|ANTIHYPERTENSIVES|C2
50845|BETA-BLOCKING AGENTS|C7
50845|OPHTHALMOLOGICALS|S1
50843|ANTIHYPERTENSIVES|C2
50840|PARASITOLOGY|P
50840|ANTI-MALARIALS|P1D
50839|ANDROGENS, EXCLUDING G3E, G3F|G3B
50837|ANTIEMETICS AND ANTINAUSEANTS|A4
50836|NOOTROPICS|N6D
50820|ANTIVIRALS FOR SYSTEMIC USE|J5
50817|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
50800|ANTI-ARRHYTHMICS|C1B
50800|ANTIHYPERTENSIVES|C2
50800|ANALGESICS|N2
50800|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
50798|NOOTROPICS|N6D
50778|IMMUNOSTIMULATING AGENTS|L3
50717|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
50702|PARASITOLOGY|P
50699|SYSTEMIC ANTIBACTERIALS|J1
50697|SYSTEMIC ANTIBACTERIALS|J1
50678|ANTIVIRALS FOR SYSTEMIC USE|J5
50643|RADIODIAGNOSTIC AGENTS|T1G
50642|RADIODIAGNOSTIC AGENTS|T1G
50641|CENTRAL NERVOUS SYSTEM|N
50641|RADIODIAGNOSTIC AGENTS|T1G
50640|CENTRAL NERVOUS SYSTEM|N
50640|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
50640|RADIODIAGNOSTIC AGENTS|T1G
50639|Interferons, beta|L3B2
50638|RADIODIAGNOSTIC AGENTS|T1G
50637|SYSTEMIC ANTIBACTERIALS|J1
50637|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
50629|SYSTEMIC ANTIBACTERIALS|J1
50625|CARDIOVASCULAR SYSTEM|C
50621|OPHTHALMOLOGICALS|S1
50618|CARDIOVASCULAR SYSTEM|C
50618|RADIODIAGNOSTIC AGENTS|T1G
50617|CALCIUM ANTAGONISTS|C8
50617|ANTIVIRALS FOR SYSTEMIC USE|J5
50617|IMMUNOSTIMULATING AGENTS|L3
50601|RADIODIAGNOSTIC AGENTS|T1G
50600|RADIODIAGNOSTIC AGENTS|T1G
50599|RADIODIAGNOSTIC AGENTS|T1G
50597|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
50582|NOOTROPICS|N6D
50581|DPP-IV inhibitor antidiabetics|A10B6
50580|RADIODIAGNOSTIC AGENTS|T1G
50579|ANTIVIRALS FOR SYSTEMIC USE|J5
50565|RADIODIAGNOSTIC AGENTS|T1G
50564|VACCINES|J7
50563|RADIODIAGNOSTIC AGENTS|T1G
50562|RADIODIAGNOSTIC AGENTS|T1G
50538|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
50522|RADIODIAGNOSTIC AGENTS|T1G
50500|ANALGESICS|N2
50485|ANTIVIRALS FOR SYSTEMIC USE|J5
50484|ANTI-EPILEPTICS|N3A
50482|SYSTEMIC ANTIBACTERIALS|J1
50480|Urinary incontinence products|G4B4
50480|CENTRAL NERVOUS SYSTEM|N
50478|HYPNOTICS/SEDATIVES|N5B
50467|DRUGS USED IN DIABETES|A10
50467|NOOTROPICS|N6D
50465|ANALGESICS|N2
50464|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
50463|DRUGS USED IN DIABETES|A10
50462|ANALGESICS|N2
50460|DRUGS USED IN DIABETES|A10
50460|HUMAN INSULINS AND ANALOGUES|A10C
50460|Human insulins and analogues, intermediate-acting|A10C2
50458|ANTIVIRALS FOR SYSTEMIC USE|J5
50457|Coxibs|M1A3
50457|ANALGESICS|N2
50437|ANTIVIRALS FOR SYSTEMIC USE|J5
50417|RESPIRATORY SYSTEM|R
50411|SYSTEMIC ANTIBACTERIALS|J1
50409|Topical dermatological antifungals|D1A1
50409|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
50407|SYSTEMIC ANTIBACTERIALS|J1
50406|WOUND HEALING AGENTS|D3
50405|NOOTROPICS|N6D
50405|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
50404|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
50402|ANDROGENS, EXCLUDING G3E, G3F|G3B
50401|DIRECT THROMBIN INHIBITORS|B1E
50384|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
50381|CARDIAC THERAPY|C1
50381|NOOTROPICS|N6D
50381|OPHTHALMOLOGICALS|S1
50370|DRUGS USED IN DIABETES|A10
50370|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
50370|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
50367|ALKYLATING AGENTS|L1A
50366|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
50365|DRUGS USED IN DIABETES|A10
50363|ANTIVIRALS FOR SYSTEMIC USE|J5
50357|VACCINES|J7
50338|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
50318|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
50317|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
50317|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
50298|SYSTEMIC ANTIBACTERIALS|J1
50284|IMMUNOSTIMULATING AGENTS|L3
50282|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
50282|OPHTHALMOLOGICALS|S1
50278|ANTIVIRALS FOR SYSTEMIC USE|J5
50261|ANALGESICS|N2
50259|ANTIHYPERTENSIVES|C2
50258|VACCINES|J7
50257|OPHTHALMOLOGICALS|S1
50245|PLATELET AGGREGATION INHIBITORS|B1C
50245|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
50237|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
50218|ANTIPSYCHOTICS|N5A
50201|ANTIVIRALS FOR SYSTEMIC USE|J5
50199|ANTIVIRALS FOR SYSTEMIC USE|J5
50199|IMMUNOSTIMULATING AGENTS|L3
50198|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
50197|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
50182|ANTIVIRALS FOR SYSTEMIC USE|J5
50180|ANALGESICS|N2
50180|ANTIPSYCHOTICS|N5A
50180|NOOTROPICS|N6D
50178|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
50178|IMMUNOSUPPRESSIVE AGENTS|L4
50177|Factors II, VII, IX and X|B2D2
50169|ANALGESICS|N2
50167|GASTROPROKINETICS|A3F
50165|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
50163|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
50163|IMMUNOSUPPRESSIVE AGENTS|L4
50163|SYSTEMIC ANTIHISTAMINES|R6
50162|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
50161|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
50160|ANTIVIRALS FOR SYSTEMIC USE|J5
50159|PLATELET AGGREGATION INHIBITORS|B1C
50158|ANTIVIRALS FOR SYSTEMIC USE|J5
50157|GASTROPROKINETICS|A3F
50142|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
50141|ANTIVIRALS FOR SYSTEMIC USE|J5
50139|DERMATOLOGICALS|D
50123|DIRECT THROMBIN INHIBITORS|B1E
50120|Ocular antineovascularisation products|S1P
50119|WOUND HEALING AGENTS|D3
50119|OPHTHALMOLOGICALS|S1
50118|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
50101|ANTIVIRALS FOR SYSTEMIC USE|J5
50081|ANTIVIRALS FOR SYSTEMIC USE|J5
50079|SYSTEMIC ANTIBACTERIALS|J1
50079|VACCINES|J7
50077|ANTIEMETICS AND ANTINAUSEANTS|A4
50065|DIRECT THROMBIN INHIBITORS|B1E
50059|DERMATOLOGICALS|D
50059|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
50040|IMMUNOSUPPRESSIVE AGENTS|L4
50038|ANTIVIRALS FOR SYSTEMIC USE|J5
50038|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
50038|Non-nucleoside reverse transcriptase inhibitors|J5C3
50037|SYSTEMIC ANTIBACTERIALS|J1
50023|ANTIVIRALS FOR SYSTEMIC USE|J5
50022|PLATELET AGGREGATION INHIBITORS|B1C
50020|ANTIVIRALS FOR SYSTEMIC USE|J5
50019|FIBRINOLYTICS|B1D
50018|TRANQUILLISERS|N5C
50007|ANALGESICS|N2
50003|ANALGESICS|N2
50001|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
50000|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
49998|DRUGS USED IN DIABETES|A10
49998|Glitazone antidiabetics|A10B4
49984|ANTIPSYCHOTICS|N5A
49984|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
49981|ANTI-MIGRAINE PREPARATIONS|N2C
49980|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
49978|ANALGESICS|N2
49978|ANTI-EPILEPTICS|N3
49919|VACCINES|J7
49918|VACCINES|J7
49917|VACCINES|J7
49917|IMMUNOSTIMULATING AGENTS|L3
49905|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
49905|Erectile dysfunction products|G4B3
49904|ANALGESICS|N2
49902|ANTI-EPILEPTICS|N3A
49901|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
49898|VACCINES|J7
49897|VACCINES|J7
49883|ANALGESICS|N2
49882|GASTROPROKINETICS|A3F
49882|LAXATIVES|A6
49880|ANTIVIRALS FOR SYSTEMIC USE|J5
49840|GASTROPROKINETICS|A3F
49839|SYSTEMIC ANTIBACTERIALS|J1
49839|CEPHALOSPORINS|J1D
49837|MACROLIDES AND SIMILAR TYPES|J1F
49829|Biguanide antidiabetics|A10B2
49828|ANTIVIRALS FOR SYSTEMIC USE|J5
49827|OPHTHALMOLOGICALS|S1
49824|DRUGS USED IN DIABETES|A10
49819|ANTIVIRALS FOR SYSTEMIC USE|J5
49799|NOOTROPICS|N6D
49798|ANTIVIRALS FOR SYSTEMIC USE|J5
49781|IMMUNOSUPPRESSIVE AGENTS|L4
49779|ANTIVIRALS FOR SYSTEMIC USE|J5
49778|ANTIPSYCHOTICS|N5A
49778|TRANQUILLISERS|N5C
49778|NOOTROPICS|N6D
49777|ANTIEMETICS AND ANTINAUSEANTS|A4
49777|SRNI antidepressants|N6A5
49767|HUMAN INSULINS AND ANALOGUES|A10C
49767|Human insulins and analogues, long-acting|A10C5
49763|SYSTEMIC ANTIBACTERIALS|J1
49762|PARASITOLOGY|P
49761|SYSTEMIC ANTIBACTERIALS|J1
49760|SYSTEMIC ANTIBACTERIALS|J1
49757|SYSTEMIC ANTIBACTERIALS|J1
49737|ANTIVIRALS FOR SYSTEMIC USE|J5
49720|ANTIHYPERTENSIVES|C2
49718|ANTIVIRALS FOR SYSTEMIC USE|J5
49717|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
49717|DRUGS USED IN DIABETES|A10
49703|CARDIOVASCULAR SYSTEM|C
49702|SYSTEMIC ANTIBACTERIALS|J1
49683|ANTIVIRALS FOR SYSTEMIC USE|J5
49682|ANTIVIRALS FOR SYSTEMIC USE|J5
49682|Interferons, alpha|L3B1
49680|Coxibs|M1A3
49679|Factor VIII|B2D1
49677|DIRECT THROMBIN INHIBITORS|B1E
49663|Interferons, beta|L3B2
49661|IMMUNOSUPPRESSIVE AGENTS|L4
49659|ANTIEMETICS AND ANTINAUSEANTS|A4
49657|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
49640|IMMUNOSTIMULATING AGENTS|L3
49639|ANTIVIRALS FOR SYSTEMIC USE|J5
49638|ANTIVIRALS FOR SYSTEMIC USE|J5
49618|ANTIHYPERTENSIVES|C2
49618|CALCIUM ANTAGONISTS|C8
49599|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
49597|Urinary incontinence products|G4B4
49581|SYSTEMIC ANTIBACTERIALS|J1
49577|ANALGESICS|N2
49561|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
49547|NOOTROPICS|N6D
49544|CARDIOVASCULAR SYSTEM|C
49541|SYSTEMIC ANTIBACTERIALS|J1
49537|SYSTEMIC ANTIBACTERIALS|J1
49507|ALKYLATING AGENTS|L1A
49503|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
49479|ANTI-EPILEPTICS|N3
49479|RADIODIAGNOSTIC AGENTS|T1G
49461|SYSTEMIC ANTIBACTERIALS|J1
49439|IMMUNOSTIMULATING AGENTS|L3
49424|CARDIOVASCULAR SYSTEM|C
49422|Interferons, beta|L3B2
49420|PARASITOLOGY|P
49417|IMMUNOSTIMULATING AGENTS|L3
49408|CARDIOVASCULAR SYSTEM|C
49408|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
49407|SYSTEMIC ANTIBACTERIALS|J1
49406|ANTIVIRALS FOR SYSTEMIC USE|J5
49399|ALKYLATING AGENTS|L1A
49385|ANTI-MIGRAINE PREPARATIONS|N2C
49383|ANDROGENS, EXCLUDING G3E, G3F|G3B
49378|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
49344|ANALGESICS|N2
49342|ANALGESICS|N2
49341|ANALGESICS|N2
49317|ANALGESICS|N2
49317|SSRI antidepressants|N6A4
49317|SRNI antidepressants|N6A5
49302|ANTIVIRALS FOR SYSTEMIC USE|J5
49301|ANTIVIRALS FOR SYSTEMIC USE|J5
49299|ANTI-ACNE PREPARATIONS|D10
49299|MACROLIDES AND SIMILAR TYPES|J1F
49280|ALKYLATING AGENTS|L1A
49259|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
49240|ANALGESICS|N2
49222|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
49222|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
49219|ANTIVIRALS FOR SYSTEMIC USE|J5
49219|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
49217|ANTIVIRALS FOR SYSTEMIC USE|J5
49204|PLATELET AGGREGATION INHIBITORS|B1C
49201|ANALGESICS|N2
49200|SYSTEMIC ANTIBACTERIALS|J1
49198|IMMUNOSTIMULATING AGENTS|L3
49179|NOOTROPICS|N6D
49178|CARDIOVASCULAR SYSTEM|C
49162|SYSTEMIC ANTIBACTERIALS|J1
49138|DRUGS USED IN DIABETES|A10
49138|HUMAN INSULINS AND ANALOGUES|A10C
49138|Human insulins and analogues, intermediate-acting|A10C2
49118|Urinary incontinence products|G4B4
49098|ANALGESICS|N2
49097|PLATELET AGGREGATION INHIBITORS|B1C
49077|Biguanide antidiabetics|A10B2
49060|Biguanide antidiabetics|A10B2
49059|TRANQUILLISERS|N5C
49057|IMMUNOSUPPRESSIVE AGENTS|L4
49041|ANTIVIRALS FOR SYSTEMIC USE|J5
49040|ANTIVIRALS FOR SYSTEMIC USE|J5
49025|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
49023|MRI AGENTS|T1E
49020|ANTIVIRALS FOR SYSTEMIC USE|J5
49019|MRI AGENTS|T1E
49017|SYSTEMIC ANTIBACTERIALS|J1
49002|ANTIVIRALS FOR SYSTEMIC USE|J5
49001|ANTIHYPERTENSIVES|C2
48999|CARDIOVASCULAR SYSTEM|C
48998|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48998|SSRI antidepressants|N6A4
48983|Interferons, beta|L3B2
48979|SYSTEMIC ANTIBACTERIALS|J1
48977|PARASITOLOGY|P
48977|ANTI-MALARIALS|P1D
48964|ANALGESICS|N2
48963|ANTI-EPILEPTICS|N3
48963|TRANQUILLISERS|N5C
48962|BETA-BLOCKING AGENTS|C7
48959|MRI AGENTS|T1E
48958|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
48957|ANALGESICS|N2
48950|RESPIRATORY SYSTEM|R
48945|ANAESTHETICS, LOCAL|N1B
48943|DIAGNOSTIC AGENTS|T
48940|SYSTEMIC ANTIBACTERIALS|J1
48940|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
48940|OPHTHALMOLOGICAL ANTI-INFLAMMATORY/ANTI-INFECTIVE COMBINATIONS|S1C
48938|B2-STIMULANTS|R3A
48937|SYSTEMIC ANTIBACTERIALS|J1
48937|CEPHALOSPORINS|J1D
48920|ANTI-ARRHYTHMICS|C1B
48918|ANALGESICS|N2
48917|ANALGESICS|N2
48909|ANTIHYPERTENSIVES|C2
48906|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
48902|ANTIEMETICS AND ANTINAUSEANTS|A4
48902|TRANQUILLISERS|N5C
48902|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48902|ANTITUSSIVES|R5D
48901|IMMUNOSTIMULATING AGENTS|L3
48899|SYSTEMIC ANTIBACTERIALS|J1
48899|MACROLIDES AND SIMILAR TYPES|J1F
48897|ULTRASOUND AGENTS|T1F
48881|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
48880|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
48877|DERMATOLOGICALS|D
48857|ANTIVIRALS FOR SYSTEMIC USE|J5
48857|IMMUNOSTIMULATING AGENTS|L3
48838|ANTI-EPILEPTICS|N3A
48817|IMMUNOSUPPRESSIVE AGENTS|L4
48802|WOUND HEALING AGENTS|D3
48798|NOOTROPICS|N6D
48797|DIRECT THROMBIN INHIBITORS|B1E
48779|ANTIVIRALS FOR SYSTEMIC USE|J5
48758|ANTIVIRALS FOR SYSTEMIC USE|J5
48739|NOOTROPICS|N6D
48738|ANTIHYPERTENSIVES|C2
48719|ANALGESICS|N2
48717|ANTIVIRALS FOR SYSTEMIC USE|J5
48698|ANALGESICS|N2
48680|ANTIHYPERTENSIVES|C2
48680|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
48680|Statins (HMG-CoA reductase inhibitors)|C10A1
48679|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48678|DRUGS USED IN DIABETES|A10
48677|OPHTHALMOLOGICALS|S1
48668|Ocular antineovascularisation products|S1P
48667|SYSTEMIC ANTIBACTERIALS|J1
48665|CARDIOVASCULAR SYSTEM|C
48665|CENTRAL NERVOUS SYSTEM|N
48665|TRANQUILLISERS|N5C
48662|CARDIOVASCULAR SYSTEM|C
48662|ANTIPSYCHOTICS|N5A
48661|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
48660|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48660|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
48660|ANTI-EPILEPTICS|N3A
48660|NOOTROPICS|N6D
48659|DRUGS USED IN DIABETES|A10
48658|IMMUNOSUPPRESSIVE AGENTS|L4
48657|CARDIOVASCULAR SYSTEM|C
48657|Erectile dysfunction products|G4B3
48657|ANTIVIRALS FOR SYSTEMIC USE|J5
48657|RESPIRATORY SYSTEM|R
48657|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
48648|DRUGS USED IN DIABETES|A10
48647|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
48646|Vitamin A|A11C1
48646|CARDIOVASCULAR SYSTEM|C
48646|RESPIRATORY SYSTEM|R
48645|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
48644|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48643|ANTIPSYCHOTICS|N5A
48643|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48642|TRANQUILLISERS|N5C
48642|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48641|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48629|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48629|SSRI antidepressants|N6A4
48625|HYPNOTICS/SEDATIVES|N5B
48622|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48621|Erectile dysfunction products|G4B3
48618|Non-nucleoside reverse transcriptase inhibitors|J5C3
48601|ANTI-EPILEPTICS|N3A
48599|RESPIRATORY SYSTEM|R
48598|NOOTROPICS|N6D
48558|Topical dermatological antifungals|D1A1
48558|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
48557|TRANQUILLISERS|N5C
48557|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
48557|SSRI antidepressants|N6A4
48547|BPH (benign prostatic hypertrophy) products |G4C
48547|Antigonadotrophin-releasing hormones|H1C3
48545|Antigonadotrophin-releasing hormones|H1C3
48540|HYPNOTICS/SEDATIVES|N5B
48539|OPHTHALMOLOGICALS|S1
48537|IMMUNOSUPPRESSIVE AGENTS|L4
48537|OPHTHALMOLOGICALS|S1
48519|SYSTEMIC ANTIBACTERIALS|J1
48518|ANTIHYPERTENSIVES|C2
48518|BETA-BLOCKING AGENTS|C7
48518|Miotics and antiglaucoma preparations, topical|S1E2
48517|B2-STIMULANTS|R3A
48503|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
48500|ANTI-EPILEPTICS|N3A
48500|SSRI antidepressants|N6A4
48500|SRNI antidepressants|N6A5
48498|SYSTEMIC ANTIBACTERIALS|J1
48497|ANALGESICS|N2
48497|SSRI antidepressants|N6A4
48497|SRNI antidepressants|N6A5
48479|ANALGESICS|N2
48479|SSRI antidepressants|N6A4
48479|SRNI antidepressants|N6A5
48478|ANTI-EPILEPTICS|N3
48478|ANTIPSYCHOTICS|N5A
48477|ANTIHYPERTENSIVES|C2
48460|ANTIVIRALS FOR SYSTEMIC USE|J5
48459|ANTIVIRALS FOR SYSTEMIC USE|J5
48458|ANTIVIRALS FOR SYSTEMIC USE|J5
48457|ANTIVIRALS FOR SYSTEMIC USE|J5
48440|ANTIVIRALS FOR SYSTEMIC USE|J5
48439|ANTIVIRALS FOR SYSTEMIC USE|J5
48438|ANTIVIRALS FOR SYSTEMIC USE|J5
48417|ANTI-EPILEPTICS|N3A
48399|Carbapenems|J1P2
48398|Carbapenems|J1P2
48397|Carbapenems|J1P2
48383|BETA-BLOCKING AGENTS|C7
48381|ANTI-GOUT PREPARATIONS|M4
48381|TRANQUILLISERS|N5C
48380|ANTI-GOUT PREPARATIONS|M4
48380|TRANQUILLISERS|N5C
48379|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
48378|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
48377|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
48362|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
48361|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
48360|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
48359|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
48358|ANTIVIRALS FOR SYSTEMIC USE|J5
48357|ANTIVIRALS FOR SYSTEMIC USE|J5
48344|ANTIVIRALS FOR SYSTEMIC USE|J5
48342|ANTIVIRALS FOR SYSTEMIC USE|J5
48341|ANTIVIRALS FOR SYSTEMIC USE|J5
48340|ANTIVIRALS FOR SYSTEMIC USE|J5
48337|Protease inhibitors|J5C2
48240|Urinary incontinence products|G4B4
48237|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48230|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48229|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48228|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48221|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48220|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48219|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48218|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
48217|ANALGESICS|N2
48217|SSRI antidepressants|N6A4
48217|SRNI antidepressants|N6A5
48181|ANALGESICS|N2
48181|SSRI antidepressants|N6A4
48181|SRNI antidepressants|N6A5
48160|ANTI-ACNE PREPARATIONS|D10
48160|SYSTEMIC ANTIBACTERIALS|J1
48159|ANTI-ACNE PREPARATIONS|D10
48159|SYSTEMIC ANTIBACTERIALS|J1
48158|ANTI-ACNE PREPARATIONS|D10
48158|SYSTEMIC ANTIBACTERIALS|J1
48157|SYSTEMIC ANTIBACTERIALS|J1
48141|ANTI-ARRHYTHMICS|C1B
48140|ANTI-ARRHYTHMICS|C1B
48139|ANTI-ARRHYTHMICS|C1B
48099|IMMUNOSTIMULATING AGENTS|L3
48080|Factor VIII|B2D1
48079|Factor VIII|B2D1
48058|ANTIVIRALS FOR SYSTEMIC USE|J5
48057|ANTIVIRALS FOR SYSTEMIC USE|J5
48037|ANTIVIRALS FOR SYSTEMIC USE|J5
48018|ANTIVIRALS FOR SYSTEMIC USE|J5
47979|DIRECT THROMBIN INHIBITORS|B1E
47978|DIRECT THROMBIN INHIBITORS|B1E
47939|CARDIOVASCULAR SYSTEM|C
47938|CARDIOVASCULAR SYSTEM|C
47937|CARDIOVASCULAR SYSTEM|C
47924|ANTIMETABOLITES|L1B
47923|ANTIMETABOLITES|L1B
47922|DPP-IV inhibitor antidiabetics|A10B6
47921|B2-STIMULANTS|R3A
47920|TRANQUILLISERS|N5C
47920|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47919|ANTIPSYCHOTICS|N5A
47918|ANTIPSYCHOTICS|N5A
47918|NOOTROPICS|N6D
47917|ANTIPSYCHOTICS|N5A
47917|NOOTROPICS|N6D
47909|ANTIPSYCHOTICS|N5A
47909|NOOTROPICS|N6D
47908|ANTIPSYCHOTICS|N5A
47908|NOOTROPICS|N6D
47907|DPP-IV inhibitor antidiabetics|A10B6
47906|DPP-IV inhibitor antidiabetics|A10B6
47905|ANTIHYPERTENSIVES|C2
47905|ACE INHIBITORS, PLAIN|C9A
47903|ANTIHYPERTENSIVES|C2
47903|ACE INHIBITORS, PLAIN|C9A
47901|IMMUNOSUPPRESSIVE AGENTS|L4
47877|ANTIHYPERTENSIVES|C2
47877|DIURETICS|C3
47877|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
47860|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
47840|CARDIOVASCULAR SYSTEM|C
47803|ANTIVIRALS FOR SYSTEMIC USE|J5
47801|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47800|OPHTHALMOLOGICALS|S1
47800|Ocular antineovascularisation products|S1P
47799|IMMUNOSTIMULATING AGENTS|L3
47798|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47797|DERMATOLOGICALS|D
47797|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
47797|ANTI-ACNE PREPARATIONS|D10
47797|SYSTEMIC ANTIBACTERIALS|J1
47782|ANAESTHETICS|N1
47782|HYPNOTICS/SEDATIVES|N5B
47782|TRANQUILLISERS|N5C
47780|ANAESTHETICS|N1
47780|HYPNOTICS/SEDATIVES|N5B
47780|TRANQUILLISERS|N5C
47778|PLATELET AGGREGATION INHIBITORS|B1C
47778|OPHTHALMOLOGICALS|S1
47777|PLATELET AGGREGATION INHIBITORS|B1C
47777|CARDIOVASCULAR SYSTEM|C
47761|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
47759|ANALGESICS|N2
47759|ANTI-MIGRAINE PREPARATIONS|N2C
47758|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47757|Ocular antineovascularisation products|S1P
47734|ANTI-ACNE PREPARATIONS|D10
47733|ANTI-GOUT PREPARATIONS|M4
47732|RESPIRATORY SYSTEM|R
47723|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47721|CARDIOVASCULAR SYSTEM|C
47721|ANALGESICS|N2
47719|ANTIHYPERTENSIVES|C2
47717|ANTIVIRALS FOR SYSTEMIC USE|J5
47704|DIRECT THROMBIN INHIBITORS|B1E
47703|DIRECT THROMBIN INHIBITORS|B1E
47702|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47699|ANALGESICS|N2
47698|ANALGESICS|N2
47678|ANTIHYPERTENSIVES|C2
47677|ANTIVIRALS FOR SYSTEMIC USE|J5
47662|ANTI-EPILEPTICS|N3A
47644|PLATELET AGGREGATION INHIBITORS|B1C
47643|CARDIOVASCULAR SYSTEM|C
47643|ANTIHYPERTENSIVES|C2
47642|MUSCLE RELAXANTS|M3
47638|ANALGESICS|N2
47618|ANALGESICS|N2
47605|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47605|SSRI antidepressants|N6A4
47604|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47603|TRANQUILLISERS|N5C
47602|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
47601|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47601|SSRI antidepressants|N6A4
47598|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47598|SSRI antidepressants|N6A4
47585|ANALGESICS|N2
47583|ANALGESICS|N2
47581|ANALGESICS|N2
47581|SSRI antidepressants|N6A4
47581|SRNI antidepressants|N6A5
47579|ANALGESICS|N2
47577|NOOTROPICS|N6D
47562|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47560|DRUGS USED IN DIABETES|A10
47560|RADIODIAGNOSTIC AGENTS|T1G
47557|ANTI-ARRHYTHMICS|C1B
47552|NOOTROPICS|N6D
47550|VACCINES|J7
47547|HUMAN INSULINS AND ANALOGUES|A10C
47547|Human insulins and analogues, long-acting|A10C5
47546|NOOTROPICS|N6D
47541|ANTI-EPILEPTICS|N3A
47541|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
47538|PLATELET AGGREGATION INHIBITORS|B1C
47538|CARDIOVASCULAR SYSTEM|C
47538|ANTIHYPERTENSIVES|C2
47538|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
47538|Statins (HMG-CoA reductase inhibitors)|C10A1
47521|ANTI-EPILEPTICS|N3A
47518|ANTIVIRALS FOR SYSTEMIC USE|J5
47513|HUMAN INSULINS AND ANALOGUES|A10C
47513|Human insulins and analogues, intermediate-acting|A10C2
47508|OPHTHALMOLOGICALS|S1
47505|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
47504|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47504|DRUGS USED IN DIABETES|A10
47504|CARDIOVASCULAR SYSTEM|C
47503|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
47503|Statins (HMG-CoA reductase inhibitors)|C10A1
47501|ANTIHYPERTENSIVES|C2
47500|ANALGESICS|N2
47499|HUMAN INSULINS AND ANALOGUES|A10C
47499|Human insulins and analogues, intermediate-acting|A10C2
47497|ANALGESICS|N2
47497|ANTI-EPILEPTICS|N3
47486|ANTIHYPERTENSIVES|C2
47485|ANTIHYPERTENSIVES|C2
47485|BETA-BLOCKING AGENTS|C7
47484|ANTI-EPILEPTICS|N3A
47484|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
47483|ANALGESICS|N2
47483|ANTI-MIGRAINE PREPARATIONS|N2C
47480|DRUGS USED IN DIABETES|A10
47480|DPP-IV inhibitor antidiabetics|A10B6
47478|BPH (benign prostatic hypertrophy) products |G4C
47457|ANTIEMETICS AND ANTINAUSEANTS|A4
47440|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
47438|DERMATOLOGICALS|D
47438|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
47438|ANTI-ACNE PREPARATIONS|D10
47437|DRUGS USED IN DIABETES|A10
47437|HUMAN INSULINS AND ANALOGUES|A10C
47437|Human insulins and analogues, intermediate-acting|A10C2
47424|ANTIVIRALS FOR SYSTEMIC USE|J5
47423|ANTIDIURETIC HORMONES|H4D
47422|DRUGS USED IN DIABETES|A10
47419|ANDROGENS, EXCLUDING G3E, G3F|G3B
47418|ANDROGENS, EXCLUDING G3E, G3F|G3B
47418|NOOTROPICS|N6D
47417|ANDROGENS, EXCLUDING G3E, G3F|G3B
47397|ANTI-EPILEPTICS|N3A
47382|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47381|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
47381|IMMUNOSUPPRESSIVE AGENTS|L4
47380|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
47379|Urinary incontinence products|G4B4
47378|DERMATOLOGICALS|D
47378|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
47362|Protease inhibitors|J5C2
47360|ANALGESICS|N2
47358|SYSTEMIC ANTIBACTERIALS|J1
47357|ANTI-EPILEPTICS|N3A
47357|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
47341|CARDIOVASCULAR SYSTEM|C
47340|NOOTROPICS|N6D
47340|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
47339|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
47338|ANALGESICS|N2
47337|ANTIVIRALS FOR SYSTEMIC USE|J5
47304|IMMUNOSTIMULATING AGENTS|L3
47303|DERMATOLOGICALS|D
47303|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
47303|ANTI-ACNE PREPARATIONS|D10
47302|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47302|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
47300|Systemic dermatological antifungals|D1A2
47299|SYSTEMIC ANTIBACTERIALS|J1
47298|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
47297|SYSTEMIC ANTIBACTERIALS|J1
47277|WOUND HEALING AGENTS|D3
47266|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
47261|ANTIVIRALS FOR SYSTEMIC USE|J5
47258|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47257|ANTIHYPERTENSIVES|C2
47246|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
47244|ANTIVIRALS FOR SYSTEMIC USE|J5
47241|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47241|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
47241|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
47241|THYROID THERAPY|H3
47240|ANALGESICS|N2
47240|ANTI-MIGRAINE PREPARATIONS|N2C
47238|ANTIPSYCHOTICS|N5A
47234|ANALGESICS|N2
47232|ANTIEMETICS AND ANTINAUSEANTS|A4
47232|SSRI antidepressants|N6A4
47232|SRNI antidepressants|N6A5
47231|SYSTEMIC ANTIBACTERIALS|J1
47230|SYSTEMIC ANTIBACTERIALS|J1
47228|PARASITOLOGY|P
47227|DIRECT THROMBIN INHIBITORS|B1E
47222|CARDIAC THERAPY|C1
47221|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
47220|Topical dermatological antifungals|D1A1
47220|SYSTEMIC ANTIBACTERIALS|J1
47220|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
47218|Urinary incontinence products|G4B4
47206|HYPNOTICS/SEDATIVES|N5B
47204|ANALGESICS|N2
47204|ANTI-MIGRAINE PREPARATIONS|N2C
47203|Erectile dysfunction products|G4B3
47202|ANTI-MIGRAINE PREPARATIONS|N2C
47200|ANTIPSYCHOTICS|N5A
47178|ANTIHYPERTENSIVES|C2
47177|ANTIHYPERTENSIVES|C2
47177|CALCIUM ANTAGONISTS|C8
47167|ANALGESICS|N2
47166|DRUGS USED IN DIABETES|A10
47163|ALKYLATING AGENTS|L1A
47162|ANTIVIRALS FOR SYSTEMIC USE|J5
47161|NOOTROPICS|N6D
47159|HEPARINS |B1B
47159|RESPIRATORY SYSTEM|R
47158|ANTI-EPILEPTICS|N3
47142|ANTIVIRALS FOR SYSTEMIC USE|J5
47140|SYSTEMIC ANTIBACTERIALS|J1
47139|PARASITOLOGY|P
47137|IMMUNOSUPPRESSIVE AGENTS|L4
47124|ANTIPSYCHOTICS|N5A
47123|SYSTEMIC ANTIBACTERIALS|J1
47123|PARASITOLOGY|P
47123|ANTI-MALARIALS|P1D
47119|ANTIHYPERTENSIVES|C2
47119|BETA-BLOCKING AGENTS|C7
47099|ANALGESICS|N2
47097|Urinary incontinence products|G4B4
47078|SYSTEMIC ANTIBACTERIALS|J1
47077|ANTIHYPERTENSIVES|C2
47077|CALCIUM ANTAGONISTS|C8
47063|Coxibs|M1A3
47063|ANALGESICS|N2
47062|SYSTEMIC ANTIHISTAMINES|R6
47059|PLATELET AGGREGATION INHIBITORS|B1C
47059|Coxibs|M1A3
47059|ANALGESICS|N2
47037|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
47020|NOOTROPICS|N6D
47019|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
47018|ANTIVIRALS FOR SYSTEMIC USE|J5
47017|ANTI-ACNE PREPARATIONS|D10
47017|SYSTEMIC ANTIBACTERIALS|J1
47000|ALKYLATING AGENTS|L1A
46999|ANTI-ACNE PREPARATIONS|D10
46999|SYSTEMIC ANTIBACTERIALS|J1
46958|IMMUNOSTIMULATING AGENTS|L3
46942|ANTIHYPERTENSIVES|C2
46942|ACE INHIBITORS, PLAIN|C9A
46941|ANTIHYPERTENSIVES|C2
46941|ACE INHIBITORS, PLAIN|C9A
46939|ANTIHYPERTENSIVES|C2
46939|DIURETICS|C3
46939|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
46937|NOOTROPICS|N6D
46935|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
46934|ANTIHYPERTENSIVES|C2
46931|CEPHALOSPORINS|J1D
46930|B2-STIMULANTS|R3A
46928|ANTIHYPERTENSIVES|C2
46927|ANTI-ACNE PREPARATIONS|D10
46927|SYSTEMIC ANTIBACTERIALS|J1
46927|PARASITOLOGY|P
46927|ANTI-MALARIALS|P1D
46926|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
46925|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
46924|IMMUNOSTIMULATING AGENTS|L3
46922|SYSTEMIC ANTIBACTERIALS|J1
46921|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
46917|NOOTROPICS|N6D
46900|NOOTROPICS|N6D
46898|ANALGESICS|N2
46897|ANTIVIRALS FOR SYSTEMIC USE|J5
46896|HYPNOTICS/SEDATIVES|N5B
46895|ANTI-EPILEPTICS|N3A
46894|Coxibs|M1A3
46890|Sulphonylurea antidiabetics|A10B1
46884|SYSTEMIC ANTIBACTERIALS|J1
46884|ANTIVIRALS FOR SYSTEMIC USE|J5
46883|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
46882|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
46880|DRUGS USED IN DIABETES|A10
46879|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
46867|SYSTEMIC ANTIBACTERIALS|J1
46866|SYSTEMIC ANTIBACTERIALS|J1
46864|SYSTEMIC ANTIBACTERIALS|J1
46863|ANALGESICS|N2
46863|ANTI-EPILEPTICS|N3
46862|SYSTEMIC ANTIBACTERIALS|J1
46862|Carbapenems|J1P2
46860|SYSTEMIC ANTIBACTERIALS|J1
46859|SYSTEMIC ANTIBACTERIALS|J1
46858|B2-STIMULANTS|R3A
46857|ANTI-EPILEPTICS|N3
46857|ANTI-EPILEPTICS|N3A
46857|TRANQUILLISERS|N5C
46857|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
46857|OPHTHALMOLOGICALS|S1
46849|SYSTEMIC ANTIBACTERIALS|J1
46848|SYSTEMIC ANTIBACTERIALS|J1
46844|SYSTEMIC ANTIBACTERIALS|J1
46843|SYSTEMIC ANTIBACTERIALS|J1
46842|SYSTEMIC ANTIBACTERIALS|J1
46841|SYSTEMIC ANTIBACTERIALS|J1
46841|PARASITOLOGY|P
46841|ANTI-MALARIALS|P1D
46840|SYSTEMIC ANTIBACTERIALS|J1
46839|B2-STIMULANTS|R3A
46838|SYSTEMIC ANTIBACTERIALS|J1
46837|SYSTEMIC ANTIBACTERIALS|J1
46818|ANTIMETABOLITES|L1B
46805|DIRECT THROMBIN INHIBITORS|B1E
46802|RESPIRATORY SYSTEM|R
46801|DIRECT THROMBIN INHIBITORS|B1E
46800|ANTIVIRALS FOR SYSTEMIC USE|J5
46798|DIRECT THROMBIN INHIBITORS|B1E
46797|Erectile dysfunction products|G4B3
46782|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
46781|ANALGESICS|N2
46781|ANTI-MIGRAINE PREPARATIONS|N2C
46780|PARASITOLOGY|P
46762|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
46761|Protease inhibitors|J5C2
46759|SYSTEMIC ANTIBACTERIALS|J1
46758|ANALGESICS|N2
46738|Erectile dysfunction products|G4B3
46737|ANALGESICS|N2
46721|RESPIRATORY SYSTEM|R
46701|ANALGESICS|N2
46687|DPP-IV inhibitor antidiabetics|A10B6
46686|DPP-IV inhibitor antidiabetics|A10B6
46685|ANTIHYPERTENSIVES|C2
46681|ANTIFIBRINOLYTICS|B2A
46658|SYSTEMIC ANTIBACTERIALS|J1
46658|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
46657|ANTIVIRALS FOR SYSTEMIC USE|J5
46644|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
46642|SYSTEMIC ANTIBACTERIALS|J1
46639|SYSTEMIC ANTIBACTERIALS|J1
46638|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
46638|ANDROGENS, EXCLUDING G3E, G3F|G3B
46638|BPH (benign prostatic hypertrophy) products |G4C
46637|TRANQUILLISERS|N5C
46623|ANALGESICS|N2
46619|DRUGS USED IN DIABETES|A10
46613|RESPIRATORY SYSTEM|R
46612|VACCINES|J7
46611|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
46610|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
46609|DRUGS USED IN DIABETES|A10
46597|ANTIHYPERTENSIVES|C2
46597|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
46584|PLATELET AGGREGATION INHIBITORS|B1C
46583|SYSTEMIC ANTIBACTERIALS|J1
46580|SYSTEMIC ANTIBACTERIALS|J1
46562|DPP-IV inhibitor antidiabetics|A10B6
46561|ANTIPSYCHOTICS|N5A
46561|NOOTROPICS|N6D
46558|NOOTROPICS|N6D
46537|Combinations of sulphonylureas and biguanide antidiabetics|A10B3
46477|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
46439|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
46438|ANTI-EPILEPTICS|N3A
46437|ANTI-EPILEPTICS|N3A
46424|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
46423|Urinary incontinence products|G4B4
46422|ANTIEMETICS AND ANTINAUSEANTS|A4
46421|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
46420|TRANQUILLISERS|N5C
46419|ANALGESICS|N2
46418|ANDROGENS, EXCLUDING G3E, G3F|G3B
46398|ANTIVIRALS FOR SYSTEMIC USE|J5
46398|VACCINES|J7
46378|IMMUNOSUPPRESSIVE AGENTS|L4
46360|Coxibs|M1A3
46359|GASTROPROKINETICS|A3F
46358|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
46357|ANTIHYPERTENSIVES|C2
46337|ANTI-MIGRAINE PREPARATIONS|N2C
46324|ANALGESICS|N2
46321|ANTI-MIGRAINE PREPARATIONS|N2C
46321|HYPNOTICS/SEDATIVES|N5B
46320|ANTI-EPILEPTICS|N3
46319|PARASITOLOGY|P
46318|ANALGESICS|N2
46300|SYSTEMIC ANTIBACTERIALS|J1
46300|ANTIVIRALS FOR SYSTEMIC USE|J5
46300|IMMUNOSTIMULATING AGENTS|L3
46292|ANALGESICS|N2
46290|ANTIEMETICS AND ANTINAUSEANTS|A4
46289|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
46287|ANTI-ACNE PREPARATIONS|D10
46287|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
46287|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
46286|ANTIEMETICS AND ANTINAUSEANTS|A4
46285|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
46285|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
46284|IMMUNOSUPPRESSIVE AGENTS|L4
46282|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
46280|ANTIHYPERTENSIVES|C2
46280|ANTI-MIGRAINE PREPARATIONS|N2C
46257|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
46257|IMMUNOSUPPRESSIVE AGENTS|L4
46240|NOOTROPICS|N6D
46237|Coxibs|M1A3
46237|ANALGESICS|N2
46219|SYSTEMIC ANTIBACTERIALS|J1
46218|PLATELET AGGREGATION INHIBITORS|B1C
46200|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
46199|NOOTROPICS|N6D
46197|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
46197|Statins (HMG-CoA reductase inhibitors)|C10A1
46197|Coxibs|M1A3
46183|ANALGESICS|N2
46182|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
46180|DPP-IV inhibitor antidiabetics|A10B6
46179|RADIODIAGNOSTIC AGENTS|T1G
46177|RESPIRATORY SYSTEM|R
46144|NOOTROPICS|N6D
46143|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
46141|BETA-BLOCKING AGENTS|C7
46141|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
46140|BETA-BLOCKING AGENTS|C7
46140|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
46139|DRUGS USED IN DIABETES|A10
46119|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
46118|ANTIVIRALS FOR SYSTEMIC USE|J5
46078|ANTIHYPERTENSIVES|C2
46077|ANALGESICS|N2
46059|WOUND HEALING AGENTS|D3
46059|SYSTEMIC ANTIBACTERIALS|J1
46057|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
46037|ANAESTHETICS, LOCAL|N1B
46037|ANALGESICS|N2
46037|ANTI-MIGRAINE PREPARATIONS|N2C
46023|FIBRINOLYTICS|B1D
46022|ANTIHYPERTENSIVES|C2
46022|DIURETICS|C3
46019|DIRECT THROMBIN INHIBITORS|B1E
46003|ANALGESICS|N2
45998|ANTIVIRALS FOR SYSTEMIC USE|J5
45977|Erectile dysfunction products|G4B3
45977|ANTI-EPILEPTICS|N3A
45977|NOOTROPICS|N6D
45966|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
45966|Statins (HMG-CoA reductase inhibitors)|C10A1
45965|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
45965|Statins (HMG-CoA reductase inhibitors)|C10A1
45960|ALKYLATING AGENTS|L1A
45897|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
45877|IMMUNOSTIMULATING AGENTS|L3
45862|ANTIVIRALS FOR SYSTEMIC USE|J5
45858|Non-nucleoside reverse transcriptase inhibitors|J5C3
45857|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
45849|ANALGESICS|N2
45847|ANTI-ACNE PREPARATIONS|D10
45838|DERMATOLOGICALS|D
45838|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
45838|ANTI-ACNE PREPARATIONS|D10
45778|Protease inhibitors|J5C2
45769|ANDROGENS, EXCLUDING G3E, G3F|G3B
45769|ANALGESICS|N2
45765|ANALGESICS|N2
45764|Urinary incontinence products|G4B4
45763|ANALGESICS|N2
45757|Erectile dysfunction products|G4B3
45745|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45740|ANTIEMETICS AND ANTINAUSEANTS|A4
45739|Topical dermatological antifungals|D1A1
45739|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
45738|BPH (benign prostatic hypertrophy) products |G4C
45727|Antigonadotrophin-releasing hormones|H1C3
45724|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45722|SYSTEMIC ANTIBACTERIALS|J1
45706|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
45703|SYSTEMIC ANTIBACTERIALS|J1
45700|SYSTEMIC ANTIBACTERIALS|J1
45698|Interferons, beta|L3B2
45687|PLATELET AGGREGATION INHIBITORS|B1C
45684|ANTIVIRALS FOR SYSTEMIC USE|J5
45684|Interferons, alpha|L3B1
45682|OPHTHALMOLOGICALS|S1
45679|RESPIRATORY SYSTEM|R
45679|LUNG SURFACTANTS|R7C
45668|PLATELET AGGREGATION INHIBITORS|B1C
45668|ANALGESICS|N2
45665|ANTIPSYCHOTICS|N5A
45664|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45664|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
45661|ANTI-ARRHYTHMICS|C1B
45660|ANALGESICS|N2
45657|CARDIOVASCULAR SYSTEM|C
45649|Interferons, beta|L3B2
45646|ANTIVIRALS FOR SYSTEMIC USE|J5
45646|Interferons, alpha|L3B1
45643|SSRI antidepressants|N6A4
45640|ANTIVIRALS FOR SYSTEMIC USE|J5
45626|ANTIVIRALS FOR SYSTEMIC USE|J5
45618|ANTIVIRALS FOR SYSTEMIC USE|J5
45617|ANDROGENS, EXCLUDING G3E, G3F|G3B
45598|ANALGESICS|N2
45597|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45581|CARDIOVASCULAR SYSTEM|C
45581|ANTI-ARRHYTHMICS|C1B
45576|SYSTEMIC ANTIBACTERIALS|J1
45575|FIBRINOLYTICS|B1D
45574|ANTIPSYCHOTICS|N5A
45574|NOOTROPICS|N6D
45573|ANALGESICS|N2
45572|SRNI antidepressants|N6A5
45567|HYPNOTICS/SEDATIVES|N5B
45566|ANTIPSYCHOTICS|N5A
45565|ANALGESICS|N2
45564|ANALGESICS|N2
45563|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
45562|IMMUNOSTIMULATING AGENTS|L3
45558|ANTIVIRALS FOR SYSTEMIC USE|J5
45558|Protease inhibitors|J5C2
45557|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
45545|HUMAN INSULINS AND ANALOGUES|A10C
45545|Human insulins and analogues, intermediate-acting|A10C2
45541|IMMUNOSUPPRESSIVE AGENTS|L4
45539|HUMAN INSULINS AND ANALOGUES|A10C
45539|Human insulins and analogues, intermediate-acting|A10C2
45537|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45537|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
45532|HUMAN INSULINS AND ANALOGUES|A10C
45532|Human insulins and analogues, intermediate-acting|A10C2
45522|DRUGS USED IN DIABETES|A10
45518|NOOTROPICS|N6D
45499|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
45499|IMMUNOSUPPRESSIVE AGENTS|L4
45499|RESPIRATORY SYSTEM|R
45498|HYPNOTICS/SEDATIVES|N5B
45479|ANTIVIRALS FOR SYSTEMIC USE|J5
45462|ANAESTHETICS|N1
45462|TRANQUILLISERS|N5C
45441|NOOTROPICS|N6D
45439|DERMATOLOGICALS|D
45422|DRUGS USED IN DIABETES|A10
45421|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
45420|DPP-IV inhibitor antidiabetics|A10B6
45419|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
45418|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45401|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
45398|ANTIVIRALS FOR SYSTEMIC USE|J5
45397|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45380|DRUGS USED IN DIABETES|A10
45379|Factor VIII|B2D1
45378|ANTIVIRALS FOR SYSTEMIC USE|J5
45359|SYSTEMIC ANTIBACTERIALS|J1
45358|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45358|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
45357|DERMATOLOGICALS|D
45346|CENTRAL NERVOUS SYSTEM|N
45345|ANAESTHETICS, LOCAL|N1B
45345|ANALGESICS|N2
45340|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
45338|HUMAN INSULINS AND ANALOGUES|A10C
45338|Human insulins and analogues, intermediate-acting|A10C2
45337|WOUND HEALING AGENTS|D3
45317|DRUGS USED IN DIABETES|A10
45317|Human insulins and analogues, fast-acting|A10C1
45299|ANTIVIRALS FOR SYSTEMIC USE|J5
45298|SSRI antidepressants|N6A4
45297|ANTIVIRALS FOR SYSTEMIC USE|J5
45278|ANALGESICS|N2
45257|DRUGS USED IN DIABETES|A10
45257|ANTIHYPERTENSIVES|C2
45257|ACE INHIBITORS, PLAIN|C9A
45247|ANALGESICS|N2
45242|Erectile dysfunction products|G4B3
45240|LAXATIVES|A6
45239|NOOTROPICS|N6D
45238|NOOTROPICS|N6D
45237|ANALGESICS|N2
45217|ANALGESICS|N2
45202|ANTI-EPILEPTICS|N3A
45201|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
45179|CENTRAL NERVOUS SYSTEM|N
45179|ANALGESICS|N2
45160|SYSTEMIC ANTIBACTERIALS|J1
45157|ANTI-GOUT PREPARATIONS|M4
45138|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
45138|ULTRASOUND AGENTS|T1F
45117|ANTIVIRALS FOR SYSTEMIC USE|J5
45078|IMMUNOSUPPRESSIVE AGENTS|L4
45077|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
45058|ANTIVIRALS FOR SYSTEMIC USE|J5
45037|ANTIVIRALS FOR SYSTEMIC USE|J5
45022|ANTIVIRALS FOR SYSTEMIC USE|J5
45018|ANTIHYPERTENSIVES|C2
45018|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
45000|ANTIVIRALS FOR SYSTEMIC USE|J5
44999|Antigonadotrophin-releasing hormones|H1C3
44997|Coxibs|M1A3
44979|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
44978|NOOTROPICS|N6D
44977|WOUND HEALING AGENTS|D3
44939|SYSTEMIC ANTIBACTERIALS|J1
44937|AMINOGLYCOSIDES|J1K
44921|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
44918|Urinary incontinence products|G4B4
44897|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
44860|ANALGESICS|N2
44858|ANALGESICS|N2
44818|ANTIEMETICS AND ANTINAUSEANTS|A4
44818|APPETITE STIMULANTS|A15
44818|ANTI-MIGRAINE PREPARATIONS|N2C
44817|HEPARINS |B1B
44799|ANTIVIRALS FOR SYSTEMIC USE|J5
44798|IMMUNOSUPPRESSIVE AGENTS|L4
44785|AMINOGLYCOSIDES|J1K
44780|AMINOGLYCOSIDES|J1K
44779|ANTIVIRALS FOR SYSTEMIC USE|J5
44777|CALCIUM ANTAGONISTS|C8
44777|ANALGESICS|N2
44760|NOOTROPICS|N6D
44759|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
44759|ANTI-ACNE PREPARATIONS|D10
44759|SYSTEMIC ANTIBACTERIALS|J1
44758|THYROID THERAPY|H3
44739|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
44738|SYSTEMIC ANTIBACTERIALS|J1
44738|IMMUNOSTIMULATING AGENTS|L3
44737|IMMUNOSUPPRESSIVE AGENTS|L4
44737|RESPIRATORY SYSTEM|R
44722|ANALGESICS|N2
44719|PARASITOLOGY|P
44719|ANTI-MALARIALS|P1D
44700|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
44700|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
44699|ANALGESICS|N2
44697|ANTI-EPILEPTICS|N3
44677|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
44677|SSRI antidepressants|N6A4
44677|SRNI antidepressants|N6A5
44661|ANTIVIRALS FOR SYSTEMIC USE|J5
44639|ANALGESICS|N2
44638|HYPNOTICS/SEDATIVES|N5B
44637|HYPNOTICS/SEDATIVES|N5B
44617|NOOTROPICS|N6D
44606|ANTIVIRALS FOR SYSTEMIC USE|J5
44605|ANTIVIRALS FOR SYSTEMIC USE|J5
44605|Non-nucleoside reverse transcriptase inhibitors|J5C3
44604|DIRECT THROMBIN INHIBITORS|B1E
44602|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
44601|ANTIHYPERTENSIVES|C2
44601|ACE INHIBITORS, PLAIN|C9A
44600|ANTIHYPERTENSIVES|C2
44598|ANTIHYPERTENSIVES|C2
44598|DIURETICS|C3
44578|ANTI-EPILEPTICS|N3
44577|ANTI-EPILEPTICS|N3
44562|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
44561|SYSTEMIC ANTIBACTERIALS|J1
44541|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
44541|ANALGESICS|N2
44521|IMMUNOSTIMULATING AGENTS|L3
44518|SYSTEMIC ANTIBACTERIALS|J1
44517|HYPNOTICS/SEDATIVES|N5B
44517|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
44502|SYSTEMIC ANTIBACTERIALS|J1
44501|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
44499|DPP-IV inhibitor antidiabetics|A10B6
44498|SYSTEMIC ANTIBACTERIALS|J1
44497|IMMUNOSTIMULATING AGENTS|L3
44482|ANALGESICS|N2
44480|CARDIOVASCULAR SYSTEM|C
44480|MRI AGENTS|T1E
44461|TRANQUILLISERS|N5C
44461|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
44440|NOOTROPICS|N6D
44438|SYSTEMIC ANTIBACTERIALS|J1
44437|ANTIHYPERTENSIVES|C2
44437|CALCIUM ANTAGONISTS|C8
44418|ANTIPSYCHOTICS|N5A
44418|TRANQUILLISERS|N5C
44418|NOOTROPICS|N6D
44417|DPP-IV inhibitor antidiabetics|A10B6
44416|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
44415|B2-STIMULANTS|R3A
44413|ANTIHYPERTENSIVES|C2
44413|CALCIUM ANTAGONISTS|C8
44413|ACE INHIBITORS, PLAIN|C9A
44412|Ocular anti-allergics, antihistamines|S1G1
44411|ANTI-MIGRAINE PREPARATIONS|N2C
44410|ANTI-ARRHYTHMICS|C1B
44406|SYSTEMIC ANTIBACTERIALS|J1
44406|Carbapenems|J1P2
44405|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
44404|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
44403|ANAESTHETICS, LOCAL|N1B
44402|B2-STIMULANTS|R3A
44401|SYSTEMIC ANTIBACTERIALS|J1
44400|SYSTEMIC ANTIBACTERIALS|J1
44398|ANTIULCERANTS|A2B
44397|ANALGESICS|N2
44389|THYROID THERAPY|H3
44388|ANTI-EPILEPTICS|N3A
44387|ANTIULCERANTS|A2B
44385|MACROLIDES AND SIMILAR TYPES|J1F
44384|SYSTEMIC ANTIBACTERIALS|J1
44384|CEPHALOSPORINS|J1D
44383|ALKYLATING AGENTS|L1A
44382|PLATELET AGGREGATION INHIBITORS|B1C
44380|ANTIVIRALS FOR SYSTEMIC USE|J5
44380|IMMUNOSTIMULATING AGENTS|L3
44379|ANDROGENS, EXCLUDING G3E, G3F|G3B
44376|ANTI-EPILEPTICS|N3
44374|ANTI-ARRHYTHMICS|C1B
44373|ANTIVIRALS FOR SYSTEMIC USE|J5
44372|ANTIHYPERTENSIVES|C2
44371|ANTIPSYCHOTICS|N5A
44370|SYSTEMIC ANTIBACTERIALS|J1
44370|MACROLIDES AND SIMILAR TYPES|J1F
44369|CEPHALOSPORINS|J1D
44368|SYSTEMIC ANTIBACTERIALS|J1
44368|CEPHALOSPORINS|J1D
44367|SYSTEMIC ANTIBACTERIALS|J1
44367|CEPHALOSPORINS|J1D
44366|ANTIHYPERTENSIVES|C2
44366|ACE INHIBITORS, PLAIN|C9A
44364|TRANQUILLISERS|N5C
44363|SYSTEMIC ANTIBACTERIALS|J1
44363|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
44362|TRANQUILLISERS|N5C
44361|ANTIVIRALS FOR SYSTEMIC USE|J5
44361|IMMUNOSTIMULATING AGENTS|L3
44359|IMMUNOSTIMULATING AGENTS|L3
44357|FIBRINOLYTICS|B1D
44357|ANTI-ARRHYTHMICS|C1B
44318|Vitamin A|A11C1
44318|ANTI-ACNE PREPARATIONS|D10
44317|CEPHALOSPORINS|J1D
44316|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
44315|BETA-BLOCKING AGENTS|C7
44313|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
44313|Statins (HMG-CoA reductase inhibitors)|C10A1
44311|ANTIVIRALS FOR SYSTEMIC USE|J5
44310|B2-STIMULANTS|R3A
44308|HYPNOTICS/SEDATIVES|N5B
44305|ANTIULCERANTS|A2B
44305|SYSTEMIC ANTIBACTERIALS|J1
44304|ANTIULCERANTS|A2B
44303|ANAESTHETICS, GENERAL|N1A
44303|TRANQUILLISERS|N5C
44302|ANTIHYPERTENSIVES|C2
44302|BETA-BLOCKING AGENTS|C7
44302|ANALGESICS|N2
44301|Coxibs|M1A3
44301|ANALGESICS|N2
44300|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
44300|Statins (HMG-CoA reductase inhibitors)|C10A1
44299|Systemic dermatological antifungals|D1A2
44299|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
44295|CARDIOVASCULAR SYSTEM|C
44292|Systemic dermatological antifungals|D1A2
44292|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
44291|SYSTEMIC ANTIBACTERIALS|J1
44290|ANTIHYPERTENSIVES|C2
44289|ANTIHYPERTENSIVES|C2
44289|ACE INHIBITORS, PLAIN|C9A
44288|ANTIHYPERTENSIVES|C2
44287|ANTI-EPILEPTICS|N3
44286|CALCITONINS|H4A
44283|Factor VIII|B2D1
44281|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
44280|ANTIHYPERTENSIVES|C2
44278|Ocular antineovascularisation products|S1P
44264|ANALGESICS|N2
44264|ANTI-EPILEPTICS|N3
44264|ANTI-EPILEPTICS|N3A
44259|TRANQUILLISERS|N5C
44258|ANTIVIRALS FOR SYSTEMIC USE|J5
44239|IMMUNOSUPPRESSIVE AGENTS|L4
44237|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
44222|IMMUNOSUPPRESSIVE AGENTS|L4
44220|SYSTEMIC ANTIBACTERIALS|J1
44218|TRANQUILLISERS|N5C
44200|DRUGS USED IN DIABETES|A10
44178|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
44178|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
44122|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
44121|SYSTEMIC ANTIBACTERIALS|J1
44119|SYSTEMIC ANTIBACTERIALS|J1
44118|SYSTEMIC ANTIBACTERIALS|J1
44117|SYSTEMIC ANTIBACTERIALS|J1
44078|CENTRAL NERVOUS SYSTEM|N
44017|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
44017|SRNI antidepressants|N6A5
43997|PSYCHOSTIMULANTS|N6B
43981|NOOTROPICS|N6D
43980|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
43960|ANALGESICS|N2
43958|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
43958|IMMUNOSUPPRESSIVE AGENTS|L4
43957|SYSTEMIC ANTIBACTERIALS|J1
43897|HYPNOTICS/SEDATIVES|N5B
43879|DPP-IV inhibitor antidiabetics|A10B6
43841|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
43824|ANTIPSYCHOTICS|N5A
43824|TRANQUILLISERS|N5C
43824|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
43824|NOOTROPICS|N6D
43823|BPH (benign prostatic hypertrophy) products |G4C
43820|ANALGESICS|N2
43820|TRANQUILLISERS|N5C
43820|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
43819|DIRECT THROMBIN INHIBITORS|B1E
43799|ANTIVIRALS FOR SYSTEMIC USE|J5
43799|Protease inhibitors|J5C2
43757|ANTIVIRALS FOR SYSTEMIC USE|J5
43741|B2-STIMULANTS|R3A
43740|ANTIEMETICS AND ANTINAUSEANTS|A4
43740|HYPNOTICS/SEDATIVES|N5B
43740|TRANQUILLISERS|N5C
43740|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
43739|ANALGESICS|N2
43720|ANALGESICS|N2
43720|ANTI-MIGRAINE PREPARATIONS|N2C
43718|B2-STIMULANTS|R3A
43698|SYSTEMIC ANTIBACTERIALS|J1
43698|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
43697|ALKYLATING AGENTS|L1A
43678|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
43659|PLATELET AGGREGATION INHIBITORS|B1C
43659|DIRECT THROMBIN INHIBITORS|B1E
43638|ANTI-EPILEPTICS|N3A
43598|IMMUNOSTIMULATING AGENTS|L3
43577|ANTIVIRALS FOR SYSTEMIC USE|J5
43540|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
43539|ANTIVIRALS FOR SYSTEMIC USE|J5
43538|IMMUNOSUPPRESSIVE AGENTS|L4
43538|OPHTHALMOLOGICALS|S1
43438|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
43437|ANTI-EPILEPTICS|N3A
43418|ANALGESICS|N2
43417|BPH (benign prostatic hypertrophy) products |G4C
43417|Antigonadotrophin-releasing hormones|H1C3
43397|CARDIOVASCULAR SYSTEM|C
43378|ANALGESICS|N2
43377|NOOTROPICS|N6D
43298|ANAESTHETICS|N1
43298|ANALGESICS|N2
43259|ANALGESICS|N2
43257|TRANQUILLISERS|N5C
43240|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
43238|DRUGS USED IN DIABETES|A10
43221|ANTIPSYCHOTICS|N5A
43221|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
43218|RADIODIAGNOSTIC AGENTS|T1G
43199|CARDIOVASCULAR SYSTEM|C
43198|ANTIULCERANTS|A2B
43198|SYSTEMIC ANTIBACTERIALS|J1
43137|CENTRAL NERVOUS SYSTEM|N
43137|ANTI-EPILEPTICS|N3A
43078|ANTIPSYCHOTICS|N5A
43078|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
43078|NOOTROPICS|N6D
43058|ANTIVIRALS FOR SYSTEMIC USE|J5
43058|ANALGESICS|N2
43039|DIRECT THROMBIN INHIBITORS|B1E
43039|CARDIOVASCULAR SYSTEM|C
43038|ANTIHYPERTENSIVES|C2
43037|ANALGESICS|N2
43028|ANALGESICS|N2
43028|ANTI-MIGRAINE PREPARATIONS|N2C
43026|PLATELET AGGREGATION INHIBITORS|B1C
43023|ANALGESICS|N2
43022|ANALGESICS|N2
43021|ANALGESICS|N2
43021|SRNI antidepressants|N6A5
43020|ANALGESICS|N2
43018|ANALGESICS|N2
43001|ANALGESICS|N2
42998|ANALGESICS|N2
42997|NOOTROPICS|N6D
42958|ANTIVIRALS FOR SYSTEMIC USE|J5
42957|PARASITOLOGY|P
42901|TRANQUILLISERS|N5C
42901|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
42900|Factor VIII|B2D1
42899|NOOTROPICS|N6D
42898|NOOTROPICS|N6D
42897|NOOTROPICS|N6D
42877|ANTIVIRALS FOR SYSTEMIC USE|J5
42862|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
42862|DRUGS USED IN DIABETES|A10
42859|ANTI-EPILEPTICS|N3A
42858|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
42798|ANTIVIRALS FOR SYSTEMIC USE|J5
42797|ANTI-EPILEPTICS|N3
42797|NOOTROPICS|N6D
42760|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
42740|CARDIOVASCULAR SYSTEM|C
42724|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
42724|IMMUNOSUPPRESSIVE AGENTS|L4
42721|MRI AGENTS|T1E
42719|CARDIOVASCULAR SYSTEM|C
42719|NOOTROPICS|N6D
42677|ANALGESICS|N2
42665|ANTI-EPILEPTICS|N3
42665|ANTIPSYCHOTICS|N5A
42665|TRANQUILLISERS|N5C
42663|ANALGESICS|N2
42661|ANTIHYPERTENSIVES|C2
42660|IMMUNOSUPPRESSIVE AGENTS|L4
42657|ANTIVIRALS FOR SYSTEMIC USE|J5
42657|Interferons, alpha|L3B1
42649|CARDIOVASCULAR SYSTEM|C
42637|HYPNOTICS/SEDATIVES|N5B
42637|TRANQUILLISERS|N5C
42620|PARASITOLOGY|P
42619|DIRECT THROMBIN INHIBITORS|B1E
42563|ANTI-EPILEPTICS|N3A
42561|WOUND HEALING AGENTS|D3
42505|ANTIVIRALS FOR SYSTEMIC USE|J5
42503|NOOTROPICS|N6D
42500|CARDIOVASCULAR SYSTEM|C
42499|ANTIVIRALS FOR SYSTEMIC USE|J5
42498|NOOTROPICS|N6D
42479|SYSTEMIC ANTIBACTERIALS|J1
42421|FIBRINOLYTICS|B1D
42419|ANTI-EPILEPTICS|N3A
42418|OPHTHALMOLOGICALS|S1
42418|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
42417|DPP-IV inhibitor antidiabetics|A10B6
42398|SYSTEMIC ANTIBACTERIALS|J1
42384|ANTIPSYCHOTICS|N5A
42378|CARDIOVASCULAR SYSTEM|C
42360|ANALGESICS|N2
42337|ANTIVIRALS FOR SYSTEMIC USE|J5
42337|IMMUNOSTIMULATING AGENTS|L3
42301|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
42300|NOOTROPICS|N6D
42298|ANTI-EPILEPTICS|N3A
42298|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
42297|CENTRAL NERVOUS SYSTEM|N
42279|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
42261|ANALGESICS|N2
42259|RESPIRATORY SYSTEM|R
42258|ANTI-MIGRAINE PREPARATIONS|N2C
42244|Non-nucleoside reverse transcriptase inhibitors|J5C3
42243|SYSTEMIC ANTIBACTERIALS|J1
42241|SYSTEMIC ANTIBACTERIALS|J1
42224|NOOTROPICS|N6D
42223|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
42222|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
42221|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
42203|DRUGS USED IN DIABETES|A10
42203|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
42202|ANALGESICS|N2
42202|ANTI-MIGRAINE PREPARATIONS|N2C
42199|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
42181|AMINOGLYCOSIDES|J1K
42179|PLATELET AGGREGATION INHIBITORS|B1C
42179|CENTRAL NERVOUS SYSTEM|N
42152|ANALGESICS|N2
42148|ANALGESICS|N2
42147|SYSTEMIC ANTIBACTERIALS|J1
42147|MACROLIDES AND SIMILAR TYPES|J1F
42146|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
42146|CENTRAL NERVOUS SYSTEM|N
42145|ANTIVIRALS FOR SYSTEMIC USE|J5
42144|ANALGESICS|N2
42142|TRANQUILLISERS|N5C
42142|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
42139|SYSTEMIC ANTIBACTERIALS|J1
42124|ANALGESICS|N2
42122|CARDIOVASCULAR SYSTEM|C
42121|ANALGESICS|N2
42120|ANTIVIRALS FOR SYSTEMIC USE|J5
42107|CEPHALOSPORINS|J1D
42103|SYSTEMIC ANTIHISTAMINES|R6
42102|ANTI-ARRHYTHMICS|C1B
42069|ANTIVIRALS FOR SYSTEMIC USE|J5
42064|NOOTROPICS|N6D
42064|RESPIRATORY SYSTEM|R
42061|ANTIEMETICS AND ANTINAUSEANTS|A4
42059|Urinary incontinence products|G4B4
42040|ANTIVIRALS FOR SYSTEMIC USE|J5
42039|ANTI-EPILEPTICS|N3A
42038|ANTIEMETICS AND ANTINAUSEANTS|A4
42038|APPETITE STIMULANTS|A15
42038|ANALGESICS|N2
42037|SYSTEMIC ANTIBACTERIALS|J1
42037|VACCINES|J7
42017|DIRECT THROMBIN INHIBITORS|B1E
42005|HYPNOTICS/SEDATIVES|N5B
42004|ANTIVIRALS FOR SYSTEMIC USE|J5
42004|Interferons, alpha|L3B1
41982|ANALGESICS|N2
41981|SYSTEMIC ANTIBACTERIALS|J1
41962|ANTIVIRALS FOR SYSTEMIC USE|J5
41960|SYSTEMIC ANTIBACTERIALS|J1
41958|SYSTEMIC ANTIBACTERIALS|J1
41957|SYSTEMIC ANTIBACTERIALS|J1
41947|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
41947|IMMUNOSUPPRESSIVE AGENTS|L4
41944|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
41943|SYSTEMIC ANTIBACTERIALS|J1
41941|SYSTEMIC ANTIBACTERIALS|J1
41940|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
41938|ANTIPSYCHOTICS|N5A
41920|ANTIPSYCHOTICS|N5A
41919|ANALGESICS|N2
41919|TRANQUILLISERS|N5C
41918|TRANQUILLISERS|N5C
41903|Urinary incontinence products|G4B4
41902|ANTIVIRALS FOR SYSTEMIC USE|J5
41899|CENTRAL NERVOUS SYSTEM|N
41899|RESPIRATORY SYSTEM|R
41881|ANTIVIRALS FOR SYSTEMIC USE|J5
41878|PLATELET AGGREGATION INHIBITORS|B1C
41878|CARDIOVASCULAR SYSTEM|C
41865|Systemic dermatological antifungals|D1A2
41865|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
41865|PARASITOLOGY|P
41862|SYSTEMIC ANTIBACTERIALS|J1
41861|SYSTEMIC ANTIBACTERIALS|J1
41859|SYSTEMIC ANTIBACTERIALS|J1
41858|SYSTEMIC ANTIBACTERIALS|J1
41857|SYSTEMIC ANTIBACTERIALS|J1
41838|RESPIRATORY SYSTEM|R
41837|Urinary incontinence products|G4B4
41822|ANTIHYPERTENSIVES|C2
41822|ACE INHIBITORS, PLAIN|C9A
41819|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
41819|SYSTEMIC ANTIBACTERIALS|J1
41819|ANTIVIRALS FOR SYSTEMIC USE|J5
41817|CENTRAL NERVOUS SYSTEM|N
41817|ANTI-MIGRAINE PREPARATIONS|N2C
41817|TRANQUILLISERS|N5C
41800|ANTIVIRALS FOR SYSTEMIC USE|J5
41799|ANTIVIRALS FOR SYSTEMIC USE|J5
41799|ANTI-EPILEPTICS|N3A
41781|ANTIVIRALS FOR SYSTEMIC USE|J5
41780|ANTIMETABOLITES|L1B
41778|CARDIOVASCULAR SYSTEM|C
41778|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
41758|PARASITOLOGY|P
41757|PARASITOLOGY|P
41737|ANTIHYPERTENSIVES|C2
41737|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
41705|ANALGESICS|N2
41705|ANTI-MIGRAINE PREPARATIONS|N2C
41705|ANTI-EPILEPTICS|N3
41705|ANTI-EPILEPTICS|N3A
41680|HUMAN INSULINS AND ANALOGUES|A10C
41680|Human insulins and analogues, intermediate-acting|A10C2
41679|DIRECT THROMBIN INHIBITORS|B1E
41677|SYSTEMIC ANTIBACTERIALS|J1
41657|ANTIVIRALS FOR SYSTEMIC USE|J5
41597|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
41582|ANTIVIRALS FOR SYSTEMIC USE|J5
41581|RESPIRATORY SYSTEM|R
41579|ANTI-ARRHYTHMICS|C1B
41541|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
41541|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
41540|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
41525|Erectile dysfunction products|G4B3
41524|ANTIPSYCHOTICS|N5A
41524|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
41519|ANALGESICS|N2
41518|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
41517|ANTIPSYCHOTICS|N5A
41501|ANALGESICS|N2
41500|Coxibs|M1A3
41500|ANALGESICS|N2
41499|ANALGESICS|N2
41481|ANTIVIRALS FOR SYSTEMIC USE|J5
41481|Interferons, alpha|L3B1
41480|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
41478|RESPIRATORY SYSTEM|R
41437|SYSTEMIC ANTIBACTERIALS|J1
41402|ANTI-EPILEPTICS|N3
41401|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
41401|TRANQUILLISERS|N5C
41401|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
41377|ANALGESICS|N2
41344|ANTIVIRALS FOR SYSTEMIC USE|J5
41342|PARASITOLOGY|P
41342|ANTI-MALARIALS|P1D
41341|GASTROPROKINETICS|A3F
41341|APPETITE STIMULANTS|A15
41340|Protease inhibitors|J5C2
41339|ANTIVIRALS FOR SYSTEMIC USE|J5
41338|SYSTEMIC ANTIBACTERIALS|J1
41338|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
41337|CALCITONINS|H4A
41331|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
41330|PARASITOLOGY|P
41328|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
41327|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
41327|SSRI antidepressants|N6A4
41325|ANTIPSYCHOTICS|N5A
41325|NOOTROPICS|N6D
41324|NOOTROPICS|N6D
41298|ALKYLATING AGENTS|L1A
41297|CENTRAL NERVOUS SYSTEM|N
41277|Erectile dysfunction products|G4B3
41241|ANALGESICS|N2
41240|IMMUNOSUPPRESSIVE AGENTS|L4
41221|GASTROPROKINETICS|A3F
41221|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
41217|ANTIVIRALS FOR SYSTEMIC USE|J5
41200|SYSTEMIC ANTIBACTERIALS|J1
41183|Antigonadotrophin-releasing hormones|H1C3
41181|ANTIVIRALS FOR SYSTEMIC USE|J5
41180|SYSTEMIC ANTIBACTERIALS|J1
41178|ANTIVIRALS FOR SYSTEMIC USE|J5
41162|IMMUNOSUPPRESSIVE AGENTS|L4
41161|HYPNOTICS/SEDATIVES|N5B
41161|TRANQUILLISERS|N5C
41160|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
41159|SYSTEMIC ANTIBACTERIALS|J1
41137|ANTI-EPILEPTICS|N3
41118|ANTIVIRALS FOR SYSTEMIC USE|J5
41118|VACCINES|J7
41117|ANTIVIRALS FOR SYSTEMIC USE|J5
41117|VACCINES|J7
41116|ANTIVIRALS FOR SYSTEMIC USE|J5
41115|NOOTROPICS|N6D
41113|FIBRINOLYTICS|B1D
41112|FIBRINOLYTICS|B1D
41091|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
41089|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
41079|VACCINES|J7
41078|ANTIVIRALS FOR SYSTEMIC USE|J5
41074|ANTIVIRALS FOR SYSTEMIC USE|J5
41073|Erectile dysfunction products|G4B3
41071|CARDIOVASCULAR SYSTEM|C
41071|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
41052|RESPIRATORY SYSTEM|R
41051|GROWTH HORMONES|H4C
41033|IMMUNOSUPPRESSIVE AGENTS|L4
41032|ANTIVIRALS FOR SYSTEMIC USE|J5
41031|ANALGESICS|N2
41031|ANTI-MIGRAINE PREPARATIONS|N2C
41031|ANTI-EPILEPTICS|N3
41029|ANTIHYPERTENSIVES|C2
41012|ANALGESICS|N2
41011|ANAESTHETICS, LOCAL|N1B
41011|ANALGESICS|N2
41009|ANTIVIRALS FOR SYSTEMIC USE|J5
40995|ANALGESICS|N2
40991|CALCIUM ANTAGONISTS|C8
40989|SYSTEMIC ANTIBACTERIALS|J1
40972|ANTIVIRALS FOR SYSTEMIC USE|J5
40931|CEPHALOSPORINS|J1D
40909|DIAGNOSTIC AGENTS|T
40892|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40889|IMMUNOSTIMULATING AGENTS|L3
40870|ANTIVIRALS FOR SYSTEMIC USE|J5
40860|ANALGESICS|N2
40860|ANTIPSYCHOTICS|N5A
40860|NOOTROPICS|N6D
40859|ANTIPSYCHOTICS|N5A
40859|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
40858|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40858|NOOTROPICS|N6D
40857|ANAESTHETICS|N1
40857|ANTI-EPILEPTICS|N3
40857|HYPNOTICS/SEDATIVES|N5B
40857|TRANQUILLISERS|N5C
40855|ANALGESICS|N2
40855|ANTIPSYCHOTICS|N5A
40854|TRANQUILLISERS|N5C
40854|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
40851|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40851|ANTI-EPILEPTICS|N3A
40851|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
40851|SSRI antidepressants|N6A4
40851|SRNI antidepressants|N6A5
40850|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40850|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
40850|SSRI antidepressants|N6A4
40850|SRNI antidepressants|N6A5
40849|TRANQUILLISERS|N5C
40816|DRUGS USED IN DIABETES|A10
40813|DRUGS USED IN DIABETES|A10
40809|NOOTROPICS|N6D
40792|ANTIVIRALS FOR SYSTEMIC USE|J5
40790|SYSTEMIC ANTIBACTERIALS|J1
40790|IMMUNOSTIMULATING AGENTS|L3
40770|ANTIVIRALS FOR SYSTEMIC USE|J5
40753|ANTIVIRALS FOR SYSTEMIC USE|J5
40739|ANTIVIRALS FOR SYSTEMIC USE|J5
40739|Non-nucleoside reverse transcriptase inhibitors|J5C3
40736|PLATELET AGGREGATION INHIBITORS|B1C
40733|DIRECT THROMBIN INHIBITORS|B1E
40731|SYSTEMIC ANTIBACTERIALS|J1
40717|ANTIVIRALS FOR SYSTEMIC USE|J5
40716|PLATELET AGGREGATION INHIBITORS|B1C
40712|IMMUNOSUPPRESSIVE AGENTS|L4
40711|ANTIVIRALS FOR SYSTEMIC USE|J5
40709|IMMUNOSTIMULATING AGENTS|L3
40700|NOOTROPICS|N6D
40700|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
40695|ANTIVIRALS FOR SYSTEMIC USE|J5
40695|ANTIMETABOLITES|L1B
40689|ANTIVIRALS FOR SYSTEMIC USE|J5
40669|GASTROPROKINETICS|A3F
40669|LAXATIVES|A6
40652|WOUND HEALING AGENTS|D3
40649|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
40637|SYSTEMIC ANTIBACTERIALS|J1
40634|DRUGS USED IN DIABETES|A10
40633|WOUND HEALING AGENTS|D3
40632|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
40616|FIBRINOLYTICS|B1D
40616|CARDIOVASCULAR SYSTEM|C
40612|PLATELET AGGREGATION INHIBITORS|B1C
40612|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
40611|FIBRINOLYTICS|B1D
40610|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
40609|TRANQUILLISERS|N5C
40591|FIBRINOLYTICS|B1D
40587|ANTIHYPERTENSIVES|C2
40586|NOOTROPICS|N6D
40585|DRUGS USED IN DIABETES|A10
40584|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
40582|ANAESTHETICS, LOCAL|N1B
40582|ANALGESICS|N2
40581|ANTIVIRALS FOR SYSTEMIC USE|J5
40580|ANTIVIRALS FOR SYSTEMIC USE|J5
40580|VACCINES|J7
40579|Erectile dysfunction products|G4B3
40578|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40577|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
40575|SYSTEMIC ANTIBACTERIALS|J1
40575|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
40575|ANTIVIRALS FOR SYSTEMIC USE|J5
40574|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
40573|ANTI-EPILEPTICS|N3A
40572|NOOTROPICS|N6D
40571|NOOTROPICS|N6D
40570|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
40569|Factors II, VII, IX and X|B2D2
40560|HEPARINS |B1B
40556|IMMUNOSTIMULATING AGENTS|L3
40552|PLATELET AGGREGATION INHIBITORS|B1C
40551|ANALGESICS|N2
40549|ANALGESICS|N2
40533|ANTI-EPILEPTICS|N3
40533|TRANQUILLISERS|N5C
40532|ANTIVIRALS FOR SYSTEMIC USE|J5
40478|ANTIVIRALS FOR SYSTEMIC USE|J5
40477|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
40475|ALKYLATING AGENTS|L1A
40474|SYSTEMIC ANTIBACTERIALS|J1
40473|NOOTROPICS|N6D
40471|ANTIVIRALS FOR SYSTEMIC USE|J5
40453|ANALGESICS|N2
40451|DERMATOLOGICALS|D
40451|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
40425|CENTRAL NERVOUS SYSTEM|N
40425|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
40419|ANTIVIRALS FOR SYSTEMIC USE|J5
40418|ANTIVIRALS FOR SYSTEMIC USE|J5
40417|ANTIVIRALS FOR SYSTEMIC USE|J5
40411|RESPIRATORY SYSTEM|R
40392|DRUGS USED IN DIABETES|A10
40391|SYSTEMIC ANTIBACTERIALS|J1
40390|ANTIVIRALS FOR SYSTEMIC USE|J5
40390|IMMUNOSTIMULATING AGENTS|L3
40375|ANAESTHETICS|N1
40375|ANALGESICS|N2
40371|RADIODIAGNOSTIC AGENTS|T1G
40369|ALKYLATING AGENTS|L1A
40364|SYSTEMIC ANTIBACTERIALS|J1
40363|DRUGS USED IN DIABETES|A10
40363|HUMAN INSULINS AND ANALOGUES|A10C
40363|Human insulins and analogues, intermediate-acting|A10C2
40357|SYSTEMIC ANTIBACTERIALS|J1
40356|CARDIOVASCULAR SYSTEM|C
40353|ANTI-EPILEPTICS|N3A
40349|ANAESTHETICS|N1
40338|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
40336|FIBRINOLYTICS|B1D
40335|ANTIVIRALS FOR SYSTEMIC USE|J5
40334|ANTIVIRALS FOR SYSTEMIC USE|J5
40332|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
40328|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40327|VACCINES|J7
40326|ANTIHYPERTENSIVES|C2
40326|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
40325|IMMUNOSTIMULATING AGENTS|L3
40323|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
40321|SYSTEMIC ANTIBACTERIALS|J1
40319|SYSTEMIC ANTIBACTERIALS|J1
40318|ANTIVIRALS FOR SYSTEMIC USE|J5
40317|ANDROGENS, EXCLUDING G3E, G3F|G3B
40316|SYSTEMIC ANTIBACTERIALS|J1
40313|DIAGNOSTIC AGENTS|T
40312|DIAGNOSTIC AGENTS|T
40311|DIAGNOSTIC AGENTS|T
40310|BPH (benign prostatic hypertrophy) products |G4C
40310|DIAGNOSTIC AGENTS|T
40309|CARDIOVASCULAR SYSTEM|C
40308|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40308|DRUGS USED IN DIABETES|A10
40307|ANTIVIRALS FOR SYSTEMIC USE|J5
40305|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
40304|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40301|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40301|ANTIHYPERTENSIVES|C2
40301|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
40300|Protease inhibitors|J5C2
40295|ANTIFIBRINOLYTICS|B2A
40294|Urinary incontinence products|G4B4
40294|ANALGESICS|N2
40294|SSRI antidepressants|N6A4
40294|SRNI antidepressants|N6A5
40271|ANTIEMETICS AND ANTINAUSEANTS|A4
40268|PARASITOLOGY|P
40265|IMMUNOSTIMULATING AGENTS|L3
40264|IMMUNOSUPPRESSIVE AGENTS|L4
40262|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40262|DRUGS USED IN DIABETES|A10
40260|ANALGESICS|N2
40259|ANTIEMETICS AND ANTINAUSEANTS|A4
40258|CENTRAL NERVOUS SYSTEM|N
40257|Antigonadotrophin-releasing hormones|H1C3
40251|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40243|DRUGS USED IN DIABETES|A10
40242|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
40241|SYSTEMIC ANTIBACTERIALS|J1
40240|SYSTEMIC ANTIBACTERIALS|J1
40239|ANTIVIRALS FOR SYSTEMIC USE|J5
40235|ANTIVIRALS FOR SYSTEMIC USE|J5
40234|ANALGESICS|N2
40233|DRUGS USED IN DIABETES|A10
40232|WOUND HEALING AGENTS|D3
40231|ANTIVIRALS FOR SYSTEMIC USE|J5
40229|ANTIVIRALS FOR SYSTEMIC USE|J5
40209|CALCIUM ANTAGONISTS|C8
40209|ANTI-MIGRAINE PREPARATIONS|N2C
40198|IMMUNOSUPPRESSIVE AGENTS|L4
40197|ANALGESICS|N2
40196|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
40193|NOOTROPICS|N6D
40193|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
40192|CARDIAC THERAPY|C1
40192|ANTIHYPERTENSIVES|C2
40191|HYPNOTICS/SEDATIVES|N5B
40191|TRANQUILLISERS|N5C
40182|FIBRINOLYTICS|B1D
40182|DIRECT THROMBIN INHIBITORS|B1E
40179|ANTIVIRALS FOR SYSTEMIC USE|J5
40177|CARDIOVASCULAR SYSTEM|C
40177|ANTIHYPERTENSIVES|C2
40175|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
40169|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
40163|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40161|SYSTEMIC ANTIBACTERIALS|J1
40158|ANTIHYPERTENSIVES|C2
40158|ACE INHIBITORS, PLAIN|C9A
40152|ANAESTHETICS, LOCAL|N1B
40152|ANALGESICS|N2
40152|ANTI-MIGRAINE PREPARATIONS|N2C
40129|DIRECT THROMBIN INHIBITORS|B1E
40119|BPH (benign prostatic hypertrophy) products |G4C
40113|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40113|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
40109|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40109|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
40099|CARDIOVASCULAR SYSTEM|C
40098|HYPNOTICS/SEDATIVES|N5B
40096|ANALGESICS|N2
40095|ANALGESICS|N2
40094|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40093|NOOTROPICS|N6D
40092|ANTI-EPILEPTICS|N3A
40091|ANTIVIRALS FOR SYSTEMIC USE|J5
40090|SYSTEMIC ANTIBACTERIALS|J1
40089|CENTRAL NERVOUS SYSTEM|N
40089|ANTIPSYCHOTICS|N5A
40089|NOOTROPICS|N6D
40071|ANTIVIRALS FOR SYSTEMIC USE|J5
40069|NOOTROPICS|N6D
40059|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
40054|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40051|DPP-IV inhibitor antidiabetics|A10B6
40034|Urinary incontinence products|G4B4
40033|NOOTROPICS|N6D
40032|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40032|CARDIOVASCULAR SYSTEM|C
40031|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
40030|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
40029|ANTI-EPILEPTICS|N3A
40011|ANALGESICS|N2
40010|ANALGESICS|N2
40009|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
40009|Urinary incontinence products|G4B4
39990|ANAESTHETICS, LOCAL|N1B
39976|Erectile dysfunction products|G4B3
39976|ANTI-EPILEPTICS|N3A
39954|ANTIHYPERTENSIVES|C2
39953|ANALGESICS|N2
39952|ANTI-GOUT PREPARATIONS|M4
39911|ANTIVIRALS FOR SYSTEMIC USE|J5
39902|SYSTEMIC ANTIBACTERIALS|J1
39900|ANTIHYPERTENSIVES|C2
39899|ANTIHYPERTENSIVES|C2
39898|TRANQUILLISERS|N5C
39897|ANALGESICS|N2
39897|SSRI antidepressants|N6A4
39897|SRNI antidepressants|N6A5
39896|ANAESTHETICS, LOCAL|N1B
39896|ANALGESICS|N2
39895|ANALGESICS|N2
39894|TRANQUILLISERS|N5C
39894|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
39894|SSRI antidepressants|N6A4
39894|SRNI antidepressants|N6A5
39893|ANALGESICS|N2
39872|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
39870|ANTIVIRALS FOR SYSTEMIC USE|J5
39836|ALKYLATING AGENTS|L1A
39835|SYSTEMIC ANTIBACTERIALS|J1
39832|GASTROPROKINETICS|A3F
39831|WOUND HEALING AGENTS|D3
39830|DERMATOLOGICALS|D
39791|NOOTROPICS|N6D
39791|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
39774|ANTIVIRALS FOR SYSTEMIC USE|J5
39770|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
39769|TRANQUILLISERS|N5C
39769|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
39769|SSRI antidepressants|N6A4
39753|GASTROPROKINETICS|A3F
39751|LUNG SURFACTANTS|R7C
39731|NOOTROPICS|N6D
39711|HEPARINS |B1B
39692|ANALGESICS|N2
39689|ANTIULCERANTS|A2B
39689|ANTIHYPERTENSIVES|C2
39672|ANALGESICS|N2
39650|DRUGS USED IN DIABETES|A10
39649|Erectile dysfunction products|G4B3
39618|PARASITOLOGY|P
39617|FIBRINOLYTICS|B1D
39616|SYSTEMIC ANTIBACTERIALS|J1
39611|Erectile dysfunction products|G4B3
39610|ANTI-MALARIALS|P1D
39592|DRUGS USED IN DIABETES|A10
39592|ANTIHYPERTENSIVES|C2
39592|Erectile dysfunction products|G4B3
39592|RESPIRATORY SYSTEM|R
39571|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
39571|TRANQUILLISERS|N5C
39571|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
39530|CENTRAL NERVOUS SYSTEM|N
39529|SSRI antidepressants|N6A4
39519|RESPIRATORY SYSTEM|R
39518|DRUGS USED IN DIABETES|A10
39517|DRUGS USED IN DIABETES|A10
39517|HUMAN INSULINS AND ANALOGUES|A10C
39517|Human insulins and analogues, long-acting|A10C5
39516|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
39516|DRUGS USED IN DIABETES|A10
39512|CARDIOVASCULAR SYSTEM|C
39512|ANTIHYPERTENSIVES|C2
39509|SYSTEMIC ANTIBACTERIALS|J1
39493|ANALGESICS|N2
39491|ANTI-MIGRAINE PREPARATIONS|N2C
39490|ANTI-MIGRAINE PREPARATIONS|N2C
39471|ANTI-ARRHYTHMICS|C1B
39471|Urinary incontinence products|G4B4
39471|CENTRAL NERVOUS SYSTEM|N
39470|DIURETICS|C3
39432|ANTIPSYCHOTICS|N5A
39432|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
39432|NOOTROPICS|N6D
39432|RESPIRATORY SYSTEM|R
39430|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
39429|SSRI antidepressants|N6A4
39429|NOOTROPICS|N6D
39429|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
39413|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
39413|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
39409|Erectile dysfunction products|G4B3
39409|Urinary incontinence products|G4B4
39372|ANTIVIRALS FOR SYSTEMIC USE|J5
39372|IMMUNOSTIMULATING AGENTS|L3
39372|PARASITOLOGY|P
39371|ANTIHYPERTENSIVES|C2
39371|RESPIRATORY SYSTEM|R
39350|ANTI-EPILEPTICS|N3A
39350|ANTIPSYCHOTICS|N5A
39332|RADIODIAGNOSTIC AGENTS|T1G
39313|SYSTEMIC ANTIBACTERIALS|J1
39312|NOOTROPICS|N6D
39291|DPP-IV inhibitor antidiabetics|A10B6
39290|SYSTEMIC ANTIBACTERIALS|J1
39262|ANALGESICS|N2
39258|ANTIVIRALS FOR SYSTEMIC USE|J5
39244|CARDIOVASCULAR SYSTEM|C
39244|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
39241|Erectile dysfunction products|G4B3
39232|ANTIVIRALS FOR SYSTEMIC USE|J5
39213|IMMUNOSTIMULATING AGENTS|L3
39194|IMMUNOSUPPRESSIVE AGENTS|L4
39178|ANTI-EPILEPTICS|N3A
39174|ANALGESICS|N2
39173|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
39173|ANALGESICS|N2
39173|ANTIPSYCHOTICS|N5A
39173|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
39173|SRNI antidepressants|N6A5
39162|SYSTEMIC ANTIBACTERIALS|J1
39162|Carbapenems|J1P2
39160|GASTROPROKINETICS|A3F
39157|IMMUNOSUPPRESSIVE AGENTS|L4
39156|BPH (benign prostatic hypertrophy) products |G4C
39154|CARDIOVASCULAR SYSTEM|C
39154|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
39152|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
39151|BPH (benign prostatic hypertrophy) products |G4C
39150|ANALGESICS|N2
39149|IMMUNOSUPPRESSIVE AGENTS|L4
39122|ALKYLATING AGENTS|L1A
39090|ANTIHYPERTENSIVES|C2
39090|DIURETICS|C3
39089|SYSTEMIC ANTIBACTERIALS|J1
39089|ANTIVIRALS FOR SYSTEMIC USE|J5
39069|ANTIVIRALS FOR SYSTEMIC USE|J5
39065|TRANQUILLISERS|N5C
39065|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
39057|ANDROGENS, EXCLUDING G3E, G3F|G3B
39054|DERMATOLOGICALS|D
39052|WOUND HEALING AGENTS|D3
39051|Topical dermatological antifungals|D1A1
39051|SYSTEMIC ANTIBACTERIALS|J1
39051|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
39051|ANTIVIRALS FOR SYSTEMIC USE|J5
39050|DERMATOLOGICALS|D
39049|DERMATOLOGICALS|D
39014|ANTIVIRALS FOR SYSTEMIC USE|J5
39013|ANTIVIRALS FOR SYSTEMIC USE|J5
39011|ANTIVIRALS FOR SYSTEMIC USE|J5
39010|SYSTEMIC ANTIBACTERIALS|J1
39009|RESPIRATORY SYSTEM|R
38990|Non-nucleoside reverse transcriptase inhibitors|J5C3
38989|ANTIVIRALS FOR SYSTEMIC USE|J5
38971|ANTIVIRALS FOR SYSTEMIC USE|J5
38969|ANALGESICS|N2
38953|ANTI-EPILEPTICS|N3A
38953|ANTIPSYCHOTICS|N5A
38953|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
38953|NOOTROPICS|N6D
38949|SYSTEMIC ANTIBACTERIALS|J1
38914|Protease inhibitors|J5C2
38913|ANALGESICS|N2
38910|SYSTEMIC ANTIBACTERIALS|J1
38910|AMINOGLYCOSIDES|J1K
38909|ANTI-ARRHYTHMICS|C1B
38889|ANTIVIRALS FOR SYSTEMIC USE|J5
38874|SYSTEMIC ANTIBACTERIALS|J1
38873|SYSTEMIC ANTIBACTERIALS|J1
38871|CENTRAL NERVOUS SYSTEM|N
38858|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
38833|ANTI-EPILEPTICS|N3A
38832|ANALGESICS|N2
38831|ANALGESICS|N2
38830|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
38830|IMMUNOSUPPRESSIVE AGENTS|L4
38829|ANAESTHETICS, LOCAL|N1B
38820|RESPIRATORY SYSTEM|R
38818|MACROLIDES AND SIMILAR TYPES|J1F
38812|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
38809|RESPIRATORY SYSTEM|R
38789|ANDROGENS, EXCLUDING G3E, G3F|G3B
38789|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
38781|SYSTEMIC ANTIBACTERIALS|J1
38781|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
38778|ANTIPSYCHOTICS|N5A
38777|NOOTROPICS|N6D
38776|IMMUNOSUPPRESSIVE AGENTS|L4
38772|SYSTEMIC ANTIBACTERIALS|J1
38771|SYSTEMIC ANTIBACTERIALS|J1
38770|ANTIVIRALS FOR SYSTEMIC USE|J5
38770|RESPIRATORY SYSTEM|R
38769|SYSTEMIC ANTIBACTERIALS|J1
38756|SYSTEMIC ANTIBACTERIALS|J1
38750|WOUND HEALING AGENTS|D3
38749|CARDIAC THERAPY|C1
38729|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
38711|ANTI-EPILEPTICS|N3
38711|ANTIPSYCHOTICS|N5A
38709|ANALGESICS|N2
38709|ANTI-MIGRAINE PREPARATIONS|N2C
38691|VACCINES|J7
38691|IMMUNOSTIMULATING AGENTS|L3
38669|ANALGESICS|N2
38649|ANTIVIRALS FOR SYSTEMIC USE|J5
38636|ANTIVIRALS FOR SYSTEMIC USE|J5
38634|ANALGESICS|N2
38617|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
38611|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
38591|GASTROPROKINETICS|A3F
38589|PARASITOLOGY|P
38571|IMMUNOSTIMULATING AGENTS|L3
38570|ANTI-EPILEPTICS|N3A
38569|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
38558|IMMUNOSUPPRESSIVE AGENTS|L4
38556|ANTIVIRALS FOR SYSTEMIC USE|J5
38556|ANALGESICS|N2
38551|ANTIVIRALS FOR SYSTEMIC USE|J5
38550|ANTI-EPILEPTICS|N3A
38529|ANTIVIRALS FOR SYSTEMIC USE|J5
38529|IMMUNOSTIMULATING AGENTS|L3
38511|CARDIOVASCULAR SYSTEM|C
38494|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
38493|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
38492|Coxibs|M1A3
38492|ANALGESICS|N2
38492|SSRI antidepressants|N6A4
38492|SRNI antidepressants|N6A5
38490|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
38489|PLATELET AGGREGATION INHIBITORS|B1C
38473|SYSTEMIC ANTIBACTERIALS|J1
38472|SYSTEMIC ANTIBACTERIALS|J1
38472|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
38471|IMMUNOSUPPRESSIVE AGENTS|L4
38470|ANTI-EPILEPTICS|N3A
38411|RESPIRATORY SYSTEM|R
38380|ANTI-EPILEPTICS|N3A
38380|NOOTROPICS|N6D
38377|ANALGESICS|N2
38376|ANTI-ARRHYTHMICS|C1B
38374|FIBRINOLYTICS|B1D
38373|ANTI-ARRHYTHMICS|C1B
38358|CENTRAL NERVOUS SYSTEM|N
38358|TRANQUILLISERS|N5C
38357|ANTIPSYCHOTICS|N5A
38354|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
38353|VACCINES|J7
38351|ANTI-EPILEPTICS|N3A
38350|ANTIVIRALS FOR SYSTEMIC USE|J5
38349|ANTIVIRALS FOR SYSTEMIC USE|J5
38329|Protease inhibitors|J5C2
38311|DRUGS USED IN DIABETES|A10
38311|HUMAN INSULINS AND ANALOGUES|A10C
38311|Human insulins and analogues, long-acting|A10C5
38292|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
38289|CENTRAL NERVOUS SYSTEM|N
38269|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
38252|WOUND HEALING AGENTS|D3
38230|IMMUNOSUPPRESSIVE AGENTS|L4
38212|Erectile dysfunction products|G4B3
38211|ANTI-ARRHYTHMICS|C1B
38210|ANTIPSYCHOTICS|N5A
38210|SSRI antidepressants|N6A4
38192|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
38192|ANTI-ACNE PREPARATIONS|D10
38192|BPH (benign prostatic hypertrophy) products |G4C
38173|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
38173|SSRI antidepressants|N6A4
38173|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
38172|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
38172|DRUGS USED IN DIABETES|A10
38153|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
38153|ANALGESICS|N2
38153|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
38130|SYSTEMIC ANTIBACTERIALS|J1
38116|ANALGESICS|N2
38115|SYSTEMIC ANTIBACTERIALS|J1
38115|ANTIVIRALS FOR SYSTEMIC USE|J5
38114|SYSTEMIC ANTIBACTERIALS|J1
38112|SYSTEMIC ANTIBACTERIALS|J1
38111|ALKYLATING AGENTS|L1A
38110|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
38109|HEPARINS |B1B
38109|FIBRINOLYTICS|B1D
38096|ANTIEMETICS AND ANTINAUSEANTS|A4
38094|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
38094|ANTIPSYCHOTICS|N5A
38093|ANTI-EPILEPTICS|N3A
38093|TRANQUILLISERS|N5C
38093|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
38091|ANALGESICS|N2
38090|ANALGESICS|N2
38089|Urinary incontinence products|G4B4
38089|ANALGESICS|N2
38073|ANALGESICS|N2
38072|SYSTEMIC ANTIBACTERIALS|J1
38070|ANALGESICS|N2
38069|ANTIVIRALS FOR SYSTEMIC USE|J5
38069|VACCINES|J7
38053|IMMUNOSUPPRESSIVE AGENTS|L4
38051|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
38049|SYSTEMIC ANTIBACTERIALS|J1
38030|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
38029|SYSTEMIC ANTIBACTERIALS|J1
37991|ANTI-MIGRAINE PREPARATIONS|N2C
37974|IMMUNOSTIMULATING AGENTS|L3
37972|ANTIVIRALS FOR SYSTEMIC USE|J5
37971|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
37969|ANALGESICS|N2
37957|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
37956|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
37956|ANTI-MIGRAINE PREPARATIONS|N2C
37954|IMMUNOSUPPRESSIVE AGENTS|L4
37953|HUMAN INSULINS AND ANALOGUES|A10C
37953|Human insulins and analogues, long-acting|A10C5
37951|ANALGESICS|N2
37930|SYSTEMIC ANTIBACTERIALS|J1
37930|CEPHALOSPORINS|J1D
37929|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
37929|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
37891|ANTIVIRALS FOR SYSTEMIC USE|J5
37890|SYSTEMIC ANTIBACTERIALS|J1
37890|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
37869|ANAESTHETICS, LOCAL|N1B
37869|ANALGESICS|N2
37813|FIBRINOLYTICS|B1D
37810|VACCINES|J7
37800|PLATELET AGGREGATION INHIBITORS|B1C
37800|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
37797|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
37795|ANTIVIRALS FOR SYSTEMIC USE|J5
37794|ANTI-MIGRAINE PREPARATIONS|N2C
37792|ANALGESICS|N2
37792|ANTI-MIGRAINE PREPARATIONS|N2C
37791|SYSTEMIC ANTIBACTERIALS|J1
37789|ANTI-MIGRAINE PREPARATIONS|N2C
37781|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
37777|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
37774|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
37770|IMMUNOSUPPRESSIVE AGENTS|L4
37756|ANTI-GOUT PREPARATIONS|M4
37750|ANTI-EPILEPTICS|N3A
37749|ANTI-EPILEPTICS|N3A
37740|ANTI-EPILEPTICS|N3A
37739|FIBRINOLYTICS|B1D
37739|CARDIOVASCULAR SYSTEM|C
37737|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
37737|SSRI antidepressants|N6A4
37733|ANALGESICS|N2
37733|ANTI-MIGRAINE PREPARATIONS|N2C
37733|ANTITUSSIVES|R5D
37731|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
37724|Protease inhibitors|J5C2
37718|Ocular antineovascularisation products|S1P
37716|Miotics and antiglaucoma preparations, topical|S1E2
37713|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
37712|PARASITOLOGY|P
37711|ANALGESICS|N2
37693|ANTIPSYCHOTICS|N5A
37693|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
37672|NOOTROPICS|N6D
37671|BPH (benign prostatic hypertrophy) products |G4C
37669|CENTRAL NERVOUS SYSTEM|N
37629|PARASITOLOGY|P
37629|ANTI-MALARIALS|P1D
37592|ANTI-EPILEPTICS|N3
37590|MACROLIDES AND SIMILAR TYPES|J1F
37589|DERMATOLOGICALS|D
37571|VACCINES|J7
37569|SYSTEMIC ANTIBACTERIALS|J1
37549|SYSTEMIC ANTIBACTERIALS|J1
37534|ANTIVIRALS FOR SYSTEMIC USE|J5
37532|Erectile dysfunction products|G4B3
37529|SYSTEMIC ANTIBACTERIALS|J1
37510|SYSTEMIC ANTIBACTERIALS|J1
37509|SYSTEMIC ANTIBACTERIALS|J1
37497|Carbapenems|J1P2
37496|SYSTEMIC ANTIBACTERIALS|J1
37492|SYSTEMIC ANTIBACTERIALS|J1
37491|ANTI-EPILEPTICS|N3A
37490|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
37489|ANTIPSYCHOTICS|N5A
37489|TRANQUILLISERS|N5C
37489|NOOTROPICS|N6D
37473|IMMUNOSUPPRESSIVE AGENTS|L4
37472|IMMUNOSUPPRESSIVE AGENTS|L4
37470|SYSTEMIC ANTIBACTERIALS|J1
37470|Monobactams|J1P1
37469|RESPIRATORY SYSTEM|R
37453|RESPIRATORY SYSTEM|R
37451|SYSTEMIC ANTIBACTERIALS|J1
37450|ANTIVIRALS FOR SYSTEMIC USE|J5
37431|SYSTEMIC ANTIBACTERIALS|J1
37430|SYSTEMIC ANTIBACTERIALS|J1
37418|OPHTHALMOLOGICALS|S1
37417|SYSTEMIC ANTIBACTERIALS|J1
37416|CARDIOVASCULAR SYSTEM|C
37415|ANTI-ARRHYTHMICS|C1B
37411|SYSTEMIC ANTIBACTERIALS|J1
37410|CEPHALOSPORINS|J1D
37409|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
37392|PLATELET AGGREGATION INHIBITORS|B1C
37392|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
37391|IMMUNOSUPPRESSIVE AGENTS|L4
37370|ANTIMETABOLITES|L1B
37330|WOUND HEALING AGENTS|D3
37330|SYSTEMIC ANTIBACTERIALS|J1
37310|IMMUNOSTIMULATING AGENTS|L3
37291|ALKYLATING AGENTS|L1A
37271|ANTIVIRALS FOR SYSTEMIC USE|J5
37271|Non-nucleoside reverse transcriptase inhibitors|J5C3
37209|SYSTEMIC ANTIBACTERIALS|J1
37155|ANTIVIRALS FOR SYSTEMIC USE|J5
37153|SYSTEMIC ANTIBACTERIALS|J1
37110|CENTRAL NERVOUS SYSTEM|N
37093|Interferons, beta|L3B2
37090|ANTIVIRALS FOR SYSTEMIC USE|J5
37074|Interferons, beta|L3B2
37073|ANTIVIRALS FOR SYSTEMIC USE|J5
37073|Interferons, alpha|L3B1
37073|Interferons, beta|L3B2
37072|TRANQUILLISERS|N5C
37071|Interferons, alpha|L3B1
37071|Interferons, beta|L3B2
37070|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
37049|ANTIVIRALS FOR SYSTEMIC USE|J5
37033|TRANQUILLISERS|N5C
37030|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
37030|SSRI antidepressants|N6A4
37012|ANTIHYPERTENSIVES|C2
37012|Miotics and antiglaucoma preparations, topical|S1E2
37011|SYSTEMIC ANTIBACTERIALS|J1
36974|ANALGESICS|N2
36973|Erectile dysfunction products|G4B3
36972|ANTI-EPILEPTICS|N3A
36972|ANTIPSYCHOTICS|N5A
36969|ANALGESICS|N2
36957|NOOTROPICS|N6D
36953|ANALGESICS|N2
36953|NOOTROPICS|N6D
36939|CARDIAC THERAPY|C1
36937|ANTI-EPILEPTICS|N3
36936|NOOTROPICS|N6D
36935|ANALGESICS|N2
36933|ANTI-EPILEPTICS|N3A
36892|NOOTROPICS|N6D
36891|ALKYLATING AGENTS|L1A
36879|DPP-IV inhibitor antidiabetics|A10B6
36878|IMMUNOSUPPRESSIVE AGENTS|L4
36877|ANALGESICS|N2
36875|NOOTROPICS|N6D
36874|ANALGESICS|N2
36870|DIRECT THROMBIN INHIBITORS|B1E
36852|IMMUNOSUPPRESSIVE AGENTS|L4
36851|PSYCHOSTIMULANTS|N6B
36850|NOOTROPICS|N6D
36849|ANTIPSYCHOTICS|N5A
36834|DERMATOLOGICALS|D
36833|SYSTEMIC ANTIBACTERIALS|J1
36832|SYSTEMIC ANTIBACTERIALS|J1
36831|ANALGESICS|N2
36830|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
36829|ANALGESICS|N2
36823|ANALGESICS|N2
36823|ANTI-EPILEPTICS|N3A
36821|NOOTROPICS|N6D
36819|ANTI-EPILEPTICS|N3A
36818|ANTIPSYCHOTICS|N5A
36817|ANTI-EPILEPTICS|N3A
36815|NOOTROPICS|N6D
36812|NOOTROPICS|N6D
36811|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
36755|IMMUNOSUPPRESSIVE AGENTS|L4
36754|PARASITOLOGY|P
36753|SYSTEMIC ANTIBACTERIALS|J1
36752|PARASITOLOGY|P
36751|ANTIVIRALS FOR SYSTEMIC USE|J5
36718|PLATELET AGGREGATION INHIBITORS|B1C
36717|ANTI-ARRHYTHMICS|C1B
36717|BETA-BLOCKING AGENTS|C7
36715|ANTI-EPILEPTICS|N3A
36715|NOOTROPICS|N6D
36713|IMMUNOSUPPRESSIVE AGENTS|L4
36630|ANTIVIRALS FOR SYSTEMIC USE|J5
36630|IMMUNOSTIMULATING AGENTS|L3
36629|ANTIVIRALS FOR SYSTEMIC USE|J5
36617|ANTIHYPERTENSIVES|C2
36617|Erectile dysfunction products|G4B3
36615|BPH (benign prostatic hypertrophy) products |G4C
36613|ANALGESICS|N2
36611|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
36601|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
36601|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
36591|ANTIVIRALS FOR SYSTEMIC USE|J5
36569|CENTRAL NERVOUS SYSTEM|N
36569|ANALGESICS|N2
36569|ANTIPSYCHOTICS|N5A
36569|HYPNOTICS/SEDATIVES|N5B
36569|TRANQUILLISERS|N5C
36569|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
36555|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
36554|TRANQUILLISERS|N5C
36554|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
36553|ANALGESICS|N2
36553|ANTI-MIGRAINE PREPARATIONS|N2C
36550|ANTIVIRALS FOR SYSTEMIC USE|J5
36549|Coxibs|M1A3
36549|ANALGESICS|N2
36540|IMMUNOSUPPRESSIVE AGENTS|L4
36537|ANTIVIRALS FOR SYSTEMIC USE|J5
36536|ANTIVIRALS FOR SYSTEMIC USE|J5
36532|HUMAN INSULINS AND ANALOGUES|A10C
36532|Human insulins and analogues, intermediate-acting|A10C2
36516|ANTIVIRALS FOR SYSTEMIC USE|J5
36513|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
36511|ANTI-ARRHYTHMICS|C1B
36509|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
36496|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
36495|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
36494|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
36493|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
36492|SYSTEMIC ANTIBACTERIALS|J1
36492|CEPHALOSPORINS|J1D
36490|BPH (benign prostatic hypertrophy) products |G4C
36477|TRANQUILLISERS|N5C
36477|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
36453|ANTIVIRALS FOR SYSTEMIC USE|J5
36451|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
36449|ANALGESICS|N2
36394|IMMUNOSUPPRESSIVE AGENTS|L4
36389|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
36389|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
36389|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
36371|ANALGESICS|N2
36371|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
36370|IMMUNOSUPPRESSIVE AGENTS|L4
36369|VACCINES|J7
36352|Ocular antineovascularisation products|S1P
36332|PLATELET AGGREGATION INHIBITORS|B1C
36331|VACCINES|J7
36293|SYSTEMIC ANTIBACTERIALS|J1
36273|ANTI-EPILEPTICS|N3
36272|SYSTEMIC ANTIBACTERIALS|J1
36271|SYSTEMIC ANTIBACTERIALS|J1
36271|VACCINES|J7
36270|ANTIVIRALS FOR SYSTEMIC USE|J5
36270|VACCINES|J7
36269|SYSTEMIC ANTIBACTERIALS|J1
36250|Antigonadotrophin-releasing hormones|H1C3
36249|ANTIVIRALS FOR SYSTEMIC USE|J5
36249|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
36237|Erectile dysfunction products|G4B3
36235|ANTI-ARRHYTHMICS|C1B
36234|IMMUNOSUPPRESSIVE AGENTS|L4
36233|IMMUNOSUPPRESSIVE AGENTS|L4
36232|ANTI-EPILEPTICS|N3
36231|IMMUNOSUPPRESSIVE AGENTS|L4
36230|LAXATIVES|A6
36215|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
36215|IMMUNOSTIMULATING AGENTS|L3
36210|CARDIOVASCULAR SYSTEM|C
36210|ANTI-MIGRAINE PREPARATIONS|N2C
36210|ANTIPSYCHOTICS|N5A
36210|TRANQUILLISERS|N5C
36210|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
36209|HUMAN INSULINS AND ANALOGUES|A10C
36209|Human insulins and analogues, intermediate-acting|A10C2
36190|ALKYLATING AGENTS|L1A
36176|IMMUNOSUPPRESSIVE AGENTS|L4
36173|SYSTEMIC ANTIBACTERIALS|J1
36171|ANTIHYPERTENSIVES|C2
36169|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
36154|ANALGESICS|N2
36154|SSRI antidepressants|N6A4
36154|SRNI antidepressants|N6A5
36150|ANALGESICS|N2
36149|VACCINES|J7
36129|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
36115|Coxibs|M1A3
36114|Coxibs|M1A3
36114|ANALGESICS|N2
36111|ANTIVIRALS FOR SYSTEMIC USE|J5
36109|BPH (benign prostatic hypertrophy) products |G4C
36073|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
36069|RESPIRATORY SYSTEM|R
35990|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
35981|NOOTROPICS|N6D
35981|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
35978|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
35978|DRUGS USED IN DIABETES|A10
35977|ANALGESICS|N2
35974|SYSTEMIC ANTIBACTERIALS|J1
35973|PLATELET AGGREGATION INHIBITORS|B1C
35973|FIBRINOLYTICS|B1D
35972|IMMUNOSUPPRESSIVE AGENTS|L4
35971|Protease inhibitors|J5C2
35970|SYSTEMIC ANTIBACTERIALS|J1
35955|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
35953|CENTRAL NERVOUS SYSTEM|N
35953|NOOTROPICS|N6D
35951|ANALGESICS|N2
35950|WOUND HEALING AGENTS|D3
35949|CARDIOVASCULAR SYSTEM|C
35910|ANTI-EPILEPTICS|N3A
35899|TRANQUILLISERS|N5C
35899|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
35898|ANTIPSYCHOTICS|N5A
35897|ANTIPSYCHOTICS|N5A
35897|HYPNOTICS/SEDATIVES|N5B
35894|ANTI-EPILEPTICS|N3A
35893|ANALGESICS|N2
35888|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
35887|OPHTHALMOLOGICALS|S1
35872|ANTIHYPERTENSIVES|C2
35849|SYSTEMIC ANTIBACTERIALS|J1
35841|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
35838|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
35837|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
35836|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
35835|ALKYLATING AGENTS|L1A
35828|ANTIVIRALS FOR SYSTEMIC USE|J5
35828|ANALGESICS|N2
35819|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
35818|ANTIVIRALS FOR SYSTEMIC USE|J5
35815|SYSTEMIC ANTIBACTERIALS|J1
35815|ANTIVIRALS FOR SYSTEMIC USE|J5
35814|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
35813|ANTIVIRALS FOR SYSTEMIC USE|J5
35812|ANTIVIRALS FOR SYSTEMIC USE|J5
35809|LABOUR INHIBITORS|G2E
35808|ANTIHYPERTENSIVES|C2
35791|ANTIVIRALS FOR SYSTEMIC USE|J5
35791|IMMUNOSTIMULATING AGENTS|L3
35790|ANTIVIRALS FOR SYSTEMIC USE|J5
35789|ANAESTHETICS, GENERAL|N1A
35788|SYSTEMIC ANTIBACTERIALS|J1
35777|ANTIVIRALS FOR SYSTEMIC USE|J5
35776|ANTI-ACNE PREPARATIONS|D10
35772|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
35772|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
35767|PARASITOLOGY|P
35753|ANTIHYPERTENSIVES|C2
35753|OPHTHALMOLOGICALS|S1
35753|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
35750|IMMUNOSUPPRESSIVE AGENTS|L4
35749|CALCIUM ANTAGONISTS|C8
35748|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
35747|SYSTEMIC ANTIBACTERIALS|J1
35733|ANTIVIRALS FOR SYSTEMIC USE|J5
35727|ANTIVIRALS FOR SYSTEMIC USE|J5
35708|CENTRAL NERVOUS SYSTEM|N
35691|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
35687|ANTIVIRALS FOR SYSTEMIC USE|J5
35668|CENTRAL NERVOUS SYSTEM|N
35666|SYSTEMIC ANTIBACTERIALS|J1
35643|ANTIEMETICS AND ANTINAUSEANTS|A4
35643|ANALGESICS|N2
35640|RESPIRATORY SYSTEM|R
35620|ALKYLATING AGENTS|L1A
35619|ANTI-ACNE PREPARATIONS|D10
35599|CEPHALOSPORINS|J1D
35559|IMMUNOSUPPRESSIVE AGENTS|L4
35540|PLATELET AGGREGATION INHIBITORS|B1C
35540|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
35502|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
35501|SYSTEMIC ANTIBACTERIALS|J1
35500|SYSTEMIC ANTIBACTERIALS|J1
35480|Protease inhibitors|J5C2
35460|SYSTEMIC ANTIBACTERIALS|J1
35444|SYSTEMIC ANTIBACTERIALS|J1
35442|Monobactams|J1P1
35441|SYSTEMIC ANTIBACTERIALS|J1
35441|Monobactams|J1P1
35440|SYSTEMIC ANTIBACTERIALS|J1
35427|ANAESTHETICS, LOCAL|N1B
35427|ANALGESICS|N2
35425|DIRECT THROMBIN INHIBITORS|B1E
35423|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
35423|PARASITOLOGY|P
35422|BPH (benign prostatic hypertrophy) products |G4C
35419|ANTIVIRALS FOR SYSTEMIC USE|J5
35403|IMMUNOSUPPRESSIVE AGENTS|L4
35401|ANTI-EPILEPTICS|N3
35400|SYSTEMIC ANTIBACTERIALS|J1
35400|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
35400|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
35399|PARASITOLOGY|P
35386|WOUND HEALING AGENTS|D3
35365|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
35364|ANALGESICS|N2
35359|VACCINES|J7
35339|DRUGS USED IN DIABETES|A10
35323|ANTIVIRALS FOR SYSTEMIC USE|J5
35320|ANTIHYPERTENSIVES|C2
35319|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
35319|NOOTROPICS|N6D
35280|ANTI-EPILEPTICS|N3A
35280|NOOTROPICS|N6D
35279|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
35262|ANTIVIRALS FOR SYSTEMIC USE|J5
35260|ANTIVIRALS FOR SYSTEMIC USE|J5
35259|ANALGESICS|N2
35259|ANTI-MIGRAINE PREPARATIONS|N2C
35245|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
35239|THYROID THERAPY|H3
35239|Miotics and antiglaucoma preparations, topical|S1E2
35226|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
35223|ANTIPSYCHOTICS|N5A
35223|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
35222|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
35222|ANTI-EPILEPTICS|N3A
35221|ANALGESICS|N2
35219|CARDIOVASCULAR SYSTEM|C
35219|ULTRASOUND AGENTS|T1F
35187|CENTRAL NERVOUS SYSTEM|N
35186|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
35181|ANTIHYPERTENSIVES|C2
35179|PLATELET AGGREGATION INHIBITORS|B1C
35179|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
35169|ANTIHYPERTENSIVES|C2
35168|MRI AGENTS|T1E
35167|SYSTEMIC ANTIBACTERIALS|J1
35166|Urinary incontinence products|G4B4
35165|CARDIAC THERAPY|C1
35165|ANTIHYPERTENSIVES|C2
35161|ULTRASOUND AGENTS|T1F
35159|PLATELET AGGREGATION INHIBITORS|B1C
35139|RADIODIAGNOSTIC AGENTS|T1G
35128|PARASITOLOGY|P
35128|ANTI-MALARIALS|P1D
35126|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
35125|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
35124|PLATELET AGGREGATION INHIBITORS|B1C
35120|ANTIVIRALS FOR SYSTEMIC USE|J5
35108|SYSTEMIC ANTIBACTERIALS|J1
35107|Protease inhibitors|J5C2
35105|ANAESTHETICS, LOCAL|N1B
35105|ANALGESICS|N2
35104|ANALGESICS|N2
35103|ANTIVIRALS FOR SYSTEMIC USE|J5
35100|MACROLIDES AND SIMILAR TYPES|J1F
35086|PLATELET AGGREGATION INHIBITORS|B1C
35085|ANTIVIRALS FOR SYSTEMIC USE|J5
35082|HUMAN INSULINS AND ANALOGUES|A10C
35082|Human insulins and analogues, intermediate-acting|A10C2
35080|ANTIVIRALS FOR SYSTEMIC USE|J5
35079|PARASITOLOGY|P
35079|ANTI-MALARIALS|P1D
35060|PLATELET AGGREGATION INHIBITORS|B1C
35060|CARDIOVASCULAR SYSTEM|C
35059|ANTIVIRALS FOR SYSTEMIC USE|J5
35043|CARDIOVASCULAR SYSTEM|C
35043|ANTIHYPERTENSIVES|C2
35043|Miotics and antiglaucoma preparations, topical|S1E2
35040|PLATELET AGGREGATION INHIBITORS|B1C
35040|DIRECT THROMBIN INHIBITORS|B1E
35022|SYSTEMIC ANTIBACTERIALS|J1
35020|ANTIVIRALS FOR SYSTEMIC USE|J5
34999|SYSTEMIC ANTIBACTERIALS|J1
34999|ANTIVIRALS FOR SYSTEMIC USE|J5
34984|SYSTEMIC ANTIBACTERIALS|J1
34981|Glitazone antidiabetics|A10B4
34960|Glitazone antidiabetics|A10B4
34960|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
34959|SYSTEMIC ANTIBACTERIALS|J1
34939|MRI AGENTS|T1E
34919|MRI AGENTS|T1E
34904|Urinary incontinence products|G4B4
34899|DRUGS USED IN DIABETES|A10
34899|IMMUNOSUPPRESSIVE AGENTS|L4
34886|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
34883|Urinary incontinence products|G4B4
34880|ANALGESICS|N2
34879|SYSTEMIC ANTIBACTERIALS|J1
34879|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
34866|SYSTEMIC ANTIBACTERIALS|J1
34863|Non-nucleoside reverse transcriptase inhibitors|J5C3
34860|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
34860|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
34859|CARDIOVASCULAR SYSTEM|C
34840|BPH (benign prostatic hypertrophy) products |G4C
34820|ANDROGENS, EXCLUDING G3E, G3F|G3B
34820|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
34808|ANTIVIRALS FOR SYSTEMIC USE|J5
34807|ANTIVIRALS FOR SYSTEMIC USE|J5
34806|ANALGESICS|N2
34806|ANTI-MIGRAINE PREPARATIONS|N2C
34802|ANTIVIRALS FOR SYSTEMIC USE|J5
34787|TRANQUILLISERS|N5C
34786|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
34785|ANTIPSYCHOTICS|N5A
34780|ANTIPSYCHOTICS|N5A
34780|NOOTROPICS|N6D
34759|SYSTEMIC ANTIBACTERIALS|J1
34746|ANTIVIRALS FOR SYSTEMIC USE|J5
34745|BPH (benign prostatic hypertrophy) products |G4C
34745|Antigonadotrophin-releasing hormones|H1C3
34744|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
34743|ALKYLATING AGENTS|L1A
34721|ANTI-ARRHYTHMICS|C1B
34719|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
34702|ANALGESICS|N2
34701|ANTI-ACNE PREPARATIONS|D10
34701|SYSTEMIC ANTIBACTERIALS|J1
34700|Non-nucleoside reverse transcriptase inhibitors|J5C3
34699|ANTIVIRALS FOR SYSTEMIC USE|J5
34679|ANTIVIRALS FOR SYSTEMIC USE|J5
34666|IMMUNOSUPPRESSIVE AGENTS|L4
34664|ANTIVIRALS FOR SYSTEMIC USE|J5
34664|IMMUNOSTIMULATING AGENTS|L3
34663|ANTIVIRALS FOR SYSTEMIC USE|J5
34662|CARDIOVASCULAR SYSTEM|C
34662|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
34662|Statins (HMG-CoA reductase inhibitors)|C10A1
34661|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
34661|SSRI antidepressants|N6A4
34660|ANALGESICS|N2
34660|HYPNOTICS/SEDATIVES|N5B
34660|TRANQUILLISERS|N5C
34639|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
34628|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
34621|ANTI-ACNE PREPARATIONS|D10
34620|IMMUNOSUPPRESSIVE AGENTS|L4
34605|IMMUNOSTIMULATING AGENTS|L3
34588|Factor VIII|B2D1
34586|SYSTEMIC ANTIBACTERIALS|J1
34579|ALKYLATING AGENTS|L1A
34568|ANTIEMETICS AND ANTINAUSEANTS|A4
34531|SYSTEMIC ANTIBACTERIALS|J1
34529|SYSTEMIC ANTIBACTERIALS|J1
34527|SYSTEMIC ANTIHISTAMINES|R6
34521|ANTIVIRALS FOR SYSTEMIC USE|J5
34520|Factor VIII|B2D1
34519|Factor VIII|B2D1
34503|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
34501|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
34501|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
34501|Statins (HMG-CoA reductase inhibitors)|C10A1
34499|SYSTEMIC ANTIBACTERIALS|J1
34499|ANTIVIRALS FOR SYSTEMIC USE|J5
34480|ANTIVIRALS FOR SYSTEMIC USE|J5
34471|SYSTEMIC ANTIBACTERIALS|J1
34470|CARDIOVASCULAR SYSTEM|C
34469|SYSTEMIC ANTIBACTERIALS|J1
34466|ANALGESICS|N2
34465|DRUGS USED IN DIABETES|A10
34465|HUMAN INSULINS AND ANALOGUES|A10C
34465|Human insulins and analogues, intermediate-acting|A10C2
34464|SYSTEMIC ANTIBACTERIALS|J1
34463|SYSTEMIC ANTIBACTERIALS|J1
34461|ANALGESICS|N2
34459|WOUND HEALING AGENTS|D3
34446|ANTIVIRALS FOR SYSTEMIC USE|J5
34445|CARDIOVASCULAR SYSTEM|C
34445|ANTIHYPERTENSIVES|C2
34413|Bile stone therapy|A5A2
34413|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
34407|PLATELET AGGREGATION INHIBITORS|B1C
34405|Inhibitors of the Kallikrein-kinin-system|B2C2
34404|NOOTROPICS|N6D
34402|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
34399|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
34379|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
34379|IMMUNOSUPPRESSIVE AGENTS|L4
34360|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
34359|IMMUNOSUPPRESSIVE AGENTS|L4
34340|ANTIVIRALS FOR SYSTEMIC USE|J5
34325|ANTI-ACNE PREPARATIONS|D10
34325|ANTIVIRALS FOR SYSTEMIC USE|J5
34323|DPP-IV inhibitor antidiabetics|A10B6
34322|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
34321|SYSTEMIC ANTIBACTERIALS|J1
34319|ANALGESICS|N2
34302|RESPIRATORY SYSTEM|R
34302|LUNG SURFACTANTS|R7C
34301|SYSTEMIC ANTIBACTERIALS|J1
34301|PARASITOLOGY|P
34300|ANTI-EPILEPTICS|N3A
34299|ANTIPSYCHOTICS|N5A
34290|ANTIVIRALS FOR SYSTEMIC USE|J5
34287|CALCITONINS|H4A
34286|ANALGESICS|N2
34285|DIURETICS|C3
34285|Urinary incontinence products|G4B4
34285|ANTIDIURETIC HORMONES|H4D
34239|CARDIOVASCULAR SYSTEM|C
34224|ANTIVIRALS FOR SYSTEMIC USE|J5
34223|IMMUNOSUPPRESSIVE AGENTS|L4
34221|CARDIOVASCULAR SYSTEM|C
34220|ANTIPSYCHOTICS|N5A
34206|VACCINES|J7
34205|SYSTEMIC ANTIBACTERIALS|J1
34204|SYSTEMIC ANTIBACTERIALS|J1
34204|CEPHALOSPORINS|J1D
34202|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
34202|DRUGS USED IN DIABETES|A10
34201|CARDIOVASCULAR SYSTEM|C
34201|RESPIRATORY SYSTEM|R
34182|Erectile dysfunction products|G4B3
34181|CENTRAL NERVOUS SYSTEM|N
34180|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
34180|IMMUNOSUPPRESSIVE AGENTS|L4
34179|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
34179|ANALGESICS|N2
34164|ANALGESICS|N2
34143|ALKYLATING AGENTS|L1A
34142|IMMUNOSUPPRESSIVE AGENTS|L4
34125|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
34125|IMMUNOSUPPRESSIVE AGENTS|L4
34121|TRANQUILLISERS|N5C
34120|Erectile dysfunction products|G4B3
34119|CENTRAL NERVOUS SYSTEM|N
34107|Erectile dysfunction products|G4B3
34102|ANDROGENS, EXCLUDING G3E, G3F|G3B
34099|CARDIOVASCULAR SYSTEM|C
34083|ANTIVIRALS FOR SYSTEMIC USE|J5
34083|Interferons, beta|L3B2
34081|DRUGS USED IN DIABETES|A10
34081|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
34067|ANTIVIRALS FOR SYSTEMIC USE|J5
34063|ANTIULCERANTS|A2B
34062|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
34061|ULTRASOUND AGENTS|T1F
34061|RADIODIAGNOSTIC AGENTS|T1G
34059|DRUGS USED IN DIABETES|A10
34042|SYSTEMIC ANTIBACTERIALS|J1
34039|APPETITE STIMULANTS|A15
34022|IMMUNOSUPPRESSIVE AGENTS|L4
34022|ANTI-EPILEPTICS|N3A
34019|ANTI-ARRHYTHMICS|C1B
34003|BPH (benign prostatic hypertrophy) products |G4C
34000|TRANQUILLISERS|N5C
33979|ANALGESICS|N2
33966|ANDROGENS, EXCLUDING G3E, G3F|G3B
33963|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
33962|ANTI-EPILEPTICS|N3
33962|ANTI-EPILEPTICS|N3A
33961|ANTIVIRALS FOR SYSTEMIC USE|J5
33959|SYSTEMIC ANTIBACTERIALS|J1
33945|Urinary incontinence products|G4B4
33944|TRANQUILLISERS|N5C
33943|ANALGESICS|N2
33940|SYSTEMIC ANTIBACTERIALS|J1
33927|ANALGESICS|N2
33927|ANTI-EPILEPTICS|N3A
33926|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
33926|TRANQUILLISERS|N5C
33926|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
33923|SYSTEMIC ANTIBACTERIALS|J1
33921|CARDIOVASCULAR SYSTEM|C
33921|MRI AGENTS|T1E
33920|ANAESTHETICS, GENERAL|N1A
33909|DRUGS USED IN DIABETES|A10
33908|ANTI-ACNE PREPARATIONS|D10
33908|VACCINES|J7
33906|CARDIOVASCULAR SYSTEM|C
33905|Non-nucleoside reverse transcriptase inhibitors|J5C3
33886|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
33884|CARDIOVASCULAR SYSTEM|C
33882|ANTIEMETICS AND ANTINAUSEANTS|A4
33848|SYSTEMIC ANTIBACTERIALS|J1
33848|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
33846|ANTIVIRALS FOR SYSTEMIC USE|J5
33842|SYSTEMIC ANTIBACTERIALS|J1
33839|ANTIEMETICS AND ANTINAUSEANTS|A4
33820|Protease inhibitors|J5C2
33770|TRANQUILLISERS|N5C
33770|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
33769|ANALGESICS|N2
33765|NOOTROPICS|N6D
33764|ANTIPSYCHOTICS|N5A
33761|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
33760|ANTIHYPERTENSIVES|C2
33746|PLATELET AGGREGATION INHIBITORS|B1C
33733|IMMUNOSTIMULATING AGENTS|L3
33729|Statins (HMG-CoA reductase inhibitors)|C10A1
33729|DERMATOLOGICALS|D
33726|SYSTEMIC ANTIBACTERIALS|J1
33725|ANTI-MIGRAINE PREPARATIONS|N2C
33722|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
33720|IMMUNOSUPPRESSIVE AGENTS|L4
33718|ANTIVIRALS FOR SYSTEMIC USE|J5
33676|FIBRINOLYTICS|B1D
33675|PLATELET AGGREGATION INHIBITORS|B1C
33674|ANTI-ARRHYTHMICS|C1B
33673|IMMUNOSTIMULATING AGENTS|L3
33671|FIBRINOLYTICS|B1D
33661|HYPNOTICS/SEDATIVES|N5B
33660|ANALGESICS|N2
33655|Vitamin D|A11C2
33651|ANTIVIRALS FOR SYSTEMIC USE|J5
33638|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
33637|CARDIOVASCULAR SYSTEM|C
33637|DIURETICS|C3
33629|NOOTROPICS|N6D
33628|ANTIVIRALS FOR SYSTEMIC USE|J5
33624|ALKYLATING AGENTS|L1A
33616|PARASITOLOGY|P
33588|IMMUNOSTIMULATING AGENTS|L3
33585|ANALGESICS|N2
33582|ANTIPSYCHOTICS|N5A
33576|ANTIPSYCHOTICS|N5A
33573|ANTIVIRALS FOR SYSTEMIC USE|J5
33557|CARDIOVASCULAR SYSTEM|C
33530|RESPIRATORY SYSTEM|R
33499|ANTIHYPERTENSIVES|C2
33499|Miotics and antiglaucoma preparations, topical|S1E2
33497|ANALGESICS|N2
33490|Urinary incontinence products|G4B4
33478|ANTIVIRALS FOR SYSTEMIC USE|J5
33477|ANTIMETABOLITES|L1B
33475|ANTIHYPERTENSIVES|C2
33475|CALCIUM ANTAGONISTS|C8
33475|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
33475|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
33475|Statins (HMG-CoA reductase inhibitors)|C10A1
33451|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
33450|ANALGESICS|N2
33398|ANALGESICS|N2
33391|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
33390|ANTIVIRALS FOR SYSTEMIC USE|J5
33376|ANTIVIRALS FOR SYSTEMIC USE|J5
33374|ANTIVIRALS FOR SYSTEMIC USE|J5
33372|CARDIOVASCULAR SYSTEM|C
33372|ANTIHYPERTENSIVES|C2
33370|ANTIVIRALS FOR SYSTEMIC USE|J5
33360|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
33360|ANALGESICS|N2
33333|SYSTEMIC ANTIBACTERIALS|J1
33333|RADIODIAGNOSTIC AGENTS|T1G
33330|ANTI-ARRHYTHMICS|C1B
33311|PARASITOLOGY|P
33292|TRANQUILLISERS|N5C
33292|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
33291|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
33270|ANALGESICS|N2
33270|ANTI-MIGRAINE PREPARATIONS|N2C
33238|ANTIVIRALS FOR SYSTEMIC USE|J5
33237|ANTIVIRALS FOR SYSTEMIC USE|J5
33231|ANTI-EPILEPTICS|N3
33231|HYPNOTICS/SEDATIVES|N5B
33231|TRANQUILLISERS|N5C
33230|ANALGESICS|N2
33212|ANTIEMETICS AND ANTINAUSEANTS|A4
33177|SYSTEMIC ANTIBACTERIALS|J1
33175|DIRECT THROMBIN INHIBITORS|B1E
33174|ANALGESICS|N2
33172|ANTI-ARRHYTHMICS|C1B
33171|ANTIVIRALS FOR SYSTEMIC USE|J5
33171|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
33170|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
33160|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
33158|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
33156|PARASITOLOGY|P
33155|IMMUNOSTIMULATING AGENTS|L3
33154|SYSTEMIC ANTIBACTERIALS|J1
33153|SYSTEMIC ANTIBACTERIALS|J1
33151|SYSTEMIC ANTIBACTERIALS|J1
33132|SYSTEMIC ANTIBACTERIALS|J1
33117|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
33116|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
33115|SYSTEMIC ANTIBACTERIALS|J1
33114|ANTIVIRALS FOR SYSTEMIC USE|J5
33111|NOOTROPICS|N6D
33095|CARDIAC THERAPY|C1
33092|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
33092|SSRI antidepressants|N6A4
33090|Erectile dysfunction products|G4B3
33073|SYSTEMIC ANTIBACTERIALS|J1
33073|PARASITOLOGY|P
33071|IMMUNOSUPPRESSIVE AGENTS|L4
33050|ANALGESICS|N2
33019|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
33019|ANTI-EPILEPTICS|N3
33019|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
33012|CARDIOVASCULAR SYSTEM|C
33012|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
33011|NOOTROPICS|N6D
33005|ANTI-EPILEPTICS|N3A
33004|SYSTEMIC ANTIBACTERIALS|J1
33004|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
33003|SYSTEMIC ANTIBACTERIALS|J1
33002|ANTIVIRALS FOR SYSTEMIC USE|J5
33001|ANTIVIRALS FOR SYSTEMIC USE|J5
32999|ANTIVIRALS FOR SYSTEMIC USE|J5
32998|SYSTEMIC ANTIBACTERIALS|J1
32997|ANTIVIRALS FOR SYSTEMIC USE|J5
32995|ANTIVIRALS FOR SYSTEMIC USE|J5
32993|ANALGESICS|N2
32993|ANTI-MIGRAINE PREPARATIONS|N2C
32992|ANTIEMETICS AND ANTINAUSEANTS|A4
32992|TRANQUILLISERS|N5C
32992|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
32990|Non-nucleoside reverse transcriptase inhibitors|J5C3
32977|IMMUNOSTIMULATING AGENTS|L3
32975|Erectile dysfunction products|G4B3
32972|ANALGESICS|N2
32972|ANTI-MIGRAINE PREPARATIONS|N2C
32972|ANTI-EPILEPTICS|N3
32972|ANTIPSYCHOTICS|N5A
32972|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
32971|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
32935|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
32934|ANAESTHETICS, GENERAL|N1A
32934|ANTI-EPILEPTICS|N3
32934|HYPNOTICS/SEDATIVES|N5B
32932|ANTIVIRALS FOR SYSTEMIC USE|J5
32930|DRUGS USED IN DIABETES|A10
32930|CARDIOVASCULAR SYSTEM|C
32917|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
32917|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
32914|SYSTEMIC ANTIBACTERIALS|J1
32914|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
32914|ANTIVIRALS FOR SYSTEMIC USE|J5
32893|ANALGESICS|N2
32892|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
32892|CENTRAL NERVOUS SYSTEM|N
32892|ANALGESICS|N2
32892|NOOTROPICS|N6D
32890|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
32874|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
32872|ANTIVIRALS FOR SYSTEMIC USE|J5
32871|ANALGESICS|N2
32859|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
32859|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
32858|ANTIVIRALS FOR SYSTEMIC USE|J5
32857|SYSTEMIC ANTIBACTERIALS|J1
32856|SYSTEMIC ANTIBACTERIALS|J1
32850|ANTIULCERANTS|A2B
32850|CENTRAL NERVOUS SYSTEM|N
32834|ANTIVIRALS FOR SYSTEMIC USE|J5
32833|SYSTEMIC ANTIBACTERIALS|J1
32832|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
32832|CENTRAL NERVOUS SYSTEM|N
32831|NOOTROPICS|N6D
32830|SYSTEMIC ANTIBACTERIALS|J1
32810|ANTIHYPERTENSIVES|C2
32810|Erectile dysfunction products|G4B3
32810|BPH (benign prostatic hypertrophy) products |G4C
32797|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
32795|IMMUNOSUPPRESSIVE AGENTS|L4
32794|CENTRAL NERVOUS SYSTEM|N
32793|ANTIVIRALS FOR SYSTEMIC USE|J5
32779|ANALGESICS|N2
32779|ANTI-EPILEPTICS|N3
32776|ANTI-EPILEPTICS|N3A
32772|ANTI-EPILEPTICS|N3A
32772|NOOTROPICS|N6D
32762|ANALGESICS|N2
32758|NOOTROPICS|N6D
32757|ANTIVIRALS FOR SYSTEMIC USE|J5
32756|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
32755|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
32733|TRANQUILLISERS|N5C
32730|CENTRAL NERVOUS SYSTEM|N
32716|RADIODIAGNOSTIC AGENTS|T1G
32712|CARDIOVASCULAR SYSTEM|C
32695|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
32693|Statins (HMG-CoA reductase inhibitors)|C10A1
32677|ANTI-ARRHYTHMICS|C1B
32676|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
32676|THYROID THERAPY|H3
32675|ANTIVIRALS FOR SYSTEMIC USE|J5
32674|CARDIAC THERAPY|C1
32673|ANTIVIRALS FOR SYSTEMIC USE|J5
32672|ANTIVIRALS FOR SYSTEMIC USE|J5
32671|ANTIVIRALS FOR SYSTEMIC USE|J5
32658|DRUGS USED IN DIABETES|A10
32658|HUMAN INSULINS AND ANALOGUES|A10C
32658|Human insulins and analogues, long-acting|A10C5
32654|ANTIVIRALS FOR SYSTEMIC USE|J5
32653|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
32652|ANTIVIRALS FOR SYSTEMIC USE|J5
32652|Interferons, alpha|L3B1
32643|DERMATOLOGICALS|D
32643|WOUND HEALING AGENTS|D3
32643|ANTIVIRALS FOR SYSTEMIC USE|J5
32641|ANTIHYPERTENSIVES|C2
32640|PARASITOLOGY|P
32636|DRUGS USED IN DIABETES|A10
32634|SYSTEMIC ANTIBACTERIALS|J1
32632|ANTIVIRALS FOR SYSTEMIC USE|J5
32613|Antigonadotrophin-releasing hormones|H1C3
32613|VACCINES|J7
32611|SYSTEMIC ANTIBACTERIALS|J1
32600|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
32599|CENTRAL NERVOUS SYSTEM|N
32599|ANALGESICS|N2
32598|NOOTROPICS|N6D
32597|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
32595|ANTI-EPILEPTICS|N3A
32594|BPH (benign prostatic hypertrophy) products |G4C
32593|ANTIPSYCHOTICS|N5A
32593|NOOTROPICS|N6D
32592|ANALGESICS|N2
32591|IMMUNOSUPPRESSIVE AGENTS|L4
32590|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
32577|FIBRINOLYTICS|B1D
32572|ANTIVIRALS FOR SYSTEMIC USE|J5
32551|ANALGESICS|N2
32531|GROWTH HORMONES|H4C
32529|ANTIVIRALS FOR SYSTEMIC USE|J5
32529|Interferons, alpha|L3B1
32528|GROWTH HORMONES|H4C
32527|Urinary incontinence products|G4B4
32520|Ocular antineovascularisation products|S1P
32518|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
32518|DRUGS USED IN DIABETES|A10
32518|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
32513|ANTIVIRALS FOR SYSTEMIC USE|J5
32511|BPH (benign prostatic hypertrophy) products |G4C
32491|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
32490|B2-STIMULANTS|R3A
32452|ANTI-EPILEPTICS|N3A
32451|ANTI-EPILEPTICS|N3A
32450|SYSTEMIC ANTIBACTERIALS|J1
32436|ANTIVIRALS FOR SYSTEMIC USE|J5
32435|SYSTEMIC ANTIBACTERIALS|J1
32432|ANTIVIRALS FOR SYSTEMIC USE|J5
32431|MUSCLE RELAXANTS|M3
32431|ANALGESICS|N2
32431|NOOTROPICS|N6D
32413|Urinary incontinence products|G4B4
32413|Coxibs|M1A3
32412|Coxibs|M1A3
32411|IMMUNOSTIMULATING AGENTS|L3
32410|ANTI-EPILEPTICS|N3A
32395|Urinary incontinence products|G4B4
32393|SYSTEMIC ANTIBACTERIALS|J1
32392|NOOTROPICS|N6D
32375|WOUND HEALING AGENTS|D3
32372|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
32370|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
32356|DERMATOLOGICALS|D
32355|B2-STIMULANTS|R3A
32354|IMMUNOSUPPRESSIVE AGENTS|L4
32351|DIRECT THROMBIN INHIBITORS|B1E
32337|ANALGESICS|N2
32294|ANALGESICS|N2
32290|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
32251|NOOTROPICS|N6D
32213|ANTI-EPILEPTICS|N3A
32212|SYSTEMIC ANTIBACTERIALS|J1
32210|ANTIHYPERTENSIVES|C2
32210|OPHTHALMOLOGICALS|S1
32193|IMMUNOSTIMULATING AGENTS|L3
32190|PLATELET AGGREGATION INHIBITORS|B1C
32190|CARDIOVASCULAR SYSTEM|C
32171|SRNI antidepressants|N6A5
32151|PARASITOLOGY|P
32150|ANTIPSYCHOTICS|N5A
32150|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
32111|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
32110|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
32096|PARASITOLOGY|P
32095|IMMUNOSUPPRESSIVE AGENTS|L4
32094|ANTIVIRALS FOR SYSTEMIC USE|J5
32091|SYSTEMIC ANTIBACTERIALS|J1
32074|ANALGESICS|N2
32073|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
32055|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
32053|IMMUNOSUPPRESSIVE AGENTS|L4
32052|ALKYLATING AGENTS|L1A
32030|HUMAN INSULINS AND ANALOGUES|A10C
32030|Human insulins and analogues, intermediate-acting|A10C2
32012|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
32011|Topical dermatological antifungals|D1A1
32011|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
32003|SYSTEMIC ANTIBACTERIALS|J1
31999|TRANQUILLISERS|N5C
31997|ANTI-EPILEPTICS|N3
31993|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
31992|HYPNOTICS/SEDATIVES|N5B
31978|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
31977|ANALGESICS|N2
31974|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
31974|ANTI-ACNE PREPARATIONS|D10
31972|ALKYLATING AGENTS|L1A
31967|SYSTEMIC ANTIBACTERIALS|J1
31966|ANALGESICS|N2
31962|ANTIVIRALS FOR SYSTEMIC USE|J5
31961|ANALGESICS|N2
31958|ANALGESICS|N2
31952|PLATELET AGGREGATION INHIBITORS|B1C
31931|ANALGESICS|N2
31930|ANALGESICS|N2
31912|IMMUNOSTIMULATING AGENTS|L3
31910|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31890|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
31877|ANTIVIRALS FOR SYSTEMIC USE|J5
31876|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
31872|Vitamin D|A11C2
31872|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
31858|ANTIVIRALS FOR SYSTEMIC USE|J5
31856|DIRECT THROMBIN INHIBITORS|B1E
31856|Inhibitors of the Kallikrein-kinin-system|B2C2
31856|CARDIOVASCULAR SYSTEM|C
31835|SYSTEMIC ANTIBACTERIALS|J1
31833|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
31832|IMMUNOSTIMULATING AGENTS|L3
31811|PARASITOLOGY|P
31791|ANTIVIRALS FOR SYSTEMIC USE|J5
31777|SYSTEMIC ANTIBACTERIALS|J1
31774|ANTIVIRALS FOR SYSTEMIC USE|J5
31774|IMMUNOSTIMULATING AGENTS|L3
31771|ANALGESICS|N2
31755|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
31754|CARDIOVASCULAR SYSTEM|C
31753|DRUGS USED IN DIABETES|A10
31753|HUMAN INSULINS AND ANALOGUES|A10C
31753|Human insulins and analogues, fast-acting|A10C1
31753|Human insulins and analogues, long-acting|A10C5
31751|CEPHALOSPORINS|J1D
31750|IMMUNOSUPPRESSIVE AGENTS|L4
31716|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
31696|NOOTROPICS|N6D
31695|ANTI-EPILEPTICS|N3A
31693|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31693|ANTI-EPILEPTICS|N3
31692|IMMUNOSUPPRESSIVE AGENTS|L4
31691|ANTIPSYCHOTICS|N5A
31690|ANTI-EPILEPTICS|N3A
31690|ANTIPSYCHOTICS|N5A
31679|IMMUNOSUPPRESSIVE AGENTS|L4
31678|ANTIVIRALS FOR SYSTEMIC USE|J5
31677|IMMUNOSUPPRESSIVE AGENTS|L4
31676|ANALGESICS|N2
31675|SYSTEMIC ANTIBACTERIALS|J1
31670|ANTI-EPILEPTICS|N3A
31657|CEPHALOSPORINS|J1D
31654|Urinary incontinence products|G4B4
31652|PLATELET AGGREGATION INHIBITORS|B1C
31651|ANTIVIRALS FOR SYSTEMIC USE|J5
31633|CENTRAL NERVOUS SYSTEM|N
31625|ANTI-EPILEPTICS|N3
31621|SYSTEMIC ANTIBACTERIALS|J1
31620|Factor VIII|B2D1
31615|ANDROGENS, EXCLUDING G3E, G3F|G3B
31614|ANDROGENS, EXCLUDING G3E, G3F|G3B
31613|ANALGESICS|N2
31612|PLATELET AGGREGATION INHIBITORS|B1C
31612|DIRECT THROMBIN INHIBITORS|B1E
31590|DRUGS USED IN DIABETES|A10
31590|HUMAN INSULINS AND ANALOGUES|A10C
31590|Human insulins and analogues, intermediate-acting|A10C2
31581|DRUGS USED IN DIABETES|A10
31579|PARASITOLOGY|P
31578|ANALGESICS|N2
31573|FIBRINOLYTICS|B1D
31561|ANALGESICS|N2
31556|ANTIVIRALS FOR SYSTEMIC USE|J5
31531|IMMUNOSTIMULATING AGENTS|L3
31531|INTERFERONS|L3B
31497|ANALGESICS|N2
31496|Erectile dysfunction products|G4B3
31495|SYSTEMIC ANTIBACTERIALS|J1
31495|MACROLIDES AND SIMILAR TYPES|J1F
31483|ANALGESICS|N2
31483|ANTI-MIGRAINE PREPARATIONS|N2C
31482|Coxibs|M1A3
31482|ANALGESICS|N2
31482|ANTI-MIGRAINE PREPARATIONS|N2C
31481|ANTIEMETICS AND ANTINAUSEANTS|A4
31481|Coxibs|M1A3
31481|ANALGESICS|N2
31481|ANTI-MIGRAINE PREPARATIONS|N2C
31479|CARDIAC THERAPY|C1
31478|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
31478|SRNI antidepressants|N6A5
31477|ANTI-EPILEPTICS|N3A
31476|NOOTROPICS|N6D
31475|ANALGESICS|N2
31475|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
31474|ANTI-EPILEPTICS|N3
31473|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31472|ANTI-EPILEPTICS|N3
31472|ANTI-EPILEPTICS|N3A
31471|ANTIHYPERTENSIVES|C2
31471|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
31456|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
31455|ANALGESICS|N2
31455|ANTIPSYCHOTICS|N5A
31453|DIRECT THROMBIN INHIBITORS|B1E
31453|ANTI-ARRHYTHMICS|C1B
31452|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
31451|SYSTEMIC ANTIBACTERIALS|J1
31450|ANALGESICS|N2
31450|ANTI-MIGRAINE PREPARATIONS|N2C
31440|CARDIAC THERAPY|C1
31438|HYPNOTICS/SEDATIVES|N5B
31437|CARDIOVASCULAR SYSTEM|C
31434|DRUGS USED IN DIABETES|A10
31431|ANALGESICS|N2
31419|ANALGESICS|N2
31419|ANTI-EPILEPTICS|N3
31419|HYPNOTICS/SEDATIVES|N5B
31419|NOOTROPICS|N6D
31416|RADIODIAGNOSTIC AGENTS|T1G
31415|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31413|ANAESTHETICS|N1
31412|DRUGS USED IN DIABETES|A10
31412|HUMAN INSULINS AND ANALOGUES|A10C
31412|Human insulins and analogues, fast-acting|A10C1
31411|ANTIPSYCHOTICS|N5A
31400|SYSTEMIC ANTIBACTERIALS|J1
31399|ANTIVIRALS FOR SYSTEMIC USE|J5
31398|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31397|LUNG SURFACTANTS|R7C
31394|ANTIPSYCHOTICS|N5A
31393|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
31391|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31390|TRANQUILLISERS|N5C
31390|NOOTROPICS|N6D
31375|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
31371|ANDROGENS, EXCLUDING G3E, G3F|G3B
31370|PLATELET AGGREGATION INHIBITORS|B1C
31370|CARDIOVASCULAR SYSTEM|C
31363|CENTRAL NERVOUS SYSTEM|N
31362|CENTRAL NERVOUS SYSTEM|N
31358|VACCINES|J7
31355|ANALGESICS|N2
31339|ALKYLATING AGENTS|L1A
31338|CENTRAL NERVOUS SYSTEM|N
31333|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31332|VACCINES|J7
31331|SYSTEMIC ANTIBACTERIALS|J1
31317|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
31315|VACCINES|J7
31313|ANTIVIRALS FOR SYSTEMIC USE|J5
31310|CENTRAL NERVOUS SYSTEM|N
31310|ANTIPSYCHOTICS|N5A
31304|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
31303|B2-STIMULANTS|R3A
31302|CARDIOVASCULAR SYSTEM|C
31300|OPHTHALMOLOGICALS|S1
31298|ANTIPSYCHOTICS|N5A
31297|Erectile dysfunction products|G4B3
31296|RESPIRATORY SYSTEM|R
31295|SYSTEMIC ANTIBACTERIALS|J1
31276|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
31275|SYSTEMIC ANTIBACTERIALS|J1
31272|ANALGESICS|N2
31272|ANTI-EPILEPTICS|N3
31272|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
31271|CARDIOVASCULAR SYSTEM|C
31250|ANALGESICS|N2
31250|ANTI-EPILEPTICS|N3A
31241|CARDIOVASCULAR SYSTEM|C
31241|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
31241|ANTI-EPILEPTICS|N3
31240|CARDIOVASCULAR SYSTEM|C
31239|BPH (benign prostatic hypertrophy) products |G4C
31234|CARDIOVASCULAR SYSTEM|C
31230|ANTIVIRALS FOR SYSTEMIC USE|J5
31214|ANTI-ARRHYTHMICS|C1B
31213|PLATELET AGGREGATION INHIBITORS|B1C
31213|Erectile dysfunction products|G4B3
31210|WOUND HEALING AGENTS|D3
31199|ANTI-EPILEPTICS|N3A
31199|ANTIPSYCHOTICS|N5A
31195|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31193|PARASITOLOGY|P
31193|ANTI-MALARIALS|P1D
31190|Coxibs|M1A3
31190|ANALGESICS|N2
31173|ANTIULCERANTS|A2B
31172|ANTI-EPILEPTICS|N3A
31170|PLATELET AGGREGATION INHIBITORS|B1C
31156|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31152|ANTI-ARRHYTHMICS|C1B
31134|ANALGESICS|N2
31115|ANALGESICS|N2
31114|Protease inhibitors|J5C2
31112|ANALGESICS|N2
31111|SYSTEMIC ANTIBACTERIALS|J1
31110|ANALGESICS|N2
31100|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
31099|ANALGESICS|N2
31097|Urinary incontinence products|G4B4
31096|SYSTEMIC ANTIBACTERIALS|J1
31091|ANTIVIRALS FOR SYSTEMIC USE|J5
31080|ANTIVIRALS FOR SYSTEMIC USE|J5
31079|SYSTEMIC ANTIBACTERIALS|J1
31057|VACCINES|J7
31040|ANALGESICS|N2
31038|DRUGS USED IN DIABETES|A10
31038|HUMAN INSULINS AND ANALOGUES|A10C
31033|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
31033|CENTRAL NERVOUS SYSTEM|N
31031|PARASITOLOGY|P
31014|Erectile dysfunction products|G4B3
31010|SYSTEMIC ANTIBACTERIALS|J1
31010|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30943|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
30943|DRUGS USED IN DIABETES|A10
30937|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30936|PARASITOLOGY|P
30936|ANTI-MALARIALS|P1D
30930|ANTIHYPERTENSIVES|C2
30912|SYSTEMIC ANTIBACTERIALS|J1
30897|ANTIPSYCHOTICS|N5A
30893|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
30892|TRANQUILLISERS|N5C
30892|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
30892|SSRI antidepressants|N6A4
30892|SRNI antidepressants|N6A5
30892|NOOTROPICS|N6D
30891|ANTI-EPILEPTICS|N3A
30890|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
30890|SSRI antidepressants|N6A4
30890|SRNI antidepressants|N6A5
30890|NOOTROPICS|N6D
30880|CARDIOVASCULAR SYSTEM|C
30880|ANALGESICS|N2
30880|TRANQUILLISERS|N5C
30880|NOOTROPICS|N6D
30878|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30878|PARASITOLOGY|P
30877|SYSTEMIC ANTIBACTERIALS|J1
30875|ANTI-EPILEPTICS|N3
30865|ANTI-EPILEPTICS|N3A
30862|SYSTEMIC ANTIBACTERIALS|J1
30861|SYSTEMIC ANTIBACTERIALS|J1
30859|SYSTEMIC ANTIBACTERIALS|J1
30858|PARASITOLOGY|P
30857|Systemic dermatological antifungals|D1A2
30857|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30856|DIRECT THROMBIN INHIBITORS|B1E
30856|CARDIOVASCULAR SYSTEM|C
30855|ANALGESICS|N2
30853|SYSTEMIC ANTIBACTERIALS|J1
30853|CEPHALOSPORINS|J1D
30851|ANTI-ARRHYTHMICS|C1B
30831|SYSTEMIC ANTIBACTERIALS|J1
30830|SYSTEMIC ANTIBACTERIALS|J1
30829|SYSTEMIC ANTIBACTERIALS|J1
30828|SYSTEMIC ANTIBACTERIALS|J1
30827|SYSTEMIC ANTIBACTERIALS|J1
30826|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30825|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
30821|ANTIVIRALS FOR SYSTEMIC USE|J5
30820|SYSTEMIC ANTIBACTERIALS|J1
30820|Carbapenems|J1P2
30818|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
30811|ANTIVIRALS FOR SYSTEMIC USE|J5
30810|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30809|ANTIPSYCHOTICS|N5A
30809|NOOTROPICS|N6D
30807|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30806|SYSTEMIC ANTIBACTERIALS|J1
30806|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30805|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30804|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30802|CEPHALOSPORINS|J1D
30799|SYSTEMIC ANTIBACTERIALS|J1
30797|SYSTEMIC ANTIBACTERIALS|J1
30796|SYSTEMIC ANTIBACTERIALS|J1
30794|SYSTEMIC ANTIBACTERIALS|J1
30792|ANALGESICS|N2
30776|GASTROPROKINETICS|A3F
30775|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
30774|Biguanide antidiabetics|A10B2
30771|CARDIOVASCULAR SYSTEM|C
30771|ANDROGENS, EXCLUDING G3E, G3F|G3B
30752|MACROLIDES AND SIMILAR TYPES|J1F
30744|ANTIPSYCHOTICS|N5A
30743|ANALGESICS|N2
30742|ANTIPSYCHOTICS|N5A
30738|CENTRAL NERVOUS SYSTEM|N
30737|IMMUNOSUPPRESSIVE AGENTS|L4
30732|ANTIVIRALS FOR SYSTEMIC USE|J5
30731|ANTI-EPILEPTICS|N3A
30714|FIBRINOLYTICS|B1D
30713|ANTI-MIGRAINE PREPARATIONS|N2C
30712|B2-STIMULANTS|R3A
30711|CARDIOVASCULAR SYSTEM|C
30711|ANTIHYPERTENSIVES|C2
30711|Urinary incontinence products|G4B4
30711|BPH (benign prostatic hypertrophy) products |G4C
30710|DIRECT THROMBIN INHIBITORS|B1E
30710|ANTIHYPERTENSIVES|C2
30690|ANTIVIRALS FOR SYSTEMIC USE|J5
30688|SYSTEMIC ANTIBACTERIALS|J1
30687|SYSTEMIC ANTIBACTERIALS|J1
30687|MACROLIDES AND SIMILAR TYPES|J1F
30686|SYSTEMIC ANTIBACTERIALS|J1
30683|SYSTEMIC ANTIBACTERIALS|J1
30682|ANTIVIRALS FOR SYSTEMIC USE|J5
30682|Non-nucleoside reverse transcriptase inhibitors|J5C3
30680|SYSTEMIC ANTIBACTERIALS|J1
30679|ANTIVIRALS FOR SYSTEMIC USE|J5
30679|Interferons, alpha|L3B1
30678|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
30678|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
30676|SYSTEMIC ANTIBACTERIALS|J1
30672|SYSTEMIC ANTIBACTERIALS|J1
30658|DRUGS USED IN DIABETES|A10
30656|SYSTEMIC ANTIBACTERIALS|J1
30655|ANALGESICS|N2
30654|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30654|PARASITOLOGY|P
30653|ULTRASOUND AGENTS|T1F
30635|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
30634|ANTIVIRALS FOR SYSTEMIC USE|J5
30633|ANTIVIRALS FOR SYSTEMIC USE|J5
30631|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
30615|ANDROGENS, EXCLUDING G3E, G3F|G3B
30614|HYPNOTICS/SEDATIVES|N5B
30612|MACROLIDES AND SIMILAR TYPES|J1F
30612|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30594|ALKYLATING AGENTS|L1A
30593|SYSTEMIC ANTIBACTERIALS|J1
30592|ANTIVIRALS FOR SYSTEMIC USE|J5
30592|Non-nucleoside reverse transcriptase inhibitors|J5C3
30575|CARDIOVASCULAR SYSTEM|C
30496|SYSTEMIC ANTIBACTERIALS|J1
30494|Erectile dysfunction products|G4B3
30490|DRUGS USED IN DIABETES|A10
30490|CENTRAL NERVOUS SYSTEM|N
30490|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
30477|ANTIULCERANTS|A2B
30476|IMMUNOSUPPRESSIVE AGENTS|L4
30475|Carbapenems|J1P2
30474|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30457|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
30457|TRANQUILLISERS|N5C
30457|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
30456|ANALGESICS|N2
30456|SSRI antidepressants|N6A4
30456|SRNI antidepressants|N6A5
30455|ANTIHYPERTENSIVES|C2
30454|ANTI-EPILEPTICS|N3
30453|DIRECT THROMBIN INHIBITORS|B1E
30453|CARDIOVASCULAR SYSTEM|C
30452|SYSTEMIC ANTIBACTERIALS|J1
30451|ANTIVIRALS FOR SYSTEMIC USE|J5
30450|PLATELET AGGREGATION INHIBITORS|B1C
30414|DERMATOLOGICALS|D
30412|ANTIPSYCHOTICS|N5A
30412|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
30410|IMMUNOSUPPRESSIVE AGENTS|L4
30385|NOOTROPICS|N6D
30384|SYSTEMIC ANTIBACTERIALS|J1
30382|ANTIVIRALS FOR SYSTEMIC USE|J5
30372|PARASITOLOGY|P
30371|ANTIPSYCHOTICS|N5A
30370|HEPARINS |B1B
30358|BPH (benign prostatic hypertrophy) products |G4C
30355|Protease inhibitors|J5C2
30353|DIRECT THROMBIN INHIBITORS|B1E
30351|SYSTEMIC ANTIBACTERIALS|J1
30331|ANTIVIRALS FOR SYSTEMIC USE|J5
30330|TRANQUILLISERS|N5C
30313|IMMUNOSUPPRESSIVE AGENTS|L4
30312|ANTI-ARRHYTHMICS|C1B
30311|ANTIPSYCHOTICS|N5A
30310|ANTIULCERANTS|A2B
30304|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
30300|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
30300|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
30298|IMMUNOSUPPRESSIVE AGENTS|L4
30296|BPH (benign prostatic hypertrophy) products |G4C
30295|BPH (benign prostatic hypertrophy) products |G4C
30294|MRI AGENTS|T1E
30293|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
30278|ANTIVIRALS FOR SYSTEMIC USE|J5
30276|ANTIEMETICS AND ANTINAUSEANTS|A4
30274|ANTIVIRALS FOR SYSTEMIC USE|J5
30273|ANTIVIRALS FOR SYSTEMIC USE|J5
30271|TRANQUILLISERS|N5C
30271|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
30259|SYSTEMIC ANTIBACTERIALS|J1
30258|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
30255|IMMUNOSUPPRESSIVE AGENTS|L4
30253|ANALGESICS|N2
30253|ANTI-MIGRAINE PREPARATIONS|N2C
30252|CENTRAL NERVOUS SYSTEM|N
30252|ANTIPSYCHOTICS|N5A
30252|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
30252|NOOTROPICS|N6D
30251|SYSTEMIC ANTIBACTERIALS|J1
30251|AMINOGLYCOSIDES|J1K
30236|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
30236|ANALGESICS|N2
30232|ANTIEMETICS AND ANTINAUSEANTS|A4
30213|ANTIVIRALS FOR SYSTEMIC USE|J5
30193|VACCINES|J7
30191|ANTIVIRALS FOR SYSTEMIC USE|J5
30175|Erectile dysfunction products|G4B3
30172|ANTIHYPERTENSIVES|C2
30171|CARDIOVASCULAR SYSTEM|C
30153|ANTIVIRALS FOR SYSTEMIC USE|J5
30151|DRUGS USED IN DIABETES|A10
30141|ANTIVIRALS FOR SYSTEMIC USE|J5
30140|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
30139|ANALGESICS|N2
30136|Erectile dysfunction products|G4B3
30134|VACCINES|J7
30133|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
30117|ANTI-ARRHYTHMICS|C1B
30116|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
30115|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
30112|ANTIMETABOLITES|L1B
30111|IMMUNOSUPPRESSIVE AGENTS|L4
30110|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
30091|ANALGESICS|N2
30078|Urinary incontinence products|G4B4
30076|ANTIVIRALS FOR SYSTEMIC USE|J5
30073|Ocular antineovascularisation products|S1P
30072|ANTITUSSIVES|R5D
30071|ANTIVIRALS FOR SYSTEMIC USE|J5
30070|ANALGESICS|N2
30061|AMINOGLYCOSIDES|J1K
30060|ANALGESICS|N2
30059|CARDIOVASCULAR SYSTEM|C
30058|IMMUNOSTIMULATING AGENTS|L3
30053|Coxibs|M1A3
30053|ANALGESICS|N2
30050|ANTI-EPILEPTICS|N3A
30050|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
30034|Vitamin D|A11C2
30012|ANTIVIRALS FOR SYSTEMIC USE|J5
29992|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
29980|SYSTEMIC ANTIBACTERIALS|J1
29979|SYSTEMIC ANTIBACTERIALS|J1
29978|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29978|PARASITOLOGY|P
29977|ANTIVIRALS FOR SYSTEMIC USE|J5
29971|SYSTEMIC ANTIBACTERIALS|J1
29971|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29955|SYSTEMIC ANTIBACTERIALS|J1
29954|SYSTEMIC ANTIBACTERIALS|J1
29953|TRANQUILLISERS|N5C
29953|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
29952|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29932|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
29931|IMMUNOSUPPRESSIVE AGENTS|L4
29915|Antigonadotrophin-releasing hormones|H1C3
29913|ANALGESICS|N2
29912|Factor VIII|B2D1
29912|Factors II, VII, IX and X|B2D2
29891|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
29879|TRANQUILLISERS|N5C
29878|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29877|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29876|SYSTEMIC ANTIBACTERIALS|J1
29875|ANTI-EPILEPTICS|N3
29874|ANALGESICS|N2
29872|IMMUNOSUPPRESSIVE AGENTS|L4
29870|CARDIAC THERAPY|C1
29855|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
29854|ANTIVIRALS FOR SYSTEMIC USE|J5
29853|B2-STIMULANTS|R3A
29852|DRUGS USED IN DIABETES|A10
29851|NOOTROPICS|N6D
29839|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
29835|CARDIOVASCULAR SYSTEM|C
29835|MRI AGENTS|T1E
29834|CARDIAC THERAPY|C1
29833|ANTIHYPERTENSIVES|C2
29833|Erectile dysfunction products|G4B3
29830|ANTIVIRALS FOR SYSTEMIC USE|J5
29810|BPH (benign prostatic hypertrophy) products |G4C
29790|ANTIPSYCHOTICS|N5A
29770|ANALGESICS|N2
29754|ANALGESICS|N2
29753|ANTIPSYCHOTICS|N5A
29751|SYSTEMIC ANTIBACTERIALS|J1
29751|ANTIVIRALS FOR SYSTEMIC USE|J5
29750|ANALGESICS|N2
29735|ANTI-ARRHYTHMICS|C1B
29733|SYSTEMIC ANTIBACTERIALS|J1
29730|PARASITOLOGY|P
29717|ANTIHYPERTENSIVES|C2
29714|ANTIPSYCHOTICS|N5A
29710|ANTIPSYCHOTICS|N5A
29693|ANTIEMETICS AND ANTINAUSEANTS|A4
29672|IMMUNOSUPPRESSIVE AGENTS|L4
29657|Urinary incontinence products|G4B4
29656|RESPIRATORY SYSTEM|R
29655|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
29651|PARASITOLOGY|P
29636|CARDIOVASCULAR SYSTEM|C
29636|MRI AGENTS|T1E
29634|HYPNOTICS/SEDATIVES|N5B
29632|ANALGESICS|N2
29632|ANTI-MIGRAINE PREPARATIONS|N2C
29623|ANALGESICS|N2
29620|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
29619|BPH (benign prostatic hypertrophy) products |G4C
29616|SYSTEMIC ANTIBACTERIALS|J1
29615|TRANQUILLISERS|N5C
29612|PLATELET AGGREGATION INHIBITORS|B1C
29610|SYSTEMIC ANTIBACTERIALS|J1
29597|RESPIRATORY SYSTEM|R
29596|ANAESTHETICS, LOCAL|N1B
29596|ANALGESICS|N2
29591|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
29591|Alpha-glucosidase inhibitor antidiabetics|A10B5
29572|SYSTEMIC ANTIBACTERIALS|J1
29572|CEPHALOSPORINS|J1D
29570|HYPNOTICS/SEDATIVES|N5B
29554|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
29554|SSRI antidepressants|N6A4
29553|CENTRAL NERVOUS SYSTEM|N
29552|CALCITONINS|H4A
29532|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29531|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29530|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
29514|ANTIVIRALS FOR SYSTEMIC USE|J5
29513|ANTIVIRALS FOR SYSTEMIC USE|J5
29512|Bile stone therapy|A5A2
29512|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
29511|HUMAN INSULINS AND ANALOGUES|A10C
29511|Human insulins and analogues, intermediate-acting|A10C2
29502|CARDIOVASCULAR SYSTEM|C
29499|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29499|VACCINES|J7
29497|ANTIHYPERTENSIVES|C2
29493|ANTIPSYCHOTICS|N5A
29492|ANTIPSYCHOTICS|N5A
29492|SSRI antidepressants|N6A4
29470|ANTIVIRALS FOR SYSTEMIC USE|J5
29451|DERMATOLOGICALS|D
29451|Systemic dermatological antifungals|D1A2
29451|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29450|PARASITOLOGY|P
29447|ANTIVIRALS FOR SYSTEMIC USE|J5
29434|ANALGESICS|N2
29417|NOOTROPICS|N6D
29416|NOOTROPICS|N6D
29413|ANTIVIRALS FOR SYSTEMIC USE|J5
29411|PARASITOLOGY|P
29391|ANTIVIRALS FOR SYSTEMIC USE|J5
29391|IMMUNOSTIMULATING AGENTS|L3
29377|SYSTEMIC ANTIBACTERIALS|J1
29375|ANTI-EPILEPTICS|N3
29373|ANTIPSYCHOTICS|N5A
29373|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
29372|ANALGESICS|N2
29370|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
29359|ANTIVIRALS FOR SYSTEMIC USE|J5
29355|ANTI-ARRHYTHMICS|C1B
29354|MACROLIDES AND SIMILAR TYPES|J1F
29353|Erectile dysfunction products|G4B3
29350|SYSTEMIC ANTIBACTERIALS|J1
29350|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29335|ANTIHYPERTENSIVES|C2
29335|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
29334|CEPHALOSPORINS|J1D
29332|CEPHALOSPORINS|J1D
29316|ANTIHYPERTENSIVES|C2
29316|ACE INHIBITORS, PLAIN|C9A
29314|Erectile dysfunction products|G4B3
29312|ANTIVIRALS FOR SYSTEMIC USE|J5
29312|Non-nucleoside reverse transcriptase inhibitors|J5C3
29311|SYSTEMIC ANTIBACTERIALS|J1
29295|ANTI-EPILEPTICS|N3A
29294|IMMUNOSUPPRESSIVE AGENTS|L4
29277|ANALGESICS|N2
29277|ANTIPSYCHOTICS|N5A
29276|DRUGS USED IN DIABETES|A10
29276|HUMAN INSULINS AND ANALOGUES|A10C
29276|Human insulins and analogues, intermediate-acting|A10C2
29275|Glitazone antidiabetics|A10B4
29275|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
29273|ANALGESICS|N2
29273|ANTI-EPILEPTICS|N3
29273|ANTIPSYCHOTICS|N5A
29273|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
29270|SYSTEMIC ANTIBACTERIALS|J1
29262|ANAESTHETICS|N1
29262|ANALGESICS|N2
29261|Carbapenems|J1P2
29260|ANTIVIRALS FOR SYSTEMIC USE|J5
29256|ANALGESICS|N2
29253|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29253|IMMUNOSUPPRESSIVE AGENTS|L4
29245|ANTIVIRALS FOR SYSTEMIC USE|J5
29241|Coxibs|M1A3
29238|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
29237|PARASITOLOGY|P
29236|DRUGS USED IN DIABETES|A10
29236|HUMAN INSULINS AND ANALOGUES|A10C
29236|Human insulins and analogues, intermediate-acting|A10C2
29235|APPETITE STIMULANTS|A15
29215|ANTITUSSIVES|R5D
29212|SYSTEMIC ANTIBACTERIALS|J1
29199|CARDIOVASCULAR SYSTEM|C
29199|ANTIHYPERTENSIVES|C2
29199|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
29198|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
29195|DRUGS USED IN DIABETES|A10
29195|HUMAN INSULINS AND ANALOGUES|A10C
29195|Human insulins and analogues, intermediate-acting|A10C2
29193|Urinary incontinence products|G4B4
29193|ANALGESICS|N2
29193|ANTITUSSIVES|R5D
29192|Protease inhibitors|J5C2
29190|CEPHALOSPORINS|J1D
29182|Combinations of sulphonylureas and biguanide antidiabetics|A10B3
29175|SYSTEMIC ANTIBACTERIALS|J1
29175|ANTIVIRALS FOR SYSTEMIC USE|J5
29172|ANTI-ACNE PREPARATIONS|D10
29157|PLATELET AGGREGATION INHIBITORS|B1C
29157|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
29154|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29153|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
29152|Systemic dermatological antifungals|D1A2
29152|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29129|SYSTEMIC ANTIBACTERIALS|J1
29129|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
29128|ANALGESICS|N2
29127|CEPHALOSPORINS|J1D
29126|MRI AGENTS|T1E
29125|SYSTEMIC ANTIBACTERIALS|J1
29123|BPH (benign prostatic hypertrophy) products |G4C
29119|PLATELET AGGREGATION INHIBITORS|B1C
29119|Fibrinogen|B2D5
29118|ANTI-EPILEPTICS|N3
29112|ANALGESICS|N2
29111|CEPHALOSPORINS|J1D
29083|DRUGS USED IN DIABETES|A10
29081|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
29080|SYSTEMIC ANTIBACTERIALS|J1
29076|DIURETICS|C3
29074|ANTIULCERANTS|A2B
29073|ANTIULCERANTS|A2B
29070|IMMUNOSUPPRESSIVE AGENTS|L4
29051|ANDROGENS, EXCLUDING G3E, G3F|G3B
29031|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
29031|ANTI-ACNE PREPARATIONS|D10
29031|ANTIVIRALS FOR SYSTEMIC USE|J5
29019|SYSTEMIC ANTIBACTERIALS|J1
29010|APPETITE STIMULANTS|A15
28990|ANTI-ACNE PREPARATIONS|D10
28951|DIRECT THROMBIN INHIBITORS|B1E
28951|ANTI-ARRHYTHMICS|C1B
28934|ANTIPSYCHOTICS|N5A
28931|NOOTROPICS|N6D
28930|ANTI-MIGRAINE PREPARATIONS|N2C
28911|ANTIHYPERTENSIVES|C2
28910|VACCINES|J7
28890|ANTIVIRALS FOR SYSTEMIC USE|J5
28871|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
28871|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
28857|VACCINES|J7
28856|VACCINES|J7
28856|RESPIRATORY SYSTEM|R
28844|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
28840|ANALGESICS|N2
28840|ANTI-MIGRAINE PREPARATIONS|N2C
28839|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
28839|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
28837|NOOTROPICS|N6D
28836|ANTI-EPILEPTICS|N3A
28834|ANALGESICS|N2
28833|TRANQUILLISERS|N5C
28833|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
28832|TRANQUILLISERS|N5C
28831|ANALGESICS|N2
28830|TRANQUILLISERS|N5C
28816|SYSTEMIC ANTIBACTERIALS|J1
28815|ANTIHYPERTENSIVES|C2
28815|CALCIUM ANTAGONISTS|C8
28813|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
28812|Non-nucleoside reverse transcriptase inhibitors|J5C3
28799|CALCIUM ANTAGONISTS|C8
28799|Erectile dysfunction products|G4B3
28798|FIBRINOLYTICS|B1D
28795|ANALGESICS|N2
28791|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
28772|ANALGESICS|N2
28710|ANTIPSYCHOTICS|N5A
28697|SYSTEMIC ANTIBACTERIALS|J1
28697|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
28696|Urinary incontinence products|G4B4
28696|ANALGESICS|N2
28694|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
28693|ANTIVIRALS FOR SYSTEMIC USE|J5
28671|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
28634|ANTI-ACNE PREPARATIONS|D10
28632|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
28631|Vitamin B6 (pyridoxine), plain|A11X2
28631|CARDIOVASCULAR SYSTEM|C
28631|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
28630|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
28594|ANTI-ARRHYTHMICS|C1B
28592|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
28591|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
28591|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
28590|SYSTEMIC ANTIBACTERIALS|J1
28574|CALCIUM ANTAGONISTS|C8
28572|ANALGESICS|N2
28560|CARDIOVASCULAR SYSTEM|C
28558|SYSTEMIC ANTIBACTERIALS|J1
28558|Carbapenems|J1P2
28554|SYSTEMIC ANTIBACTERIALS|J1
28554|PARASITOLOGY|P
28553|ANALGESICS|N2
28552|ANTITUSSIVES|R5D
28540|ANTI-EPILEPTICS|N3
28539|OPHTHALMOLOGICALS|S1
28536|ANALGESICS|N2
28536|SSRI antidepressants|N6A4
28533|DIRECT THROMBIN INHIBITORS|B1E
28530|ANALGESICS|N2
28471|BPH (benign prostatic hypertrophy) products |G4C
28470|BPH (benign prostatic hypertrophy) products |G4C
28454|IMMUNOSUPPRESSIVE AGENTS|L4
28453|BPH (benign prostatic hypertrophy) products |G4C
28453|Antigonadotrophin-releasing hormones|H1C3
28452|ANTIULCERANTS|A2B
28451|ANTIVIRALS FOR SYSTEMIC USE|J5
28450|ANTIVIRALS FOR SYSTEMIC USE|J5
28450|IMMUNOSTIMULATING AGENTS|L3
28434|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
28434|Glitazone antidiabetics|A10B4
28433|ANTIPSYCHOTICS|N5A
28433|HYPNOTICS/SEDATIVES|N5B
28432|Erectile dysfunction products|G4B3
28431|ANTIHYPERTENSIVES|C2
28430|ANTIVIRALS FOR SYSTEMIC USE|J5
28430|IMMUNOSUPPRESSIVE AGENTS|L4
28410|SYSTEMIC ANTIBACTERIALS|J1
28397|PLATELET AGGREGATION INHIBITORS|B1C
28395|NOOTROPICS|N6D
28392|ANTIVIRALS FOR SYSTEMIC USE|J5
28391|ANTIVIRALS FOR SYSTEMIC USE|J5
28390|ANTIVIRALS FOR SYSTEMIC USE|J5
28379|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
28373|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
28359|DERMATOLOGICALS|D
28359|THYROID THERAPY|H3
28358|HEPARINS |B1B
28358|WOUND HEALING AGENTS|D3
28355|RADIODIAGNOSTIC AGENTS|T1G
28354|Interferons, beta|L3B2
28353|DERMATOLOGICALS|D
28351|ANTI-EPILEPTICS|N3A
28282|ALKYLATING AGENTS|L1A
28279|ANTIVIRALS FOR SYSTEMIC USE|J5
28273|Vitamin D|A11C2
28272|ALKYLATING AGENTS|L1A
28270|ALKYLATING AGENTS|L1A
28255|ANTIVIRALS FOR SYSTEMIC USE|J5
28252|DRUGS USED IN DIABETES|A10
28233|ANTIVIRALS FOR SYSTEMIC USE|J5
28231|ANTIEMETICS AND ANTINAUSEANTS|A4
28230|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
28230|NOOTROPICS|N6D
28219|PLATELET AGGREGATION INHIBITORS|B1C
28218|TRANQUILLISERS|N5C
28218|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
28218|SSRI antidepressants|N6A4
28214|ANTIVIRALS FOR SYSTEMIC USE|J5
28212|SYSTEMIC ANTIBACTERIALS|J1
28211|ANALGESICS|N2
28210|PARASITOLOGY|P
28195|ANTI-MIGRAINE PREPARATIONS|N2C
28194|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
28194|IMMUNOSUPPRESSIVE AGENTS|L4
28190|ANTIHYPERTENSIVES|C2
28175|CALCIUM ANTAGONISTS|C8
28173|ANTI-GOUT PREPARATIONS|M4
28172|SYSTEMIC ANTIBACTERIALS|J1
28171|ANALGESICS|N2
28162|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
28162|HYPNOTICS/SEDATIVES|N5B
28157|CARDIOVASCULAR SYSTEM|C
28155|Erectile dysfunction products|G4B3
28135|IMMUNOSTIMULATING AGENTS|L3
28133|ANALGESICS|N2
28133|ANTI-EPILEPTICS|N3
28133|ANTI-EPILEPTICS|N3A
28132|Non-nucleoside reverse transcriptase inhibitors|J5C3
28131|SYSTEMIC ANTIBACTERIALS|J1
28131|CEPHALOSPORINS|J1D
28130|Coxibs|M1A3
28130|ANALGESICS|N2
28113|CARDIOVASCULAR SYSTEM|C
28110|ANTIVIRALS FOR SYSTEMIC USE|J5
28090|Alpha-glucosidase inhibitor antidiabetics|A10B5
28053|ANALGESICS|N2
28052|ANALGESICS|N2
28051|PLATELET AGGREGATION INHIBITORS|B1C
28050|ANALGESICS|N2
28050|ANTI-EPILEPTICS|N3A
28050|ANTIPSYCHOTICS|N5A
28050|NOOTROPICS|N6D
28034|CARDIOVASCULAR SYSTEM|C
28034|ANTIHYPERTENSIVES|C2
28034|ACE INHIBITORS, PLAIN|C9A
28033|ANTI-ARRHYTHMICS|C1B
28032|ANTIVIRALS FOR SYSTEMIC USE|J5
28031|ANTIVIRALS FOR SYSTEMIC USE|J5
28030|TRANQUILLISERS|N5C
28011|ANTIVIRALS FOR SYSTEMIC USE|J5
28010|ANTI-ARRHYTHMICS|C1B
27975|NOOTROPICS|N6D
27974|ANALGESICS|N2
27974|ANTI-EPILEPTICS|N3
27973|IMMUNOSUPPRESSIVE AGENTS|L4
27953|DRUGS USED IN DIABETES|A10
27952|ANTIVIRALS FOR SYSTEMIC USE|J5
27951|ANTIHYPERTENSIVES|C2
27951|CALCIUM ANTAGONISTS|C8
27951|ACE INHIBITORS, PLAIN|C9A
27950|SYSTEMIC ANTIBACTERIALS|J1
27913|RESPIRATORY SYSTEM|R
27912|ANAESTHETICS, LOCAL|N1B
27912|ANALGESICS|N2
27910|ANDROGENS, EXCLUDING G3E, G3F|G3B
27894|ANALGESICS|N2
27893|ANALGESICS|N2
27891|ANALGESICS|N2
27850|HEPARINS |B1B
27821|Urinary incontinence products|G4B4
27820|CALCIUM ANTAGONISTS|C8
27819|NOOTROPICS|N6D
27818|ANTI-EPILEPTICS|N3A
27818|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
27817|Antigonadotrophin-releasing hormones|H1C3
27816|HYPNOTICS/SEDATIVES|N5B
27815|TRANQUILLISERS|N5C
27814|ANTIPSYCHOTICS|N5A
27814|TRANQUILLISERS|N5C
27814|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
27811|CARDIOVASCULAR SYSTEM|C
27792|ANTI-GOUT PREPARATIONS|M4
27770|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
27751|DRUGS USED IN DIABETES|A10
27751|ANTI-ARRHYTHMICS|C1B
27751|ANTIHYPERTENSIVES|C2
27751|ANALGESICS|N2
27751|ANTI-EPILEPTICS|N3
27750|ANALGESICS|N2
27730|VACCINES|J7
27700|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
27697|HYPNOTICS/SEDATIVES|N5B
27697|SYSTEMIC ANTIHISTAMINES|R6
27695|ANTIEMETICS AND ANTINAUSEANTS|A4
27694|ANTIVIRALS FOR SYSTEMIC USE|J5
27693|ANTI-GOUT PREPARATIONS|M4
27690|Erectile dysfunction products|G4B3
27673|DRUGS USED IN DIABETES|A10
27672|ANALGESICS|N2
27651|CALCIUM ANTAGONISTS|C8
27594|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
27590|ANTI-ACNE PREPARATIONS|D10
27575|ALKYLATING AGENTS|L1A
27574|ANTIVIRALS FOR SYSTEMIC USE|J5
27574|Non-nucleoside reverse transcriptase inhibitors|J5C3
27571|SYSTEMIC ANTIBACTERIALS|J1
27556|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
27550|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
27532|CENTRAL NERVOUS SYSTEM|N
27532|ANTI-EPILEPTICS|N3A
27532|TRANQUILLISERS|N5C
27532|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
27530|DIURETICS|C3
27493|ANTIVIRALS FOR SYSTEMIC USE|J5
27492|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
27471|ANTIVIRALS FOR SYSTEMIC USE|J5
27470|Coxibs|M1A3
27470|ANALGESICS|N2
27454|Biguanide antidiabetics|A10B2
27452|Urinary incontinence products|G4B4
27451|IMMUNOSTIMULATING AGENTS|L3
27432|ANALGESICS|N2
27390|SYSTEMIC ANTIBACTERIALS|J1
27372|ANTI-EPILEPTICS|N3A
27371|SYSTEMIC ANTIBACTERIALS|J1
27352|SYSTEMIC ANTIBACTERIALS|J1
27333|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
27332|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
27331|ANALGESICS|N2
27330|ANALGESICS|N2
27312|ANTI-ACNE PREPARATIONS|D10
27310|CEPHALOSPORINS|J1D
27270|GROWTH HORMONES|H4C
27259|PARASITOLOGY|P
27256|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
27231|ANTIPSYCHOTICS|N5A
27230|PLATELET AGGREGATION INHIBITORS|B1C
27230|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
27212|ANALGESICS|N2
27211|SYSTEMIC ANTIBACTERIALS|J1
27210|HUMAN INSULINS AND ANALOGUES|A10C
27210|Human insulins and analogues, fast-acting|A10C1
27181|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
27180|Bile stone therapy|A5A2
27180|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
27177|VACCINES|J7
27177|ANTI-MALARIALS|P1D
27174|CARDIOVASCULAR SYSTEM|C
27173|NOOTROPICS|N6D
27156|ANALGESICS|N2
27154|ANTIVIRALS FOR SYSTEMIC USE|J5
27150|Erectile dysfunction products|G4B3
27150|Urinary incontinence products|G4B4
27150|SRNI antidepressants|N6A5
27131|ANTIVIRALS FOR SYSTEMIC USE|J5
27130|SYSTEMIC ANTIBACTERIALS|J1
27130|Carbapenems|J1P2
27111|Protease inhibitors|J5C2
27110|FIBRINOLYTICS|B1D
27090|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
27081|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
27070|ANTIHYPERTENSIVES|C2
27051|DERMATOLOGICALS|D
27050|ANALGESICS|N2
27031|ANALGESICS|N2
27030|HUMAN INSULINS AND ANALOGUES|A10C
27030|Human insulins and analogues, intermediate-acting|A10C2
27011|ANTIVIRALS FOR SYSTEMIC USE|J5
26991|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
26990|ANTI-ACNE PREPARATIONS|D10
26990|SYSTEMIC ANTIBACTERIALS|J1
26931|DIRECT THROMBIN INHIBITORS|B1E
26930|ANTIVIRALS FOR SYSTEMIC USE|J5
26919|ANALGESICS|N2
26916|ALKYLATING AGENTS|L1A
26910|SYSTEMIC ANTIBACTERIALS|J1
26910|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
26891|ANALGESICS|N2
26837|IMMUNOSTIMULATING AGENTS|L3
26836|ANTIVIRALS FOR SYSTEMIC USE|J5
26834|MACROLIDES AND SIMILAR TYPES|J1F
26833|SYSTEMIC ANTIBACTERIALS|J1
26832|ANTIPSYCHOTICS|N5A
26831|HEPARINS |B1B
26831|DIRECT THROMBIN INHIBITORS|B1E
26830|SYSTEMIC ANTIBACTERIALS|J1
26810|Factors II, VII, IX and X|B2D2
26770|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
26770|Glitazone antidiabetics|A10B4
26770|ANTIHYPERTENSIVES|C2
26753|ANTIEMETICS AND ANTINAUSEANTS|A4
26753|Urinary incontinence products|G4B4
26753|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
26751|ANTIULCERANTS|A2B
26737|B2-STIMULANTS|R3A
26735|SYSTEMIC ANTIBACTERIALS|J1
26734|VACCINES|J7
26733|ANTIHYPERTENSIVES|C2
26733|BETA-BLOCKING AGENTS|C7
26733|Miotics and antiglaucoma preparations, topical|S1E2
26732|ANTI-ARRHYTHMICS|C1B
26730|ANTIHYPERTENSIVES|C2
26713|DERMATOLOGICALS|D
26692|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
26675|FIBRINOLYTICS|B1D
26673|DIRECT THROMBIN INHIBITORS|B1E
26673|ANTI-ARRHYTHMICS|C1B
26671|IMMUNOSUPPRESSIVE AGENTS|L4
26651|SYSTEMIC ANTIBACTERIALS|J1
26630|ANTI-ARRHYTHMICS|C1B
26610|WOUND HEALING AGENTS|D3
26610|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
26597|GASTROPROKINETICS|A3F
26590|ANTI-MIGRAINE PREPARATIONS|N2C
26575|PLATELET AGGREGATION INHIBITORS|B1C
26574|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
26560|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
26557|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
26556|PARASITOLOGY|P
26555|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
26555|SSRI antidepressants|N6A4
26554|IMMUNOSUPPRESSIVE AGENTS|L4
26535|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
26533|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
26532|B2-STIMULANTS|R3A
26531|ANTIHYPERTENSIVES|C2
26531|BETA-BLOCKING AGENTS|C7
26531|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
26530|Erectile dysfunction products|G4B3
26500|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
26499|TRANQUILLISERS|N5C
26498|TRANQUILLISERS|N5C
26496|ANALGESICS|N2
26496|TRANQUILLISERS|N5C
26493|SYSTEMIC ANTIBACTERIALS|J1
26492|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
26491|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
26490|TRANQUILLISERS|N5C
26490|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
26472|ANALGESICS|N2
26451|NOOTROPICS|N6D
26450|BPH (benign prostatic hypertrophy) products |G4C
26430|PLATELET AGGREGATION INHIBITORS|B1C
26410|ANTIHYPERTENSIVES|C2
26390|ANTI-EPILEPTICS|N3
26370|SYSTEMIC ANTIBACTERIALS|J1
26351|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
26335|ANTIHYPERTENSIVES|C2
26334|ANTIVIRALS FOR SYSTEMIC USE|J5
26332|ANALGESICS|N2
26331|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
26311|Urinary incontinence products|G4B4
26310|ANTIVIRALS FOR SYSTEMIC USE|J5
26298|RESPIRATORY SYSTEM|R
26298|LUNG SURFACTANTS|R7C
26295|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
26293|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
26292|INTERFERONS|L3B
26291|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
26290|ANTIVIRALS FOR SYSTEMIC USE|J5
26271|DRUGS USED IN DIABETES|A10
26271|ANTIVIRALS FOR SYSTEMIC USE|J5
26253|CARDIOVASCULAR SYSTEM|C
26250|DRUGS USED IN DIABETES|A10
26250|CARDIOVASCULAR SYSTEM|C
26241|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
26241|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
26239|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
26237|CARDIOVASCULAR SYSTEM|C
26236|ANTIVIRALS FOR SYSTEMIC USE|J5
26231|ANTIHYPERTENSIVES|C2
26231|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
26231|Miotics and antiglaucoma preparations, topical|S1E2
26230|ANALGESICS|N2
26212|ANTIPSYCHOTICS|N5A
26211|HUMAN INSULINS AND ANALOGUES|A10C
26192|ANALGESICS|N2
26191|HEPARINS |B1B
26191|DIRECT THROMBIN INHIBITORS|B1E
26170|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
26159|ANTIVIRALS FOR SYSTEMIC USE|J5
26159|Non-nucleoside reverse transcriptase inhibitors|J5C3
26154|ANTIHYPERTENSIVES|C2
26150|VACCINES|J7
26115|Protease inhibitors|J5C2
26114|BPH (benign prostatic hypertrophy) products |G4C
26113|CARDIAC THERAPY|C1
26113|RESPIRATORY SYSTEM|R
26110|PARASITOLOGY|P
26090|ANALGESICS|N2
26074|BPH (benign prostatic hypertrophy) products |G4C
26071|ANALGESICS|N2
26060|ANALGESICS|N2
26059|CARDIOVASCULAR SYSTEM|C
26058|ACE INHIBITORS, PLAIN|C9A
26056|CALCIUM ANTAGONISTS|C8
26055|ANTIPSYCHOTICS|N5A
26054|ANALGESICS|N2
26051|ANTIPSYCHOTICS|N5A
26030|ANTI-EPILEPTICS|N3
26013|SYSTEMIC ANTIBACTERIALS|J1
26012|ANTI-EPILEPTICS|N3A
26010|PSYCHOSTIMULANTS|N6B
25994|PSYCHOSTIMULANTS|N6B
25993|ANTI-EPILEPTICS|N3
25991|ANTI-EPILEPTICS|N3A
25973|ANTIPSYCHOTICS|N5A
25972|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
25971|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25971|PARASITOLOGY|P
25953|CARDIOVASCULAR SYSTEM|C
25953|MRI AGENTS|T1E
25950|ANALGESICS|N2
25933|Factor VIII|B2D1
25913|SYSTEMIC ANTIBACTERIALS|J1
25912|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
25899|Non-nucleoside reverse transcriptase inhibitors|J5C3
25898|ANTI-MIGRAINE PREPARATIONS|N2C
25898|ANTI-EPILEPTICS|N3
25898|NOOTROPICS|N6D
25897|ANTI-EPILEPTICS|N3
25896|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
25895|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
25892|Coxibs|M1A3
25891|ANALGESICS|N2
25878|ANTIPSYCHOTICS|N5A
25878|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
25877|ANTIPSYCHOTICS|N5A
25877|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
25876|ANTIPSYCHOTICS|N5A
25875|ANTIHYPERTENSIVES|C2
25875|ANALGESICS|N2
25872|ANTI-EPILEPTICS|N3A
25852|ANTI-EPILEPTICS|N3
25851|ANALGESICS|N2
25835|Coxibs|M1A3
25831|ANTI-EPILEPTICS|N3A
25811|WOUND HEALING AGENTS|D3
25796|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25795|CARDIOVASCULAR SYSTEM|C
25790|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
25790|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
25783|ANTIVIRALS FOR SYSTEMIC USE|J5
25780|ANTI-MIGRAINE PREPARATIONS|N2C
25779|ANALGESICS|N2
25773|ANALGESICS|N2
25772|ALKYLATING AGENTS|L1A
25734|ANDROGENS, EXCLUDING G3E, G3F|G3B
25734|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
25730|DERMATOLOGICALS|D
25730|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
25675|WOUND HEALING AGENTS|D3
25674|Urinary incontinence products|G4B4
25673|BETA-BLOCKING AGENTS|C7
25653|ANAESTHETICS, GENERAL|N1A
25632|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25631|ANTI-EPILEPTICS|N3
25613|ANALGESICS|N2
25612|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25590|PLATELET AGGREGATION INHIBITORS|B1C
25590|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
25570|CARDIAC THERAPY|C1
25570|ANTIHYPERTENSIVES|C2
25554|MACROLIDES AND SIMILAR TYPES|J1F
25536|Non-nucleoside reverse transcriptase inhibitors|J5C3
25535|Non-nucleoside reverse transcriptase inhibitors|J5C3
25498|PARASITOLOGY|P
25494|Antigonadotrophin-releasing hormones|H1C3
25471|SYSTEMIC ANTIBACTERIALS|J1
25470|SYSTEMIC ANTIBACTERIALS|J1
25461|DRUGS USED IN DIABETES|A10
25460|SYSTEMIC ANTIBACTERIALS|J1
25460|RESPIRATORY SYSTEM|R
25459|ANTIPSYCHOTICS|N5A
25456|SYSTEMIC ANTIBACTERIALS|J1
25455|SYSTEMIC ANTIBACTERIALS|J1
25454|ANALGESICS|N2
25454|ANTI-EPILEPTICS|N3A
25453|Interferons, beta|L3B2
25452|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25451|Interferons, alpha|L3B1
25450|SYSTEMIC ANTIBACTERIALS|J1
25430|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25430|ANTIVIRALS FOR SYSTEMIC USE|J5
25412|Non-nucleoside reverse transcriptase inhibitors|J5C3
25411|PARASITOLOGY|P
25410|SYSTEMIC ANTIBACTERIALS|J1
25407|SYSTEMIC ANTIBACTERIALS|J1
25406|SYSTEMIC ANTIBACTERIALS|J1
25405|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25404|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25403|SYSTEMIC ANTIBACTERIALS|J1
25363|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
25363|ANTIHYPERTENSIVES|C2
25363|Erectile dysfunction products|G4B3
25362|PARASITOLOGY|P
25348|ANTIHYPERTENSIVES|C2
25348|BETA-BLOCKING AGENTS|C7
25348|CALCIUM ANTAGONISTS|C8
25343|ANALGESICS|N2
25323|ANALGESICS|N2
25323|ANTI-EPILEPTICS|N3
25323|ANTIPSYCHOTICS|N5A
25322|ANTIULCERANTS|A2B
25322|SYSTEMIC ANTIBACTERIALS|J1
25302|ULTRASOUND AGENTS|T1F
25283|ANALGESICS|N2
25264|ANALGESICS|N2
25263|ANTIHYPERTENSIVES|C2
25262|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
25245|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
25222|ANALGESICS|N2
25207|DIRECT THROMBIN INHIBITORS|B1E
25182|ANTIVIRALS FOR SYSTEMIC USE|J5
25167|SYSTEMIC ANTIBACTERIALS|J1
25166|IMMUNOSUPPRESSIVE AGENTS|L4
25166|SYSTEMIC ANTIHISTAMINES|R6
25165|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
25162|SYSTEMIC ANTIBACTERIALS|J1
25162|Carbapenems|J1P2
25148|ANTIPSYCHOTICS|N5A
25147|PLATELET AGGREGATION INHIBITORS|B1C
25147|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
25146|PLATELET AGGREGATION INHIBITORS|B1C
25146|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
25144|PLATELET AGGREGATION INHIBITORS|B1C
25144|CARDIOVASCULAR SYSTEM|C
25143|PLATELET AGGREGATION INHIBITORS|B1C
25131|CENTRAL NERVOUS SYSTEM|N
25131|ANALGESICS|N2
25131|ANTI-EPILEPTICS|N3
25128|ANTIHYPERTENSIVES|C2
25127|DIRECT THROMBIN INHIBITORS|B1E
25124|Erectile dysfunction products|G4B3
25124|Urinary incontinence products|G4B4
25122|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
25104|TRANQUILLISERS|N5C
25104|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
25103|ANALGESICS|N2
25103|ANTI-EPILEPTICS|N3A
25102|ANTIHYPERTENSIVES|C2
25089|ANTIPSYCHOTICS|N5A
25089|NOOTROPICS|N6D
25084|ANALGESICS|N2
25071|IMMUNOSUPPRESSIVE AGENTS|L4
25068|ANALGESICS|N2
25068|ANTIPSYCHOTICS|N5A
25068|NOOTROPICS|N6D
25065|DRUGS USED IN DIABETES|A10
25063|DRUGS USED IN DIABETES|A10
25062|IMMUNOSTIMULATING AGENTS|L3
25050|CENTRAL NERVOUS SYSTEM|N
25050|SSRI antidepressants|N6A4
25049|IMMUNOSUPPRESSIVE AGENTS|L4
25047|ANTI-EPILEPTICS|N3A
25043|DIRECT THROMBIN INHIBITORS|B1E
25042|DIRECT THROMBIN INHIBITORS|B1E
25026|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
25023|SYSTEMIC ANTIBACTERIALS|J1
25023|ANTIVIRALS FOR SYSTEMIC USE|J5
25023|IMMUNOSTIMULATING AGENTS|L3
25022|ANTI-EPILEPTICS|N3
25009|SRNI antidepressants|N6A5
25009|PSYCHOSTIMULANTS|N6B
25004|PSYCHOSTIMULANTS|N6B
24962|TRANQUILLISERS|N5C
24962|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
24951|SYSTEMIC ANTIBACTERIALS|J1
24949|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
24949|DRUGS USED IN DIABETES|A10
24948|ANTI-ACNE PREPARATIONS|D10
24947|ANTI-ACNE PREPARATIONS|D10
24945|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
24942|ANTI-EPILEPTICS|N3A
24926|ANTIVIRALS FOR SYSTEMIC USE|J5
24926|IMMUNOSTIMULATING AGENTS|L3
24926|INTERFERONS|L3B
24926|PARASITOLOGY|P
24891|ANTI-EPILEPTICS|N3
24890|OPHTHALMOLOGICALS|S1
24889|ANTIPSYCHOTICS|N5A
24887|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
24885|ANTIVIRALS FOR SYSTEMIC USE|J5
24885|IMMUNOSTIMULATING AGENTS|L3
24882|DRUGS USED IN DIABETES|A10
24862|CARDIAC THERAPY|C1
24849|ANTIHYPERTENSIVES|C2
24849|CALCIUM ANTAGONISTS|C8
24844|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
24844|IMMUNOSUPPRESSIVE AGENTS|L4
24844|OPHTHALMOLOGICALS|S1
24843|ANTIPSYCHOTICS|N5A
24842|ANTI-EPILEPTICS|N3A
24783|ANTIVIRALS FOR SYSTEMIC USE|J5
24763|DIRECT THROMBIN INHIBITORS|B1E
24762|ANALGESICS|N2
24724|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
24702|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
24702|ANTIHYPERTENSIVES|C2
24683|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
24674|CENTRAL NERVOUS SYSTEM|N
24674|ANTIPSYCHOTICS|N5A
24673|SYSTEMIC ANTIBACTERIALS|J1
24672|PLATELET AGGREGATION INHIBITORS|B1C
24671|APPETITE STIMULANTS|A15
24664|ANTIPSYCHOTICS|N5A
24663|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
24625|ANTI-EPILEPTICS|N3A
24625|NOOTROPICS|N6D
24624|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
24624|ANTIPSYCHOTICS|N5A
24623|DIRECT THROMBIN INHIBITORS|B1E
24604|ANALGESICS|N2
24602|MUSCULO-SKELETAL SYSTEM|M
24602|ANALGESICS|N2
24582|Vitamin E, plain|A11X3
24565|DIRECT THROMBIN INHIBITORS|B1E
24542|DIRECT THROMBIN INHIBITORS|B1E
24522|ANTIVIRALS FOR SYSTEMIC USE|J5
24509|TRANQUILLISERS|N5C
24507|ANALGESICS|N2
24503|ANTI-EPILEPTICS|N3A
24489|ANALGESICS|N2
24488|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
24487|ANALGESICS|N2
24487|ANTI-MIGRAINE PREPARATIONS|N2C
24486|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
24484|ANTI-ARRHYTHMICS|C1B
24476|ANALGESICS|N2
24474|PLATELET AGGREGATION INHIBITORS|B1C
24474|CARDIOVASCULAR SYSTEM|C
24474|DIURETICS|C3
24473|ANTI-EPILEPTICS|N3A
24471|ANTIVIRALS FOR SYSTEMIC USE|J5
24471|Protease inhibitors|J5C2
24470|ANALGESICS|N2
24467|SYSTEMIC ANTIBACTERIALS|J1
24466|DRUGS USED IN DIABETES|A10
24465|ANTI-EPILEPTICS|N3
24463|ANTI-EPILEPTICS|N3
24463|ANTI-EPILEPTICS|N3A
24452|Non-nucleoside reverse transcriptase inhibitors|J5C3
24451|ANTIHYPERTENSIVES|C2
24448|DIRECT THROMBIN INHIBITORS|B1E
24447|ANTIVIRALS FOR SYSTEMIC USE|J5
24447|VACCINES|J7
24446|Erectile dysfunction products|G4B3
24443|DIURETICS|C3
24426|ANTIHYPERTENSIVES|C2
24424|ANALGESICS|N2
24407|ANTIVIRALS FOR SYSTEMIC USE|J5
24406|PLATELET AGGREGATION INHIBITORS|B1C
24406|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
24404|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
24385|ALKYLATING AGENTS|L1A
24384|HYPNOTICS/SEDATIVES|N5B
24384|TRANQUILLISERS|N5C
24383|ANTIHYPERTENSIVES|C2
24367|DIRECT THROMBIN INHIBITORS|B1E
24343|DIRECT THROMBIN INHIBITORS|B1E
24343|ANTI-ARRHYTHMICS|C1B
24324|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
24322|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
24304|ANTIVIRALS FOR SYSTEMIC USE|J5
24303|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
24245|VACCINES|J7
24243|ANTIVIRALS FOR SYSTEMIC USE|J5
24242|ANALGESICS|N2
24242|ANTI-EPILEPTICS|N3
24242|ANTI-EPILEPTICS|N3A
24242|NOOTROPICS|N6D
24242|ANTITUSSIVES|R5D
24223|SYSTEMIC ANTIBACTERIALS|J1
24222|Vitamin E, plain|A11X3
24222|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
24208|ANDROGENS, EXCLUDING G3E, G3F|G3B
24207|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
24203|GASTROPROKINETICS|A3F
24202|ANTI-EPILEPTICS|N3A
24202|TRANQUILLISERS|N5C
24202|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
24190|PARASITOLOGY|P
24189|ANTIHYPERTENSIVES|C2
24189|DIURETICS|C3
24187|ANTIVIRALS FOR SYSTEMIC USE|J5
24184|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
24183|SYSTEMIC ANTIBACTERIALS|J1
24172|HUMAN INSULINS AND ANALOGUES|A10C
24172|Human insulins and analogues, intermediate-acting|A10C2
24167|ANTIPSYCHOTICS|N5A
24167|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
24166|BPH (benign prostatic hypertrophy) products |G4C
24149|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
24148|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
24146|HUMAN INSULINS AND ANALOGUES|A10C
24146|Human insulins and analogues, intermediate-acting|A10C2
24144|DPP-IV inhibitor antidiabetics|A10B6
24123|DRUGS USED IN DIABETES|A10
24122|DRUGS USED IN DIABETES|A10
24090|ANTI-ARRHYTHMICS|C1B
24090|ANTIHYPERTENSIVES|C2
24089|ACE INHIBITORS, PLAIN|C9A
24088|IMMUNOSTIMULATING AGENTS|L3
24083|VACCINES|J7
24082|VACCINES|J7
24066|ALKYLATING AGENTS|L1A
24026|DIRECT THROMBIN INHIBITORS|B1E
24025|ANTI-EPILEPTICS|N3
24024|TRANQUILLISERS|N5C
24022|ANTIPSYCHOTICS|N5A
23983|SYSTEMIC ANTIBACTERIALS|J1
23983|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
23924|IMMUNOSTIMULATING AGENTS|L3
23923|CARDIOVASCULAR SYSTEM|C
23923|ANTIHYPERTENSIVES|C2
23922|PLATELET AGGREGATION INHIBITORS|B1C
23922|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
23921|BPH (benign prostatic hypertrophy) products |G4C
23919|SYSTEMIC ANTIBACTERIALS|J1
23902|Erectile dysfunction products|G4B3
23893|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
23890|ANALGESICS|N2
23888|SYSTEMIC ANTIBACTERIALS|J1
23880|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
23859|SYSTEMIC ANTIBACTERIALS|J1
23859|Carbapenems|J1P2
23820|IMMUNOSUPPRESSIVE AGENTS|L4
23799|MRI AGENTS|T1E
23788|ANALGESICS|N2
23784|ANTIVIRALS FOR SYSTEMIC USE|J5
23782|PLATELET AGGREGATION INHIBITORS|B1C
23782|CARDIAC THERAPY|C1
23781|ANTIVIRALS FOR SYSTEMIC USE|J5
23779|NOOTROPICS|N6D
23739|CALCIUM ANTAGONISTS|C8
23719|ANTIPSYCHOTICS|N5A
23701|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
23701|IMMUNOSUPPRESSIVE AGENTS|L4
23699|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
23684|MACROLIDES AND SIMILAR TYPES|J1F
23679|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
23625|ANTIVIRALS FOR SYSTEMIC USE|J5
23624|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
23624|ANTIMETABOLITES|L1B
23620|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
23605|ANTIPSYCHOTICS|N5A
23605|HYPNOTICS/SEDATIVES|N5B
23604|VACCINES|J7
23600|Coxibs|M1A3
23600|ANALGESICS|N2
23527|ANTIVIRALS FOR SYSTEMIC USE|J5
23523|ANALGESICS|N2
23521|ANTIHYPERTENSIVES|C2
23521|Erectile dysfunction products|G4B3
23499|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
23479|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
23479|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
23459|PARASITOLOGY|P
23459|ANTI-MALARIALS|P1D
23419|SYSTEMIC ANTIBACTERIALS|J1
23407|B2-STIMULANTS|R3A
23406|ANTIVIRALS FOR SYSTEMIC USE|J5
23404|ANTIPSYCHOTICS|N5A
23402|CENTRAL NERVOUS SYSTEM|N
23401|CENTRAL NERVOUS SYSTEM|N
23401|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
23381|DRUGS USED IN DIABETES|A10
23381|HUMAN INSULINS AND ANALOGUES|A10C
23381|Human insulins and analogues, fast-acting|A10C1
23361|Erectile dysfunction products|G4B3
23360|ANTI-EPILEPTICS|N3
23360|TRANQUILLISERS|N5C
23359|CALCIUM ANTAGONISTS|C8
23340|Coxibs|M1A3
23319|DIRECT THROMBIN INHIBITORS|B1E
23303|DIRECT THROMBIN INHIBITORS|B1E
23302|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
23302|HUMAN INSULINS AND ANALOGUES|A10C
23299|DIRECT THROMBIN INHIBITORS|B1E
23283|Non-nucleoside reverse transcriptase inhibitors|J5C3
23279|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
23279|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
23279|SSRI antidepressants|N6A4
23279|SRNI antidepressants|N6A5
23243|ANALGESICS|N2
23242|BPH (benign prostatic hypertrophy) products |G4C
23222|SYSTEMIC ANTIBACTERIALS|J1
23221|IMMUNOSTIMULATING AGENTS|L3
23220|Antigonadotrophin-releasing hormones|H1C3
23163|GROWTH HORMONES|H4C
23140|ANTIVIRALS FOR SYSTEMIC USE|J5
23139|ANTIVIRALS FOR SYSTEMIC USE|J5
23133|ANTIHYPERTENSIVES|C2
23132|ANALGESICS|N2
23132|B2-STIMULANTS|R3A
23127|SYSTEMIC ANTIBACTERIALS|J1
23099|ANTIHYPERTENSIVES|C2
23042|ANALGESICS|N2
23041|ANALGESICS|N2
23039|DERMATOLOGICALS|D
23018|ANALGESICS|N2
23017|Protease inhibitors|J5C2
23015|ANAESTHETICS, LOCAL|N1B
23015|ANALGESICS|N2
23005|ANTIEMETICS AND ANTINAUSEANTS|A4
23001|SYSTEMIC ANTIBACTERIALS|J1
22980|VACCINES|J7
22980|IMMUNOSTIMULATING AGENTS|L3
22966|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
22964|ALKYLATING AGENTS|L1A
22962|ANTIMETABOLITES|L1B
22960|VACCINES|J7
22954|ANTIEMETICS AND ANTINAUSEANTS|A4
22940|ANALGESICS|N2
22917|VACCINES|J7
22916|ANTIPSYCHOTICS|N5A
22916|NOOTROPICS|N6D
22894|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
22889|ANTIHYPERTENSIVES|C2
22885|SYSTEMIC ANTIBACTERIALS|J1
22885|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
22878|ANALGESICS|N2
22874|ANTI-EPILEPTICS|N3A
22861|VACCINES|J7
22860|ANALGESICS|N2
22859|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
22859|TRANQUILLISERS|N5C
22855|Erectile dysfunction products|G4B3
22835|ANALGESICS|N2
22814|PARASITOLOGY|P
22807|TRANQUILLISERS|N5C
22806|ANTI-EPILEPTICS|N3A
22805|ANTI-ARRHYTHMICS|C1B
22803|ANTI-EPILEPTICS|N3
22803|TRANQUILLISERS|N5C
22799|DIRECT THROMBIN INHIBITORS|B1E
22797|ANTIVIRALS FOR SYSTEMIC USE|J5
22795|IMMUNOSUPPRESSIVE AGENTS|L4
22794|Coxibs|M1A3
22794|ANALGESICS|N2
22784|Non-nucleoside reverse transcriptase inhibitors|J5C3
22783|DRUGS USED IN DIABETES|A10
22783|HUMAN INSULINS AND ANALOGUES|A10C
22783|Human insulins and analogues, intermediate-acting|A10C2
22782|NOOTROPICS|N6D
22780|ANTIPSYCHOTICS|N5A
22778|SYSTEMIC ANTIBACTERIALS|J1
22777|ANTIVIRALS FOR SYSTEMIC USE|J5
22776|ANTIVIRALS FOR SYSTEMIC USE|J5
22774|IMMUNOSUPPRESSIVE AGENTS|L4
22754|ANTI-EPILEPTICS|N3
22739|ANTIVIRALS FOR SYSTEMIC USE|J5
22738|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
22734|ANALGESICS|N2
22734|ANTI-MIGRAINE PREPARATIONS|N2C
22716|ANTIVIRALS FOR SYSTEMIC USE|J5
22715|ANTIHYPERTENSIVES|C2
22698|TRANQUILLISERS|N5C
22698|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
22695|CENTRAL NERVOUS SYSTEM|N
22674|Protease inhibitors|J5C2
22654|CARDIOVASCULAR SYSTEM|C
22639|CARDIOVASCULAR SYSTEM|C
22637|Urinary incontinence products|G4B4
22637|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
22624|ANTI-ARRHYTHMICS|C1B
22624|ANTIHYPERTENSIVES|C2
22623|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
22622|B2-STIMULANTS|R3A
22614|SYSTEMIC ANTIBACTERIALS|J1
22614|ANTIVIRALS FOR SYSTEMIC USE|J5
22594|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
22555|CENTRAL NERVOUS SYSTEM|N
22555|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
22534|SYSTEMIC ANTIHISTAMINES|R6
22522|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
22522|SRNI antidepressants|N6A5
22519|ANTI-EPILEPTICS|N3
22519|ANTIPSYCHOTICS|N5A
22519|HYPNOTICS/SEDATIVES|N5B
22518|SYSTEMIC ANTIBACTERIALS|J1
22517|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
22515|MRI AGENTS|T1E
22497|VACCINES|J7
22495|VACCINES|J7
22476|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
22454|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
22439|ANALGESICS|N2
22438|RESPIRATORY SYSTEM|R
22437|ANTIVIRALS FOR SYSTEMIC USE|J5
22395|OPHTHALMOLOGICALS|S1
22395|Ocular antineovascularisation products|S1P
22394|ANTIHYPERTENSIVES|C2
22394|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
22377|ANTIVIRALS FOR SYSTEMIC USE|J5
22376|Protease inhibitors|J5C2
22354|ANTIVIRALS FOR SYSTEMIC USE|J5
22338|PARASITOLOGY|P
22337|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
22337|SSRI antidepressants|N6A4
22335|DRUGS USED IN DIABETES|A10
22317|SYSTEMIC ANTIBACTERIALS|J1
22306|ANALGESICS|N2
22301|MACROLIDES AND SIMILAR TYPES|J1F
22300|SYSTEMIC ANTIBACTERIALS|J1
22299|ANTIVIRALS FOR SYSTEMIC USE|J5
22276|SYSTEMIC ANTIBACTERIALS|J1
22275|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
22274|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
22236|ANALGESICS|N2
22221|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
22219|ANTIVIRALS FOR SYSTEMIC USE|J5
22218|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
22218|DRUGS USED IN DIABETES|A10
22218|Erectile dysfunction products|G4B3
22216|ANTI-GOUT PREPARATIONS|M4
22216|ANALGESICS|N2
22214|WOUND HEALING AGENTS|D3
22214|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
22214|OPHTHALMOLOGICALS|S1
22209|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
22208|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
22207|IMMUNOSUPPRESSIVE AGENTS|L4
22204|SYSTEMIC ANTIBACTERIALS|J1
22203|ANAESTHETICS, LOCAL|N1B
22203|ANALGESICS|N2
22202|ANTIVIRALS FOR SYSTEMIC USE|J5
22198|ANALGESICS|N2
22197|ANTIHYPERTENSIVES|C2
22180|MUSCULO-SKELETAL SYSTEM|M
22175|ANDROGENS, EXCLUDING G3E, G3F|G3B
22154|SYSTEMIC ANTIBACTERIALS|J1
22115|TRANQUILLISERS|N5C
22115|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
22094|Coxibs|M1A3
22094|ANALGESICS|N2
22077|PARASITOLOGY|P
22076|WOUND HEALING AGENTS|D3
22076|AMINOGLYCOSIDES|J1K
22076|PARASITOLOGY|P
22066|GROWTH HORMONES|H4C
22015|SYSTEMIC ANTIBACTERIALS|J1
22014|ANTIVIRALS FOR SYSTEMIC USE|J5
22014|IMMUNOSTIMULATING AGENTS|L3
21994|Erectile dysfunction products|G4B3
21994|BPH (benign prostatic hypertrophy) products |G4C
21976|VACCINES|J7
21966|VACCINES|J7
21960|ANALGESICS|N2
21960|ANTI-MIGRAINE PREPARATIONS|N2C
21960|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
21960|SSRI antidepressants|N6A4
21960|ANTITUSSIVES|R5D
21959|IMMUNOSTIMULATING AGENTS|L3
21957|SYSTEMIC ANTIBACTERIALS|J1
21936|Coxibs|M1A3
21927|WOUND HEALING AGENTS|D3
21926|PLATELET AGGREGATION INHIBITORS|B1C
21926|FIBRINOLYTICS|B1D
21922|PLATELET AGGREGATION INHIBITORS|B1C
21922|FIBRINOLYTICS|B1D
21922|CARDIOVASCULAR SYSTEM|C
21921|WOUND HEALING AGENTS|D3
21916|DIRECT THROMBIN INHIBITORS|B1E
21915|ANTI-ARRHYTHMICS|C1B
21914|PLATELET AGGREGATION INHIBITORS|B1C
21896|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
21852|ANTIHYPERTENSIVES|C2
21852|ACE INHIBITORS, PLAIN|C9A
21843|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
21840|ANTIVIRALS FOR SYSTEMIC USE|J5
21835|ANTI-EPILEPTICS|N3
21835|ANTIPSYCHOTICS|N5A
21834|IMMUNOSUPPRESSIVE AGENTS|L4
21823|Factor VIII|B2D1
21821|ANTIVIRALS FOR SYSTEMIC USE|J5
21820|ANTIPSYCHOTICS|N5A
21818|DPP-IV inhibitor antidiabetics|A10B6
21817|ANTI-EPILEPTICS|N3
21815|SYSTEMIC ANTIBACTERIALS|J1
21814|Non-nucleoside reverse transcriptase inhibitors|J5C3
21779|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
21778|Coxibs|M1A3
21778|ANALGESICS|N2
21760|APPETITE STIMULANTS|A15
21759|FIBRINOLYTICS|B1D
21755|CENTRAL NERVOUS SYSTEM|N
21715|SYSTEMIC ANTIBACTERIALS|J1
21714|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
21694|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
21678|CENTRAL NERVOUS SYSTEM|N
21667|PLATELET AGGREGATION INHIBITORS|B1C
21667|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
21662|CARDIOVASCULAR SYSTEM|C
21662|ANTIHYPERTENSIVES|C2
21656|ANTIULCERANTS|A2B
21655|SYSTEMIC ANTIBACTERIALS|J1
21635|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
21634|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
21634|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
21621|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
21621|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
21620|ANTIVIRALS FOR SYSTEMIC USE|J5
21617|Glitazone antidiabetics|A10B4
21617|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
21614|IMMUNOSTIMULATING AGENTS|L3
21600|ANALGESICS|N2
21599|SYSTEMIC ANTIBACTERIALS|J1
21597|ANALGESICS|N2
21582|ANTIVIRALS FOR SYSTEMIC USE|J5
21575|ANTIVIRALS FOR SYSTEMIC USE|J5
21560|SYSTEMIC ANTIBACTERIALS|J1
21556|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
21556|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
21541|CARDIOVASCULAR SYSTEM|C
21540|ANTIVIRALS FOR SYSTEMIC USE|J5
21539|ANTIVIRALS FOR SYSTEMIC USE|J5
21538|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
21520|IMMUNOSUPPRESSIVE AGENTS|L4
21516|DRUGS USED IN DIABETES|A10
21516|CENTRAL NERVOUS SYSTEM|N
21510|ANALGESICS|N2
21508|PARASITOLOGY|P
21503|ANTIEMETICS AND ANTINAUSEANTS|A4
21503|MUSCLE RELAXANTS|M3
21503|ANALGESICS|N2
21501|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
21478|NOOTROPICS|N6D
21477|ANALGESICS|N2
21474|PLATELET AGGREGATION INHIBITORS|B1C
21474|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
21474|CARDIOVASCULAR SYSTEM|C
21465|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
21464|INTERFERONS|L3B
21441|ALKYLATING AGENTS|L1A
21435|ANTIPSYCHOTICS|N5A
21430|Topical dermatological antifungals|D1A1
21430|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
21428|ANDROGENS, EXCLUDING G3E, G3F|G3B
21427|Protease inhibitors|J5C2
21425|PLATELET AGGREGATION INHIBITORS|B1C
21425|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
21424|Coxibs|M1A3
21424|ANALGESICS|N2
21420|PLATELET AGGREGATION INHIBITORS|B1C
21420|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
21418|CARDIOVASCULAR SYSTEM|C
21417|SYSTEMIC ANTIHISTAMINES|R6
21414|ANALGESICS|N2
21398|NOOTROPICS|N6D
21397|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
21335|ANTIVIRALS FOR SYSTEMIC USE|J5
21303|SYSTEMIC ANTIBACTERIALS|J1
21303|CEPHALOSPORINS|J1D
21301|HUMAN INSULINS AND ANALOGUES|A10C
21301|Human insulins and analogues, intermediate-acting|A10C2
21300|CALCITONINS|H4A
21298|B2-STIMULANTS|R3A
21294|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
21279|IMMUNOSUPPRESSIVE AGENTS|L4
21266|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
21256|PLATELET AGGREGATION INHIBITORS|B1C
21234|ANTIHYPERTENSIVES|C2
21219|ANALGESICS|N2
21219|ANTI-EPILEPTICS|N3A
21219|ANTIPSYCHOTICS|N5A
21219|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
21218|B2-STIMULANTS|R3A
21217|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
21216|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
21197|PLATELET AGGREGATION INHIBITORS|B1C
21175|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
21174|APPETITE STIMULANTS|A15
21174|GROWTH HORMONES|H4C
21158|ANTIVIRALS FOR SYSTEMIC USE|J5
21157|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
21154|ANTIHYPERTENSIVES|C2
21139|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
21138|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
21137|ANTIPSYCHOTICS|N5A
21135|PARASITOLOGY|P
21118|CARDIOVASCULAR SYSTEM|C
21118|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
21096|ANTIPSYCHOTICS|N5A
21094|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
21077|ANTI-EPILEPTICS|N3
21074|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
21066|ANTI-MALARIALS|P1D
21063|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
21062|ANTI-EPILEPTICS|N3
21058|ANTIVIRALS FOR SYSTEMIC USE|J5
21058|IMMUNOSTIMULATING AGENTS|L3
21054|PARASITOLOGY|P
21045|B2-STIMULANTS|R3A
21043|CARDIAC THERAPY|C1
21043|ANTI-ARRHYTHMICS|C1B
21038|ANTI-MIGRAINE PREPARATIONS|N2C
21038|ANTI-EPILEPTICS|N3
21037|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
21030|ANTIPSYCHOTICS|N5A
21026|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
21024|NOOTROPICS|N6D
21021|NOOTROPICS|N6D
21019|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
21018|ANTI-EPILEPTICS|N3A
21003|ANTI-EPILEPTICS|N3A
20997|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
20997|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
20995|IMMUNOSUPPRESSIVE AGENTS|L4
20962|RESPIRATORY SYSTEM|R
20961|BETA-BLOCKING AGENTS|C7
20961|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
20960|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
20957|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
20956|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
20955|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
20955|Erectile dysfunction products|G4B3
20940|NOOTROPICS|N6D
20939|ANTIHYPERTENSIVES|C2
20939|DIURETICS|C3
20925|ANTIPSYCHOTICS|N5A
20923|PLATELET AGGREGATION INHIBITORS|B1C
20922|ANTI-EPILEPTICS|N3
20920|ANTI-EPILEPTICS|N3
20918|NOOTROPICS|N6D
20917|SRNI antidepressants|N6A5
20915|VACCINES|J7
20910|ANTI-GOUT PREPARATIONS|M4
20909|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
20908|CALCIUM ANTAGONISTS|C8
20907|ANTIVIRALS FOR SYSTEMIC USE|J5
20906|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
20905|Coxibs|M1A3
20900|ANTI-EPILEPTICS|N3
20898|ANTI-EPILEPTICS|N3
20896|PROLACTIN INHIBITORS|G2D
20878|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
20877|Antigonadotrophin-releasing hormones|H1C3
20876|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
20864|SYSTEMIC ANTIBACTERIALS|J1
20859|B2-STIMULANTS|R3A
20854|ANTI-EPILEPTICS|N3A
20823|Erectile dysfunction products|G4B3
20823|ANTI-EPILEPTICS|N3A
20822|Inhibitors of the Kallikrein-kinin-system|B2C2
20822|ANALGESICS|N2
20819|ANTI-EPILEPTICS|N3
20797|ANTI-EPILEPTICS|N3
20797|TRANQUILLISERS|N5C
20785|SYSTEMIC ANTIBACTERIALS|J1
20784|DRUGS USED IN DIABETES|A10
20782|ANTIVIRALS FOR SYSTEMIC USE|J5
20778|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
20777|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
20776|ANTIPSYCHOTICS|N5A
20775|ANTIVIRALS FOR SYSTEMIC USE|J5
20763|DRUGS USED IN DIABETES|A10
20763|ANALGESICS|N2
20756|ANALGESICS|N2
20755|OPHTHALMOLOGICALS|S1
20743|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
20738|CARDIOVASCULAR SYSTEM|C
20737|ANTIPSYCHOTICS|N5A
20735|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
20734|ANTIVIRALS FOR SYSTEMIC USE|J5
20725|ANTIVIRALS FOR SYSTEMIC USE|J5
20718|NOOTROPICS|N6D
20718|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
20717|NOOTROPICS|N6D
20716|ANTI-EPILEPTICS|N3
20716|ANTI-EPILEPTICS|N3A
20715|NOOTROPICS|N6D
20696|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
20688|ANALGESICS|N2
20685|SYSTEMIC ANTIBACTERIALS|J1
20684|ANALGESICS|N2
20682|MRI AGENTS|T1E
20679|ANTIVIRALS FOR SYSTEMIC USE|J5
20678|ULTRASOUND AGENTS|T1F
20676|DRUGS USED IN DIABETES|A10
20665|Topical dermatological antifungals|D1A1
20665|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
20664|TRANQUILLISERS|N5C
20664|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
20663|DIURETICS|C3
20663|ANTIDIURETIC HORMONES|H4D
20658|ANTI-ACNE PREPARATIONS|D10
20658|SYSTEMIC ANTIBACTERIALS|J1
20657|ANTI-ACNE PREPARATIONS|D10
20657|SYSTEMIC ANTIBACTERIALS|J1
20656|ANTIVIRALS FOR SYSTEMIC USE|J5
20654|ANTI-EPILEPTICS|N3
20654|RADIODIAGNOSTIC AGENTS|T1G
20638|VACCINES|J7
20637|ANTIVIRALS FOR SYSTEMIC USE|J5
20634|SYSTEMIC ANTIBACTERIALS|J1
20634|VACCINES|J7
20615|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
20594|ANTI-EPILEPTICS|N3
20576|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
20542|OPHTHALMOLOGICALS|S1
20534|DERMATOLOGICALS|D
20518|Factor VIII|B2D1
20495|Coxibs|M1A3
20495|ANALGESICS|N2
20465|Non-nucleoside reverse transcriptase inhibitors|J5C3
20463|ANALGESICS|N2
20463|ANTI-EPILEPTICS|N3
20462|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
20461|ANALGESICS|N2
20460|ANALGESICS|N2
20459|ANALGESICS|N2
20458|ANALGESICS|N2
20458|ANTI-MIGRAINE PREPARATIONS|N2C
20456|SYSTEMIC ANTIBACTERIALS|J1
20454|ANTIVIRALS FOR SYSTEMIC USE|J5
20437|ANTIHYPERTENSIVES|C2
20394|ANTITUSSIVES|R5D
20374|IMMUNOSUPPRESSIVE AGENTS|L4
20368|ANTIVIRALS FOR SYSTEMIC USE|J5
20365|IMMUNOSTIMULATING AGENTS|L3
20362|ANTIHYPERTENSIVES|C2
20357|IMMUNOSUPPRESSIVE AGENTS|L4
20356|DIRECT THROMBIN INHIBITORS|B1E
20355|ANTIPSYCHOTICS|N5A
20335|ANTIHYPERTENSIVES|C2
20335|CALCIUM ANTAGONISTS|C8
20334|Non-nucleoside reverse transcriptase inhibitors|J5C3
20254|TRANQUILLISERS|N5C
20254|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
20237|ANTI-EPILEPTICS|N3
20236|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
20236|NOOTROPICS|N6D
20235|CALCIUM ANTAGONISTS|C8
20225|ANTI-EPILEPTICS|N3
20223|CARDIOVASCULAR SYSTEM|C
20222|CEPHALOSPORINS|J1D
20220|CALCIUM ANTAGONISTS|C8
20220|ANALGESICS|N2
20214|ANALGESICS|N2
20200|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
20199|PLATELET AGGREGATION INHIBITORS|B1C
20199|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
20197|ANTI-GOUT PREPARATIONS|M4
20195|FIBRINOLYTICS|B1D
20177|ANALGESICS|N2
20177|ANTI-MIGRAINE PREPARATIONS|N2C
20177|ANTI-EPILEPTICS|N3
20175|ANAESTHETICS, LOCAL|N1B
20168|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
20167|ANTIHYPERTENSIVES|C2
20167|ANALGESICS|N2
20161|ANALGESICS|N2
20160|ANTIHYPERTENSIVES|C2
20156|ANTIPSYCHOTICS|N5A
20155|Urinary incontinence products|G4B4
20154|DRUGS USED IN DIABETES|A10
20137|ANTIHYPERTENSIVES|C2
20136|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
20134|CALCIUM ANTAGONISTS|C8
20134|ANALGESICS|N2
20121|ANTIVIRALS FOR SYSTEMIC USE|J5
20117|SYSTEMIC ANTIBACTERIALS|J1
20114|SYSTEMIC ANTIBACTERIALS|J1
20075|SYSTEMIC ANTIBACTERIALS|J1
20075|MACROLIDES AND SIMILAR TYPES|J1F
20061|APPETITE STIMULANTS|A15
20059|SYSTEMIC ANTIBACTERIALS|J1
20058|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
20057|NOOTROPICS|N6D
20041|ANALGESICS|N2
20040|PARASITOLOGY|P
20037|ANTI-EPILEPTICS|N3
20036|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
20035|ANTI-MIGRAINE PREPARATIONS|N2C
20034|BPH (benign prostatic hypertrophy) products |G4C
20004|DIRECT THROMBIN INHIBITORS|B1E
20000|CEPHALOSPORINS|J1D
19984|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
19982|ANTIHYPERTENSIVES|C2
19981|PLATELET AGGREGATION INHIBITORS|B1C
19981|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
19980|ANDROGENS, EXCLUDING G3E, G3F|G3B
19980|SYSTEMIC ANTIBACTERIALS|J1
19980|ANTIVIRALS FOR SYSTEMIC USE|J5
19979|ANTIHYPERTENSIVES|C2
19978|DRUGS USED IN DIABETES|A10
19974|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
19963|ANTIHYPERTENSIVES|C2
19959|ANTI-ARRHYTHMICS|C1B
19958|DRUGS USED IN DIABETES|A10
19956|ANTIEMETICS AND ANTINAUSEANTS|A4
19956|ANTIPSYCHOTICS|N5A
19956|TRANQUILLISERS|N5C
19955|ANTIEMETICS AND ANTINAUSEANTS|A4
19955|CENTRAL NERVOUS SYSTEM|N
19940|SYSTEMIC ANTIBACTERIALS|J1
19938|SYSTEMIC ANTIBACTERIALS|J1
19936|DIRECT THROMBIN INHIBITORS|B1E
19934|ANTI-EPILEPTICS|N3
19934|ANTIPSYCHOTICS|N5A
19934|TRANQUILLISERS|N5C
19932|CENTRAL NERVOUS SYSTEM|N
19932|ANTI-EPILEPTICS|N3A
19928|SYSTEMIC ANTIBACTERIALS|J1
19927|SYSTEMIC ANTIBACTERIALS|J1
19926|CALCIUM ANTAGONISTS|C8
19926|NOOTROPICS|N6D
19923|SYSTEMIC ANTIBACTERIALS|J1
19922|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19922|PARASITOLOGY|P
19921|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19919|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19917|SYSTEMIC ANTIBACTERIALS|J1
19916|ANTIHYPERTENSIVES|C2
19915|SYSTEMIC ANTIBACTERIALS|J1
19906|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19905|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19904|ALKYLATING AGENTS|L1A
19902|PARASITOLOGY|P
19901|PLATELET AGGREGATION INHIBITORS|B1C
19898|SYSTEMIC ANTIBACTERIALS|J1
19898|Carbapenems|J1P2
19894|SYSTEMIC ANTIBACTERIALS|J1
19894|Carbapenems|J1P2
19891|IMMUNOSUPPRESSIVE AGENTS|L4
19890|ANTI-EPILEPTICS|N3A
19888|ANTIVIRALS FOR SYSTEMIC USE|J5
19887|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19886|SYSTEMIC ANTIBACTERIALS|J1
19884|TRANQUILLISERS|N5C
19883|ANALGESICS|N2
19883|ANTI-MIGRAINE PREPARATIONS|N2C
19883|TRANQUILLISERS|N5C
19882|SYSTEMIC ANTIBACTERIALS|J1
19881|Coxibs|M1A3
19880|CENTRAL NERVOUS SYSTEM|N
19864|IMMUNOSUPPRESSIVE AGENTS|L4
19863|TRANQUILLISERS|N5C
19863|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
19862|SYSTEMIC ANTIBACTERIALS|J1
19861|ANTIPSYCHOTICS|N5A
19860|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
19854|Urinary incontinence products|G4B4
19853|TRANQUILLISERS|N5C
19853|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
19852|SYSTEMIC ANTIBACTERIALS|J1
19852|MACROLIDES AND SIMILAR TYPES|J1F
19850|ANTI-EPILEPTICS|N3A
19849|ANALGESICS|N2
19847|ANTIPSYCHOTICS|N5A
19847|HYPNOTICS/SEDATIVES|N5B
19847|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
19844|ANTI-ARRHYTHMICS|C1B
19843|SYSTEMIC ANTIBACTERIALS|J1
19840|CARDIOVASCULAR SYSTEM|C
19840|ANTI-ARRHYTHMICS|C1B
19838|ANTIVIRALS FOR SYSTEMIC USE|J5
19837|DIRECT THROMBIN INHIBITORS|B1E
19836|DIRECT THROMBIN INHIBITORS|B1E
19835|DIRECT THROMBIN INHIBITORS|B1E
19829|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19828|CALCIUM ANTAGONISTS|C8
19824|ANTI-ARRHYTHMICS|C1B
19823|DRUGS USED IN DIABETES|A10
19801|MACROLIDES AND SIMILAR TYPES|J1F
19794|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19793|SYSTEMIC ANTIBACTERIALS|J1
19793|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19787|ANALGESICS|N2
19786|CENTRAL NERVOUS SYSTEM|N
19785|SYSTEMIC ANTIBACTERIALS|J1
19785|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19785|ANTIVIRALS FOR SYSTEMIC USE|J5
19784|BPH (benign prostatic hypertrophy) products |G4C
19780|ANTIVIRALS FOR SYSTEMIC USE|J5
19762|NOOTROPICS|N6D
19761|SYSTEMIC ANTIBACTERIALS|J1
19761|Carbapenems|J1P2
19760|ANTI-ARRHYTHMICS|C1B
19744|Protease inhibitors|J5C2
19743|SYSTEMIC ANTIBACTERIALS|J1
19743|Carbapenems|J1P2
19742|CENTRAL NERVOUS SYSTEM|N
19742|ANTI-EPILEPTICS|N3
19741|DIRECT THROMBIN INHIBITORS|B1E
19722|CENTRAL NERVOUS SYSTEM|N
19709|DIAGNOSTIC AGENTS|T
19703|ANTI-EPILEPTICS|N3
19701|CALCIUM ANTAGONISTS|C8
19700|VACCINES|J7
19683|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
19682|CENTRAL NERVOUS SYSTEM|N
19682|PARASITOLOGY|P
19681|DIRECT THROMBIN INHIBITORS|B1E
19681|CARDIOVASCULAR SYSTEM|C
19680|ANTI-EPILEPTICS|N3
19662|GROWTH HORMONES|H4C
19648|ANTIHYPERTENSIVES|C2
19648|DIURETICS|C3
19646|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
19646|PARASITOLOGY|P
19645|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
19644|Protease inhibitors|J5C2
19643|SYSTEMIC ANTIBACTERIALS|J1
19642|ANTI-EPILEPTICS|N3
19641|ANTI-EPILEPTICS|N3A
19640|ANTI-EPILEPTICS|N3
19622|SYSTEMIC ANTIBACTERIALS|J1
19622|VACCINES|J7
19609|PLATELET AGGREGATION INHIBITORS|B1C
19609|Fibrinogen|B2D5
19608|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
19608|CENTRAL NERVOUS SYSTEM|N
19608|ANALGESICS|N2
19608|ANTI-EPILEPTICS|N3
19580|CARDIOVASCULAR SYSTEM|C
19580|ANTIHYPERTENSIVES|C2
19563|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
19563|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
19562|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
19561|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
19560|SYSTEMIC ANTIBACTERIALS|J1
19526|CALCIUM ANTAGONISTS|C8
19526|ANTI-EPILEPTICS|N3
19525|PLATELET AGGREGATION INHIBITORS|B1C
19500|ANTI-ARRHYTHMICS|C1B
19463|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
19460|CARDIOVASCULAR SYSTEM|C
19460|Coxibs|M1A3
19460|ANALGESICS|N2
19440|ANALGESICS|N2
19364|ANTI-EPILEPTICS|N3A
19364|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
19363|ANTI-ARRHYTHMICS|C1B
19363|ANTIHYPERTENSIVES|C2
19360|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19344|IMMUNOSUPPRESSIVE AGENTS|L4
19341|ALKYLATING AGENTS|L1A
19337|PARASITOLOGY|P
19337|ANTI-MALARIALS|P1D
19336|DRUGS USED IN DIABETES|A10
19333|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
19331|ANTI-MIGRAINE PREPARATIONS|N2C
19331|ANTIPSYCHOTICS|N5A
19331|HYPNOTICS/SEDATIVES|N5B
19331|TRANQUILLISERS|N5C
19331|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
19326|ANALGESICS|N2
19325|Protease inhibitors|J5C2
19324|ANALGESICS|N2
19305|SYSTEMIC ANTIBACTERIALS|J1
19300|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
19300|ANTIVIRALS FOR SYSTEMIC USE|J5
19285|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
19285|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
19283|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
19283|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
19282|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
19282|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
19261|ANDROGENS, EXCLUDING G3E, G3F|G3B
19240|ANTI-ARRHYTHMICS|C1B
19232|ANTIVIRALS FOR SYSTEMIC USE|J5
19232|Interferons, beta|L3B2
19231|ANTIPSYCHOTICS|N5A
19230|ANTI-MIGRAINE PREPARATIONS|N2C
19229|TRANQUILLISERS|N5C
19229|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
19226|BPH (benign prostatic hypertrophy) products |G4C
19224|Urinary incontinence products|G4B4
19223|SYSTEMIC ANTIBACTERIALS|J1
19222|ANTI-EPILEPTICS|N3
19222|NOOTROPICS|N6D
19221|ANTIPSYCHOTICS|N5A
19200|DRUGS USED IN DIABETES|A10
19182|Antigonadotrophin-releasing hormones|H1C3
19161|ANTIVIRALS FOR SYSTEMIC USE|J5
19160|ANAESTHETICS, LOCAL|N1B
19141|IMMUNOSUPPRESSIVE AGENTS|L4
19120|OPHTHALMOLOGICALS|S1
19120|Ocular antineovascularisation products|S1P
19081|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
19080|DRUGS USED IN DIABETES|A10
19080|CARDIOVASCULAR SYSTEM|C
19080|ANTI-EPILEPTICS|N3A
19040|ANALGESICS|N2
19020|CALCIUM ANTAGONISTS|C8
19002|BPH (benign prostatic hypertrophy) products |G4C
19001|PLATELET AGGREGATION INHIBITORS|B1C
18987|ANTIVIRALS FOR SYSTEMIC USE|J5
18986|ANTIVIRALS FOR SYSTEMIC USE|J5
18984|ANTIVIRALS FOR SYSTEMIC USE|J5
18983|GASTROPROKINETICS|A3F
18983|LAXATIVES|A6
18945|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
18944|ANTIHYPERTENSIVES|C2
18944|CENTRAL NERVOUS SYSTEM|N
18944|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
18944|SSRI antidepressants|N6A4
18942|ANTIHYPERTENSIVES|C2
18900|ANTIULCERANTS|A2B
18892|PLATELET AGGREGATION INHIBITORS|B1C
18892|CARDIOVASCULAR SYSTEM|C
18891|ANTI-ARRHYTHMICS|C1B
18891|ANAESTHETICS|N1
18891|ANTI-EPILEPTICS|N3
18889|SYSTEMIC ANTIBACTERIALS|J1
18887|ANALGESICS|N2
18883|ANALGESICS|N2
18883|TRANQUILLISERS|N5C
18882|DERMATOLOGICALS|D
18880|WOUND HEALING AGENTS|D3
18873|HYPNOTICS/SEDATIVES|N5B
18873|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
18872|ANTIVIRALS FOR SYSTEMIC USE|J5
18870|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
18870|Urinary incontinence products|G4B4
18870|ANALGESICS|N2
18870|TRANQUILLISERS|N5C
18870|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
18870|SSRI antidepressants|N6A4
18869|ANTIULCERANTS|A2B
18861|ANALGESICS|N2
18800|ANTIVIRALS FOR SYSTEMIC USE|J5
18781|ANTIHYPERTENSIVES|C2
18740|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
18705|ANALGESICS|N2
18704|WOUND HEALING AGENTS|D3
18704|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
18704|DIAGNOSTIC AGENTS|T
18703|ANTIPSYCHOTICS|N5A
18703|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
18693|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
18692|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
18691|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
18690|Factor VIII|B2D1
18688|ANTI-EPILEPTICS|N3A
18685|Factor VIII|B2D1
18603|ANTIVIRALS FOR SYSTEMIC USE|J5
18580|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
18540|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
18522|ANTIVIRALS FOR SYSTEMIC USE|J5
18484|ANTIVIRALS FOR SYSTEMIC USE|J5
18484|Interferons, alpha|L3B1
18460|Antigonadotrophin-releasing hormones|H1C3
18442|ANTIHYPERTENSIVES|C2
18440|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
18440|IMMUNOSUPPRESSIVE AGENTS|L4
18425|ANTIHYPERTENSIVES|C2
18424|ANTI-ARRHYTHMICS|C1B
18420|ANTIVIRALS FOR SYSTEMIC USE|J5
18411|DIRECT THROMBIN INHIBITORS|B1E
18410|DRUGS USED IN DIABETES|A10
18409|ANTIVIRALS FOR SYSTEMIC USE|J5
18408|ANTI-EPILEPTICS|N3A
18405|DIRECT THROMBIN INHIBITORS|B1E
18401|CARDIOVASCULAR SYSTEM|C
18401|ANTIHYPERTENSIVES|C2
18401|ACE INHIBITORS, PLAIN|C9A
18382|SYSTEMIC ANTIBACTERIALS|J1
18364|SYSTEMIC ANTIBACTERIALS|J1
18360|Alpha-glucosidase inhibitor antidiabetics|A10B5
18360|ANTIVIRALS FOR SYSTEMIC USE|J5
18340|PSYCHOSTIMULANTS|N6B
18325|ANTIMETABOLITES|L1B
18324|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
18320|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
18320|VACCINES|J7
18280|MACROLIDES AND SIMILAR TYPES|J1F
18280|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
18266|CARDIOVASCULAR SYSTEM|C
18266|ANTIHYPERTENSIVES|C2
18266|ACE INHIBITORS, PLAIN|C9A
18264|SYSTEMIC ANTIBACTERIALS|J1
18260|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
18259|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
18259|CENTRAL NERVOUS SYSTEM|N
18256|PLATELET AGGREGATION INHIBITORS|B1C
18256|Fibrinogen|B2D5
18252|ANTIHYPERTENSIVES|C2
18250|Urinary incontinence products|G4B4
18244|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
18244|SSRI antidepressants|N6A4
18242|CARDIAC THERAPY|C1
18242|ANTIVIRALS FOR SYSTEMIC USE|J5
18240|ANALGESICS|N2
18238|Urinary incontinence products|G4B4
18237|SYSTEMIC ANTIBACTERIALS|J1
18237|Carbapenems|J1P2
18232|ANTIEMETICS AND ANTINAUSEANTS|A4
18232|ANALGESICS|N2
18227|ANALGESICS|N2
18226|ANTIVIRALS FOR SYSTEMIC USE|J5
18223|TRANQUILLISERS|N5C
18223|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
18222|ANTI-EPILEPTICS|N3
18218|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
18214|TRANQUILLISERS|N5C
18214|NOOTROPICS|N6D
18212|PLATELET AGGREGATION INHIBITORS|B1C
18212|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
18211|DIRECT THROMBIN INHIBITORS|B1E
18206|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
18206|Statins (HMG-CoA reductase inhibitors)|C10A1
18203|RESPIRATORY SYSTEM|R
18197|SYSTEMIC ANTIBACTERIALS|J1
18197|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
18196|ANTIVIRALS FOR SYSTEMIC USE|J5
18188|ANTIVIRALS FOR SYSTEMIC USE|J5
18187|ANTIVIRALS FOR SYSTEMIC USE|J5
18186|ANTI-EPILEPTICS|N3
18185|ANTI-EPILEPTICS|N3
18184|CENTRAL NERVOUS SYSTEM|N
18182|Factor VIII|B2D1
18181|HYPNOTICS/SEDATIVES|N5B
18171|ANTI-EPILEPTICS|N3A
18171|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
18170|ANTI-MIGRAINE PREPARATIONS|N2C
18168|DERMATOLOGICALS|D
18168|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
18164|IMMUNOSUPPRESSIVE AGENTS|L4
18163|ANTIHYPERTENSIVES|C2
18163|Erectile dysfunction products|G4B3
18149|Glitazone antidiabetics|A10B4
18140|ANTIEMETICS AND ANTINAUSEANTS|A4
18132|Protease inhibitors|J5C2
18130|NOOTROPICS|N6D
18130|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
18117|IMMUNOSUPPRESSIVE AGENTS|L4
18114|WOUND HEALING AGENTS|D3
18114|MUSCULO-SKELETAL SYSTEM|M
18112|ANALGESICS|N2
18111|ANDROGENS, EXCLUDING G3E, G3F|G3B
18111|ANALGESICS|N2
18108|IMMUNOSUPPRESSIVE AGENTS|L4
18102|ANTIPSYCHOTICS|N5A
18102|TRANQUILLISERS|N5C
18101|PLATELET AGGREGATION INHIBITORS|B1C
18101|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
18097|CENTRAL NERVOUS SYSTEM|N
18097|ANALGESICS|N2
18097|ANTI-EPILEPTICS|N3A
18092|ANTI-EPILEPTICS|N3A
18090|FIBRINOLYTICS|B1D
18088|ANTIHYPERTENSIVES|C2
18080|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
18079|WOUND HEALING AGENTS|D3
18078|WOUND HEALING AGENTS|D3
18074|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
18064|DIRECT THROMBIN INHIBITORS|B1E
18063|CARDIOVASCULAR SYSTEM|C
18063|ANTIHYPERTENSIVES|C2
18063|CALCIUM ANTAGONISTS|C8
18062|ANTIHYPERTENSIVES|C2
18061|SYSTEMIC ANTIBACTERIALS|J1
18050|ANTI-EPILEPTICS|N3
18047|CENTRAL NERVOUS SYSTEM|N
18044|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
18040|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
18039|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
18038|FIBRINOLYTICS|B1D
18038|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
18036|DRUGS USED IN DIABETES|A10
18030|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
18028|SYSTEMIC ANTIBACTERIALS|J1
18026|PLATELET AGGREGATION INHIBITORS|B1C
18022|SYSTEMIC ANTIBACTERIALS|J1
18022|ANTIVIRALS FOR SYSTEMIC USE|J5
18018|NOOTROPICS|N6D
18016|SYSTEMIC ANTIBACTERIALS|J1
18015|ANTIPSYCHOTICS|N5A
18001|ANTIHYPERTENSIVES|C2
18000|ANALGESICS|N2
17996|ANTI-EPILEPTICS|N3A
17991|ALKYLATING AGENTS|L1A
17988|ALKYLATING AGENTS|L1A
17986|ANTIVIRALS FOR SYSTEMIC USE|J5
17984|PLATELET AGGREGATION INHIBITORS|B1C
17984|DIRECT THROMBIN INHIBITORS|B1E
17980|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
17978|CARDIOVASCULAR SYSTEM|C
17978|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
17976|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
17976|DRUGS USED IN DIABETES|A10
17976|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
17975|CENTRAL NERVOUS SYSTEM|N
17975|ANTI-EPILEPTICS|N3
17973|ANTI-EPILEPTICS|N3
17971|ANTIVIRALS FOR SYSTEMIC USE|J5
17962|CARDIOVASCULAR SYSTEM|C
17960|PLATELET AGGREGATION INHIBITORS|B1C
17959|ANTIULCERANTS|A2B
17955|WOUND HEALING AGENTS|D3
17954|DIRECT THROMBIN INHIBITORS|B1E
17950|ANTIVIRALS FOR SYSTEMIC USE|J5
17946|ANTIVIRALS FOR SYSTEMIC USE|J5
17942|ANTIVIRALS FOR SYSTEMIC USE|J5
17939|ANTIVIRALS FOR SYSTEMIC USE|J5
17938|IMMUNOSUPPRESSIVE AGENTS|L4
17936|ANTIVIRALS FOR SYSTEMIC USE|J5
17935|ANTIVIRALS FOR SYSTEMIC USE|J5
17934|BPH (benign prostatic hypertrophy) products |G4C
17924|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
17923|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
17922|ANALGESICS|N2
17922|ANTI-MIGRAINE PREPARATIONS|N2C
17922|ANTI-EPILEPTICS|N3
17922|ANTIPSYCHOTICS|N5A
17922|TRANQUILLISERS|N5C
17922|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17917|ANTIULCERANTS|A2B
17915|ANTIHYPERTENSIVES|C2
17913|PLATELET AGGREGATION INHIBITORS|B1C
17913|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
17910|ANALGESICS|N2
17910|ANTI-MIGRAINE PREPARATIONS|N2C
17909|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
17902|ANTI-MIGRAINE PREPARATIONS|N2C
17902|HYPNOTICS/SEDATIVES|N5B
17902|TRANQUILLISERS|N5C
17902|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17896|CALCIUM ANTAGONISTS|C8
17896|ANTI-EPILEPTICS|N3
17895|ANTIHYPERTENSIVES|C2
17893|DIRECT THROMBIN INHIBITORS|B1E
17891|CARDIOVASCULAR SYSTEM|C
17891|ANTIVIRALS FOR SYSTEMIC USE|J5
17890|PLATELET AGGREGATION INHIBITORS|B1C
17890|ANTIPSYCHOTICS|N5A
17887|ANTIVIRALS FOR SYSTEMIC USE|J5
17886|Erectile dysfunction products|G4B3
17875|ANALGESICS|N2
17875|SSRI antidepressants|N6A4
17875|SRNI antidepressants|N6A5
17873|SYSTEMIC ANTIBACTERIALS|J1
17872|ANALGESICS|N2
17866|IMMUNOSUPPRESSIVE AGENTS|L4
17864|ANTIVIRALS FOR SYSTEMIC USE|J5
17863|ANTIULCERANTS|A2B
17863|CALCIUM ANTAGONISTS|C8
17861|DIRECT THROMBIN INHIBITORS|B1E
17858|PLATELET AGGREGATION INHIBITORS|B1C
17857|HYPNOTICS/SEDATIVES|N5B
17856|ANTI-GOUT PREPARATIONS|M4
17856|ANALGESICS|N2
17856|ANTI-MIGRAINE PREPARATIONS|N2C
17855|ANALGESICS|N2
17854|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
17853|Coxibs|M1A3
17853|ANALGESICS|N2
17852|ANTIVIRALS FOR SYSTEMIC USE|J5
17851|CARDIOVASCULAR SYSTEM|C
17851|DERMATOLOGICALS|D
17845|Urinary incontinence products|G4B4
17843|SYSTEMIC ANTIBACTERIALS|J1
17842|ANTIVIRALS FOR SYSTEMIC USE|J5
17842|IMMUNOSTIMULATING AGENTS|L3
17841|IMMUNOSUPPRESSIVE AGENTS|L4
17837|ANDROGENS, EXCLUDING G3E, G3F|G3B
17835|SYSTEMIC ANTIBACTERIALS|J1
17835|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
17831|SYSTEMIC ANTIBACTERIALS|J1
17830|SYSTEMIC ANTIBACTERIALS|J1
17829|VACCINES|J7
17825|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
17825|PARASITOLOGY|P
17824|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17824|SSRI antidepressants|N6A4
17820|IMMUNOSUPPRESSIVE AGENTS|L4
17818|CARDIOVASCULAR SYSTEM|C
17817|ALKYLATING AGENTS|L1A
17814|ANTI-EPILEPTICS|N3
17813|DIRECT THROMBIN INHIBITORS|B1E
17813|CARDIOVASCULAR SYSTEM|C
17807|Inhibitors of the Kallikrein-kinin-system|B2C2
17805|HYPNOTICS/SEDATIVES|N5B
17804|ANALGESICS|N2
17800|ANTIVIRALS FOR SYSTEMIC USE|J5
17793|B2-STIMULANTS|R3A
17792|GASTROPROKINETICS|A3F
17790|ANTI-ARRHYTHMICS|C1B
17790|CALCIUM ANTAGONISTS|C8
17787|ANTI-ARRHYTHMICS|C1B
17787|CALCIUM ANTAGONISTS|C8
17783|TRANQUILLISERS|N5C
17783|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17781|BPH (benign prostatic hypertrophy) products |G4C
17780|SYSTEMIC ANTIBACTERIALS|J1
17778|DRUGS USED IN DIABETES|A10
17778|HUMAN INSULINS AND ANALOGUES|A10C
17778|Human insulins and analogues, intermediate-acting|A10C2
17776|MUSCLE RELAXANTS|M3
17776|ANAESTHETICS|N1
17776|HYPNOTICS/SEDATIVES|N5B
17773|SYSTEMIC ANTIBACTERIALS|J1
17765|ANTIVIRALS FOR SYSTEMIC USE|J5
17764|CARDIOVASCULAR SYSTEM|C
17760|PLATELET AGGREGATION INHIBITORS|B1C
17760|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
17760|Fibrinogen|B2D5
17750|ALKYLATING AGENTS|L1A
17745|CARDIAC THERAPY|C1
17745|ANTIHYPERTENSIVES|C2
17745|ACE INHIBITORS, PLAIN|C9A
17744|ALKYLATING AGENTS|L1A
17739|WOUND HEALING AGENTS|D3
17737|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
17731|PLATELET AGGREGATION INHIBITORS|B1C
17731|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
17728|ANTI-EPILEPTICS|N3
17727|ANALGESICS|N2
17712|ANTIPSYCHOTICS|N5A
17711|ANTIPSYCHOTICS|N5A
17706|ANTIVIRALS FOR SYSTEMIC USE|J5
17705|ANALGESICS|N2
17700|SYSTEMIC ANTIBACTERIALS|J1
17695|Protease inhibitors|J5C2
17690|ANTIVIRALS FOR SYSTEMIC USE|J5
17689|ANTIHYPERTENSIVES|C2
17681|Non-nucleoside reverse transcriptase inhibitors|J5C3
17680|DIRECT THROMBIN INHIBITORS|B1E
17673|ANTIHYPERTENSIVES|C2
17673|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
17672|OPHTHALMOLOGICALS|S1
17671|BPH (benign prostatic hypertrophy) products |G4C
17670|BPH (benign prostatic hypertrophy) products |G4C
17669|SYSTEMIC ANTIBACTERIALS|J1
17668|BPH (benign prostatic hypertrophy) products |G4C
17667|SYSTEMIC ANTIBACTERIALS|J1
17663|Antigonadotrophin-releasing hormones|H1C3
17659|ANTIPSYCHOTICS|N5A
17658|ANTIPSYCHOTICS|N5A
17657|ANTI-MIGRAINE PREPARATIONS|N2C
17656|TRANQUILLISERS|N5C
17656|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17651|PARASITOLOGY|P
17650|CENTRAL NERVOUS SYSTEM|N
17650|ANTI-EPILEPTICS|N3A
17649|NOOTROPICS|N6D
17646|SYSTEMIC ANTIBACTERIALS|J1
17645|PLATELET AGGREGATION INHIBITORS|B1C
17643|Urinary incontinence products|G4B4
17638|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
17636|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
17635|ANTIHYPERTENSIVES|C2
17632|CARDIOVASCULAR SYSTEM|C
17632|ANTIHYPERTENSIVES|C2
17631|SYSTEMIC ANTIBACTERIALS|J1
17630|SYSTEMIC ANTIBACTERIALS|J1
17629|PLATELET AGGREGATION INHIBITORS|B1C
17629|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
17627|ANTIHYPERTENSIVES|C2
17626|ANTIHYPERTENSIVES|C2
17625|ANTIVIRALS FOR SYSTEMIC USE|J5
17623|ANTI-EPILEPTICS|N3
17621|ANTIVIRALS FOR SYSTEMIC USE|J5
17621|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
17612|ANTIVIRALS FOR SYSTEMIC USE|J5
17609|ANTIVIRALS FOR SYSTEMIC USE|J5
17603|PARASITOLOGY|P
17594|ANALGESICS|N2
17593|ANTIULCERANTS|A2B
17590|TRANQUILLISERS|N5C
17590|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17586|DIRECT THROMBIN INHIBITORS|B1E
17583|DIRECT THROMBIN INHIBITORS|B1E
17579|ANTIVIRALS FOR SYSTEMIC USE|J5
17564|ANTI-EPILEPTICS|N3
17561|Urinary incontinence products|G4B4
17558|TRANQUILLISERS|N5C
17558|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17558|SSRI antidepressants|N6A4
17557|DIAGNOSTIC AGENTS|T
17556|CARDIOVASCULAR SYSTEM|C
17556|CALCIUM ANTAGONISTS|C8
17553|ANALGESICS|N2
17552|ANALGESICS|N2
17551|ALKYLATING AGENTS|L1A
17548|CALCIUM ANTAGONISTS|C8
17547|SYSTEMIC ANTIBACTERIALS|J1
17543|ANTIPSYCHOTICS|N5A
17543|NOOTROPICS|N6D
17537|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
17536|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
17534|GASTROPROKINETICS|A3F
17534|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
17533|PLATELET AGGREGATION INHIBITORS|B1C
17532|ANTIHYPERTENSIVES|C2
17532|DIURETICS|C3
17531|ANTIHYPERTENSIVES|C2
17531|Erectile dysfunction products|G4B3
17530|ANTIULCERANTS|A2B
17518|TRANQUILLISERS|N5C
17518|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17518|SSRI antidepressants|N6A4
17515|ANTI-EPILEPTICS|N3A
17515|ANTIPSYCHOTICS|N5A
17513|SYSTEMIC ANTIBACTERIALS|J1
17509|VACCINES|J7
17509|IMMUNOSTIMULATING AGENTS|L3
17497|ANALGESICS|N2
17494|WOUND HEALING AGENTS|D3
17492|NOOTROPICS|N6D
17487|NOOTROPICS|N6D
17482|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
17477|ANTI-ARRHYTHMICS|C1B
17475|OPHTHALMOLOGICALS|S1
17470|PLATELET AGGREGATION INHIBITORS|B1C
17469|PARASITOLOGY|P
17465|ANTIPSYCHOTICS|N5A
17465|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
17464|ANALGESICS|N2
17464|ANTIPSYCHOTICS|N5A
17464|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
17463|ANTIVIRALS FOR SYSTEMIC USE|J5
17459|HYPNOTICS/SEDATIVES|N5B
17458|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17457|BPH (benign prostatic hypertrophy) products |G4C
17456|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
17454|ANALGESICS|N2
17451|ANALGESICS|N2
17450|ANTI-GOUT PREPARATIONS|M4
17446|ANALGESICS|N2
17446|RESPIRATORY SYSTEM|R
17440|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
17430|CARDIOVASCULAR SYSTEM|C
17428|ANTIVIRALS FOR SYSTEMIC USE|J5
17427|Glitazone antidiabetics|A10B4
17426|DRUGS USED IN DIABETES|A10
17426|HUMAN INSULINS AND ANALOGUES|A10C
17426|Human insulins and analogues, intermediate-acting|A10C2
17425|ANTIVIRALS FOR SYSTEMIC USE|J5
17417|ANTIVIRALS FOR SYSTEMIC USE|J5
17415|ANTIHYPERTENSIVES|C2
17412|ANTI-ARRHYTHMICS|C1B
17411|HEPARINS |B1B
17411|CARDIOVASCULAR SYSTEM|C
17410|ANTIHYPERTENSIVES|C2
17410|DIURETICS|C3
17409|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
17407|ANTI-GOUT PREPARATIONS|M4
17403|ANALGESICS|N2
17394|Urinary incontinence products|G4B4
17393|ANTI-ARRHYTHMICS|C1B
17388|FIBRINOLYTICS|B1D
17386|DRUGS USED IN DIABETES|A10
17386|HUMAN INSULINS AND ANALOGUES|A10C
17386|Human insulins and analogues, intermediate-acting|A10C2
17385|CARDIOVASCULAR SYSTEM|C
17385|ULTRASOUND AGENTS|T1F
17384|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
17382|MRI AGENTS|T1E
17379|ANALGESICS|N2
17378|SYSTEMIC ANTIBACTERIALS|J1
17371|CENTRAL NERVOUS SYSTEM|N
17371|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17371|SSRI antidepressants|N6A4
17371|SRNI antidepressants|N6A5
17371|NOOTROPICS|N6D
17369|IMMUNOSUPPRESSIVE AGENTS|L4
17367|PLATELET AGGREGATION INHIBITORS|B1C
17367|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
17365|NOOTROPICS|N6D
17360|SYSTEMIC ANTIBACTERIALS|J1
17357|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
17357|SYSTEMIC ANTIBACTERIALS|J1
17355|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17355|SSRI antidepressants|N6A4
17355|SRNI antidepressants|N6A5
17353|PLATELET AGGREGATION INHIBITORS|B1C
17352|CALCIUM ANTAGONISTS|C8
17349|ANTIHYPERTENSIVES|C2
17349|Urinary incontinence products|G4B4
17346|PARASITOLOGY|P
17346|ANTI-MALARIALS|P1D
17345|Antigonadotrophin-releasing hormones|H1C3
17344|TRANQUILLISERS|N5C
17344|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17342|SYSTEMIC ANTIBACTERIALS|J1
17340|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
17336|ANTIHYPERTENSIVES|C2
17335|ANTIVIRALS FOR SYSTEMIC USE|J5
17326|CARDIOVASCULAR SYSTEM|C
17326|ANTI-ARRHYTHMICS|C1B
17325|IMMUNOSUPPRESSIVE AGENTS|L4
17320|CARDIAC THERAPY|C1
17318|DIRECT THROMBIN INHIBITORS|B1E
17314|PLATELET AGGREGATION INHIBITORS|B1C
17314|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
17308|SYSTEMIC ANTIBACTERIALS|J1
17307|Protease inhibitors|J5C2
17303|SYSTEMIC ANTIBACTERIALS|J1
17303|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
17302|ANTI-EPILEPTICS|N3A
17297|ANTIULCERANTS|A2B
17282|ANALGESICS|N2
17282|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17281|DERMATOLOGICALS|D
17281|IMMUNOSUPPRESSIVE AGENTS|L4
17280|SYSTEMIC ANTIBACTERIALS|J1
17279|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
17276|ANTI-EPILEPTICS|N3A
17270|ANTIULCERANTS|A2B
17265|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
17263|NOOTROPICS|N6D
17263|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
17260|IMMUNOSUPPRESSIVE AGENTS|L4
17257|DRUGS USED IN DIABETES|A10
17257|CENTRAL NERVOUS SYSTEM|N
17256|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
17253|PARASITOLOGY|P
17249|SYSTEMIC ANTIBACTERIALS|J1
17248|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
17247|ANTIPSYCHOTICS|N5A
17246|ANTIPSYCHOTICS|N5A
17241|ANTIHYPERTENSIVES|C2
17241|DIURETICS|C3
17241|TRANQUILLISERS|N5C
17241|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17240|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
17239|TRANQUILLISERS|N5C
17239|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17237|SYSTEMIC ANTIBACTERIALS|J1
17236|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
17235|Non-nucleoside reverse transcriptase inhibitors|J5C3
17234|SYSTEMIC ANTIBACTERIALS|J1
17234|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
17234|PARASITOLOGY|P
17232|DIRECT THROMBIN INHIBITORS|B1E
17229|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
17229|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
17227|CARDIOVASCULAR SYSTEM|C
17223|BPH (benign prostatic hypertrophy) products |G4C
17222|ANTIPSYCHOTICS|N5A
17221|SYSTEMIC ANTIBACTERIALS|J1
17221|MACROLIDES AND SIMILAR TYPES|J1F
17219|MACROLIDES AND SIMILAR TYPES|J1F
17214|NOOTROPICS|N6D
17213|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
17210|PARASITOLOGY|P
17202|SYSTEMIC ANTIBACTERIALS|J1
17200|ANTIVIRALS FOR SYSTEMIC USE|J5
17198|SYSTEMIC ANTIBACTERIALS|J1
17195|IMMUNOSUPPRESSIVE AGENTS|L4
17194|CARDIOVASCULAR SYSTEM|C
17185|ANTIVIRALS FOR SYSTEMIC USE|J5
17180|ANTI-EPILEPTICS|N3A
17180|NOOTROPICS|N6D
17179|ANTIPSYCHOTICS|N5A
17179|NOOTROPICS|N6D
17177|IMMUNOSTIMULATING AGENTS|L3
17171|CALCIUM ANTAGONISTS|C8
17167|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
17166|ANTI-ARRHYTHMICS|C1B
17162|CARDIOVASCULAR SYSTEM|C
17161|CARDIOVASCULAR SYSTEM|C
17161|ANTIHYPERTENSIVES|C2
17157|ANTI-EPILEPTICS|N3
17154|NOOTROPICS|N6D
17147|ANTIULCERANTS|A2B
17132|SYSTEMIC ANTIBACTERIALS|J1
17132|TRANQUILLISERS|N5C
17132|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17131|ANTI-ARRHYTHMICS|C1B
17131|CALCIUM ANTAGONISTS|C8
17130|TRANQUILLISERS|N5C
17130|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17129|TRANQUILLISERS|N5C
17129|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17115|SYSTEMIC ANTIBACTERIALS|J1
17113|ANTIVIRALS FOR SYSTEMIC USE|J5
17111|RADIODIAGNOSTIC AGENTS|T1G
17109|DERMATOLOGICALS|D
17109|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
17108|RADIODIAGNOSTIC AGENTS|T1G
17107|ANTIVIRALS FOR SYSTEMIC USE|J5
17106|PLATELET AGGREGATION INHIBITORS|B1C
17104|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
17104|SSRI antidepressants|N6A4
17103|ANALGESICS|N2
17100|ANTIVIRALS FOR SYSTEMIC USE|J5
17096|ANALGESICS|N2
17095|PARASITOLOGY|P
17094|TRANQUILLISERS|N5C
17091|IMMUNOSTIMULATING AGENTS|L3
17090|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
17079|Carbapenems|J1P2
17075|SYSTEMIC ANTIBACTERIALS|J1
17072|CARDIOVASCULAR SYSTEM|C
17071|SYSTEMIC ANTIBACTERIALS|J1
17071|CEPHALOSPORINS|J1D
17069|VACCINES|J7
17066|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
17065|ANTIHYPERTENSIVES|C2
17064|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
17061|Glitazone antidiabetics|A10B4
17061|ANTI-ARRHYTHMICS|C1B
17061|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
17060|ANTI-ARRHYTHMICS|C1B
17059|DIRECT THROMBIN INHIBITORS|B1E
17059|ANTI-ARRHYTHMICS|C1B
17054|CENTRAL NERVOUS SYSTEM|N
17054|ANALGESICS|N2
17053|RESPIRATORY SYSTEM|R
17051|CARDIOVASCULAR SYSTEM|C
17051|B2-STIMULANTS|R3A
17046|CEPHALOSPORINS|J1D
17044|Protease inhibitors|J5C2
17042|DRUGS USED IN DIABETES|A10
17042|ANTIVIRALS FOR SYSTEMIC USE|J5
17041|FIBRINOLYTICS|B1D
17033|HUMAN INSULINS AND ANALOGUES|A10C
17033|Human insulins and analogues, intermediate-acting|A10C2
17032|ANALGESICS|N2
17029|ANTIULCERANTS|A2B
17029|SYSTEMIC ANTIBACTERIALS|J1
17027|SYSTEMIC ANTIBACTERIALS|J1
17027|Carbapenems|J1P2
17026|ANTIULCERANTS|A2B
17026|VACCINES|J7
17025|SYSTEMIC ANTIBACTERIALS|J1
17025|Carbapenems|J1P2
17023|VACCINES|J7
17022|VACCINES|J7
17016|SYSTEMIC ANTIBACTERIALS|J1
17016|VACCINES|J7
17014|DRUGS USED IN DIABETES|A10
17012|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
17012|DRUGS USED IN DIABETES|A10
17010|PLATELET AGGREGATION INHIBITORS|B1C
17010|CARDIOVASCULAR SYSTEM|C
17009|ANTIVIRALS FOR SYSTEMIC USE|J5
17000|CARDIOVASCULAR SYSTEM|C
17000|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16997|ANTI-ARRHYTHMICS|C1B
16995|CARDIOVASCULAR SYSTEM|C
16995|CENTRAL NERVOUS SYSTEM|N
16994|SYSTEMIC ANTIBACTERIALS|J1
16988|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
16986|CARDIAC THERAPY|C1
16986|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16984|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16983|WOUND HEALING AGENTS|D3
16982|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16975|NOOTROPICS|N6D
16975|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
16971|SYSTEMIC ANTIBACTERIALS|J1
16969|PARASITOLOGY|P
16967|ANTIHYPERTENSIVES|C2
16966|CALCIUM ANTAGONISTS|C8
16965|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16965|PARASITOLOGY|P
16964|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16963|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16962|RESPIRATORY SYSTEM|R
16959|NOOTROPICS|N6D
16954|SYSTEMIC ANTIBACTERIALS|J1
16949|ANTI-MIGRAINE PREPARATIONS|N2C
16948|ANTI-EPILEPTICS|N3A
16943|PARASITOLOGY|P
16943|ANTI-MALARIALS|P1D
16940|ANALGESICS|N2
16938|ACTH|H1A
16937|Coxibs|M1A3
16937|ANALGESICS|N2
16936|ANTIVIRALS FOR SYSTEMIC USE|J5
16935|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16935|IMMUNOSUPPRESSIVE AGENTS|L4
16934|ANALGESICS|N2
16931|ANTI-EPILEPTICS|N3A
16931|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16931|SSRI antidepressants|N6A4
16931|SRNI antidepressants|N6A5
16930|PLATELET AGGREGATION INHIBITORS|B1C
16930|Fibrinogen|B2D5
16928|PLATELET AGGREGATION INHIBITORS|B1C
16928|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
16928|Fibrinogen|B2D5
16926|SYSTEMIC ANTIBACTERIALS|J1
16926|CEPHALOSPORINS|J1D
16925|ANALGESICS|N2
16924|ANALGESICS|N2
16923|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16922|CARDIOVASCULAR SYSTEM|C
16922|ANTIHYPERTENSIVES|C2
16920|ANALGESICS|N2
16918|ANALGESICS|N2
16917|ANALGESICS|N2
16915|ANTIMETABOLITES|L1B
16914|SYSTEMIC ANTIBACTERIALS|J1
16911|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16907|ANTIHYPERTENSIVES|C2
16906|WOUND HEALING AGENTS|D3
16905|ANTIPSYCHOTICS|N5A
16905|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16905|SRNI antidepressants|N6A5
16904|HUMAN INSULINS AND ANALOGUES|A10C
16904|Human insulins and analogues, intermediate-acting|A10C2
16903|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16900|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16900|GROWTH HORMONES|H4C
16899|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16897|ANTIVIRALS FOR SYSTEMIC USE|J5
16896|Coxibs|M1A3
16896|ANALGESICS|N2
16894|VACCINES|J7
16891|Topical dermatological antifungals|D1A1
16891|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16888|DIURETICS|C3
16887|CARDIOVASCULAR SYSTEM|C
16883|TRANQUILLISERS|N5C
16883|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16882|CARDIOVASCULAR SYSTEM|C
16881|SYSTEMIC ANTIBACTERIALS|J1
16878|Coxibs|M1A3
16877|ANTIHYPERTENSIVES|C2
16876|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16874|Erectile dysfunction products|G4B3
16872|ANTIPSYCHOTICS|N5A
16872|TRANQUILLISERS|N5C
16872|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16872|SSRI antidepressants|N6A4
16869|NOOTROPICS|N6D
16867|TRANQUILLISERS|N5C
16864|NOOTROPICS|N6D
16863|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16861|TRANQUILLISERS|N5C
16854|Coxibs|M1A3
16853|VACCINES|J7
16852|ANTIVIRALS FOR SYSTEMIC USE|J5
16850|ANTIVIRALS FOR SYSTEMIC USE|J5
16847|VACCINES|J7
16839|ANTIHYPERTENSIVES|C2
16835|PLATELET AGGREGATION INHIBITORS|B1C
16834|IMMUNOSUPPRESSIVE AGENTS|L4
16833|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16831|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16831|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16828|ALKYLATING AGENTS|L1A
16826|SYSTEMIC ANTIBACTERIALS|J1
16825|SYSTEMIC ANTIBACTERIALS|J1
16824|SYSTEMIC ANTIBACTERIALS|J1
16822|SYSTEMIC ANTIBACTERIALS|J1
16820|DIRECT THROMBIN INHIBITORS|B1E
16818|NOOTROPICS|N6D
16817|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16816|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
16812|DIURETICS|C3
16811|PLATELET AGGREGATION INHIBITORS|B1C
16811|ANTIHYPERTENSIVES|C2
16807|ANALGESICS|N2
16807|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16802|VACCINES|J7
16801|TRANQUILLISERS|N5C
16800|ANTI-EPILEPTICS|N3
16798|ANTIPSYCHOTICS|N5A
16797|ANTI-EPILEPTICS|N3A
16797|NOOTROPICS|N6D
16795|ANTIPSYCHOTICS|N5A
16793|NOOTROPICS|N6D
16792|TRANQUILLISERS|N5C
16785|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16782|ANTIHYPERTENSIVES|C2
16782|Erectile dysfunction products|G4B3
16781|BPH (benign prostatic hypertrophy) products |G4C
16777|BPH (benign prostatic hypertrophy) products |G4C
16776|ANTIHYPERTENSIVES|C2
16774|IMMUNOSUPPRESSIVE AGENTS|L4
16773|ANTIVIRALS FOR SYSTEMIC USE|J5
16773|Non-nucleoside reverse transcriptase inhibitors|J5C3
16770|PARASITOLOGY|P
16766|ANTIVIRALS FOR SYSTEMIC USE|J5
16765|ANTIFIBRINOLYTICS|B2A
16765|Inhibitors of the Kallikrein-kinin-system|B2C2
16762|ANTIPSYCHOTICS|N5A
16761|SYSTEMIC ANTIBACTERIALS|J1
16761|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16755|SYSTEMIC ANTIBACTERIALS|J1
16755|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16755|PARASITOLOGY|P
16754|SYSTEMIC ANTIBACTERIALS|J1
16754|CEPHALOSPORINS|J1D
16753|MACROLIDES AND SIMILAR TYPES|J1F
16752|SYSTEMIC ANTIBACTERIALS|J1
16749|CEPHALOSPORINS|J1D
16748|ANTIEMETICS AND ANTINAUSEANTS|A4
16748|ANTIVIRALS FOR SYSTEMIC USE|J5
16748|ANALGESICS|N2
16748|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16745|ANTIVIRALS FOR SYSTEMIC USE|J5
16744|IMMUNOSUPPRESSIVE AGENTS|L4
16743|NOOTROPICS|N6D
16739|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16738|ANTIHYPERTENSIVES|C2
16737|PARASITOLOGY|P
16735|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16732|ANTI-EPILEPTICS|N3A
16731|ANTIHYPERTENSIVES|C2
16730|CARDIOVASCULAR SYSTEM|C
16730|ANTIHYPERTENSIVES|C2
16726|Coxibs|M1A3
16724|BETA-BLOCKING AGENTS|C7
16724|Miotics and antiglaucoma preparations, topical|S1E2
16723|ANTIHYPERTENSIVES|C2
16723|CALCIUM ANTAGONISTS|C8
16723|ACE INHIBITORS, PLAIN|C9A
16721|ANTIVIRALS FOR SYSTEMIC USE|J5
16719|PLATELET AGGREGATION INHIBITORS|B1C
16715|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16714|IMMUNOSUPPRESSIVE AGENTS|L4
16713|TRANQUILLISERS|N5C
16713|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16711|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16710|IMMUNOSTIMULATING AGENTS|L3
16707|SYSTEMIC ANTIHISTAMINES|R6
16704|ANTIVIRALS FOR SYSTEMIC USE|J5
16703|ANTIVIRALS FOR SYSTEMIC USE|J5
16701|PLATELET AGGREGATION INHIBITORS|B1C
16701|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
16698|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16696|ANTIVIRALS FOR SYSTEMIC USE|J5
16691|DIRECT THROMBIN INHIBITORS|B1E
16690|CARDIOVASCULAR SYSTEM|C
16689|ANAESTHETICS, GENERAL|N1A
16689|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16686|ALKYLATING AGENTS|L1A
16683|TRANQUILLISERS|N5C
16683|SSRI antidepressants|N6A4
16681|DIRECT THROMBIN INHIBITORS|B1E
16680|ANALGESICS|N2
16679|ANTIVIRALS FOR SYSTEMIC USE|J5
16677|SYSTEMIC ANTIBACTERIALS|J1
16677|CEPHALOSPORINS|J1D
16677|Carbapenems|J1P2
16676|IMMUNOSUPPRESSIVE AGENTS|L4
16674|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16674|Alpha-glucosidase inhibitor antidiabetics|A10B5
16673|ANTIHYPERTENSIVES|C2
16673|ANTI-EPILEPTICS|N3A
16673|TRANQUILLISERS|N5C
16672|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16671|SYSTEMIC ANTIBACTERIALS|J1
16670|ANTIVIRALS FOR SYSTEMIC USE|J5
16666|ANTI-EPILEPTICS|N3A
16661|SYSTEMIC ANTIBACTERIALS|J1
16659|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16657|ANTI-ARRHYTHMICS|C1B
16656|MACROLIDES AND SIMILAR TYPES|J1F
16653|ANTIPSYCHOTICS|N5A
16651|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16649|ANTIPSYCHOTICS|N5A
16649|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16649|NOOTROPICS|N6D
16645|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16643|ANAESTHETICS, GENERAL|N1A
16633|ANTI-ARRHYTHMICS|C1B
16632|ANALGESICS|N2
16629|ANTIVIRALS FOR SYSTEMIC USE|J5
16628|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16625|ANTI-EPILEPTICS|N3A
16622|ANTIVIRALS FOR SYSTEMIC USE|J5
16615|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16614|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16614|Statins (HMG-CoA reductase inhibitors)|C10A1
16611|ANTIEMETICS AND ANTINAUSEANTS|A4
16611|TRANQUILLISERS|N5C
16607|ANAESTHETICS, LOCAL|N1B
16605|BPH (benign prostatic hypertrophy) products |G4C
16600|ANALGESICS|N2
16599|PLATELET AGGREGATION INHIBITORS|B1C
16599|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
16596|ANTIEMETICS AND ANTINAUSEANTS|A4
16596|TRANQUILLISERS|N5C
16593|ANTIPSYCHOTICS|N5A
16591|CARDIOVASCULAR SYSTEM|C
16591|ANTIHYPERTENSIVES|C2
16590|BPH (benign prostatic hypertrophy) products |G4C
16587|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16586|Protease inhibitors|J5C2
16585|Glitazone antidiabetics|A10B4
16582|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16577|ANTIVIRALS FOR SYSTEMIC USE|J5
16573|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16565|ANTIPSYCHOTICS|N5A
16564|CENTRAL NERVOUS SYSTEM|N
16564|ANALGESICS|N2
16564|ANTI-EPILEPTICS|N3A
16564|ANTIPSYCHOTICS|N5A
16562|Factor VIII|B2D1
16556|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16553|DRUGS USED IN DIABETES|A10
16546|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16545|SYSTEMIC ANTIBACTERIALS|J1
16544|DRUGS USED IN DIABETES|A10
16530|ANTIPSYCHOTICS|N5A
16529|ANALGESICS|N2
16526|DIRECT THROMBIN INHIBITORS|B1E
16525|SYSTEMIC ANTIBACTERIALS|J1
16523|CARDIOVASCULAR SYSTEM|C
16523|ANTIVIRALS FOR SYSTEMIC USE|J5
16522|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16521|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
16517|Factor VIII|B2D1
16517|Factors II, VII, IX and X|B2D2
16516|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
16513|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16511|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16507|Coxibs|M1A3
16506|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
16502|DERMATOLOGICALS|D
16502|WOUND HEALING AGENTS|D3
16476|ANTI-ACNE PREPARATIONS|D10
16476|SYSTEMIC ANTIBACTERIALS|J1
16474|ANTIHYPERTENSIVES|C2
16471|ANTIHYPERTENSIVES|C2
16470|ANTIMETABOLITES|L1B
16468|ANTIVIRALS FOR SYSTEMIC USE|J5
16467|ANTIVIRALS FOR SYSTEMIC USE|J5
16463|ANALGESICS|N2
16463|ANTI-MIGRAINE PREPARATIONS|N2C
16463|ANTI-EPILEPTICS|N3
16462|PLATELET AGGREGATION INHIBITORS|B1C
16462|ANTIHYPERTENSIVES|C2
16462|CALCIUM ANTAGONISTS|C8
16461|Coxibs|M1A3
16459|ANTIVIRALS FOR SYSTEMIC USE|J5
16451|IMMUNOSTIMULATING AGENTS|L3
16447|ANTIVIRALS FOR SYSTEMIC USE|J5
16442|ANTIHYPERTENSIVES|C2
16441|ANTIHYPERTENSIVES|C2
16441|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
16440|SYSTEMIC ANTIBACTERIALS|J1
16440|Interferons, gamma|L3B3
16437|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16436|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16435|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16434|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16429|ANTIEMETICS AND ANTINAUSEANTS|A4
16429|TRANQUILLISERS|N5C
16429|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16428|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16428|Statins (HMG-CoA reductase inhibitors)|C10A1
16427|ANALGESICS|N2
16425|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16423|ANTIPSYCHOTICS|N5A
16412|PLATELET AGGREGATION INHIBITORS|B1C
16412|FIBRINOLYTICS|B1D
16410|ANTI-EPILEPTICS|N3
16409|ANTIVIRALS FOR SYSTEMIC USE|J5
16408|PLATELET AGGREGATION INHIBITORS|B1C
16408|Fibrinogen|B2D5
16406|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16405|VACCINES|J7
16404|ANTI-EPILEPTICS|N3A
16404|NOOTROPICS|N6D
16403|NOOTROPICS|N6D
16398|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16392|CARDIOVASCULAR SYSTEM|C
16392|ANTIHYPERTENSIVES|C2
16390|CARDIOVASCULAR SYSTEM|C
16390|ANTIHYPERTENSIVES|C2
16382|ANTIMETABOLITES|L1B
16378|ANTIVIRALS FOR SYSTEMIC USE|J5
16373|PLATELET AGGREGATION INHIBITORS|B1C
16369|Protease inhibitors|J5C2
16365|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16361|ANALGESICS|N2
16361|ANTI-EPILEPTICS|N3
16356|CARDIOVASCULAR SYSTEM|C
16354|SYSTEMIC ANTIBACTERIALS|J1
16351|ANTIPSYCHOTICS|N5A
16349|TRANQUILLISERS|N5C
16347|SYSTEMIC ANTIBACTERIALS|J1
16346|SYSTEMIC ANTIBACTERIALS|J1
16344|TRANQUILLISERS|N5C
16344|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16343|ANTIHYPERTENSIVES|C2
16343|CALCIUM ANTAGONISTS|C8
16339|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16334|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16332|SYSTEMIC ANTIBACTERIALS|J1
16331|SYSTEMIC ANTIBACTERIALS|J1
16331|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16330|SYSTEMIC ANTIBACTERIALS|J1
16328|SYSTEMIC ANTIBACTERIALS|J1
16327|DIRECT THROMBIN INHIBITORS|B1E
16325|SYSTEMIC ANTIBACTERIALS|J1
16323|SYSTEMIC ANTIBACTERIALS|J1
16320|ANTIVIRALS FOR SYSTEMIC USE|J5
16318|ANTIVIRALS FOR SYSTEMIC USE|J5
16317|SYSTEMIC ANTIBACTERIALS|J1
16316|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16315|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16314|ANALGESICS|N2
16314|NOOTROPICS|N6D
16313|SYSTEMIC ANTIBACTERIALS|J1
16312|PARASITOLOGY|P
16309|Non-nucleoside reverse transcriptase inhibitors|J5C3
16308|DRUGS USED IN DIABETES|A10
16308|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16308|IMMUNOSUPPRESSIVE AGENTS|L4
16306|ANALGESICS|N2
16302|VACCINES|J7
16295|FIBRINOLYTICS|B1D
16294|ANTIULCERANTS|A2B
16293|SYSTEMIC ANTIBACTERIALS|J1
16292|SYSTEMIC ANTIBACTERIALS|J1
16292|MACROLIDES AND SIMILAR TYPES|J1F
16291|SYSTEMIC ANTIBACTERIALS|J1
16290|IMMUNOSTIMULATING AGENTS|L3
16285|IMMUNOSUPPRESSIVE AGENTS|L4
16282|Protease inhibitors|J5C2
16275|ANTIMETABOLITES|L1B
16274|ANTIMETABOLITES|L1B
16272|ANTIMETABOLITES|L1B
16268|ANTIVIRALS FOR SYSTEMIC USE|J5
16267|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16266|ANTI-ACNE PREPARATIONS|D10
16266|SYSTEMIC ANTIBACTERIALS|J1
16262|ANTIPSYCHOTICS|N5A
16262|NOOTROPICS|N6D
16261|DIRECT THROMBIN INHIBITORS|B1E
16259|PLATELET AGGREGATION INHIBITORS|B1C
16259|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
16253|ANTI-MIGRAINE PREPARATIONS|N2C
16252|PARASITOLOGY|P
16250|ANALGESICS|N2
16250|ANTI-EPILEPTICS|N3
16249|PLATELET AGGREGATION INHIBITORS|B1C
16247|SYSTEMIC ANTIBACTERIALS|J1
16245|ANTI-ARRHYTHMICS|C1B
16239|DRUGS USED IN DIABETES|A10
16238|ANALGESICS|N2
16237|CENTRAL NERVOUS SYSTEM|N
16236|CARDIOVASCULAR SYSTEM|C
16232|ANALGESICS|N2
16229|CENTRAL NERVOUS SYSTEM|N
16229|NOOTROPICS|N6D
16228|ANALGESICS|N2
16228|ANTI-EPILEPTICS|N3
16227|DPP-IV inhibitor antidiabetics|A10B6
16224|ANALGESICS|N2
16224|ANTI-EPILEPTICS|N3
16220|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
16216|ANALGESICS|N2
16209|WOUND HEALING AGENTS|D3
16207|DIURETICS|C3
16206|DIURETICS|C3
16205|ANTIEMETICS AND ANTINAUSEANTS|A4
16205|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
16205|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16205|PARASITOLOGY|P
16204|ANTIHYPERTENSIVES|C2
16204|IMMUNOSTIMULATING AGENTS|L3
16201|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16201|Alpha-glucosidase inhibitor antidiabetics|A10B5
16196|ANAESTHETICS|N1
16196|ANALGESICS|N2
16194|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16194|NOOTROPICS|N6D
16188|DRUGS USED IN DIABETES|A10
16187|SYSTEMIC ANTIBACTERIALS|J1
16185|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16184|CEPHALOSPORINS|J1D
16183|ANTIPSYCHOTICS|N5A
16181|ANTIULCERANTS|A2B
16181|SYSTEMIC ANTIBACTERIALS|J1
16169|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16168|GASTROPROKINETICS|A3F
16167|ANTIVIRALS FOR SYSTEMIC USE|J5
16165|ANALGESICS|N2
16160|DIRECT THROMBIN INHIBITORS|B1E
16158|ANTIVIRALS FOR SYSTEMIC USE|J5
16156|DRUGS USED IN DIABETES|A10
16156|ANTIHYPERTENSIVES|C2
16156|ANTIVIRALS FOR SYSTEMIC USE|J5
16155|SYSTEMIC ANTIBACTERIALS|J1
16151|CARDIOVASCULAR SYSTEM|C
16150|NOOTROPICS|N6D
16148|ANTIVIRALS FOR SYSTEMIC USE|J5
16147|CEPHALOSPORINS|J1D
16143|ANTIHYPERTENSIVES|C2
16139|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16139|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16139|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16138|IMMUNOSUPPRESSIVE AGENTS|L4
16132|BPH (benign prostatic hypertrophy) products |G4C
16131|ANTI-EPILEPTICS|N3A
16130|IMMUNOSUPPRESSIVE AGENTS|L4
16127|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16126|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16125|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16124|ANTIVIRALS FOR SYSTEMIC USE|J5
16123|Erectile dysfunction products|G4B3
16117|ANTIEMETICS AND ANTINAUSEANTS|A4
16116|ANALGESICS|N2
16115|BPH (benign prostatic hypertrophy) products |G4C
16110|ANTIHYPERTENSIVES|C2
16107|DIRECT THROMBIN INHIBITORS|B1E
16105|ANALGESICS|N2
16105|ANTI-EPILEPTICS|N3
16105|ANTIPSYCHOTICS|N5A
16105|TRANQUILLISERS|N5C
16105|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16103|ANTIPSYCHOTICS|N5A
16101|SYSTEMIC ANTIBACTERIALS|J1
16093|ANTIVIRALS FOR SYSTEMIC USE|J5
16092|TRANQUILLISERS|N5C
16091|ANTIVIRALS FOR SYSTEMIC USE|J5
16086|TRANQUILLISERS|N5C
16086|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16084|SYSTEMIC ANTIBACTERIALS|J1
16083|IMMUNOSUPPRESSIVE AGENTS|L4
16082|SYSTEMIC ANTIBACTERIALS|J1
16077|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
16075|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16074|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
16073|ANTIHYPERTENSIVES|C2
16073|DIURETICS|C3
16073|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
16071|ANALGESICS|N2
16067|ANTIHYPERTENSIVES|C2
16066|PLATELET AGGREGATION INHIBITORS|B1C
16066|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
16064|ANTIVIRALS FOR SYSTEMIC USE|J5
16062|MUSCULO-SKELETAL SYSTEM|M
16061|SYSTEMIC ANTIBACTERIALS|J1
16059|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16057|IMMUNOSTIMULATING AGENTS|L3
16056|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16052|ANTIPSYCHOTICS|N5A
16051|ANTIPSYCHOTICS|N5A
16050|ANTI-EPILEPTICS|N3
16049|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16049|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16048|ANTIPSYCHOTICS|N5A
16047|Protease inhibitors|J5C2
16046|ANTIPSYCHOTICS|N5A
16043|CARDIOVASCULAR SYSTEM|C
16042|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16042|SSRI antidepressants|N6A4
16042|SRNI antidepressants|N6A5
16040|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16039|ANTIVIRALS FOR SYSTEMIC USE|J5
16037|CARDIOVASCULAR SYSTEM|C
16036|ANTI-EPILEPTICS|N3
16032|ANTIHYPERTENSIVES|C2
16032|ACE INHIBITORS, PLAIN|C9A
16030|ANTIHYPERTENSIVES|C2
16028|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16026|ANTIEMETICS AND ANTINAUSEANTS|A4
16026|SYSTEMIC ANTIBACTERIALS|J1
16024|ANTIVIRALS FOR SYSTEMIC USE|J5
16022|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
16022|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
16021|ANTIEMETICS AND ANTINAUSEANTS|A4
16021|ANALGESICS|N2
16018|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
16014|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
16013|DIRECT THROMBIN INHIBITORS|B1E
16012|Protease inhibitors|J5C2
16010|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
16009|ANTI-ARRHYTHMICS|C1B
16008|ANALGESICS|N2
16007|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
16006|CEPHALOSPORINS|J1D
16005|ANTIHYPERTENSIVES|C2
16004|SYSTEMIC ANTIBACTERIALS|J1
16002|CENTRAL NERVOUS SYSTEM|N
16000|ANALGESICS|N2
15993|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15993|DRUGS USED IN DIABETES|A10
15992|ANTIHYPERTENSIVES|C2
15991|ANTIHYPERTENSIVES|C2
15981|DIRECT THROMBIN INHIBITORS|B1E
15980|FIBRINOLYTICS|B1D
15980|DIRECT THROMBIN INHIBITORS|B1E
15980|Inhibitors of the Kallikrein-kinin-system|B2C2
15978|ANTIVIRALS FOR SYSTEMIC USE|J5
15978|CENTRAL NERVOUS SYSTEM|N
15976|PARASITOLOGY|P
15975|IMMUNOSTIMULATING AGENTS|L3
15975|Interferons, gamma|L3B3
15972|TRANQUILLISERS|N5C
15972|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15971|ANTIPSYCHOTICS|N5A
15969|DIRECT THROMBIN INHIBITORS|B1E
15968|ANALGESICS|N2
15968|ANTI-MIGRAINE PREPARATIONS|N2C
15968|ANTI-EPILEPTICS|N3
15966|ANALGESICS|N2
15963|ANALGESICS|N2
15963|ANTI-MIGRAINE PREPARATIONS|N2C
15962|SYSTEMIC ANTIBACTERIALS|J1
15961|CALCIUM ANTAGONISTS|C8
15961|ANALGESICS|N2
15956|DIRECT THROMBIN INHIBITORS|B1E
15955|Ocular antineovascularisation products|S1P
15953|SYSTEMIC ANTIBACTERIALS|J1
15953|ANTIVIRALS FOR SYSTEMIC USE|J5
15951|ANTIVIRALS FOR SYSTEMIC USE|J5
15951|VACCINES|J7
15948|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15948|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
15947|VACCINES|J7
15946|ANTIULCERANTS|A2B
15945|GASTROPROKINETICS|A3F
15943|SYSTEMIC ANTIBACTERIALS|J1
15941|ANTIHYPERTENSIVES|C2
15939|ANTIPSYCHOTICS|N5A
15939|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15938|CALCIUM ANTAGONISTS|C8
15934|Protease inhibitors|J5C2
15933|Protease inhibitors|J5C2
15929|CARDIOVASCULAR SYSTEM|C
15926|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15926|Statins (HMG-CoA reductase inhibitors)|C10A1
15925|SYSTEMIC ANTIBACTERIALS|J1
15922|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15921|ANTIVIRALS FOR SYSTEMIC USE|J5
15913|DIRECT THROMBIN INHIBITORS|B1E
15910|ANTIVIRALS FOR SYSTEMIC USE|J5
15908|CARDIOVASCULAR SYSTEM|C
15908|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
15902|SYSTEMIC ANTIBACTERIALS|J1
15901|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15898|NOOTROPICS|N6D
15896|ANTIVIRALS FOR SYSTEMIC USE|J5
15895|ANTIVIRALS FOR SYSTEMIC USE|J5
15894|NOOTROPICS|N6D
15893|ANTI-ARRHYTHMICS|C1B
15892|ANTIHYPERTENSIVES|C2
15887|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15886|PLATELET AGGREGATION INHIBITORS|B1C
15886|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
15885|DIRECT THROMBIN INHIBITORS|B1E
15883|SYSTEMIC ANTIBACTERIALS|J1
15882|SYSTEMIC ANTIBACTERIALS|J1
15881|ANTIVIRALS FOR SYSTEMIC USE|J5
15873|DRUGS USED IN DIABETES|A10
15873|HUMAN INSULINS AND ANALOGUES|A10C
15873|Human insulins and analogues, intermediate-acting|A10C2
15872|PARASITOLOGY|P
15867|PARASITOLOGY|P
15866|ANTIVIRALS FOR SYSTEMIC USE|J5
15865|ANTIVIRALS FOR SYSTEMIC USE|J5
15861|FIBRINOLYTICS|B1D
15859|SYSTEMIC ANTIBACTERIALS|J1
15859|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15857|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15857|ANTI-EPILEPTICS|N3A
15857|SSRI antidepressants|N6A4
15857|SRNI antidepressants|N6A5
15857|NOOTROPICS|N6D
15855|SYSTEMIC ANTIBACTERIALS|J1
15854|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15853|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15852|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15849|IMMUNOSUPPRESSIVE AGENTS|L4
15847|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
15841|ANTIHYPERTENSIVES|C2
15841|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
15840|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15839|ANTIHYPERTENSIVES|C2
15839|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
15838|ANTIHYPERTENSIVES|C2
15838|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
15837|ANTIHYPERTENSIVES|C2
15837|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
15835|ANTIHYPERTENSIVES|C2
15834|ANTIHYPERTENSIVES|C2
15832|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
15831|ANTIHYPERTENSIVES|C2
15830|DERMATOLOGICALS|D
15829|ANTIHYPERTENSIVES|C2
15828|PLATELET AGGREGATION INHIBITORS|B1C
15828|ANTIHYPERTENSIVES|C2
15826|ANALGESICS|N2
15824|SYSTEMIC ANTIBACTERIALS|J1
15824|Carbapenems|J1P2
15823|ANTIVIRALS FOR SYSTEMIC USE|J5
15822|ANTIVIRALS FOR SYSTEMIC USE|J5
15821|ANALGESICS|N2
15814|PARASITOLOGY|P
15812|CARDIOVASCULAR SYSTEM|C
15810|PLATELET AGGREGATION INHIBITORS|B1C
15809|DERMATOLOGICALS|D
15807|ANALGESICS|N2
15806|CARDIOVASCULAR SYSTEM|C
15806|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
15804|ANTIVIRALS FOR SYSTEMIC USE|J5
15802|PLATELET AGGREGATION INHIBITORS|B1C
15798|ANALGESICS|N2
15797|ANTI-MIGRAINE PREPARATIONS|N2C
15797|HYPNOTICS/SEDATIVES|N5B
15797|TRANQUILLISERS|N5C
15795|DERMATOLOGICALS|D
15788|ANTI-EPILEPTICS|N3
15784|Factor VIII|B2D1
15783|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15781|TRANQUILLISERS|N5C
15779|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15774|ANALGESICS|N2
15772|ANTI-ARRHYTHMICS|C1B
15769|LUNG SURFACTANTS|R7C
15768|IMMUNOSTIMULATING AGENTS|L3
15767|CARDIOVASCULAR SYSTEM|C
15762|ANTIHYPERTENSIVES|C2
15760|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15758|ANTIEMETICS AND ANTINAUSEANTS|A4
15756|ANTIVIRALS FOR SYSTEMIC USE|J5
15753|WOUND HEALING AGENTS|D3
15749|ANALGESICS|N2
15749|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
15748|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
15748|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
15745|ANTI-EPILEPTICS|N3A
15744|Carbapenems|J1P2
15743|SYSTEMIC ANTIBACTERIALS|J1
15742|ANALGESICS|N2
15741|ANTIHYPERTENSIVES|C2
15741|CALCIUM ANTAGONISTS|C8
15741|ACE INHIBITORS, PLAIN|C9A
15740|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
15738|ANTIPSYCHOTICS|N5A
15736|ANTI-EPILEPTICS|N3A
15736|NOOTROPICS|N6D
15732|IMMUNOSTIMULATING AGENTS|L3
15730|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15727|ANTI-MIGRAINE PREPARATIONS|N2C
15721|PARASITOLOGY|P
15719|ANTIVIRALS FOR SYSTEMIC USE|J5
15716|GASTROPROKINETICS|A3F
15716|LAXATIVES|A6
15715|ANALGESICS|N2
15715|ANTI-EPILEPTICS|N3
15715|ANTI-EPILEPTICS|N3A
15712|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
15712|Urinary incontinence products|G4B4
15712|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
15710|PLATELET AGGREGATION INHIBITORS|B1C
15710|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
15709|CENTRAL NERVOUS SYSTEM|N
15705|PLATELET AGGREGATION INHIBITORS|B1C
15705|CARDIOVASCULAR SYSTEM|C
15703|Bile stone therapy|A5A2
15703|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15701|ANTIPSYCHOTICS|N5A
15698|PLATELET AGGREGATION INHIBITORS|B1C
15698|Fibrinogen|B2D5
15696|Protease inhibitors|J5C2
15684|ANTIEMETICS AND ANTINAUSEANTS|A4
15684|Urinary incontinence products|G4B4
15684|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
15684|ANALGESICS|N2
15683|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15679|TRANQUILLISERS|N5C
15679|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15678|SYSTEMIC ANTIBACTERIALS|J1
15675|DERMATOLOGICALS|D
15675|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
15675|ANTI-ACNE PREPARATIONS|D10
15673|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15668|CARDIAC THERAPY|C1
15667|SYSTEMIC ANTIBACTERIALS|J1
15664|SYSTEMIC ANTIBACTERIALS|J1
15660|PLATELET AGGREGATION INHIBITORS|B1C
15656|ANTI-EPILEPTICS|N3A
15653|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15652|ANTI-MIGRAINE PREPARATIONS|N2C
15651|ANTI-ARRHYTHMICS|C1B
15651|CALCIUM ANTAGONISTS|C8
15648|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
15644|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15644|ANALGESICS|N2
15644|TRANQUILLISERS|N5C
15644|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15641|ANALGESICS|N2
15641|ANTI-MIGRAINE PREPARATIONS|N2C
15641|ANTI-EPILEPTICS|N3
15640|PARASITOLOGY|P
15640|ANTI-MALARIALS|P1D
15639|PARASITOLOGY|P
15637|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15637|BPH (benign prostatic hypertrophy) products |G4C
15637|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15628|ANTIHYPERTENSIVES|C2
15628|DIURETICS|C3
15622|ANTIVIRALS FOR SYSTEMIC USE|J5
15619|IMMUNOSUPPRESSIVE AGENTS|L4
15618|ANTIVIRALS FOR SYSTEMIC USE|J5
15616|ANALGESICS|N2
15615|CENTRAL NERVOUS SYSTEM|N
15615|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15614|TRANQUILLISERS|N5C
15609|PARASITOLOGY|P
15608|ANTIVIRALS FOR SYSTEMIC USE|J5
15603|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15601|DIRECT THROMBIN INHIBITORS|B1E
15600|PLATELET AGGREGATION INHIBITORS|B1C
15600|Fibrinogen|B2D5
15597|PARASITOLOGY|P
15596|SYSTEMIC ANTIBACTERIALS|J1
15596|ANTIVIRALS FOR SYSTEMIC USE|J5
15596|IMMUNOSTIMULATING AGENTS|L3
15593|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15593|OPHTHALMOLOGICALS|S1
15592|ANTIVIRALS FOR SYSTEMIC USE|J5
15589|ANTIVIRALS FOR SYSTEMIC USE|J5
15587|VACCINES|J7
15585|CARDIOVASCULAR SYSTEM|C
15584|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
15583|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
15582|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
15582|ANTI-EPILEPTICS|N3A
15578|ANTIVIRALS FOR SYSTEMIC USE|J5
15576|IMMUNOSTIMULATING AGENTS|L3
15575|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15574|PLATELET AGGREGATION INHIBITORS|B1C
15574|FIBRINOLYTICS|B1D
15574|Coxibs|M1A3
15572|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15570|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15566|CALCIUM ANTAGONISTS|C8
15566|ANALGESICS|N2
15559|ANTI-ARRHYTHMICS|C1B
15556|ANTIHYPERTENSIVES|C2
15554|ANTI-ARRHYTHMICS|C1B
15550|Urinary incontinence products|G4B4
15549|ANTIPSYCHOTICS|N5A
15548|DRUGS USED IN DIABETES|A10
15547|SYSTEMIC ANTIBACTERIALS|J1
15546|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15546|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
15545|SYSTEMIC ANTIBACTERIALS|J1
15544|ANALGESICS|N2
15537|CARDIOVASCULAR SYSTEM|C
15537|ANTIHYPERTENSIVES|C2
15535|CALCIUM ANTAGONISTS|C8
15535|NOOTROPICS|N6D
15533|NOOTROPICS|N6D
15532|PLATELET AGGREGATION INHIBITORS|B1C
15524|CENTRAL NERVOUS SYSTEM|N
15521|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
15511|CALCIUM ANTAGONISTS|C8
15510|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15510|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
15509|ANTIHYPERTENSIVES|C2
15508|ANTIHYPERTENSIVES|C2
15507|ANTIHYPERTENSIVES|C2
15506|ANTIHYPERTENSIVES|C2
15505|ANTIHYPERTENSIVES|C2
15501|ANTIHYPERTENSIVES|C2
15500|ANTIHYPERTENSIVES|C2
15496|SYSTEMIC ANTIBACTERIALS|J1
15494|DRUGS USED IN DIABETES|A10
15494|HUMAN INSULINS AND ANALOGUES|A10C
15494|Human insulins and analogues, intermediate-acting|A10C2
15493|ANTIVIRALS FOR SYSTEMIC USE|J5
15483|ANDROGENS, EXCLUDING G3E, G3F|G3B
15482|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
15477|ANALGESICS|N2
15475|ANTIVIRALS FOR SYSTEMIC USE|J5
15473|NOOTROPICS|N6D
15472|ANALGESICS|N2
15472|ANTI-MIGRAINE PREPARATIONS|N2C
15467|Glitazone antidiabetics|A10B4
15467|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15463|Coxibs|M1A3
15463|ANALGESICS|N2
15462|PLATELET AGGREGATION INHIBITORS|B1C
15462|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
15458|Protease inhibitors|J5C2
15454|ANTI-EPILEPTICS|N3
15450|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
15449|DERMATOLOGICALS|D
15447|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
15446|BPH (benign prostatic hypertrophy) products |G4C
15440|ANTIVIRALS FOR SYSTEMIC USE|J5
15439|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15438|ANTIVIRALS FOR SYSTEMIC USE|J5
15437|ANTIPSYCHOTICS|N5A
15433|ANTIHYPERTENSIVES|C2
15419|Antigonadotrophin-releasing hormones|H1C3
15417|ANTI-EPILEPTICS|N3
15412|ANTIVIRALS FOR SYSTEMIC USE|J5
15411|Factors II, VII, IX and X|B2D2
15410|CENTRAL NERVOUS SYSTEM|N
15406|NOOTROPICS|N6D
15402|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15402|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15397|PARASITOLOGY|P
15396|TRANQUILLISERS|N5C
15394|ANTIVIRALS FOR SYSTEMIC USE|J5
15374|WOUND HEALING AGENTS|D3
15373|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
15371|ANTI-ACNE PREPARATIONS|D10
15371|BPH (benign prostatic hypertrophy) products |G4C
15370|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15370|ANTI-ACNE PREPARATIONS|D10
15367|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15363|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
15362|MUSCULO-SKELETAL SYSTEM|M
15360|CARDIOVASCULAR SYSTEM|C
15360|ANTIHYPERTENSIVES|C2
15358|ANTIHYPERTENSIVES|C2
15357|ANTIHYPERTENSIVES|C2
15352|CARDIOVASCULAR SYSTEM|C
15352|ANTIHYPERTENSIVES|C2
15344|ANTIVIRALS FOR SYSTEMIC USE|J5
15335|ANTIHYPERTENSIVES|C2
15330|TRANQUILLISERS|N5C
15318|IMMUNOSUPPRESSIVE AGENTS|L4
15315|ANALGESICS|N2
15314|ANTIHYPERTENSIVES|C2
15311|Interferons, alpha|L3B1
15311|Interferons, gamma|L3B3
15308|CALCIUM ANTAGONISTS|C8
15305|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
15302|ANTIHYPERTENSIVES|C2
15300|ANTI-ARRHYTHMICS|C1B
15296|NOOTROPICS|N6D
15295|SYSTEMIC ANTIBACTERIALS|J1
15294|SYSTEMIC ANTIBACTERIALS|J1
15293|SYSTEMIC ANTIBACTERIALS|J1
15292|ANTIEMETICS AND ANTINAUSEANTS|A4
15291|ANTIPSYCHOTICS|N5A
15290|ANTIPSYCHOTICS|N5A
15290|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15290|NOOTROPICS|N6D
15289|ANTIEMETICS AND ANTINAUSEANTS|A4
15287|ANTIHYPERTENSIVES|C2
15287|DIURETICS|C3
15286|ANTI-ARRHYTHMICS|C1B
15285|BPH (benign prostatic hypertrophy) products |G4C
15284|ANTIVIRALS FOR SYSTEMIC USE|J5
15284|Interferons, gamma|L3B3
15283|IMMUNOSUPPRESSIVE AGENTS|L4
15282|SYSTEMIC ANTIBACTERIALS|J1
15281|BPH (benign prostatic hypertrophy) products |G4C
15280|PLATELET AGGREGATION INHIBITORS|B1C
15280|CARDIOVASCULAR SYSTEM|C
15280|ANTIHYPERTENSIVES|C2
15277|ANTIPSYCHOTICS|N5A
15276|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15275|ANTIULCERANTS|A2B
15273|ANTI-ARRHYTHMICS|C1B
15271|ANTIPSYCHOTICS|N5A
15271|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15268|PLATELET AGGREGATION INHIBITORS|B1C
15268|DIRECT THROMBIN INHIBITORS|B1E
15267|ANTIVIRALS FOR SYSTEMIC USE|J5
15265|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15265|SSRI antidepressants|N6A4
15262|ANTIVIRALS FOR SYSTEMIC USE|J5
15261|HUMAN INSULINS AND ANALOGUES|A10C
15261|Human insulins and analogues, intermediate-acting|A10C2
15260|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
15257|IMMUNOSTIMULATING AGENTS|L3
15254|ANTIVIRALS FOR SYSTEMIC USE|J5
15252|ANTIVIRALS FOR SYSTEMIC USE|J5
15250|ANTIVIRALS FOR SYSTEMIC USE|J5
15249|ANTIVIRALS FOR SYSTEMIC USE|J5
15248|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
15242|VACCINES|J7
15241|VACCINES|J7
15238|ANAESTHETICS, LOCAL|N1B
15236|MACROLIDES AND SIMILAR TYPES|J1F
15233|ANAESTHETICS, LOCAL|N1B
15233|ANALGESICS|N2
15231|Non-nucleoside reverse transcriptase inhibitors|J5C3
15228|ANTIVIRALS FOR SYSTEMIC USE|J5
15227|ANTIHYPERTENSIVES|C2
15221|ANTIHYPERTENSIVES|C2
15220|HUMAN INSULINS AND ANALOGUES|A10C
15220|Human insulins and analogues, long-acting|A10C5
15214|DRUGS USED IN DIABETES|A10
15214|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15210|HUMAN INSULINS AND ANALOGUES|A10C
15210|Human insulins and analogues, intermediate-acting|A10C2
15205|ANTIVIRALS FOR SYSTEMIC USE|J5
15203|ANTI-MIGRAINE PREPARATIONS|N2C
15202|CALCITONINS|H4A
15201|Erectile dysfunction products|G4B3
15198|ANAESTHETICS, LOCAL|N1B
15198|ANALGESICS|N2
15197|ANAESTHETICS, LOCAL|N1B
15195|CARDIOVASCULAR SYSTEM|C
15195|ULTRASOUND AGENTS|T1F
15193|RADIODIAGNOSTIC AGENTS|T1G
15191|ANALGESICS|N2
15186|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15186|PARASITOLOGY|P
15183|TRANQUILLISERS|N5C
15183|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15183|SSRI antidepressants|N6A4
15182|DRUGS USED IN DIABETES|A10
15177|ANTIVIRALS FOR SYSTEMIC USE|J5
15176|CARDIOVASCULAR SYSTEM|C
15173|CARDIOVASCULAR SYSTEM|C
15173|CENTRAL NERVOUS SYSTEM|N
15172|ANTIHYPERTENSIVES|C2
15172|CALCIUM ANTAGONISTS|C8
15171|ANTIHYPERTENSIVES|C2
15171|CALCIUM ANTAGONISTS|C8
15170|CARDIOVASCULAR SYSTEM|C
15170|CALCIUM ANTAGONISTS|C8
15169|ANTIHYPERTENSIVES|C2
15169|CALCIUM ANTAGONISTS|C8
15164|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
15164|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15163|ANTI-ARRHYTHMICS|C1B
15162|ANTI-ARRHYTHMICS|C1B
15159|ANTIHYPERTENSIVES|C2
15151|ANTIVIRALS FOR SYSTEMIC USE|J5
15150|ANTIVIRALS FOR SYSTEMIC USE|J5
15135|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15133|ANTI-ARRHYTHMICS|C1B
15132|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15131|TRANQUILLISERS|N5C
15131|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15126|ANTIVIRALS FOR SYSTEMIC USE|J5
15126|Interferons, alpha|L3B1
15119|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
15109|ANTIPSYCHOTICS|N5A
15109|TRANQUILLISERS|N5C
15105|CENTRAL NERVOUS SYSTEM|N
15105|ANTI-EPILEPTICS|N3A
15102|SYSTEMIC ANTIBACTERIALS|J1
15097|DRUGS USED IN DIABETES|A10
15097|HUMAN INSULINS AND ANALOGUES|A10C
15097|Human insulins and analogues, intermediate-acting|A10C2
15086|SYSTEMIC ANTIBACTERIALS|J1
15085|SYSTEMIC ANTIBACTERIALS|J1
15077|ANTIEMETICS AND ANTINAUSEANTS|A4
15075|NOOTROPICS|N6D
15073|NOOTROPICS|N6D
15071|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15067|HYPNOTICS/SEDATIVES|N5B
15065|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
15065|SSRI antidepressants|N6A4
15064|ANTIVIRALS FOR SYSTEMIC USE|J5
15062|IMMUNOSUPPRESSIVE AGENTS|L4
15059|DRUGS USED IN DIABETES|A10
15059|HUMAN INSULINS AND ANALOGUES|A10C
15059|Human insulins and analogues, intermediate-acting|A10C2
15058|SYSTEMIC ANTIBACTERIALS|J1
15055|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
15055|IMMUNOSUPPRESSIVE AGENTS|L4
15052|ANTIHYPERTENSIVES|C2
15052|DIURETICS|C3
15052|ACE INHIBITORS, PLAIN|C9A
15039|PLATELET AGGREGATION INHIBITORS|B1C
15037|MACROLIDES AND SIMILAR TYPES|J1F
15035|IMMUNOSUPPRESSIVE AGENTS|L4
15034|SYSTEMIC ANTIBACTERIALS|J1
15032|SYSTEMIC ANTIBACTERIALS|J1
15030|ANALGESICS|N2
15029|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
15027|Urinary incontinence products|G4B4
15027|Coxibs|M1A3
15025|NOOTROPICS|N6D
15023|ANTIPSYCHOTICS|N5A
15020|ANTIPSYCHOTICS|N5A
15014|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
15012|ANTI-EPILEPTICS|N3A
15004|ANTI-EPILEPTICS|N3
15003|SYSTEMIC ANTIBACTERIALS|J1
15003|VACCINES|J7
15001|SYSTEMIC ANTIBACTERIALS|J1
14998|DIRECT THROMBIN INHIBITORS|B1E
14995|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14995|GLUCAGON|H4B
14993|ANTIVIRALS FOR SYSTEMIC USE|J5
14992|DIRECT THROMBIN INHIBITORS|B1E
14989|ANTIHYPERTENSIVES|C2
14989|DIURETICS|C3
14989|ACE INHIBITORS, PLAIN|C9A
14982|ANTIVIRALS FOR SYSTEMIC USE|J5
14975|ANTIVIRALS FOR SYSTEMIC USE|J5
14972|ANTIVIRALS FOR SYSTEMIC USE|J5
14968|SYSTEMIC ANTIBACTERIALS|J1
14967|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
14964|CARDIOVASCULAR SYSTEM|C
14962|CARDIOVASCULAR SYSTEM|C
14960|ANTIVIRALS FOR SYSTEMIC USE|J5
14958|ANTIEMETICS AND ANTINAUSEANTS|A4
14955|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
14954|ANTI-ACNE PREPARATIONS|D10
14954|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
14954|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
14953|RESPIRATORY SYSTEM|R
14947|ANTIPSYCHOTICS|N5A
14944|NOOTROPICS|N6D
14939|ANTI-EPILEPTICS|N3A
14938|ANTI-EPILEPTICS|N3A
14937|ANALGESICS|N2
14935|ANTI-MIGRAINE PREPARATIONS|N2C
14935|ANTI-EPILEPTICS|N3
14935|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14934|IMMUNOSUPPRESSIVE AGENTS|L4
14933|ANTIHYPERTENSIVES|C2
14932|Protease inhibitors|J5C2
14931|Protease inhibitors|J5C2
14930|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
14930|IMMUNOSUPPRESSIVE AGENTS|L4
14921|ANTIVIRALS FOR SYSTEMIC USE|J5
14917|ANTI-EPILEPTICS|N3A
14914|SYSTEMIC ANTIBACTERIALS|J1
14912|Antigonadotrophin-releasing hormones|H1C3
14909|DRUGS USED IN DIABETES|A10
14908|ANTIVIRALS FOR SYSTEMIC USE|J5
14898|NOOTROPICS|N6D
14893|IMMUNOSTIMULATING AGENTS|L3
14890|CARDIOVASCULAR SYSTEM|C
14890|ANTIHYPERTENSIVES|C2
14888|DIAGNOSTIC AGENTS|T
14887|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14887|IMMUNOSUPPRESSIVE AGENTS|L4
14885|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
14880|ANTIHYPERTENSIVES|C2
14879|SYSTEMIC ANTIBACTERIALS|J1
14877|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
14868|DIRECT THROMBIN INHIBITORS|B1E
14862|IMMUNOSUPPRESSIVE AGENTS|L4
14861|IMMUNOSTIMULATING AGENTS|L3
14859|ALKYLATING AGENTS|L1A
14852|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14852|ANTIVIRALS FOR SYSTEMIC USE|J5
14850|ANALGESICS|N2
14848|ANTI-EPILEPTICS|N3A
14843|FIBRINOLYTICS|B1D
14839|ANTIPSYCHOTICS|N5A
14838|HYPNOTICS/SEDATIVES|N5B
14836|ANTI-EPILEPTICS|N3
14835|CARDIOVASCULAR SYSTEM|C
14834|CARDIOVASCULAR SYSTEM|C
14834|CARDIAC THERAPY|C1
14834|ANTIHYPERTENSIVES|C2
14833|BPH (benign prostatic hypertrophy) products |G4C
14831|ANTIHYPERTENSIVES|C2
14831|ACE INHIBITORS, PLAIN|C9A
14829|CARDIOVASCULAR SYSTEM|C
14824|ANTIVIRALS FOR SYSTEMIC USE|J5
14821|DIRECT THROMBIN INHIBITORS|B1E
14819|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14812|ANTIVIRALS FOR SYSTEMIC USE|J5
14808|SYSTEMIC ANTIBACTERIALS|J1
14807|SYSTEMIC ANTIBACTERIALS|J1
14807|CEPHALOSPORINS|J1D
14802|DRUGS USED IN DIABETES|A10
14802|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14801|SYSTEMIC ANTIBACTERIALS|J1
14798|PLATELET AGGREGATION INHIBITORS|B1C
14798|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14798|Fibrinogen|B2D5
14797|SYSTEMIC ANTIHISTAMINES|R6
14796|PLATELET AGGREGATION INHIBITORS|B1C
14796|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14795|ANTI-ARRHYTHMICS|C1B
14793|TRANQUILLISERS|N5C
14792|TRANQUILLISERS|N5C
14790|ANALGESICS|N2
14790|ANTI-MIGRAINE PREPARATIONS|N2C
14790|ANTI-EPILEPTICS|N3
14788|ANTIPSYCHOTICS|N5A
14787|CENTRAL NERVOUS SYSTEM|N
14786|ANTI-MIGRAINE PREPARATIONS|N2C
14783|PLATELET AGGREGATION INHIBITORS|B1C
14781|ANTI-ACNE PREPARATIONS|D10
14780|ANTIULCERANTS|A2B
14780|SYSTEMIC ANTIBACTERIALS|J1
14778|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14775|ANTIPSYCHOTICS|N5A
14765|PLATELET AGGREGATION INHIBITORS|B1C
14761|IMMUNOSUPPRESSIVE AGENTS|L4
14758|ANTIPSYCHOTICS|N5A
14755|SYSTEMIC ANTIBACTERIALS|J1
14755|PARASITOLOGY|P
14752|IMMUNOSUPPRESSIVE AGENTS|L4
14751|ANTIVIRALS FOR SYSTEMIC USE|J5
14749|ANTIULCERANTS|A2B
14741|ANTI-EPILEPTICS|N3
14741|ANTI-EPILEPTICS|N3A
14741|HYPNOTICS/SEDATIVES|N5B
14741|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14740|ANTI-EPILEPTICS|N3
14740|ANTI-EPILEPTICS|N3A
14740|HYPNOTICS/SEDATIVES|N5B
14740|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14734|ANTIVIRALS FOR SYSTEMIC USE|J5
14733|ANTI-EPILEPTICS|N3A
14731|CALCIUM ANTAGONISTS|C8
14731|ANALGESICS|N2
14731|ANTI-EPILEPTICS|N3
14729|ANTI-EPILEPTICS|N3A
14721|VACCINES|J7
14718|IMMUNOSUPPRESSIVE AGENTS|L4
14715|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
14715|ANTI-EPILEPTICS|N3A
14712|PLATELET AGGREGATION INHIBITORS|B1C
14711|ANTIVIRALS FOR SYSTEMIC USE|J5
14706|ANTIVIRALS FOR SYSTEMIC USE|J5
14705|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
14701|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14699|ANTI-ARRHYTHMICS|C1B
14693|ANALGESICS|N2
14692|ANTIVIRALS FOR SYSTEMIC USE|J5
14688|ANTI-MIGRAINE PREPARATIONS|N2C
14687|ANTI-MIGRAINE PREPARATIONS|N2C
14681|ANTIVIRALS FOR SYSTEMIC USE|J5
14681|Protease inhibitors|J5C2
14675|TRANQUILLISERS|N5C
14674|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
14671|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
14670|PLATELET AGGREGATION INHIBITORS|B1C
14670|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14669|PLATELET AGGREGATION INHIBITORS|B1C
14669|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14668|CALCIUM ANTAGONISTS|C8
14668|BPH (benign prostatic hypertrophy) products |G4C
14666|ANALGESICS|N2
14666|NOOTROPICS|N6D
14665|PLATELET AGGREGATION INHIBITORS|B1C
14665|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14664|IMMUNOSTIMULATING AGENTS|L3
14660|DIRECT THROMBIN INHIBITORS|B1E
14658|ANAESTHETICS, LOCAL|N1B
14658|ANALGESICS|N2
14656|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
14654|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14653|ANALGESICS|N2
14652|CARDIOVASCULAR SYSTEM|C
14651|ANALGESICS|N2
14651|ANTI-MIGRAINE PREPARATIONS|N2C
14650|ANTI-MIGRAINE PREPARATIONS|N2C
14643|ANTIMETABOLITES|L1B
14641|PLATELET AGGREGATION INHIBITORS|B1C
14641|Fibrinogen|B2D5
14640|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
14640|PARASITOLOGY|P
14634|SYSTEMIC ANTIBACTERIALS|J1
14632|ANTIVIRALS FOR SYSTEMIC USE|J5
14629|ANTIVIRALS FOR SYSTEMIC USE|J5
14623|SYSTEMIC ANTIBACTERIALS|J1
14622|IMMUNOSUPPRESSIVE AGENTS|L4
14621|IMMUNOSUPPRESSIVE AGENTS|L4
14620|ANTIVIRALS FOR SYSTEMIC USE|J5
14620|IMMUNOSTIMULATING AGENTS|L3
14619|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14619|IMMUNOSUPPRESSIVE AGENTS|L4
14615|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
14609|ANTIVIRALS FOR SYSTEMIC USE|J5
14608|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
14606|IMMUNOSUPPRESSIVE AGENTS|L4
14605|ANTIVIRALS FOR SYSTEMIC USE|J5
14605|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
14604|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
14603|ANTIHYPERTENSIVES|C2
14602|ANTI-ACNE PREPARATIONS|D10
14602|BPH (benign prostatic hypertrophy) products |G4C
14601|ANTIULCERANTS|A2B
14598|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14597|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14597|DRUGS USED IN DIABETES|A10
14596|CARDIOVASCULAR SYSTEM|C
14596|RADIODIAGNOSTIC AGENTS|T1G
14594|PLATELET AGGREGATION INHIBITORS|B1C
14594|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14589|ANTIVIRALS FOR SYSTEMIC USE|J5
14586|Alpha-glucosidase inhibitor antidiabetics|A10B5
14583|PLATELET AGGREGATION INHIBITORS|B1C
14582|ANTIVIRALS FOR SYSTEMIC USE|J5
14580|ALKYLATING AGENTS|L1A
14578|ANTIMETABOLITES|L1B
14577|ANTIVIRALS FOR SYSTEMIC USE|J5
14576|ANTIVIRALS FOR SYSTEMIC USE|J5
14571|ANTIULCERANTS|A2B
14565|DRUGS USED IN DIABETES|A10
14565|HUMAN INSULINS AND ANALOGUES|A10C
14565|Human insulins and analogues, intermediate-acting|A10C2
14564|ANTIVIRALS FOR SYSTEMIC USE|J5
14562|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
14560|MRI AGENTS|T1E
14549|ANTI-EPILEPTICS|N3A
14549|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14549|NOOTROPICS|N6D
14548|ANTIVIRALS FOR SYSTEMIC USE|J5
14545|PLATELET AGGREGATION INHIBITORS|B1C
14545|ANTI-GOUT PREPARATIONS|M4
14544|Protease inhibitors|J5C2
14543|NOOTROPICS|N6D
14542|ANTIVIRALS FOR SYSTEMIC USE|J5
14541|TRANQUILLISERS|N5C
14541|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14539|PARASITOLOGY|P
14539|ANTI-MALARIALS|P1D
14536|ANALGESICS|N2
14535|Vitamin D|A11C2
14535|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14533|NOOTROPICS|N6D
14532|ANTIVIRALS FOR SYSTEMIC USE|J5
14527|ANTIHYPERTENSIVES|C2
14527|CALCIUM ANTAGONISTS|C8
14526|Coxibs|M1A3
14526|ANALGESICS|N2
14525|ANALGESICS|N2
14524|Coxibs|M1A3
14524|ANALGESICS|N2
14523|Coxibs|M1A3
14523|ANALGESICS|N2
14522|SYSTEMIC ANTIBACTERIALS|J1
14521|SYSTEMIC ANTIBACTERIALS|J1
14520|SYSTEMIC ANTIBACTERIALS|J1
14519|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
14518|ANALGESICS|N2
14515|ANTIVIRALS FOR SYSTEMIC USE|J5
14513|CARDIAC THERAPY|C1
14513|ACE INHIBITORS, PLAIN|C9A
14508|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14507|IMMUNOSUPPRESSIVE AGENTS|L4
14505|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14504|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14501|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14501|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
14500|PLATELET AGGREGATION INHIBITORS|B1C
14500|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14500|CARDIAC THERAPY|C1
14499|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14498|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14494|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
14493|ANTIVIRALS FOR SYSTEMIC USE|J5
14491|ANTI-MIGRAINE PREPARATIONS|N2C
14491|TRANQUILLISERS|N5C
14489|ANTI-MIGRAINE PREPARATIONS|N2C
14484|PSYCHOSTIMULANTS|N6B
14479|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14479|DRUGS USED IN DIABETES|A10
14478|BPH (benign prostatic hypertrophy) products |G4C
14471|ANTI-EPILEPTICS|N3
14471|TRANQUILLISERS|N5C
14471|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14458|Protease inhibitors|J5C2
14455|PLATELET AGGREGATION INHIBITORS|B1C
14455|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14454|ANTI-EPILEPTICS|N3
14452|NOOTROPICS|N6D
14450|CARDIOVASCULAR SYSTEM|C
14450|ANTIHYPERTENSIVES|C2
14449|ANTIHYPERTENSIVES|C2
14447|ANTIHYPERTENSIVES|C2
14446|ANTIHYPERTENSIVES|C2
14443|Protease inhibitors|J5C2
14437|NOOTROPICS|N6D
14436|SYSTEMIC ANTIBACTERIALS|J1
14434|ANTIVIRALS FOR SYSTEMIC USE|J5
14433|ANTIEMETICS AND ANTINAUSEANTS|A4
14431|DIRECT THROMBIN INHIBITORS|B1E
14430|ANALGESICS|N2
14429|ANTI-ARRHYTHMICS|C1B
14429|ANTIHYPERTENSIVES|C2
14427|VACCINES|J7
14424|Coxibs|M1A3
14424|ANALGESICS|N2
14421|DRUGS USED IN DIABETES|A10
14421|HUMAN INSULINS AND ANALOGUES|A10C
14421|Human insulins and analogues, intermediate-acting|A10C2
14417|MUSCULO-SKELETAL SYSTEM|M
14415|DRUGS USED IN DIABETES|A10
14415|OPHTHALMOLOGICALS|S1
14414|ANTIULCERANTS|A2B
14410|ANAESTHETICS, LOCAL|N1B
14410|ANALGESICS|N2
14404|TRANQUILLISERS|N5C
14400|IMMUNOSTIMULATING AGENTS|L3
14396|ANTIVIRALS FOR SYSTEMIC USE|J5
14394|IMMUNOSUPPRESSIVE AGENTS|L4
14392|IMMUNOSTIMULATING AGENTS|L3
14391|ANALGESICS|N2
14391|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14381|ANTIHYPERTENSIVES|C2
14381|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
14375|NOOTROPICS|N6D
14372|ANTI-ARRHYTHMICS|C1B
14372|ANTIHYPERTENSIVES|C2
14372|CALCIUM ANTAGONISTS|C8
14371|ANDROGENS, EXCLUDING G3E, G3F|G3B
14370|ANALGESICS|N2
14360|ANTIVIRALS FOR SYSTEMIC USE|J5
14359|IMMUNOSUPPRESSIVE AGENTS|L4
14356|VACCINES|J7
14353|ANTI-EPILEPTICS|N3A
14350|ANTIVIRALS FOR SYSTEMIC USE|J5
14349|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
14346|SYSTEMIC ANTIBACTERIALS|J1
14336|B2-STIMULANTS|R3A
14333|DERMATOLOGICALS|D
14330|ANDROGENS, EXCLUDING G3E, G3F|G3B
14330|BPH (benign prostatic hypertrophy) products |G4C
14329|ANALGESICS|N2
14321|ANTIHYPERTENSIVES|C2
14318|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
14317|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
14316|CENTRAL NERVOUS SYSTEM|N
14315|ANTI-EPILEPTICS|N3A
14315|NOOTROPICS|N6D
14309|PLATELET AGGREGATION INHIBITORS|B1C
14308|ANALGESICS|N2
14307|DIRECT THROMBIN INHIBITORS|B1E
14305|DIAGNOSTIC AGENTS|T
14303|SYSTEMIC ANTIBACTERIALS|J1
14297|OPHTHALMOLOGICALS|S1
14291|ANTIVIRALS FOR SYSTEMIC USE|J5
14289|ANTI-MALARIALS|P1D
14287|MUSCULO-SKELETAL SYSTEM|M
14286|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14265|BPH (benign prostatic hypertrophy) products |G4C
14255|Vitamin D|A11C2
14254|ANDROGENS, EXCLUDING G3E, G3F|G3B
14249|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
14249|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
14232|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14232|ANTIVIRALS FOR SYSTEMIC USE|J5
14232|Interferons, alpha|L3B1
14232|ANTITUSSIVES|R5D
14228|ANTI-ARRHYTHMICS|C1B
14228|ANTIHYPERTENSIVES|C2
14228|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14227|ANDROGENS, EXCLUDING G3E, G3F|G3B
14224|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
14221|VACCINES|J7
14216|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14215|Urinary incontinence products|G4B4
14215|CENTRAL NERVOUS SYSTEM|N
14215|ANALGESICS|N2
14215|TRANQUILLISERS|N5C
14215|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14214|NOOTROPICS|N6D
14212|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
14211|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14210|ANTIVIRALS FOR SYSTEMIC USE|J5
14209|ANTIPSYCHOTICS|N5A
14208|PLATELET AGGREGATION INHIBITORS|B1C
14208|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14207|ANTIHYPERTENSIVES|C2
14207|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
14194|SYSTEMIC ANTIBACTERIALS|J1
14190|IMMUNOSUPPRESSIVE AGENTS|L4
14189|PLATELET AGGREGATION INHIBITORS|B1C
14188|ANALGESICS|N2
14186|ANTIHYPERTENSIVES|C2
14185|ANTIHYPERTENSIVES|C2
14178|ANTI-MIGRAINE PREPARATIONS|N2C
14175|EXPECTORANTS|R5C
14174|ANTIVIRALS FOR SYSTEMIC USE|J5
14170|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14170|IMMUNOSUPPRESSIVE AGENTS|L4
14163|CARDIAC THERAPY|C1
14163|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14163|OPHTHALMOLOGICALS|S1
14162|CARDIOVASCULAR SYSTEM|C
14162|CENTRAL NERVOUS SYSTEM|N
14161|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14161|DRUGS USED IN DIABETES|A10
14161|CARDIOVASCULAR SYSTEM|C
14161|CENTRAL NERVOUS SYSTEM|N
14153|ANTI-MIGRAINE PREPARATIONS|N2C
14153|ANTIPSYCHOTICS|N5A
14151|ANTIVIRALS FOR SYSTEMIC USE|J5
14150|ANTIVIRALS FOR SYSTEMIC USE|J5
14149|SYSTEMIC ANTIBACTERIALS|J1
14148|ANTIMETABOLITES|L1B
14143|ANTI-ARRHYTHMICS|C1B
14135|WOUND HEALING AGENTS|D3
14135|IMMUNOSTIMULATING AGENTS|L3
14132|ANTIVIRALS FOR SYSTEMIC USE|J5
14127|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14125|CARDIOVASCULAR SYSTEM|C
14118|Factor VIII|B2D1
14117|SYSTEMIC ANTIBACTERIALS|J1
14116|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
14111|ANALGESICS|N2
14110|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
14106|ANTIVIRALS FOR SYSTEMIC USE|J5
14102|IMMUNOSUPPRESSIVE AGENTS|L4
14098|ANTIVIRALS FOR SYSTEMIC USE|J5
14097|Coxibs|M1A3
14097|ANALGESICS|N2
14096|CARDIOVASCULAR SYSTEM|C
14096|ANTIHYPERTENSIVES|C2
14094|VACCINES|J7
14092|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14088|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14088|DRUGS USED IN DIABETES|A10
14088|ANTIHYPERTENSIVES|C2
14088|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14088|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
14087|ANTI-ARRHYTHMICS|C1B
14084|DIRECT THROMBIN INHIBITORS|B1E
14082|ANTI-ARRHYTHMICS|C1B
14081|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14081|NOOTROPICS|N6D
14080|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
14077|DRUGS USED IN DIABETES|A10
14076|Urinary incontinence products|G4B4
14076|ANALGESICS|N2
14076|ANTIPSYCHOTICS|N5A
14076|ANTITUSSIVES|R5D
14073|FIBRINOLYTICS|B1D
14070|Erectile dysfunction products|G4B3
14068|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
14067|ULTRASOUND AGENTS|T1F
14064|ANTIHYPERTENSIVES|C2
14064|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
14064|ANALGESICS|N2
14064|OPHTHALMOLOGICALS|S1
14064|Miotics and antiglaucoma preparations, systemic|S1E1
14063|TRANQUILLISERS|N5C
14062|ANTIHYPERTENSIVES|C2
14060|PLATELET AGGREGATION INHIBITORS|B1C
14060|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
14043|ANTIVIRALS FOR SYSTEMIC USE|J5
14040|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
14037|ANTIULCERANTS|A2B
14036|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
14034|Preparations to prevent cataract and anticataractogenics, topical|S1N2
14026|ANALGESICS|N2
14025|ANALGESICS|N2
14024|ANALGESICS|N2
14022|ANALGESICS|N2
14021|CALCIUM ANTAGONISTS|C8
14021|ANALGESICS|N2
14016|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
14012|ANTI-EPILEPTICS|N3
14010|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
14008|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
14007|ANALGESICS|N2
14005|BPH (benign prostatic hypertrophy) products |G4C
14004|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
14003|WOUND HEALING AGENTS|D3
14003|Erectile dysfunction products|G4B3
14001|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
14000|PLATELET AGGREGATION INHIBITORS|B1C
14000|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
13999|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13998|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13997|ANTIHYPERTENSIVES|C2
13997|ACE INHIBITORS, PLAIN|C9A
13996|ANTIHYPERTENSIVES|C2
13996|ACE INHIBITORS, PLAIN|C9A
13995|ANTIHYPERTENSIVES|C2
13995|ACE INHIBITORS, PLAIN|C9A
13994|ANTIHYPERTENSIVES|C2
13991|IMMUNOSUPPRESSIVE AGENTS|L4
13989|PLATELET AGGREGATION INHIBITORS|B1C
13989|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
13987|IMMUNOSUPPRESSIVE AGENTS|L4
13985|ANALGESICS|N2
13983|ANTIEMETICS AND ANTINAUSEANTS|A4
13982|PARASITOLOGY|P
13980|HYPNOTICS/SEDATIVES|N5B
13979|TRANQUILLISERS|N5C
13978|ANTIULCERANTS|A2B
13978|WOUND HEALING AGENTS|D3
13977|FIBRINOLYTICS|B1D
13975|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
13975|IMMUNOSUPPRESSIVE AGENTS|L4
13971|ANTIVIRALS FOR SYSTEMIC USE|J5
13968|ANTIULCERANTS|A2B
13967|ANTIULCERANTS|A2B
13963|ANTIHYPERTENSIVES|C2
13963|CALCIUM ANTAGONISTS|C8
13960|Non-nucleoside reverse transcriptase inhibitors|J5C3
13957|ANTIPSYCHOTICS|N5A
13956|PLATELET AGGREGATION INHIBITORS|B1C
13956|ANTIHYPERTENSIVES|C2
13955|SYSTEMIC ANTIBACTERIALS|J1
13952|IMMUNOSUPPRESSIVE AGENTS|L4
13940|ANTIVIRALS FOR SYSTEMIC USE|J5
13939|ANTIVIRALS FOR SYSTEMIC USE|J5
13931|ANALGESICS|N2
13930|ANALGESICS|N2
13927|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
13926|ANALGESICS|N2
13921|ANTIVIRALS FOR SYSTEMIC USE|J5
13918|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13916|ANTIVIRALS FOR SYSTEMIC USE|J5
13916|IMMUNOSTIMULATING AGENTS|L3
13914|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13906|DERMATOLOGICALS|D
13906|IMMUNOSUPPRESSIVE AGENTS|L4
13901|IMMUNOSUPPRESSIVE AGENTS|L4
13899|IMMUNOSTIMULATING AGENTS|L3
13895|IMMUNOSUPPRESSIVE AGENTS|L4
13888|ANTIHYPERTENSIVES|C2
13886|ANTI-ARRHYTHMICS|C1B
13882|ANTI-ACNE PREPARATIONS|D10
13881|PLATELET AGGREGATION INHIBITORS|B1C
13877|ANALGESICS|N2
13874|Coxibs|M1A3
13874|ANALGESICS|N2
13868|ANTIVIRALS FOR SYSTEMIC USE|J5
13865|ANTIHYPERTENSIVES|C2
13865|WOUND HEALING AGENTS|D3
13865|ANTIVIRALS FOR SYSTEMIC USE|J5
13863|IMMUNOSUPPRESSIVE AGENTS|L4
13859|Protease inhibitors|J5C2
13856|DIRECT THROMBIN INHIBITORS|B1E
13853|ANTIULCERANTS|A2B
13853|SYSTEMIC ANTIBACTERIALS|J1
13847|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
13847|ANTIVIRALS FOR SYSTEMIC USE|J5
13845|IMMUNOSUPPRESSIVE AGENTS|L4
13844|IMMUNOSUPPRESSIVE AGENTS|L4
13843|IMMUNOSUPPRESSIVE AGENTS|L4
13842|IMMUNOSUPPRESSIVE AGENTS|L4
13840|IMMUNOSUPPRESSIVE AGENTS|L4
13838|ANTI-ARRHYTHMICS|C1B
13831|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13826|ANTIVIRALS FOR SYSTEMIC USE|J5
13825|ANTIVIRALS FOR SYSTEMIC USE|J5
13824|SYSTEMIC ANTIBACTERIALS|J1
13824|Carbapenems|J1P2
13823|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13823|ANTIVIRALS FOR SYSTEMIC USE|J5
13820|IMMUNOSUPPRESSIVE AGENTS|L4
13819|CARDIOVASCULAR SYSTEM|C
13819|ANTIHYPERTENSIVES|C2
13816|NOOTROPICS|N6D
13815|NOOTROPICS|N6D
13814|NOOTROPICS|N6D
13811|DRUGS USED IN DIABETES|A10
13806|SYSTEMIC ANTIBACTERIALS|J1
13805|CARDIOVASCULAR SYSTEM|C
13805|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13804|SYSTEMIC ANTIBACTERIALS|J1
13801|ANALGESICS|N2
13801|ANTI-EPILEPTICS|N3A
13799|DRUGS USED IN DIABETES|A10
13797|ANTIVIRALS FOR SYSTEMIC USE|J5
13796|SYSTEMIC ANTIBACTERIALS|J1
13795|SYSTEMIC ANTIBACTERIALS|J1
13785|SYSTEMIC ANTIBACTERIALS|J1
13784|Coxibs|M1A3
13784|ANALGESICS|N2
13783|ANALGESICS|N2
13782|Coxibs|M1A3
13781|ANALGESICS|N2
13778|ANTIFIBRINOLYTICS|B2A
13775|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13774|Antigonadotrophin-releasing hormones|H1C3
13771|ANTIVIRALS FOR SYSTEMIC USE|J5
13770|ANTIVIRALS FOR SYSTEMIC USE|J5
13769|ANTIVIRALS FOR SYSTEMIC USE|J5
13767|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
13767|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13766|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
13763|Erectile dysfunction products|G4B3
13762|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
13760|ANTIVIRALS FOR SYSTEMIC USE|J5
13759|IMMUNOSUPPRESSIVE AGENTS|L4
13754|ALKYLATING AGENTS|L1A
13744|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13743|PLATELET AGGREGATION INHIBITORS|B1C
13743|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
13740|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13739|PLATELET AGGREGATION INHIBITORS|B1C
13739|ANTIHYPERTENSIVES|C2
13738|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13738|ACTH|H1A
13737|ANTI-EPILEPTICS|N3A
13732|ANTIPSYCHOTICS|N5A
13731|ANTIPSYCHOTICS|N5A
13730|ANALGESICS|N2
13730|ANTI-EPILEPTICS|N3
13729|ANALGESICS|N2
13729|ANTI-EPILEPTICS|N3
13728|ANTIVIRALS FOR SYSTEMIC USE|J5
13718|ANTI-EPILEPTICS|N3A
13717|ANTI-EPILEPTICS|N3A
13716|ANTI-EPILEPTICS|N3A
13715|ANTI-EPILEPTICS|N3A
13714|EXPECTORANTS|R5C
13704|IMMUNOSUPPRESSIVE AGENTS|L4
13703|IMMUNOSUPPRESSIVE AGENTS|L4
13699|CARDIOVASCULAR SYSTEM|C
13698|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
13694|PLATELET AGGREGATION INHIBITORS|B1C
13694|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
13693|ANTIVIRALS FOR SYSTEMIC USE|J5
13691|CEPHALOSPORINS|J1D
13689|Carbapenems|J1P2
13686|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13684|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13681|ANTIVIRALS FOR SYSTEMIC USE|J5
13681|Protease inhibitors|J5C2
13675|CARDIOVASCULAR SYSTEM|C
13673|ANTIVIRALS FOR SYSTEMIC USE|J5
13672|ANTI-ARRHYTHMICS|C1B
13672|ANTIHYPERTENSIVES|C2
13672|CENTRAL NERVOUS SYSTEM|N
13671|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
13670|ANTI-ARRHYTHMICS|C1B
13669|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
13669|TRANQUILLISERS|N5C
13668|ANTI-ARRHYTHMICS|C1B
13668|ANTIHYPERTENSIVES|C2
13668|CALCIUM ANTAGONISTS|C8
13664|CEPHALOSPORINS|J1D
13663|ANTIHYPERTENSIVES|C2
13663|CALCIUM ANTAGONISTS|C8
13663|ACE INHIBITORS, PLAIN|C9A
13657|CEPHALOSPORINS|J1D
13649|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13648|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
13648|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13644|ANTIHYPERTENSIVES|C2
13642|ANTIPSYCHOTICS|N5A
13641|ANTIPSYCHOTICS|N5A
13633|ANTIVIRALS FOR SYSTEMIC USE|J5
13632|ANTI-MIGRAINE PREPARATIONS|N2C
13631|ANTI-ACNE PREPARATIONS|D10
13631|SYSTEMIC ANTIBACTERIALS|J1
13630|MACROLIDES AND SIMILAR TYPES|J1F
13629|Carbapenems|J1P2
13628|ANTIVIRALS FOR SYSTEMIC USE|J5
13626|SYSTEMIC ANTIBACTERIALS|J1
13626|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
13623|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
13622|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13618|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
13618|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13616|ANTI-ACNE PREPARATIONS|D10
13616|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
13616|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13615|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
13615|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13612|SYSTEMIC ANTIBACTERIALS|J1
13600|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13599|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13598|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
13598|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13595|SYSTEMIC ANTIBACTERIALS|J1
13588|ANTIVIRALS FOR SYSTEMIC USE|J5
13586|ANTIHYPERTENSIVES|C2
13585|ANTI-ARRHYTHMICS|C1B
13583|TRANQUILLISERS|N5C
13582|APPETITE STIMULANTS|A15
13581|Antigonadotrophin-releasing hormones|H1C3
13580|ANTIPSYCHOTICS|N5A
13579|TRANQUILLISERS|N5C
13576|CALCITONINS|H4A
13574|Non-nucleoside reverse transcriptase inhibitors|J5C3
13572|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13570|CARDIOVASCULAR SYSTEM|C
13570|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13568|CARDIOVASCULAR SYSTEM|C
13568|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13563|ALKYLATING AGENTS|L1A
13554|ANTIHYPERTENSIVES|C2
13552|ANTIHYPERTENSIVES|C2
13551|ANTIHYPERTENSIVES|C2
13550|ANTIHYPERTENSIVES|C2
13549|ANTIHYPERTENSIVES|C2
13548|ANTIHYPERTENSIVES|C2
13547|ANTIHYPERTENSIVES|C2
13546|ANTIEMETICS AND ANTINAUSEANTS|A4
13546|ANALGESICS|N2
13545|ANTIEMETICS AND ANTINAUSEANTS|A4
13545|ANALGESICS|N2
13544|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13543|ALKYLATING AGENTS|L1A
13540|ANDROGENS, EXCLUDING G3E, G3F|G3B
13539|ANTIHYPERTENSIVES|C2
13539|ACE INHIBITORS, PLAIN|C9A
13538|DIRECT THROMBIN INHIBITORS|B1E
13537|ANTIHYPERTENSIVES|C2
13537|CALCIUM ANTAGONISTS|C8
13534|ANTIPSYCHOTICS|N5A
13533|DIRECT THROMBIN INHIBITORS|B1E
13532|IMMUNOSUPPRESSIVE AGENTS|L4
13529|ANTIHYPERTENSIVES|C2
13529|CALCIUM ANTAGONISTS|C8
13529|ACE INHIBITORS, PLAIN|C9A
13528|BETA-BLOCKING AGENTS|C7
13528|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
13519|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13514|ANTIHYPERTENSIVES|C2
13514|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
13513|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13512|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13509|VACCINES|J7
13506|ANTI-MIGRAINE PREPARATIONS|N2C
13496|SYSTEMIC ANTIBACTERIALS|J1
13496|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13496|IMMUNOSTIMULATING AGENTS|L3
13495|TRANQUILLISERS|N5C
13494|TRANQUILLISERS|N5C
13493|ANALGESICS|N2
13492|ANALGESICS|N2
13488|DIRECT THROMBIN INHIBITORS|B1E
13485|SYSTEMIC ANTIBACTERIALS|J1
13484|ANTIHYPERTENSIVES|C2
13482|PLATELET AGGREGATION INHIBITORS|B1C
13478|PARASITOLOGY|P
13477|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13477|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13476|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13476|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13475|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13473|ANALGESICS|N2
13472|ANALGESICS|N2
13468|ANALGESICS|N2
13466|ANTI-EPILEPTICS|N3A
13462|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13462|PARASITOLOGY|P
13460|ANTIVIRALS FOR SYSTEMIC USE|J5
13458|CEPHALOSPORINS|J1D
13457|CEPHALOSPORINS|J1D
13455|Protease inhibitors|J5C2
13454|Protease inhibitors|J5C2
13446|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
13445|IMMUNOSUPPRESSIVE AGENTS|L4
13444|ANTIHYPERTENSIVES|C2
13440|Urinary incontinence products|G4B4
13426|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
13424|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
13422|HUMAN INSULINS AND ANALOGUES|A10C
13422|Human insulins and analogues, intermediate-acting|A10C2
13421|HEPARINS |B1B
13420|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
13418|SYSTEMIC ANTIBACTERIALS|J1
13418|IMMUNOSUPPRESSIVE AGENTS|L4
13416|ANTIVIRALS FOR SYSTEMIC USE|J5
13416|PARASITOLOGY|P
13413|ALKYLATING AGENTS|L1A
13409|ANTI-EPILEPTICS|N3A
13408|ANTIVIRALS FOR SYSTEMIC USE|J5
13405|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
13404|SYSTEMIC ANTIHISTAMINES|R6
13403|NOOTROPICS|N6D
13403|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
13399|CARDIOVASCULAR SYSTEM|C
13399|ANTIHYPERTENSIVES|C2
13397|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13396|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13395|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13394|TRANQUILLISERS|N5C
13393|TRANQUILLISERS|N5C
13390|ANALGESICS|N2
13389|ANALGESICS|N2
13387|SYSTEMIC ANTIBACTERIALS|J1
13386|SYSTEMIC ANTIBACTERIALS|J1
13383|FIBRINOLYTICS|B1D
13377|ANTI-EPILEPTICS|N3A
13377|ANTIPSYCHOTICS|N5A
13370|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13356|ANTIVIRALS FOR SYSTEMIC USE|J5
13355|Protease inhibitors|J5C2
13353|ANTIVIRALS FOR SYSTEMIC USE|J5
13352|ANTITUSSIVES|R5D
13350|TRANQUILLISERS|N5C
13350|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13349|ANTI-EPILEPTICS|N3
13349|HYPNOTICS/SEDATIVES|N5B
13349|TRANQUILLISERS|N5C
13340|ANTIVIRALS FOR SYSTEMIC USE|J5
13340|IMMUNOSUPPRESSIVE AGENTS|L4
13340|ANTI-EPILEPTICS|N3
13338|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13338|ANTIVIRALS FOR SYSTEMIC USE|J5
13338|OPHTHALMOLOGICALS|S1
13337|ANTI-ACNE PREPARATIONS|D10
13337|BPH (benign prostatic hypertrophy) products |G4C
13332|ANTI-ACNE PREPARATIONS|D10
13332|BPH (benign prostatic hypertrophy) products |G4C
13331|ANTIHYPERTENSIVES|C2
13329|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13328|IMMUNOSUPPRESSIVE AGENTS|L4
13326|SYSTEMIC ANTIBACTERIALS|J1
13326|IMMUNOSUPPRESSIVE AGENTS|L4
13323|SYSTEMIC ANTIBACTERIALS|J1
13318|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
13316|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13314|ANTIVIRALS FOR SYSTEMIC USE|J5
13308|Protease inhibitors|J5C2
13307|Protease inhibitors|J5C2
13305|IMMUNOSTIMULATING AGENTS|L3
13300|SYSTEMIC ANTIBACTERIALS|J1
13300|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13300|ANTIVIRALS FOR SYSTEMIC USE|J5
13299|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
13299|IMMUNOSUPPRESSIVE AGENTS|L4
13288|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13287|SYSTEMIC ANTIBACTERIALS|J1
13286|SYSTEMIC ANTIBACTERIALS|J1
13281|ANTIVIRALS FOR SYSTEMIC USE|J5
13276|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13270|VACCINES|J7
13270|ANTI-EPILEPTICS|N3A
13269|CALCITONINS|H4A
13268|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13266|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13265|ANTIHYPERTENSIVES|C2
13265|CALCIUM ANTAGONISTS|C8
13259|ANTIVIRALS FOR SYSTEMIC USE|J5
13258|ANTIVIRALS FOR SYSTEMIC USE|J5
13257|CENTRAL NERVOUS SYSTEM|N
13253|ANALGESICS|N2
13251|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13239|ANTIMETABOLITES|L1B
13236|ALKYLATING AGENTS|L1A
13235|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13234|ANTIVIRALS FOR SYSTEMIC USE|J5
13234|IMMUNOSTIMULATING AGENTS|L3
13233|ANTIHYPERTENSIVES|C2
13232|ANTIHYPERTENSIVES|C2
13231|ANTIHYPERTENSIVES|C2
13230|ANTIHYPERTENSIVES|C2
13229|ANTIPSYCHOTICS|N5A
13228|ANTIPSYCHOTICS|N5A
13227|TRANQUILLISERS|N5C
13226|CARDIOVASCULAR SYSTEM|C
13226|ANTIHYPERTENSIVES|C2
13226|ACE INHIBITORS, PLAIN|C9A
13225|PLATELET AGGREGATION INHIBITORS|B1C
13225|Fibrinogen|B2D5
13223|PLATELET AGGREGATION INHIBITORS|B1C
13223|Fibrinogen|B2D5
13219|ANTIHYPERTENSIVES|C2
13218|ALKYLATING AGENTS|L1A
13217|ANTIHYPERTENSIVES|C2
13216|ANTIHYPERTENSIVES|C2
13215|ANTI-ARRHYTHMICS|C1B
13214|FIBRINOLYTICS|B1D
13213|VACCINES|J7
13212|SYSTEMIC ANTIBACTERIALS|J1
13212|ANTIVIRALS FOR SYSTEMIC USE|J5
13210|ANALGESICS|N2
13209|ANTIEMETICS AND ANTINAUSEANTS|A4
13209|ANALGESICS|N2
13209|TRANQUILLISERS|N5C
13209|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13207|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
13205|ANTIHYPERTENSIVES|C2
13205|CALCIUM ANTAGONISTS|C8
13204|ANTIHYPERTENSIVES|C2
13204|CALCIUM ANTAGONISTS|C8
13202|ANTIHYPERTENSIVES|C2
13202|CALCIUM ANTAGONISTS|C8
13201|SYSTEMIC ANTIBACTERIALS|J1
13200|ANTI-ARRHYTHMICS|C1B
13199|ANTI-EPILEPTICS|N3A
13198|Miotics and antiglaucoma preparations, topical|S1E2
13193|IMMUNOSUPPRESSIVE AGENTS|L4
13192|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13190|TRANQUILLISERS|N5C
13189|ANTIHYPERTENSIVES|C2
13189|BPH (benign prostatic hypertrophy) products |G4C
13188|TRANQUILLISERS|N5C
13188|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13188|NOOTROPICS|N6D
13186|MRI AGENTS|T1E
13182|ANTIHYPERTENSIVES|C2
13181|ANTIPSYCHOTICS|N5A
13181|TRANQUILLISERS|N5C
13178|CENTRAL NERVOUS SYSTEM|N
13177|TRANQUILLISERS|N5C
13177|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13176|TRANQUILLISERS|N5C
13174|PLATELET AGGREGATION INHIBITORS|B1C
13174|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
13173|TRANQUILLISERS|N5C
13172|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13171|TRANQUILLISERS|N5C
13171|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13169|TRANQUILLISERS|N5C
13169|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13167|ANTIHYPERTENSIVES|C2
13167|ACE INHIBITORS, PLAIN|C9A
13162|ANDROGENS, EXCLUDING G3E, G3F|G3B
13161|ANALGESICS|N2
13157|IMMUNOSTIMULATING AGENTS|L3
13155|ALKYLATING AGENTS|L1A
13154|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13154|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13153|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13153|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13152|Antigonadotrophin-releasing hormones|H1C3
13150|ANTIVIRALS FOR SYSTEMIC USE|J5
13144|ANTIEMETICS AND ANTINAUSEANTS|A4
13144|ANALGESICS|N2
13144|ANTI-MIGRAINE PREPARATIONS|N2C
13142|ALKYLATING AGENTS|L1A
13141|ANALGESICS|N2
13140|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13139|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13138|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
13137|ANALGESICS|N2
13136|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13136|GROWTH HORMONES|H4C
13136|MUSCULO-SKELETAL SYSTEM|M
13135|ANTI-ACNE PREPARATIONS|D10
13134|BPH (benign prostatic hypertrophy) products |G4C
13128|SYSTEMIC ANTIBACTERIALS|J1
13128|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13128|PARASITOLOGY|P
13127|Coxibs|M1A3
13127|ANALGESICS|N2
13123|IMMUNOSUPPRESSIVE AGENTS|L4
13122|ANTIVIRALS FOR SYSTEMIC USE|J5
13119|SYSTEMIC ANTIBACTERIALS|J1
13117|SYSTEMIC ANTIBACTERIALS|J1
13116|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13116|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13115|ANTI-EPILEPTICS|N3A
13113|ANTIPSYCHOTICS|N5A
13112|FIBRINOLYTICS|B1D
13112|DIRECT THROMBIN INHIBITORS|B1E
13108|ANTIVIRALS FOR SYSTEMIC USE|J5
13105|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
13105|ANTI-ACNE PREPARATIONS|D10
13104|ANTIHYPERTENSIVES|C2
13104|CALCIUM ANTAGONISTS|C8
13103|ANTIHYPERTENSIVES|C2
13099|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13098|ANTIHYPERTENSIVES|C2
13097|ANTI-ARRHYTHMICS|C1B
13096|APPETITE STIMULANTS|A15
13096|MUSCLE RELAXANTS|M3
13096|ANALGESICS|N2
13094|IMMUNOSUPPRESSIVE AGENTS|L4
13093|SYSTEMIC ANTIBACTERIALS|J1
13088|ANALGESICS|N2
13086|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
13083|ANTIVIRALS FOR SYSTEMIC USE|J5
13081|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
13081|ANTIVIRALS FOR SYSTEMIC USE|J5
13080|ANALGESICS|N2
13080|ANTI-EPILEPTICS|N3
13079|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
13079|SSRI antidepressants|N6A4
13079|SRNI antidepressants|N6A5
13078|ANTIVIRALS FOR SYSTEMIC USE|J5
13077|NOOTROPICS|N6D
13076|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
13075|ANTIVIRALS FOR SYSTEMIC USE|J5
13075|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
13074|ANTIVIRALS FOR SYSTEMIC USE|J5
13071|ANTIEMETICS AND ANTINAUSEANTS|A4
13070|ANTI-ARRHYTHMICS|C1B
13069|ANTIPSYCHOTICS|N5A
13068|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
13066|CARDIOVASCULAR SYSTEM|C
13066|ANTIHYPERTENSIVES|C2
13066|CALCIUM ANTAGONISTS|C8
13063|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
13060|ANTI-ACNE PREPARATIONS|D10
13060|BPH (benign prostatic hypertrophy) products |G4C
13059|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
13059|CARDIAC THERAPY|C1
13059|ANTIHYPERTENSIVES|C2
13053|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
13051|ANTI-ACNE PREPARATIONS|D10
13051|SYSTEMIC ANTIBACTERIALS|J1
13045|DERMATOLOGICALS|D
13042|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
13042|IMMUNOSUPPRESSIVE AGENTS|L4
13038|ANTIHYPERTENSIVES|C2
13031|CARDIOVASCULAR SYSTEM|C
13026|ANTI-ARRHYTHMICS|C1B
13017|NOOTROPICS|N6D
13016|ANTIULCERANTS|A2B
13013|FIBRINOLYTICS|B1D
13012|FIBRINOLYTICS|B1D
13011|CARDIOVASCULAR SYSTEM|C
13011|CENTRAL NERVOUS SYSTEM|N
13007|ANTIHYPERTENSIVES|C2
13007|DIURETICS|C3
13006|PARASITOLOGY|P
13004|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
13001|ANTI-EPILEPTICS|N3
13001|TRANQUILLISERS|N5C
12996|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12995|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12991|ANTIVIRALS FOR SYSTEMIC USE|J5
12991|OPHTHALMOLOGICALS|S1
12989|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
12987|ANTIVIRALS FOR SYSTEMIC USE|J5
12986|Coxibs|M1A3
12986|ANALGESICS|N2
12984|SYSTEMIC ANTIBACTERIALS|J1
12983|SYSTEMIC ANTIBACTERIALS|J1
12981|SYSTEMIC ANTIBACTERIALS|J1
12980|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
12978|SYSTEMIC ANTIBACTERIALS|J1
12976|ANTIFIBRINOLYTICS|B2A
12976|CARDIAC THERAPY|C1
12974|ANTIVIRALS FOR SYSTEMIC USE|J5
12974|INTERFERONS|L3B
12970|PARASITOLOGY|P
12969|SYSTEMIC ANTIBACTERIALS|J1
12965|ALKYLATING AGENTS|L1A
12964|ALKYLATING AGENTS|L1A
12963|ANTIVIRALS FOR SYSTEMIC USE|J5
12958|DERMATOLOGICALS|D
12958|ANTI-ACNE PREPARATIONS|D10
12956|ANTIHYPERTENSIVES|C2
12955|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12951|ANTIVIRALS FOR SYSTEMIC USE|J5
12948|ANTI-ARRHYTHMICS|C1B
12946|ANTI-EPILEPTICS|N3A
12945|IMMUNOSTIMULATING AGENTS|L3
12944|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12940|ANTIVIRALS FOR SYSTEMIC USE|J5
12935|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12932|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12928|DRUGS USED IN DIABETES|A10
12928|IMMUNOSTIMULATING AGENTS|L3
12928|HYPNOTICS/SEDATIVES|N5B
12927|SYSTEMIC ANTIBACTERIALS|J1
12924|Carbapenems|J1P2
12922|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
12922|SYSTEMIC ANTIBACTERIALS|J1
12918|ANTIVIRALS FOR SYSTEMIC USE|J5
12915|SYSTEMIC ANTIBACTERIALS|J1
12910|ANTIHYPERTENSIVES|C2
12910|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
12909|ANTI-ARRHYTHMICS|C1B
12907|ANTIHYPERTENSIVES|C2
12907|DIURETICS|C3
12906|CALCITONINS|H4A
12901|DIAGNOSTIC AGENTS|T
12897|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
12892|VACCINES|J7
12886|VACCINES|J7
12884|CARDIOVASCULAR SYSTEM|C
12883|IMMUNOSUPPRESSIVE AGENTS|L4
12881|DIRECT THROMBIN INHIBITORS|B1E
12880|VACCINES|J7
12869|CALCITONINS|H4A
12866|ANTIEMETICS AND ANTINAUSEANTS|A4
12866|APPETITE STIMULANTS|A15
12866|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
12865|IMMUNOSTIMULATING AGENTS|L3
12863|DRUGS USED IN DIABETES|A10
12863|ANTIVIRALS FOR SYSTEMIC USE|J5
12861|VACCINES|J7
12860|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12860|VACCINES|J7
12859|VACCINES|J7
12858|VACCINES|J7
12856|ANTI-EPILEPTICS|N3A
12852|BPH (benign prostatic hypertrophy) products |G4C
12851|ANTI-EPILEPTICS|N3
12850|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12848|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12847|Urinary incontinence products|G4B4
12846|ANALGESICS|N2
12843|GROWTH HORMONES|H4C
12838|Miotics and antiglaucoma preparations, topical|S1E2
12835|HEPARINS |B1B
12835|FIBRINOLYTICS|B1D
12834|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
12834|SYSTEMIC ANTIBACTERIALS|J1
12833|IMMUNOSTIMULATING AGENTS|L3
12831|ANTI-ARRHYTHMICS|C1B
12830|VACCINES|J7
12824|SYSTEMIC ANTIBACTERIALS|J1
12821|ANTI-EPILEPTICS|N3A
12820|LUNG SURFACTANTS|R7C
12818|PLATELET AGGREGATION INHIBITORS|B1C
12812|CARDIOVASCULAR SYSTEM|C
12811|SYSTEMIC ANTIBACTERIALS|J1
12808|ANTIHYPERTENSIVES|C2
12806|RESPIRATORY SYSTEM|R
12804|IMMUNOSUPPRESSIVE AGENTS|L4
12802|ANTIVIRALS FOR SYSTEMIC USE|J5
12801|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12800|PARASITOLOGY|P
12785|ANTI-ACNE PREPARATIONS|D10
12784|SYSTEMIC ANTIBACTERIALS|J1
12784|AMINOGLYCOSIDES|J1K
12783|Factor VIII|B2D1
12781|ANALGESICS|N2
12781|ANTI-EPILEPTICS|N3
12776|FIBRINOLYTICS|B1D
12773|Factors II, VII, IX and X|B2D2
12772|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12771|ANALGESICS|N2
12769|CARDIAC THERAPY|C1
12767|ALKYLATING AGENTS|L1A
12765|ANTIULCERANTS|A2B
12765|TRANQUILLISERS|N5C
12764|ANTI-MIGRAINE PREPARATIONS|N2C
12758|RESPIRATORY SYSTEM|R
12756|ANTIEMETICS AND ANTINAUSEANTS|A4
12755|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12754|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12752|ANTIHYPERTENSIVES|C2
12751|ANTIHYPERTENSIVES|C2
12748|Vitamin D|A11C2
12748|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12740|MRI AGENTS|T1E
12738|ANTIVIRALS FOR SYSTEMIC USE|J5
12738|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
12737|OPHTHALMOLOGICALS|S1
12732|Protease inhibitors|J5C2
12730|CALCIUM ANTAGONISTS|C8
12727|IMMUNOSUPPRESSIVE AGENTS|L4
12726|NOOTROPICS|N6D
12723|PLATELET AGGREGATION INHIBITORS|B1C
12723|SYSTEMIC ANTIBACTERIALS|J1
12722|SYSTEMIC ANTIBACTERIALS|J1
12720|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12719|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
12718|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
12717|Coxibs|M1A3
12715|FIBRINOLYTICS|B1D
12713|SYSTEMIC ANTIBACTERIALS|J1
12712|SYSTEMIC ANTIBACTERIALS|J1
12711|BPH (benign prostatic hypertrophy) products |G4C
12710|ANALGESICS|N2
12708|ANTI-ACNE PREPARATIONS|D10
12708|ANTIVIRALS FOR SYSTEMIC USE|J5
12706|B2-STIMULANTS|R3A
12704|SYSTEMIC ANTIBACTERIALS|J1
12698|CARDIOVASCULAR SYSTEM|C
12698|RESPIRATORY SYSTEM|R
12696|ANALGESICS|N2
12696|ANTI-EPILEPTICS|N3
12696|ANTI-EPILEPTICS|N3A
12696|TRANQUILLISERS|N5C
12691|ANTIVIRALS FOR SYSTEMIC USE|J5
12690|DIRECT THROMBIN INHIBITORS|B1E
12689|ANTIVIRALS FOR SYSTEMIC USE|J5
12689|IMMUNOSTIMULATING AGENTS|L3
12689|Interferons, alpha|L3B1
12688|DIRECT THROMBIN INHIBITORS|B1E
12687|ANTIVIRALS FOR SYSTEMIC USE|J5
12687|Interferons, alpha|L3B1
12686|ANTIPSYCHOTICS|N5A
12681|PLATELET AGGREGATION INHIBITORS|B1C
12681|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12680|SYSTEMIC ANTIBACTERIALS|J1
12680|ANTIVIRALS FOR SYSTEMIC USE|J5
12679|ANTIVIRALS FOR SYSTEMIC USE|J5
12673|ANTIVIRALS FOR SYSTEMIC USE|J5
12670|ANTIVIRALS FOR SYSTEMIC USE|J5
12667|ANTIVIRALS FOR SYSTEMIC USE|J5
12666|ANTIVIRALS FOR SYSTEMIC USE|J5
12664|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12663|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12660|ANTI-EPILEPTICS|N3A
12657|ANTIVIRALS FOR SYSTEMIC USE|J5
12655|ANALGESICS|N2
12651|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12651|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
12650|ANTIPSYCHOTICS|N5A
12649|CALCIUM ANTAGONISTS|C8
12649|ANTI-MIGRAINE PREPARATIONS|N2C
12648|ANTI-EPILEPTICS|N3
12648|TRANQUILLISERS|N5C
12647|Coxibs|M1A3
12647|ANALGESICS|N2
12644|SYSTEMIC ANTIBACTERIALS|J1
12643|ANALGESICS|N2
12642|PARASITOLOGY|P
12641|PARASITOLOGY|P
12640|SYSTEMIC ANTIBACTERIALS|J1
12639|IMMUNOSUPPRESSIVE AGENTS|L4
12636|IMMUNOSUPPRESSIVE AGENTS|L4
12634|SYSTEMIC ANTIBACTERIALS|J1
12633|SYSTEMIC ANTIBACTERIALS|J1
12632|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12631|CARDIOVASCULAR SYSTEM|C
12631|ANTIVIRALS FOR SYSTEMIC USE|J5
12630|ANTIVIRALS FOR SYSTEMIC USE|J5
12629|NOOTROPICS|N6D
12626|PLATELET AGGREGATION INHIBITORS|B1C
12626|CARDIOVASCULAR SYSTEM|C
12619|VACCINES|J7
12618|VACCINES|J7
12617|BPH (benign prostatic hypertrophy) products |G4C
12617|VACCINES|J7
12613|VACCINES|J7
12611|SYSTEMIC ANTIBACTERIALS|J1
12610|CALCIUM ANTAGONISTS|C8
12610|ANTI-EPILEPTICS|N3
12608|ANTIPSYCHOTICS|N5A
12607|ANTIPSYCHOTICS|N5A
12604|ANTIHYPERTENSIVES|C2
12604|ANALGESICS|N2
12601|SYSTEMIC ANTIBACTERIALS|J1
12595|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12593|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
12591|ANALGESICS|N2
12588|PLATELET AGGREGATION INHIBITORS|B1C
12588|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12587|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
12586|CARDIOVASCULAR SYSTEM|C
12586|ANTIHYPERTENSIVES|C2
12584|PLATELET AGGREGATION INHIBITORS|B1C
12584|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12582|BPH (benign prostatic hypertrophy) products |G4C
12581|BPH (benign prostatic hypertrophy) products |G4C
12580|SYSTEMIC ANTIBACTERIALS|J1
12579|SYSTEMIC ANTIBACTERIALS|J1
12574|ANTIVIRALS FOR SYSTEMIC USE|J5
12573|ANALGESICS|N2
12572|Protease inhibitors|J5C2
12571|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12570|PLATELET AGGREGATION INHIBITORS|B1C
12569|ANALGESICS|N2
12566|TRANQUILLISERS|N5C
12565|IMMUNOSTIMULATING AGENTS|L3
12564|PLATELET AGGREGATION INHIBITORS|B1C
12564|Fibrinogen|B2D5
12562|ANTIPSYCHOTICS|N5A
12561|ANTIVIRALS FOR SYSTEMIC USE|J5
12558|ANTI-EPILEPTICS|N3A
12558|ANTIPSYCHOTICS|N5A
12558|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
12557|PLATELET AGGREGATION INHIBITORS|B1C
12557|Coxibs|M1A3
12557|ANALGESICS|N2
12556|PLATELET AGGREGATION INHIBITORS|B1C
12556|Urinary incontinence products|G4B4
12556|ANTI-EPILEPTICS|N3A
12555|NOOTROPICS|N6D
12555|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
12555|PARASITOLOGY|P
12549|CALCIUM ANTAGONISTS|C8
12548|CALCIUM ANTAGONISTS|C8
12544|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12543|SYSTEMIC ANTIBACTERIALS|J1
12543|Carbapenems|J1P2
12534|CARDIOVASCULAR SYSTEM|C
12534|ANTIHYPERTENSIVES|C2
12533|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12532|ANTIHYPERTENSIVES|C2
12530|PLATELET AGGREGATION INHIBITORS|B1C
12530|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12530|Fibrinogen|B2D5
12529|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12528|BPH (benign prostatic hypertrophy) products |G4C
12526|CARDIOVASCULAR SYSTEM|C
12526|MRI AGENTS|T1E
12525|MRI AGENTS|T1E
12505|PLATELET AGGREGATION INHIBITORS|B1C
12505|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12504|PLATELET AGGREGATION INHIBITORS|B1C
12503|PLATELET AGGREGATION INHIBITORS|B1C
12502|DRUGS USED IN DIABETES|A10
12499|DERMATOLOGICALS|D
12499|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12497|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12496|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12495|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12494|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12487|SYSTEMIC ANTIBACTERIALS|J1
12486|TRANQUILLISERS|N5C
12483|CARDIOVASCULAR SYSTEM|C
12483|ANTIHYPERTENSIVES|C2
12478|CARDIOVASCULAR SYSTEM|C
12471|DRUGS USED IN DIABETES|A10
12468|PLATELET AGGREGATION INHIBITORS|B1C
12466|ANTI-MIGRAINE PREPARATIONS|N2C
12462|ANTI-EPILEPTICS|N3
12461|TRANQUILLISERS|N5C
12460|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12459|DRUGS USED IN DIABETES|A10
12458|DRUGS USED IN DIABETES|A10
12457|DRUGS USED IN DIABETES|A10
12456|DRUGS USED IN DIABETES|A10
12455|DRUGS USED IN DIABETES|A10
12451|DRUGS USED IN DIABETES|A10
12448|DRUGS USED IN DIABETES|A10
12446|DRUGS USED IN DIABETES|A10
12445|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12445|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
12444|DRUGS USED IN DIABETES|A10
12443|DRUGS USED IN DIABETES|A10
12441|Bile stone therapy|A5A2
12441|MACROLIDES AND SIMILAR TYPES|J1F
12440|Bile stone therapy|A5A2
12440|MACROLIDES AND SIMILAR TYPES|J1F
12439|MACROLIDES AND SIMILAR TYPES|J1F
12438|Bile stone therapy|A5A2
12438|MACROLIDES AND SIMILAR TYPES|J1F
12437|ANTIVIRALS FOR SYSTEMIC USE|J5
12436|SYSTEMIC ANTIBACTERIALS|J1
12436|VACCINES|J7
12435|VACCINES|J7
12434|ANTIVIRALS FOR SYSTEMIC USE|J5
12434|IMMUNOSTIMULATING AGENTS|L3
12433|ANAESTHETICS, LOCAL|N1B
12430|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12429|ANTIHYPERTENSIVES|C2
12429|ANTI-MIGRAINE PREPARATIONS|N2C
12428|ANTIHYPERTENSIVES|C2
12427|PLATELET AGGREGATION INHIBITORS|B1C
12427|ANTIHYPERTENSIVES|C2
12425|DPP-IV inhibitor antidiabetics|A10B6
12421|PLATELET AGGREGATION INHIBITORS|B1C
12421|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12420|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
12420|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12420|Statins (HMG-CoA reductase inhibitors)|C10A1
12419|ANTIHYPERTENSIVES|C2
12418|ANALGESICS|N2
12417|ANALGESICS|N2
12416|ANTIHYPERTENSIVES|C2
12414|ANALGESICS|N2
12407|ANTIHYPERTENSIVES|C2
12405|PLATELET AGGREGATION INHIBITORS|B1C
12405|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12403|ANTI-EPILEPTICS|N3
12401|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12400|ANDROGENS, EXCLUDING G3E, G3F|G3B
12399|ANTI-EPILEPTICS|N3
12398|ANTIVIRALS FOR SYSTEMIC USE|J5
12397|SYSTEMIC ANTIBACTERIALS|J1
12395|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12393|BPH (benign prostatic hypertrophy) products |G4C
12392|CALCIUM ANTAGONISTS|C8
12391|ANTIULCERANTS|A2B
12381|DRUGS USED IN DIABETES|A10
12377|ANALGESICS|N2
12373|ANTIHYPERTENSIVES|C2
12372|CARDIOVASCULAR SYSTEM|C
12371|ANALGESICS|N2
12369|ANTIVIRALS FOR SYSTEMIC USE|J5
12365|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12364|ANDROGENS, EXCLUDING G3E, G3F|G3B
12362|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12362|IMMUNOSUPPRESSIVE AGENTS|L4
12360|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12355|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
12353|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12352|ANTI-EPILEPTICS|N3A
12351|ANTI-EPILEPTICS|N3
12351|TRANQUILLISERS|N5C
12349|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
12348|SYSTEMIC ANTIBACTERIALS|J1
12347|MRI AGENTS|T1E
12346|PLATELET AGGREGATION INHIBITORS|B1C
12345|Vitamin D|A11C2
12345|DERMATOLOGICALS|D
12345|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
12342|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12341|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12337|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12332|ALKYLATING AGENTS|L1A
12331|ALKYLATING AGENTS|L1A
12327|DRUGS USED IN DIABETES|A10
12326|DIRECT THROMBIN INHIBITORS|B1E
12326|DIAGNOSTIC AGENTS|T
12324|ANTI-EPILEPTICS|N3A
12324|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
12319|ANALGESICS|N2
12319|ANTI-EPILEPTICS|N3
12319|ANTI-EPILEPTICS|N3A
12319|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
12315|ANTI-ACNE PREPARATIONS|D10
12314|DIAGNOSTIC AGENTS|T
12311|ANTIVIRALS FOR SYSTEMIC USE|J5
12308|Vitamin D|A11C2
12304|ANTIVIRALS FOR SYSTEMIC USE|J5
12303|SYSTEMIC ANTIBACTERIALS|J1
12297|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12288|ANTIVIRALS FOR SYSTEMIC USE|J5
12266|ANTI-EPILEPTICS|N3A
12261|IMMUNOSUPPRESSIVE AGENTS|L4
12260|IMMUNOSTIMULATING AGENTS|L3
12254|ALKYLATING AGENTS|L1A
12253|ALKYLATING AGENTS|L1A
12252|ALKYLATING AGENTS|L1A
12243|ALKYLATING AGENTS|L1A
12242|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
12241|ANALGESICS|N2
12241|ANTI-MIGRAINE PREPARATIONS|N2C
12240|PLATELET AGGREGATION INHIBITORS|B1C
12235|SYSTEMIC ANTIBACTERIALS|J1
12234|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12234|Erectile dysfunction products|G4B3
12232|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12232|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
12231|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12228|ANTIVIRALS FOR SYSTEMIC USE|J5
12227|SYSTEMIC ANTIBACTERIALS|J1
12227|ANTIVIRALS FOR SYSTEMIC USE|J5
12225|ANTIVIRALS FOR SYSTEMIC USE|J5
12222|ANTIVIRALS FOR SYSTEMIC USE|J5
12222|IMMUNOSTIMULATING AGENTS|L3
12222|PARASITOLOGY|P
12218|ANTIHYPERTENSIVES|C2
12216|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
12214|ANTI-MIGRAINE PREPARATIONS|N2C
12211|DERMATOLOGICALS|D
12208|ANTIPSYCHOTICS|N5A
12205|ANTIMETABOLITES|L1B
12201|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12198|IMMUNOSTIMULATING AGENTS|L3
12188|ALKYLATING AGENTS|L1A
12186|HYPNOTICS/SEDATIVES|N5B
12183|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12179|ULTRASOUND AGENTS|T1F
12176|ANTIHYPERTENSIVES|C2
12175|DRUGS USED IN DIABETES|A10
12175|ANTIHYPERTENSIVES|C2
12174|CARDIOVASCULAR SYSTEM|C
12173|ANTIHYPERTENSIVES|C2
12172|ANTIULCERANTS|A2B
12171|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12170|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
12170|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12168|ANTI-ACNE PREPARATIONS|D10
12168|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12167|ANTI-ACNE PREPARATIONS|D10
12167|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
12166|ALKYLATING AGENTS|L1A
12166|ANTIMETABOLITES|L1B
12164|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12163|BETA-BLOCKING AGENTS|C7
12162|Protease inhibitors|J5C2
12161|Protease inhibitors|J5C2
12158|DIRECT THROMBIN INHIBITORS|B1E
12155|ALKYLATING AGENTS|L1A
12151|ANTIHYPERTENSIVES|C2
12149|DRUGS USED IN DIABETES|A10
12146|SYSTEMIC ANTIBACTERIALS|J1
12146|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12146|PARASITOLOGY|P
12141|ANTIHYPERTENSIVES|C2
12138|APPETITE STIMULANTS|A15
12135|ANTI-GOUT PREPARATIONS|M4
12135|ANALGESICS|N2
12135|NOOTROPICS|N6D
12134|ALKYLATING AGENTS|L1A
12132|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12132|PARASITOLOGY|P
12130|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
12130|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
12127|ANTIVIRALS FOR SYSTEMIC USE|J5
12126|CENTRAL NERVOUS SYSTEM|N
12122|ANTIVIRALS FOR SYSTEMIC USE|J5
12119|ANALGESICS|N2
12119|ANTI-EPILEPTICS|N3A
12119|ANTIPSYCHOTICS|N5A
12119|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
12118|ANALGESICS|N2
12115|Erectile dysfunction products|G4B3
12114|ANAESTHETICS, LOCAL|N1B
12114|ANALGESICS|N2
12113|Urinary incontinence products|G4B4
12108|ANTITUSSIVES|R5D
12107|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12105|DRUGS USED IN DIABETES|A10
12105|ANTI-EPILEPTICS|N3A
12104|ANTIVIRALS FOR SYSTEMIC USE|J5
12103|IMMUNOSUPPRESSIVE AGENTS|L4
12098|ANTI-EPILEPTICS|N3
12097|TRANQUILLISERS|N5C
12096|ANALGESICS|N2
12091|PLATELET AGGREGATION INHIBITORS|B1C
12091|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12090|ANTIHYPERTENSIVES|C2
12089|IMMUNOSUPPRESSIVE AGENTS|L4
12088|NOOTROPICS|N6D
12086|ANTIVIRALS FOR SYSTEMIC USE|J5
12083|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
12081|NOOTROPICS|N6D
12080|SYSTEMIC ANTIBACTERIALS|J1
12076|VACCINES|J7
12074|ANTI-EPILEPTICS|N3
12073|SYSTEMIC ANTIBACTERIALS|J1
12072|IMMUNOSUPPRESSIVE AGENTS|L4
12071|SYSTEMIC ANTIBACTERIALS|J1
12068|ANTI-EPILEPTICS|N3A
12067|ANTIEMETICS AND ANTINAUSEANTS|A4
12067|ANALGESICS|N2
12064|ANALGESICS|N2
12064|HYPNOTICS/SEDATIVES|N5B
12062|IMMUNOSUPPRESSIVE AGENTS|L4
12062|ANALGESICS|N2
12061|IMMUNOSTIMULATING AGENTS|L3
12060|SYSTEMIC ANTIBACTERIALS|J1
12059|ANTIVIRALS FOR SYSTEMIC USE|J5
12056|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
12055|IMMUNOSUPPRESSIVE AGENTS|L4
12054|HUMAN INSULINS AND ANALOGUES|A10C
12044|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12043|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12039|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
12036|ANALGESICS|N2
12036|TRANQUILLISERS|N5C
12035|ANTIHYPERTENSIVES|C2
12034|ANTI-EPILEPTICS|N3A
12034|ANTIPSYCHOTICS|N5A
12034|NOOTROPICS|N6D
12032|Other oral antidiabetics|A10B9
12032|CARDIOVASCULAR SYSTEM|C
12032|Ocular antineovascularisation products|S1P
12031|SYSTEMIC ANTIBACTERIALS|J1
12031|Carbapenems|J1P2
12030|ANTIHYPERTENSIVES|C2
12029|PLATELET AGGREGATION INHIBITORS|B1C
12029|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
12028|ANTIPSYCHOTICS|N5A
12027|TRANQUILLISERS|N5C
12026|ANTIPSYCHOTICS|N5A
12025|ANTIPSYCHOTICS|N5A
12024|ANTIPSYCHOTICS|N5A
12022|ANTIHYPERTENSIVES|C2
12022|ANALGESICS|N2
12022|ANTI-MIGRAINE PREPARATIONS|N2C
12022|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
12018|ANALGESICS|N2
12018|ANTI-MIGRAINE PREPARATIONS|N2C
12017|SYSTEMIC ANTIBACTERIALS|J1
12015|ANTI-EPILEPTICS|N3
12013|Coxibs|M1A3
12013|ANTI-GOUT PREPARATIONS|M4
12013|ANALGESICS|N2
12012|ANTIMETABOLITES|L1B
12011|ANTIMETABOLITES|L1B
12009|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
12008|ANTIVIRALS FOR SYSTEMIC USE|J5
12006|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12005|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12004|ANTIPSYCHOTICS|N5A
12003|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
12000|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11978|ALKYLATING AGENTS|L1A
11976|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
11976|Coxibs|M1A3
11974|ANTIHYPERTENSIVES|C2
11974|CALCIUM ANTAGONISTS|C8
11972|ANTI-EPILEPTICS|N3A
11969|ANTI-EPILEPTICS|N3A
11969|ANTIPSYCHOTICS|N5A
11969|TRANQUILLISERS|N5C
11969|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11968|TRANQUILLISERS|N5C
11965|ANALGESICS|N2
11963|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11963|PARASITOLOGY|P
11962|ANALGESICS|N2
11962|ANTI-EPILEPTICS|N3A
11961|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11959|SYSTEMIC ANTIBACTERIALS|J1
11958|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11957|CARDIAC THERAPY|C1
11956|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11955|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11949|ANTIVIRALS FOR SYSTEMIC USE|J5
11948|PARASITOLOGY|P
11948|ANTI-MALARIALS|P1D
11942|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
11941|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
11939|ANDROGENS, EXCLUDING G3E, G3F|G3B
11938|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
11936|CARDIOVASCULAR SYSTEM|C
11936|MRI AGENTS|T1E
11933|ANTIVIRALS FOR SYSTEMIC USE|J5
11930|ANTIHYPERTENSIVES|C2
11929|ULTRASOUND AGENTS|T1F
11928|ALKYLATING AGENTS|L1A
11927|CARDIOVASCULAR SYSTEM|C
11926|Protease inhibitors|J5C2
11923|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11923|Statins (HMG-CoA reductase inhibitors)|C10A1
11922|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11922|Statins (HMG-CoA reductase inhibitors)|C10A1
11917|DERMATOLOGICALS|D
11916|CARDIOVASCULAR SYSTEM|C
11916|ANTIVIRALS FOR SYSTEMIC USE|J5
11916|ANALGESICS|N2
11915|ANTI-ACNE PREPARATIONS|D10
11912|DRUGS USED IN DIABETES|A10
11912|HUMAN INSULINS AND ANALOGUES|A10C
11912|Human insulins and analogues, intermediate-acting|A10C2
11911|IMMUNOSTIMULATING AGENTS|L3
11910|ANTIMETABOLITES|L1B
11909|SYSTEMIC ANTIBACTERIALS|J1
11908|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
11906|FIBRINOLYTICS|B1D
11906|CARDIOVASCULAR SYSTEM|C
11906|ANTIVIRALS FOR SYSTEMIC USE|J5
11904|BPH (benign prostatic hypertrophy) products |G4C
11901|ANTIHYPERTENSIVES|C2
11901|ACE INHIBITORS, PLAIN|C9A
11900|ANTIHYPERTENSIVES|C2
11898|ANALGESICS|N2
11898|TRANQUILLISERS|N5C
11898|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11895|DRUGS USED IN DIABETES|A10
11895|HUMAN INSULINS AND ANALOGUES|A10C
11895|Human insulins and analogues, intermediate-acting|A10C2
11894|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11893|ANDROGENS, EXCLUDING G3E, G3F|G3B
11890|ANTIPSYCHOTICS|N5A
11886|ANTIVIRALS FOR SYSTEMIC USE|J5
11883|ANTIULCERANTS|A2B
11881|Coxibs|M1A3
11879|IMMUNOSUPPRESSIVE AGENTS|L4
11877|ANTI-MIGRAINE PREPARATIONS|N2C
11876|ANTI-MIGRAINE PREPARATIONS|N2C
11869|ANTI-MIGRAINE PREPARATIONS|N2C
11868|MRI AGENTS|T1E
11866|ANTIVIRALS FOR SYSTEMIC USE|J5
11864|ANTIVIRALS FOR SYSTEMIC USE|J5
11863|ANTIVIRALS FOR SYSTEMIC USE|J5
11862|CENTRAL NERVOUS SYSTEM|N
11862|MRI AGENTS|T1E
11860|ANTIVIRALS FOR SYSTEMIC USE|J5
11859|ANTIULCERANTS|A2B
11858|ANTIHYPERTENSIVES|C2
11856|ANTIHYPERTENSIVES|C2
11854|ANTIHYPERTENSIVES|C2
11854|ANALGESICS|N2
11852|ANTIPSYCHOTICS|N5A
11850|ANTIVIRALS FOR SYSTEMIC USE|J5
11849|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11848|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11846|CARDIOVASCULAR SYSTEM|C
11845|CARDIOVASCULAR SYSTEM|C
11844|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11843|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11842|ANTI-MIGRAINE PREPARATIONS|N2C
11841|CARDIOVASCULAR SYSTEM|C
11841|ANTIHYPERTENSIVES|C2
11840|ANTIULCERANTS|A2B
11839|ANTIHYPERTENSIVES|C2
11839|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
11836|TRANQUILLISERS|N5C
11833|PARASITOLOGY|P
11832|ANALGESICS|N2
11832|TRANQUILLISERS|N5C
11828|ANTI-EPILEPTICS|N3A
11828|ANTIPSYCHOTICS|N5A
11827|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11826|FIBRINOLYTICS|B1D
11825|CALCITONINS|H4A
11824|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
11823|ANTIVIRALS FOR SYSTEMIC USE|J5
11821|ANAESTHETICS, LOCAL|N1B
11816|ANTIHYPERTENSIVES|C2
11815|ANTIHYPERTENSIVES|C2
11812|ANTIHYPERTENSIVES|C2
11812|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
11810|ANTIVIRALS FOR SYSTEMIC USE|J5
11805|IMMUNOSUPPRESSIVE AGENTS|L4
11801|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11801|IMMUNOSUPPRESSIVE AGENTS|L4
11703|Coxibs|M1A3
11703|ANALGESICS|N2
11700|ANTI-MIGRAINE PREPARATIONS|N2C
11699|ANTIVIRALS FOR SYSTEMIC USE|J5
11696|ANTIHYPERTENSIVES|C2
11696|ACE INHIBITORS, PLAIN|C9A
11694|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
11694|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
11693|PLATELET AGGREGATION INHIBITORS|B1C
11693|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
11689|NOOTROPICS|N6D
11689|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
11687|CENTRAL NERVOUS SYSTEM|N
11687|MRI AGENTS|T1E
11686|MRI AGENTS|T1E
11684|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
11682|FIBRINOLYTICS|B1D
11682|CARDIOVASCULAR SYSTEM|C
11675|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
11669|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11667|VACCINES|J7
11665|MRI AGENTS|T1E
11664|ANTIVIRALS FOR SYSTEMIC USE|J5
11660|ANTIVIRALS FOR SYSTEMIC USE|J5
11659|ANTIHYPERTENSIVES|C2
11659|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
11658|SYSTEMIC ANTIBACTERIALS|J1
11658|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11656|ANTI-EPILEPTICS|N3
11653|ANTIULCERANTS|A2B
11651|ANTIVIRALS FOR SYSTEMIC USE|J5
11648|PARASITOLOGY|P
11648|ANTI-MALARIALS|P1D
11644|IMMUNOSTIMULATING AGENTS|L3
11643|ANTIVIRALS FOR SYSTEMIC USE|J5
11642|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
11642|ANTIPSYCHOTICS|N5A
11642|SRNI antidepressants|N6A5
11640|MRI AGENTS|T1E
11639|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
11636|PLATELET AGGREGATION INHIBITORS|B1C
11636|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
11636|Fibrinogen|B2D5
11635|SYSTEMIC ANTIBACTERIALS|J1
11634|ANTI-EPILEPTICS|N3
11633|CARDIOVASCULAR SYSTEM|C
11632|ANTIPSYCHOTICS|N5A
11632|TRANQUILLISERS|N5C
11632|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11629|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11629|SSRI antidepressants|N6A4
11628|ANTI-ARRHYTHMICS|C1B
11628|ANAESTHETICS, LOCAL|N1B
11624|ANTIHYPERTENSIVES|C2
11624|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
11621|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11621|Coxibs|M1A3
11616|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11615|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
11615|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
11613|VACCINES|J7
11607|ANTIVIRALS FOR SYSTEMIC USE|J5
11605|PSYCHOSTIMULANTS|N6B
11602|ANALGESICS|N2
11601|MUSCULO-SKELETAL SYSTEM|M
11601|ANALGESICS|N2
11597|CALCITONINS|H4A
11596|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11591|HYPNOTICS/SEDATIVES|N5B
11590|ANTI-EPILEPTICS|N3
11590|TRANQUILLISERS|N5C
11589|OPHTHALMOLOGICALS|S1
11587|SYSTEMIC ANTIBACTERIALS|J1
11585|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11584|ANTIEMETICS AND ANTINAUSEANTS|A4
11582|VACCINES|J7
11580|ANTI-EPILEPTICS|N3A
11578|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11578|IMMUNOSUPPRESSIVE AGENTS|L4
11575|VACCINES|J7
11573|ANTIHYPERTENSIVES|C2
11573|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
11572|Miotics and antiglaucoma preparations, topical|S1E2
11564|AMINOGLYCOSIDES|J1K
11562|CARDIOVASCULAR SYSTEM|C
11562|ANTIHYPERTENSIVES|C2
11561|ANTIVIRALS FOR SYSTEMIC USE|J5
11560|ANTIVIRALS FOR SYSTEMIC USE|J5
11557|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
11557|SRNI antidepressants|N6A5
11550|ANTI-EPILEPTICS|N3A
11550|NOOTROPICS|N6D
11549|Erectile dysfunction products|G4B3
11548|IMMUNOSTIMULATING AGENTS|L3
11547|ANALGESICS|N2
11547|ANTI-EPILEPTICS|N3A
11547|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11547|NOOTROPICS|N6D
11543|CARDIOVASCULAR SYSTEM|C
11543|ANTIHYPERTENSIVES|C2
11543|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
11541|SYSTEMIC ANTIBACTERIALS|J1
11531|ANTIPSYCHOTICS|N5A
11528|CARDIOVASCULAR SYSTEM|C
11525|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11524|ANTI-EPILEPTICS|N3A
11520|ANTIPSYCHOTICS|N5A
11518|HEPARINS |B1B
11517|PARASITOLOGY|P
11514|VACCINES|J7
11510|CARDIOVASCULAR SYSTEM|C
11510|SYSTEMIC ANTIBACTERIALS|J1
11510|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11510|ANTIVIRALS FOR SYSTEMIC USE|J5
11507|IMMUNOSTIMULATING AGENTS|L3
11502|ALKYLATING AGENTS|L1A
11492|ANTIHYPERTENSIVES|C2
11491|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
11491|CARDIOVASCULAR SYSTEM|C
11491|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11491|ANDROGENS, EXCLUDING G3E, G3F|G3B
11490|ANALGESICS|N2
11489|ANTIHYPERTENSIVES|C2
11487|ANALGESICS|N2
11485|ANTIVIRALS FOR SYSTEMIC USE|J5
11484|Protease inhibitors|J5C2
11483|ANTIVIRALS FOR SYSTEMIC USE|J5
11482|SYSTEMIC ANTIBACTERIALS|J1
11479|ANTIVIRALS FOR SYSTEMIC USE|J5
11478|ANTIPSYCHOTICS|N5A
11477|ANTIPSYCHOTICS|N5A
11476|ANTIPSYCHOTICS|N5A
11472|ANTIPSYCHOTICS|N5A
11471|ANTIPSYCHOTICS|N5A
11470|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11468|ANTI-EPILEPTICS|N3A
11468|TRANQUILLISERS|N5C
11465|SYSTEMIC ANTIBACTERIALS|J1
11465|ALKYLATING AGENTS|L1A
11463|DIRECT THROMBIN INHIBITORS|B1E
11461|ALKYLATING AGENTS|L1A
11460|ANTIHYPERTENSIVES|C2
11456|IMMUNOSUPPRESSIVE AGENTS|L4
11452|ANTIVIRALS FOR SYSTEMIC USE|J5
11444|DIRECT THROMBIN INHIBITORS|B1E
11443|DIRECT THROMBIN INHIBITORS|B1E
11440|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11438|PLATELET AGGREGATION INHIBITORS|B1C
11438|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
11438|Fibrinogen|B2D5
11437|IMMUNOSUPPRESSIVE AGENTS|L4
11436|PLATELET AGGREGATION INHIBITORS|B1C
11436|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
11434|ALKYLATING AGENTS|L1A
11427|ANALGESICS|N2
11426|IMMUNOSUPPRESSIVE AGENTS|L4
11425|DIAGNOSTIC AGENTS|T
11424|MUSCULO-SKELETAL SYSTEM|M
11423|HYPNOTICS/SEDATIVES|N5B
11404|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
11403|TRANQUILLISERS|N5C
11403|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11402|CENTRAL NERVOUS SYSTEM|N
11402|ANTI-EPILEPTICS|N3A
11402|ANTIPSYCHOTICS|N5A
11401|ANTI-EPILEPTICS|N3
11400|ANALGESICS|N2
11399|CARDIOVASCULAR SYSTEM|C
11396|IMMUNOSTIMULATING AGENTS|L3
11393|ANTIVIRALS FOR SYSTEMIC USE|J5
11392|IMMUNOSUPPRESSIVE AGENTS|L4
11389|ANTIHYPERTENSIVES|C2
11386|IMMUNOSUPPRESSIVE AGENTS|L4
11385|DERMATOLOGICALS|D
11385|IMMUNOSUPPRESSIVE AGENTS|L4
11384|VACCINES|J7
11381|Antigonadotrophin-releasing hormones|H1C3
11380|CARDIOVASCULAR SYSTEM|C
11380|ANTI-ARRHYTHMICS|C1B
11380|CALCIUM ANTAGONISTS|C8
11376|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11375|SYSTEMIC ANTIBACTERIALS|J1
11373|ANTIVIRALS FOR SYSTEMIC USE|J5
11372|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
11372|Statins (HMG-CoA reductase inhibitors)|C10A1
11370|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11369|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11368|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11367|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11366|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11364|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11362|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11361|SYSTEMIC ANTIBACTERIALS|J1
11360|SYSTEMIC ANTIBACTERIALS|J1
11360|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11359|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
11358|ANTI-EPILEPTICS|N3
11358|ANTI-EPILEPTICS|N3A
11347|Urinary incontinence products|G4B4
11346|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11345|ANTIULCERANTS|A2B
11344|SYSTEMIC ANTIBACTERIALS|J1
11343|IMMUNOSTIMULATING AGENTS|L3
11342|PLATELET AGGREGATION INHIBITORS|B1C
11342|CARDIOVASCULAR SYSTEM|C
11341|CARDIOVASCULAR SYSTEM|C
11321|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
11319|IMMUNOSUPPRESSIVE AGENTS|L4
11302|ANTIVIRALS FOR SYSTEMIC USE|J5
11301|ANALGESICS|N2
11291|ANTIVIRALS FOR SYSTEMIC USE|J5
11291|PARASITOLOGY|P
11290|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11287|DRUGS USED IN DIABETES|A10
11282|IMMUNOSUPPRESSIVE AGENTS|L4
11278|IMMUNOSUPPRESSIVE AGENTS|L4
11271|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11269|ANAESTHETICS, LOCAL|N1B
11267|NOOTROPICS|N6D
11266|Miotics and antiglaucoma preparations, topical|S1E2
11263|BETA-BLOCKING AGENTS|C7
11263|Miotics and antiglaucoma preparations, topical|S1E2
11260|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11259|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11256|ANTIVIRALS FOR SYSTEMIC USE|J5
11255|ANTIVIRALS FOR SYSTEMIC USE|J5
11254|LUNG SURFACTANTS|R7C
11251|PARASITOLOGY|P
11248|SYSTEMIC ANTIBACTERIALS|J1
11246|DIAGNOSTIC AGENTS|T
11244|ANALGESICS|N2
11244|ANTI-MIGRAINE PREPARATIONS|N2C
11243|PLATELET AGGREGATION INHIBITORS|B1C
11242|ANTIVIRALS FOR SYSTEMIC USE|J5
11237|ANDROGENS, EXCLUDING G3E, G3F|G3B
11236|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
11233|SYSTEMIC ANTIBACTERIALS|J1
11232|SYSTEMIC ANTIBACTERIALS|J1
11232|AMINOGLYCOSIDES|J1K
11229|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11223|IMMUNOSUPPRESSIVE AGENTS|L4
11222|ANTIHYPERTENSIVES|C2
11219|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
11214|IMMUNOSTIMULATING AGENTS|L3
11213|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11212|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
11212|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
11203|HEPARINS |B1B
11201|ANTIPSYCHOTICS|N5A
11198|ANTIPSYCHOTICS|N5A
11197|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
11195|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
11195|TRANQUILLISERS|N5C
11193|ANTI-EPILEPTICS|N3
11192|ANTI-EPILEPTICS|N3
11191|IMMUNOSUPPRESSIVE AGENTS|L4
11190|ANTIVIRALS FOR SYSTEMIC USE|J5
11189|ANTIHYPERTENSIVES|C2
11189|DIURETICS|C3
11188|DERMATOLOGICALS|D
11186|ANTIMETABOLITES|L1B
11183|ANTI-ACNE PREPARATIONS|D10
11182|PARASITOLOGY|P
11179|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11178|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11174|ANTIVIRALS FOR SYSTEMIC USE|J5
11172|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
11171|ANTI-ACNE PREPARATIONS|D10
11170|IMMUNOSUPPRESSIVE AGENTS|L4
11169|Vitamin D|A11C2
11169|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
11169|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11161|ANTIVIRALS FOR SYSTEMIC USE|J5
11160|ANTIVIRALS FOR SYSTEMIC USE|J5
11158|CARDIOVASCULAR SYSTEM|C
11158|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11158|IMMUNOSUPPRESSIVE AGENTS|L4
11156|GROWTH HORMONES|H4C
11149|ALKYLATING AGENTS|L1A
11141|IMMUNOSUPPRESSIVE AGENTS|L4
11140|Protease inhibitors|J5C2
11139|RADIODIAGNOSTIC AGENTS|T1G
11138|VACCINES|J7
11136|ANTI-EPILEPTICS|N3A
11134|ANTI-MIGRAINE PREPARATIONS|N2C
11134|TRANQUILLISERS|N5C
11134|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
11131|CENTRAL NERVOUS SYSTEM|N
11130|RADIODIAGNOSTIC AGENTS|T1G
11129|ALKYLATING AGENTS|L1A
11116|ANTIMETABOLITES|L1B
11115|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11115|SYSTEMIC ANTIBACTERIALS|J1
11115|ANTIVIRALS FOR SYSTEMIC USE|J5
11114|DIAGNOSTIC AGENTS|T
11111|ANALGESICS|N2
11106|NOOTROPICS|N6D
11105|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
11104|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
11102|ANTIVIRALS FOR SYSTEMIC USE|J5
11101|Coxibs|M1A3
11101|ANALGESICS|N2
11100|GASTROPROKINETICS|A3F
11100|ANTI-ARRHYTHMICS|C1B
11099|ANTIHYPERTENSIVES|C2
11099|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
11098|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11098|VACCINES|J7
11095|ANTIHYPERTENSIVES|C2
11092|BPH (benign prostatic hypertrophy) products |G4C
11091|ANTIVIRALS FOR SYSTEMIC USE|J5
11090|ANTIVIRALS FOR SYSTEMIC USE|J5
11089|SYSTEMIC ANTIBACTERIALS|J1
11089|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11089|ANTIVIRALS FOR SYSTEMIC USE|J5
11089|PARASITOLOGY|P
11088|SYSTEMIC ANTIBACTERIALS|J1
11087|SYSTEMIC ANTIBACTERIALS|J1
11086|SYSTEMIC ANTIBACTERIALS|J1
11083|SYSTEMIC ANTIBACTERIALS|J1
11081|CARDIOVASCULAR SYSTEM|C
11081|ANTI-ARRHYTHMICS|C1B
11081|ANTIHYPERTENSIVES|C2
11081|CALCIUM ANTAGONISTS|C8
11075|ANTIVIRALS FOR SYSTEMIC USE|J5
11075|Protease inhibitors|J5C2
11073|MACROLIDES AND SIMILAR TYPES|J1F
11072|MACROLIDES AND SIMILAR TYPES|J1F
11070|SYSTEMIC ANTIBACTERIALS|J1
11070|Carbapenems|J1P2
11069|ANTIVIRALS FOR SYSTEMIC USE|J5
11068|SYSTEMIC ANTIBACTERIALS|J1
11067|ANTIVIRALS FOR SYSTEMIC USE|J5
11062|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
11059|ANALGESICS|N2
11059|ANTI-MIGRAINE PREPARATIONS|N2C
11059|ANTI-EPILEPTICS|N3
11057|ANALGESICS|N2
11057|ANTI-MIGRAINE PREPARATIONS|N2C
11057|ANTI-EPILEPTICS|N3
11055|Monobactams|J1P1
11054|Monobactams|J1P1
11053|SYSTEMIC ANTIBACTERIALS|J1
11052|Carbapenems|J1P2
11047|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11046|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11042|MACROLIDES AND SIMILAR TYPES|J1F
11041|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11041|PARASITOLOGY|P
11039|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11036|SYSTEMIC ANTIBACTERIALS|J1
11031|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11030|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11029|SYSTEMIC ANTIBACTERIALS|J1
11028|SYSTEMIC ANTIBACTERIALS|J1
11027|Systemic dermatological antifungals|D1A2
11027|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
11026|CEPHALOSPORINS|J1D
11022|CEPHALOSPORINS|J1D
11021|SYSTEMIC ANTIBACTERIALS|J1
11020|CENTRAL NERVOUS SYSTEM|N
11020|MRI AGENTS|T1E
11016|CEPHALOSPORINS|J1D
11015|SYSTEMIC ANTIBACTERIALS|J1
11015|CEPHALOSPORINS|J1D
11014|CEPHALOSPORINS|J1D
11011|ANTI-EPILEPTICS|N3
11009|CENTRAL NERVOUS SYSTEM|N
11008|SYSTEMIC ANTIBACTERIALS|J1
11008|ANTIVIRALS FOR SYSTEMIC USE|J5
11008|LUNG SURFACTANTS|R7C
11007|SYSTEMIC ANTIBACTERIALS|J1
11007|LUNG SURFACTANTS|R7C
11006|ANTIPSYCHOTICS|N5A
11006|TRANQUILLISERS|N5C
11004|CEPHALOSPORINS|J1D
11001|PARASITOLOGY|P
11000|SYSTEMIC ANTIBACTERIALS|J1
10999|SYSTEMIC ANTIBACTERIALS|J1
10997|SYSTEMIC ANTIBACTERIALS|J1
10996|ANTIPSYCHOTICS|N5A
10995|B2-STIMULANTS|R3A
10994|SYSTEMIC ANTIBACTERIALS|J1
10992|TRANQUILLISERS|N5C
10992|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10990|ANTI-MIGRAINE PREPARATIONS|N2C
10990|TRANQUILLISERS|N5C
10990|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10989|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10988|CARDIOVASCULAR SYSTEM|C
10988|ANTIHYPERTENSIVES|C2
10987|ANTIPSYCHOTICS|N5A
10986|ANTI-MIGRAINE PREPARATIONS|N2C
10986|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10984|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10983|CARDIOVASCULAR SYSTEM|C
10982|PLATELET AGGREGATION INHIBITORS|B1C
10982|ANTIHYPERTENSIVES|C2
10978|ANTIEMETICS AND ANTINAUSEANTS|A4
10978|ANALGESICS|N2
10978|ANTI-MIGRAINE PREPARATIONS|N2C
10975|Erectile dysfunction products|G4B3
10972|SYSTEMIC ANTIBACTERIALS|J1
10971|SYSTEMIC ANTIBACTERIALS|J1
10971|PARASITOLOGY|P
10964|ANAESTHETICS, GENERAL|N1A
10963|PLATELET AGGREGATION INHIBITORS|B1C
10963|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
10962|IMMUNOSUPPRESSIVE AGENTS|L4
10960|Urinary incontinence products|G4B4
10959|BPH (benign prostatic hypertrophy) products |G4C
10958|ANALGESICS|N2
10958|ANTI-MIGRAINE PREPARATIONS|N2C
10955|PLATELET AGGREGATION INHIBITORS|B1C
10954|Coxibs|M1A3
10948|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
10947|ANTIHYPERTENSIVES|C2
10946|Urinary incontinence products|G4B4
10944|CARDIOVASCULAR SYSTEM|C
10944|ANTIHYPERTENSIVES|C2
10941|VACCINES|J7
10937|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10937|IMMUNOSUPPRESSIVE AGENTS|L4
10934|ANTI-GOUT PREPARATIONS|M4
10930|ANTIULCERANTS|A2B
10927|CARDIAC THERAPY|C1
10927|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10926|CEPHALOSPORINS|J1D
10924|IMMUNOSUPPRESSIVE AGENTS|L4
10922|Urinary incontinence products|G4B4
10921|ANTIHYPERTENSIVES|C2
10919|ANTIHYPERTENSIVES|C2
10919|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
10918|PLATELET AGGREGATION INHIBITORS|B1C
10917|IMMUNOSUPPRESSIVE AGENTS|L4
10916|PLATELET AGGREGATION INHIBITORS|B1C
10914|ANTIHYPERTENSIVES|C2
10912|TRANQUILLISERS|N5C
10911|ANTIHYPERTENSIVES|C2
10909|ANTIHYPERTENSIVES|C2
10908|CARDIOVASCULAR SYSTEM|C
10908|TRANQUILLISERS|N5C
10907|ANALGESICS|N2
10904|TRANQUILLISERS|N5C
10903|TRANQUILLISERS|N5C
10898|ANTI-EPILEPTICS|N3
10894|Bile stone therapy|A5A2
10894|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10893|CALCIUM ANTAGONISTS|C8
10893|ANALGESICS|N2
10892|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10892|IMMUNOSUPPRESSIVE AGENTS|L4
10890|ANTI-ACNE PREPARATIONS|D10
10890|SYSTEMIC ANTIBACTERIALS|J1
10887|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
10885|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
10883|ANTIVIRALS FOR SYSTEMIC USE|J5
10879|ANTI-EPILEPTICS|N3
10878|CENTRAL NERVOUS SYSTEM|N
10874|DERMATOLOGICALS|D
10874|SYSTEMIC ANTIBACTERIALS|J1
10874|LUNG SURFACTANTS|R7C
10873|ANALGESICS|N2
10873|ANTI-MIGRAINE PREPARATIONS|N2C
10872|ANALGESICS|N2
10872|TRANQUILLISERS|N5C
10865|IMMUNOSUPPRESSIVE AGENTS|L4
10863|ANTIPSYCHOTICS|N5A
10862|ANTIPSYCHOTICS|N5A
10861|ANTIPSYCHOTICS|N5A
10856|ANTIVIRALS FOR SYSTEMIC USE|J5
10855|Coxibs|M1A3
10855|ANALGESICS|N2
10853|MRI AGENTS|T1E
10852|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10851|ANALGESICS|N2
10850|ANTI-ARRHYTHMICS|C1B
10849|ANALGESICS|N2
10849|ANTIPSYCHOTICS|N5A
10849|TRANQUILLISERS|N5C
10849|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10849|NOOTROPICS|N6D
10847|DIRECT THROMBIN INHIBITORS|B1E
10847|ANTIHYPERTENSIVES|C2
10847|Protease inhibitors|J5C2
10845|ANTIVIRALS FOR SYSTEMIC USE|J5
10840|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10834|IMMUNOSUPPRESSIVE AGENTS|L4
10833|ANALGESICS|N2
10833|ANTI-MIGRAINE PREPARATIONS|N2C
10829|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10827|GROWTH HORMONES|H4C
10825|ANTIVIRALS FOR SYSTEMIC USE|J5
10822|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10821|IMMUNOSUPPRESSIVE AGENTS|L4
10820|DIAGNOSTIC AGENTS|T
10819|TRANQUILLISERS|N5C
10817|ANALGESICS|N2
10816|ANTI-EPILEPTICS|N3
10816|PARASITOLOGY|P
10814|CARDIOVASCULAR SYSTEM|C
10814|ANTIHYPERTENSIVES|C2
10814|ACE INHIBITORS, PLAIN|C9A
10813|CARDIOVASCULAR SYSTEM|C
10813|ANTIHYPERTENSIVES|C2
10813|ACE INHIBITORS, PLAIN|C9A
10812|ANTIHYPERTENSIVES|C2
10812|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
10808|ANTIHYPERTENSIVES|C2
10804|ANALGESICS|N2
10803|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
10802|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
10800|CARDIOVASCULAR SYSTEM|C
10800|ANTIHYPERTENSIVES|C2
10799|BETA-BLOCKING AGENTS|C7
10799|ANTI-MIGRAINE PREPARATIONS|N2C
10798|CARDIOVASCULAR SYSTEM|C
10797|ANTIHYPERTENSIVES|C2
10796|ANTIHYPERTENSIVES|C2
10791|MRI AGENTS|T1E
10777|ANALGESICS|N2
10776|SYSTEMIC ANTIBACTERIALS|J1
10776|AMINOGLYCOSIDES|J1K
10772|CARDIOVASCULAR SYSTEM|C
10772|ULTRASOUND AGENTS|T1F
10771|ANALGESICS|N2
10770|PLATELET AGGREGATION INHIBITORS|B1C
10770|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
10770|Fibrinogen|B2D5
10768|ANALGESICS|N2
10768|ANTI-MIGRAINE PREPARATIONS|N2C
10768|ANTI-EPILEPTICS|N3A
10768|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10765|ANALGESICS|N2
10765|ANTI-EPILEPTICS|N3
10762|ANTIULCERANTS|A2B
10761|VACCINES|J7
10760|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10760|IMMUNOSUPPRESSIVE AGENTS|L4
10756|ANTIVIRALS FOR SYSTEMIC USE|J5
10749|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10748|DIRECT THROMBIN INHIBITORS|B1E
10742|ANTIEMETICS AND ANTINAUSEANTS|A4
10742|ANALGESICS|N2
10741|ANTI-ACNE PREPARATIONS|D10
10738|IMMUNOSUPPRESSIVE AGENTS|L4
10736|IMMUNOSUPPRESSIVE AGENTS|L4
10734|DRUGS USED IN DIABETES|A10
10734|ANTIVIRALS FOR SYSTEMIC USE|J5
10734|ANALGESICS|N2
10734|ANTI-MIGRAINE PREPARATIONS|N2C
10733|ANTIEMETICS AND ANTINAUSEANTS|A4
10733|TRANQUILLISERS|N5C
10731|ANTI-EPILEPTICS|N3
10730|CENTRAL NERVOUS SYSTEM|N
10730|ANTI-EPILEPTICS|N3
10729|SYSTEMIC ANTIBACTERIALS|J1
10729|ANTIVIRALS FOR SYSTEMIC USE|J5
10728|ANTIVIRALS FOR SYSTEMIC USE|J5
10726|ANDROGENS, EXCLUDING G3E, G3F|G3B
10725|Coxibs|M1A3
10725|ANALGESICS|N2
10724|DRUGS USED IN DIABETES|A10
10724|ANTIHYPERTENSIVES|C2
10721|SYSTEMIC ANTIBACTERIALS|J1
10720|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10720|PARASITOLOGY|P
10719|OPHTHALMOLOGICALS|S1
10711|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
10708|ANTI-EPILEPTICS|N3A
10708|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10707|ANTIVIRALS FOR SYSTEMIC USE|J5
10707|IMMUNOSTIMULATING AGENTS|L3
10706|OPHTHALMOLOGICALS|S1
10705|ANTIVIRALS FOR SYSTEMIC USE|J5
10704|ANTI-EPILEPTICS|N3A
10704|TRANQUILLISERS|N5C
10704|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10704|NOOTROPICS|N6D
10703|TRANQUILLISERS|N5C
10703|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10701|SYSTEMIC ANTIBACTERIALS|J1
10700|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10700|IMMUNOSUPPRESSIVE AGENTS|L4
10698|ANTIPSYCHOTICS|N5A
10698|SSRI antidepressants|N6A4
10689|ANTIPSYCHOTICS|N5A
10689|HYPNOTICS/SEDATIVES|N5B
10688|ANTIVIRALS FOR SYSTEMIC USE|J5
10687|ANTIPSYCHOTICS|N5A
10686|SYSTEMIC ANTIBACTERIALS|J1
10685|ANTIVIRALS FOR SYSTEMIC USE|J5
10684|SYSTEMIC ANTIBACTERIALS|J1
10676|SYSTEMIC ANTIBACTERIALS|J1
10675|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10673|CEPHALOSPORINS|J1D
10672|ANTIPSYCHOTICS|N5A
10670|HYPNOTICS/SEDATIVES|N5B
10669|ANTIVIRALS FOR SYSTEMIC USE|J5
10668|ANTI-ARRHYTHMICS|C1B
10668|THYROID PREPARATIONS|H3A
10663|ANTIVIRALS FOR SYSTEMIC USE|J5
10660|ANTIVIRALS FOR SYSTEMIC USE|J5
10658|ANTIVIRALS FOR SYSTEMIC USE|J5
10655|ANTIVIRALS FOR SYSTEMIC USE|J5
10651|CARDIOVASCULAR SYSTEM|C
10649|DIRECT THROMBIN INHIBITORS|B1E
10648|ANTIVIRALS FOR SYSTEMIC USE|J5
10644|PLATELET AGGREGATION INHIBITORS|B1C
10644|CARDIOVASCULAR SYSTEM|C
10643|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
10640|SYSTEMIC ANTIBACTERIALS|J1
10638|IMMUNOSUPPRESSIVE AGENTS|L4
10635|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
10633|CARDIOVASCULAR SYSTEM|C
10630|ANTIVIRALS FOR SYSTEMIC USE|J5
10629|ANTIVIRALS FOR SYSTEMIC USE|J5
10627|TRANQUILLISERS|N5C
10626|ANTIEMETICS AND ANTINAUSEANTS|A4
10626|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10625|ANTI-ARRHYTHMICS|C1B
10621|ANTIVIRALS FOR SYSTEMIC USE|J5
10620|ANTIHYPERTENSIVES|C2
10620|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
10619|ANTIHYPERTENSIVES|C2
10616|ANTIVIRALS FOR SYSTEMIC USE|J5
10615|ANTI-EPILEPTICS|N3
10615|TRANQUILLISERS|N5C
10613|ANTIVIRALS FOR SYSTEMIC USE|J5
10610|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
10608|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
10608|ANTIHYPERTENSIVES|C2
10605|ANTIVIRALS FOR SYSTEMIC USE|J5
10605|INTERFERONS|L3B
10598|CARDIOVASCULAR SYSTEM|C
10598|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
10597|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10597|ANTI-ACNE PREPARATIONS|D10
10595|ANTI-ACNE PREPARATIONS|D10
10595|TOPICAL ANTI-ACNE PREPARATIONS|D10A
10591|ANTIVIRALS FOR SYSTEMIC USE|J5
10589|TRANQUILLISERS|N5C
10587|CARDIOVASCULAR SYSTEM|C
10580|ANTI-EPILEPTICS|N3A
10578|CARDIOVASCULAR SYSTEM|C
10577|ANTIVIRALS FOR SYSTEMIC USE|J5
10574|ANTIMETABOLITES|L1B
10573|CARDIOVASCULAR SYSTEM|C
10573|ANTIHYPERTENSIVES|C2
10572|ANTIHYPERTENSIVES|C2
10571|CARDIOVASCULAR SYSTEM|C
10569|DRUGS USED IN DIABETES|A10
10568|ANDROGENS, EXCLUDING G3E, G3F|G3B
10567|CARDIOVASCULAR SYSTEM|C
10566|CARDIOVASCULAR SYSTEM|C
10563|ANTI-ACNE PREPARATIONS|D10
10558|ANTI-ACNE PREPARATIONS|D10
10557|ANTIVIRALS FOR SYSTEMIC USE|J5
10556|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10555|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10553|ANTIHYPERTENSIVES|C2
10547|B2-STIMULANTS|R3A
10546|HUMAN INSULINS AND ANALOGUES|A10C
10546|Human insulins and analogues, intermediate-acting|A10C2
10544|Erectile dysfunction products|G4B3
10543|ANALGESICS|N2
10539|ANTIEMETICS AND ANTINAUSEANTS|A4
10539|CENTRAL NERVOUS SYSTEM|N
10538|ULTRASOUND AGENTS|T1F
10536|MRI AGENTS|T1E
10535|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10534|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
10534|IMMUNOSUPPRESSIVE AGENTS|L4
10531|VACCINES|J7
10529|CARDIOVASCULAR SYSTEM|C
10526|CARDIOVASCULAR SYSTEM|C
10524|ANTI-MIGRAINE PREPARATIONS|N2C
10518|ANTI-EPILEPTICS|N3
10518|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10516|ANALGESICS|N2
10513|DIRECT THROMBIN INHIBITORS|B1E
10511|PLATELET AGGREGATION INHIBITORS|B1C
10511|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
10510|CENTRAL NERVOUS SYSTEM|N
10510|NOOTROPICS|N6D
10510|Ocular antineovascularisation products|S1P
10508|PLATELET AGGREGATION INHIBITORS|B1C
10508|CARDIOVASCULAR SYSTEM|C
10504|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10504|NOOTROPICS|N6D
10499|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10498|PLATELET AGGREGATION INHIBITORS|B1C
10498|CARDIOVASCULAR SYSTEM|C
10497|CARDIAC THERAPY|C1
10496|ANTIHYPERTENSIVES|C2
10495|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10495|SYSTEMIC ANTIBACTERIALS|J1
10495|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10495|PARASITOLOGY|P
10494|ANTIVIRALS FOR SYSTEMIC USE|J5
10493|PARASITOLOGY|P
10490|Coxibs|M1A3
10490|ANALGESICS|N2
10489|PLATELET AGGREGATION INHIBITORS|B1C
10489|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
10489|Fibrinogen|B2D5
10487|ANTI-ARRHYTHMICS|C1B
10485|PLATELET AGGREGATION INHIBITORS|B1C
10484|FIBRINOLYTICS|B1D
10480|ALKYLATING AGENTS|L1A
10479|PLATELET AGGREGATION INHIBITORS|B1C
10479|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
10478|PLATELET AGGREGATION INHIBITORS|B1C
10477|DIRECT THROMBIN INHIBITORS|B1E
10476|DIRECT THROMBIN INHIBITORS|B1E
10475|DIRECT THROMBIN INHIBITORS|B1E
10474|DIRECT THROMBIN INHIBITORS|B1E
10471|ANTIHYPERTENSIVES|C2
10468|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10465|ANTI-EPILEPTICS|N3
10463|ANTIHYPERTENSIVES|C2
10463|CALCIUM ANTAGONISTS|C8
10461|TRANQUILLISERS|N5C
10461|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10460|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10457|TRANQUILLISERS|N5C
10456|ANTI-EPILEPTICS|N3A
10454|ANTI-GOUT PREPARATIONS|M4
10449|IMMUNOSUPPRESSIVE AGENTS|L4
10448|ANTIVIRALS FOR SYSTEMIC USE|J5
10446|ANALGESICS|N2
10446|ANTI-EPILEPTICS|N3
10446|TRANQUILLISERS|N5C
10444|PLATELET AGGREGATION INHIBITORS|B1C
10442|ANTIHYPERTENSIVES|C2
10442|ACE INHIBITORS, PLAIN|C9A
10441|RESPIRATORY SYSTEM|R
10441|ANTITUSSIVES|R5D
10440|ANTI-EPILEPTICS|N3
10440|ANTI-EPILEPTICS|N3A
10436|ANALGESICS|N2
10436|ANTI-EPILEPTICS|N3
10435|CENTRAL NERVOUS SYSTEM|N
10434|ANTI-ARRHYTHMICS|C1B
10433|CARDIAC THERAPY|C1
10433|ANTIHYPERTENSIVES|C2
10430|CARDIAC THERAPY|C1
10430|ANTIHYPERTENSIVES|C2
10427|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10427|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
10426|ANALGESICS|N2
10423|CARDIAC THERAPY|C1
10421|ANTI-ARRHYTHMICS|C1B
10418|VACCINES|J7
10416|ANALGESICS|N2
10415|GASTROPROKINETICS|A3F
10415|ANALGESICS|N2
10413|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
10412|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
10412|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
10411|HUMAN INSULINS AND ANALOGUES|A10C
10411|Human insulins and analogues, fast-acting|A10C1
10407|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10406|SYSTEMIC ANTIBACTERIALS|J1
10405|ANTIVIRALS FOR SYSTEMIC USE|J5
10405|IMMUNOSTIMULATING AGENTS|L3
10398|ANTIHYPERTENSIVES|C2
10398|ACE INHIBITORS, PLAIN|C9A
10396|ANTIHYPERTENSIVES|C2
10396|ACE INHIBITORS, PLAIN|C9A
10395|IMMUNOSUPPRESSIVE AGENTS|L4
10392|SYSTEMIC ANTIBACTERIALS|J1
10391|ANTI-EPILEPTICS|N3A
10391|NOOTROPICS|N6D
10389|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10386|IMMUNOSTIMULATING AGENTS|L3
10385|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
10375|SYSTEMIC ANTIBACTERIALS|J1
10374|SYSTEMIC ANTIBACTERIALS|J1
10374|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10373|CARDIOVASCULAR SYSTEM|C
10373|IMMUNOSTIMULATING AGENTS|L3
10372|ANTIVIRALS FOR SYSTEMIC USE|J5
10368|PARASITOLOGY|P
10360|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10359|Factor VIII|B2D1
10354|NOOTROPICS|N6D
10353|ANALGESICS|N2
10351|Systemic dermatological antifungals|D1A2
10351|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10347|ANALGESICS|N2
10345|ANTIHYPERTENSIVES|C2
10345|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
10344|IMMUNOSUPPRESSIVE AGENTS|L4
10343|IMMUNOSUPPRESSIVE AGENTS|L4
10342|IMMUNOSUPPRESSIVE AGENTS|L4
10341|CARDIAC THERAPY|C1
10341|ULTRASOUND AGENTS|T1F
10337|DIRECT THROMBIN INHIBITORS|B1E
10333|ANTIVIRALS FOR SYSTEMIC USE|J5
10333|Protease inhibitors|J5C2
10328|ANTIMETABOLITES|L1B
10325|PARASITOLOGY|P
10320|ANTIVIRALS FOR SYSTEMIC USE|J5
10318|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10317|IMMUNOSTIMULATING AGENTS|L3
10316|Non-nucleoside reverse transcriptase inhibitors|J5C3
10315|IMMUNOSTIMULATING AGENTS|L3
10312|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
10306|BPH (benign prostatic hypertrophy) products |G4C
10305|HYPNOTICS/SEDATIVES|N5B
10305|TRANQUILLISERS|N5C
10302|ANTI-ARRHYTHMICS|C1B
10302|ANTIHYPERTENSIVES|C2
10302|BPH (benign prostatic hypertrophy) products |G4C
10298|ANALGESICS|N2
10297|CARDIOVASCULAR SYSTEM|C
10296|CARDIOVASCULAR SYSTEM|C
10296|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10290|ANTI-EPILEPTICS|N3
10289|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
10287|Protease inhibitors|J5C2
10282|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
10281|ANALGESICS|N2
10280|SYSTEMIC ANTIBACTERIALS|J1
10276|ANTIVIRALS FOR SYSTEMIC USE|J5
10276|INTERFERONS|L3B
10272|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10270|IMMUNOSUPPRESSIVE AGENTS|L4
10269|Coxibs|M1A3
10267|MACROLIDES AND SIMILAR TYPES|J1F
10263|WOUND HEALING AGENTS|D3
10259|ANTIVIRALS FOR SYSTEMIC USE|J5
10258|CEPHALOSPORINS|J1D
10256|ANTIVIRALS FOR SYSTEMIC USE|J5
10255|ANTI-ACNE PREPARATIONS|D10
10254|ANTIVIRALS FOR SYSTEMIC USE|J5
10252|DRUGS USED IN DIABETES|A10
10252|HUMAN INSULINS AND ANALOGUES|A10C
10252|Human insulins and analogues, long-acting|A10C5
10251|ANTIVIRALS FOR SYSTEMIC USE|J5
10250|DERMATOLOGICALS|D
10248|ANTIULCERANTS|A2B
10247|PLATELET AGGREGATION INHIBITORS|B1C
10247|Fibrinogen|B2D5
10245|ANTIHYPERTENSIVES|C2
10240|NOOTROPICS|N6D
10239|NOOTROPICS|N6D
10230|Protease inhibitors|J5C2
10229|CEPHALOSPORINS|J1D
10211|AMINOGLYCOSIDES|J1K
10206|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10203|ANTIHYPERTENSIVES|C2
10203|CALCIUM ANTAGONISTS|C8
10202|CARDIOVASCULAR SYSTEM|C
10202|ANTIHYPERTENSIVES|C2
10202|DIURETICS|C3
10202|ACE INHIBITORS, PLAIN|C9A
10199|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
10199|ANTI-EPILEPTICS|N3A
10192|NOOTROPICS|N6D
10191|IMMUNOSTIMULATING AGENTS|L3
10191|NOOTROPICS|N6D
10188|IMMUNOSUPPRESSIVE AGENTS|L4
10187|DERMATOLOGICALS|D
10186|CARDIOVASCULAR SYSTEM|C
10186|ANTIHYPERTENSIVES|C2
10186|Erectile dysfunction products|G4B3
10185|DRUGS USED IN DIABETES|A10
10182|TRANQUILLISERS|N5C
10182|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10180|ANTIVIRALS FOR SYSTEMIC USE|J5
10174|Coxibs|M1A3
10172|ANTIVIRALS FOR SYSTEMIC USE|J5
10172|Non-nucleoside reverse transcriptase inhibitors|J5C3
10166|ANTI-ACNE PREPARATIONS|D10
10166|BPH (benign prostatic hypertrophy) products |G4C
10165|Protease inhibitors|J5C2
10164|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10164|SSRI antidepressants|N6A4
10162|ANTIVIRALS FOR SYSTEMIC USE|J5
10154|IMMUNOSUPPRESSIVE AGENTS|L4
10151|ANTIVIRALS FOR SYSTEMIC USE|J5
10146|WOUND HEALING AGENTS|D3
10144|ANTI-GOUT PREPARATIONS|M4
10142|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
10122|ANTIVIRALS FOR SYSTEMIC USE|J5
10121|IMMUNOSUPPRESSIVE AGENTS|L4
10120|Erectile dysfunction products|G4B3
10120|BPH (benign prostatic hypertrophy) products |G4C
10118|CARDIOVASCULAR SYSTEM|C
10118|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
10118|ANTI-EPILEPTICS|N3A
10118|ANTIPSYCHOTICS|N5A
10118|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10118|NOOTROPICS|N6D
10115|PLATELET AGGREGATION INHIBITORS|B1C
10115|CARDIOVASCULAR SYSTEM|C
10115|ANTIHYPERTENSIVES|C2
10115|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10113|ANALGESICS|N2
10106|ANTIPSYCHOTICS|N5A
10106|TRANQUILLISERS|N5C
10106|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10102|CARDIOVASCULAR SYSTEM|C
10098|CEPHALOSPORINS|J1D
10097|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10097|IMMUNOSUPPRESSIVE AGENTS|L4
10092|TRANQUILLISERS|N5C
10089|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10084|ANTIMETABOLITES|L1B
10083|ANTI-EPILEPTICS|N3A
10082|ANTIVIRALS FOR SYSTEMIC USE|J5
10081|CARDIOVASCULAR SYSTEM|C
10081|ULTRASOUND AGENTS|T1F
10061|CEPHALOSPORINS|J1D
10060|ANTIVIRALS FOR SYSTEMIC USE|J5
10057|PLATELET AGGREGATION INHIBITORS|B1C
10055|CENTRAL NERVOUS SYSTEM|N
10054|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
10053|CARDIAC THERAPY|C1
10053|ANTIHYPERTENSIVES|C2
10053|ACE INHIBITORS, PLAIN|C9A
10052|CARDIAC THERAPY|C1
10052|ANTIHYPERTENSIVES|C2
10052|ACE INHIBITORS, PLAIN|C9A
10050|ANTIHYPERTENSIVES|C2
10048|ALKYLATING AGENTS|L1A
10045|CARDIOVASCULAR SYSTEM|C
10045|ANTIHYPERTENSIVES|C2
10045|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10042|ANTI-EPILEPTICS|N3
10042|TRANQUILLISERS|N5C
10041|ANTIEMETICS AND ANTINAUSEANTS|A4
10041|ANALGESICS|N2
10041|ANTI-MIGRAINE PREPARATIONS|N2C
10041|HYPNOTICS/SEDATIVES|N5B
10041|TRANQUILLISERS|N5C
10037|ANTIEMETICS AND ANTINAUSEANTS|A4
10037|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
10037|DRUGS USED IN DIABETES|A10
10037|ANALGESICS|N2
10035|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
10030|ANTIHYPERTENSIVES|C2
10029|PLATELET AGGREGATION INHIBITORS|B1C
10029|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
10024|Protease inhibitors|J5C2
10022|ANTI-EPILEPTICS|N3A
10021|TRANQUILLISERS|N5C
10021|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
10017|ANTI-EPILEPTICS|N3A
10016|ANTI-MIGRAINE PREPARATIONS|N2C
10009|IMMUNOSUPPRESSIVE AGENTS|L4
10006|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
10005|PLATELET AGGREGATION INHIBITORS|B1C
10004|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
10004|ANTIVIRALS FOR SYSTEMIC USE|J5
10003|ANTIPSYCHOTICS|N5A
10001|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9993|ANTITUSSIVES|R5D
9992|SYSTEMIC ANTIBACTERIALS|J1
9988|Topical dermatological antifungals|D1A1
9988|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9986|PLATELET AGGREGATION INHIBITORS|B1C
9986|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
9985|ANTIULCERANTS|A2B
9983|GASTROPROKINETICS|A3F
9982|CARDIAC THERAPY|C1
9981|PARASITOLOGY|P
9980|PLATELET AGGREGATION INHIBITORS|B1C
9978|HYPNOTICS/SEDATIVES|N5B
9978|TRANQUILLISERS|N5C
9978|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9977|ANTI-EPILEPTICS|N3A
9975|ANALGESICS|N2
9973|ANALGESICS|N2
9969|ANTI-EPILEPTICS|N3A
9968|ANTI-ARRHYTHMICS|C1B
9965|ANTIULCERANTS|A2B
9963|ANTIVIRALS FOR SYSTEMIC USE|J5
9959|ANTI-ARRHYTHMICS|C1B
9959|ANTIHYPERTENSIVES|C2
9959|CALCIUM ANTAGONISTS|C8
9953|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9953|Statins (HMG-CoA reductase inhibitors)|C10A1
9951|CARDIOVASCULAR SYSTEM|C
9951|CALCIUM ANTAGONISTS|C8
9950|ALKYLATING AGENTS|L1A
9946|TRANQUILLISERS|N5C
9945|ANTIPSYCHOTICS|N5A
9944|CARDIOVASCULAR SYSTEM|C
9944|SYSTEMIC ANTIBACTERIALS|J1
9944|ANTIVIRALS FOR SYSTEMIC USE|J5
9943|TRANQUILLISERS|N5C
9943|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9943|SSRI antidepressants|N6A4
9941|SYSTEMIC ANTIBACTERIALS|J1
9941|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9940|IMMUNOSTIMULATING AGENTS|L3
9938|MUSCULO-SKELETAL SYSTEM|M
9937|ALKYLATING AGENTS|L1A
9935|SYSTEMIC ANTIBACTERIALS|J1
9928|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9928|THYROID THERAPY|H3
9927|PLATELET AGGREGATION INHIBITORS|B1C
9920|CARDIOVASCULAR SYSTEM|C
9916|SYSTEMIC ANTIBACTERIALS|J1
9915|ANALGESICS|N2
9913|NOOTROPICS|N6D
9912|ANTIULCERANTS|A2B
9911|CEPHALOSPORINS|J1D
9909|CARDIAC THERAPY|C1
9906|Miotics and antiglaucoma preparations, topical|S1E2
9901|CARDIOVASCULAR SYSTEM|C
9901|ANTIHYPERTENSIVES|C2
9901|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
9896|ANTIVIRALS FOR SYSTEMIC USE|J5
9896|IMMUNOSTIMULATING AGENTS|L3
9893|CARDIOVASCULAR SYSTEM|C
9893|ANTIHYPERTENSIVES|C2
9890|ANTIVIRALS FOR SYSTEMIC USE|J5
9887|ANTIHYPERTENSIVES|C2
9887|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
9865|ANTIVIRALS FOR SYSTEMIC USE|J5
9864|ULTRASOUND AGENTS|T1F
9863|CARDIAC THERAPY|C1
9863|ULTRASOUND AGENTS|T1F
9862|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
9859|VACCINES|J7
9857|ANALGESICS|N2
9855|ANTIHYPERTENSIVES|C2
9853|SYSTEMIC ANTIBACTERIALS|J1
9853|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9853|ANTIVIRALS FOR SYSTEMIC USE|J5
9849|IMMUNOSUPPRESSIVE AGENTS|L4
9847|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
9847|TRANQUILLISERS|N5C
9847|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9839|ANALGESICS|N2
9838|PLATELET AGGREGATION INHIBITORS|B1C
9838|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
9832|PARASITOLOGY|P
9829|ALKYLATING AGENTS|L1A
9824|CEPHALOSPORINS|J1D
9823|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
9822|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
9816|ANTIVIRALS FOR SYSTEMIC USE|J5
9815|Protease inhibitors|J5C2
9812|Vitamin D|A11C2
9808|ANTIVIRALS FOR SYSTEMIC USE|J5
9802|IMMUNOSUPPRESSIVE AGENTS|L4
9799|ANTI-ACNE PREPARATIONS|D10
9798|RESPIRATORY SYSTEM|R
9798|LUNG SURFACTANTS|R7C
9796|ANTIEMETICS AND ANTINAUSEANTS|A4
9795|ANTI-MIGRAINE PREPARATIONS|N2C
9785|ANTIVIRALS FOR SYSTEMIC USE|J5
9768|ANTI-EPILEPTICS|N3A
9766|ANALGESICS|N2
9765|ANALGESICS|N2
9760|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9758|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9754|ANTIEMETICS AND ANTINAUSEANTS|A4
9753|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9753|PARASITOLOGY|P
9752|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9752|PARASITOLOGY|P
9748|ANTIVIRALS FOR SYSTEMIC USE|J5
9740|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9734|DRUGS USED IN DIABETES|A10
9733|ANTIVIRALS FOR SYSTEMIC USE|J5
9733|Interferons, alpha|L3B1
9732|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9732|IMMUNOSUPPRESSIVE AGENTS|L4
9731|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9726|Factor VIII|B2D1
9721|PLATELET AGGREGATION INHIBITORS|B1C
9712|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9709|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
9704|RADIODIAGNOSTIC AGENTS|T1G
9702|ANTIVIRALS FOR SYSTEMIC USE|J5
9702|Interferons, beta|L3B2
9699|DERMATOLOGICALS|D
9699|SYSTEMIC ANTIBACTERIALS|J1
9698|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
9695|ANTIPSYCHOTICS|N5A
9694|IMMUNOSTIMULATING AGENTS|L3
9693|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9689|TRANQUILLISERS|N5C
9686|ANTIULCERANTS|A2B
9685|ANALGESICS|N2
9684|TRANQUILLISERS|N5C
9682|ANTIHYPERTENSIVES|C2
9682|CALCIUM ANTAGONISTS|C8
9681|ANTIHYPERTENSIVES|C2
9681|BETA-BLOCKING AGENTS|C7
9680|PLATELET AGGREGATION INHIBITORS|B1C
9679|PLATELET AGGREGATION INHIBITORS|B1C
9676|ANTIULCERANTS|A2B
9669|Coxibs|M1A3
9669|ANALGESICS|N2
9668|BETA-BLOCKING AGENTS|C7
9668|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
9663|ANTI-EPILEPTICS|N3
9663|ANTIPSYCHOTICS|N5A
9661|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9661|CENTRAL NERVOUS SYSTEM|N
9658|Antigonadotrophin-releasing hormones|H1C3
9658|VACCINES|J7
9657|Coxibs|M1A3
9655|B2-STIMULANTS|R3A
9654|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9652|ANTIHYPERTENSIVES|C2
9652|CALCIUM ANTAGONISTS|C8
9642|ANTIVIRALS FOR SYSTEMIC USE|J5
9640|ANALGESICS|N2
9638|ANALGESICS|N2
9638|ANTI-MIGRAINE PREPARATIONS|N2C
9636|ANTIMETABOLITES|L1B
9634|DRUGS USED IN DIABETES|A10
9633|ANTIULCERANTS|A2B
9630|SYSTEMIC ANTIBACTERIALS|J1
9627|PLATELET AGGREGATION INHIBITORS|B1C
9627|SYSTEMIC ANTIHISTAMINES|R6
9626|ANTIULCERANTS|A2B
9625|ANTIPSYCHOTICS|N5A
9624|ANALGESICS|N2
9623|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9622|DRUGS USED IN DIABETES|A10
9620|ANTIVIRALS FOR SYSTEMIC USE|J5
9617|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9614|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9614|SYSTEMIC ANTIBACTERIALS|J1
9612|ANTIULCERANTS|A2B
9612|SYSTEMIC ANTIBACTERIALS|J1
9610|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9610|PARASITOLOGY|P
9609|ANTIVIRALS FOR SYSTEMIC USE|J5
9608|SYSTEMIC ANTIBACTERIALS|J1
9608|CEPHALOSPORINS|J1D
9607|ANTI-EPILEPTICS|N3
9606|ANTI-GOUT PREPARATIONS|M4
9605|ANTI-GOUT PREPARATIONS|M4
9603|IMMUNOSTIMULATING AGENTS|L3
9599|DRUGS USED IN DIABETES|A10
9598|ANALGESICS|N2
9598|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
9596|IMMUNOSUPPRESSIVE AGENTS|L4
9595|NOOTROPICS|N6D
9594|ANTIULCERANTS|A2B
9594|NOOTROPICS|N6D
9591|PARASITOLOGY|P
9590|ANTIHYPERTENSIVES|C2
9588|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
9587|ANALGESICS|N2
9586|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9585|SYSTEMIC ANTIBACTERIALS|J1
9584|ANTI-EPILEPTICS|N3A
9579|GASTROPROKINETICS|A3F
9577|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9575|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9574|NOOTROPICS|N6D
9573|PLATELET AGGREGATION INHIBITORS|B1C
9571|PARASITOLOGY|P
9567|VACCINES|J7
9566|NOOTROPICS|N6D
9563|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9561|DERMATOLOGICALS|D
9561|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9561|ANTIVIRALS FOR SYSTEMIC USE|J5
9557|ANTI-MIGRAINE PREPARATIONS|N2C
9556|CALCIUM ANTAGONISTS|C8
9555|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9553|CARDIAC THERAPY|C1
9553|ANTIHYPERTENSIVES|C2
9552|CALCIUM ANTAGONISTS|C8
9551|CALCIUM ANTAGONISTS|C8
9549|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
9545|DERMATOLOGICALS|D
9545|IMMUNOSTIMULATING AGENTS|L3
9544|ANTI-ARRHYTHMICS|C1B
9544|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
9544|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9542|CARDIOVASCULAR SYSTEM|C
9542|DERMATOLOGICALS|D
9542|BPH (benign prostatic hypertrophy) products |G4C
9542|OPHTHALMOLOGICALS|S1
9541|SYSTEMIC ANTIBACTERIALS|J1
9539|SYSTEMIC ANTIBACTERIALS|J1
9539|ANTIVIRALS FOR SYSTEMIC USE|J5
9539|Non-nucleoside reverse transcriptase inhibitors|J5C3
9538|ANTIHYPERTENSIVES|C2
9537|TRANQUILLISERS|N5C
9534|CALCIUM ANTAGONISTS|C8
9533|ANTIPSYCHOTICS|N5A
9532|CALCIUM ANTAGONISTS|C8
9530|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9530|PARASITOLOGY|P
9528|ANTI-ARRHYTHMICS|C1B
9528|CALCIUM ANTAGONISTS|C8
9527|IMMUNOSTIMULATING AGENTS|L3
9526|IMMUNOSTIMULATING AGENTS|L3
9525|ANTIHYPERTENSIVES|C2
9523|ANTIHYPERTENSIVES|C2
9522|NOOTROPICS|N6D
9520|CARDIAC THERAPY|C1
9520|ANTIHYPERTENSIVES|C2
9516|CALCIUM ANTAGONISTS|C8
9516|ANTI-MIGRAINE PREPARATIONS|N2C
9516|ANTI-EPILEPTICS|N3
9515|ANTIEMETICS AND ANTINAUSEANTS|A4
9515|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9510|TRANQUILLISERS|N5C
9510|NOOTROPICS|N6D
9509|NOOTROPICS|N6D
9509|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
9506|NOOTROPICS|N6D
9505|NOOTROPICS|N6D
9503|ANTIHYPERTENSIVES|C2
9502|NOOTROPICS|N6D
9499|NOOTROPICS|N6D
9498|ANTIPSYCHOTICS|N5A
9497|TRANQUILLISERS|N5C
9494|NOOTROPICS|N6D
9493|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9493|IMMUNOSTIMULATING AGENTS|L3
9488|VACCINES|J7
9487|PLATELET AGGREGATION INHIBITORS|B1C
9487|Erectile dysfunction products|G4B3
9486|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9485|IMMUNOSUPPRESSIVE AGENTS|L4
9484|ANTIVIRALS FOR SYSTEMIC USE|J5
9480|ANTI-EPILEPTICS|N3A
9475|BPH (benign prostatic hypertrophy) products |G4C
9475|Antigonadotrophin-releasing hormones|H1C3
9472|ANTIHYPERTENSIVES|C2
9472|CALCIUM ANTAGONISTS|C8
9470|ANTIVIRALS FOR SYSTEMIC USE|J5
9467|Interferons, beta|L3B2
9465|SYSTEMIC ANTIBACTERIALS|J1
9465|PARASITOLOGY|P
9464|IMMUNOSTIMULATING AGENTS|L3
9462|IMMUNOSTIMULATING AGENTS|L3
9461|ANTIHYPERTENSIVES|C2
9461|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
9458|LUNG SURFACTANTS|R7C
9457|PLATELET AGGREGATION INHIBITORS|B1C
9455|DRUGS USED IN DIABETES|A10
9454|SYSTEMIC ANTIBACTERIALS|J1
9451|ANTIULCERANTS|A2B
9449|CALCIUM ANTAGONISTS|C8
9449|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9446|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9445|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9444|ANTIHYPERTENSIVES|C2
9442|Protease inhibitors|J5C2
9441|Protease inhibitors|J5C2
9440|CARDIAC THERAPY|C1
9440|ANTIHYPERTENSIVES|C2
9440|CALCIUM ANTAGONISTS|C8
9439|ANTI-ARRHYTHMICS|C1B
9438|ANTIPSYCHOTICS|N5A
9438|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9438|NOOTROPICS|N6D
9437|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9436|PLATELET AGGREGATION INHIBITORS|B1C
9436|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
9434|CALCIUM ANTAGONISTS|C8
9434|ANALGESICS|N2
9426|ANTIHYPERTENSIVES|C2
9420|ANTIHYPERTENSIVES|C2
9419|ANTIULCERANTS|A2B
9417|PARASITOLOGY|P
9415|ANTI-ARRHYTHMICS|C1B
9414|ANTIHYPERTENSIVES|C2
9414|CALCIUM ANTAGONISTS|C8
9413|ANTIHYPERTENSIVES|C2
9413|CALCIUM ANTAGONISTS|C8
9412|ANTIHYPERTENSIVES|C2
9411|ANTI-ACNE PREPARATIONS|D10
9411|TOPICAL ANTI-ACNE PREPARATIONS|D10A
9409|NOOTROPICS|N6D
9409|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
9408|ANTI-ARRHYTHMICS|C1B
9405|ANTIHYPERTENSIVES|C2
9402|IMMUNOSUPPRESSIVE AGENTS|L4
9400|IMMUNOSUPPRESSIVE AGENTS|L4
9391|CALCIUM ANTAGONISTS|C8
9388|Coxibs|M1A3
9387|ANTIULCERANTS|A2B
9386|CARDIOVASCULAR SYSTEM|C
9383|ANTI-EPILEPTICS|N3A
9382|ANTI-EPILEPTICS|N3A
9381|Urinary incontinence products|G4B4
9381|ANALGESICS|N2
9380|IMMUNOSTIMULATING AGENTS|L3
9376|MRI AGENTS|T1E
9375|ANTIHYPERTENSIVES|C2
9375|DIURETICS|C3
9374|TRANQUILLISERS|N5C
9372|ANTI-ARRHYTHMICS|C1B
9369|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
9365|ANTIVIRALS FOR SYSTEMIC USE|J5
9364|RESPIRATORY SYSTEM|R
9364|SYSTEMIC ANTIHISTAMINES|R6
9363|ANTIHYPERTENSIVES|C2
9360|ANTIHYPERTENSIVES|C2
9358|ANTIVIRALS FOR SYSTEMIC USE|J5
9356|Coxibs|M1A3
9355|NOOTROPICS|N6D
9354|IMMUNOSTIMULATING AGENTS|L3
9351|ANTIHYPERTENSIVES|C2
9349|CENTRAL NERVOUS SYSTEM|N
9349|PARASITOLOGY|P
9347|ANTI-EPILEPTICS|N3A
9346|PARASITOLOGY|P
9345|CARDIAC THERAPY|C1
9345|ANTIHYPERTENSIVES|C2
9345|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
9344|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
9343|ANTI-EPILEPTICS|N3A
9343|PARASITOLOGY|P
9340|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9340|PARASITOLOGY|P
9337|PARASITOLOGY|P
9335|ANTIHYPERTENSIVES|C2
9332|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
9329|ANTIDIURETIC HORMONES|H4D
9326|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9325|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9324|IMMUNOSUPPRESSIVE AGENTS|L4
9323|ANTIPSYCHOTICS|N5A
9322|ANTIPSYCHOTICS|N5A
9321|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
9317|PLATELET AGGREGATION INHIBITORS|B1C
9316|CEPHALOSPORINS|J1D
9313|ANTIHYPERTENSIVES|C2
9310|SYSTEMIC ANTIBACTERIALS|J1
9310|ANTIVIRALS FOR SYSTEMIC USE|J5
9309|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9308|RADIODIAGNOSTIC AGENTS|T1G
9307|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
9306|ANTIHYPERTENSIVES|C2
9305|Coxibs|M1A3
9304|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
9303|ANTIVIRALS FOR SYSTEMIC USE|J5
9303|CENTRAL NERVOUS SYSTEM|N
9302|ANTIVIRALS FOR SYSTEMIC USE|J5
9300|CARDIOVASCULAR SYSTEM|C
9300|ANTI-ARRHYTHMICS|C1B
9298|IMMUNOSUPPRESSIVE AGENTS|L4
9296|ANTIHYPERTENSIVES|C2
9294|IMMUNOSUPPRESSIVE AGENTS|L4
9293|TRANQUILLISERS|N5C
9292|Urinary incontinence products|G4B4
9292|NOOTROPICS|N6D
9289|TRANQUILLISERS|N5C
9289|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9285|PLATELET AGGREGATION INHIBITORS|B1C
9285|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
9284|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9280|CARDIOVASCULAR SYSTEM|C
9277|ANALGESICS|N2
9273|Protease inhibitors|J5C2
9272|ANTIHYPERTENSIVES|C2
9272|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
9271|DRUGS USED IN DIABETES|A10
9271|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9270|ANTIVIRALS FOR SYSTEMIC USE|J5
9265|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9259|ANTIVIRALS FOR SYSTEMIC USE|J5
9258|IMMUNOSUPPRESSIVE AGENTS|L4
9257|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
9254|IMMUNOSTIMULATING AGENTS|L3
9253|ANTIVIRALS FOR SYSTEMIC USE|J5
9252|ANTIVIRALS FOR SYSTEMIC USE|J5
9251|SYSTEMIC ANTIBACTERIALS|J1
9250|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9246|ANTIHYPERTENSIVES|C2
9246|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
9245|ANTIHYPERTENSIVES|C2
9245|BETA-BLOCKING AGENTS|C7
9242|NOOTROPICS|N6D
9241|NOOTROPICS|N6D
9240|NOOTROPICS|N6D
9239|NOOTROPICS|N6D
9237|VACCINES|J7
9236|ANTIHYPERTENSIVES|C2
9236|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
9235|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9230|ANTIVIRALS FOR SYSTEMIC USE|J5
9229|CARDIOVASCULAR SYSTEM|C
9229|ANTIHYPERTENSIVES|C2
9223|SYSTEMIC ANTIBACTERIALS|J1
9222|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9219|DIRECT THROMBIN INHIBITORS|B1E
9218|ANTIVIRALS FOR SYSTEMIC USE|J5
9215|CARDIOVASCULAR SYSTEM|C
9214|SYSTEMIC ANTIBACTERIALS|J1
9213|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
9208|ANTIVIRALS FOR SYSTEMIC USE|J5
9201|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
9201|ANTIVIRALS FOR SYSTEMIC USE|J5
9201|ANALGESICS|N2
9199|ANTI-EPILEPTICS|N3
9198|SYSTEMIC ANTIBACTERIALS|J1
9197|PARASITOLOGY|P
9195|MRI AGENTS|T1E
9193|ANTIVIRALS FOR SYSTEMIC USE|J5
9193|MRI AGENTS|T1E
9192|ANTIPSYCHOTICS|N5A
9183|BPH (benign prostatic hypertrophy) products |G4C
9182|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
9180|PLATELET AGGREGATION INHIBITORS|B1C
9179|ANTIEMETICS AND ANTINAUSEANTS|A4
9177|DIRECT THROMBIN INHIBITORS|B1E
9172|CALCIUM ANTAGONISTS|C8
9170|CARDIOVASCULAR SYSTEM|C
9167|CENTRAL NERVOUS SYSTEM|N
9167|ANTI-EPILEPTICS|N3
9163|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9159|Antigonadotrophin-releasing hormones|H1C3
9157|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9155|Protease inhibitors|J5C2
9154|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9147|CALCIUM ANTAGONISTS|C8
9145|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
9145|CENTRAL NERVOUS SYSTEM|N
9145|ANALGESICS|N2
9145|ANTI-EPILEPTICS|N3
9145|HYPNOTICS/SEDATIVES|N5B
9145|TRANQUILLISERS|N5C
9144|CALCIUM ANTAGONISTS|C8
9144|ANTI-EPILEPTICS|N3
9144|ANTIPSYCHOTICS|N5A
9143|CALCIUM ANTAGONISTS|C8
9141|ANTI-EPILEPTICS|N3A
9141|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9134|ANTIPSYCHOTICS|N5A
9132|ANTIVIRALS FOR SYSTEMIC USE|J5
9131|ANTI-EPILEPTICS|N3A
9126|SYSTEMIC ANTIBACTERIALS|J1
9125|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9122|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9120|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
9119|ANALGESICS|N2
9115|FIBRINOLYTICS|B1D
9114|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
9113|CALCIUM ANTAGONISTS|C8
9112|ALKYLATING AGENTS|L1A
9111|CARDIOVASCULAR SYSTEM|C
9110|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
9110|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
9110|ANTIPSYCHOTICS|N5A
9108|DRUGS USED IN DIABETES|A10
9108|ANTIHYPERTENSIVES|C2
9107|ANALGESICS|N2
9106|ANTIULCERANTS|A2B
9104|ANTIVIRALS FOR SYSTEMIC USE|J5
9103|HUMAN INSULINS AND ANALOGUES|A10C
9103|Human insulins and analogues, intermediate-acting|A10C2
9102|ANTIHYPERTENSIVES|C2
9102|CALCIUM ANTAGONISTS|C8
9101|Antigonadotrophin-releasing hormones|H1C3
9100|B2-STIMULANTS|R3A
9098|B2-STIMULANTS|R3A
9096|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
9095|ANTI-MIGRAINE PREPARATIONS|N2C
9095|SSRI antidepressants|N6A4
9093|ANTIHYPERTENSIVES|C2
9090|ANTIVIRALS FOR SYSTEMIC USE|J5
9089|SYSTEMIC ANTIBACTERIALS|J1
9089|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9087|SYSTEMIC ANTIBACTERIALS|J1
9086|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
9086|PARASITOLOGY|P
9081|ANTIHYPERTENSIVES|C2
9078|DIRECT THROMBIN INHIBITORS|B1E
9074|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9072|ANTI-ARRHYTHMICS|C1B
9072|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
9071|IMMUNOSUPPRESSIVE AGENTS|L4
9067|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
9067|ANAESTHETICS, GENERAL|N1A
9061|ANALGESICS|N2
9061|ANTI-MIGRAINE PREPARATIONS|N2C
9061|ANTI-EPILEPTICS|N3
9061|ANTIPSYCHOTICS|N5A
9061|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
9057|ANDROGENS, EXCLUDING G3E, G3F|G3B
9048|VACCINES|J7
9045|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
9041|SYSTEMIC ANTIBACTERIALS|J1
9035|ANTIHYPERTENSIVES|C2
9033|SYSTEMIC ANTIBACTERIALS|J1
9032|FIBRINOLYTICS|B1D
9030|DIRECT THROMBIN INHIBITORS|B1E
9022|ANTI-MIGRAINE PREPARATIONS|N2C
9018|NOOTROPICS|N6D
9013|NOOTROPICS|N6D
9012|NOOTROPICS|N6D
9011|SYSTEMIC ANTIBACTERIALS|J1
9008|ANTI-EPILEPTICS|N3
9008|HYPNOTICS/SEDATIVES|N5B
9007|ANTI-MIGRAINE PREPARATIONS|N2C
9007|ANTI-EPILEPTICS|N3
9001|ANTI-ACNE PREPARATIONS|D10
9000|Urinary incontinence products|G4B4
9000|BPH (benign prostatic hypertrophy) products |G4C
9000|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
9000|ANALGESICS|N2
9000|ANTI-MIGRAINE PREPARATIONS|N2C
9000|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8999|Coxibs|M1A3
8997|DERMATOLOGICALS|D
8996|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8995|IMMUNOSTIMULATING AGENTS|L3
8994|ANTIHYPERTENSIVES|C2
8994|Urinary incontinence products|G4B4
8990|ANTIPSYCHOTICS|N5A
8987|ANTIVIRALS FOR SYSTEMIC USE|J5
8985|ANTIVIRALS FOR SYSTEMIC USE|J5
8984|CARDIOVASCULAR SYSTEM|C
8984|CALCIUM ANTAGONISTS|C8
8979|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8976|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8974|ANTI-EPILEPTICS|N3
8973|ANTI-EPILEPTICS|N3
8972|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
8972|ANTIHYPERTENSIVES|C2
8970|ANALGESICS|N2
8970|ANTIPSYCHOTICS|N5A
8970|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8969|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
8969|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8967|ANTI-EPILEPTICS|N3
8967|ANTI-EPILEPTICS|N3A
8966|HYPNOTICS/SEDATIVES|N5B
8966|TRANQUILLISERS|N5C
8965|PLATELET AGGREGATION INHIBITORS|B1C
8964|ANTIHYPERTENSIVES|C2
8963|ANTI-EPILEPTICS|N3
8961|ANTI-EPILEPTICS|N3
8959|WOUND HEALING AGENTS|D3
8959|IMMUNOSTIMULATING AGENTS|L3
8959|Interferons, gamma|L3B3
8958|ANTI-EPILEPTICS|N3A
8957|MRI AGENTS|T1E
8956|HYPNOTICS/SEDATIVES|N5B
8956|TRANQUILLISERS|N5C
8956|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8956|SSRI antidepressants|N6A4
8955|ANTIHYPERTENSIVES|C2
8955|BETA-BLOCKING AGENTS|C7
8953|ANTIVIRALS FOR SYSTEMIC USE|J5
8952|ANALGESICS|N2
8950|ANTIVIRALS FOR SYSTEMIC USE|J5
8949|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8949|IMMUNOSUPPRESSIVE AGENTS|L4
8946|ANTIHYPERTENSIVES|C2
8944|PLATELET AGGREGATION INHIBITORS|B1C
8942|ANTIVIRALS FOR SYSTEMIC USE|J5
8940|Urinary incontinence products|G4B4
8938|ANTI-EPILEPTICS|N3A
8938|ANTIPSYCHOTICS|N5A
8938|NOOTROPICS|N6D
8935|ANTIULCERANTS|A2B
8934|ALKYLATING AGENTS|L1A
8932|NOOTROPICS|N6D
8931|SYSTEMIC ANTIBACTERIALS|J1
8927|ANALGESICS|N2
8925|ANALGESICS|N2
8922|Non-nucleoside reverse transcriptase inhibitors|J5C3
8919|SYSTEMIC ANTIBACTERIALS|J1
8918|SYSTEMIC ANTIBACTERIALS|J1
8918|PARASITOLOGY|P
8918|LUNG SURFACTANTS|R7C
8914|SYSTEMIC ANTIBACTERIALS|J1
8912|SYSTEMIC ANTIBACTERIALS|J1
8911|SYSTEMIC ANTIBACTERIALS|J1
8910|SYSTEMIC ANTIBACTERIALS|J1
8907|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8906|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8904|IMMUNOSUPPRESSIVE AGENTS|L4
8902|NOOTROPICS|N6D
8901|SYSTEMIC ANTIBACTERIALS|J1
8899|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
8899|CALCIUM ANTAGONISTS|C8
8899|ANTI-MIGRAINE PREPARATIONS|N2C
8899|ANTI-EPILEPTICS|N3
8899|ANTI-EPILEPTICS|N3A
8898|ANTIHYPERTENSIVES|C2
8897|ANTIHYPERTENSIVES|C2
8897|Miotics and antiglaucoma preparations, topical|S1E2
8896|PARASITOLOGY|P
8894|SYSTEMIC ANTIBACTERIALS|J1
8891|IMMUNOSUPPRESSIVE AGENTS|L4
8890|ANTIPSYCHOTICS|N5A
8890|TRANQUILLISERS|N5C
8890|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8889|ANTI-EPILEPTICS|N3
8888|PLATELET AGGREGATION INHIBITORS|B1C
8884|TRANQUILLISERS|N5C
8883|TRANQUILLISERS|N5C
8879|IMMUNOSUPPRESSIVE AGENTS|L4
8876|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8875|DIAGNOSTIC AGENTS|T
8874|ANALGESICS|N2
8868|DIRECT THROMBIN INHIBITORS|B1E
8868|CARDIOVASCULAR SYSTEM|C
8864|Coxibs|M1A3
8864|ANALGESICS|N2
8863|ANAESTHETICS, LOCAL|N1B
8861|ANALGESICS|N2
8859|B2-STIMULANTS|R3A
8858|ANTI-EPILEPTICS|N3A
8858|NOOTROPICS|N6D
8857|ANTIHYPERTENSIVES|C2
8856|CARDIOVASCULAR SYSTEM|C
8856|ACTH|H1A
8856|DIAGNOSTIC AGENTS|T
8854|ANTIPSYCHOTICS|N5A
8854|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8853|ANTIULCERANTS|A2B
8852|DIRECT THROMBIN INHIBITORS|B1E
8848|ANALGESICS|N2
8846|ANTIVIRALS FOR SYSTEMIC USE|J5
8839|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8832|Sulphonylurea antidiabetics|A10B1
8831|IMMUNOSUPPRESSIVE AGENTS|L4
8831|ANALGESICS|N2
8819|PLATELET AGGREGATION INHIBITORS|B1C
8818|PLATELET AGGREGATION INHIBITORS|B1C
8817|CARDIOVASCULAR SYSTEM|C
8817|ANTIHYPERTENSIVES|C2
8816|ANTIHYPERTENSIVES|C2
8816|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8815|CARDIOVASCULAR SYSTEM|C
8815|ANTIHYPERTENSIVES|C2
8815|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8814|PLATELET AGGREGATION INHIBITORS|B1C
8814|CARDIOVASCULAR SYSTEM|C
8813|CARDIAC THERAPY|C1
8813|CALCIUM ANTAGONISTS|C8
8809|SYSTEMIC ANTIBACTERIALS|J1
8809|CEPHALOSPORINS|J1D
8806|ANTI-EPILEPTICS|N3
8803|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8803|SSRI antidepressants|N6A4
8802|PARASITOLOGY|P
8801|CENTRAL NERVOUS SYSTEM|N
8799|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
8798|IMMUNOSTIMULATING AGENTS|L3
8796|IMMUNOSUPPRESSIVE AGENTS|L4
8795|SYSTEMIC ANTIBACTERIALS|J1
8788|ANALGESICS|N2
8786|OPHTHALMOLOGICALS|S1
8785|IMMUNOSUPPRESSIVE AGENTS|L4
8783|ANALGESICS|N2
8781|PLATELET AGGREGATION INHIBITORS|B1C
8781|CARDIOVASCULAR SYSTEM|C
8781|ANTIHYPERTENSIVES|C2
8781|Erectile dysfunction products|G4B3
8778|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
8778|SSRI antidepressants|N6A4
8778|SRNI antidepressants|N6A5
8776|IMMUNOSTIMULATING AGENTS|L3
8773|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8773|SSRI antidepressants|N6A4
8772|ANTI-EPILEPTICS|N3A
8772|NOOTROPICS|N6D
8769|TRANQUILLISERS|N5C
8767|Protease inhibitors|J5C2
8766|ANTI-EPILEPTICS|N3
8765|ANTI-ARRHYTHMICS|C1B
8764|ANTI-ARRHYTHMICS|C1B
8759|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8758|ANTI-MIGRAINE PREPARATIONS|N2C
8757|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
8756|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8755|Statins (HMG-CoA reductase inhibitors)|C10A1
8753|SYSTEMIC ANTIBACTERIALS|J1
8747|ANTIVIRALS FOR SYSTEMIC USE|J5
8741|CARDIAC THERAPY|C1
8741|ANTIHYPERTENSIVES|C2
8741|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8740|ANTIHYPERTENSIVES|C2
8737|TRANQUILLISERS|N5C
8736|TRANQUILLISERS|N5C
8735|Urinary incontinence products|G4B4
8733|ANTI-EPILEPTICS|N3
8732|ANTIPSYCHOTICS|N5A
8732|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8732|NOOTROPICS|N6D
8730|ANTIPSYCHOTICS|N5A
8729|ANTIPSYCHOTICS|N5A
8727|TRANQUILLISERS|N5C
8726|NOOTROPICS|N6D
8725|ANTI-MIGRAINE PREPARATIONS|N2C
8724|CALCIUM ANTAGONISTS|C8
8722|HYPNOTICS/SEDATIVES|N5B
8721|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
8720|ANTIHYPERTENSIVES|C2
8720|CALCIUM ANTAGONISTS|C8
8718|ANTI-ARRHYTHMICS|C1B
8717|CARDIAC THERAPY|C1
8717|ANTIHYPERTENSIVES|C2
8717|DIURETICS|C3
8716|ANTIHYPERTENSIVES|C2
8716|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8715|ANTI-MIGRAINE PREPARATIONS|N2C
8714|Systemic dermatological antifungals|D1A2
8714|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8713|ANTIHYPERTENSIVES|C2
8713|Erectile dysfunction products|G4B3
8712|TRANQUILLISERS|N5C
8712|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8711|IMMUNOSUPPRESSIVE AGENTS|L4
8708|ANTI-MALARIALS|P1D
8707|ANTIVIRALS FOR SYSTEMIC USE|J5
8701|WOUND HEALING AGENTS|D3
8700|WOUND HEALING AGENTS|D3
8699|ANTIHYPERTENSIVES|C2
8698|ANTIHYPERTENSIVES|C2
8697|ANALGESICS|N2
8696|ANTIHYPERTENSIVES|C2
8696|CALCIUM ANTAGONISTS|C8
8695|TRANQUILLISERS|N5C
8689|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8688|ANTIPSYCHOTICS|N5A
8687|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8684|ANTIPSYCHOTICS|N5A
8683|ANTI-EPILEPTICS|N3
8680|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8676|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
8675|ANTI-ARRHYTHMICS|C1B
8674|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8673|ANTIPSYCHOTICS|N5A
8671|ALKYLATING AGENTS|L1A
8670|ANTIVIRALS FOR SYSTEMIC USE|J5
8669|CEPHALOSPORINS|J1D
8664|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8663|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8659|IMMUNOSUPPRESSIVE AGENTS|L4
8657|SYSTEMIC ANTIBACTERIALS|J1
8642|SYSTEMIC ANTIBACTERIALS|J1
8638|ANTIHYPERTENSIVES|C2
8637|ANTIHYPERTENSIVES|C2
8631|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8631|PARASITOLOGY|P
8630|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8630|PARASITOLOGY|P
8627|ANTIHYPERTENSIVES|C2
8625|VACCINES|J7
8621|IMMUNOSTIMULATING AGENTS|L3
8620|IMMUNOSTIMULATING AGENTS|L3
8617|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8616|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8615|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8614|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8613|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8612|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8611|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8609|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8606|ANTIHYPERTENSIVES|C2
8605|ANTIHYPERTENSIVES|C2
8604|DRUGS USED IN DIABETES|A10
8603|ANTIPSYCHOTICS|N5A
8602|ANALGESICS|N2
8597|ANTIHYPERTENSIVES|C2
8595|ANALGESICS|N2
8594|ANTI-ARRHYTHMICS|C1B
8593|ANTI-EPILEPTICS|N3
8592|ANTI-EPILEPTICS|N3
8591|IMMUNOSUPPRESSIVE AGENTS|L4
8590|VACCINES|J7
8587|ANALGESICS|N2
8587|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8586|ANTIEMETICS AND ANTINAUSEANTS|A4
8586|ANALGESICS|N2
8586|ANTI-MIGRAINE PREPARATIONS|N2C
8581|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8564|ANTIHYPERTENSIVES|C2
8561|ANTIPSYCHOTICS|N5A
8561|TRANQUILLISERS|N5C
8558|ANALGESICS|N2
8556|ANTIPSYCHOTICS|N5A
8555|ANTIHYPERTENSIVES|C2
8555|DIURETICS|C3
8552|ANTIPSYCHOTICS|N5A
8549|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8548|ANTI-MIGRAINE PREPARATIONS|N2C
8547|TRANQUILLISERS|N5C
8546|TRANQUILLISERS|N5C
8545|ANTIHYPERTENSIVES|C2
8545|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8544|ANTIHYPERTENSIVES|C2
8544|ACE INHIBITORS, PLAIN|C9A
8541|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8540|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8539|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8537|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8529|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
8527|ANTI-GOUT PREPARATIONS|M4
8524|PLATELET AGGREGATION INHIBITORS|B1C
8524|DIRECT THROMBIN INHIBITORS|B1E
8522|PLATELET AGGREGATION INHIBITORS|B1C
8517|ANTIHYPERTENSIVES|C2
8516|ANTIHYPERTENSIVES|C2
8514|TRANQUILLISERS|N5C
8513|TRANQUILLISERS|N5C
8513|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8512|TRANQUILLISERS|N5C
8510|HYPNOTICS/SEDATIVES|N5B
8507|PLATELET AGGREGATION INHIBITORS|B1C
8506|PLATELET AGGREGATION INHIBITORS|B1C
8506|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
8506|Fibrinogen|B2D5
8505|DIRECT THROMBIN INHIBITORS|B1E
8504|DIRECT THROMBIN INHIBITORS|B1E
8503|DIRECT THROMBIN INHIBITORS|B1E
8502|DIRECT THROMBIN INHIBITORS|B1E
8501|ANTIPSYCHOTICS|N5A
8497|TRANQUILLISERS|N5C
8491|ANTIHYPERTENSIVES|C2
8490|ANTIHYPERTENSIVES|C2
8489|ANTIHYPERTENSIVES|C2
8488|ANTIHYPERTENSIVES|C2
8483|ANTIHYPERTENSIVES|C2
8483|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8482|ANTIHYPERTENSIVES|C2
8482|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8481|PLATELET AGGREGATION INHIBITORS|B1C
8481|Fibrinogen|B2D5
8480|PLATELET AGGREGATION INHIBITORS|B1C
8480|Fibrinogen|B2D5
8474|Protease inhibitors|J5C2
8472|Protease inhibitors|J5C2
8471|Protease inhibitors|J5C2
8466|TRANQUILLISERS|N5C
8465|TRANQUILLISERS|N5C
8463|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8462|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8461|ANTIHYPERTENSIVES|C2
8461|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8460|ANTIVIRALS FOR SYSTEMIC USE|J5
8450|ANTIHYPERTENSIVES|C2
8450|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8448|ANTIHYPERTENSIVES|C2
8446|ANALGESICS|N2
8446|ANTIPSYCHOTICS|N5A
8441|ANTIVIRALS FOR SYSTEMIC USE|J5
8441|ANTIPSYCHOTICS|N5A
8440|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8440|IMMUNOSUPPRESSIVE AGENTS|L4
8436|Coxibs|M1A3
8433|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8432|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8431|SYSTEMIC ANTIBACTERIALS|J1
8430|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
8429|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8426|Carbapenems|J1P2
8422|CEPHALOSPORINS|J1D
8421|CEPHALOSPORINS|J1D
8420|Carbapenems|J1P2
8417|Carbapenems|J1P2
8414|SYSTEMIC ANTIBACTERIALS|J1
8408|Protease inhibitors|J5C2
8404|ALKYLATING AGENTS|L1A
8399|SYSTEMIC ANTIBACTERIALS|J1
8399|Carbapenems|J1P2
8398|Protease inhibitors|J5C2
8393|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8393|IMMUNOSUPPRESSIVE AGENTS|L4
8389|ANTIPSYCHOTICS|N5A
8388|ANTI-EPILEPTICS|N3A
8379|Coxibs|M1A3
8378|ANTI-EPILEPTICS|N3A
8378|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8375|ANTIEMETICS AND ANTINAUSEANTS|A4
8375|ANTIHYPERTENSIVES|C2
8374|ANTIHYPERTENSIVES|C2
8373|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8371|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
8369|ANTIHYPERTENSIVES|C2
8369|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8368|ANALGESICS|N2
8368|ANTI-MIGRAINE PREPARATIONS|N2C
8367|ANTIPSYCHOTICS|N5A
8365|Coxibs|M1A3
8361|SYSTEMIC ANTIBACTERIALS|J1
8360|SYSTEMIC ANTIBACTERIALS|J1
8359|SYSTEMIC ANTIBACTERIALS|J1
8358|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8358|SRNI antidepressants|N6A5
8357|ANTIHYPERTENSIVES|C2
8357|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8352|TRANQUILLISERS|N5C
8350|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8348|ANTIULCERANTS|A2B
8345|ANTIPSYCHOTICS|N5A
8344|ANTIPSYCHOTICS|N5A
8342|TRANQUILLISERS|N5C
8341|TRANQUILLISERS|N5C
8340|TRANQUILLISERS|N5C
8339|ANTI-ARRHYTHMICS|C1B
8338|ANTIHYPERTENSIVES|C2
8338|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8336|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8336|PARASITOLOGY|P
8334|PLATELET AGGREGATION INHIBITORS|B1C
8332|CARDIOVASCULAR SYSTEM|C
8330|ANTIHYPERTENSIVES|C2
8330|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
8327|PLATELET AGGREGATION INHIBITORS|B1C
8325|OPHTHALMOLOGICAL CORTICOSTEROIDS|S1B
8325|Miotics and antiglaucoma preparations, systemic|S1E1
8324|ALKYLATING AGENTS|L1A
8321|ANTIVIRALS FOR SYSTEMIC USE|J5
8315|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8314|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
8314|DRUGS USED IN DIABETES|A10
8307|ANAESTHETICS, LOCAL|N1B
8307|ANALGESICS|N2
8306|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
8301|ANTIHYPERTENSIVES|C2
8299|IMMUNOSUPPRESSIVE AGENTS|L4
8296|TRANQUILLISERS|N5C
8295|ANTI-EPILEPTICS|N3
8290|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
8289|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8288|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8286|ANTIHYPERTENSIVES|C2
8284|ANTIHYPERTENSIVES|C2
8276|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
8274|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8273|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
8272|ANTIHYPERTENSIVES|C2
8272|DIURETICS|C3
8272|CALCIUM ANTAGONISTS|C8
8269|BPH (benign prostatic hypertrophy) products |G4C
8268|ANTI-EPILEPTICS|N3
8266|CALCIUM ANTAGONISTS|C8
8265|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
8265|ANTI-ACNE PREPARATIONS|D10
8263|Antigonadotrophin-releasing hormones|H1C3
8262|PLATELET AGGREGATION INHIBITORS|B1C
8261|ANTIHYPERTENSIVES|C2
8255|ANTIVIRALS FOR SYSTEMIC USE|J5
8255|Protease inhibitors|J5C2
8254|Protease inhibitors|J5C2
8253|ANTIHYPERTENSIVES|C2
8252|ANTI-EPILEPTICS|N3
8250|TRANQUILLISERS|N5C
8250|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8249|Coxibs|M1A3
8243|ANTI-EPILEPTICS|N3
8240|ANTIHYPERTENSIVES|C2
8240|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8233|FIBRINOLYTICS|B1D
8232|ANALGESICS|N2
8231|RESPIRATORY SYSTEM|R
8229|PLATELET AGGREGATION INHIBITORS|B1C
8229|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
8222|ANTI-EPILEPTICS|N3A
8222|NOOTROPICS|N6D
8221|ANTI-MIGRAINE PREPARATIONS|N2C
8220|ANTIPSYCHOTICS|N5A
8219|ANALGESICS|N2
8215|ANTIEMETICS AND ANTINAUSEANTS|A4
8214|ANTIEMETICS AND ANTINAUSEANTS|A4
8213|ANTIHYPERTENSIVES|C2
8213|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8212|ANTIPSYCHOTICS|N5A
8211|PLATELET AGGREGATION INHIBITORS|B1C
8208|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
8206|ANTI-ARRHYTHMICS|C1B
8205|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8204|PLATELET AGGREGATION INHIBITORS|B1C
8203|ANALGESICS|N2
8203|ANTI-EPILEPTICS|N3
8202|TRANQUILLISERS|N5C
8201|CARDIOVASCULAR SYSTEM|C
8199|ANTI-EPILEPTICS|N3
8199|TRANQUILLISERS|N5C
8199|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8197|ANTI-EPILEPTICS|N3
8195|PLATELET AGGREGATION INHIBITORS|B1C
8195|Fibrinogen|B2D5
8192|ANTIHYPERTENSIVES|C2
8192|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8191|Protease inhibitors|J5C2
8190|ANTIVIRALS FOR SYSTEMIC USE|J5
8188|PARASITOLOGY|P
8187|TRANQUILLISERS|N5C
8186|SYSTEMIC ANTIBACTERIALS|J1
8186|PARASITOLOGY|P
8185|ANALGESICS|N2
8183|ANALGESICS|N2
8182|DIRECT THROMBIN INHIBITORS|B1E
8180|VACCINES|J7
8177|TRANQUILLISERS|N5C
8175|SYSTEMIC ANTIBACTERIALS|J1
8162|ANTIHYPERTENSIVES|C2
8162|CALCIUM ANTAGONISTS|C8
8159|ANTIVIRALS FOR SYSTEMIC USE|J5
8156|ANTI-EPILEPTICS|N3
8155|ANTI-EPILEPTICS|N3
8155|ANTIPSYCHOTICS|N5A
8154|ANTI-EPILEPTICS|N3
8154|ANTIPSYCHOTICS|N5A
8153|ANTI-EPILEPTICS|N3
8153|ANTIPSYCHOTICS|N5A
8152|ANTIHYPERTENSIVES|C2
8150|ANTIHYPERTENSIVES|C2
8150|ACE INHIBITORS, PLAIN|C9A
8148|ANTIPSYCHOTICS|N5A
8147|ANALGESICS|N2
8147|ANTI-MIGRAINE PREPARATIONS|N2C
8145|Protease inhibitors|J5C2
8144|ANTIPSYCHOTICS|N5A
8143|ANTIHYPERTENSIVES|C2
8142|NOOTROPICS|N6D
8141|PLATELET AGGREGATION INHIBITORS|B1C
8140|ANALGESICS|N2
8140|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8138|PLATELET AGGREGATION INHIBITORS|B1C
8137|ANTIHYPERTENSIVES|C2
8137|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8135|ANTIHYPERTENSIVES|C2
8135|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8132|ANTIHYPERTENSIVES|C2
8128|ANTIHYPERTENSIVES|C2
8127|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
8126|ANTIHYPERTENSIVES|C2
8126|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
8124|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
8119|ANTIHYPERTENSIVES|C2
8119|DIURETICS|C3
8115|NOOTROPICS|N6D
8114|IMMUNOSUPPRESSIVE AGENTS|L4
8111|ANTIVIRALS FOR SYSTEMIC USE|J5
8108|VACCINES|J7
8106|ANTI-EPILEPTICS|N3A
8100|ANTIVIRALS FOR SYSTEMIC USE|J5
8099|IMMUNOSUPPRESSIVE AGENTS|L4
8089|ANALGESICS|N2
8089|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
8087|ANTIPSYCHOTICS|N5A
8087|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8087|NOOTROPICS|N6D
8086|IMMUNOSUPPRESSIVE AGENTS|L4
8084|ANDROGENS, EXCLUDING G3E, G3F|G3B
8083|ANTIVIRALS FOR SYSTEMIC USE|J5
8081|CENTRAL NERVOUS SYSTEM|N
8081|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
8080|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
8079|ANTIPSYCHOTICS|N5A
8073|ANALGESICS|N2
8068|VACCINES|J7
8067|PLATELET AGGREGATION INHIBITORS|B1C
8066|ANTIVIRALS FOR SYSTEMIC USE|J5
8065|ANTIVIRALS FOR SYSTEMIC USE|J5
8064|ANTIVIRALS FOR SYSTEMIC USE|J5
8064|IMMUNOSTIMULATING AGENTS|L3
8060|ANALGESICS|N2
8060|NOOTROPICS|N6D
8059|ANTIVIRALS FOR SYSTEMIC USE|J5
8057|ANTIVIRALS FOR SYSTEMIC USE|J5
8056|ANTI-EPILEPTICS|N3
8054|ANTIVIRALS FOR SYSTEMIC USE|J5
8053|ANTI-EPILEPTICS|N3
8052|ANTI-EPILEPTICS|N3
8052|NOOTROPICS|N6D
8050|SYSTEMIC ANTIBACTERIALS|J1
8046|ANTI-ACNE PREPARATIONS|D10
8046|SYSTEMIC ANTIBACTERIALS|J1
8038|Coxibs|M1A3
8038|ANALGESICS|N2
8036|ANTI-EPILEPTICS|N3A
8034|ANTI-ACNE PREPARATIONS|D10
8033|NOOTROPICS|N6D
8032|FIBRINOLYTICS|B1D
8024|SYSTEMIC ANTIBACTERIALS|J1
8021|IMMUNOSUPPRESSIVE AGENTS|L4
8018|CARDIOVASCULAR SYSTEM|C
8018|BETA-BLOCKING AGENTS|C7
8016|ANTI-EPILEPTICS|N3
8015|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
8014|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
8013|CALCIUM ANTAGONISTS|C8
8013|ANALGESICS|N2
8013|ANTI-MIGRAINE PREPARATIONS|N2C
8012|DIAGNOSTIC AGENTS|T
8009|ANTI-ARRHYTHMICS|C1B
8009|ANTIHYPERTENSIVES|C2
8007|TRANQUILLISERS|N5C
8004|TRANQUILLISERS|N5C
8002|ANTIHYPERTENSIVES|C2
8001|ANTIHYPERTENSIVES|C2
8000|ANTI-ACNE PREPARATIONS|D10
7999|ANTI-ACNE PREPARATIONS|D10
7998|ANTI-ACNE PREPARATIONS|D10
7995|Coxibs|M1A3
7994|ANTIHYPERTENSIVES|C2
7992|NOOTROPICS|N6D
7991|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
7989|ANTIPSYCHOTICS|N5A
7989|NOOTROPICS|N6D
7986|PARASITOLOGY|P
7982|IMMUNOSUPPRESSIVE AGENTS|L4
7981|ANTIHYPERTENSIVES|C2
7980|ANTIHYPERTENSIVES|C2
7980|ACE INHIBITORS, PLAIN|C9A
7979|ANTIHYPERTENSIVES|C2
7979|CALCIUM ANTAGONISTS|C8
7978|ANTIHYPERTENSIVES|C2
7978|CALCIUM ANTAGONISTS|C8
7972|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7972|SYSTEMIC ANTIBACTERIALS|J1
7972|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7971|ANALGESICS|N2
7971|ANTI-EPILEPTICS|N3A
7970|ANTIHYPERTENSIVES|C2
7970|ANALGESICS|N2
7970|ANTI-MIGRAINE PREPARATIONS|N2C
7969|BETA-BLOCKING AGENTS|C7
7967|PLATELET AGGREGATION INHIBITORS|B1C
7966|PLATELET AGGREGATION INHIBITORS|B1C
7965|PLATELET AGGREGATION INHIBITORS|B1C
7964|PLATELET AGGREGATION INHIBITORS|B1C
7962|PLATELET AGGREGATION INHIBITORS|B1C
7962|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
7962|Fibrinogen|B2D5
7960|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
7959|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
7958|ANTIHYPERTENSIVES|C2
7958|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7957|ANTIHYPERTENSIVES|C2
7957|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7956|ANTIHYPERTENSIVES|C2
7956|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7955|ANTIHYPERTENSIVES|C2
7954|ANTIHYPERTENSIVES|C2
7954|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7946|DRUGS USED IN DIABETES|A10
7945|DRUGS USED IN DIABETES|A10
7944|DRUGS USED IN DIABETES|A10
7943|DRUGS USED IN DIABETES|A10
7942|IMMUNOSUPPRESSIVE AGENTS|L4
7940|Protease inhibitors|J5C2
7939|SYSTEMIC ANTIBACTERIALS|J1
7938|Erectile dysfunction products|G4B3
7937|ANTIHYPERTENSIVES|C2
7937|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7935|NOOTROPICS|N6D
7935|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
7933|CALCITONINS|H4A
7932|DERMATOLOGICALS|D
7932|Topical dermatological antifungals|D1A1
7932|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
7932|ANTI-ACNE PREPARATIONS|D10
7932|TOPICAL ANTI-ACNE PREPARATIONS|D10A
7932|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7932|ANTIVIRALS FOR SYSTEMIC USE|J5
7927|ANTIHYPERTENSIVES|C2
7927|CALCIUM ANTAGONISTS|C8
7926|ANTIHYPERTENSIVES|C2
7926|CALCIUM ANTAGONISTS|C8
7925|TRANQUILLISERS|N5C
7921|PARASITOLOGY|P
7920|ANTIHYPERTENSIVES|C2
7920|CALCIUM ANTAGONISTS|C8
7918|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
7917|DERMATOLOGICALS|D
7917|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7914|ANTIHYPERTENSIVES|C2
7914|CALCIUM ANTAGONISTS|C8
7910|FIBRINOLYTICS|B1D
7910|CARDIAC THERAPY|C1
7907|ANTI-ARRHYTHMICS|C1B
7906|DIRECT THROMBIN INHIBITORS|B1E
7906|CARDIOVASCULAR SYSTEM|C
7904|ANTIVIRALS FOR SYSTEMIC USE|J5
7901|DRUGS USED IN DIABETES|A10
7898|IMMUNOSUPPRESSIVE AGENTS|L4
7893|IMMUNOSUPPRESSIVE AGENTS|L4
7891|ANTI-ACNE PREPARATIONS|D10
7891|MACROLIDES AND SIMILAR TYPES|J1F
7888|IMMUNOSTIMULATING AGENTS|L3
7879|ANALGESICS|N2
7877|ANTIVIRALS FOR SYSTEMIC USE|J5
7877|IMMUNOSUPPRESSIVE AGENTS|L4
7876|IMMUNOSUPPRESSIVE AGENTS|L4
7870|PLATELET AGGREGATION INHIBITORS|B1C
7868|Protease inhibitors|J5C2
7867|ANTIVIRALS FOR SYSTEMIC USE|J5
7867|Protease inhibitors|J5C2
7865|DERMATOLOGICALS|D
7865|BPH (benign prostatic hypertrophy) products |G4C
7864|ANTIEMETICS AND ANTINAUSEANTS|A4
7858|ANTIVIRALS FOR SYSTEMIC USE|J5
7857|CARDIOVASCULAR SYSTEM|C
7857|CALCIUM ANTAGONISTS|C8
7856|ANTIHYPERTENSIVES|C2
7856|CALCIUM ANTAGONISTS|C8
7855|ANTIHYPERTENSIVES|C2
7855|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7854|ANTIHYPERTENSIVES|C2
7854|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7853|ANTIHYPERTENSIVES|C2
7853|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7852|ANTIHYPERTENSIVES|C2
7852|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7851|ANTIHYPERTENSIVES|C2
7851|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7849|ANTIHYPERTENSIVES|C2
7845|ANTI-EPILEPTICS|N3
7843|ANTI-EPILEPTICS|N3
7843|TRANQUILLISERS|N5C
7842|ANTI-EPILEPTICS|N3
7840|ANTI-ARRHYTHMICS|C1B
7840|CALCIUM ANTAGONISTS|C8
7837|ANTIPSYCHOTICS|N5A
7837|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7836|ANTIPSYCHOTICS|N5A
7835|ANTIPSYCHOTICS|N5A
7833|TRANQUILLISERS|N5C
7832|ANTIPSYCHOTICS|N5A
7830|TRANQUILLISERS|N5C
7829|TRANQUILLISERS|N5C
7828|TRANQUILLISERS|N5C
7827|TRANQUILLISERS|N5C
7824|ANTIHYPERTENSIVES|C2
7824|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7822|ANTIHYPERTENSIVES|C2
7822|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7820|PLATELET AGGREGATION INHIBITORS|B1C
7819|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
7818|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
7817|ANTI-ACNE PREPARATIONS|D10
7812|ANTIHYPERTENSIVES|C2
7807|ANTI-EPILEPTICS|N3
7807|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7806|ANTIPSYCHOTICS|N5A
7804|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
7803|ANTIHYPERTENSIVES|C2
7802|CALCIUM ANTAGONISTS|C8
7802|Urinary incontinence products|G4B4
7801|ANTIHYPERTENSIVES|C2
7800|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
7799|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7798|ANTIHYPERTENSIVES|C2
7798|ANTI-MIGRAINE PREPARATIONS|N2C
7797|ANTI-ARRHYTHMICS|C1B
7796|ANTIHYPERTENSIVES|C2
7796|Urinary incontinence products|G4B4
7794|ANTI-MIGRAINE PREPARATIONS|N2C
7791|ANTIULCERANTS|A2B
7790|B2-STIMULANTS|R3A
7788|TRANQUILLISERS|N5C
7788|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7787|ANTI-EPILEPTICS|N3A
7786|ANTIPSYCHOTICS|N5A
7785|ANTIHYPERTENSIVES|C2
7784|ANTI-EPILEPTICS|N3A
7783|ANTIHYPERTENSIVES|C2
7782|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7782|SSRI antidepressants|N6A4
7781|ANTIPSYCHOTICS|N5A
7781|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7780|PARASITOLOGY|P
7773|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7771|ANTIHYPERTENSIVES|C2
7770|ANTIEMETICS AND ANTINAUSEANTS|A4
7769|TRANQUILLISERS|N5C
7768|TRANQUILLISERS|N5C
7767|ANALGESICS|N2
7766|ANALGESICS|N2
7764|ANALGESICS|N2
7762|NOOTROPICS|N6D
7761|NOOTROPICS|N6D
7760|ANALGESICS|N2
7757|ANALGESICS|N2
7756|ANTI-EPILEPTICS|N3
7756|ANTI-EPILEPTICS|N3A
7755|NOOTROPICS|N6D
7755|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
7754|ANAESTHETICS, GENERAL|N1A
7754|ANALGESICS|N2
7753|ANAESTHETICS, GENERAL|N1A
7752|ANALGESICS|N2
7751|ANAESTHETICS|N1
7750|ANAESTHETICS, GENERAL|N1A
7748|BETA-BLOCKING AGENTS|C7
7747|BETA-BLOCKING AGENTS|C7
7746|CALCIUM ANTAGONISTS|C8
7745|ANTIVIRALS FOR SYSTEMIC USE|J5
7741|ANALGESICS|N2
7741|ANTI-MIGRAINE PREPARATIONS|N2C
7738|ANALGESICS|N2
7736|RADIODIAGNOSTIC AGENTS|T1G
7734|PLATELET AGGREGATION INHIBITORS|B1C
7733|ANTIHYPERTENSIVES|C2
7731|ALKYLATING AGENTS|L1A
7730|ALKYLATING AGENTS|L1A
7727|IMMUNOSTIMULATING AGENTS|L3
7727|ANALGESICS|N2
7726|Coxibs|M1A3
7702|ALKYLATING AGENTS|L1A
7700|ANTIVIRALS FOR SYSTEMIC USE|J5
7699|ANTIVIRALS FOR SYSTEMIC USE|J5
7696|ANTIVIRALS FOR SYSTEMIC USE|J5
7694|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7693|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7691|ANTIVIRALS FOR SYSTEMIC USE|J5
7688|ANTIVIRALS FOR SYSTEMIC USE|J5
7686|ANTIVIRALS FOR SYSTEMIC USE|J5
7683|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7682|ANTI-ARRHYTHMICS|C1B
7679|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7679|IMMUNOSUPPRESSIVE AGENTS|L4
7677|ANTIHYPERTENSIVES|C2
7675|ANTIHYPERTENSIVES|C2
7673|IMMUNOSUPPRESSIVE AGENTS|L4
7671|ANTIHYPERTENSIVES|C2
7671|ANTI-EPILEPTICS|N3A
7670|GASTROPROKINETICS|A3F
7670|ANTIEMETICS AND ANTINAUSEANTS|A4
7668|GASTROPROKINETICS|A3F
7665|ANTI-EPILEPTICS|N3
7663|ANTIHYPERTENSIVES|C2
7663|DIURETICS|C3
7662|ANALGESICS|N2
7660|IMMUNOSUPPRESSIVE AGENTS|L4
7658|HUMAN INSULINS AND ANALOGUES|A10C
7653|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7652|SYSTEMIC ANTIBACTERIALS|J1
7652|ANTIVIRALS FOR SYSTEMIC USE|J5
7651|ANTIHYPERTENSIVES|C2
7648|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7647|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
7646|IMMUNOSTIMULATING AGENTS|L3
7645|VACCINES|J7
7641|CARDIOVASCULAR SYSTEM|C
7638|DRUGS USED IN DIABETES|A10
7636|Factor VIII|B2D1
7635|Factor VIII|B2D1
7635|Factors II, VII, IX and X|B2D2
7633|Factors II, VII, IX and X|B2D2
7631|ANTI-EPILEPTICS|N3A
7630|DRUGS USED IN DIABETES|A10
7628|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
7627|ANTIHYPERTENSIVES|C2
7626|IMMUNOSTIMULATING AGENTS|L3
7625|GROWTH HORMONES|H4C
7622|ANTIHYPERTENSIVES|C2
7621|DRUGS USED IN DIABETES|A10
7620|ANTIVIRALS FOR SYSTEMIC USE|J5
7618|ANTIHYPERTENSIVES|C2
7618|CALCIUM ANTAGONISTS|C8
7614|ANTIHYPERTENSIVES|C2
7602|PLATELET AGGREGATION INHIBITORS|B1C
7601|ANTIVIRALS FOR SYSTEMIC USE|J5
7601|Interferons, beta|L3B2
7597|ANTIHYPERTENSIVES|C2
7597|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7594|MUSCULO-SKELETAL SYSTEM|M
7593|CARDIOVASCULAR SYSTEM|C
7590|Antigrowth hormones|H1C2
7586|Interferons, beta|L3B2
7584|Factor VIII|B2D1
7583|ANTIVIRALS FOR SYSTEMIC USE|J5
7580|ANTIVIRALS FOR SYSTEMIC USE|J5
7574|VACCINES|J7
7565|OPHTHALMOLOGICALS|S1
7563|VACCINES|J7
7553|IMMUNOSTIMULATING AGENTS|L3
7552|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7550|ALKYLATING AGENTS|L1A
7548|ANTIVIRALS FOR SYSTEMIC USE|J5
7545|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7543|ANTIVIRALS FOR SYSTEMIC USE|J5
7538|ANTIVIRALS FOR SYSTEMIC USE|J5
7537|SYSTEMIC ANTIBACTERIALS|J1
7537|ANTIVIRALS FOR SYSTEMIC USE|J5
7529|IMMUNOSUPPRESSIVE AGENTS|L4
7525|ANTI-MIGRAINE PREPARATIONS|N2C
7525|TRANQUILLISERS|N5C
7524|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
7517|ANTIVIRALS FOR SYSTEMIC USE|J5
7517|Interferons, alpha|L3B1
7514|GROWTH HORMONES|H4C
7497|ANTIVIRALS FOR SYSTEMIC USE|J5
7495|IMMUNOSUPPRESSIVE AGENTS|L4
7486|IMMUNOSUPPRESSIVE AGENTS|L4
7484|IMMUNOSUPPRESSIVE AGENTS|L4
7479|ANTI-EPILEPTICS|N3A
7478|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
7475|NOOTROPICS|N6D
7473|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7472|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
7470|ANTIULCERANTS|A2B
7469|VACCINES|J7
7464|ANTIVIRALS FOR SYSTEMIC USE|J5
7464|Interferons, alpha|L3B1
7462|ANTIVIRALS FOR SYSTEMIC USE|J5
7461|DERMATOLOGICALS|D
7459|ANTIVIRALS FOR SYSTEMIC USE|J5
7458|ANTIVIRALS FOR SYSTEMIC USE|J5
7450|Urinary incontinence products|G4B4
7448|ANTIVIRALS FOR SYSTEMIC USE|J5
7448|Interferons, alpha|L3B1
7446|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7446|IMMUNOSUPPRESSIVE AGENTS|L4
7444|DERMATOLOGICALS|D
7439|PARASITOLOGY|P
7435|PARASITOLOGY|P
7433|IMMUNOSTIMULATING AGENTS|L3
7432|ANTI-EPILEPTICS|N3A
7431|ANTI-EPILEPTICS|N3A
7430|IMMUNOSUPPRESSIVE AGENTS|L4
7424|PLATELET AGGREGATION INHIBITORS|B1C
7422|ANTI-EPILEPTICS|N3A
7419|ANTIVIRALS FOR SYSTEMIC USE|J5
7416|WOUND HEALING AGENTS|D3
7415|ANTIVIRALS FOR SYSTEMIC USE|J5
7404|ANTIVIRALS FOR SYSTEMIC USE|J5
7402|RADIODIAGNOSTIC AGENTS|T1G
7401|ANTIVIRALS FOR SYSTEMIC USE|J5
7401|IMMUNOSTIMULATING AGENTS|L3
7400|FIBRINOLYTICS|B1D
7398|ANTIVIRALS FOR SYSTEMIC USE|J5
7396|IMMUNOSUPPRESSIVE AGENTS|L4
7394|ANALGESICS|N2
7393|IMMUNOSUPPRESSIVE AGENTS|L4
7393|RESPIRATORY SYSTEM|R
7392|ANTIVIRALS FOR SYSTEMIC USE|J5
7388|FIBRINOLYTICS|B1D
7387|ANTIVIRALS FOR SYSTEMIC USE|J5
7387|IMMUNOSTIMULATING AGENTS|L3
7387|Interferons, alpha|L3B1
7378|HUMAN INSULINS AND ANALOGUES|A10C
7378|Human insulins and analogues, intermediate-acting|A10C2
7371|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7370|Urinary incontinence products|G4B4
7369|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7367|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7367|PARASITOLOGY|P
7366|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7366|PARASITOLOGY|P
7365|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
7365|PARASITOLOGY|P
7361|PLATELET AGGREGATION INHIBITORS|B1C
7361|Fibrinogen|B2D5
7357|ULTRASOUND AGENTS|T1F
7355|ANTIPSYCHOTICS|N5A
7355|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7355|SSRI antidepressants|N6A4
7353|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
7352|BPH (benign prostatic hypertrophy) products |G4C
7349|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
7348|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
7344|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
7344|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
7337|ANTI-EPILEPTICS|N3
7336|ANTIHYPERTENSIVES|C2
7336|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7335|ANTIHYPERTENSIVES|C2
7335|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7334|Protease inhibitors|J5C2
7333|Protease inhibitors|J5C2
7332|ANTIHYPERTENSIVES|C2
7332|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7330|ANTIHYPERTENSIVES|C2
7330|CALCIUM ANTAGONISTS|C8
7328|ANTIHYPERTENSIVES|C2
7326|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
7325|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
7319|ANTIHYPERTENSIVES|C2
7319|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7318|ANTIHYPERTENSIVES|C2
7318|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7317|ANTIHYPERTENSIVES|C2
7317|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7316|TRANQUILLISERS|N5C
7315|ANTI-EPILEPTICS|N3
7315|TRANQUILLISERS|N5C
7312|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
7311|ANTIHYPERTENSIVES|C2
7311|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7310|Protease inhibitors|J5C2
7309|TRANQUILLISERS|N5C
7308|TRANQUILLISERS|N5C
7307|ANTIHYPERTENSIVES|C2
7307|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7302|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
7301|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
7300|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
7299|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
7297|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
7296|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
7293|Antigonadotrophin-releasing hormones|H1C3
7283|PLATELET AGGREGATION INHIBITORS|B1C
7277|ANTIVIRALS FOR SYSTEMIC USE|J5
7276|ANTIHYPERTENSIVES|C2
7276|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7275|ANTIHYPERTENSIVES|C2
7275|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
7274|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7274|IMMUNOSUPPRESSIVE AGENTS|L4
7271|CENTRAL NERVOUS SYSTEM|N
7271|ANTI-EPILEPTICS|N3
7271|ANTI-EPILEPTICS|N3A
7270|BPH (benign prostatic hypertrophy) products |G4C
7268|ANTIHYPERTENSIVES|C2
7268|ANTIPSYCHOTICS|N5A
7265|DRUGS USED IN DIABETES|A10
7265|ANTIHYPERTENSIVES|C2
7265|HYPNOTICS/SEDATIVES|N5B
7265|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
7264|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7262|ANTIHYPERTENSIVES|C2
7262|DIURETICS|C3
7259|FIBRINOLYTICS|B1D
7252|WOUND HEALING AGENTS|D3
7252|SYSTEMIC ANTIBACTERIALS|J1
7247|Factor VIII|B2D1
7247|Factors II, VII, IX and X|B2D2
7238|ANTIVIRALS FOR SYSTEMIC USE|J5
7237|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7237|ANTIVIRALS FOR SYSTEMIC USE|J5
7234|IMMUNOSTIMULATING AGENTS|L3
7233|ANTIVIRALS FOR SYSTEMIC USE|J5
7230|ANTIVIRALS FOR SYSTEMIC USE|J5
7229|ANTIVIRALS FOR SYSTEMIC USE|J5
7227|ANTIVIRALS FOR SYSTEMIC USE|J5
7224|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
7219|IMMUNOSTIMULATING AGENTS|L3
7218|ANTIVIRALS FOR SYSTEMIC USE|J5
7216|SYSTEMIC ANTIBACTERIALS|J1
7214|ANTIVIRALS FOR SYSTEMIC USE|J5
7212|ANTIVIRALS FOR SYSTEMIC USE|J5
7210|LUNG SURFACTANTS|R7C
7209|ANTIVIRALS FOR SYSTEMIC USE|J5
7208|ANTIVIRALS FOR SYSTEMIC USE|J5
7204|ANTIHYPERTENSIVES|C2
7199|ANTIVIRALS FOR SYSTEMIC USE|J5
7195|PLATELET AGGREGATION INHIBITORS|B1C
7195|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7194|ANTIVIRALS FOR SYSTEMIC USE|J5
7187|NOOTROPICS|N6D
7183|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7183|IMMUNOSUPPRESSIVE AGENTS|L4
7182|ANTIVIRALS FOR SYSTEMIC USE|J5
7181|DRUGS USED IN DIABETES|A10
7179|IMMUNOSUPPRESSIVE AGENTS|L4
7177|IMMUNOSUPPRESSIVE AGENTS|L4
7171|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7171|IMMUNOSUPPRESSIVE AGENTS|L4
7157|ANTIPSYCHOTICS|N5A
7152|IMMUNOSTIMULATING AGENTS|L3
7145|ANTIVIRALS FOR SYSTEMIC USE|J5
7133|DERMATOLOGICALS|D
7130|FIBRINOLYTICS|B1D
7129|IMMUNOSTIMULATING AGENTS|L3
7125|ANTIVIRALS FOR SYSTEMIC USE|J5
7121|IMMUNOSTIMULATING AGENTS|L3
7118|IMMUNOSUPPRESSIVE AGENTS|L4
7110|IMMUNOSTIMULATING AGENTS|L3
7106|ANTIVIRALS FOR SYSTEMIC USE|J5
7103|ANALGESICS|N2
7095|ANTIVIRALS FOR SYSTEMIC USE|J5
7092|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7084|DIAGNOSTIC AGENTS|T
7083|ANTIVIRALS FOR SYSTEMIC USE|J5
7074|ANTIVIRALS FOR SYSTEMIC USE|J5
7074|IMMUNOSTIMULATING AGENTS|L3
7069|ANTIVIRALS FOR SYSTEMIC USE|J5
7067|ANTIVIRALS FOR SYSTEMIC USE|J5
7059|IMMUNOSUPPRESSIVE AGENTS|L4
7055|ANTIVIRALS FOR SYSTEMIC USE|J5
7028|IMMUNOSUPPRESSIVE AGENTS|L4
7025|ANTIVIRALS FOR SYSTEMIC USE|J5
7025|IMMUNOSUPPRESSIVE AGENTS|L4
7022|Protease inhibitors|J5C2
7021|Protease inhibitors|J5C2
7016|PLATELET AGGREGATION INHIBITORS|B1C
7016|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
7016|Fibrinogen|B2D5
7016|CARDIOVASCULAR SYSTEM|C
7015|ALKYLATING AGENTS|L1A
7013|DIRECT THROMBIN INHIBITORS|B1E
7010|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
7004|ANTIHYPERTENSIVES|C2
7002|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6996|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6994|ANALGESICS|N2
6994|ANTIPSYCHOTICS|N5A
6994|TRANQUILLISERS|N5C
6993|IMMUNOSUPPRESSIVE AGENTS|L4
6987|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6984|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
6968|SYSTEMIC ANTIBACTERIALS|J1
6965|IMMUNOSTIMULATING AGENTS|L3
6962|CALCIUM ANTAGONISTS|C8
6961|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6958|FIBRINOLYTICS|B1D
6957|Interferons, alpha|L3B1
6955|ANTIVIRALS FOR SYSTEMIC USE|J5
6954|ANTI-MIGRAINE PREPARATIONS|N2C
6952|ANTIHYPERTENSIVES|C2
6952|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6951|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
6950|TRANQUILLISERS|N5C
6949|DIAGNOSTIC AGENTS|T
6943|ALKYLATING AGENTS|L1A
6941|ANTIEMETICS AND ANTINAUSEANTS|A4
6938|CALCIUM ANTAGONISTS|C8
6938|ANTI-EPILEPTICS|N3
6936|DIAGNOSTIC AGENTS|T
6934|ANTIVIRALS FOR SYSTEMIC USE|J5
6934|IMMUNOSTIMULATING AGENTS|L3
6934|PARASITOLOGY|P
6927|ANTIVIRALS FOR SYSTEMIC USE|J5
6920|ANTIVIRALS FOR SYSTEMIC USE|J5
6920|IMMUNOSUPPRESSIVE AGENTS|L4
6913|ANTIHYPERTENSIVES|C2
6913|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6907|ANTIHYPERTENSIVES|C2
6907|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6904|SYSTEMIC ANTIBACTERIALS|J1
6897|DIRECT THROMBIN INHIBITORS|B1E
6894|IMMUNOSUPPRESSIVE AGENTS|L4
6893|FIBRINOLYTICS|B1D
6889|PLATELET AGGREGATION INHIBITORS|B1C
6889|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
6887|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6887|Statins (HMG-CoA reductase inhibitors)|C10A1
6886|ANTI-ACNE PREPARATIONS|D10
6885|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
6885|ANALGESICS|N2
6885|ANTIPSYCHOTICS|N5A
6885|TRANQUILLISERS|N5C
6884|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6878|ANTI-ARRHYTHMICS|C1B
6877|PARASITOLOGY|P
6875|ALKYLATING AGENTS|L1A
6871|Factors II, VII, IX and X|B2D2
6869|GROWTH HORMONES|H4C
6868|PARASITOLOGY|P
6865|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6865|IMMUNOSTIMULATING AGENTS|L3
6864|ANTIMETABOLITES|L1B
6861|ALKYLATING AGENTS|L1A
6859|IMMUNOSTIMULATING AGENTS|L3
6857|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6857|ANTIVIRALS FOR SYSTEMIC USE|J5
6857|IMMUNOSUPPRESSIVE AGENTS|L4
6854|ANALGESICS|N2
6850|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6850|ANTIVIRALS FOR SYSTEMIC USE|J5
6850|ANALGESICS|N2
6847|DIAGNOSTIC AGENTS|T
6845|IMMUNOSUPPRESSIVE AGENTS|L4
6837|IMMUNOSUPPRESSIVE AGENTS|L4
6833|NOOTROPICS|N6D
6831|Erectile dysfunction products|G4B3
6828|Factors II, VII, IX and X|B2D2
6819|FIBRINOLYTICS|B1D
6818|Antigonadotrophin-releasing hormones|H1C3
6817|BPH (benign prostatic hypertrophy) products |G4C
6817|Antigonadotrophin-releasing hormones|H1C3
6815|ANTIVIRALS FOR SYSTEMIC USE|J5
6814|CARDIOVASCULAR SYSTEM|C
6814|ANTIHYPERTENSIVES|C2
6814|DIURETICS|C3
6811|PLATELET AGGREGATION INHIBITORS|B1C
6810|IMMUNOSTIMULATING AGENTS|L3
6808|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6808|IMMUNOSUPPRESSIVE AGENTS|L4
6804|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
6802|IMMUNOSUPPRESSIVE AGENTS|L4
6793|ANTI-ARRHYTHMICS|C1B
6791|WOUND HEALING AGENTS|D3
6785|NOOTROPICS|N6D
6784|ANTIVIRALS FOR SYSTEMIC USE|J5
6784|Interferons, alpha|L3B1
6779|MACROLIDES AND SIMILAR TYPES|J1F
6778|Protease inhibitors|J5C2
6777|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
6775|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6774|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6770|DIRECT THROMBIN INHIBITORS|B1E
6769|DIRECT THROMBIN INHIBITORS|B1E
6768|DIRECT THROMBIN INHIBITORS|B1E
6767|DIRECT THROMBIN INHIBITORS|B1E
6766|DIRECT THROMBIN INHIBITORS|B1E
6765|ANTIHYPERTENSIVES|C2
6764|ANTIHYPERTENSIVES|C2
6764|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6763|ANTIHYPERTENSIVES|C2
6763|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6762|CARDIOVASCULAR SYSTEM|C
6762|ANTIHYPERTENSIVES|C2
6761|CARDIOVASCULAR SYSTEM|C
6760|IMMUNOSUPPRESSIVE AGENTS|L4
6756|PLATELET AGGREGATION INHIBITORS|B1C
6756|Coxibs|M1A3
6755|DIRECT THROMBIN INHIBITORS|B1E
6752|CARDIOVASCULAR SYSTEM|C
6752|ANTIHYPERTENSIVES|C2
6752|ACE INHIBITORS, PLAIN|C9A
6747|ANTIVIRALS FOR SYSTEMIC USE|J5
6747|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
6743|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6741|ANTIVIRALS FOR SYSTEMIC USE|J5
6740|ANTIVIRALS FOR SYSTEMIC USE|J5
6738|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6725|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6721|IMMUNOSTIMULATING AGENTS|L3
6720|ANTI-EPILEPTICS|N3
6719|PLATELET AGGREGATION INHIBITORS|B1C
6719|ALKYLATING AGENTS|L1A
6711|BPH (benign prostatic hypertrophy) products |G4C
6709|Non-nucleoside reverse transcriptase inhibitors|J5C3
6707|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6706|Topical dermatological antifungals|D1A1
6706|SYSTEMIC ANTIBACTERIALS|J1
6706|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6701|SYSTEMIC ANTIBACTERIALS|J1
6695|SYSTEMIC ANTIBACTERIALS|J1
6686|ALKYLATING AGENTS|L1A
6685|CARDIOVASCULAR SYSTEM|C
6685|CENTRAL NERVOUS SYSTEM|N
6684|BPH (benign prostatic hypertrophy) products |G4C
6683|ANTIVIRALS FOR SYSTEMIC USE|J5
6681|ANTIVIRALS FOR SYSTEMIC USE|J5
6678|CEPHALOSPORINS|J1D
6675|SYSTEMIC ANTIBACTERIALS|J1
6672|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6671|CEPHALOSPORINS|J1D
6664|ANTIVIRALS FOR SYSTEMIC USE|J5
6663|FIBRINOLYTICS|B1D
6657|PLATELET AGGREGATION INHIBITORS|B1C
6654|Urinary incontinence products|G4B4
6643|CARDIOVASCULAR SYSTEM|C
6642|CARDIOVASCULAR SYSTEM|C
6641|ANTIHYPERTENSIVES|C2
6636|TRANQUILLISERS|N5C
6634|CARDIOVASCULAR SYSTEM|C
6634|ANTIHYPERTENSIVES|C2
6633|PLATELET AGGREGATION INHIBITORS|B1C
6630|ANTIHYPERTENSIVES|C2
6629|ANTIHYPERTENSIVES|C2
6628|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6626|ANALGESICS|N2
6622|ANDROGENS, EXCLUDING G3E, G3F|G3B
6622|IMMUNOSUPPRESSIVE AGENTS|L4
6619|ALKYLATING AGENTS|L1A
6611|ALKYLATING AGENTS|L1A
6609|IMMUNOSTIMULATING AGENTS|L3
6608|ALKYLATING AGENTS|L1A
6607|ALKYLATING AGENTS|L1A
6600|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6599|IMMUNOSTIMULATING AGENTS|L3
6593|ANTI-EPILEPTICS|N3A
6591|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6588|ANTIHYPERTENSIVES|C2
6588|BPH (benign prostatic hypertrophy) products |G4C
6587|ANTIHYPERTENSIVES|C2
6587|CALCIUM ANTAGONISTS|C8
6583|DRUGS USED IN DIABETES|A10
6580|ANALGESICS|N2
6578|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
6577|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
6573|IMMUNOSUPPRESSIVE AGENTS|L4
6572|HUMAN INSULINS AND ANALOGUES|A10C
6572|Human insulins and analogues, long-acting|A10C5
6570|IMMUNOSUPPRESSIVE AGENTS|L4
6567|DIRECT THROMBIN INHIBITORS|B1E
6566|ANTIVIRALS FOR SYSTEMIC USE|J5
6565|Protease inhibitors|J5C2
6564|Protease inhibitors|J5C2
6563|Protease inhibitors|J5C2
6561|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6560|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6559|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6558|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6556|ANTI-EPILEPTICS|N3A
6555|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6555|Statins (HMG-CoA reductase inhibitors)|C10A1
6549|ANTIHYPERTENSIVES|C2
6549|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6548|ANTIHYPERTENSIVES|C2
6548|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6546|ANTIHYPERTENSIVES|C2
6546|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6545|ANTIHYPERTENSIVES|C2
6545|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6539|ANTIHYPERTENSIVES|C2
6537|ANTIHYPERTENSIVES|C2
6537|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6536|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6535|ANTIHYPERTENSIVES|C2
6534|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
6534|Statins (HMG-CoA reductase inhibitors)|C10A1
6533|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6530|ANTIHYPERTENSIVES|C2
6530|ANTI-EPILEPTICS|N3
6524|CARDIOVASCULAR SYSTEM|C
6524|CALCIUM ANTAGONISTS|C8
6519|ANTIHYPERTENSIVES|C2
6519|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6516|ANTIHYPERTENSIVES|C2
6510|DIRECT THROMBIN INHIBITORS|B1E
6508|ANTI-EPILEPTICS|N3A
6508|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
6506|ANTIHYPERTENSIVES|C2
6502|ANTIHYPERTENSIVES|C2
6500|ANTI-ARRHYTHMICS|C1B
6499|DIRECT THROMBIN INHIBITORS|B1E
6496|PLATELET AGGREGATION INHIBITORS|B1C
6495|ANTIHYPERTENSIVES|C2
6494|ANTIHYPERTENSIVES|C2
6494|CALCIUM ANTAGONISTS|C8
6493|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6493|Statins (HMG-CoA reductase inhibitors)|C10A1
6490|ANTIHYPERTENSIVES|C2
6489|ANTIHYPERTENSIVES|C2
6488|DIRECT THROMBIN INHIBITORS|B1E
6486|ANTIHYPERTENSIVES|C2
6486|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6485|PLATELET AGGREGATION INHIBITORS|B1C
6482|CARDIOVASCULAR SYSTEM|C
6481|ANTIPSYCHOTICS|N5A
6480|TRANQUILLISERS|N5C
6477|ANTI-EPILEPTICS|N3
6475|NOOTROPICS|N6D
6473|ANALGESICS|N2
6472|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
6470|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
6462|TRANQUILLISERS|N5C
6461|ANTIPSYCHOTICS|N5A
6456|ANTIPSYCHOTICS|N5A
6453|CARDIOVASCULAR SYSTEM|C
6453|ANTIHYPERTENSIVES|C2
6445|TRANQUILLISERS|N5C
6442|ANTI-EPILEPTICS|N3
6441|TRANQUILLISERS|N5C
6438|ANTIEMETICS AND ANTINAUSEANTS|A4
6435|ANALGESICS|N2
6433|ANTI-EPILEPTICS|N3
6432|NOOTROPICS|N6D
6431|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6430|ANTIHYPERTENSIVES|C2
6429|PLATELET AGGREGATION INHIBITORS|B1C
6429|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
6427|PLATELET AGGREGATION INHIBITORS|B1C
6426|CARDIOVASCULAR SYSTEM|C
6426|ANTI-ARRHYTHMICS|C1B
6425|ANTIHYPERTENSIVES|C2
6425|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6424|ANTIHYPERTENSIVES|C2
6423|ANTI-ARRHYTHMICS|C1B
6422|PLATELET AGGREGATION INHIBITORS|B1C
6422|ANTI-ARRHYTHMICS|C1B
6421|TRANQUILLISERS|N5C
6420|ANTI-ARRHYTHMICS|C1B
6419|ALKYLATING AGENTS|L1A
6418|FIBRINOLYTICS|B1D
6417|IMMUNOSUPPRESSIVE AGENTS|L4
6415|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6410|BPH (benign prostatic hypertrophy) products |G4C
6410|ANTIMETABOLITES|L1B
6409|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
6409|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
6402|Antigonadotrophin-releasing hormones|H1C3
6401|ANTI-ARRHYTHMICS|C1B
6399|ANTI-ARRHYTHMICS|C1B
6398|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6395|IMMUNOSTIMULATING AGENTS|L3
6394|IMMUNOSUPPRESSIVE AGENTS|L4
6391|Factor VIII|B2D1
6389|ANTIVIRALS FOR SYSTEMIC USE|J5
6384|ANTIVIRALS FOR SYSTEMIC USE|J5
6383|DRUGS USED IN DIABETES|A10
6381|MUSCULO-SKELETAL SYSTEM|M
6381|Coxibs|M1A3
6379|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6377|TRANQUILLISERS|N5C
6372|ANTIPSYCHOTICS|N5A
6372|TRANQUILLISERS|N5C
6371|Topical dermatological antifungals|D1A1
6371|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6364|SYSTEMIC ANTIHISTAMINES|R6
6363|Urinary incontinence products|G4B4
6362|ANALGESICS|N2
6359|ANTIEMETICS AND ANTINAUSEANTS|A4
6359|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6348|ANALGESICS|N2
6346|ANTI-EPILEPTICS|N3
6346|ANTIPSYCHOTICS|N5A
6343|ANTIHYPERTENSIVES|C2
6343|CALCIUM ANTAGONISTS|C8
6342|ANTIVIRALS FOR SYSTEMIC USE|J5
6340|CEPHALOSPORINS|J1D
6337|ANTIPSYCHOTICS|N5A
6333|SYSTEMIC ANTIHISTAMINES|R6
6332|PLATELET AGGREGATION INHIBITORS|B1C
6321|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
6318|RADIODIAGNOSTIC AGENTS|T1G
6317|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6316|ANTIVIRALS FOR SYSTEMIC USE|J5
6312|ANALGESICS|N2
6309|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6308|ANTI-ACNE PREPARATIONS|D10
6306|ANTIVIRALS FOR SYSTEMIC USE|J5
6305|IMMUNOSUPPRESSIVE AGENTS|L4
6303|Coxibs|M1A3
6303|ANALGESICS|N2
6296|HUMAN INSULINS AND ANALOGUES|A10C
6296|Human insulins and analogues, intermediate-acting|A10C2
6292|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
6289|CARDIOVASCULAR SYSTEM|C
6288|ANALGESICS|N2
6288|ANTI-MIGRAINE PREPARATIONS|N2C
6288|ANTI-EPILEPTICS|N3
6281|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6280|SYSTEMIC ANTIBACTERIALS|J1
6279|SYSTEMIC ANTIBACTERIALS|J1
6278|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6278|PARASITOLOGY|P
6277|ANTIVIRALS FOR SYSTEMIC USE|J5
6276|SYSTEMIC ANTIBACTERIALS|J1
6276|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6273|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6269|ANTIVIRALS FOR SYSTEMIC USE|J5
6262|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6261|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
6260|SYSTEMIC ANTIBACTERIALS|J1
6259|ANALGESICS|N2
6258|ANTIHYPERTENSIVES|C2
6258|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6257|PLATELET AGGREGATION INHIBITORS|B1C
6256|ANTIHYPERTENSIVES|C2
6256|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6252|Factor VIII|B2D1
6243|PLATELET AGGREGATION INHIBITORS|B1C
6242|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
6241|Non-nucleoside reverse transcriptase inhibitors|J5C3
6240|SYSTEMIC ANTIBACTERIALS|J1
6239|ANTIPSYCHOTICS|N5A
6237|ANTIHYPERTENSIVES|C2
6236|ANTIVIRALS FOR SYSTEMIC USE|J5
6232|Coxibs|M1A3
6231|FIBRINOLYTICS|B1D
6226|ANTIHYPERTENSIVES|C2
6214|ANTIPSYCHOTICS|N5A
6214|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
6206|ANALGESICS|N2
6206|NOOTROPICS|N6D
6205|MACROLIDES AND SIMILAR TYPES|J1F
6204|ANALGESICS|N2
6203|ANTIHYPERTENSIVES|C2
6203|CALCIUM ANTAGONISTS|C8
6200|DIRECT THROMBIN INHIBITORS|B1E
6198|VACCINES|J7
6195|CALCITONINS|H4A
6194|ANTI-EPILEPTICS|N3A
6194|ANTIPSYCHOTICS|N5A
6193|ANTIPSYCHOTICS|N5A
6191|IMMUNOSTIMULATING AGENTS|L3
6189|ANTI-MIGRAINE PREPARATIONS|N2C
6189|ANTI-EPILEPTICS|N3
6189|ANTIPSYCHOTICS|N5A
6189|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
6186|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
6183|CENTRAL NERVOUS SYSTEM|N
6180|CARDIOVASCULAR SYSTEM|C
6180|ULTRASOUND AGENTS|T1F
6178|IMMUNOSTIMULATING AGENTS|L3
6168|ANTIHYPERTENSIVES|C2
6167|ANTI-ARRHYTHMICS|C1B
6164|ANTIVIRALS FOR SYSTEMIC USE|J5
6164|Interferons, alpha|L3B1
6162|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6162|SYSTEMIC ANTIBACTERIALS|J1
6161|ANTI-EPILEPTICS|N3
6159|VACCINES|J7
6158|ANTIHYPERTENSIVES|C2
6158|CALCIUM ANTAGONISTS|C8
6156|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6156|ANTIMETABOLITES|L1B
6154|ANTIVIRALS FOR SYSTEMIC USE|J5
6154|Interferons, alpha|L3B1
6153|ANTI-ARRHYTHMICS|C1B
6152|SYSTEMIC ANTIBACTERIALS|J1
6150|MUSCLE RELAXANTS, CENTRALLY ACTING|M3B
6149|ANTIHYPERTENSIVES|C2
6145|MACROLIDES AND SIMILAR TYPES|J1F
6144|NOOTROPICS|N6D
6141|ANTIPSYCHOTICS|N5A
6140|B2-STIMULANTS|R3A
6137|ANTI-MIGRAINE PREPARATIONS|N2C
6135|PARASITOLOGY|P
6134|ANTIVIRALS FOR SYSTEMIC USE|J5
6132|PLATELET AGGREGATION INHIBITORS|B1C
6132|ANTIHYPERTENSIVES|C2
6130|Inhibitors of the Kallikrein-kinin-system|B2C2
6129|IMMUNOSTIMULATING AGENTS|L3
6128|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
6119|GASTROPROKINETICS|A3F
6119|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
6118|ANALGESICS|N2
6114|MUSCULO-SKELETAL SYSTEM|M
6112|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
6111|ANTIHYPERTENSIVES|C2
6111|CALCIUM ANTAGONISTS|C8
6110|ALKYLATING AGENTS|L1A
6108|ANTIVIRALS FOR SYSTEMIC USE|J5
6108|Interferons, alpha|L3B1
6106|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6106|ANTI-ACNE PREPARATIONS|D10
6104|ANTIULCERANTS|A2B
6104|SYSTEMIC ANTIBACTERIALS|J1
6101|DRUGS USED IN DIABETES|A10
6100|ANALGESICS|N2
6099|PLATELET AGGREGATION INHIBITORS|B1C
6098|VITAMIN C, INCLUDING COMBINATIONS WITH MINERALS|A11G
6093|SYSTEMIC ANTIBACTERIALS|J1
6093|ANTIVIRALS FOR SYSTEMIC USE|J5
6091|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
6088|ANTI-EPILEPTICS|N3
6085|ANTI-ARRHYTHMICS|C1B
6083|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
6083|ANALGESICS|N2
6079|IMMUNOSTIMULATING AGENTS|L3
6078|ANTIHYPERTENSIVES|C2
6076|Coxibs|M1A3
6074|ANTIVIRALS FOR SYSTEMIC USE|J5
6074|PARASITOLOGY|P
6073|ANTIPSYCHOTICS|N5A
6073|TRANQUILLISERS|N5C
6071|Coxibs|M1A3
6071|ANALGESICS|N2
6071|ANTI-MIGRAINE PREPARATIONS|N2C
6069|ANALGESICS|N2
6069|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
6069|SSRI antidepressants|N6A4
6064|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
6062|ANTIHYPERTENSIVES|C2
6062|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
6051|DRUGS USED IN DIABETES|A10
6050|Biguanide antidiabetics|A10B2
6048|ANTI-EPILEPTICS|N3
6048|TRANQUILLISERS|N5C
6047|PARASITOLOGY|P
6046|ANTIVIRALS FOR SYSTEMIC USE|J5
6045|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
6043|ANTIPSYCHOTICS|N5A
6039|TRANQUILLISERS|N5C
6039|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
6039|SSRI antidepressants|N6A4
6039|SRNI antidepressants|N6A5
6033|ANTIHYPERTENSIVES|C2
6033|DIURETICS|C3
6027|ANAESTHETICS, GENERAL|N1A
6018|ANTITUSSIVES|R5D
6017|ANTIHYPERTENSIVES|C2
6017|ACE INHIBITORS, PLAIN|C9A
6015|BETA-BLOCKING AGENTS|C7
6015|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
6014|ANTIPSYCHOTICS|N5A
6014|Miotics and antiglaucoma preparations, topical|S1E2
6013|ANTIVIRALS FOR SYSTEMIC USE|J5
6012|ANTIVIRALS FOR SYSTEMIC USE|J5
6012|ANTI-EPILEPTICS|N3
6012|ANTI-EPILEPTICS|N3A
6012|OPHTHALMOLOGICALS|S1
6009|ANALGESICS|N2
6007|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
6006|IMMUNOSTIMULATING AGENTS|L3
6005|CARDIOVASCULAR SYSTEM|C
6004|ANTIHYPERTENSIVES|C2
6002|CEPHALOSPORINS|J1D
5999|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
5999|IMMUNOSUPPRESSIVE AGENTS|L4
5997|ANTIHYPERTENSIVES|C2
5995|ANTIHYPERTENSIVES|C2
5995|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5993|Coxibs|M1A3
5989|ANTIPSYCHOTICS|N5A
5988|ANTIVIRALS FOR SYSTEMIC USE|J5
5986|TRANQUILLISERS|N5C
5986|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5986|SRNI antidepressants|N6A5
5982|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5978|NOOTROPICS|N6D
5977|ULTRASOUND AGENTS|T1F
5975|SYSTEMIC ANTIBACTERIALS|J1
5975|CEPHALOSPORINS|J1D
5973|CEPHALOSPORINS|J1D
5972|CEPHALOSPORINS|J1D
5971|SYSTEMIC ANTIBACTERIALS|J1
5971|Monobactams|J1P1
5970|CEPHALOSPORINS|J1D
5969|SYSTEMIC ANTIBACTERIALS|J1
5969|CEPHALOSPORINS|J1D
5965|NOOTROPICS|N6D
5962|SYSTEMIC ANTIBACTERIALS|J1
5958|Topical dermatological antifungals|D1A1
5958|SYSTEMIC ANTIBACTERIALS|J1
5958|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5956|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5956|PARASITOLOGY|P
5955|SYSTEMIC ANTIBACTERIALS|J1
5955|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5954|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
5949|DIRECT THROMBIN INHIBITORS|B1E
5944|IMMUNOSUPPRESSIVE AGENTS|L4
5943|PLATELET AGGREGATION INHIBITORS|B1C
5943|ANTIHYPERTENSIVES|C2
5937|IMMUNOSUPPRESSIVE AGENTS|L4
5931|ANTIHYPERTENSIVES|C2
5931|BETA-BLOCKING AGENTS|C7
5929|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
5929|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5929|SRNI antidepressants|N6A5
5927|VACCINES|J7
5925|VACCINES|J7
5921|CALCITONINS|H4A
5919|ANTI-ARRHYTHMICS|C1B
5919|BETA-BLOCKING AGENTS|C7
5919|ANTI-MIGRAINE PREPARATIONS|N2C
5919|TRANQUILLISERS|N5C
5914|ANTIHYPERTENSIVES|C2
5913|TRANQUILLISERS|N5C
5912|NOOTROPICS|N6D
5911|ANTIVIRALS FOR SYSTEMIC USE|J5
5910|ANTIMETABOLITES|L1B
5909|ANTIHYPERTENSIVES|C2
5907|TRANQUILLISERS|N5C
5907|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5907|SSRI antidepressants|N6A4
5907|SRNI antidepressants|N6A5
5903|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5900|ALKYLATING AGENTS|L1A
5894|DIURETICS|C3
5891|ANALGESICS|N2
5889|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5889|SSRI antidepressants|N6A4
5885|CARDIOVASCULAR SYSTEM|C
5884|CARDIOVASCULAR SYSTEM|C
5883|CARDIOVASCULAR SYSTEM|C
5883|CALCIUM ANTAGONISTS|C8
5882|CARDIOVASCULAR SYSTEM|C
5882|CALCIUM ANTAGONISTS|C8
5881|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5871|ANTIHYPERTENSIVES|C2
5871|ANTI-MIGRAINE PREPARATIONS|N2C
5870|CARDIOVASCULAR SYSTEM|C
5867|PLATELET AGGREGATION INHIBITORS|B1C
5867|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5867|CARDIAC THERAPY|C1
5862|ANTIHYPERTENSIVES|C2
5862|ACE INHIBITORS, PLAIN|C9A
5859|ANTI-EPILEPTICS|N3A
5856|B2-STIMULANTS|R3A
5855|IMMUNOSUPPRESSIVE AGENTS|L4
5854|ANTI-ARRHYTHMICS|C1B
5854|CALCIUM ANTAGONISTS|C8
5852|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5845|TRANQUILLISERS|N5C
5841|ANTIPSYCHOTICS|N5A
5840|ANTIPSYCHOTICS|N5A
5834|ANTIVIRALS FOR SYSTEMIC USE|J5
5833|PLATELET AGGREGATION INHIBITORS|B1C
5827|SYSTEMIC ANTIBACTERIALS|J1
5826|TRANQUILLISERS|N5C
5826|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5825|SYSTEMIC ANTIBACTERIALS|J1
5822|IMMUNOSTIMULATING AGENTS|L3
5821|ANTIVIRALS FOR SYSTEMIC USE|J5
5820|IMMUNOSTIMULATING AGENTS|L3
5817|BPH (benign prostatic hypertrophy) products |G4C
5816|ANTIHYPERTENSIVES|C2
5816|BETA-BLOCKING AGENTS|C7
5811|ANTIHYPERTENSIVES|C2
5810|Coxibs|M1A3
5809|ANTI-EPILEPTICS|N3A
5808|ANTIHYPERTENSIVES|C2
5800|ANTIULCERANTS|A2B
5797|ANTIHYPERTENSIVES|C2
5797|BPH (benign prostatic hypertrophy) products |G4C
5796|IMMUNOSTIMULATING AGENTS|L3
5794|TRANQUILLISERS|N5C
5794|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5793|SYSTEMIC ANTIBACTERIALS|J1
5792|SYSTEMIC ANTIBACTERIALS|J1
5791|ALKYLATING AGENTS|L1A
5789|HUMAN INSULINS AND ANALOGUES|A10C
5787|ALKYLATING AGENTS|L1A
5785|PLATELET AGGREGATION INHIBITORS|B1C
5782|ALKYLATING AGENTS|L1A
5778|ANTI-EPILEPTICS|N3
5775|ANTIPSYCHOTICS|N5A
5773|ANTIMETABOLITES|L1B
5766|ANALGESICS|N2
5763|ANTI-MIGRAINE PREPARATIONS|N2C
5761|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
5758|ANTIHYPERTENSIVES|C2
5753|ANALGESICS|N2
5745|Protease inhibitors|J5C2
5742|Protease inhibitors|J5C2
5741|Protease inhibitors|J5C2
5737|Protease inhibitors|J5C2
5736|SYSTEMIC ANTIBACTERIALS|J1
5736|PARASITOLOGY|P
5734|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5733|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5731|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5731|PARASITOLOGY|P
5730|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5729|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5728|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5728|PARASITOLOGY|P
5727|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5725|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5722|SYSTEMIC ANTIBACTERIALS|J1
5720|SYSTEMIC ANTIBACTERIALS|J1
5717|SYSTEMIC ANTIBACTERIALS|J1
5716|CEPHALOSPORINS|J1D
5715|CEPHALOSPORINS|J1D
5709|CEPHALOSPORINS|J1D
5707|CEPHALOSPORINS|J1D
5705|SYSTEMIC ANTIBACTERIALS|J1
5703|SYSTEMIC ANTIBACTERIALS|J1
5701|SYSTEMIC ANTIBACTERIALS|J1
5697|WOUND HEALING AGENTS|D3
5697|SYSTEMIC ANTIBACTERIALS|J1
5696|SYSTEMIC ANTIBACTERIALS|J1
5692|SYSTEMIC ANTIBACTERIALS|J1
5692|CEPHALOSPORINS|J1D
5688|SYSTEMIC ANTIBACTERIALS|J1
5687|SYSTEMIC ANTIBACTERIALS|J1
5681|SYSTEMIC ANTIBACTERIALS|J1
5679|ANTIHYPERTENSIVES|C2
5675|PLATELET AGGREGATION INHIBITORS|B1C
5675|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5674|PLATELET AGGREGATION INHIBITORS|B1C
5674|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5672|DIRECT THROMBIN INHIBITORS|B1E
5669|ANTIHYPERTENSIVES|C2
5668|ANTIHYPERTENSIVES|C2
5666|ANTI-EPILEPTICS|N3
5665|ANALGESICS|N2
5665|ANTI-MIGRAINE PREPARATIONS|N2C
5665|ANTI-EPILEPTICS|N3
5665|TRANQUILLISERS|N5C
5665|NOOTROPICS|N6D
5661|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
5661|DRUGS USED IN DIABETES|A10
5661|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5660|DRUGS USED IN DIABETES|A10
5659|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5658|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5651|ANTIVIRALS FOR SYSTEMIC USE|J5
5648|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5647|ANTIHYPERTENSIVES|C2
5646|PLATELET AGGREGATION INHIBITORS|B1C
5646|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5645|DRUGS USED IN DIABETES|A10
5645|ANALGESICS|N2
5643|ANTIEMETICS AND ANTINAUSEANTS|A4
5643|ANTI-ARRHYTHMICS|C1B
5643|ANTI-MIGRAINE PREPARATIONS|N2C
5630|CALCIUM ANTAGONISTS|C8
5629|ANTIHYPERTENSIVES|C2
5629|CALCIUM ANTAGONISTS|C8
5628|CALCIUM ANTAGONISTS|C8
5624|SYSTEMIC ANTIBACTERIALS|J1
5623|SYSTEMIC ANTIBACTERIALS|J1
5622|SYSTEMIC ANTIBACTERIALS|J1
5615|CEPHALOSPORINS|J1D
5598|ALKYLATING AGENTS|L1A
5587|ANTIMETABOLITES|L1B
5584|ANTIMETABOLITES|L1B
5583|ANTIMETABOLITES|L1B
5582|ALKYLATING AGENTS|L1A
5574|ALKYLATING AGENTS|L1A
5571|ALKYLATING AGENTS|L1A
5570|ALKYLATING AGENTS|L1A
5556|ANTIHYPERTENSIVES|C2
5555|ANTIHYPERTENSIVES|C2
5554|ANTIHYPERTENSIVES|C2
5552|PLATELET AGGREGATION INHIBITORS|B1C
5551|PLATELET AGGREGATION INHIBITORS|B1C
5550|PLATELET AGGREGATION INHIBITORS|B1C
5549|PLATELET AGGREGATION INHIBITORS|B1C
5549|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5549|Fibrinogen|B2D5
5548|PLATELET AGGREGATION INHIBITORS|B1C
5548|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5548|Fibrinogen|B2D5
5547|DIRECT THROMBIN INHIBITORS|B1E
5546|DIRECT THROMBIN INHIBITORS|B1E
5536|ANALGESICS|N2
5535|ANTIHYPERTENSIVES|C2
5534|ANTIHYPERTENSIVES|C2
5534|CALCIUM ANTAGONISTS|C8
5532|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5531|CARDIOVASCULAR SYSTEM|C
5531|ANTIHYPERTENSIVES|C2
5531|BETA-BLOCKING AGENTS|C7
5530|ANTIPSYCHOTICS|N5A
5530|TRANQUILLISERS|N5C
5530|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5530|NOOTROPICS|N6D
5529|ANTI-EPILEPTICS|N3A
5528|PLATELET AGGREGATION INHIBITORS|B1C
5528|ANTIHYPERTENSIVES|C2
5527|PLATELET AGGREGATION INHIBITORS|B1C
5527|Coxibs|M1A3
5526|PLATELET AGGREGATION INHIBITORS|B1C
5526|Coxibs|M1A3
5523|GASTROPROKINETICS|A3F
5523|ANTIEMETICS AND ANTINAUSEANTS|A4
5521|TRANQUILLISERS|N5C
5518|NOOTROPICS|N6D
5514|ANTIHYPERTENSIVES|C2
5514|CALCIUM ANTAGONISTS|C8
5511|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5510|PLATELET AGGREGATION INHIBITORS|B1C
5508|EXPECTORANTS|R5C
5506|DIURETICS|C3
5505|ANTIHYPERTENSIVES|C2
5504|PLATELET AGGREGATION INHIBITORS|B1C
5503|ANTIHYPERTENSIVES|C2
5502|CALCIUM ANTAGONISTS|C8
5501|CALCIUM ANTAGONISTS|C8
5499|ANTIHYPERTENSIVES|C2
5499|CALCIUM ANTAGONISTS|C8
5498|CARDIOVASCULAR SYSTEM|C
5498|DIURETICS|C3
5496|CALCIUM ANTAGONISTS|C8
5494|ANTI-ARRHYTHMICS|C1B
5494|CALCIUM ANTAGONISTS|C8
5492|Protease inhibitors|J5C2
5490|ANTIHYPERTENSIVES|C2
5490|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5488|ANTIHYPERTENSIVES|C2
5488|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5487|ANTIHYPERTENSIVES|C2
5487|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5486|ANTIHYPERTENSIVES|C2
5486|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5483|ANTIHYPERTENSIVES|C2
5483|ACE INHIBITORS, PLAIN|C9A
5481|NOOTROPICS|N6D
5480|ANTIPSYCHOTICS|N5A
5479|PLATELET AGGREGATION INHIBITORS|B1C
5479|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5479|Fibrinogen|B2D5
5477|PLATELET AGGREGATION INHIBITORS|B1C
5455|ANTIHYPERTENSIVES|C2
5450|TRANQUILLISERS|N5C
5444|SYSTEMIC ANTIBACTERIALS|J1
5443|VACCINES|J7
5441|SYSTEMIC ANTIHISTAMINES|R6
5440|ANTIEMETICS AND ANTINAUSEANTS|A4
5439|GASTROPROKINETICS|A3F
5439|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
5436|ANTI-EPILEPTICS|N3A
5434|ANTI-EPILEPTICS|N3
5433|ANTI-EPILEPTICS|N3
5432|ANTI-EPILEPTICS|N3
5425|ANTIHYPERTENSIVES|C2
5422|DIURETICS|C3
5421|DRUGS USED IN DIABETES|A10
5420|SYSTEMIC ANTIBACTERIALS|J1
5418|SYSTEMIC ANTIBACTERIALS|J1
5417|SYSTEMIC ANTIBACTERIALS|J1
5416|CEPHALOSPORINS|J1D
5415|IMMUNOSTIMULATING AGENTS|L3
5414|ANTIHYPERTENSIVES|C2
5413|ANTIHYPERTENSIVES|C2
5412|ANTIHYPERTENSIVES|C2
5412|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5411|Coxibs|M1A3
5409|PLATELET AGGREGATION INHIBITORS|B1C
5408|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
5408|ANTI-GOUT PREPARATIONS|M4
5406|ANALGESICS|N2
5405|PLATELET AGGREGATION INHIBITORS|B1C
5404|ANTIHYPERTENSIVES|C2
5404|DIURETICS|C3
5400|CARDIOVASCULAR SYSTEM|C
5400|ANTI-ARRHYTHMICS|C1B
5391|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
5391|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5388|IMMUNOSUPPRESSIVE AGENTS|L4
5384|ANTIHYPERTENSIVES|C2
5381|ANALGESICS|N2
5379|PLATELET AGGREGATION INHIBITORS|B1C
5379|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5379|Fibrinogen|B2D5
5369|ANTIVIRALS FOR SYSTEMIC USE|J5
5368|ANTI-EPILEPTICS|N3
5368|NOOTROPICS|N6D
5359|CALCIUM ANTAGONISTS|C8
5359|NOOTROPICS|N6D
5358|B2-STIMULANTS|R3A
5357|NOOTROPICS|N6D
5356|ANAESTHETICS, GENERAL|N1A
5355|LUNG SURFACTANTS|R7C
5353|ANTI-ACNE PREPARATIONS|D10
5349|CARDIOVASCULAR SYSTEM|C
5349|ULTRASOUND AGENTS|T1F
5341|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5334|PLATELET AGGREGATION INHIBITORS|B1C
5334|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
5334|CARDIOVASCULAR SYSTEM|C
5333|ANTIHYPERTENSIVES|C2
5333|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5331|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5328|ANTI-MIGRAINE PREPARATIONS|N2C
5321|Protease inhibitors|J5C2
5319|ANTI-ACNE PREPARATIONS|D10
5319|BPH (benign prostatic hypertrophy) products |G4C
5317|Non-nucleoside reverse transcriptase inhibitors|J5C3
5315|ANTIHYPERTENSIVES|C2
5315|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5314|ANTIHYPERTENSIVES|C2
5314|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5312|ANTIULCERANTS|A2B
5312|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5309|ANTI-EPILEPTICS|N3
5309|TRANQUILLISERS|N5C
5308|ANTI-ACNE PREPARATIONS|D10
5308|SYSTEMIC ANTIBACTERIALS|J1
5307|DRUGS USED IN DIABETES|A10
5306|Protease inhibitors|J5C2
5301|Alpha-glucosidase inhibitor antidiabetics|A10B5
5301|ANTIVIRALS FOR SYSTEMIC USE|J5
5298|ANTIHYPERTENSIVES|C2
5298|ACE INHIBITORS, PLAIN|C9A
5296|Coxibs|M1A3
5296|ANALGESICS|N2
5295|Protease inhibitors|J5C2
5293|ANTIHYPERTENSIVES|C2
5293|BPH (benign prostatic hypertrophy) products |G4C
5293|ANTI-MIGRAINE PREPARATIONS|N2C
5290|ANALGESICS|N2
5288|ANALGESICS|N2
5281|ANTIHYPERTENSIVES|C2
5281|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5272|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
5271|TRANQUILLISERS|N5C
5268|TRANQUILLISERS|N5C
5266|ANTIHYPERTENSIVES|C2
5266|BPH (benign prostatic hypertrophy) products |G4C
5265|ANTI-MIGRAINE PREPARATIONS|N2C
5265|ANTI-EPILEPTICS|N3
5262|ANTIHYPERTENSIVES|C2
5259|PLATELET AGGREGATION INHIBITORS|B1C
5259|CARDIOVASCULAR SYSTEM|C
5258|ANTIHYPERTENSIVES|C2
5258|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5256|ANTIVIRALS FOR SYSTEMIC USE|J5
5254|ANALGESICS|N2
5225|ANTIPSYCHOTICS|N5A
5205|IMMUNOSUPPRESSIVE AGENTS|L4
5204|IMMUNOSUPPRESSIVE AGENTS|L4
5203|IMMUNOSUPPRESSIVE AGENTS|L4
5199|ANTI-EPILEPTICS|N3A
5197|BPH (benign prostatic hypertrophy) products |G4C
5190|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
5188|ANALGESICS|N2
5188|TRANQUILLISERS|N5C
5186|Factor VIII|B2D1
5178|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
5151|CARDIOVASCULAR SYSTEM|C
5151|ANTIHYPERTENSIVES|C2
5150|TRANQUILLISERS|N5C
5149|ANALGESICS|N2
5148|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
5147|ANTI-ARRHYTHMICS|C1B
5141|ANTI-ARRHYTHMICS|C1B
5141|BETA-BLOCKING AGENTS|C7
5141|CALCIUM ANTAGONISTS|C8
5138|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
5137|IMMUNOSUPPRESSIVE AGENTS|L4
5130|TRANQUILLISERS|N5C
5125|TRANQUILLISERS|N5C
5125|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5121|Vitamin K|B2B1
5120|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
5119|ANTIVIRALS FOR SYSTEMIC USE|J5
5115|ANTIHYPERTENSIVES|C2
5115|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
5113|ANTIHYPERTENSIVES|C2
5111|TRANQUILLISERS|N5C
5110|ANTIHYPERTENSIVES|C2
5110|TRANQUILLISERS|N5C
5108|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
5108|Statins (HMG-CoA reductase inhibitors)|C10A1
5051|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
5051|ANTIHYPERTENSIVES|C2
5051|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
5048|ANTIHYPERTENSIVES|C2
5033|ANTIEMETICS AND ANTINAUSEANTS|A4
5033|TRANQUILLISERS|N5C
5033|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
5032|ANTIPSYCHOTICS|N5A
5032|TRANQUILLISERS|N5C
5030|ANALGESICS|N2
5024|ANTIHYPERTENSIVES|C2
5024|ANTI-EPILEPTICS|N3A
5024|ANTIPSYCHOTICS|N5A
5023|ANTI-EPILEPTICS|N3
5023|ANTI-EPILEPTICS|N3A
5022|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4996|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4993|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4992|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4991|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4990|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4989|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4989|Statins (HMG-CoA reductase inhibitors)|C10A1
4988|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4987|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4986|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4985|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4984|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4974|ANTIHYPERTENSIVES|C2
4972|ANTIHYPERTENSIVES|C2
4972|DIURETICS|C3
4971|ANTIHYPERTENSIVES|C2
4971|DIURETICS|C3
4965|ANTIHYPERTENSIVES|C2
4963|ANTIHYPERTENSIVES|C2
4960|ANTIHYPERTENSIVES|C2
4959|ANTIHYPERTENSIVES|C2
4958|ANTIHYPERTENSIVES|C2
4957|ANTIHYPERTENSIVES|C2
4956|ANTIHYPERTENSIVES|C2
4955|ANTIHYPERTENSIVES|C2
4954|ANTIHYPERTENSIVES|C2
4950|ANTIHYPERTENSIVES|C2
4948|ANTIHYPERTENSIVES|C2
4946|ANTIHYPERTENSIVES|C2
4945|ANTIHYPERTENSIVES|C2
4944|ANTIHYPERTENSIVES|C2
4943|ANTIHYPERTENSIVES|C2
4941|ANTIHYPERTENSIVES|C2
4935|ANTIHYPERTENSIVES|C2
4935|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
4931|ANTIHYPERTENSIVES|C2
4931|ACE INHIBITORS, PLAIN|C9A
4929|ANTIHYPERTENSIVES|C2
4929|ACE INHIBITORS, PLAIN|C9A
4927|ANTIHYPERTENSIVES|C2
4927|ACE INHIBITORS, PLAIN|C9A
4926|ANTIHYPERTENSIVES|C2
4926|ACE INHIBITORS, PLAIN|C9A
4925|ANTIHYPERTENSIVES|C2
4925|ACE INHIBITORS, PLAIN|C9A
4924|ANTIHYPERTENSIVES|C2
4924|ACE INHIBITORS, PLAIN|C9A
4921|NOOTROPICS|N6D
4920|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
4919|CALCIUM ANTAGONISTS|C8
4918|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4918|SRNI antidepressants|N6A5
4916|NOOTROPICS|N6D
4916|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
4914|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4914|ANTI-EPILEPTICS|N3A
4911|NOOTROPICS|N6D
4910|NOOTROPICS|N6D
4908|ANALGESICS|N2
4908|ANTI-EPILEPTICS|N3A
4906|NOOTROPICS|N6D
4903|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4903|NOOTROPICS|N6D
4902|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4902|SRNI antidepressants|N6A5
4902|NOOTROPICS|N6D
4901|ANTI-EPILEPTICS|N3
4901|ANTI-EPILEPTICS|N3A
4900|NOOTROPICS|N6D
4899|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4898|SRNI antidepressants|N6A5
4898|NOOTROPICS|N6D
4897|ANTIPSYCHOTICS|N5A
4896|NOOTROPICS|N6D
4896|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
4894|ANTI-EPILEPTICS|N3A
4892|ANTI-EPILEPTICS|N3A
4891|ANTI-EPILEPTICS|N3A
4888|NOOTROPICS|N6D
4886|NOOTROPICS|N6D
4885|ANTIEMETICS AND ANTINAUSEANTS|A4
4884|ANTIPSYCHOTICS|N5A
4884|TRANQUILLISERS|N5C
4883|TRANQUILLISERS|N5C
4882|ANTIHYPERTENSIVES|C2
4881|ANTIPSYCHOTICS|N5A
4881|TRANQUILLISERS|N5C
4879|ANTIHYPERTENSIVES|C2
4876|ANTIPSYCHOTICS|N5A
4875|ANTI-MIGRAINE PREPARATIONS|N2C
4872|TRANQUILLISERS|N5C
4871|TRANQUILLISERS|N5C
4870|ANTIPSYCHOTICS|N5A
4869|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4864|ANTIHYPERTENSIVES|C2
4860|ANTIEMETICS AND ANTINAUSEANTS|A4
4858|MUSCLE RELAXANTS|M3
4858|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4858|SSRI antidepressants|N6A4
4858|SRNI antidepressants|N6A5
4857|TRANQUILLISERS|N5C
4855|TRANQUILLISERS|N5C
4855|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4853|ANTIPSYCHOTICS|N5A
4853|HYPNOTICS/SEDATIVES|N5B
4853|TRANQUILLISERS|N5C
4853|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4850|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4850|SSRI antidepressants|N6A4
4846|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4846|SSRI antidepressants|N6A4
4845|ANTI-EPILEPTICS|N3A
4845|ANTIPSYCHOTICS|N5A
4844|TRANQUILLISERS|N5C
4843|ANTI-MIGRAINE PREPARATIONS|N2C
4842|ANTIEMETICS AND ANTINAUSEANTS|A4
4840|TRANQUILLISERS|N5C
4838|TRANQUILLISERS|N5C
4838|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4837|TRANQUILLISERS|N5C
4836|ANTIEMETICS AND ANTINAUSEANTS|A4
4834|ANTI-MIGRAINE PREPARATIONS|N2C
4833|TRANQUILLISERS|N5C
4833|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4833|SSRI antidepressants|N6A4
4832|ANTI-MIGRAINE PREPARATIONS|N2C
4832|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4831|TRANQUILLISERS|N5C
4830|ANALGESICS|N2
4829|ANTIEMETICS AND ANTINAUSEANTS|A4
4828|ANTIHYPERTENSIVES|C2
4825|ANTI-ARRHYTHMICS|C1B
4823|ANTI-ARRHYTHMICS|C1B
4822|ANTIHYPERTENSIVES|C2
4821|ANTIHYPERTENSIVES|C2
4819|ANTI-ARRHYTHMICS|C1B
4816|ANTI-ARRHYTHMICS|C1B
4815|ANTIHYPERTENSIVES|C2
4814|ANTI-ARRHYTHMICS|C1B
4813|ANTIHYPERTENSIVES|C2
4812|ANTIHYPERTENSIVES|C2
4810|ANTIHYPERTENSIVES|C2
4810|Urinary incontinence products|G4B4
4746|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4745|ANTIHYPERTENSIVES|C2
4743|PLATELET AGGREGATION INHIBITORS|B1C
4736|ANTI-MIGRAINE PREPARATIONS|N2C
4735|ANTIVIRALS FOR SYSTEMIC USE|J5
4734|MUSCLE RELAXANTS, PERIPHERALLY ACTING|M3A
4733|ANTIHYPERTENSIVES|C2
4733|Erectile dysfunction products|G4B3
4732|ANTI-MIGRAINE PREPARATIONS|N2C
4728|ANTIVIRALS FOR SYSTEMIC USE|J5
4728|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
4727|CARDIOVASCULAR SYSTEM|C
4726|ANTIPSYCHOTICS|N5A
4725|ANALGESICS|N2
4723|HYPNOTICS/SEDATIVES|N5B
4722|IMMUNOSUPPRESSIVE AGENTS|L4
4720|PLATELET AGGREGATION INHIBITORS|B1C
4718|ANTI-ACNE PREPARATIONS|D10
4716|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
4715|ANTIEMETICS AND ANTINAUSEANTS|A4
4715|ANTI-MIGRAINE PREPARATIONS|N2C
4715|TRANQUILLISERS|N5C
4713|BPH (benign prostatic hypertrophy) products |G4C
4710|TRANQUILLISERS|N5C
4707|ANTIEMETICS AND ANTINAUSEANTS|A4
4706|ANTIHYPERTENSIVES|C2
4706|ACE INHIBITORS, PLAIN|C9A
4704|ANTIHYPERTENSIVES|C2
4704|Urinary incontinence products|G4B4
4702|FIBRINOLYTICS|B1D
4701|NOOTROPICS|N6D
4701|OPHTHALMOLOGICALS|S1
4700|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4697|ANTIHYPERTENSIVES|C2
4696|ANTIHYPERTENSIVES|C2
4696|BETA-BLOCKING AGENTS|C7
4696|CALCIUM ANTAGONISTS|C8
4694|PLATELET AGGREGATION INHIBITORS|B1C
4694|ANTIHYPERTENSIVES|C2
4693|ANTIHYPERTENSIVES|C2
4691|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4689|IMMUNOSUPPRESSIVE AGENTS|L4
4688|ANTIEMETICS AND ANTINAUSEANTS|A4
4685|PLATELET AGGREGATION INHIBITORS|B1C
4685|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4684|IMMUNOSTIMULATING AGENTS|L3
4682|IMMUNOSUPPRESSIVE AGENTS|L4
4681|ANTIPSYCHOTICS|N5A
4680|ANALGESICS|N2
4679|ANTIHYPERTENSIVES|C2
4678|TRANQUILLISERS|N5C
4678|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4677|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4677|IMMUNOSUPPRESSIVE AGENTS|L4
4676|ANTIPSYCHOTICS|N5A
4671|ANTIVIRALS FOR SYSTEMIC USE|J5
4670|CENTRAL NERVOUS SYSTEM|N
4667|ANTI-ARRHYTHMICS|C1B
4665|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4665|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4662|Coxibs|M1A3
4661|ANTIPSYCHOTICS|N5A
4661|TRANQUILLISERS|N5C
4659|NOOTROPICS|N6D
4658|DRUGS USED IN DIABETES|A10
4658|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4658|IMMUNOSUPPRESSIVE AGENTS|L4
4658|ANTI-EPILEPTICS|N3A
4657|ANTIVIRALS FOR SYSTEMIC USE|J5
4652|NOOTROPICS|N6D
4651|ANTI-MIGRAINE PREPARATIONS|N2C
4651|ANTI-EPILEPTICS|N3
4648|ANALGESICS|N2
4648|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4648|SSRI antidepressants|N6A4
4648|SRNI antidepressants|N6A5
4647|NOOTROPICS|N6D
4647|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
4644|ANALGESICS|N2
4641|FIBRINOLYTICS|B1D
4638|PARASITOLOGY|P
4637|PARASITOLOGY|P
4635|SYSTEMIC ANTIBACTERIALS|J1
4635|PARASITOLOGY|P
4634|ANTIHYPERTENSIVES|C2
4634|Miotics and antiglaucoma preparations, topical|S1E2
4633|PLATELET AGGREGATION INHIBITORS|B1C
4633|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4630|ANTI-EPILEPTICS|N3A
4629|TRANQUILLISERS|N5C
4622|ANTI-EPILEPTICS|N3A
4621|ANTIVIRALS FOR SYSTEMIC USE|J5
4618|Protease inhibitors|J5C2
4616|NOOTROPICS|N6D
4614|CARDIOVASCULAR SYSTEM|C
4613|SYSTEMIC ANTIBACTERIALS|J1
4612|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4611|Protease inhibitors|J5C2
4610|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4609|ANTIULCERANTS|A2B
4609|PLATELET AGGREGATION INHIBITORS|B1C
4609|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4608|ANTI-EPILEPTICS|N3
4607|ANTIHYPERTENSIVES|C2
4603|VACCINES|J7
4598|IMMUNOSTIMULATING AGENTS|L3
4595|ANTIEMETICS AND ANTINAUSEANTS|A4
4593|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4593|PARASITOLOGY|P
4590|PLATELET AGGREGATION INHIBITORS|B1C
4590|NOOTROPICS|N6D
4587|NOOTROPICS|N6D
4586|NOOTROPICS|N6D
4582|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
4580|ANTIHYPERTENSIVES|C2
4580|ACE INHIBITORS, PLAIN|C9A
4579|ANALGESICS|N2
4579|SSRI antidepressants|N6A4
4579|SRNI antidepressants|N6A5
4576|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
4576|ANTIHYPERTENSIVES|C2
4576|ANTI-MIGRAINE PREPARATIONS|N2C
4576|ANTI-EPILEPTICS|N3
4573|ANTI-EPILEPTICS|N3A
4573|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4571|DERMATOLOGICALS|D
4567|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4567|ANTIVIRALS FOR SYSTEMIC USE|J5
4567|IMMUNOSUPPRESSIVE AGENTS|L4
4565|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4565|PARASITOLOGY|P
4562|IMMUNOSTIMULATING AGENTS|L3
4559|IMMUNOSUPPRESSIVE AGENTS|L4
4554|ANTI-EPILEPTICS|N3
4552|FIBRINOLYTICS|B1D
4552|DIRECT THROMBIN INHIBITORS|B1E
4551|DIRECT THROMBIN INHIBITORS|B1E
4549|NOOTROPICS|N6D
4548|SYSTEMIC ANTIBACTERIALS|J1
4545|IMMUNOSTIMULATING AGENTS|L3
4539|SYSTEMIC ANTIBACTERIALS|J1
4537|CALCIUM ANTAGONISTS|C8
4537|Urinary incontinence products|G4B4
4536|ANTIHYPERTENSIVES|C2
4535|ANTIHYPERTENSIVES|C2
4535|PROLACTIN INHIBITORS|G2D
4535|ANALGESICS|N2
4535|ANTI-EPILEPTICS|N3A
4534|Urinary incontinence products|G4B4
4533|Systemic dermatological antifungals|D1A2
4533|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4531|Coxibs|M1A3
4531|ANALGESICS|N2
4530|Coxibs|M1A3
4529|ALKYLATING AGENTS|L1A
4528|ANTIHYPERTENSIVES|C2
4528|ACE INHIBITORS, PLAIN|C9A
4525|ANALGESICS|N2
4523|PLATELET AGGREGATION INHIBITORS|B1C
4523|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4523|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4522|ANTI-ARRHYTHMICS|C1B
4522|ANTIHYPERTENSIVES|C2
4522|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
4522|ANTI-MIGRAINE PREPARATIONS|N2C
4519|ALKYLATING AGENTS|L1A
4518|IMMUNOSTIMULATING AGENTS|L3
4517|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4516|SYSTEMIC ANTIBACTERIALS|J1
4515|IMMUNOSUPPRESSIVE AGENTS|L4
4514|SYSTEMIC ANTIBACTERIALS|J1
4512|ANTI-EPILEPTICS|N3A
4512|ANTIPSYCHOTICS|N5A
4512|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
4511|SYSTEMIC ANTIBACTERIALS|J1
4510|IMMUNOSUPPRESSIVE AGENTS|L4
4509|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
4508|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
4507|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4506|IMMUNOSUPPRESSIVE AGENTS|L4
4505|B2-STIMULANTS|R3A
4503|NOOTROPICS|N6D
4502|GASTROPROKINETICS|A3F
4500|ANTIHYPERTENSIVES|C2
4500|DIURETICS|C3
4500|ACE INHIBITORS, PLAIN|C9A
4498|TRANQUILLISERS|N5C
4497|ANTI-ARRHYTHMICS|C1B
4491|ANTI-MIGRAINE PREPARATIONS|N2C
4491|TRANQUILLISERS|N5C
4489|PLATELET AGGREGATION INHIBITORS|B1C
4487|PLATELET AGGREGATION INHIBITORS|B1C
4487|CARDIOVASCULAR SYSTEM|C
4486|DERMATOLOGICALS|D
4486|ANTI-ACNE PREPARATIONS|D10
4485|IMMUNOSTIMULATING AGENTS|L3
4479|IMMUNOSTIMULATING AGENTS|L3
4478|CARDIOVASCULAR SYSTEM|C
4475|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
4475|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4475|TRANQUILLISERS|N5C
4475|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4474|NOOTROPICS|N6D
4473|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4472|ANTIEMETICS AND ANTINAUSEANTS|A4
4472|CARDIOVASCULAR SYSTEM|C
4472|ANTIHYPERTENSIVES|C2
4472|DIURETICS|C3
4471|Urinary incontinence products|G4B4
4471|ANALGESICS|N2
4471|TRANQUILLISERS|N5C
4471|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4470|ANTIPSYCHOTICS|N5A
4469|ANTIHYPERTENSIVES|C2
4466|ANTIPSYCHOTICS|N5A
4466|HYPNOTICS/SEDATIVES|N5B
4466|TRANQUILLISERS|N5C
4466|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4463|ANTIHYPERTENSIVES|C2
4463|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
4461|Protease inhibitors|J5C2
4460|CALCIUM ANTAGONISTS|C8
4459|CALCIUM ANTAGONISTS|C8
4458|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4458|IMMUNOSUPPRESSIVE AGENTS|L4
4457|ANTIPSYCHOTICS|N5A
4455|ANTIPSYCHOTICS|N5A
4451|ANTI-MIGRAINE PREPARATIONS|N2C
4450|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4450|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4449|ANTIVIRALS FOR SYSTEMIC USE|J5
4448|PLATELET AGGREGATION INHIBITORS|B1C
4447|ANTIHYPERTENSIVES|C2
4447|CALCIUM ANTAGONISTS|C8
4446|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4445|ANTIHYPERTENSIVES|C2
4445|CALCIUM ANTAGONISTS|C8
4444|ANTIHYPERTENSIVES|C2
4444|DIURETICS|C3
4441|ANTIHYPERTENSIVES|C2
4441|ACE INHIBITORS, PLAIN|C9A
4440|SYSTEMIC ANTIBACTERIALS|J1
4437|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4431|DRUGS USED IN DIABETES|A10
4430|DRUGS USED IN DIABETES|A10
4429|DRUGS USED IN DIABETES|A10
4429|MUSCULO-SKELETAL SYSTEM|M
4427|CARDIOVASCULAR SYSTEM|C
4427|ANALGESICS|N2
4425|SYSTEMIC ANTIBACTERIALS|J1
4425|ANTIVIRALS FOR SYSTEMIC USE|J5
4421|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4419|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4416|GROWTH HORMONES|H4C
4415|Protease inhibitors|J5C2
4414|ANTIHYPERTENSIVES|C2
4414|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
4413|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4413|IMMUNOSTIMULATING AGENTS|L3
4412|PLATELET AGGREGATION INHIBITORS|B1C
4412|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4411|PLATELET AGGREGATION INHIBITORS|B1C
4411|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4409|Coxibs|M1A3
4409|ANALGESICS|N2
4408|ANTIVIRALS FOR SYSTEMIC USE|J5
4408|IMMUNOSUPPRESSIVE AGENTS|L4
4407|ANTI-ACNE PREPARATIONS|D10
4407|BPH (benign prostatic hypertrophy) products |G4C
4405|FIBRINOLYTICS|B1D
4404|ANTIHYPERTENSIVES|C2
4403|CARDIOVASCULAR SYSTEM|C
4401|ANTIPSYCHOTICS|N5A
4401|TRANQUILLISERS|N5C
4396|ANTIHYPERTENSIVES|C2
4396|CALCIUM ANTAGONISTS|C8
4395|ANTI-ARRHYTHMICS|C1B
4392|ANTIHYPERTENSIVES|C2
4391|HYPNOTICS/SEDATIVES|N5B
4391|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4391|NOOTROPICS|N6D
4390|IMMUNOSTIMULATING AGENTS|L3
4387|NOOTROPICS|N6D
4387|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
4385|IMMUNOSUPPRESSIVE AGENTS|L4
4382|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4382|IMMUNOSTIMULATING AGENTS|L3
4380|DIRECT THROMBIN INHIBITORS|B1E
4379|NOOTROPICS|N6D
4379|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
4378|NOOTROPICS|N6D
4377|FIBRINOLYTICS|B1D
4374|ANTIHYPERTENSIVES|C2
4373|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4372|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4372|SYSTEMIC ANTIHISTAMINES|R6
4371|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4370|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
4370|CENTRAL NERVOUS SYSTEM|N
4370|ANTIPSYCHOTICS|N5A
4369|PLATELET AGGREGATION INHIBITORS|B1C
4369|SYSTEMIC ANTIHISTAMINES|R6
4368|SYSTEMIC ANTIBACTERIALS|J1
4367|ANTIEMETICS AND ANTINAUSEANTS|A4
4364|Protease inhibitors|J5C2
4363|ANTIEMETICS AND ANTINAUSEANTS|A4
4362|PLATELET AGGREGATION INHIBITORS|B1C
4362|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4361|ANTIHYPERTENSIVES|C2
4361|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
4360|ANTIHYPERTENSIVES|C2
4360|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
4359|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4358|ANTIHYPERTENSIVES|C2
4358|ACE INHIBITORS, PLAIN|C9A
4356|PLATELET AGGREGATION INHIBITORS|B1C
4356|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4352|ANTIHYPERTENSIVES|C2
4352|DIURETICS|C3
4351|DERMATOLOGICALS|D
4350|SYSTEMIC ANTIBACTERIALS|J1
4350|PARASITOLOGY|P
4349|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4345|ANTIHYPERTENSIVES|C2
4345|DIURETICS|C3
4343|PLATELET AGGREGATION INHIBITORS|B1C
4343|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4342|PLATELET AGGREGATION INHIBITORS|B1C
4340|FIBRINOLYTICS|B1D
4339|PLATELET AGGREGATION INHIBITORS|B1C
4338|NOOTROPICS|N6D
4331|NOOTROPICS|N6D
4330|ANTI-MIGRAINE PREPARATIONS|N2C
4330|SSRI antidepressants|N6A4
4330|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
4328|ANTIHYPERTENSIVES|C2
4326|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4325|ANTI-ARRHYTHMICS|C1B
4325|ANTIHYPERTENSIVES|C2
4325|CALCIUM ANTAGONISTS|C8
4324|ANTIPSYCHOTICS|N5A
4324|TRANQUILLISERS|N5C
4324|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4323|PLATELET AGGREGATION INHIBITORS|B1C
4322|ANTIPSYCHOTICS|N5A
4322|TRANQUILLISERS|N5C
4322|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4320|Coxibs|M1A3
4320|ANALGESICS|N2
4318|SYSTEMIC ANTIHISTAMINES|R6
4317|ANTIDIURETIC HORMONES|H4D
4317|NOOTROPICS|N6D
4316|SYSTEMIC ANTIBACTERIALS|J1
4316|CEPHALOSPORINS|J1D
4315|CEPHALOSPORINS|J1D
4313|MRI AGENTS|T1E
4312|MRI AGENTS|T1E
4311|ANTIHYPERTENSIVES|C2
4311|CALCIUM ANTAGONISTS|C8
4310|PLATELET AGGREGATION INHIBITORS|B1C
4310|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4310|DIRECT THROMBIN INHIBITORS|B1E
4309|ANTIHYPERTENSIVES|C2
4309|CALCIUM ANTAGONISTS|C8
4308|CARDIOVASCULAR SYSTEM|C
4308|CALCIUM ANTAGONISTS|C8
4307|CALCIUM ANTAGONISTS|C8
4302|NOOTROPICS|N6D
4300|NOOTROPICS|N6D
4299|ANTIHYPERTENSIVES|C2
4299|DIURETICS|C3
4296|ANTIVIRALS FOR SYSTEMIC USE|J5
4295|ALKYLATING AGENTS|L1A
4294|CARDIOVASCULAR SYSTEM|C
4294|ANTIHYPERTENSIVES|C2
4294|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4291|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4290|CALCIUM ANTAGONISTS|C8
4288|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4287|ANTI-ARRHYTHMICS|C1B
4286|Erectile dysfunction products|G4B3
4284|ANALGESICS|N2
4283|SYSTEMIC ANTIBACTERIALS|J1
4283|PARASITOLOGY|P
4282|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4280|Coxibs|M1A3
4278|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4276|ANALGESICS|N2
4275|SYSTEMIC ANTIBACTERIALS|J1
4274|PROLACTIN INHIBITORS|G2D
4274|ANTIPSYCHOTICS|N5A
4274|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4274|SSRI antidepressants|N6A4
4271|ANAESTHETICS, LOCAL|N1B
4271|ANALGESICS|N2
4270|ANTI-ARRHYTHMICS|C1B
4269|ANTI-EPILEPTICS|N3A
4269|ANTIPSYCHOTICS|N5A
4268|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4268|NOOTROPICS|N6D
4264|PLATELET AGGREGATION INHIBITORS|B1C
4264|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
4263|PARASITOLOGY|P
4263|ANTI-MALARIALS|P1D
4261|ANTIHYPERTENSIVES|C2
4260|NOOTROPICS|N6D
4259|Protease inhibitors|J5C2
4257|ANTIHYPERTENSIVES|C2
4257|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4254|Carbapenems|J1P2
4254|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4253|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4252|CEPHALOSPORINS|J1D
4251|ANTIVIRALS FOR SYSTEMIC USE|J5
4250|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4248|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4247|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4246|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4245|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4244|ANTI-ARRHYTHMICS|C1B
4243|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4242|CALCIUM ANTAGONISTS|C8
4242|PARASITOLOGY|P
4241|DIRECT THROMBIN INHIBITORS|B1E
4240|CEPHALOSPORINS|J1D
4240|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4237|ANTIPSYCHOTICS|N5A
4237|TRANQUILLISERS|N5C
4237|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4236|ANTIPSYCHOTICS|N5A
4235|ANTI-ARRHYTHMICS|C1B
4235|ANTIHYPERTENSIVES|C2
4232|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
4230|SYSTEMIC ANTIBACTERIALS|J1
4229|SYSTEMIC ANTIBACTERIALS|J1
4228|PLATELET AGGREGATION INHIBITORS|B1C
4225|CARDIOVASCULAR SYSTEM|C
4225|CARDIAC THERAPY|C1
4225|ANTI-ARRHYTHMICS|C1B
4225|PARASITOLOGY|P
4225|LUNG SURFACTANTS|R7C
4224|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
4220|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
4217|ANTIEMETICS AND ANTINAUSEANTS|A4
4215|DRUGS USED IN DIABETES|A10
4215|Glitazone antidiabetics|A10B4
4214|CARDIOVASCULAR SYSTEM|C
4211|GASTROPROKINETICS|A3F
4209|ANTIHYPERTENSIVES|C2
4208|ANAESTHETICS, GENERAL|N1A
4208|ANALGESICS|N2
4206|CARDIOVASCULAR SYSTEM|C
4206|ANTIHYPERTENSIVES|C2
4205|ANTI-ARRHYTHMICS|C1B
4204|ANTI-MIGRAINE PREPARATIONS|N2C
4204|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4204|SRNI antidepressants|N6A5
4202|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
4202|Statins (HMG-CoA reductase inhibitors)|C10A1
4200|IMMUNOSUPPRESSIVE AGENTS|L4
4198|SYSTEMIC ANTIBACTERIALS|J1
4197|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
4196|CARDIOVASCULAR SYSTEM|C
4196|ANTIHYPERTENSIVES|C2
4196|ACE INHIBITORS, PLAIN|C9A
4187|ANTIHYPERTENSIVES|C2
4182|Erectile dysfunction products|G4B3
4182|ANTI-EPILEPTICS|N3A
4181|ANTIHYPERTENSIVES|C2
4181|ACE INHIBITORS, PLAIN|C9A
4180|HYPNOTICS/SEDATIVES|N5B
4180|TRANQUILLISERS|N5C
4179|ANTIVIRALS FOR SYSTEMIC USE|J5
4178|SYSTEMIC ANTIBACTERIALS|J1
4176|SYSTEMIC ANTIBACTERIALS|J1
4168|FIBRINOLYTICS|B1D
4167|CARDIOVASCULAR SYSTEM|C
4163|ANALGESICS|N2
4161|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
4161|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
4161|MUSCULO-SKELETAL SYSTEM|M
4160|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
4160|MUSCULO-SKELETAL SYSTEM|M
4158|ANTIHYPERTENSIVES|C2
4158|ACE INHIBITORS, PLAIN|C9A
4157|CARDIOVASCULAR SYSTEM|C
4157|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
4157|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
4156|CARDIOVASCULAR SYSTEM|C
4156|ANTIHYPERTENSIVES|C2
4155|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
4155|Statins (HMG-CoA reductase inhibitors)|C10A1
4154|ANALGESICS|N2
4152|NOOTROPICS|N6D
4151|ANTI-EPILEPTICS|N3A
4151|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
4147|BPH (benign prostatic hypertrophy) products |G4C
4145|ANTIVIRALS FOR SYSTEMIC USE|J5
4142|FIBRINOLYTICS|B1D
4141|FIBRINOLYTICS|B1D
4140|FIBRINOLYTICS|B1D
4139|FIBRINOLYTICS|B1D
4135|ANTIVIRALS FOR SYSTEMIC USE|J5
4134|ANTIHYPERTENSIVES|C2
4131|ALKYLATING AGENTS|L1A
4129|ANTIMETABOLITES|L1B
4127|Coxibs|M1A3
4127|ANALGESICS|N2
4125|CARDIOVASCULAR SYSTEM|C
4124|B2-STIMULANTS|R3A
4123|ANALGESICS|N2
4122|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
4119|ANTIHYPERTENSIVES|C2
4119|Erectile dysfunction products|G4B3
4119|BPH (benign prostatic hypertrophy) products |G4C
4119|MUSCLE RELAXANTS|M3
4061|ANTIHYPERTENSIVES|C2
3858|VACCINES|J7
3857|VACCINES|J7
3850|IMMUNOSUPPRESSIVE AGENTS|L4
3850|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
3849|ANTI-ARRHYTHMICS|C1B
3847|ANTIPSYCHOTICS|N5A
3842|ANTI-ARRHYTHMICS|C1B
3842|ANAESTHETICS|N1
3841|ANTIPSYCHOTICS|N5A
3840|CARDIOVASCULAR SYSTEM|C
3840|ANTIHYPERTENSIVES|C2
3837|TRANQUILLISERS|N5C
3836|CARDIOVASCULAR SYSTEM|C
3836|ANTIHYPERTENSIVES|C2
3835|TRANQUILLISERS|N5C
3834|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3832|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3831|ANTIHYPERTENSIVES|C2
3824|ANTIHYPERTENSIVES|C2
3824|ANALGESICS|N2
3822|ANALGESICS|N2
3821|ALKYLATING AGENTS|L1A
3810|ANTIEMETICS AND ANTINAUSEANTS|A4
3809|TRANQUILLISERS|N5C
3805|PLATELET AGGREGATION INHIBITORS|B1C
3801|DERMATOLOGICALS|D
3801|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3801|Coxibs|M1A3
3800|DERMATOLOGICALS|D
3800|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3800|Coxibs|M1A3
3799|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
3798|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3793|ANDROGENS, EXCLUDING G3E, G3F|G3B
3792|ALKYLATING AGENTS|L1A
3791|ANTIVIRALS FOR SYSTEMIC USE|J5
3789|CARDIOVASCULAR SYSTEM|C
3789|ANTI-ARRHYTHMICS|C1B
3782|ALKYLATING AGENTS|L1A
3781|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
3778|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3778|SRNI antidepressants|N6A5
3776|ANTI-ARRHYTHMICS|C1B
3775|ANTIPSYCHOTICS|N5A
3774|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3774|SRNI antidepressants|N6A5
3773|IMMUNOSUPPRESSIVE AGENTS|L4
3769|Antigonadotrophin-releasing hormones|H1C3
3768|ANTIPSYCHOTICS|N5A
3765|ANTI-ARRHYTHMICS|C1B
3762|ANTIPSYCHOTICS|N5A
3759|ANALGESICS|N2
3757|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3755|ANTI-ACNE PREPARATIONS|D10
3755|BPH (benign prostatic hypertrophy) products |G4C
3752|ANTI-ARRHYTHMICS|C1B
3750|ANTIEMETICS AND ANTINAUSEANTS|A4
3750|TRANQUILLISERS|N5C
3744|DIAGNOSTIC AGENTS|T
3742|ANALGESICS|N2
3740|PARASITOLOGY|P
3739|ANTIVIRALS FOR SYSTEMIC USE|J5
3738|ANTIPSYCHOTICS|N5A
3735|ANTIEMETICS AND ANTINAUSEANTS|A4
3735|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
3735|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
3733|CARDIOVASCULAR SYSTEM|C
3732|ANTIPSYCHOTICS|N5A
3726|IMMUNOSTIMULATING AGENTS|L3
3725|IMMUNOSTIMULATING AGENTS|L3
3718|ANTIVIRALS FOR SYSTEMIC USE|J5
3716|ANTI-EPILEPTICS|N3
3716|ANTIPSYCHOTICS|N5A
3715|ANTIPSYCHOTICS|N5A
3713|ANTI-EPILEPTICS|N3
3710|CARDIOVASCULAR SYSTEM|C
3709|ALKYLATING AGENTS|L1A
3706|ANALGESICS|N2
3701|TRANQUILLISERS|N5C
3700|ANTIVIRALS FOR SYSTEMIC USE|J5
3700|Non-nucleoside reverse transcriptase inhibitors|J5C3
3697|CENTRAL NERVOUS SYSTEM|N
3692|NOOTROPICS|N6D
3691|ANTIPSYCHOTICS|N5A
3691|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3691|NOOTROPICS|N6D
3690|TRANQUILLISERS|N5C
3690|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3690|SSRI antidepressants|N6A4
3688|ALKYLATING AGENTS|L1A
3687|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3687|NOOTROPICS|N6D
3686|ANTIHYPERTENSIVES|C2
3685|IMMUNOSTIMULATING AGENTS|L3
3684|ANALGESICS|N2
3682|ANTIHYPERTENSIVES|C2
3682|CALCIUM ANTAGONISTS|C8
3681|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3680|ANTI-EPILEPTICS|N3A
3679|ANTI-EPILEPTICS|N3A
3678|SYSTEMIC ANTIBACTERIALS|J1
3676|CARDIOVASCULAR SYSTEM|C
3671|PLATELET AGGREGATION INHIBITORS|B1C
3669|ANTIVIRALS FOR SYSTEMIC USE|J5
3669|IMMUNOSUPPRESSIVE AGENTS|L4
3663|ANTIVIRALS FOR SYSTEMIC USE|J5
3663|IMMUNOSTIMULATING AGENTS|L3
3661|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3660|MRI AGENTS|T1E
3659|ANTIHYPERTENSIVES|C2
3659|ACE INHIBITORS, PLAIN|C9A
3658|GASTROPROKINETICS|A3F
3657|ANALGESICS|N2
3656|ANTI-ARRHYTHMICS|C1B
3652|CARDIOVASCULAR SYSTEM|C
3650|ANTIVIRALS FOR SYSTEMIC USE|J5
3650|IMMUNOSTIMULATING AGENTS|L3
3649|CARDIOVASCULAR SYSTEM|C
3649|IMMUNOSTIMULATING AGENTS|L3
3647|ANTIHYPERTENSIVES|C2
3647|ACE INHIBITORS, PLAIN|C9A
3645|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3645|PSYCHOSTIMULANTS|N6B
3644|ANTIPSYCHOTICS|N5A
3644|TRANQUILLISERS|N5C
3644|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3642|SYSTEMIC ANTIBACTERIALS|J1
3642|ANTIVIRALS FOR SYSTEMIC USE|J5
3641|SYSTEMIC ANTIBACTERIALS|J1
3639|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3634|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3632|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3631|TRANQUILLISERS|N5C
3630|ANTI-EPILEPTICS|N3
3630|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3625|ALKYLATING AGENTS|L1A
3619|TRANQUILLISERS|N5C
3619|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3616|SYSTEMIC ANTIBACTERIALS|J1
3616|Carbapenems|J1P2
3615|CARDIOVASCULAR SYSTEM|C
3615|ANTIHYPERTENSIVES|C2
3615|BETA-BLOCKING AGENTS|C7
3614|ALKYLATING AGENTS|L1A
3609|CARDIOVASCULAR SYSTEM|C
3604|CARDIOVASCULAR SYSTEM|C
3603|DIRECT THROMBIN INHIBITORS|B1E
3602|CARDIOVASCULAR SYSTEM|C
3600|ANTI-EPILEPTICS|N3A
3598|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3596|ANTIHYPERTENSIVES|C2
3594|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
3593|IMMUNOSUPPRESSIVE AGENTS|L4
3591|PARASITOLOGY|P
3590|PLATELET AGGREGATION INHIBITORS|B1C
3589|ANTI-EPILEPTICS|N3
3588|ANTIHYPERTENSIVES|C2
3588|ACE INHIBITORS, PLAIN|C9A
3587|PARASITOLOGY|P
3584|ANTI-EPILEPTICS|N3
3583|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3582|DRUGS USED IN DIABETES|A10
3582|Alpha-glucosidase inhibitor antidiabetics|A10B5
3580|ANTIHYPERTENSIVES|C2
3580|ANALGESICS|N2
3579|ANTIMETABOLITES|L1B
3578|CARDIOVASCULAR SYSTEM|C
3578|ANTIHYPERTENSIVES|C2
3578|ANALGESICS|N2
3577|ANTIHYPERTENSIVES|C2
3577|ACE INHIBITORS, PLAIN|C9A
3576|ANTIHYPERTENSIVES|C2
3576|DIURETICS|C3
3575|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
3575|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3570|DERMATOLOGICALS|D
3570|SYSTEMIC ANTIHISTAMINES|R6
3569|ANTIULCERANTS|A2B
3562|PLATELET AGGREGATION INHIBITORS|B1C
3562|ANTIHYPERTENSIVES|C2
3557|ANTIEMETICS AND ANTINAUSEANTS|A4
3556|Protease inhibitors|J5C2
3552|ANTIEMETICS AND ANTINAUSEANTS|A4
3551|ANTI-EPILEPTICS|N3
3551|ANTI-EPILEPTICS|N3A
3550|ANTIPSYCHOTICS|N5A
3549|Coxibs|M1A3
3546|TRANQUILLISERS|N5C
3545|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
3544|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3544|Coxibs|M1A3
3542|CARDIOVASCULAR SYSTEM|C
3541|ANTIPSYCHOTICS|N5A
3541|NOOTROPICS|N6D
3537|ANTI-EPILEPTICS|N3
3536|ANTIMETABOLITES|L1B
3535|ANTIMETABOLITES|L1B
3534|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3532|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
3532|CARDIOVASCULAR SYSTEM|C
3532|ANTI-MIGRAINE PREPARATIONS|N2C
3532|ANTIPSYCHOTICS|N5A
3532|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3531|IMMUNOSUPPRESSIVE AGENTS|L4
3530|ANTI-MIGRAINE PREPARATIONS|N2C
3525|DIRECT THROMBIN INHIBITORS|B1E
3524|PLATELET AGGREGATION INHIBITORS|B1C
3524|ANTIHYPERTENSIVES|C2
3524|CALCIUM ANTAGONISTS|C8
3522|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3522|Statins (HMG-CoA reductase inhibitors)|C10A1
3521|IMMUNOSTIMULATING AGENTS|L3
3519|ALKYLATING AGENTS|L1A
3518|ANTI-EPILEPTICS|N3
3517|ANTIHYPERTENSIVES|C2
3517|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3517|TRANQUILLISERS|N5C
3517|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
3513|ANTIDIARRHOEALS, ORAL ELECTROLYTE REPLACERS AND INTESTINAL ANTI-INFLAMMATORIES|A7
3512|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3511|ANTIMETABOLITES|L1B
3510|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
3508|ANTI-ARRHYTHMICS|C1B
3506|ANTI-ARRHYTHMICS|C1B
3505|PLATELET AGGREGATION INHIBITORS|B1C
3505|Coxibs|M1A3
3505|ANALGESICS|N2
3501|GASTROPROKINETICS|A3F
3501|ANTIEMETICS AND ANTINAUSEANTS|A4
3498|CALCIUM ANTAGONISTS|C8
3496|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3495|MACROLIDES AND SIMILAR TYPES|J1F
3492|SYSTEMIC ANTIBACTERIALS|J1
3488|IMMUNOSUPPRESSIVE AGENTS|L4
3487|PLATELET AGGREGATION INHIBITORS|B1C
3487|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
3485|CARDIOVASCULAR SYSTEM|C
3485|CALCIUM ANTAGONISTS|C8
3484|SYSTEMIC ANTIHISTAMINES|R6
3483|ANTIVIRALS FOR SYSTEMIC USE|J5
3482|ANTI-EPILEPTICS|N3A
3478|CARDIOVASCULAR SYSTEM|C
3478|ANTIHYPERTENSIVES|C2
3475|SYSTEMIC ANTIHISTAMINES|R6
3474|Nucleoside and nucleotide reverse transcriptase inhibitors|J5C1
3471|ANTI-ARRHYTHMICS|C1B
3470|NOOTROPICS|N6D
3469|Protease inhibitors|J5C2
3468|ANTI-ARRHYTHMICS|C1B
3467|PLATELET AGGREGATION INHIBITORS|B1C
3467|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
3465|Protease inhibitors|J5C2
3463|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3460|ANTI-ARRHYTHMICS|C1B
3459|ANALGESICS|N2
3459|NOOTROPICS|N6D
3456|IMMUNOSUPPRESSIVE AGENTS|L4
3455|PARASITOLOGY|P
3454|ANTI-EPILEPTICS|N3
3453|IMMUNOSUPPRESSIVE AGENTS|L4
3452|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
3451|IMMUNOSUPPRESSIVE AGENTS|L4
3448|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3448|PARASITOLOGY|P
3446|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3446|Statins (HMG-CoA reductase inhibitors)|C10A1
3445|ANALGESICS|N2
3444|ANALGESICS|N2
3443|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3443|Statins (HMG-CoA reductase inhibitors)|C10A1
3442|BETA-BLOCKING AGENTS|C7
3442|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
3437|CALCIUM ANTAGONISTS|C8
3436|ANALGESICS|N2
3436|TRANQUILLISERS|N5C
3435|ANTIHYPERTENSIVES|C2
3435|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3434|ANTIHYPERTENSIVES|C2
3434|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3433|SYSTEMIC ANTIBACTERIALS|J1
3430|ANTIHYPERTENSIVES|C2
3428|PLATELET AGGREGATION INHIBITORS|B1C
3428|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
3428|CARDIOVASCULAR SYSTEM|C
3427|DIAGNOSTIC AGENTS|T
3425|Protease inhibitors|J5C2
3424|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3423|Coxibs|M1A3
3423|ANALGESICS|N2
3422|Coxibs|M1A3
3422|ANALGESICS|N2
3421|ALKYLATING AGENTS|L1A
3419|CALCIUM ANTAGONISTS|C8
3419|ANALGESICS|N2
3419|ANTI-MIGRAINE PREPARATIONS|N2C
3419|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
3418|ALKYLATING AGENTS|L1A
3416|ALKYLATING AGENTS|L1A
3415|Protease inhibitors|J5C2
3412|ANTHELMINTICS, EXCLUDING SCHISTOSOMICIDES|P1B
3411|Systemic dermatological antifungals|D1A2
3411|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3409|ANTIHYPERTENSIVES|C2
3409|CALCIUM ANTAGONISTS|C8
3401|PLATELET AGGREGATION INHIBITORS|B1C
3400|DIURETICS|C3
3400|ANTI-GOUT PREPARATIONS|M4
3399|TRANQUILLISERS|N5C
3399|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3398|ALKYLATING AGENTS|L1A
3397|ANTI-ARRHYTHMICS|C1B
3395|CARDIOVASCULAR SYSTEM|C
3395|DIAGNOSTIC AGENTS|T
3393|CARDIOVASCULAR SYSTEM|C
3391|DERMATOLOGICALS|D
3388|Interferons, beta|L3B2
3386|Interferons, beta|L3B2
3383|ANTIVIRALS FOR SYSTEMIC USE|J5
3379|CARDIOVASCULAR SYSTEM|C
3379|IMMUNOSUPPRESSIVE AGENTS|L4
3378|ANTIVIRALS FOR SYSTEMIC USE|J5
3374|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3374|IMMUNOSTIMULATING AGENTS|L3
3373|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3373|ANTIVIRALS FOR SYSTEMIC USE|J5
3372|CARDIOVASCULAR SYSTEM|C
3371|IMMUNOSUPPRESSIVE AGENTS|L4
3369|ANTIVIRALS FOR SYSTEMIC USE|J5
3365|DERMATOLOGICALS|D
3365|SYSTEMIC ANTIBACTERIALS|J1
3365|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3365|PARASITOLOGY|P
3363|ANTIVIRALS FOR SYSTEMIC USE|J5
3363|Interferons, alpha|L3B1
3362|Interferons, beta|L3B2
3360|ANTIVIRALS FOR SYSTEMIC USE|J5
3360|Interferons, beta|L3B2
3359|PLATELET AGGREGATION INHIBITORS|B1C
3359|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
3354|DRUGS USED IN DIABETES|A10
3354|HUMAN INSULINS AND ANALOGUES|A10C
3353|DRUGS USED IN DIABETES|A10
3353|HUMAN INSULINS AND ANALOGUES|A10C
3353|Human insulins and analogues, fast-acting|A10C1
3348|VACCINES|J7
3347|VACCINES|J7
3344|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3344|SSRI antidepressants|N6A4
3343|Urinary incontinence products|G4B4
3337|Coxibs|M1A3
3337|ANALGESICS|N2
3336|ANTIHYPERTENSIVES|C2
3336|ACE INHIBITORS, PLAIN|C9A
3333|WHOLE BLOOD AND PLASMA SUBSTITUTE SOLUTIONS|K3
3329|ANTIHYPERTENSIVES|C2
3329|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3327|ANTIHYPERTENSIVES|C2
3327|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3323|ANTIMETABOLITES|L1B
3322|PLATELET AGGREGATION INHIBITORS|B1C
3322|CARDIOVASCULAR SYSTEM|C
3320|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3318|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
3317|ANTIPSYCHOTICS|N5A
3317|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3314|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
3314|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
3312|ANTI-ARRHYTHMICS|C1B
3312|DIURETICS|C3
3310|ANALGESICS|N2
3307|ANTI-ARRHYTHMICS|C1B
3304|SYSTEMIC ANTIBACTERIALS|J1
3302|PREPARATIONS TO PREVENT CATARACT AND ANTICATARACTOGENICS|S1N
3297|IMMUNOSUPPRESSIVE AGENTS|L4
3294|SRNI antidepressants|N6A5
3294|NOOTROPICS|N6D
3293|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
3292|ANTIPSYCHOTICS|N5A
3291|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3291|Statins (HMG-CoA reductase inhibitors)|C10A1
3290|ANTI-ARRHYTHMICS|C1B
3289|Antigonadotrophin-releasing hormones|H1C3
3288|Protease inhibitors|J5C2
3285|DIRECT THROMBIN INHIBITORS|B1E
3284|DIRECT THROMBIN INHIBITORS|B1E
3283|DIRECT THROMBIN INHIBITORS|B1E
3281|ANALGESICS|N2
3280|ANALGESICS|N2
3277|ANTIVIRALS FOR SYSTEMIC USE|J5
3275|ALKYLATING AGENTS|L1A
3273|VACCINES|J7
3270|ANTIVIRALS FOR SYSTEMIC USE|J5
3267|VACCINES|J7
3266|IMMUNOSTIMULATING AGENTS|L3
3261|DIRECT THROMBIN INHIBITORS|B1E
3257|PARASITOLOGY|P
3252|VACCINES|J7
3251|VACCINES|J7
3249|IMMUNOSTIMULATING AGENTS|L3
3247|SYSTEMIC ANTIBACTERIALS|J1
3241|ANTIEMETICS AND ANTINAUSEANTS|A4
3239|ANALGESICS|N2
3236|ANTIEMETICS AND ANTINAUSEANTS|A4
3235|ANTI-MIGRAINE PREPARATIONS|N2C
3234|PLATELET AGGREGATION INHIBITORS|B1C
3233|ANTIEMETICS AND ANTINAUSEANTS|A4
3233|ANALGESICS|N2
3229|ANTIHYPERTENSIVES|C2
3228|ANTIEMETICS AND ANTINAUSEANTS|A4
3227|ANALGESICS|N2
3226|ANTIHYPERTENSIVES|C2
3225|TRANQUILLISERS|N5C
3224|TRANQUILLISERS|N5C
3223|ANTI-MIGRAINE PREPARATIONS|N2C
3220|CARDIOVASCULAR SYSTEM|C
3220|ANTIHYPERTENSIVES|C2
3220|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3219|Protease inhibitors|J5C2
3218|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3217|ANALGESICS|N2
3215|ANTI-EPILEPTICS|N3
3213|ANTIVIRALS FOR SYSTEMIC USE|J5
3210|CARDIOVASCULAR SYSTEM|C
3210|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
3208|DRUGS USED IN DIABETES|A10
3208|GLUCAGON|H4B
3207|Sulphonylurea antidiabetics|A10B1
3204|ANTIPSYCHOTICS|N5A
3203|TRANQUILLISERS|N5C
3203|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3202|CARDIOVASCULAR SYSTEM|C
3200|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3199|ANTIMETABOLITES|L1B
3197|ANTIPSYCHOTICS|N5A
3196|Antigonadotrophin-releasing hormones|H1C3
3192|ALKYLATING AGENTS|L1A
3191|MRI AGENTS|T1E
3190|MRI AGENTS|T1E
3189|CENTRAL NERVOUS SYSTEM|N
3189|MRI AGENTS|T1E
3188|ANTI-MIGRAINE PREPARATIONS|N2C
3188|ANTI-EPILEPTICS|N3
3187|PLATELET AGGREGATION INHIBITORS|B1C
3183|Coxibs|M1A3
3183|ANALGESICS|N2
3182|ANTIHYPERTENSIVES|C2
3179|ALKYLATING AGENTS|L1A
3178|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3176|DRUGS USED IN DIABETES|A10
3175|CARDIOVASCULAR SYSTEM|C
3175|ANTIHYPERTENSIVES|C2
3173|Erectile dysfunction products|G4B3
3173|NOOTROPICS|N6D
3171|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3169|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3168|CARDIOVASCULAR SYSTEM|C
3167|ANTI-EPILEPTICS|N3
3166|ANTIHYPERTENSIVES|C2
3166|ACE INHIBITORS, PLAIN|C9A
3165|SYSTEMIC ANTIBACTERIALS|J1
3164|SYSTEMIC ANTIBACTERIALS|J1
3161|ANTIVIRALS FOR SYSTEMIC USE|J5
3160|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
3160|Statins (HMG-CoA reductase inhibitors)|C10A1
3156|MACROLIDES AND SIMILAR TYPES|J1F
3154|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3153|CARDIOVASCULAR SYSTEM|C
3153|ANTIHYPERTENSIVES|C2
3150|NOOTROPICS|N6D
3149|ANTIHYPERTENSIVES|C2
3148|ANALGESICS|N2
3148|ANTI-MIGRAINE PREPARATIONS|N2C
3147|ANTIHYPERTENSIVES|C2
3147|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3146|SYSTEMIC ANTIHISTAMINES|R6
3145|SYSTEMIC ANTIBACTERIALS|J1
3145|ANTIVIRALS FOR SYSTEMIC USE|J5
3145|IMMUNOSTIMULATING AGENTS|L3
3144|CEPHALOSPORINS|J1D
3142|ANTIHYPERTENSIVES|C2
3139|ANALGESICS|N2
3138|CEPHALOSPORINS|J1D
3136|SYSTEMIC ANTIHISTAMINES|R6
3134|ANTIEMETICS AND ANTINAUSEANTS|A4
3133|CEPHALOSPORINS|J1D
3131|BPH (benign prostatic hypertrophy) products |G4C
3128|WOUND HEALING AGENTS|D3
3124|TRANQUILLISERS|N5C
3124|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3122|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3121|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
3120|ANTIVIRALS FOR SYSTEMIC USE|J5
3119|ANTIHYPERTENSIVES|C2
3119|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
3118|IMMUNOSUPPRESSIVE AGENTS|L4
3117|ANTI-EPILEPTICS|N3
3114|ALKYLATING AGENTS|L1A
3113|ALKYLATING AGENTS|L1A
3112|ALKYLATING AGENTS|L1A
3111|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3110|PLATELET AGGREGATION INHIBITORS|B1C
3107|ANTIVIRALS FOR SYSTEMIC USE|J5
3106|ALKYLATING AGENTS|L1A
3105|PLATELET AGGREGATION INHIBITORS|B1C
3105|CALCIUM ANTAGONISTS|C8
3103|ANTI-EPILEPTICS|N3
3101|SYSTEMIC ANTIBACTERIALS|J1
3099|ANTI-ARRHYTHMICS|C1B
3099|ANTIHYPERTENSIVES|C2
3099|CALCIUM ANTAGONISTS|C8
3093|Factor VIII|B2D1
3092|Factor VIII|B2D1
3091|Factor VIII|B2D1
3090|Factor VIII|B2D1
3087|Factors II, VII, IX and X|B2D2
3086|Factors II, VII, IX and X|B2D2
3084|ANALGESICS|N2
3083|ANTIHYPERTENSIVES|C2
3083|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3082|ANTIHYPERTENSIVES|C2
3082|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
3072|ALKYLATING AGENTS|L1A
3071|MUSCULO-SKELETAL SYSTEM|M
3070|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3070|IMMUNOSUPPRESSIVE AGENTS|L4
3066|OESTROGENS, EXCLUDING G3A, G3E, G3F|G3C
3065|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
3060|ALKYLATING AGENTS|L1A
3056|MACROLIDES AND SIMILAR TYPES|J1F
3055|MACROLIDES AND SIMILAR TYPES|J1F
3053|EXPECTORANTS|R5C
3052|CARDIOVASCULAR SYSTEM|C
3051|ANTIHYPERTENSIVES|C2
3051|ACE INHIBITORS, PLAIN|C9A
3050|NOOTROPICS|N6D
3050|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
3049|Ocular anti-allergics, antihistamines|S1G1
3047|BETA-BLOCKING AGENTS|C7
3045|ALKYLATING AGENTS|L1A
3044|ANALGESICS|N2
3043|IMMUNOSUPPRESSIVE AGENTS|L4
3041|CARDIOVASCULAR SYSTEM|C
3041|ANTIHYPERTENSIVES|C2
3040|ANTI-EPILEPTICS|N3
3040|HYPNOTICS/SEDATIVES|N5B
3040|TRANQUILLISERS|N5C
3040|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
3039|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
3038|ANTIHYPERTENSIVES|C2
3038|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
3037|ANALGESICS|N2
3036|CALCIUM ANTAGONISTS|C8
3036|ANTI-MIGRAINE PREPARATIONS|N2C
3035|DRUGS USED IN DIABETES|A10
3035|Alpha-glucosidase inhibitor antidiabetics|A10B5
3034|SYSTEMIC ANTIHISTAMINES|R6
3032|ANALGESICS|N2
3031|ANTIPSYCHOTICS|N5A
3030|ANTIHYPERTENSIVES|C2
3021|ANTIHYPERTENSIVES|C2
3019|Coxibs|M1A3
3019|ANALGESICS|N2
3015|DERMATOLOGICALS|D
3015|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
3015|ANTI-ACNE PREPARATIONS|D10
3015|ANTIVIRALS FOR SYSTEMIC USE|J5
3010|ALKYLATING AGENTS|L1A
3009|PLATELET AGGREGATION INHIBITORS|B1C
3009|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
3009|Fibrinogen|B2D5
3008|ANTIULCERANTS|A2B
3008|SYSTEMIC ANTIBACTERIALS|J1
3006|ANTI-EPILEPTICS|N3A
3005|ACTH|H1A
3005|NOOTROPICS|N6D
3001|PLATELET AGGREGATION INHIBITORS|B1C
2999|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2998|ANTI-ARRHYTHMICS|C1B
2997|SYSTEMIC ANTIBACTERIALS|J1
2994|ANALGESICS|N2
2993|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
2992|ANTI-MIGRAINE PREPARATIONS|N2C
2992|NOOTROPICS|N6D
2992|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
2991|CEPHALOSPORINS|J1D
2990|SYSTEMIC ANTIBACTERIALS|J1
2989|Carbapenems|J1P2
2988|PLATELET AGGREGATION INHIBITORS|B1C
2988|CARDIOVASCULAR SYSTEM|C
2986|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2985|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2983|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2981|ANTIPSYCHOTICS|N5A
2980|SYSTEMIC ANTIBACTERIALS|J1
2979|DIRECT THROMBIN INHIBITORS|B1E
2978|Coxibs|M1A3
2978|ANALGESICS|N2
2977|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2976|TOPICAL ANTIPSORIASIS PRODUCTS|D5A
2975|ANTIHYPERTENSIVES|C2
2975|DIURETICS|C3
2975|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
2974|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2973|SYSTEMIC ANTIBACTERIALS|J1
2969|ANTIHYPERTENSIVES|C2
2969|ACE INHIBITORS, PLAIN|C9A
2964|Coxibs|M1A3
2963|ANTI-ACNE PREPARATIONS|D10
2963|PROGESTOGENS, EXCLUDING G3A, G3F|G3D
2962|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2961|CEPHALOSPORINS|J1D
2958|ANTIHYPERTENSIVES|C2
2958|Miotics and antiglaucoma preparations, topical|S1E2
2957|ANTI-EPILEPTICS|N3A
2956|ANTI-ARRHYTHMICS|C1B
2956|CALCIUM ANTAGONISTS|C8
2955|ANTIEMETICS AND ANTINAUSEANTS|A4
2954|ANTI-ARRHYTHMICS|C1B
2951|ANTIHYPERTENSIVES|C2
2951|DIURETICS|C3
2948|TRANQUILLISERS|N5C
2946|IMMUNOSTIMULATING AGENTS|L3
2943|MACROLIDES AND SIMILAR TYPES|J1F
2942|ANTI-ARRHYTHMICS|C1B
2942|ANTIHYPERTENSIVES|C2
2942|BETA-BLOCKING AGENTS|C7
2941|ANTIHYPERTENSIVES|C2
2941|CALCIUM ANTAGONISTS|C8
2938|ANTIHYPERTENSIVES|C2
2938|BETA-BLOCKING AGENTS|C7
2936|ANTIVIRALS FOR SYSTEMIC USE|J5
2933|SYSTEMIC ANTIBACTERIALS|J1
2932|ANTIHYPERTENSIVES|C2
2932|BETA-BLOCKING AGENTS|C7
2931|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2931|ANDROGENS, EXCLUDING G3E, G3F|G3B
2930|ANTI-EPILEPTICS|N3
2929|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
2929|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2929|SSRI antidepressants|N6A4
2928|SYSTEMIC ANTIBACTERIALS|J1
2927|SYSTEMIC ANTIBACTERIALS|J1
2925|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2923|LUNG SURFACTANTS|R7C
2921|Erectile dysfunction products|G4B3
2919|IMMUNOSUPPRESSIVE AGENTS|L4
2918|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2915|ANTIEMETICS AND ANTINAUSEANTS|A4
2915|TRANQUILLISERS|N5C
2913|ANTIEMETICS AND ANTINAUSEANTS|A4
2912|ANTIHYPERTENSIVES|C2
2912|CALCIUM ANTAGONISTS|C8
2911|SYSTEMIC ANTIBACTERIALS|J1
2910|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2910|SSRI antidepressants|N6A4
2908|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2908|Statins (HMG-CoA reductase inhibitors)|C10A1
2904|IMMUNOSUPPRESSIVE AGENTS|L4
2903|IMMUNOSUPPRESSIVE AGENTS|L4
2902|B2-STIMULANTS|R3A
2901|ANTIVIRALS FOR SYSTEMIC USE|J5
2893|ANTI-ARRHYTHMICS|C1B
2892|ANTIHYPERTENSIVES|C2
2891|PLATELET AGGREGATION INHIBITORS|B1C
2891|DERMATOLOGICALS|D
2890|ANTIHYPERTENSIVES|C2
2890|DIURETICS|C3
2889|IMMUNOSUPPRESSIVE AGENTS|L4
2888|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2888|IMMUNOSUPPRESSIVE AGENTS|L4
2886|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2882|Carbapenems|J1P2
2881|ANTIHYPERTENSIVES|C2
2879|Coxibs|M1A3
2879|ANALGESICS|N2
2878|PLATELET AGGREGATION INHIBITORS|B1C
2876|DRUGS USED IN DIABETES|A10
2872|ANTIHYPERTENSIVES|C2
2872|DIURETICS|C3
2868|ANTIEMETICS AND ANTINAUSEANTS|A4
2868|CENTRAL NERVOUS SYSTEM|N
2868|ANALGESICS|N2
2868|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2866|ANTIVIRALS FOR SYSTEMIC USE|J5
2866|ANALGESICS|N2
2866|ANTIPSYCHOTICS|N5A
2866|TRANQUILLISERS|N5C
2865|DRUGS USED IN DIABETES|A10
2865|HUMAN INSULINS AND ANALOGUES|A10C
2864|ANTIEMETICS AND ANTINAUSEANTS|A4
2863|ANTI-MIGRAINE PREPARATIONS|N2C
2863|TRANQUILLISERS|N5C
2862|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2861|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2860|ANTIPSYCHOTICS|N5A
2859|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2859|Statins (HMG-CoA reductase inhibitors)|C10A1
2858|TRANQUILLISERS|N5C
2856|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2847|VACCINES|J7
2839|ANTI-MIGRAINE PREPARATIONS|N2C
2839|ANTI-EPILEPTICS|N3
2839|ANTIPSYCHOTICS|N5A
2837|ANTIVIRALS FOR SYSTEMIC USE|J5
2836|PLATELET AGGREGATION INHIBITORS|B1C
2830|CARDIOVASCULAR SYSTEM|C
2830|ANTIHYPERTENSIVES|C2
2830|CALCIUM ANTAGONISTS|C8
2829|SYSTEMIC ANTIBACTERIALS|J1
2829|MACROLIDES AND SIMILAR TYPES|J1F
2828|NOOTROPICS|N6D
2827|HYPNOTICS/SEDATIVES|N5B
2826|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2826|SSRI antidepressants|N6A4
2824|PLATELET AGGREGATION INHIBITORS|B1C
2822|TRANQUILLISERS|N5C
2822|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2822|SSRI antidepressants|N6A4
2821|ALKYLATING AGENTS|L1A
2820|DERMATOLOGICALS|D
2820|ANTI-ACNE PREPARATIONS|D10
2820|BPH (benign prostatic hypertrophy) products |G4C
2820|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2818|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2817|ANTI-ARRHYTHMICS|C1B
2816|ANTIHYPERTENSIVES|C2
2816|ACE INHIBITORS, PLAIN|C9A
2815|IMMUNOSUPPRESSIVE AGENTS|L4
2813|PLATELET AGGREGATION INHIBITORS|B1C
2811|ANTIHYPERTENSIVES|C2
2811|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
2808|Coxibs|M1A3
2807|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2807|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2807|Statins (HMG-CoA reductase inhibitors)|C10A1
2805|NOOTROPICS|N6D
2804|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2799|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2798|NOOTROPICS|N6D
2797|DERMATOLOGICALS|D
2796|Anti-Alzheimer products, cholinesterase inhibitors|N7D1
2790|IMMUNOSTIMULATING AGENTS|L3
2788|CARDIOVASCULAR SYSTEM|C
2788|ANTIHYPERTENSIVES|C2
2786|ANTIHYPERTENSIVES|C2
2785|ANTI-EPILEPTICS|N3
2785|TRANQUILLISERS|N5C
2782|ANTI-EPILEPTICS|N3
2781|TRANQUILLISERS|N5C
2780|ANTIPSYCHOTICS|N5A
2779|ANTIPSYCHOTICS|N5A
2776|IMMUNOSUPPRESSIVE AGENTS|L4
2773|ANTIHYPERTENSIVES|C2
2773|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
2770|ANTIVIRALS FOR SYSTEMIC USE|J5
2763|ANTI-EPILEPTICS|N3
2762|NOOTROPICS|N6D
2760|ANALGESICS|N2
2760|ANTI-EPILEPTICS|N3
2760|TRANQUILLISERS|N5C
2759|ANALGESICS|N2
2756|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2755|IMMUNOSTIMULATING AGENTS|L3
2754|IMMUNOSUPPRESSIVE AGENTS|L4
2751|ANTIHYPERTENSIVES|C2
2751|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
2750|ANTIHYPERTENSIVES|C2
2750|ACE INHIBITORS, PLAIN|C9A
2750|TRANQUILLISERS|N5C
2748|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2745|PLATELET AGGREGATION INHIBITORS|B1C
2745|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
2744|ANTIHYPERTENSIVES|C2
2744|BETA-BLOCKING AGENTS|C7
2743|ANTIHYPERTENSIVES|C2
2742|CEPHALOSPORINS|J1D
2740|CEPHALOSPORINS|J1D
2739|CEPHALOSPORINS|J1D
2738|CEPHALOSPORINS|J1D
2736|SYSTEMIC ANTIBACTERIALS|J1
2736|CEPHALOSPORINS|J1D
2735|CEPHALOSPORINS|J1D
2734|CEPHALOSPORINS|J1D
2733|CEPHALOSPORINS|J1D
2731|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2731|IMMUNOSUPPRESSIVE AGENTS|L4
2727|ALKYLATING AGENTS|L1A
2723|ANTIHYPERTENSIVES|C2
2720|ANALGESICS|N2
2718|CARDIAC THERAPY|C1
2718|ANTIHYPERTENSIVES|C2
2716|IMMUNOSUPPRESSIVE AGENTS|L4
2712|CALCITONINS|H4A
2708|CALCITONINS|H4A
2705|ANTI-EPILEPTICS|N3A
2704|PLATELET AGGREGATION INHIBITORS|B1C
2704|FIBRINOLYTICS|B1D
2699|PLATELET AGGREGATION INHIBITORS|B1C
2699|ANTIHYPERTENSIVES|C2
2698|TRANQUILLISERS|N5C
2698|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2696|SYSTEMIC ANTIBACTERIALS|J1
2695|ANALGESICS|N2
2693|CARDIAC THERAPY|C1
2693|ANTI-ARRHYTHMICS|C1B
2693|ANTIHYPERTENSIVES|C2
2690|TRANQUILLISERS|N5C
2688|ANTIVIRALS FOR SYSTEMIC USE|J5
2688|IMMUNOSTIMULATING AGENTS|L3
2688|INTERFERONS|L3B
2687|Coxibs|M1A3
2687|ANALGESICS|N2
2686|ANTIPSYCHOTICS|N5A
2685|TRANQUILLISERS|N5C
2685|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2685|SSRI antidepressants|N6A4
2684|SYSTEMIC ANTIBACTERIALS|J1
2683|ANTIHYPERTENSIVES|C2
2682|PLATELET AGGREGATION INHIBITORS|B1C
2682|Fibrinogen|B2D5
2681|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2680|SYSTEMIC ANTIBACTERIALS|J1
2678|ANTIEMETICS AND ANTINAUSEANTS|A4
2678|ANTIPSYCHOTICS|N5A
2678|TRANQUILLISERS|N5C
2676|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2675|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
2675|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2674|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
2672|Coxibs|M1A3
2672|ANALGESICS|N2
2670|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2670|IMMUNOSUPPRESSIVE AGENTS|L4
2668|CARDIOVASCULAR SYSTEM|C
2667|ANTIHYPERTENSIVES|C2
2666|LUNG SURFACTANTS|R7C
2664|CEPHALOSPORINS|J1D
2663|DIRECT THROMBIN INHIBITORS|B1E
2662|SYSTEMIC ANTIBACTERIALS|J1
2660|PLATELET AGGREGATION INHIBITORS|B1C
2655|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2655|Statins (HMG-CoA reductase inhibitors)|C10A1
2651|ALKYLATING AGENTS|L1A
2649|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2649|ANTI-ACNE PREPARATIONS|D10
2648|SYSTEMIC ANTIBACTERIALS|J1
2648|Carbapenems|J1P2
2647|ANTIPSYCHOTICS|N5A
2646|Monobactams|J1P1
2645|ANTIHYPERTENSIVES|C2
2645|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
2644|PLATELET AGGREGATION INHIBITORS|B1C
2644|CARDIOVASCULAR SYSTEM|C
2639|TRANQUILLISERS|N5C
2638|ANTIEMETICS AND ANTINAUSEANTS|A4
2638|ANALGESICS|N2
2634|ANTI-ARRHYTHMICS|C1B
2632|PLATELET AGGREGATION INHIBITORS|B1C
2632|GP IIb/IIIa (glycoprotein) antagonist platelet aggregation inhibitors|B1C3
2632|Fibrinogen|B2D5
2631|ANTIHYPERTENSIVES|C2
2631|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
2630|Carbapenems|J1P2
2628|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2626|ANTIHYPERTENSIVES|C2
2625|PLATELET AGGREGATION INHIBITORS|B1C
2625|Coxibs|M1A3
2625|ANALGESICS|N2
2623|PLATELET AGGREGATION INHIBITORS|B1C
2623|ANTIHYPERTENSIVES|C2
2622|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2622|Ocular antineovascularisation products|S1P
2620|ANTIHYPERTENSIVES|C2
2620|ACE INHIBITORS, PLAIN|C9A
2618|DERMATOLOGICALS|D
2618|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2608|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2608|ANTI-GOUT PREPARATIONS|M4
2607|ANTIVIRALS FOR SYSTEMIC USE|J5
2607|IMMUNOSUPPRESSIVE AGENTS|L4
2605|ALKYLATING AGENTS|L1A
2604|ANALGESICS|N2
2601|PLATELET AGGREGATION INHIBITORS|B1C
2599|PLATELET AGGREGATION INHIBITORS|B1C
2597|IMMUNOSTIMULATING AGENTS|L3
2597|IMMUNOSUPPRESSIVE AGENTS|L4
2595|CHOLESTEROL AND TRIGLYCERIDE REDUCTION PREPARATIONS|C10A
2595|Statins (HMG-CoA reductase inhibitors)|C10A1
2594|PLATELET AGGREGATION INHIBITORS|B1C
2593|ANTI-ARRHYTHMICS|C1B
2592|ANTIHYPERTENSIVES|C2
2592|CALCIUM ANTAGONISTS|C8
2591|RESPIRATORY SYSTEM|R
2591|B2-STIMULANTS|R3A
2590|ANTIVIRALS FOR SYSTEMIC USE|J5
2587|ANTI-ACNE PREPARATIONS|D10
2587|SYSTEMIC ANTIBACTERIALS|J1
2587|MACROLIDES AND SIMILAR TYPES|J1F
2587|PARASITOLOGY|P
2587|ANTI-MALARIALS|P1D
2584|NOOTROPICS|N6D
2583|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2580|PLATELET AGGREGATION INHIBITORS|B1C
2579|PARASITOLOGY|P
2578|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2577|PARASITOLOGY|P
2576|LABOUR INHIBITORS|G2E
2575|PLATELET AGGREGATION INHIBITORS|B1C
2574|BPH (benign prostatic hypertrophy) products |G4C
2569|ANTI-ARRHYTHMICS|C1B
2565|DIRECT THROMBIN INHIBITORS|B1E
2563|PLATELET AGGREGATION INHIBITORS|B1C
2563|CARDIOVASCULAR SYSTEM|C
2562|CARDIOVASCULAR SYSTEM|C
2561|Inhibitors of the Kallikrein-kinin-system|B2C2
2561|ANTIVIRALS FOR SYSTEMIC USE|J5
2556|ANTIHYPERTENSIVES|C2
2555|SYSTEMIC ANTIBACTERIALS|J1
2549|FIBRINOLYTICS|B1D
2549|DIRECT THROMBIN INHIBITORS|B1E
2546|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2546|IMMUNOSUPPRESSIVE AGENTS|L4
2535|IMMUNOSUPPRESSIVE AGENTS|L4
2534|IMMUNOSUPPRESSIVE AGENTS|L4
2532|ANTIHYPERTENSIVES|C2
2529|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2527|IMMUNOSUPPRESSIVE AGENTS|L4
2524|CARDIOVASCULAR SYSTEM|C
2524|IMMUNOSUPPRESSIVE AGENTS|L4
2517|ANTIVIRALS FOR SYSTEMIC USE|J5
2516|FIBRINOLYTICS|B1D
2515|NOOTROPICS|N6D
2514|ANTIHYPERTENSIVES|C2
2514|CALCIUM ANTAGONISTS|C8
2511|ANTIHYPERTENSIVES|C2
2511|DIURETICS|C3
2509|PLATELET AGGREGATION INHIBITORS|B1C
2507|Coxibs|M1A3
2507|ANALGESICS|N2
2506|ANTI-ARRHYTHMICS|C1B
2506|ANTIHYPERTENSIVES|C2
2505|ANTIVIRALS FOR SYSTEMIC USE|J5
2505|IMMUNOSTIMULATING AGENTS|L3
2504|Coxibs|M1A3
2503|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2503|PARASITOLOGY|P
2502|ANTIPSYCHOTICS|N5A
2501|PARASITOLOGY|P
2500|ANTIHYPERTENSIVES|C2
2498|IMMUNOSUPPRESSIVE AGENTS|L4
2496|DIURETICS|C3
2492|CARDIOVASCULAR SYSTEM|C
2492|MRI AGENTS|T1E
2491|PLATELET AGGREGATION INHIBITORS|B1C
2491|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2489|ANTI-ARRHYTHMICS|C1B
2488|ALKYLATING AGENTS|L1A
2486|MUSCULO-SKELETAL SYSTEM|M
2485|Erectile dysfunction products|G4B3
2480|Non-nucleoside reverse transcriptase inhibitors|J5C3
2479|ANTIPSYCHOTICS|N5A
2479|TRANQUILLISERS|N5C
2478|NOOTROPICS|N6D
2477|ANTI-ARRHYTHMICS|C1B
2476|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2475|VACCINES|J7
2474|BPH (benign prostatic hypertrophy) products |G4C
2473|ANTIPSYCHOTICS|N5A
2471|CARDIAC THERAPY|C1
2471|ULTRASOUND AGENTS|T1F
2467|SYSTEMIC ANTIBACTERIALS|J1
2463|CALCIUM ANTAGONISTS|C8
2463|ANTI-EPILEPTICS|N3
2462|ANTI-ARRHYTHMICS|C1B
2462|ANTIHYPERTENSIVES|C2
2462|CALCIUM ANTAGONISTS|C8
2462|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2460|ANTIVIRALS FOR SYSTEMIC USE|J5
2459|ANTIVIRALS FOR SYSTEMIC USE|J5
2458|VACCINES|J7
2454|ANTIVIRALS FOR SYSTEMIC USE|J5
2453|ANTIVIRALS FOR SYSTEMIC USE|J5
2452|ANTIVIRALS FOR SYSTEMIC USE|J5
2449|ANTIVIRALS FOR SYSTEMIC USE|J5
2446|ANTIHYPERTENSIVES|C2
2446|CALCIUM ANTAGONISTS|C8
2445|ANTIHYPERTENSIVES|C2
2445|CALCIUM ANTAGONISTS|C8
2443|ANTIHYPERTENSIVES|C2
2443|CALCIUM ANTAGONISTS|C8
2442|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2442|IMMUNOSUPPRESSIVE AGENTS|L4
2441|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2441|PARASITOLOGY|P
2440|Protease inhibitors|J5C2
2437|ANTIEMETICS AND ANTINAUSEANTS|A4
2437|ANALGESICS|N2
2437|TRANQUILLISERS|N5C
2436|ALKYLATING AGENTS|L1A
2435|ALKYLATING AGENTS|L1A
2434|Urinary incontinence products|G4B4
2432|VACCINES|J7
2431|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
2430|TRANQUILLISERS|N5C
2430|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2427|ANTI-DEPRESSANTS AND MOOD STABILISERS|N6A
2426|ANALGESICS|N2
2426|ANTIPSYCHOTICS|N5A
2424|ANTIPSYCHOTICS|N5A
2424|NOOTROPICS|N6D
2421|IMMUNOSUPPRESSIVE AGENTS|L4
2420|SYSTEMIC ANTIBACTERIALS|J1
2418|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
2418|ANTIHYPERTENSIVES|C2
2417|SYSTEMIC ANTIPSORIASIS PRODUCTS|D5B
2416|CARDIOVASCULAR SYSTEM|C
2416|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2416|Statins (HMG-CoA reductase inhibitors)|C10A1
2415|HYPOLIPIDAEMICS/ANTI-ATHEROMA PREPARATIONS|C10
2413|Coxibs|M1A3
2413|ANALGESICS|N2
2412|ANTI-ARRHYTHMICS|C1B
2411|ANTIPSYCHOTICS|N5A
2411|TRANQUILLISERS|N5C
2410|ANTI-ARRHYTHMICS|C1B
2407|ANTI-GOUT PREPARATIONS|M4
2406|SYSTEMIC ANTIBACTERIALS|J1
2404|ANTIHYPERTENSIVES|C2
2404|ANGIOTENSIN-II ANTAGONISTS, PLAIN|C9C
2402|Protease inhibitors|J5C2
2397|ANTI-EPILEPTICS|N3A
2396|Protease inhibitors|J5C2
2395|ANTI-EPILEPTICS|N3
2394|Antigonadotrophin-releasing hormones|H1C3
2391|MIOTICS AND ANTIGLAUCOMA PREPARATIONS|S1E
2389|ANTIHYPERTENSIVES|C2
2388|ANTIHYPERTENSIVES|C2
2387|ANTIHYPERTENSIVES|C2
2386|NOOTROPICS|N6D
2385|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
2384|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
2381|ANTIHYPERTENSIVES|C2
2381|ANTI-EPILEPTICS|N3A
2380|DIURETICS|C3
2379|ANTIOBESITY PREPARATIONS, EXCLUDING DIETETICS|A8
2377|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
2376|SYSTEMIC AGENTS FOR FUNGAL INFECTIONS|J2
